,project_id,fiscal_year,report_title,principal_investigator,supervisor,research_org,lab_staff_within_org,extramural_collab,collab_other_NCI,collab_other_NIH,publications,url
0,BC000155-14,"October 01, 2003 -  September 30, 2004",The Effect of Phytochemicals on Biochemical Mechanisms Relevant to Carcinogenesi,Grace  Yeh; PhD,Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,"Henry  Ciolino; PhD (National Cancer Institute)



Christopher J Macdonald (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ciolino H, MacDonald C, Memon O, Dankwah M, Yeh GC (2003). Dehydroepiandrosterone inhibits the expression of carcinogen-activating enzymes in vivo. Int J Cancer  105, 321-5.   https://doi.org/10.1002/ijc.11075




PubMed


 


PubMed ID 12704664",https://intramural.nih.gov/search/searchview.taf?ipid=36122
1,BC000157-14,"October 01, 2003 -  September 30, 2004",Imidodipeptides and Amino Acid Metabolites in Cell Regulation and Carcinogenesis,"James Ming Phang; MD



IRP Faculty Profile",Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,"Andy  Hu
(Biochemistry and Molecular Biology, U. of New Mexico School of Medicine)





Larry  Oberley
(Cancer Biology, U. of Iowa)





David  Valle
(Human Genetics and Pediatrics, Johns Hopkins University School of Medicine)","Sandra D White (National Cancer Institute)



Steven  Donald (National Cancer Institute)



Kazimierz S Kasprzak; PhD, DSc (National Cancer Institute)



Gregory  Buzard; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hursting SD, Lavigne JA, Berrigan D, Donehower LA, Davis BJ, Phang JM, Barrett JC, Perkins SN (2004). Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. J Nutr  134, 2482S-2486S.   https://doi.org/10.1093/jn/134.9.2482S




PubMed


 


PubMed ID 15333746
    
     


 



2.
Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS (2004). Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem  279, 40337-44.   https://doi.org/10.1074/jbc.M403057200




PubMed


 


PubMed ID 15271983",https://intramural.nih.gov/search/searchview.taf?ipid=36123
2,BC000189-11,"October 01, 2003 -  September 30, 2004",Dietary Regulation of Biochemical/Molecular Changes in Carcinogen Resistant Cell,Grace  Yeh; PhD,Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,"Henry  Ciolino; PhD (National Cancer Institute)



Christopher J Macdonald (National Cancer Institute)



Sara  Bass (National Cancer Institute)



Omar  Memon (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ciolino H, MacDonald C, Memon O, Dankwah M, Yeh GC (2003). Dehydroepiandrosterone inhibits the expression of carcinogen-activating enzymes in vivo. Int J Cancer  105, 321-5.   https://doi.org/10.1002/ijc.11075




PubMed


 


PubMed ID 12704664
    
     


 



2.
MacDonald CJ, Ciolino HP, Yeh GC (2004). The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res  64, 429-34.   https://doi.org/10.1158/0008-5472.can-03-0974




PubMed


 


PubMed ID 14729655",https://intramural.nih.gov/search/searchview.taf?ipid=36124
3,BC003229-34,"October 01, 2003 -  September 30, 2004",T-Cell Antigen Recognition and Tumor Antigens,"Ettore  Appella; MD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"William E.  Biddison
(MOLECULAR IMMUNOLOGY SECTION, National Institute of Neurological Disorders and Stroke)





Edward J.  Collins
(Microbiology and Immunology, Univ North Carolina, Chapel Hill)





Albert B.  DeLeo
(Pittsburgh Cancer Institute, Pathology)",NULL,Angela C Murphy (NHLBI),"Ordered by publication type and then author name.



1.
Buslepp J, Wang H, Biddison WE, Appella E, Collins EJ (2003). A correlation between TCR Valpha docking on MHC and CD8 dependence: implications for T cell selection. Immunity  19, 595-606.   https://doi.org/10.1016/s1074-7613(03)00269-3




PubMed


 


PubMed ID 14563323",https://intramural.nih.gov/search/searchview.taf?ipid=36125
4,BC004496-27,"October 01, 2003 -  September 30, 2004",Chromosomal Proteins and Chromosomal Functions,"Michael  Bustin; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,"Hitoshi  Shirakawa
(Tohoku U)





Robert  Hock
(Wuerzburg U)





Chaim  Cedar
(Hebrew U.)





Mark D Duncan; MD
(Department of Surgery, Johns Hopkins University)
















Larry  David; PhD
(Oregon Health University)","Jae  Lim; BS (National Cancer Institute)



Yuri  Postnikov; MD, PhD (National Cancer Institute)



Yaffa  Rubinstein (National Cancer Institute)



Thomas A Misteli; PhD (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)



Susan  Makem (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Birger Y, West KL, Postnikov YV, Lim JH, Furusawa T, Wagner JP, Laufer CS, Kraemer KH, Bustin M (2003). Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J  22, 1665-75.   https://doi.org/10.1093/emboj/cdg142




PubMed



        
     
Free Article


 


PubMed ID 12660172
         Pubmed Central ID 152887 


 



2.
Catez F, Lim JH, Hock R, Postnikov YV, Bustin M (2003). HMGN dynamics and chromatin function. Biochem Cell Biol  81, 113-22.   https://doi.org/10.1139/o03-040




PubMed


 


PubMed ID 12897844
    
     


 



3.
Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H (2003). The role of DNA methylation in setting up chromatin structure during development. Nat Genet  34, 187-92.   https://doi.org/10.1038/ng1158




PubMed


 


PubMed ID 12740577
    
     


 



4.
Körner U, Bustin M, Scheer U, Hock R (2003). Developmental role of HMGN proteins in Xenopus laevis. Mech Dev  120, 1177-92.   https://doi.org/10.1016/j.mod.2003.07.001




PubMed


 


PubMed ID 14568106
    
     


 



5.
Strichman-Almashanu LZ, Bustin M, Landsman D (2003). Retroposed copies of the HMG genes: a window to genome dynamics. Genome Res  13, 800-12.   https://doi.org/10.1101/gr.893803




PubMed



        
     
Free Article


 


PubMed ID 12727900
         Pubmed Central ID 430908 


 



6.
West KL, Postnikov YV, Birger Y, Bustin M (2003). Chromatin decompaction method by HMGN proteins. Methods Enzymol  371, 521-36.   https://doi.org/10.1016/S0076-6879(03)71039-8




PubMed


 


PubMed ID 14712726",https://intramural.nih.gov/search/searchview.taf?ipid=36126
5,BC004504-32,"October 01, 2003 -  September 30, 2004",Alterations in Interacting Signaling Pathways that Initiate Squamous Carcinogene,"Stuart H Yuspa; MD



IRP Faculty Profile",Robert  Wiltrout; PhD,"Office of the Director, NCI",NULL,"Scott  Kogan
(UCSF)
















Steven  Ogbourne
(Peplin Biotech)","Christina K Cheng (National Cancer Institute)



Luigi M De Luca; PhD (Differentiation Control Section)



Luowei  Li (National Cancer Institute)



Ulrike F Lichti; PhD (National Cancer Institute)



Bettie S Sugar (National Cancer Institute)



Kyung  Lee; PhD (National Cancer Institute)",Philip M Murphy; MD (NIAID),"Ordered by publication type and then author name.



1.
Cataisson C, Joseloff E, Murillas R, Wang A, Atwell C, Torgerson S, Gerdes M, Subleski J, Gao JL, Murphy PM, Wiltrout RH, Vinson C, Yuspa SH (2003). Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways. J Immunol  171, 2703-13.   https://doi.org/10.4049/jimmunol.171.5.2703




PubMed


 


PubMed ID 12928424",https://intramural.nih.gov/search/searchview.taf?ipid=36127
6,BC004517-28,"October 01, 2003 -  September 30, 2004",DNA Repair in Human Cancer-Prone Genetic Diseases,"Kenneth H Kraemer; MD



IRP Faculty Profile",Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Vanessa  Gonzalez-Perez (National Cancer Institute)



Kyoko  Imoto (National Cancer Institute)



Sikandar  Khan (National Cancer Institute)



Kyu-Seon  Oh (National Cancer Institute)



Debra  Schmidt (National Cancer Institute)



Takahiro  Ueda (National Cancer Institute)","Vilhelm A Bohr; MD, PhD (NIA) 



Daniel J Wattendorf (NHGRI)","Ordered by publication type and then author name.



1.
Birger Y, West KL, Postnikov YV, Lim JH, Furusawa T, Wagner JP, Laufer CS, Kraemer KH, Bustin M (2003). Chromosomal protein HMGN1 enhances the rate of DNA repair in chromatin. EMBO J  22, 1665-75.   https://doi.org/10.1093/emboj/cdg142




PubMed



        
     
Free Article


 


PubMed ID 12660172
         Pubmed Central ID 152887 


 



2.
Kraemer KH (2003). NRAS hypermutability in familial melanoma with CDKN2A mutations--cause and effect? J Natl Cancer Inst  95, 768-9.   https://doi.org/10.1093/jnci/95.11.768




PubMed


 


PubMed ID 12783922",https://intramural.nih.gov/search/searchview.taf?ipid=36128
7,BC004582-29,"October 01, 2003 -  September 30, 2004",Mechanisms of Transition Metal-Induced Carcinogenesis,"Kazimierz S Kasprzak; PhD, DSc",Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,"Karol  Bialkowski
(Clinical Biochemistry, University Medical School)





Anatoly  Zhitkovich
(Department of Pathology and Laboratory Medicine, Brown University)





Bruick  Richard K.
(Department of Biochemistry, University of Texas Southwestern Medical Center)





Wojciech  Bal
(Biophysics, Polish Academy of Science)
















Malgorzata  Jezowska-Bojczuk
(Chemistry, University of Wroclaw)","Aldona Aleksandra Karaczyn (National Cancer Institute)



Susan L North (National Cancer Institute)












Robert M Bare  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36129
8,BC004798-34,"October 01, 2003 -  September 30, 2004",Retinoids in Differentiation and Neoplasia,Luigi M De Luca; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Denise  Simmons (National Cancer Institute)



Takemi  Tanaka (National Cancer Institute)



Frank Jess Gonzalez; PhD (National Cancer Institute)



Christian Arthur Combs; PhD (National Cancer Institute)



Snorri S. Thorgeirsson; MD, PhD (National Cancer Institute)












Fausto  Andreola  (National Cancer Institute)",Joyce Allene Goldstein; PhD (NIEHS),"Ordered by publication type and then author name.



1.
Andreola F, Calvisi DF, Elizondo G, Jakowlew SB, Mariano J, Gonzalez FJ, De Luca LM (2004). Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion. Hepatology  39, 157-66.   https://doi.org/10.1002/hep.20004




PubMed


 


PubMed ID 14752834
    
     


 



2.
Andreola F, Hayhurst GP, Luo G, Ferguson SS, Gonzalez FJ, Goldstein JA, De Luca LM (2004). Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice. J Biol Chem  279, 3434-8.   https://doi.org/10.1074/jbc.M305832200




PubMed


 


PubMed ID 14623888
    
     


 



3.
Tanaka T, Dancheck BL, Trifiletti LC, Birnkrant RE, Taylor BJ, Garfield SH, Thorgeirsson U, De Luca LM (2004). Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells. Mol Cell Biol  24, 3972-82.   https://doi.org/10.1128/mcb.24.9.3972-3982.2004




PubMed



        
     
Free Article


 


PubMed ID 15082790
         Pubmed Central ID 387734",https://intramural.nih.gov/search/searchview.taf?ipid=36130
9,BC005051-01,"October 01, 2003 -  September 30, 2004",Signal Transduction Pathways of Transforming Growth Factor-beta,Anita B Roberts; PhD,Glenn  Merlino; PhD,"Laboratory of Cell Regulation and Carcinogenesis, NCI",NULL,NULL,"Lyudmila  Lyakh (National Cancer Institute)



Stacey  Byfield (National Cancer Institute)



Seble  Chekol (National Cancer Institute)



Angelina  Felici (National Cancer Institute)



Kathleen C Flanders; PhD (National Cancer Institute)



Makiko  Fujii; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36099
10,BC005093-26,"October 01, 2003 -  September 30, 2004",Growth/Differentiation Factors in Organogenesis,Alan O Perantoni; PhD,Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,"Andrey  Evseev (National Cancer Institute)



Zoia  Levashova (National Cancer Institute)



Sergey  Plisov (National Cancer Institute)



Olga  Timofeeva (National Cancer Institute)



Honghe  Wang (National Cancer Institute)



Mark B Lewandoski (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Levashova ZB, Plisov SY, Perantoni AO (2003). Conditionally immortalized cell line of inducible metanephric mesenchyme. Kidney Int  63, 2075-87.   https://doi.org/10.1046/j.1523-1755.2003.00010.x




PubMed


 


PubMed ID 12753294
    
     


 



2.
Perantoni AO (2003). Renal development: perspectives on a Wnt-dependent process. Semin Cell Dev Biol  14, 201-8.   https://doi.org/10.1016/s1084-9521(03)00022-3




PubMed


 


PubMed ID 14627118",https://intramural.nih.gov/search/searchview.taf?ipid=36132
11,BC005148-25,"October 01, 2003 -  September 30, 2004",Mammary Tumorigenesis in Inbred and Feral Mice,Robert  Callahan; PhD,Barbara V Vonderhaar; PhD,"National Cancer Institute, NCI","William J Lowther



David M Mccurdy



Tatsuro  Ohta



Ahmed M Raafat



Youping  Sun



Alexandra  Zoltan-Jones



Show all 7",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Callahan R, Egan SE (2004). Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia  9, 145-63.   https://doi.org/10.1023/B:JOMG.0000037159.63644.81




PubMed


 


PubMed ID 15300010
    
     


 



2.
De Marchis L, Cropp C, Sheng ZM, Bargo S, Callahan R, DeMarchis L (2004). Candidate target genes for loss of heterozygosity on human chromosome 17q21. Br J Cancer  90, 2384-9.   https://doi.org/10.1038/sj.bjc.6601848




PubMed



        
     
Free Article


 


PubMed ID 15187990
         Pubmed Central ID 2409524",https://intramural.nih.gov/search/searchview.taf?ipid=36133
12,BC005177-24,"October 01, 2003 -  September 30, 2004",Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,Miriam Christine Poirier; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Sarah  Leonard (National Cancer Institute)



Ofelia  Olivero; PhD (National Cancer Institute)



M. Margaret  Pratt (National Cancer Institute)



Laura  Schild (National Cancer Institute)



Irma  Vazquez (National Cancer Institute)



Sanford Martin Dawsey; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gerschenson M, Nguyen V, Ewings EL, Ceresa A, Shaw JA, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Olivero OA, Divi RL, Albert PS, Poirier MC (2004). Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Res Hum Retroviruses  20, 91-100.   https://doi.org/10.1089/088922204322749530




PubMed


 


PubMed ID 15000702
    
     


 



2.
Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA, Women and Infants Transmission Study (WITS) Group (2003). Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr  33, 175-83.   https://doi.org/10.1097/00126334-200306010-00010




PubMed


 


PubMed ID 12794551
    
     


 



3.
Schild LJ, Divi RL, Beland FA, Churchwell MI, Doerge DR, Gamboa da Costa G, Marques MM, Poirier MC (2003). Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. Cancer Res  63, 5999-6003.




PubMed


 


PubMed ID 14522927
    
     


 



4.
van Gijssel HE, Schild LJ, Watt DL, Roth MJ, Wang GQ, Dawsey SM, Albert PS, Qiao YL, Taylor PR, Dong ZW, Poirier MC (2004). Polycyclic aromatic hydrocarbon-DNA adducts determined by semiquantitative immunohistochemistry in human esophageal biopsies taken in 1985. Mutat Res  547, 55-62.   https://doi.org/10.1016/j.mrfmmm.2003.11.010




PubMed


 


PubMed ID 15013699",https://intramural.nih.gov/search/searchview.taf?ipid=36134
13,BC005216-33,"October 01, 2003 -  September 30, 2004",cAMP-dependent protein kinase in human cancer,"Yoon S Cho-Chung; MD, PhD",Douglas  Lowy; MD,"CELLULAR BIOCHEMSTRY SECT, NCI",NULL,"Sudhir  Agrawal PhD
(Hybridon Inc.)





Rakesh  Srivastava
(University of Maryland)





Robert  Klem PhD
(Genta Inc.)
















Sudhir  Agrawal
(Hybridon, Inc)","Eugen  Uhlmann PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)","Kevin Graham Becker; BS, MAS, PhD (NIA)","Ordered by publication type and then author name.



1.
Cheadle C, Cho-Chung YS, Becker KG, Vawter MP (2003). Application of z-score transformation to Affymetrix data. Appl Bioinformatics  2, 209-17.




PubMed


 


PubMed ID 15130792
    
     


 



2.
Cho YS, Cho-Chung YS   (2003) Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.  Clin Cancer Res 9:1171-8.




PubMed


 


PubMed ID 12631623
    
     


 



3.
Cho-Chung YS   (2003) Antisense DNAs as targeted genetic medicine to treat cancer.  Arch Pharm Res 26:183-91.




PubMed


 


PubMed ID 12723929
    
     


 



4.
Cho-Chung YS   (2003) cAMP signaling in cancer genesis and treatment.  Cancer Treat Res 115:123-43.




PubMed


 


PubMed ID 12613195
    
     


 



5.
Cho-Chung YS   (2003) CRE-enhancer DNA decoy: a tumor target-based genetic tool.  Ann N Y Acad Sci 1002:124-33.




PubMed


 


PubMed ID 14751830
    
     


 



6.
Cho-Chung YS (2004). Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray. Biochim Biophys Acta  1697, 71-9.   https://doi.org/10.1016/j.bbapap.2003.11.014




PubMed


 


PubMed ID 15023351
    
     


 



7.
Cho-Chung YS, Becker KG (2003). A genome-wide view of antisense. Nat Biotechnol  21, 492.   https://doi.org/10.1038/nbt0503-492a




PubMed


 


PubMed ID 12721568
    
     


 



8.
Kim YH, Lim DS, Lee JH, Lim DS, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK (2003). Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med  35, 336-49.   https://doi.org/10.1038/emm.2003.45




PubMed


 


PubMed ID 14646586
    
     


 



9.
Mani S, Goel S, Nesterova M, Martin RM, Grindel JM, Rothenberg ML, Zhang R, Tortora G, Cho-Chung YS   (2003) Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.  Ann N Y Acad Sci 1002:252-62.




PubMed


 


PubMed ID 14751840
    
     


 



10.
Nesterova MV, Cho-Chung YS (2004). Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Clin Cancer Res  10, 4568-77.   https://doi.org/10.1158/1078-0432.CCR-03-0436




PubMed


 


PubMed ID 15240549
    
     


 



11.
Cho-Chung YS (submitted in 2004) Autoantibody For Cancer Diagnostics. Patents issued: 7,838,305 (US in 2011); 4628418 (JP in 2011). Patents pending: PCT/US2005/07203 (PC application); 05729867.1 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=36136
14,BC005254-23,"October 01, 2003 -  September 30, 2004",Regulation of HTLV-I Transcription,John N Brady; PhD,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Hanxin  Lu (National Cancer Institute)



R LOUIS  Schiltz (National Cancer Institute)



Rodney Louis Schiltz; PhD (Hormone Action and Oncogenesis Section)",Vittorio  Sartorelli; MD (NIAMS),"Ordered by publication type and then author name.



1.
Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA (2004). HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood  104, 1490-7.   https://doi.org/10.1182/blood-2003-12-4174




PubMed


 


PubMed ID 15155458
    
     


 



2.
Lu H, Pise-Masison CA, Linton R, Park HU, Schiltz RL, Sartorelli V, Brady JN (2004). Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. J Virol  78, 6735-43.   https://doi.org/10.1128/JVI.78.13.6735-6743.2004




PubMed



        
     
Free Article


 


PubMed ID 15194748
         Pubmed Central ID 421680",https://intramural.nih.gov/search/searchview.taf?ipid=36137
15,BC005258-25,"October 01, 2003 -  September 30, 2004",Molecular Studies of Eukaryotic Gene Regulation,"Bruce  Paterson; PhD



IRP Faculty Profile",Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,NULL,"Concetta  Lipardi (National Cancer Institute)



Alain  Mir (National Cancer Institute)



Stefania  Porta (National Cancer Institute)



Qin  Wei (National Cancer Institute)












Hye-Jung  Baek  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kwon SY, Badenhorst P, Martin-Romero FJ, Carlson BA, Paterson BM, Gladyshev VN, Lee BJ, Hatfield DL (2003). The Drosophila selenoprotein BthD is required for survival and has a role in salivary gland development. Mol Cell Biol  23, 8495-504.   https://doi.org/10.1128/mcb.23.23.8495-8504.2003




PubMed



        
     
Free Article


 


PubMed ID 14612395
         Pubmed Central ID 262655 


 



2.
Wei Q, Lipardi C, Paterson BM (2003). Analysis of the 3(')-hydroxyl group in Drosophila siRNA function. Methods  30, 337-47.   https://doi.org/10.1016/s1046-2023(03)00053-7




PubMed


 


PubMed ID 12828948",https://intramural.nih.gov/search/searchview.taf?ipid=36138
16,BC005263-23,"October 01, 2003 -  September 30, 2004",Eukaryotic Chromatin Structure and Gene Regulation,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,"Ilaria  Rebay
(Biology, MIT)





Matthew  Voas
(Biology, MIT)","Noriko  Aita (National Cancer Institute)



Manabu  Mizuguchi (National Cancer Institute)



Keith F Weathersbee (National Cancer Institute)



Wei-Hua  Wu (National Cancer Institute)



Hua  Xiao; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Shen X, Ranallo R, Choi E, Wu C (2003). Involvement of actin-related proteins in ATP-dependent chromatin remodeling. Mol Cell  12, 147-55.   https://doi.org/10.1016/s1097-2765(03)00264-8




PubMed


 


PubMed ID 12887900
    
     


 



2.
Shen X, Xiao H, Ranallo R, Wu WH, Wu C (2003). Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science  299, 112-4.   https://doi.org/10.1126/science.1078068




PubMed


 


PubMed ID 12434013",https://intramural.nih.gov/search/searchview.taf?ipid=36139
17,BC005267-20,"October 01, 2003 -  September 30, 2004",Mechanisms of Plasmid Maintenance: Partitioning,Michael  Yarmolinsky; PhD,Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,NULL,Rotem  Edgar  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Łobocka MB, Rose DJ, Plunkett G, Rusin M, Samojedny A, Lehnherr H, Yarmolinsky MB, Blattner FR (2004). Genome of bacteriophage P1. J Bacteriol  186, 7032-68.   https://doi.org/10.1128/JB.186.21.7032-7068.2004




PubMed



        
     
Free Article


 


PubMed ID 15489417
         Pubmed Central ID 523184 


 



2.
Rodionov O, Yarmolinsky M (2004). Plasmid partitioning and the spreading of P1 partition protein ParB. Mol Microbiol  52, 1215-23.   https://doi.org/10.1111/j.1365-2958.2004.04055.x




PubMed


 


PubMed ID 15130136
    
     


 



3.
Yarmolinsky MB (2004). Bacteriophage P1 in retrospect and in prospect. J Bacteriol  186, 7025-8.   https://doi.org/10.1128/JB.186.21.7025-7028.2004




PubMed



        
     
Free Article


 


PubMed ID 15489415
         Pubmed Central ID 523185",https://intramural.nih.gov/search/searchview.taf?ipid=36140
18,BC005268-17,"October 01, 2003 -  September 30, 2004",Mechanism of Meiotic Recombination,"Michael Joseph Lichten; PhD



IRP Faculty Profile",NULL,"Laboratory of Biochemistry, NCI",NULL,NULL,"David  Eyre (National Cancer Institute)



Lea  Jessop (National Cancer Institute)



Robert  Shroff (National Cancer Institute)



Tzuchen  (Carol)  Wu (National Cancer Institute)












Cyril  Buhler  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36141
19,BC005270-23,"October 01, 2003 -  September 30, 2004",Molecular Mechanism of Action of Phorbol Ester,"Peter  Blumberg; PhD



IRP Faculty Profile",Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,"Gary  Keck
(Dept. of Chemistry, University of Utah)





Alan P. Kozikowski
(Dept. of Medicinal Chemistry, University of Illinois at Chicago)





Chaya  Brodie; PhD
(Faculty of Life Science, Bar Ilan University)





Sergio  Grinstein; MD, PhD
(Cell Biology Program, Hospital For Sick Children)





Shaoming  Wang; PhD
(U. Michigan)





Q. Jane  Wang
(Dept. of Pharmacology, University of Pittsburgh School of Medicine)


Show all 17","Susan H Garfield (Laboratory of Experimental Carcinogenesis)



Noemi  Kedei (National Cancer Institute)



Nancy E Lewin (National Cancer Institute)



Larry  Pearce (National Cancer Institute)



J. Frederic Mushinski; MD (National Cancer Institute)



Dean H. Hamer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bocklandt S, Blumberg PM, Hamer DH (2003). Activation of latent HIV-1 expression by the potent anti-tumor promoter 12-deoxyphorbol 13-phenylacetate. Antiviral Res  59, 89-98.   https://doi.org/10.1016/s0166-3542(03)00034-2




PubMed


 


PubMed ID 12895692
    
     


 



2.
Brodie C, Blumberg PM (2003). Regulation of cell apoptosis by protein kinase c delta. Apoptosis  8, 19-27.   https://doi.org/10.1023/a:1021640817208




PubMed


 


PubMed ID 12510148
    
     


 



3.
Choi Y, Kang JH, Lewin NE, Blumberg PM, Lee J, Marquez VE (2003). Conformationally constrained analogues of diacylglycerol. 19. Synthesis and protein kinase C binding affinity of diacylglycerol lactones bearing an N-hydroxylamide side chain. J Med Chem  46, 2790-3.   https://doi.org/10.1021/jm030082c




PubMed


 


PubMed ID 12801241
    
     


 



4.
Clark AS, West KA, Blumberg PM, Dennis PA (2003). Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res  63, 780-6.




PubMed


 


PubMed ID 12591726
    
     


 



5.
Hamer DH, Bocklandt S, McHugh L, Chun TW, Blumberg PM, Sigano DM, Marquez VE (2003). Rational design of drugs that induce human immunodeficiency virus replication. J Virol  77, 10227-36.   https://doi.org/10.1128/jvi.77.19.10227-10236.2003




PubMed



        
     
Free Article


 


PubMed ID 12970407
         Pubmed Central ID 228450 


 



6.
Hyman T, Huizing M, Blumberg PM, Falik-Zaccai TC, Anikster Y, Gahl WA (2003). Use of a cDNA microarray to determine molecular mechanisms involved in grey platelet syndrome. Br J Haematol  122, 142-9.   https://doi.org/10.1046/j.1365-2141.2003.04410.x




PubMed


 


PubMed ID 12823356
    
     


 



7.
Kang JH, Chung HE, Kim SY, Kim Y, Lee J, Lewin NE, Pearce LV, Blumberg PM, Marquez VE (2003). Conformationally constrained analogues of diacylglycerol (DAG). Effect on protein kinase C (PK-C) binding by the isosteric replacement of sn-1 and sn-2 esters in DAG-lactones. Bioorg Med Chem  11, 2529-39.   https://doi.org/10.1016/s0968-0896(03)00156-1




PubMed


 


PubMed ID 12757721
    
     


 



8.
Kozikowski AP, Nowak I, Petukhov PA, Etcheberrigaray R, Mohamed A, Tan M, Lewin N, Hennings H, Pearce LL, Blumberg PM (2003). New amide-bearing benzolactam-based protein kinase C modulators induce enhanced secretion of the amyloid precursor protein metabolite sAPPalpha. J Med Chem  46, 364-73.   https://doi.org/10.1021/jm020350r




PubMed


 


PubMed ID 12540236
    
     


 



9.
Lázár J, Szabó T, Kovács L, Blumberg PM, Bíró T (2003). Distinct features of recombinant rat vanilloid receptor-1 expressed in various expression systems. Cell Mol Life Sci  60, 2228-40.   https://doi.org/10.1007/s00018-003-3230-5




PubMed


 


PubMed ID 14618269
    
     


 



10.
Lee J, Lee J, Kang M, Shin M, Kim JM, Kang SU, Lim JO, Choi HK, Suh YG, Park HG, Oh U, Kim HD, Park YH, Ha HJ, Kim YH, Toth A, Wang Y, Tran R, Pearce LV, Lundberg DJ, Blumberg PM (2003). N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor. J Med Chem  46, 3116-26.   https://doi.org/10.1021/jm030089u




PubMed


 


PubMed ID 12825950
    
     


 



11.
Lewin NE, Blumberg PM (2003). [3H]Phorbol 12,13-dibutyrate binding assay for protein kinase C and related proteins. Methods Mol Biol  233, 129-56.   https://doi.org/10.1385/1-59259-397-6:129




PubMed


 


PubMed ID 12840504
    
     


 



12.
Marquez VE, Blumberg PM (2003). Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C). Acc Chem Res  36, 434-43.   https://doi.org/10.1021/ar020124b




PubMed


 


PubMed ID 12809530
    
     


 



13.
Rambaratsingh RA, Stone JC, Blumberg PM, Lorenzo PS (2003). RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes. J Biol Chem  278, 52792-801.   https://doi.org/10.1074/jbc.M308240200




PubMed


 


PubMed ID 14532295
    
     


 



14.
Sigano DM, Peach ML, Nacro K, Choi Y, Lewin NE, Nicklaus MC, Blumberg PM, Marquez VE (2003). Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C). J Med Chem  46, 1571-9.   https://doi.org/10.1021/jm020476o




PubMed


 


PubMed ID 12699375
    
     


 



15.
Sridhar J, Wei ZL, Nowak I, Lewin NE, Ayres JA, Pearce LV, Blumberg PM, Kozikowski AP (2003). New bivalent PKC ligands linked by a carbon spacer: enhancement in binding affinity. J Med Chem  46, 4196-204.   https://doi.org/10.1021/jm0302041




PubMed


 


PubMed ID 12954072
    
     


 



16.
Tóth A, Kedei N, Wang Y, Blumberg PM (2003). Arachidonyl dopamine as a ligand for the vanilloid receptor VR1 of the rat. Life Sci  73, 487-98.   https://doi.org/10.1016/s0024-3205(03)00310-2




PubMed


 


PubMed ID 12759142
    
     


 



17.
Wang QJ, Fang TW, Yang D, Lewin NE, Van Lint J, Marquez VE, Blumberg PM (2003). Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D. Mol Pharmacol  64, 1342-8.   https://doi.org/10.1124/mol.64.6.1342




PubMed


 


PubMed ID 14645664
    
     


 



18.
Wang Y, Toth A, Tran R, Szabo T, Welter JD, Blumberg PM, Lee J, Kang SU, Lim JO, Lee J (2003). High-affinity partial agonists of the vanilloid receptor. Mol Pharmacol  64, 325-33.   https://doi.org/10.1124/mol.64.2.325




PubMed


 


PubMed ID 12869637",https://intramural.nih.gov/search/searchview.taf?ipid=36142
20,BC005271-13,"October 01, 2003 -  September 30, 2004",Gene Regulation and Function: The B-ZIP Proteins,"Charles  Vinson; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,"Won-Jun  Oh (National Cancer Institute)



Vikas  Rishi (National Cancer Institute)



Julian  Rozenburg (National Cancer Institute)



Jane  Reusch (National Cancer Institute)



Charlotte  Peterson (National Cancer Institute)



Asha  Acharya (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Baccam M, Woo SY, Vinson C, Bishop GA (2003). CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol  170, 3099-108.   https://doi.org/10.4049/jimmunol.170.6.3099




PubMed


 


PubMed ID 12626566
    
     


 



2.
Cataisson C, Joseloff E, Murillas R, Wang A, Atwell C, Torgerson S, Gerdes M, Subleski J, Gao JL, Murphy PM, Wiltrout RH, Vinson C, Yuspa SH (2003). Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways. J Immunol  171, 2703-13.   https://doi.org/10.4049/jimmunol.171.5.2703




PubMed


 


PubMed ID 12928424
    
     


 



3.
Chen WG, West AE, Tao X, Corfas G, Szentirmay MN, Sawadogo M, Vinson C, Greenberg ME (2003). Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J Neurosci  23, 2572-81.




PubMed



        
     
Free Article


 


PubMed ID 12684442
         Pubmed Central ID 6742056 


 



4.
Colombo C, Haluzik M, Cutson JJ, Dietz KR, Marcus-Samuels B, Vinson C, Gavrilova O, Reitman ML (2003). Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance. J Biol Chem  278, 3992-9.   https://doi.org/10.1074/jbc.M207665200




PubMed


 


PubMed ID 12456680
    
     


 



5.
Deppmann CD, Acharya A, Rishi V, Wobbes B, Smeekens S, Taparowsky EJ, Vinson C (2004). Dimerization specificity of all 67 B-ZIP motifs in Arabidopsis thaliana: a comparison to Homo sapiens B-ZIP motifs. Nucleic Acids Res  32, 3435-45.   https://doi.org/10.1093/nar/gkh653




PubMed



        
     
Free Article


 


PubMed ID 15226410
         Pubmed Central ID 443529 


 



6.
Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML (2003). Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem  278, 34268-76.   https://doi.org/10.1074/jbc.M300043200




PubMed


 


PubMed ID 12805374
    
     


 



7.
Hahm SH, Chen Y, Vinson C, Eiden LE (2003). A calcium-initiated signaling pathway propagated through calcineurin and cAMP response element-binding protein activates proenkephalin gene transcription after depolarization. Mol Pharmacol  64, 1503-11.   https://doi.org/10.1124/mol.64.6.1503




PubMed



        
     
Free Article


 


PubMed ID 14645681
         Pubmed Central ID 4186738 


 



8.
Minn AH, Patterson NB, Pack S, Hoffmann SC, Gavrilova O, Vinson C, Harlan DM, Shalev A (2003). Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun  310, 641-5.   https://doi.org/10.1016/j.bbrc.2003.09.061




PubMed


 


PubMed ID 14521959
    
     


 



9.
Mir AA, Myakishev MV, Polesskaya OO, Moitra J, Petersen D, Miller L, Orosz A, Vinson C (2003). A search for candidate genes for lipodystrophy, obesity and diabetes via gene expression analysis of A-ZIP/F-1 mice. Genomics  81, 378-90.   https://doi.org/10.1016/s0888-7543(03)00024-7




PubMed


 


PubMed ID 12676562
    
     


 



10.
Rishi V, Vinson C (2003). Dominant-negative mutants of helix-loop-helix proteins: transcriptional inhibition. Methods Enzymol  370, 454-66.   https://doi.org/10.1016/S0076-6879(03)70039-1




PubMed


 


PubMed ID 14712667
    
     


 



11.
Szentirmay MN, Yang HX, Pawar SA, Vinson C, Sawadogo M (2003). The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells. J Biol Chem  278, 37231-40.   https://doi.org/10.1074/jbc.M305791200




PubMed


 


PubMed ID 12857727
    
     


 



12.
Tkach V, Tulchinsky E, Lukanidin E, Vinson C, Bock E, Berezin V (2003). Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility. Oncogene  22, 5045-54.   https://doi.org/10.1038/sj.onc.1206570




PubMed


 


PubMed ID 12902987
    
     


 



13.
Williams KL, Zullo AJ, Kaplan MH, Brutkiewicz RR, Deppmann CD, Vinson C, Taparowsky EJ (2003). BATF transgenic mice reveal a role for activator protein-1 in NKT cell development. J Immunol  170, 2417-26.   https://doi.org/10.4049/jimmunol.170.5.2417




PubMed


 


PubMed ID 12594265",https://intramural.nih.gov/search/searchview.taf?ipid=36143
21,BC005272-13,"October 01, 2003 -  September 30, 2004",Transcriptional regulation of development,Mark  Mortin; PhD,Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,NULL,Tamara L Jones  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Bi X, Kajava AV, Jones T, Demidenko ZN, Mortin MA (2003). The carboxy terminus of Prospero regulates its subcellular localization. Mol Cell Biol  23, 1014-24.   https://doi.org/10.1128/mcb.23.3.1014-1024.2003




PubMed



        
     
Free Article


 


PubMed ID 12529405
         Pubmed Central ID 140706",https://intramural.nih.gov/search/searchview.taf?ipid=36144
22,BC005275-09,"October 01, 2003 -  September 30, 2004",Cell cycle regulation during Drosophila eye development.,Barbara J. Thomas; PhD,Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,NULL,"Xiaoying  Jian (National Cancer Institute)



Xiang  Gao (National Cancer Institute)



Guorong  Li (National Cancer Institute)



Albert J Fornace; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36146
23,BC005317-21,"October 01, 2003 -  September 30, 2004",Role of Selenium in Cancer and Health,"Dolph Lee Hatfield; PhD



IRP Faculty Profile",Nancy H Colburn; PhD,"Molecular Biology of Selenium Section, NCI",NULL,"Marla  Berry
(Molecular Biology, U of Hawaii)





Alan  Diamond
(Nutrition, U of IL at Chicago)
















Byeong R. Lee; PhD
(College of Education, Seowon University)",Vadim  Gladyshev (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kumaraswamy E, Carlson BA, Morgan F, Miyoshi K, Robinson GW, Su D, Wang S, Southon E, Tessarollo L, Lee BJ, Gladyshev VN, Hennighausen L, Hatfield DL (2003). Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol Cell Biol  23, 1477-88.   https://doi.org/10.1128/mcb.23.5.1477-1488.2003




PubMed



        
     
Free Article


 


PubMed ID 12588969
         Pubmed Central ID 151713 


 



2.
Moustafa ME, Kumaraswamy E, Zhong N, Rao M, Carlson BA, Hatfield DL (2003). Models for assessing the role of selenoproteins in health. J Nutr  133, 2494S-2496S.   https://doi.org/10.1093/jn/133.7.2494S




PubMed


 


PubMed ID 12840229
    
     


 



3.
Rao M, Carlson BA, Novoselov SV, Weeks DP, Gladyshev VN, Hatfield DL (2003). Chlamydomonas reinhardtii selenocysteine tRNA[Ser]Sec. RNA  9, 923-30.   https://doi.org/10.1261/rna.5510503




PubMed



        
     
Free Article


 


PubMed ID 12869703
         Pubmed Central ID 1370458",https://intramural.nih.gov/search/searchview.taf?ipid=36147
24,BC005318-22,"October 01, 2003 -  September 30, 2004",Structure-Function of Cytochrome P450,Fred  Friedman; PhD,Frank Jess Gonzalez; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,NULL,Allen  Markowitz; MEE (OD),"Ordered by publication type and then author name.



1.
Bustin M, Robinson RC, Friedman FK (2004). Immunochemical analysis of chromatin. Methods Enzymol  376, 209-20.   https://doi.org/10.1016/S0076-6879(03)76014-5




PubMed


 


PubMed ID 14975308
    
     


 



2.
Chie L, Adler V, Friedman FK, Chung D, Pincus MR (2004). An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21. Protein J  23, 235-8.   https://doi.org/10.1023/b:jopc.0000026419.54902.bb




PubMed


 


PubMed ID 15200055
    
     


 



3.
Chie L, Friedman FK, Duncan T, Chen JM, Chung D, Pincus M (2004). Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling. Protein J  23, 229-34.   https://doi.org/10.1023/b:jopc.0000026418.82786.5e




PubMed


 


PubMed ID 15200054
    
     


 



4.
Duncan T, Chen JM, Friedman FK, Hyde M, Chie L, Pincus MR (2004). Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signaling. Protein J  23, 217-28.   https://doi.org/10.1023/b:jopc.0000026417.72621.1f




PubMed


 


PubMed ID 15200053
    
     


 



5.
Friedman FK, Robinson RC, Dai R (2004). Molecular modeling of mammalian cytochrome P450s. Front Biosci  9, 2796-806.   https://doi.org/10.2741/1437




PubMed


 


PubMed ID 15353315",https://intramural.nih.gov/search/searchview.taf?ipid=36148
25,BC005352-22,"October 01, 2003 -  September 30, 2004",Mechanisms in Perinatal Carcinogenesis,Lucy M Anderson; PhD,Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,"Jihee  Choe (National Cancer Institute)



Erik  Crawford (National Cancer Institute)



Janet R Fields (National Cancer Institute)



Laura  Fornwald (National Cancer Institute)



Ki Narm  Ko (National Cancer Institute)



Yih-horng  Shiao (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cisneros FJ, Wilson R, Travlos G, Anderson LM, Branch S (2003). Susceptibility to postnatal growth retardation induced by 5-AZA-2'-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor 1. Life Sci  72, 2887-94.   https://doi.org/10.1016/s0024-3205(03)00229-7




PubMed


 


PubMed ID 12697271",https://intramural.nih.gov/search/searchview.taf?ipid=36149
26,BC005367-21,"October 01, 2003 -  September 30, 2004",The Genetic Structure of Natural Populations Past and Present,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Darrell  Land
(Researcher, FLA Fish & Wildlife Conserv. Comm.)





David  MacDonald
(Zoology Dept., Wildlife Conserv. Research Unit)





David  Macdonald
(Zoology Department, Wildlife Conserv. Research Unit)





Christine  Breitenmoser-Wursten
(IUCN/SSC Cat Specialist Group, KORA)





Mike  O'Brien
(Wildlife Resources - Furbearers & Upland Game Wildlife Div., Nova Scotia Dept. of Natural Resources)





Francisco  Palomares
(Estacion Biologica de Donana)


Show all 11","Warren  Johnson (National Cancer Institute)



Joan C Menninger (National Cancer Institute)



Janice S Martenson (National Cancer Institute)



Mary A Thompson (National Cancer Institute)



Michael E Weedon (National Cancer Institute)












Carlos Antonio Driscoll; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Johnson WE, Godoy JA, Palomares F, Delibes M, Fernandes M, Revilla E, O'Brien SJ (2004). Phylogenetic and phylogeographic analysis of Iberian lynx populations. J Hered  95, 19-28.   https://doi.org/10.1093/jhered/esh006




PubMed


 


PubMed ID 14757726
    
     


 



2.
Luo SJ, Kim JH, Johnson WE, van der Walt J, Martenson J, Yuhki N, Miquelle DG, Uphyrkina O, Goodrich JM, Quigley HB, Tilson R, Brady G, Martelli P, Subramaniam V, McDougal C, Hean S, Huang SQ, Pan W, Karanth UK, Sunquist M, Smith JL, O'Brien SJ (2004). Phylogeography and genetic ancestry of tigers (Panthera tigris). PLoS Biol  2, e442.   https://doi.org/10.1371/journal.pbio.0020442




PubMed



        
     
Free Article


 


PubMed ID 15583716
         Pubmed Central ID 534810 


 



3.
Vila C, Leonard JA, Iriarte , OBrien SJ, Johnson W, Wayne RK    (2004) Vanishing populations of the highly endangered Darwin's fox Pseudalopex fulvipes. Animal Conservation. 7:147-53.",https://intramural.nih.gov/search/searchview.taf?ipid=36150
27,BC005384-21,"October 01, 2003 -  September 30, 2004",Haplotype Diversity and Molecular Epidemiology of Cytokine Genes with AIDS and C,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Sharyne  Donfield
(Hemophilia Growth and Development Study, Rho, Inc.)





David  Vlahov; PhD
(JHU Sch Public Health)
















Roger  Detels; MD
(Epidemiology, UCLA)",James Jerome Goedert; MD (Infection & Immunoepidemiology Branch),Susan P Buchbinder (OD),"Ordered by publication type and then author name.



1.
Modi WS, Goedert JJ, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C (2003). MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS  17, 2357-65.   https://doi.org/10.1097/00002030-200311070-00011




PubMed


 


PubMed ID 14571188
    
     


 



2.
Modi WS, O'Brien TR, Vlahov D, Buchbinder S, Gomperts E, Phair J, O'Brien SJ, Winkler C (2003). Haplotype diversity in the interleukin-4 gene is not associated with HIV-1 transmission and AIDS progression. Immunogenetics  55, 157-164.   https://doi.org/10.1007/s00251-003-0541-5




PubMed


 


PubMed ID 12715242",https://intramural.nih.gov/search/searchview.taf?ipid=36151
28,BC005385-21,"October 01, 2003 -  September 30, 2004","The Development of the Domestic cat, Felis catus, as an Animal Model",Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"John  Fyfe
(Michigan State U.)





John  Butler
(Biotechnology Div., Nat'l. Bureau of Standards)





Kristina  Narfstrom; DVM
(Veterinary Medicine, University of Missouri)
















Steven  Hannah
(Nestle Purina PetCare Co.)","Carlos Antonio Driscoll; PhD (National Cancer Institute)



Marilyn  Raymond; PhD (National Cancer Institute)



Janice S Martenson (National Cancer Institute)



Alfred L Roca (National Cancer Institute)












Victor A David  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36152
29,BC005389-21,"October 01, 2003 -  September 30, 2004",Reproductive Strategies in Animal Species Emphasizing Developmental Biology,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"David  Wildt (National Cancer Institute)



JoGayle  Howard (National Cancer Institute)



Budhan  Pukazhenthi (National Cancer Institute)



Katherine  Pelican (National Cancer Institute)












Janice S Martenson  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Swanson WF, Johnson W, Cambre RC, Citino SB, Quigley KB, Brousset D, Morais RN, Moreira N, OBrien SJ, Wildt DE    (2003) Reproductive status of endemic felid species in Latin American Zoos and implications for ex situ conservation. Zoo Biology. 22:421-41.",https://intramural.nih.gov/search/searchview.taf?ipid=36153
30,BC005399-21,"October 01, 2003 -  September 30, 2004",Mechanistic Targeting of Lung Cancer,Lucy M Anderson; PhD,Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,"Richard  Calvert (National Cancer Institute)



Yuk Sing Robert Cheng (National Cancer Institute)



Janet R Fields (National Cancer Institute)



Laura  Fornwald (National Cancer Institute)



Anna  Maciag (National Cancer Institute)



Malgorzata  Romanowska (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calvert RJ, Tepper S, Diwan BA, Anderson LM, Kritchevsky D (2003). Treatment with lovastatin, cholestyramine or niacin alters K-ras membrane association in mouse lung in a strain-dependent manner: results in females. Biochem Pharmacol  66, 393-403.   https://doi.org/10.1016/s0006-2952(03)00211-9




PubMed


 


PubMed ID 12907238
    
     


 



2.
Maciag A, Bialkowska A, Espiritu I, Powell D, Alvord WG, Kasprzak KS, Anderson LM, Witschi HR (2003). Gestation stage-specific oxidative deoxyribonucleic acid damage from sidestream smoke in pregnant rats and their fetuses. Arch Environ Health  58, 238-44.




PubMed


 


PubMed ID 14655905
    
     


 



3.
Sithanandam G, Smith GT, Masuda A, Takahashi T, Anderson LM, Fornwald LW (2003). Cell cycle activation in lung adenocarcinoma cells by the ErbB3/phosphatidylinositol 3-kinase/Akt pathway. Carcinogenesis  24, 1581-92.   https://doi.org/10.1093/carcin/bgg125




PubMed


 


PubMed ID 12896906",https://intramural.nih.gov/search/searchview.taf?ipid=36154
31,BC005445-20,"October 01, 2003 -  September 30, 2004",Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Ma,"Stuart H Yuspa; MD



IRP Faculty Profile",NULL,"Office of the Director, NCI",NULL,"Yuzuru  Shiio
(Institute of Systems Biology)





Robert  Eisenman
(Fred Hutchinson Cancer Research Center)
















Craig  Woodworth
(Clarkson University)","Christina K Cheng (National Cancer Institute)



Susan H Garfield (Laboratory of Experimental Carcinogenesis)



Michael  Gerdes (National Cancer Institute)



Ulrike F Lichti; PhD (National Cancer Institute)



Bettie S Sugar (National Cancer Institute)



Kwang Sun Suh (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36155
32,BC005450-21,"October 01, 2003 -  September 30, 2004",Chromatin Structure and Gene Expression,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Carol T Comlish (National Cancer Institute)



Anindya P Hendarwanto (National Cancer Institute)



Sam  John (National Cancer Institute)



Tom  Johnson (National Cancer Institute)



Yi  Qui (National Cancer Institute)



Geetha V Rayasam (National Cancer Institute)",Akhilesh Kumar Nagaich (OD),"Ordered by publication type and then author name.



1.
Bash R, Wang H, Yodh J, Hager G, Lindsay SM, Lohr D (2003). Nucleosomal arrays can be salt-reconstituted on a single-copy MMTV promoter DNA template: their properties differ in several ways from those of comparable 5S concatameric arrays. Biochemistry  42, 4681-90.   https://doi.org/10.1021/bi026887o




PubMed


 


PubMed ID 12705831
    
     


 



2.
Georgel PT, Fletcher TM, Hager GL, Hansen JC (2003). Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters. Genes Dev  17, 1617-29.   https://doi.org/10.1101/gad.1097603




PubMed



        
     
Free Article


 


PubMed ID 12842912
         Pubmed Central ID 196134 


 



3.
Hager GL, Nagaich AK, Johnson TA, Walker DA, John S (2004). Dynamics of nuclear receptor movement and transcription. Biochim Biophys Acta  1677, 46-51.   https://doi.org/10.1016/j.bbaexp.2003.09.016




PubMed


 


PubMed ID 15020044
    
     


 



4.
Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L, Lerouge T, Hager GL, Chambon P, Losson R (2003). NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J  22, 3153-63.   https://doi.org/10.1093/emboj/cdg288




PubMed



        
     
Free Article


 


PubMed ID 12805229
         Pubmed Central ID 162140",https://intramural.nih.gov/search/searchview.taf?ipid=36156
33,BC005453-20,"October 01, 2003 -  September 30, 2004",Cellular and Molecular Biology of the Hepatic Stem Cell Compartment,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Elizabeth A Conner,"Peter  Nagy
(Pathology, Sammelweiss University)
















Aranzazu  Sanchez Munoz
(Dept. Biochemistry and Molecular Biology, Compluense University)","Timothy V Benjamin (National Cancer Institute)



Valentina  Factor (Cellular and Molecular Biology Section)



Tanya N Hoang (Cellular and Molecular Biology Section)",NULL,"Ordered by publication type and then author name.



1.
Paku S, Nagy P, Kopper L, Thorgeirsson SS (2004). 2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. Hepatology  39, 1353-61.   https://doi.org/10.1002/hep.20178




PubMed


 


PubMed ID 15122764
    
     


 



2.
Sánchez A, Factor VM, Schroeder IS, Nagy P, Thorgeirsson SS (2004). Activation of NF-kappaB and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Hepatology  39, 376-85.   https://doi.org/10.1002/hep.20040




PubMed


 


PubMed ID 14767990",https://intramural.nih.gov/search/searchview.taf?ipid=36157
34,BC005480-19,"October 01, 2003 -  September 30, 2004",Molecular Epidemiology and Molecular Carcinogenesis of Human Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,"William  Travis
(AFIP)





K.  Vahakangas
(University of Oulo)





M.  Rusin
(Maria-Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland, Institute of Oncology)
















A.  Haugen
(National Institute of Occupational Health)","Elisa A Spillare (National Cancer Institute)



Elise Dawn Bowman (National Cancer Institute)



Mohammed A. Khan; PhD (National Cancer Institute)



Judith A Welsh (National Cancer Institute)



Zhipeng  Yu (National Cancer Institute)



Yun-Ling  Zheng (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC (2004). Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis  25, 2467-72.   https://doi.org/10.1093/carcin/bgh260




PubMed


 


PubMed ID 15308583
    
     


 



2.
Hofseth LJ, Robles AI, Yang Q, Wang XW, Hussain SP, Harris C (2004). p53: at the crossroads of molecular carcinogenesis and molecular epidemiology. Chest  125, 83S-5S.   https://doi.org/10.1378/chest.125.5_suppl.83s-a




PubMed


 


PubMed ID 15136428
    
     


 



3.
Milyavsky M, Shats I, Erez N, Tang X, Senderovich S, Meerson A, Tabach Y, Goldfinger N, Ginsberg D, Harris CC, Rotter V   (2003) Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.  Cancer Res 63:7147-57.




PubMed


 


PubMed ID 14612508
    
     


 



4.
Sander M, Trump BF, Harris CC, Tennant RW (2003). Seventeenth Aspen Cancer Conference: mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy. Mol Carcinog  36, 101-14.   https://doi.org/10.1002/mc.10109




PubMed


 


PubMed ID 12619032
    
     


 



5.
Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC (2003). TP53 and liver carcinogenesis. Hum Mutat  21, 201-16.   https://doi.org/10.1002/humu.10176




PubMed


 


PubMed ID 12619106
    
     


 



6.
West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA (2003). Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest  111, 81-90.   https://doi.org/10.1172/JCI16147




PubMed



        
     
Free Article


 


PubMed ID 12511591
         Pubmed Central ID 151834 


 



7.
West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA (2004). Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3'-kinase/Akt pathway in vitro and in vivo. Cancer Res  64, 446-51.   https://doi.org/10.1158/0008-5472.can-03-3241




PubMed


 


PubMed ID 14744754
    
     


 



8.
Zheng YL, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, Shields PG   (2003) Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.  Carcinogenesis 24:269-74.




PubMed


 


PubMed ID 12584177",https://intramural.nih.gov/search/searchview.taf?ipid=36158
35,BC005482-19,"October 01, 2003 -  September 30, 2004",Regulation of papillomavirus gene expression,"Carl C Baker; MD, PhD",NULL,"Laboratory of Cellular Oncology, NCI",NULL,"Laura  Mitchell; PhD
(University of Pennsylvania)





Mariano  Garcia-Blanco
(Intronn, Inc.)





Richard  Schlegel; MD, PhD
(Department of Pathology, Georgetown University Medical School)





Hans-Ulrich  Bernard
(Institute of Molecular and Cell Biology, Singapore)





M.  Puttaraju
(Intronn, Inc.)","Jesse F Quintero (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



John  Schiller; PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)












Janet M Dipasquale  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Day PM, Baker CC, Lowy DR, Schiller JT (2004). Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A  101, 14252-7.   https://doi.org/10.1073/pnas.0404229101




PubMed



        
     
Free Article


 


PubMed ID 15383670
         Pubmed Central ID 521143 


 



2.
Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, Kraemer KH (2004). Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet  13, 343-52.   https://doi.org/10.1093/hmg/ddh026




PubMed


 


PubMed ID 14662655
    
     


 



3.
Liao HJ, Baker CC, Princler GL, Derse D (2004). cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing. Virology  323, 131-40.   https://doi.org/10.1016/j.virol.2003.12.028




PubMed


 


PubMed ID 15165825",https://intramural.nih.gov/search/searchview.taf?ipid=36159
36,BC005488-19,"October 01, 2003 -  September 30, 2004",Mechanisms of Inorganic Carcinogenesis,Michael  Waalkes; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",Bhalchandra A Diwan; PhD,"David L Miller






Mukta  Webber
(Michigan State University)





Curtis  Klassen
(University of Kansas)





M Y Chen","Jie  Liu; MD, PhD (National Cancer Institute)



Wei  Qu; PhD (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)



Jerrold M Ward; DVM, PhD (National Cancer Institute)","Bruce Alexander Merrick; PhD (NIEHS) 












Ronald  Mason; PhD (NIEHS)","Ordered by publication type and then author name.



1.
Liu J, Lei D, Waalkes MP, Beliles RP, Morgan DL (2003). Genomic analysis of the rat lung following elemental mercury vapor exposure. Toxicol Sci  74, 174-81.   https://doi.org/10.1093/toxsci/kfg091




PubMed


 


PubMed ID 12730625
    
     


 



2.
Pi J, Horiguchi S, Sun Y, Nikaido M, Shimojo N, Hayashi T, Yamauchi H, Itoh K, Yamamoto M, Sun G, Waalkes MP, Kumagai Y (2003). A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic Biol Med  35, 102-13.   https://doi.org/10.1016/s0891-5849(03)00269-7




PubMed


 


PubMed ID 12826260
    
     


 



3.
Pi J, Qu W, Reece JM, Kumagai Y, Waalkes MP (2003). Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res  290, 234-45.   https://doi.org/10.1016/s0014-4827(03)00341-0




PubMed


 


PubMed ID 14567983
    
     


 



4.
Shimoda R, Achanzar WE, Qu W, Nagamine T, Takagi H, Mori M, Waalkes MP (2003). Metallothionein is a potential negative regulator of apoptosis. Toxicol Sci  73, 294-300.   https://doi.org/10.1093/toxsci/kfg095




PubMed


 


PubMed ID 12700406
    
     


 



5.
Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP (2003). Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res  286, 355-65.   https://doi.org/10.1016/s0014-4827(03)00062-4




PubMed


 


PubMed ID 12749863
    
     


 



6.
Waalkes MP (2003). Cadmium carcinogenesis. Mutat Res  533, 107-20.   https://doi.org/10.1016/j.mrfmmm.2003.07.011




PubMed


 


PubMed ID 14643415
    
     


 



7.
Waalkes MP, Ward JM, Liu J, Diwan BA (2003). Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol Appl Pharmacol  186, 7-17.   https://doi.org/10.1016/s0041-008x(02)00022-4




PubMed


 


PubMed ID 12583988",https://intramural.nih.gov/search/searchview.taf?ipid=36160
37,BC005522-17,"October 01, 2003 -  September 30, 2004",Role of Thyroid-Specific Enhancer-Binding Protein in Development,"Shioko  Kimura; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,"Atsushi  Yamada (National Cancer Institute)



Nobuo  Hoshi (National Cancer Institute)












Reiko  Kuratoni  (National Cancer Institute)","Jerrold M Ward; DVM, PhD (NIAID)","Ordered by publication type and then author name.



1.
Gonzalez FJ, Kimura S (2003). Study of P450 function using gene knockout and transgenic mice. Arch Biochem Biophys  409, 153-8.   https://doi.org/10.1016/s0003-9861(02)00364-8




PubMed


 


PubMed ID 12464254
    
     


 



2.
Kawano H, Horie M, Honma S, Kawamura K, Takeuchi K, Kimura S (2003). Aberrant trajectory of ascending dopaminergic pathway in mice lacking Nkx2.1. Exp Neurol  182, 103-12.   https://doi.org/10.1016/s0014-4886(03)00030-x




PubMed


 


PubMed ID 12821380
    
     


 



3.
Kimura S (2003). [Homeodomain transcription factor T/EBP/NKX2.1 in development and differentiation of the thyroid and lung]. Seikagaku  75, 1493-504.




PubMed


 


PubMed ID 14748143
    
     


 



4.
Kimura S, Kawabe M, Yu A, Morishima H, Fernandez-Salguero P, Hammons GJ, Ward JM, Kadlubar FF, Gonzalez FJ (2003). Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Carcinogenesis  24, 583-7.   https://doi.org/10.1093/carcin/24.3.583




PubMed


 


PubMed ID 12663521
    
     


 



5.
Moeller LC, Kimura S, Kusakabe T, Liao XH, Van Sande J, Refetoff S (2003). Hypothyroidism in thyroid transcription factor 1 haploinsufficiency is caused by reduced expression of the thyroid-stimulating hormone receptor. Mol Endocrinol  17, 2295-302.   https://doi.org/10.1210/me.2003-0175




PubMed


 


PubMed ID 12907760
    
     


 



6.
Yim SH, Ward JM, Dragan Y, Yamada A, Scacheri PC, Kimura S, Gonzalez FJ (2003). Microarray analysis using amplified mRNA from laser capture microdissection of microscopic hepatocellular precancerous lesions and frozen hepatocellular carcinomas reveals unique and consistent gene expression profiles. Toxicol Pathol  31, 295-303.   https://doi.org/10.1080/01926230390204333




PubMed


 


PubMed ID 12746117",https://intramural.nih.gov/search/searchview.taf?ipid=36161
38,BC005536-18,"October 01, 2003 -  September 30, 2004",Basic and Applied Studies in Development of an AIDS Vaccine,"Marjorie  Robert-Guroff; PhD



IRP Faculty Profile","Jay Arthur Berzofsky; MD, PhD","IMMUNE BIOLOGY OF RETROVIRAL INFECTION SECT, NCI",NULL,"Barbara  Ensoli
(Istituto Superiore di Sanita)





Catarina  Hioe
(New York University School of Medicine)





Norman  Letvin
(Beth Israel Deaconess Medical Center)





David C Montefiori; PhD
(Department of Surgery, NIAID)





Kris  Murthy; DVM, MD
(Southwest Foundation for Biomedical Research)





Keith A.  Reimann
(Beth Israel Deaconess Medical Center)


Show all 10","Genoveffa  Franchini; MD (ANIMAL MODELS and RETROVIRAL VACCINES SECT)



Bo  Peng (National Cancer Institute)



Dimiter Stanchev Dimitrov; PhD (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)



William Gregory Alvord (Office Of The Director)","Arya  Biragyn; PhD (NIA) 



Mark  Connors; MD (NIAID) 



Gary J Nabel; MD, PhD (NIAID) 



George J Grimes (CC)","Ordered by publication type and then author name.



1.
G3mez-Romn VR, Robert-Guroff M   (2003) Adenoviruses as vectors for HIV vaccines.  AIDS Rev 5:178-85.




PubMed


 


PubMed ID 14598567
    
     


 



2.
Malkevitch N, Patterson LJ, Aldrich K, Richardson E, Alvord WG, Robert-Guroff M   (2003) A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A01 rhesus macaques.  J Immunol 170:4281-9.




PubMed


 


PubMed ID 12682263
    
     


 



3.
Nan X, Peng B, Hahn TW, Richardson E, Lizonova A, Kovesdi I, Robert-Guroff M   (2003) Development of an Ad7 cosmid system and generation of an Ad7deltaE1deltaE3HIV(MN) env/rev recombinant virus.  Gene Ther 10:326-36.




PubMed


 


PubMed ID 12595891
    
     


 



4.
Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, Kalyanaraman VS, Pavlakis GN, Robert-Guroff M (2003). Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. J Virol  77, 8607-20.   https://doi.org/10.1128/jvi.77.16.8607-8620.2003




PubMed



        
     
Free Article


 


PubMed ID 12885879
         Pubmed Central ID 167211 


 



5.
Voltan R, Robert-Guroff M   (2003) Live recombinant vectors for AIDS vaccine development.  Curr Mol Med 3:273-84.




PubMed


 


PubMed ID 12699363
    
     


 



6.
Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M (2003). Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine  21, 4022-35.   https://doi.org/10.1016/s0264-410x(03)00266-4




PubMed


 


PubMed ID 12922139
    
     


 



7.
Zhao J, Pinczewski J, Gómez-Román VR, Venzon D, Kalyanaraman VS, Markham PD, Aldrich K, Moake M, Montefiori DC, Lou Y, Pavlakis GN, Robert-Guroff M (2003). Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen. J Virol  77, 8354-65.   https://doi.org/10.1128/jvi.77.15.8354-8365.2003




PubMed



        
     
Free Article


 


PubMed ID 12857905
         Pubmed Central ID 165263 


 



8.
Robert-Guroff M, Ensoli B, Peng B, Voltan R (submitted in 2004) Replication-competent Adenoviral Vectors. Patents issued: 8,926,987 (US in 2015); 9,216,214 (US in 2016); 9,732,359 (US in 2017).",https://intramural.nih.gov/search/searchview.taf?ipid=36162
39,BC005548-17,"October 01, 2003 -  September 30, 2004",Biological Functions of the Oncogenes Encoding Rho-Specific Exchange Factors,Toru  Miki; PhD,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Hiroki  Inoue (National Cancer Institute)



Takahiko  Hara (National Cancer Institute)



Hiroshi  Ishida (National Cancer Institute)



Keiju  Kamijo (National Cancer Institute)



Xiu-Fen  Liu (National Cancer Institute)



Fumihiko  Niiya (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hara T, Ishida H, Raziuddin R, Dorkhom S, Kamijo K, Miki T (2004). Novel kelch-like protein, KLEIP, is involved in actin assembly at cell-cell contact sites of Madin-Darby canine kidney cells. Mol Biol Cell  15, 1172-84.   https://doi.org/10.1091/mbc.e03-07-0531




PubMed



        
     
Free Article


 


PubMed ID 14668487
         Pubmed Central ID 363103 


 



2.
Lee JS, Kamijo K, Ohara N, Kitamura T, Miki T (2004). MgcRacGAP regulates cortical activity through RhoA during cytokinesis. Exp Cell Res  293, 275-82.   https://doi.org/10.1016/j.yexcr.2003.10.015




PubMed


 


PubMed ID 14729465
    
     


 



3.
Liu XF, Ishida H, Raziuddin R, Miki T (2004). Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity. Mol Cell Biol  24, 6665-75.   https://doi.org/10.1128/MCB.24.15.6665-6675.2004




PubMed



        
     
Free Article


 


PubMed ID 15254234
         Pubmed Central ID 444862 


 



4.
Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, Chen X, Lee CC, Lorenzi MV, Ohara N, Miki T (2004). Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem  279, 7169-79.   https://doi.org/10.1074/jbc.M306725200




PubMed


 


PubMed ID 14645260
    
     


 



5.
Saito S, Tatsumoto T, Lorenzi MV, Chedid M, Kapoor V, Sakata H, Rubin J, Miki T (2003). Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains. J Cell Biochem  90, 819-36.   https://doi.org/10.1002/jcb.10688




PubMed


 


PubMed ID 14587037
    
     


 



6.
Tatsumoto T, Sakata H, Dasso M, Miki T (2003). Potential roles of the nucleotide exchange factor ECT2 and Cdc42 GTPase in spindle assembly in Xenopus egg cell-free extracts. J Cell Biochem  90, 892-900.   https://doi.org/10.1002/jcb.10750




PubMed


 


PubMed ID 14624449",https://intramural.nih.gov/search/searchview.taf?ipid=36163
40,BC005553-35,"October 01, 2003 -  September 30, 2004",Biology of plasma cell tumor development,Stuart  Rudikoff; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,"Mary E Heller (National Cancer Institute)



Eugene  Kopantzev (National Cancer Institute)



Janet  Pumphrey (National Cancer Institute)



Ya-Wei  Qiang (National Cancer Institute)












Katie  Walsh  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Crowder C, Kopantzev E, Williams K, Lengel C, Miki T, Rudikoff S (2003). An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth. Oncogene  22, 649-59.   https://doi.org/10.1038/sj.onc.1206180




PubMed


 


PubMed ID 12569357
    
     


 



2.
Qiang YW, Endo Y, Rubin JS, Rudikoff S (2003). Wnt signaling in B-cell neoplasia. Oncogene  22, 1536-45.   https://doi.org/10.1038/sj.onc.1206239




PubMed


 


PubMed ID 12629517",https://intramural.nih.gov/search/searchview.taf?ipid=36164
41,BC005561-17,"October 01, 2003 -  September 30, 2004",Liver-Enriched Transcription Factors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Linda G Byrd (National Cancer Institute)



Connie  Cheung (National Cancer Institute)



Grace  Guo (National Cancer Institute)



Junko  Inoue (National Cancer Institute)



Insook  Kim (National Cancer Institute)



Kristopher W Krausz (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Zhang Y, Repa JJ, Inoue Y, Hayhurst GP, Gonzalez FJ, Mangelsdorf DJ (2004). Identification of a liver-specific uridine phosphorylase that is regulated by multiple lipid-sensing nuclear receptors. Mol Endocrinol  18, 851-62.   https://doi.org/10.1210/me.2003-0285




PubMed


 


PubMed ID 14715930",https://intramural.nih.gov/search/searchview.taf?ipid=36165
42,BC005562-17,"October 01, 2003 -  September 30, 2004",Xenobiotic-Metabolizing Enzymes,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Yusuke  Inoue (National Cancer Institute)



Kristopher W Krausz (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Andreola F, Hayhurst GP, Luo G, Ferguson SS, Gonzalez FJ, Goldstein JA, De Luca LM (2004). Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice. J Biol Chem  279, 3434-8.   https://doi.org/10.1074/jbc.M305832200




PubMed


 


PubMed ID 14623888
    
     


 



2.
Peterson TC, Peterson MR, Wornell PA, Blanchard MG, Gonzalez FJ (2004). Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction. Biochem Pharmacol  68, 395-402.   https://doi.org/10.1016/j.bcp.2004.03.035




PubMed


 


PubMed ID 15194011
    
     


 



3.
Takemoto K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, Yokoi T (2004). Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol  78, 309-15.   https://doi.org/10.1007/s00204-004-0550-7




PubMed


 


PubMed ID 15004665
    
     


 



4.
Wolf KK, Wood SG, Bement JL, Sinclair PR, Wrighton SA, Jeffery E, Gonzalez FJ, Sinclair JF (2004). Role of mouse CYP2E1 in the O-hydroxylation of p-nitrophenol: comparison of activities in hepatic microsomes from Cyp2e1(-/-) and wild-type mice. Drug Metab Dispos  32, 681-4.   https://doi.org/10.1124/dmd.32.7.681




PubMed


 


PubMed ID 15205381",https://intramural.nih.gov/search/searchview.taf?ipid=36166
43,BC005596-35,"October 01, 2003 -  September 30, 2004",Pathogenesis of plasma cell tumors in mice,Michael  Potter; MD,Beverly  Mock; PhD,"Laboratory of Genetics, NCI",NULL,NULL,"Elizabeth B Mushinski (National Cancer Institute)



Arthur L Shaffer (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)












Gary M Jones  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Janz S, Potter M, Rabkin CS (2003). Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer  36, 211-23.   https://doi.org/10.1002/gcc.10178




PubMed


 


PubMed ID 12557221
    
     


 



2.
Potter M (2003). Neoplastic development in plasma cells. Immunol Rev  194, 177-95.   https://doi.org/10.1034/j.1600-065x.2003.00061.x




PubMed


 


PubMed ID 12846815",https://intramural.nih.gov/search/searchview.taf?ipid=36167
44,BC005597-15,"October 01, 2003 -  September 30, 2004",Biochemistry of Energy-Dependent (Intracellular) Protein Degradation,"Michael  Maurizi; PhD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Satyendra K Singh (National Cancer Institute)












Alexander  Wlodawer; PhD  (Macromolecular Crystallography Laboratory)","Ann  Ginsburg; PhD (NHLBI) 



Alasdair C Steven; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Botos I, Melnikov EE, Cherry S, Khalatova AG, Rasulova FS, Tropea JE, Maurizi MR, Rotanova TV, Gustchina A, Wlodawer A (2004). Crystal structure of the AAA+ alpha domain of E. coli Lon protease at 1.9A resolution. J Struct Biol  146, 113-22.   https://doi.org/10.1016/j.jsb.2003.09.003




PubMed


 


PubMed ID 15037242
    
     


 



2.
Botos I, Melnikov EE, Cherry S, Tropea JE, Khalatova AG, Rasulova F, Dauter Z, Maurizi MR, Rotanova TV, Wlodawer A, Gustchina A (2004). The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J Biol Chem  279, 8140-8.   https://doi.org/10.1074/jbc.M312243200




PubMed


 


PubMed ID 14665623
    
     


 



3.
Ishikawa T, Maurizi MR, Steven AC (2004). The N-terminal substrate-binding domain of ClpA unfoldase is highly mobile and extends axially from the distal surface of ClpAP protease. J Struct Biol  146, 180-8.   https://doi.org/10.1016/j.jsb.2003.11.018




PubMed


 


PubMed ID 15037249
    
     


 



4.
Kang SG, Maurizi MR, Thompson M, Mueser T, Ahvazi B (2004). Crystallography and mutagenesis point to an essential role for the N-terminus of human mitochondrial ClpP. J Struct Biol  148, 338-52.   https://doi.org/10.1016/j.jsb.2004.07.004




PubMed


 


PubMed ID 15522782
    
     


 



5.
Maurizi MR, Xia D (2004). Protein binding and disruption by Clp/Hsp100 chaperones. Structure  12, 175-83.   https://doi.org/10.1016/j.str.2004.01.021




PubMed


 


PubMed ID 14962378
    
     


 



6.
Ortega J, Lee HS, Maurizi MR, Steven AC (2004). ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase to form active hybrid complexes. J Struct Biol  146, 217-26.   https://doi.org/10.1016/j.jsb.2003.11.023




PubMed


 


PubMed ID 15037252
    
     


 



7.
Xia D, Esser L, Singh SK, Guo F, Maurizi MR (2004). Crystallographic investigation of peptide binding sites in the N-domain of the ClpA chaperone. J Struct Biol  146, 166-79.   https://doi.org/10.1016/j.jsb.2003.11.025




PubMed


 


PubMed ID 15037248",https://intramural.nih.gov/search/searchview.taf?ipid=36168
45,BC005598-15,"October 01, 2003 -  September 30, 2004",Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells,"Michael Marc Gottesman; MD



IRP Faculty Profile",NULL,"Laboratory of Cell Biology, NCI","Claudina  Aleman; PhD







Jean-Philippe  Annereau




Adorjan  Aszalos




G. Kevin  Chen; PhD




Xingjie  Liang




Gergely  Szakacs",NULL,"Suresh V Ambudkar; PhD (Transport Biochemistry Section)



Carol O Cardarelli (National Cancer Institute)



Chava  Kimchi-Sarfaty (National Cancer Institute)



Ding wu  Shen; PhD (National Cancer Institute)



Wilfred D Vieira (National Cancer Institute)












Di S Xia; PhD, MS, BS  (Crystallography Section)",NULL,"Ordered by publication type and then author name.



1.
Liang XJ, Shen DW, Garfield S, Gottesman MM (2003). Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines. Cancer Res  63, 5909-16.




PubMed


 


PubMed ID 14522917",https://intramural.nih.gov/search/searchview.taf?ipid=36169
46,BC005599-14,"October 01, 2003 -  September 30, 2004","Tumor Suppressor Protein, p53","Ettore  Appella; MD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"Michael  Feldhaus
(Battelle/Pacific Northwest National Laboratory)





Yang  Xu
( Biology Dept, University of California, San Diego)





Larry  Donehower
(Baylor College of Medicine, Mol. Virol. & Microbiol)





Colin C Anderson; PhD","Sharlyn  Mazur; PhD (National Cancer Institute)












Oleg  Demidov  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ (2004). Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet  36, 343-50.   https://doi.org/10.1038/ng1317




PubMed


 


PubMed ID 14991053
    
     


 



2.
Lu X, Bocangel D, Nannenga B, Yamaguchi H, Appella E, Donehower LA (2004). The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell  15, 621-34.   https://doi.org/10.1016/j.molcel.2004.08.007




PubMed


 


PubMed ID 15327777",https://intramural.nih.gov/search/searchview.taf?ipid=36170
47,BC005617-16,"October 01, 2003 -  September 30, 2004",Molecular mechanisms of resistance to TGF-beta signaling,Seong-Jin  Kim; PhD,Anita B Roberts; PhD,"Laboratory of Cell Regulation and Carcinogenesis, NCI",NULL,"Yung-Jue  Bang
(Cancer Research Institute, Seoul National University School of Medicine)





Kyeong Sook  Choi
(Institute for Medical Sciences, Ajou University School of Medicine)





Joseph  Murray
(Department of Gastroenterology, Mayo Clinic)





Poul  Sorensen
(Department of Pathology and Pediatrics, University British Columbia)





Paul S.  Oh
(Department of Physiology and Functional Genomics, University of Florida College of Medicine)





Sanford  Markowitz
(Ireland Cancer Center, Case Western Reserve University School of Medicine)",Steven  Libutti; MD  (Surgl Metabolism Sect),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36171
48,BC005620-16,"October 01, 2003 -  September 30, 2004",Development of Vaccines Against Retrovirus Infection in Primates,Raoul  Benveniste; PhD,Robert  Wiltrout; PhD,"Laboratory of Cellular Oncology, NCI",NULL,"Jeffrey D Lifson; MD
(NCI)





Nancy  Haigwood
(Seattle Biomedical Research Institute)





Richard  Grant
(National Primate Research Center, University of Washington)





Larry Ottis Arthur






Shiu-Lok  Hu
(National Primate Research Center, University of Washington)
















Mary  Carrington
(IRSP, SAIC-Frederick)",NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36172
49,BC005643-14,"October 01, 2003 -  September 30, 2004",Mechanism and regulation of mRNA export,Ravi  Dhar; PhD,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Anjan  Guhathakurta; MSc, MTech (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Thakurta AG, Gopal G, Yoon JH, Saha T, Dhar R (2004). Conserved nuclear export sequences in Schizosaccharomyces pombe Mex67 and human TAP function in mRNA export by direct nuclear pore interactions. J Biol Chem  279, 17434-42.   https://doi.org/10.1074/jbc.M309731200




PubMed


 


PubMed ID 14963046",https://intramural.nih.gov/search/searchview.taf?ipid=36173
50,BC005645-15,"October 01, 2003 -  September 30, 2004",T-cell Transformation by Oncoviruses,"Genoveffa  Franchini; MD



IRP Faculty Profile","Jay Arthur Berzofsky; MD, PhD","ANIMAL MODELS and RETROVIRAL VACCINES SECT, NCI",NULL,"Michael  Lairmore
(Ohio State University)
















Patrick  Green
(Ohio State University)","Corrado  Gurgo (National Cancer Institute)



Anna  Hryniewicz (National Cancer Institute)



Fullen  Jake (National Cancer Institute)



Janos  Nacsa (National Cancer Institute)



Robyn  Parks (National Cancer Institute)



Wen-Po  Tsai (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Franchini G, Nicot C, Johnson JM (2003). Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res  89, 69-132.   https://doi.org/10.1016/s0065-230x(03)01003-0




PubMed


 


PubMed ID 14587871
    
     


 



2.
Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G (2004). HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med  10, 197-201.   https://doi.org/10.1038/nm984




PubMed


 


PubMed ID 14730358
    
     


 



3.
Younis I, Khair L, Dundr M, Lairmore MD, Franchini G, Green PL (2004). Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J Virol  78, 11077-83.   https://doi.org/10.1128/JVI.78.20.11077-11083.2004




PubMed



        
     
Free Article


 


PubMed ID 15452228
         Pubmed Central ID 521841",https://intramural.nih.gov/search/searchview.taf?ipid=36174
51,BC005652-14,"October 01, 2003 -  September 30, 2004",Identification of Single Nucleotide Polymorphisms in Cancer-Related Genes,"Michael  Dean; PhD



IRP Faculty Profile",Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Samuel  Broder
(Celera)





Kenneth  Offitt
(Sloan Kettering)





Stanley  Burt
(SAIC, ABCC)
















James  Lupski
(Genetics, Baylor University)","Sergey V Shulenin (National Cancer Institute)



Bernard C Gerrard (National Cancer Institute)



Mary  Mcnally (National Cancer Institute)












Julie  Bergeron  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Collins JR, Stephens RM, Gold B, Long B, Dean M, Burt SK (2003). An exhaustive DNA micro-satellite map of the human genome using high performance computing. Genomics  82, 10-9.   https://doi.org/10.1016/s0888-7543(03)00076-4




PubMed


 


PubMed ID 12809672
    
     


 



2.
Duh FM, Fivash M, Moody M, Li Lung M, Guo X, Stanbridge E, Dean M, Voevoda M, Hu LF, Kashuba V, Zabarovsky ER, Qian CN, Godbole S, Tean Teh B, Lerman MI (2004). Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer. Mol Cell Probes  18, 39-44.   https://doi.org/10.1016/j.mcp.2003.09.002




PubMed


 


PubMed ID 15036368
    
     


 



3.
Ogino S, Wilson RB, Gold B, Hawley P, Grody WW   (2004) Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening.  Genet Med 6:439-49.




PubMed


 


PubMed ID 15371910",https://intramural.nih.gov/search/searchview.taf?ipid=36110
52,BC005657-15,"October 01, 2003 -  September 30, 2004",Molecular Basis for the Pathogenesis of Murine Retroviruses,Sandra  Ruscetti; PhD,Nancy H Colburn; PhD,"Retroviral Molecular Pathogenesis Section, NCI",NULL,"Susan  Wilt
(VAMC, Bronx)





Michiaki  Masuda
(Dokkyo University, Japan)





Paul  Hoffman
(VAMC, Baltimore)","Charlotte A Hanson (National Cancer Institute)



Kazuo  Nishigaki (National Cancer Institute)



Delores M Thompson (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36175
53,BC005673-14,"October 01, 2003 -  September 30, 2004",Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therap,Larry K Keefer; PhD,NULL,"Laboratory of Comparative Carcinogenesis, NCI",NULL,"Scott  Bohle
(Department of Chemistry, McGill University)





Paul  Shami
(Medical Oncology, U of Utah)





Mark  Meyerhoff
(Department of Chemistry, University of Michigan)





Christian  Bogdan
(Universitat Freiburg, Institut fur Medizinische Mikrobiologie und Hygiene)





Kenneth  Tew
(Pharmacology, Fox Chase Cancer Center)





Joseph  Ivanic
(Adv. Biomed. Computing Center, SAIC)


Show all 7","Paul J Donovan (National Cancer Institute)



Michael  Waalkes; PhD (Inorganic Carcinogenesis Section)



Raymond  Nims (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)












Michael  Citro  (National Cancer Institute)","Edward H. Oldfield; MD (NINDS) 



Ryszard  Pluta; MD, PhD (NINDS) 



George J Grimes (CC)","Ordered by publication type and then author name.



1.
Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NH (2003). Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther  2, 1285-93.




PubMed


 


PubMed ID 14707269
    
     


 



2.
Liu J, Li C, Qu W, Leslie E, Bonifant CL, Buzard GS, Saavedra JE, Keefer LK, Waalkes MP (2004). Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol Cancer Ther  3, 709-14.




PubMed


 


PubMed ID 15210857
    
     


 



3.
Shami PJ, Saavedra JE, Wang LY, Bonifant CL, Diwan BA, Singh SV, Gu Y, Fox SD, Buzard GS, Citro ML, Waterhouse DJ, Davies KM, Ji X, Keefer LK (2003). JS-K, a glutathione/glutathione S-transferase-activated nitric oxide donor of the diazeniumdiolate class with potent antineoplastic activity. Mol Cancer Ther  2, 409-17.




PubMed


 


PubMed ID 12700285",https://intramural.nih.gov/search/searchview.taf?ipid=36176
54,BC005681-14,"October 01, 2003 -  September 30, 2004",Approaches to Gene Mapping Development and Applications,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Holli B Hutcheson (National Cancer Institute)



Bailey  Kessing (National Cancer Institute)



Michael J Malasky (National Cancer Institute)



Janice S Martenson (National Cancer Institute)



Mary  Mcnally (National Cancer Institute)



Shawn R Palmer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, et al. [7 more authors] (2004). A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet  74, 1001-13.   https://doi.org/10.1086/420856




PubMed



        
     
Free Article


 


PubMed ID 15088270
         Pubmed Central ID 1181963",https://intramural.nih.gov/search/searchview.taf?ipid=36177
55,BC005688-14,"October 01, 2003 -  September 30, 2004",Combination of Vaccine Modalities to Prevent HIV-I Infection and Modeling of Ear,"Genoveffa  Franchini; MD



IRP Faculty Profile",NULL,"ANIMAL MODELS and RETROVIRAL VACCINES SECT, NCI",NULL,"Michel  Morre
(Cytheris)





Jim  Tartaglia
(Aventis Pasteur)





Hana  Golding; PhD
(Division of Viral Products, CBER, FDA)





Dorothy E Scott; PhD
(Division of Hematology, CBER, FDA)





Mike  Bray
(NIAID)





Keith A.  Reimann
(Beth Israel Deaconess Medical Center)


Show all 9","Terry J Fry (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Barbara K Felber (National Cancer Institute)



George N Pavlakis; MD, PhD (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)","Bernard  Moss; MD, PhD (NIAID) 



Vanessa  Hirsch (NIAID) 



Nancy R Miller (NIAID)","Ordered by publication type and then author name.



1.
Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, Berzofsky JA (2003). Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A  100, 9458-63.   https://doi.org/10.1073/pnas.1233578100




PubMed



        
     
Free Article


 


PubMed ID 12869693
         Pubmed Central ID 170940 


 



2.
Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, Lewis MG, Berzofsky JA, Belyakov IM, Moss B, Tartaglia J, Bray M, Hirsch V, Golding H, Franchini G (2003). Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques. J Infect Dis  188, 1181-91.   https://doi.org/10.1086/378518




PubMed


 


PubMed ID 14551889
    
     


 



3.
Moniuszko M, Fry T, Tsai WP, Morre M, Assouline B, Cortez P, Lewis MG, Cairns S, Mackall C, Franchini G (2004). Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol  78, 9740-9.   https://doi.org/10.1128/JVI.78.18.9740-9749.2004




PubMed



        
     
Free Article


 


PubMed ID 15331707
         Pubmed Central ID 515001 


 



4.
Nacsa J, Radaelli A, Edghill-Smith Y, Venzon D, Tsai WP, Morghen Cde G, Panicali D, Tartaglia J, Franchini G (2004). Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. Vaccine  22, 597-606.   https://doi.org/10.1016/j.vaccine.2003.08.028




PubMed


 


PubMed ID 14741150
    
     


 



5.
Stevceva L, Moniuszko M, Alvarez X, Lackner AA, Franchini G (2004). Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques. Virology  319, 190-200.   https://doi.org/10.1016/j.virol.2003.08.046




PubMed


 


PubMed ID 14980480",https://intramural.nih.gov/search/searchview.taf?ipid=36178
56,BC005691-13,"October 01, 2003 -  September 30, 2004",Inhibition of p53 Tumor Suppressor Function by HTLV-I,John N Brady; PhD,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Michael  Radonovich (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)












Seong-Jin  Kim; PhD  (Laboratory of Cell Regulation and Carcinogenesis)",NULL,"Ordered by publication type and then author name.



1.
Chowdhury IH, Radonovich M, Mahieux R, Pise-Masison C, Muralidhar S, Brady JN (2003). P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway. J Gen Virol  84, 897-906.   https://doi.org/10.1099/vir.0.18753-0




PubMed


 


PubMed ID 12655090
    
     


 



2.
Dohoney KM, Guillerm C, Whiteford C, Elbi C, Lambert PF, Hager GL, Brady JN (2004). Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene  23, 49-57.   https://doi.org/10.1038/sj.onc.1207005




PubMed


 


PubMed ID 14712210
    
     


 



3.
Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA (2004). HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood  104, 1490-7.   https://doi.org/10.1182/blood-2003-12-4174




PubMed


 


PubMed ID 15155458
    
     


 



4.
Park HU, Jeong JH, Chung JH, Brady JN (2004). Human T-cell leukemia virus type 1 Tax interacts with Chk1 and attenuates DNA-damage induced G2 arrest mediated by Chk1. Oncogene  23, 4966-74.   https://doi.org/10.1038/sj.onc.1207644




PubMed


 


PubMed ID 15107832",https://intramural.nih.gov/search/searchview.taf?ipid=36179
57,BC005708-13,"October 01, 2003 -  September 30, 2004",Xenobiotic Receptors,"Frank Jess Gonzalez; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Linda G Byrd (National Cancer Institute)



Connie  Cheung (National Cancer Institute)



Grace  Guo (National Cancer Institute)



Junko  Inoue (National Cancer Institute)



Yusuke  Inoue (National Cancer Institute)



Insook  Kim (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Akiyama TE, Lambert G, Nicol CJ, Matsusue K, Peters JM, Brewer HB, Gonzalez FJ (2004). Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet. J Biol Chem  279, 20874-81.   https://doi.org/10.1074/jbc.M312802200




PubMed


 


PubMed ID 15001574
    
     


 



2.
Guo GL, Moffit JS, Nicol CJ, Ward JM, Aleksunes LA, Slitt AL, Kliewer SA, Manautou JE, Gonzalez FJ (2004). Enhanced acetaminophen toxicity by activation of the pregnane X receptor. Toxicol Sci  82, 374-80.   https://doi.org/10.1093/toxsci/kfh286




PubMed


 


PubMed ID 15456926
    
     


 



3.
Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, Peters JM (2004). Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med  10, 481-3.   https://doi.org/10.1038/nm1026




PubMed


 


PubMed ID 15048110
    
     


 



4.
Jia Y, Qi C, Kashireddi P, Surapureddi S, Zhu YJ, Rao MS, Le Roith D, Chambon P, Gonzalez FJ, Reddy JK (2004). Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver. J Biol Chem  279, 24427-34.   https://doi.org/10.1074/jbc.M402391200




PubMed


 


PubMed ID 15150259
    
     


 



5.
Jiang YJ, Lu B, Xu FY, Gartshore J, Taylor WA, Halayko AJ, Gonzalez FJ, Takasaki J, Choy PC, Hatch GM (2004). Stimulation of cardiac cardiolipin biosynthesis by PPARalpha activation. J Lipid Res  45, 244-52.   https://doi.org/10.1194/jlr.M300314-JLR200




PubMed


 


PubMed ID 14594999
    
     


 



6.
Kim DJ, Akiyama TE, Harman FS, Burns AM, Shan W, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM (2004). Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem  279, 23719-27.   https://doi.org/10.1074/jbc.M312063200




PubMed


 


PubMed ID 15033975
    
     


 



7.
Miyata M, Tozawa A, Otsuka H, Nakamura T, Nagata K, Gonzalez FJ, Yamazoe Y (2005). Role of farnesoid X receptor in the enhancement of canalicular bile acid output and excretion of unconjugated bile acids: a mechanism for protection against cholic acid-induced liver toxicity. J Pharmacol Exp Ther  312, 759-66.   https://doi.org/10.1124/jpet.104.076158




PubMed


 


PubMed ID 15466244
    
     


 



8.
Takemoto K, Nakajima M, Fujiki Y, Katoh M, Gonzalez FJ, Yokoi T (2004). Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol  78, 309-15.   https://doi.org/10.1007/s00204-004-0550-7




PubMed


 


PubMed ID 15004665",https://intramural.nih.gov/search/searchview.taf?ipid=36181
58,BC005725-12,"October 01, 2003 -  September 30, 2004",ABC Transporters in Human Disease and Multidrug Resistance,"Michael  Dean; PhD



IRP Faculty Profile",Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Zhang-Qun  Chen (National Cancer Institute)



Bernard C Gerrard (National Cancer Institute)



Sergey V Shulenin (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)","Hollis Bryan Brewer; MD (NHLBI) 



Alan T Remaley; MD, PhD (CC)","Ordered by publication type and then author name.



1.
Annilo T, Chen ZQ, Shulenin S, Dean M (2003). Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. Mamm Genome  14, 7-20.   https://doi.org/10.1007/s00335-002-2229-9




PubMed


 


PubMed ID 12532264
    
     


 



2.
Dean M (2003). Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. Hum Mutat  22, 261-74.   https://doi.org/10.1002/humu.10259




PubMed


 


PubMed ID 12955713",https://intramural.nih.gov/search/searchview.taf?ipid=36111
59,BC005740-12,"October 01, 2003 -  September 30, 2004",Transgenic Models for Prostate and Breast Cancer,Jeffrey E Green; MD,Anita B Roberts; PhD,"Laboratory of Cell Regulation and Carcinogenesis, NCI","John J Letterio; MD



Quang T Nguyen","Hynda K Kleinman; PhD
(NIDCR)





Ann  Chambers
(London Regional Cancer Center)





Eva  Lee
(UC Irvine)





Alfonso  Calvo
(University of Pamplona)





Maarten  Bosland
(NYU)





Sundaram  Ramakrishnan
(U of Minn)


Show all 7","Kartiki  Desai (National Cancer Institute)



Richard  Simon (Biometrics Research Branch)



Tamaro  Hudson (National Cancer Institute)



Jung-Im  Huh (National Cancer Institute)



Zi-yao  Liu (National Cancer Institute)



Aleksandra M Michalowska (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR (2003). Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol  12, 63-70.   https://doi.org/10.1097/00019606-200306000-00001




PubMed


 


PubMed ID 12766610
    
     


 



2.
Fargiano AA, Desai KV, Green JE (2003). Interrogating mouse mammary cancer models: insights from gene expression profiling. J Mammary Gland Biol Neoplasia  8, 321-34.   https://doi.org/10.1023/b:jomg.0000010032.05234.6f




PubMed


 


PubMed ID 14973376
    
     


 



3.
Gonzalez-Moreno O, Calvo A, Joshi BH, Abasolo I, Leland P, Wang Z, Montuenga L, Puri RK, Green JE (2005). Gene expression profiling identifies IL-13 receptor alpha 2 chain as a therapeutic target in prostate tumor cells overexpressing adrenomedullin. Int J Cancer  114, 870-8.   https://doi.org/10.1002/ijc.20789




PubMed


 


PubMed ID 15609296
    
     


 



4.
Holzer RG, MacDougall C, Cortright G, Atwood K, Green JE, Jorcyk CL (2003). Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model. Breast Cancer Res Treat  77, 65-76.   https://doi.org/10.1023/a:1021175931177




PubMed


 


PubMed ID 12602905
    
     


 



5.
Kaczmarczyk SJ, Green JE (2003). Induction of cre recombinase activity using modified androgen receptor ligand binding domains: a sensitive assay for ligand-receptor interactions. Nucleic Acids Res  31, e86.   https://doi.org/10.1093/nar/gng087




PubMed



        
     
Free Article


 


PubMed ID 12888538
         Pubmed Central ID 169976 


 



6.
Kavanaugh C, Green JE (2003). The use of genetically altered mice for breast cancer prevention studies. J Nutr  133, 2404S-2409S.   https://doi.org/10.1093/jn/133.7.2404S




PubMed


 


PubMed ID 12840216
    
     


 



7.
Robertson FG, Harris J, Naylor MJ, Oakes SR, Kindblom J, Dillner K, Wennbo H, Trnell J, Kelly PA, Green J, Ormandy CJ   (2003) Prostate development and carcinogenesis in prolactin receptor knockout mice.  Endocrinology 144:3196-205.




PubMed


 


PubMed ID 12810576
    
     


 



8.
Shibata MA, Kavanaugh C, Shibata E, Abe H, Nguyen P, Otsuki Y, Trepel JB, Green JE (2003). Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis  24, 453-9.   https://doi.org/10.1093/carcin/24.3.453




PubMed


 


PubMed ID 12663504
    
     


 



9.
Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S (2003). Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Res  63, 4384-8.




PubMed


 


PubMed ID 12907608",https://intramural.nih.gov/search/searchview.taf?ipid=36182
60,BC005742-12,"October 01, 2003 -  September 30, 2004",Biology of Vascular Endothelial Growth Factors in the Mammary Gland,Unnur P Thorgeirsson; MD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Manabu  Akahane (National Cancer Institute)



Takemi  Akahane (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36183
61,BC005744-12,"October 01, 2003 -  September 30, 2004",Biological Effects of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1),Unnur P Thorgeirsson; MD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Manabu  Akahane (National Cancer Institute)



Takemi  Akahane (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
de Lorenzo MS, Ripoll GV, Yoshiji H, Yamazaki M, Thorgeirsson UP, Alonso DF, Gomez DE (2003). Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1. In Vivo  17, 45-50.




PubMed


 


PubMed ID 12655789",https://intramural.nih.gov/search/searchview.taf?ipid=36184
62,BC005748-12,"October 01, 2003 -  September 30, 2004",Acquisition of Genomic Alterations During Mammary Gland Cancer Induction in Rats,Elizabeth  Snyderwine; PhD,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,"Cunping  Qiu (National Cancer Institute)



Liang  Shan (National Cancer Institute)



Andriana  Papaconstantinou (National Cancer Institute)



Ilanchezhian  Shanmugam (National Cancer Institute)



Minshu R Yu (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Qiu C, Shan L, Yu M, Snyderwine EG (2003). Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res  63, 5674-8.




PubMed


 


PubMed ID 14522882
    
     


 



2.
Shan L, Yu M, Qiu C, Snyderwine EG (2003). Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas. Am J Pathol  163, 2495-502.   https://doi.org/10.1016/S0002-9440(10)63604-8




PubMed



        
     
Free Article


 


PubMed ID 14633621
         Pubmed Central ID 1892385",https://intramural.nih.gov/search/searchview.taf?ipid=36185
63,BC005753-12,"October 01, 2003 -  September 30, 2004",HIV Tat Transcriptional Activation,John N Brady; PhD,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,"Fatah  Kashanchi
(Department of Biochemistry, George Washington University Medical School)





Ajit  Kumar
(Dept. of Biochemistry, George Washington University Medical School)",NULL,NULL,"Ordered by publication type and then author name.



1.
Watanabe T, Sugaya M, Atkins AM, Aquilino EA, Yang A, Borris DL, Brady J, Blauvelt A (2003). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells. J Virol  77, 6188-96.   https://doi.org/10.1128/jvi.77.11.6188-6196.2003




PubMed



        
     
Free Article


 


PubMed ID 12743275
         Pubmed Central ID 155023 


 



2.
Zhou M, Deng L, Kashanchi F, Brady JN, Shatkin AJ, Kumar A (2003). The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci U S A  100, 12666-71.   https://doi.org/10.1073/pnas.1835726100




PubMed



        
     
Free Article


 


PubMed ID 14569024
         Pubmed Central ID 240675",https://intramural.nih.gov/search/searchview.taf?ipid=36186
64,BC005785-10,"October 01, 2003 -  September 30, 2004",TGF-betas in breast cancer progression,"Lalage  Wakefield; PhD



IRP Faculty Profile",Anita B Roberts; PhD,"Laboratory of Cell Regulation and Carcinogenesis, NCI",NULL,"Jan  Pinkas
(PreClinical Tumor Biology, Genzyme Corp.)





Scott  Lonning
(Gene Therapy, Genzyme Corp.)





Frederick W.  Miller
(National Institute of Environmental Health Sciences, Chapel Hill, NC)
















Erwin  Bottinger
(Dept. of Medicine, Mount Sinai School of Medicine)","Miriam R Anver (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Roberts AB, Wakefield LM (2003). The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A  100, 8621-3.   https://doi.org/10.1073/pnas.1633291100




PubMed



        
     
Free Article


 


PubMed ID 12861075
         Pubmed Central ID 166359 


 



2.
Tang B, Vu M, Booker T, Santner SJ, Miller FR, Anver MR, Wakefield LM (2003). TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest  112, 1116-24.   https://doi.org/10.1172/JCI18899




PubMed



        
     
Free Article


 


PubMed ID 14523048
         Pubmed Central ID 198530 


 



3.
Tian F, DaCosta Byfield S, Parks WT, Yoo S, Felici A, Tang B, Piek E, Wakefield LM, Roberts AB (2003). Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res  63, 8284-92.




PubMed


 


PubMed ID 14678987
    
     


 



4.
Wakefield LM, Thordarson G, Nieto AI, Shyamala G, Galvez JJ, Anver MR, Cardiff RD (2003). Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice: implications for mouse modeling. Comp Med  53, 424-32.




PubMed


 


PubMed ID 14524419",https://intramural.nih.gov/search/searchview.taf?ipid=36187
65,BC005789-10,"October 01, 2003 -  September 30, 2004",In Vivo Mutagenicity and Carcinogenicity of Heterocyclic Amines in Transgenic Ro,Elizabeth  Snyderwine; PhD,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,"Liang  Shan (National Cancer Institute)



Minshu R Yu (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Snyderwine EG, Yoon HS, Knight-Jones LP, Tran M, Schut HA, Yu M (2003). Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture. Mutagenesis  18, 7-12.   https://doi.org/10.1093/mutage/18.1.7




PubMed


 


PubMed ID 12473729",https://intramural.nih.gov/search/searchview.taf?ipid=36188
66,BC005793-10,"October 01, 2003 -  September 30, 2004",Mechanism of viral hepatitis-mediated hepatocarcinogenesis,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,NULL,"Marshonna J Forgues (National Cancer Institute)



Wei  Wang; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Forgues M, Difilippantonio MJ, Linke SP, Ried T, Nagashima K, Feden J, Valerie K, Fukasawa K, Wang XW (2003). Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol  23, 5282-92.   https://doi.org/10.1128/mcb.23.15.5282-5292.2003




PubMed



        
     
Free Article


 


PubMed ID 12861014
         Pubmed Central ID 165739 


 



2.
Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, Yang Q, Garfield SH, Stürzbecher HW, Harris CC (2003). p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res  63, 2596-605.




PubMed


 


PubMed ID 12750285
    
     


 



3.
Staib F, Hussain SP, Hofseth LJ, Wang XW, Harris CC (2003). TP53 and liver carcinogenesis. Hum Mutat  21, 201-16.   https://doi.org/10.1002/humu.10176




PubMed


 


PubMed ID 12619106",https://intramural.nih.gov/search/searchview.taf?ipid=36189
67,BC005795-10,"October 01, 2003 -  September 30, 2004",p53 Tumor Suppressor Pathway,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,"Ian  Hickson; PhD
(Department ICRF Laboratories, Organization name Institute of Molecular Medicine University of Oxford)





V.  Rotter
(Weizman Institute of Science)





N.  Ellis
(Memorial Sloan Kettering Cancer Center)





M.  Rusin
(Maria-Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland, Institute of Oncology)





J.  Yokota
(National Cancer Center Research Institute)





K.  Sasajima
(Nippon Medical School)


Show all 7","Remy Marie Pedeux (National Cancer Institute)



Elisa A Spillare (National Cancer Institute)



Qin  Yang (National Cancer Institute)



Ran  Zhang (National Cancer Institute)












John  Bradsher  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
de Souza-Pinto NC, Harris CC, Bohr VA (2004). p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene  23, 6559-68.   https://doi.org/10.1038/sj.onc.1207874




PubMed


 


PubMed ID 15208669
    
     


 



2.
Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K   (2003) ING1 represses transcription by direct DNA binding and through effects on p53.  Cancer Res 63:5785-92.




PubMed


 


PubMed ID 14522900
    
     


 



3.
Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, Henning W, Pedeux R, Wang XW, Hofseth LJ, Yang Q, Garfield SH, Stürzbecher HW, Harris CC (2003). p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Res  63, 2596-605.




PubMed


 


PubMed ID 12750285
    
     


 



4.
Nagashima M, Shiseki M, Pedeux RM, Okamura S, Kitahama-Shiseki M, Miura K, Yokota J, Harris CC   (2003) A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.  Oncogene 22:343-50.




PubMed


 


PubMed ID 12545155
    
     


 



5.
Seker H, Rubbi C, Linke SP, Bowman ED, Garfield S, Hansen L, Borden KL, Milner J, Harris CC   (2003) UV-C-induced DNA damage leads to p53-dependent nuclear trafficking of PML.  Oncogene 22:1620-8.




PubMed


 


PubMed ID 12642865
    
     


 



6.
Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, Valerie K, Shay JW, Ellis NA, Wasylyk B, Harris CC   (2003) BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination.  EMBO J 22:1210-22.




PubMed



        
     
Free Article


 


PubMed ID 12606585
         Pubmed Central ID 150347 


 



7.
Shiseki M, Nagashima M, Pedeux RM, Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y, Appella E, Yokota J, Harris CC (2003). p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res  63, 2373-8.




PubMed


 


PubMed ID 12750254",https://intramural.nih.gov/search/searchview.taf?ipid=36191
68,BC005800-10,"October 01, 2003 -  September 30, 2004",Discovering Disease Susceptibility Genes in African Americans,Michael W Smith,Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Michael  Klag
(Johns Hopkins University)





David  Reich
(Harvard University)





David  Thomas
(Johns Hopkins University)





Nick  Patterson
(Broad Institute/MIT)
















Lind  Kao
(Johns Hopkins University)","Mary A Thompson (National Cancer Institute)



Michael E Weedon (National Cancer Institute)



Yvette  Berthier-Schaad (National Cancer Institute)",Jeffrey Burnett Kopp; MD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36192
69,BC006140-28,"October 01, 2003 -  September 30, 2004",Studies of Histone Functions in Chromatin; H2AX and DNA DSBs,"William M Bonner; PhD



IRP Faculty Profile",Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,"David  Brenner
(Columbia University)





Olga  Kovalchuk
(Department of Biological Sciences, University of Lethbridge)
















Igor  Panyutin
(NUCLEAR MEDICINE DEPT, CC)","Natasha  Sinogeeva (National Cancer Institute)



Duane  Pilch (National Cancer Institute)



Christophe  Redon (National Cancer Institute)



Olga A Sedelnikova; PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Nicolae C Popescu; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36193
70,BC006150-23,"October 01, 2003 -  September 30, 2004","DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs","Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Kenneth H Kraemer; MD (LAB MOLECULAR CARCINOGENESIS)



Elise C Kohn; MD (Tumor Invasion And Metastases Sect)



Robert  Shoemaker (DISCOVERY SECT)



Susan  Bates; MD (National Cancer Institute)












Nicolae C Popescu; PhD  (Molecular Cytogenetics Section)",NULL,"Ordered by publication type and then author name.



1.
Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman J (2003). Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol  4, 145-53.   https://doi.org/10.1038/ni885




PubMed


 


PubMed ID 12524539
    
     


 



2.
Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, Pilch DR, Rogakou EP, Celeste A, Chen HT, Nussenzweig A, Aladjem MI, Bonner WM, Pommier Y (2003). Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem  278, 20303-12.   https://doi.org/10.1074/jbc.M300198200




PubMed


 


PubMed ID 12660252
    
     


 



3.
Pommier Y (2004). Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem Anticancer Agents  4, 429-34.   https://doi.org/10.2174/1568011043352777




PubMed


 


PubMed ID 15379698
    
     


 



4.
Pommier Y, Kohn KW (2003). [Cell cycle and checkpoints in oncology: new therapeutic targets]. Med Sci (Paris)  19, 173-86.   https://doi.org/10.1051/medsci/2003192173




PubMed


 


PubMed ID 12836612
    
     


 



5.
Sordet O, Khan QA, Kohn KW, Pommier Y (2003). Apoptosis induced by topoisomerase inhibitors. Curr Med Chem Anticancer Agents  3, 271-90.   https://doi.org/10.2174/1568011033482378




PubMed


 


PubMed ID 12769773
    
     


 



6.
Yoshida A, Urasaki Y, Waltham M, Bergman AC, Pourquier P, Rothwell DG, Inuzuka M, Weinstein JN, Ueda T, Appella E, Hickson ID, Pommier Y (2003). Human apurinic/apyrimidinic endonuclease (Ape1) and its N-terminal truncated form (AN34) are involved in DNA fragmentation during apoptosis. J Biol Chem  278, 37768-76.   https://doi.org/10.1074/jbc.M304914200




PubMed


 


PubMed ID 12842873
    
     


 



7.
Yu D, Khan E, Khaleque MA, Lee J, Laco G, Kohlhagen G, Kharbanda S, Cheng YC, Pommier Y, Bharti A (2004). Phosphorylation of DNA topoisomerase I by the c-Abl tyrosine kinase confers camptothecin sensitivity. J Biol Chem  279, 51851-61.   https://doi.org/10.1074/jbc.M404396200




PubMed


 


PubMed ID 15448168",https://intramural.nih.gov/search/searchview.taf?ipid=36194
71,BC006161-21,"October 01, 2003 -  September 30, 2004",DNA Topoisomerases as Target of Action of Anticancer Drugs,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,"Donald  Jerina
(NIDDKD)





Anna  Granda
(University of Barcelona)





Michael  Gamcsik
(Duke Comprehensive Cancer Center)





Monroe  Wall
(Research Triangle Institute)





Peter  Muncon
(CIT)
















Mark  Cushman
(Medicinal Chemistry, Purdue University)",Susan  Bates; MD (National Cancer Institute),"Howard A. Nash; MD, PhD (NIMH)","Ordered by publication type and then author name.



1.
Chrencik JE, Burgin AB, Pommier Y, Stewart L, Redinbo MR (2003). Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex. J Biol Chem  278, 12461-6.   https://doi.org/10.1074/jbc.M212930200




PubMed


 


PubMed ID 12533542
    
     


 



2.
Daoud SS, Munson PJ, Reinhold W, Young L, Prabhu VV, Yu Q, LaRose J, Kohn KW, Weinstein JN, Pommier Y (2003). Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Cancer Res  63, 2782-93.




PubMed


 


PubMed ID 12782583
    
     


 



3.
Fan Z, Beresford PJ, Zhang D, Xu Z, Novina CD, Yoshida A, Pommier Y, Lieberman J (2003). Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol  4, 145-53.   https://doi.org/10.1038/ni885




PubMed


 


PubMed ID 12524539
    
     


 



4.
Fox BM, Xiao X, Antony S, Kohlhagen G, Pommier Y, Staker BL, Stewart L, Cushman M (2003). Design, synthesis, and biological evaluation of cytotoxic 11-alkenylindenoisoquinoline topoisomerase I inhibitors and indenoisoquinoline-camptothecin hybrids. J Med Chem  46, 3275-82.   https://doi.org/10.1021/jm0300476




PubMed


 


PubMed ID 12852757
    
     


 



5.
Khan QA, Kohlhagen G, Marshall R, Austin CA, Kalena GP, Kroth H, Sayer JM, Jerina DM, Pommier Y (2003). Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions with intercalating anticancer agents. Proc Natl Acad Sci U S A  100, 12498-503.   https://doi.org/10.1073/pnas.2032456100




PubMed



        
     
Free Article


 


PubMed ID 14523238
         Pubmed Central ID 218786 


 



6.
Meng LH, Liao ZY, Pommier Y (2003). Non-camptothecin DNA topoisomerase I inhibitors in cancer therapy. Curr Top Med Chem  3, 305-20.   https://doi.org/10.2174/1568026033452546




PubMed


 


PubMed ID 12570765
    
     


 



7.
Reinhold WC, Kouros-Mehr H, Kohn KW, Maunakea AK, Lababidi S, Roschke A, Stover K, Alexander J, Pantazis P, Miller L, Liu E, Kirsch IR, Urasaki Y, Pommier Y, Weinstein JN (2003). Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping. Cancer Res  63, 1000-11.




PubMed


 


PubMed ID 12615715
    
     


 



8.
Yoshida A, Urasaki Y, Waltham M, Bergman AC, Pourquier P, Rothwell DG, Inuzuka M, Weinstein JN, Ueda T, Appella E, Hickson ID, Pommier Y (2003). Human apurinic/apyrimidinic endonuclease (Ape1) and its N-terminal truncated form (AN34) are involved in DNA fragmentation during apoptosis. J Biol Chem  278, 37768-76.   https://doi.org/10.1074/jbc.M304914200




PubMed


 


PubMed ID 12842873",https://intramural.nih.gov/search/searchview.taf?ipid=36195
72,BC006173-19,"October 01, 2003 -  September 30, 2004",Dideoxynucleosides as Potential Anti-AIDS Drugs,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,"Jan  Balzarini; PhD
(Rega Institute, Katholieke University Leuven)





Hiroaki  Mitsuya",Stephen H Hughes; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Choi Y, George C, Comin MJ, Barchi JJ, Kim HS, Jacobson KA, Balzarini J, Mitsuya H, Boyer PL, Hughes SH, Marquez VE (2003). A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. J Med Chem  46, 3292-9.   https://doi.org/10.1021/jm030116g




PubMed


 


PubMed ID 12852759
    
     


 



2.
Choi Y, Sun G, George C, Nicklaus MC, Kelley JA, Marquez VE (2003). Synthesis and conformational analysis of a locked analogue of carbovir built on a bicyclo[3.1.0]hex-2-enyl template. Nucleosides Nucleotides Nucleic Acids  22, 2077-91.   https://doi.org/10.1081/ncn-120026631




PubMed


 


PubMed ID 14714758",https://intramural.nih.gov/search/searchview.taf?ipid=36196
73,BC006174-19,"October 01, 2003 -  September 30, 2004",Carbocyclic Nucleoside Isosteres as Potential Antitumor and Antiviral Agents,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,"Riad  Agbaria
(Ben-Gurion University, Israel)





Alexander D. MacKerell; PhD
(Dept. Pharmaceutical Sciences, University of Maryland)





Martin  Maier
(ISIS Pharmaceuticals, Inc.)





Judith  Christman
(University of Nebraska)",NULL,"Kenneth A Jacobson; BA, MS, PhD (NIDDK) 



Christophe K Tseng (NIAID)","Ordered by publication type and then author name.



1.
Choi Y, George C, Comin MJ, Barchi JJ, Kim HS, Jacobson KA, Balzarini J, Mitsuya H, Boyer PL, Hughes SH, Marquez VE (2003). A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. J Med Chem  46, 3292-9.   https://doi.org/10.1021/jm030116g




PubMed


 


PubMed ID 12852759
    
     


 



2.
Choi Y, Sun G, George C, Nicklaus MC, Kelley JA, Marquez VE (2003). Synthesis and conformational analysis of a locked analogue of carbovir built on a bicyclo[3.1.0]hex-2-enyl template. Nucleosides Nucleotides Nucleic Acids  22, 2077-91.   https://doi.org/10.1081/ncn-120026631




PubMed


 


PubMed ID 14714758
    
     


 



3.
Kim HS, Ohno M, Xu B, Kim HO, Choi Y, Ji XD, Maddileti S, Marquez VE, Harden TK, Jacobson KA (2003). 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. J Med Chem  46, 4974-87.   https://doi.org/10.1021/jm030127+




PubMed



        
     
Free Article


 


PubMed ID 14584948
         Pubmed Central ID 3408611 


 



4.
Russ P, Schelling P, Scapozza L, Folkers G, Clercq ED, Marquez VE (2003). Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine. J Med Chem  46, 5045-54.   https://doi.org/10.1021/jm030241s




PubMed


 


PubMed ID 14584954",https://intramural.nih.gov/search/searchview.taf?ipid=36197
74,BC006176-19,"October 01, 2003 -  September 30, 2004",Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,"Dina  Sigano (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cheng JC, Matsen CB, Gonzales FA, Ye W, Greer S, Marquez VE, Jones PA, Selker EU (2003). Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst  95, 399-409.   https://doi.org/10.1093/jnci/95.5.399




PubMed


 


PubMed ID 12618505
    
     


 



2.
Choi Y, Kang JH, Lewin NE, Blumberg PM, Lee J, Marquez VE (2003). Conformationally constrained analogues of diacylglycerol. 19. Synthesis and protein kinase C binding affinity of diacylglycerol lactones bearing an N-hydroxylamide side chain. J Med Chem  46, 2790-3.   https://doi.org/10.1021/jm030082c




PubMed


 


PubMed ID 12801241
    
     


 



3.
Hamer DH, Bocklandt S, McHugh L, Chun TW, Blumberg PM, Sigano DM, Marquez VE (2003). Rational design of drugs that induce human immunodeficiency virus replication. J Virol  77, 10227-36.   https://doi.org/10.1128/jvi.77.19.10227-10236.2003




PubMed



        
     
Free Article


 


PubMed ID 12970407
         Pubmed Central ID 228450 


 



4.
Marquez VE, Blumberg PM (2003). Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C). Acc Chem Res  36, 434-43.   https://doi.org/10.1021/ar020124b




PubMed


 


PubMed ID 12809530
    
     


 



5.
Marquez VE, Eritja R, Kelley JA, Vanbemmel D, Christman JK (2003). Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain. Ann N Y Acad Sci  1002, 154-64.   https://doi.org/10.1196/annals.1281.014




PubMed


 


PubMed ID 14751833
    
     


 



6.
Sigano DM, Peach ML, Nacro K, Choi Y, Lewin NE, Nicklaus MC, Blumberg PM, Marquez VE (2003). Differential binding modes of diacylglycerol (DAG) and DAG lactones to protein kinase C (PK-C). J Med Chem  46, 1571-9.   https://doi.org/10.1021/jm020476o




PubMed


 


PubMed ID 12699375
    
     


 



7.
Wang QJ, Fang TW, Yang D, Lewin NE, Van Lint J, Marquez VE, Blumberg PM (2003). Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D. Mol Pharmacol  64, 1342-8.   https://doi.org/10.1124/mol.64.6.1342




PubMed


 


PubMed ID 14645664",https://intramural.nih.gov/search/searchview.taf?ipid=36198
75,BC006177-19,"October 01, 2003 -  September 30, 2004",The Analytical Chemistry of Anti-AIDS Agents,James A Kelley; PhD,Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,"Riad  Agbaria
(Human Genetics Institute, Ben-Gurion University, Israel)





Jack R Collins; PhD
(Advanced Biomedical Computing Center, SAIC)","Sherman  Stinson (National Cancer Institute)












Lawrence R Phillips  (LAB DRUG DISCOVERY RESCH and DVPMT)","Robert Joseph Lutz; PhD (OD) 



Michael A Ussery (NIAID) 



Hao  Zhang (NIAID)","Ordered by publication type and then author name.



1.
Marquez VE, Eritja R, Kelley JA, Vanbemmel D, Christman JK (2003). Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain. Ann N Y Acad Sci  1002, 154-64.   https://doi.org/10.1196/annals.1281.014




PubMed


 


PubMed ID 14751833",https://intramural.nih.gov/search/searchview.taf?ipid=36199
76,BC006178-19,"October 01, 2003 -  September 30, 2004",Applications of New Mass Spectral Techniques,James A Kelley; PhD,Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,"Lawrence R Phillips (LAB DRUG DISCOVERY RESCH and DVPMT)



Sherman  Stinson (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)












Kirk R Gustafson; PhD  (DISCOVERY SECT)



Christopher  Lai  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choi Y, Sun G, George C, Nicklaus MC, Kelley JA, Marquez VE (2003). Synthesis and conformational analysis of a locked analogue of carbovir built on a bicyclo[3.1.0]hex-2-enyl template. Nucleosides Nucleotides Nucleic Acids  22, 2077-91.   https://doi.org/10.1081/ncn-120026631




PubMed


 


PubMed ID 14714758",https://intramural.nih.gov/search/searchview.taf?ipid=36200
77,BC006192-16,"October 01, 2003 -  September 30, 2004",Investigations on the integrated behavior of molecular regulatory networks that,"Kurt  Kohn; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,"David  Kane (National Cancer Institute)



William Curtis Reinhold (National Cancer Institute)



Olga A Sedelnikova; PhD (National Cancer Institute)



Olivier  Sordet (National Cancer Institute)



Margot  Sunshine (National Cancer Institute)



John N Weinstein; MD, PhD (National Cancer Institute)",Joseph  Riss; PhD (NICHD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36201
78,BC006198-15,"October 01, 2003 -  September 30, 2004",Inhibitors of Tyrosine Kinase-Dependent Signalling as Anticancer Agents,"Terrence R Burke; PhD



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,"Dajun  Yang
(School of Medicine, Univ. of Michigan)





Zheng  Zhang
(Computer Science and Engineering, Pennsylvania State University)





Benjamin  Neel
(Harvard University)","William Marston Linehan; MD (National Cancer Institute)



Lawrence Elliot Samelson; MD (Laboratory of Cellular and Molecular Biology)



Donald P Bottaro; PhD (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)",NULL,"Ordered by publication type and then author name.



1.
Burke TR, Lee K (2003). Phosphotyrosyl mimetics in the development of signal transduction inhibitors. Acc Chem Res  36, 426-33.   https://doi.org/10.1021/ar020127o




PubMed


 


PubMed ID 12809529
    
     


 



2.
Lee K, Burke TR (2003). CD45 protein-tyrosine phosphatase inhibitor development. Curr Top Med Chem  3, 797-807.   https://doi.org/10.2174/1568026033452267




PubMed


 


PubMed ID 12678845
    
     


 



3.
Lee K, Gao Y, Yao ZJ, Phan J, Wu L, Liang J, Waugh DS, Zhang ZY, Burke TR (2003). Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase. Bioorg Med Chem Lett  13, 2577-81.   https://doi.org/10.1016/s0960-894x(03)00481-5




PubMed


 


PubMed ID 12852970
    
     


 



4.
Lee K, Zhang M, Liu H, Yang D, Burke TR (2003). Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides. J Med Chem  46, 2621-30.   https://doi.org/10.1021/jm030049q




PubMed


 


PubMed ID 12801226
    
     


 



5.
Liu DG, Gao Y, Voigt JH, Lee K, Nicklaus MC, Wu L, Zhang ZY, Burke TR (2003). Acylsulfonamide-containing PTP1B inhibitors designed to mimic an enzyme-bound water of hydration. Bioorg Med Chem Lett  13, 3005-7.   https://doi.org/10.1016/s0960-894x(03)00635-8




PubMed


 


PubMed ID 12941322
    
     


 



6.
Phan J, Lee K, Cherry S, Tropea JE, Burke TR, Waugh DS (2003). High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Biochemistry  42, 13113-21.   https://doi.org/10.1021/bi030156m




PubMed


 


PubMed ID 14609321
    
     


 



7.
Shi ZD, Lee K, Liu H, Zhang M, Roberts LR, Worthy KM, Fivash MJ, Fisher RJ, Yang D, Burke TR (2003). A novel macrocyclic tetrapeptide mimetic that exhibits low-picomolar Grb2 SH2 domain-binding affinity. Biochem Biophys Res Commun  310, 378-83.   https://doi.org/10.1016/j.bbrc.2003.09.029




PubMed


 


PubMed ID 14521921
    
     


 



8.
Wei CQ, Gao Y, Lee K, Guo R, Li B, Zhang M, Yang D, Burke TR (2003). Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems. J Med Chem  46, 244-54.   https://doi.org/10.1021/jm0203635




PubMed


 


PubMed ID 12519063",https://intramural.nih.gov/search/searchview.taf?ipid=36202
79,BC007184-15,"October 01, 2003 -  September 30, 2004",Molecular Biology of Cellular Injury,Albert J Fornace; MD,Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,"Marcy  Grace
(Biological Dosimetry Team, Armed Forces Radiobiology Research Inst.)





David  Brenner
(Columbia University)





Chu-Xia  Deng
(NIDDK)





Joel  Greenberger
(Radiation Oncology, Univ. of Pittsburgh)





William  Gaarde
(Isis Pharmaceuticals)





Michael  O'Reilly
(Pediatrics and Environmental Medicine, Univ. of Rochester)


Show all 13","Ettore  Appella; MD (Chemical Immunology Section)



Lance A Liotta; MD, PhD (Lab Pathlgy)



Nick  Scudiero (National Cancer Institute)



Terry Anne Van Dyke (Mouse Cancer Genetics Program)



Timothy D. Veenstra; PhD (National Cancer Institute)



Scott K Durum; PhD (National Cancer Institute)","Timothy G Myers (NIAID) 



Maurice Benjamin Burg; MD (NHLBI) 



Paul S Meltzer; MD, PhD (NHGRI) 



John J O'Shea; MD (NIAMS)","Ordered by publication type and then author name.



1.
Amundson SA, Bittner M, Fornace AJ (2003). Functional genomics as a window on radiation stress signaling. Oncogene  22, 5828-33.   https://doi.org/10.1038/sj.onc.1206681




PubMed


 


PubMed ID 12947389
    
     


 



2.
Amundson SA, Fornace AJ (2004). Microarray approaches for analysis of cell cycle regulatory genes. Methods Mol Biol  241, 125-41.   https://doi.org/10.1385/1-59259-646-0:125




PubMed


 


PubMed ID 14970650
    
     


 



3.
Amundson SA, Grace MB, McLeland CB, Epperly MW, Yeager A, Zhan Q, Greenberger JS, Fornace AJ (2004). Human in vivo radiation-induced biomarkers: gene expression changes in radiotherapy patients. Cancer Res  64, 6368-71.   https://doi.org/10.1158/0008-5472.CAN-04-1883




PubMed


 


PubMed ID 15374940
    
     


 



4.
Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E, Fornace AJ (2004). Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet  36, 343-50.   https://doi.org/10.1038/ng1317




PubMed


 


PubMed ID 14991053
    
     


 



5.
Hildesheim J, Awwad RT, Fornace AJ (2004). p38 Mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J Invest Dermatol  122, 497-502.   https://doi.org/10.1111/j.1523-1747.2004.22229.x




PubMed


 


PubMed ID 15009736
    
     


 



6.
Hildesheim J, Belova GI, Tyner SD, Zhou X, Vardanian L, Fornace AJ (2004). Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene  23, 1829-37.   https://doi.org/10.1038/sj.onc.1207301




PubMed


 


PubMed ID 14647429
    
     


 



7.
Hildesheim J, Fornace AJ (2004). The dark side of light: the damaging effects of UV rays and the protective efforts of MAP kinase signaling in the epidermis. DNA Repair (Amst)  3, 567-80.   https://doi.org/10.1016/j.dnarep.2004.02.012




PubMed


 


PubMed ID 15135725
    
     


 



8.
Jiang F, Li P, Fornace AJ, Nicosia SV, Bai W (2003). G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J Biol Chem  278, 48030-40.   https://doi.org/10.1074/jbc.M308430200




PubMed


 


PubMed ID 14506229
    
     


 



9.
Koch-Paiz CA, Amundson SA, Bittner ML, Meltzer PS, Fornace AJ (2004). Functional genomics of UV radiation responses in human cells. Mutat Res  549, 65-78.   https://doi.org/10.1016/j.mrfmmm.2004.01.010




PubMed


 


PubMed ID 15120963
    
     


 



10.
Rockett JC, Burczynski ME, Fornace AJ, Herrmann PC, Krawetz SA, Dix DJ (2004). Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol Appl Pharmacol  194, 189-99.   https://doi.org/10.1016/j.taap.2003.09.005




PubMed


 


PubMed ID 14736499
    
     


 



11.
Wang X, Wang RH, Li W, Xu X, Hollander MC, Fornace AJ, Deng CX (2004). Genetic interactions between Brca1 and Gadd45a in centrosome duplication, genetic stability, and neural tube closure. J Biol Chem  279, 29606-14.   https://doi.org/10.1074/jbc.M312279200




PubMed


 


PubMed ID 15123655
    
     


 



12.
Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ, Liebermann DA, Bottinger EP, Roberts AB (2003). Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem  278, 43001-7.   https://doi.org/10.1074/jbc.M307869200




PubMed


 


PubMed ID 12933797",https://intramural.nih.gov/search/searchview.taf?ipid=36203
80,BC007333-13,"October 01, 2003 -  September 30, 2004",Pharmacology of HIV Viral DNA & Retroviral Integrases,"Yves  Pommier; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Christophe  Marchand (National Cancer Institute)



Vinay K Pathak; PhD (Viral Mutation Section)












Terrence R Burke; PhD  (ORGANIC CHEMSTRY SECT)



Allison  Johnson  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Krajewski K, Long YQ, Marchand C, Pommier Y, Roller PP (2003). Design and synthesis of dimeric HIV-1 integrase inhibitory peptides. Bioorg Med Chem Lett  13, 3203-5.   https://doi.org/10.1016/s0960-894x(03)00679-6




PubMed


 


PubMed ID 12951093
    
     


 



2.
Marchand C, Johnson AA, Karki RG, Pais GC, Zhang X, Cowansage K, Patel TA, Nicklaus MC, Burke TR, Pommier Y (2003). Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharmacol  64, 600-9.   https://doi.org/10.1124/mol.64.3.600




PubMed


 


PubMed ID 12920196",https://intramural.nih.gov/search/searchview.taf?ipid=36204
81,BC007349-12,"October 01, 2003 -  September 30, 2004",New strategies for cancer drug discovery: Integrative pharmacogenomics and pharm,"John N Weinstein; MD, PhD",Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",Kurt  Kohn; PhD,NULL,"Ari  Kahn (National Cancer Institute)



Ilan  Kirsch; MD (Acquired Gene Rearrangements Sect)



David  Kane (National Cancer Institute)



James Carl Barrett; PhD (Genome Structure and Function Section)



Sylvia  Major (National Cancer Institute)



Lance A Liotta; MD, PhD (Lab Pathlgy)",Joseph  Riss; PhD (NICHD),"Ordered by publication type and then author name.



1.
Aladjem MI, Pasa S, Parodi S, Weinstein JN, Pommier Y, Kohn KW (2004). Molecular interaction maps--a diagrammatic graphical language for bioregulatory networks. Sci STKE  2004, pe8.   https://doi.org/10.1126/stke.2222004pe8




PubMed


 


PubMed ID 14997004
    
     


 



2.
Bussey KJ, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold WC, Zeeberg B, Ajay W, Weinstein JN (2003). MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol  4, R27.   https://doi.org/10.1186/gb-2003-4-4-r27




PubMed



        
     
Free Article


 


PubMed ID 12702208
         Pubmed Central ID 154578 


 



3.
Daoud SS, Munson PJ, Reinhold W, Young L, Prabhu VV, Yu Q, LaRose J, Kohn KW, Weinstein JN, Pommier Y (2003). Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study. Cancer Res  63, 2782-93.




PubMed


 


PubMed ID 12782583
    
     


 



4.
Lee JK, Bussey KJ, Gwadry FG, Reinhold W, Riddick G, Pelletier SL, Nishizuka S, Szakacs G, Annereau JP, Shankavaram U, Lababidi S, Smith LH, Gottesman MM, Weinstein JN (2003). Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol  4, R82.   https://doi.org/10.1186/gb-2003-4-12-r82




PubMed



        
     
Free Article


 


PubMed ID 14659019
         Pubmed Central ID 329421 


 



5.
Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E, Liotta LA, Weinstein JN (2003). Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A  100, 14229-34.   https://doi.org/10.1073/pnas.2331323100




PubMed



        
     
Free Article


 


PubMed ID 14623978
         Pubmed Central ID 283574 


 



6.
Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, Bussey KJ, Kim S, Lababidi S, Lee JK, Pittaluga S, Scudiero DA, Sausville EA, Munson PJ, Petricoin EF, Liotta LA, Hewitt SM, Raffeld M, Weinstein JN (2003). Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res  63, 5243-50.




PubMed


 


PubMed ID 14500354
    
     


 



7.
Reinhold WC, Kouros-Mehr H, Kohn KW, Maunakea AK, Lababidi S, Roschke A, Stover K, Alexander J, Pantazis P, Miller L, Liu E, Kirsch IR, Urasaki Y, Pommier Y, Weinstein JN (2003). Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping. Cancer Res  63, 1000-11.




PubMed


 


PubMed ID 12615715
    
     


 



8.
Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN, Kirsch IR (2003). Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res  63, 8634-47.




PubMed


 


PubMed ID 14695175
    
     


 



9.
Yoshida A, Urasaki Y, Waltham M, Bergman AC, Pourquier P, Rothwell DG, Inuzuka M, Weinstein JN, Ueda T, Appella E, Hickson ID, Pommier Y (2003). Human apurinic/apyrimidinic endonuclease (Ape1) and its N-terminal truncated form (AN34) are involved in DNA fragmentation during apoptosis. J Biol Chem  278, 37768-76.   https://doi.org/10.1074/jbc.M304914200




PubMed


 


PubMed ID 12842873
    
     


 



10.
Zeeberg BR, Feng W, Wang G, Wang MD, Fojo AT, Sunshine M, Narasimhan S, Kane DW, Reinhold WC, Lababidi S, Bussey KJ, Riss J, Barrett JC, Weinstein JN (2003). GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol  4, R28.   https://doi.org/10.1186/gb-2003-4-4-r28




PubMed



        
     
Free Article


 


PubMed ID 12702209
         Pubmed Central ID 154579",https://intramural.nih.gov/search/searchview.taf?ipid=36205
82,BC007354-11,"October 01, 2003 -  September 30, 2004",Polypeptide Inhibitors of Cell Cycle Proliferation,Peter P Roller; PhD,Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,"David  Krag
(Burlington VT, University of Vermont School of Medicine)





Shaoming  Wang; PhD
(U. Michigan)","Christophe R Marchand (National Cancer Institute)



Vinay K Pathak; PhD (Viral Mutation Section)



Robert B  Dickson (National Cancer Institute)












Yves  Pommier; PhD  (Developmental Therapeutics Branch)",NULL,"Ordered by publication type and then author name.



1.
Krajewski K, Long YQ, Marchand C, Pommier Y, Roller PP (2003). Design and synthesis of dimeric HIV-1 integrase inhibitory peptides. Bioorg Med Chem Lett  13, 3203-5.   https://doi.org/10.1016/s0960-894x(03)00679-6




PubMed


 


PubMed ID 12951093
    
     


 



2.
Li P, Peach ML, Zhang M, Liu H, Yang D, Nicklaus M, Roller PP (2003). Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain. Bioorg Med Chem Lett  13, 895-9.   https://doi.org/10.1016/s0960-894x(03)00015-5




PubMed


 


PubMed ID 12617916
    
     


 



3.
Long YQ, Lung FD, Roller PP (2003). Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain. Bioorg Med Chem  11, 3929-36.   https://doi.org/10.1016/s0968-0896(03)00411-5




PubMed


 


PubMed ID 12927853
    
     


 



4.
Zhang M, Liu H, Guo R, Ling Y, Wu X, Li B, Roller PP, Wang S, Yang D (2003). Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol  66, 93-103.   https://doi.org/10.1016/s0006-2952(03)00248-x




PubMed


 


PubMed ID 12818369",https://intramural.nih.gov/search/searchview.taf?ipid=36206
83,BC007363-10,"October 01, 2003 -  September 30, 2004",Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs,"Terrence R Burke; PhD



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",Marc C Nicklaus,"Eric  DeClercq
(Rega Institute)
















Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)","Yves  Pommier; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Marchand C, Johnson AA, Karki RG, Pais GC, Zhang X, Cowansage K, Patel TA, Nicklaus MC, Burke TR, Pommier Y (2003). Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharmacol  64, 600-9.   https://doi.org/10.1124/mol.64.3.600




PubMed


 


PubMed ID 12920196
    
     


 



2.
Zhang X, Pais GC, Svarovskaia ES, Marchand C, Johnson AA, Karki RG, Nicklaus MC, Pathak VK, Pommier Y, Burke TR (2003). Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors. Bioorg Med Chem Lett  13, 1215-9.   https://doi.org/10.1016/s0960-894x(03)00059-3




PubMed


 


PubMed ID 12643946",https://intramural.nih.gov/search/searchview.taf?ipid=36207
84,BC007365-10,"October 01, 2003 -  September 30, 2004",Regulation of ADP-ribosylation factor,"Paul A Randazzo; MD, PhD



IRP Faculty Profile",Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,Stacey S Stauffer (National Cancer Institute),"Emily S Boja; PhD (NHLBI) 



Juan S Bonifacino; PhD (NICHD) 



Henry M. Fales; PhD (NHLBI) 



Jenny E Hinshaw; PhD (NIDDK)","Ordered by publication type and then author name.



1.
Nie Z, Boehm M, Boja ES, Vass WC, Bonifacino JS, Fales HM, Randazzo PA (2003). Specific regulation of the adaptor protein complex AP-3 by the Arf GAP AGAP1. Dev Cell  5, 513-21.   https://doi.org/10.1016/s1534-5807(03)00234-x




PubMed


 


PubMed ID 12967569
    
     


 



2.
Nie Z, Hirsch DS, Randazzo PA (2003). Arf and its many interactors. Curr Opin Cell Biol  15, 396-404.   https://doi.org/10.1016/s0955-0674(03)00071-1




PubMed


 


PubMed ID 12892779",https://intramural.nih.gov/search/searchview.taf?ipid=36208
85,BC008000-34,"October 01, 2003 -  September 30, 2004",Regulation of EGFR Gene Activity,Alfred Charles Johnson; PhD,Ira H Pastan; MD,"Office of Loan Repayment and Scholarship, NCI",NULL,"Hirotaka  Nishi
(Tokyo Medical University)
















Hassan  Ashtorab
(Howard University)",NULL,"Kuan-Teh  Jeang; PhD, MD (NIAID) 



Marjorie  Robert-Guroff; PhD (NCI)","Ordered by publication type and then author name.



1.
Nishi H, Neta G, Nishi KH, Akers LM, Rikiyama T, Proctor KN, Murphy BA, Johnson AC (2003). Analysis of the epidermal growth factor receptor promoter: the effect of nuclear factor-kappaB. Int J Mol Med  11, 49-55.




PubMed


 


PubMed ID 12469217
    
     


 



2.
Rikiyama T, Curtis J, Oikawa M, Zimonjic DB, Popescu N, Murphy BA, Wilson MA, Johnson AC (2003). GCF2: expression and molecular analysis of repression. Biochim Biophys Acta  1629, 15-25.   https://doi.org/10.1016/s0167-4781(03)00156-8




PubMed


 


PubMed ID 14522076",https://intramural.nih.gov/search/searchview.taf?ipid=36209
86,BC008226-28,"October 01, 2003 -  September 30, 2004",Prolactin Interactions in Mammary Gland Development and Tumorigenesis,Barbara V Vonderhaar; PhD,NULL,"National Cancer Institute, NCI","Erika P Ginsburg



Anita  Goldhar","Jeffrey M Rosen; PhD
(Department of cell Biology, Baylor College of Medicine)





John P. Lydon; PhD
(Department of Molecular and Cellular Biology, Baylor College of Medicine)





Mikiko  Asai-Sato
(Maternal and Neonate Center, Yokohama City University School of Medicine)





Charles  Brooks
(Department of Veterinary Biosciences, Ohio State University)





Christopher  Ormandy
(Cancer Research Program, Garvan Institute of Medical Research)





Russell  Hovey
(Department of Animal Science, University of Vermont)


Show all 7",NULL,NULL,"Ordered by publication type and then author name.



1.
Bauernhofer T, Kuss I, Friebe-Hoffmann U, Baum AS, Dworacki G, Vonderhaar BK, Whiteside TL (2003). Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer. Br J Cancer  88, 1301-9.   https://doi.org/10.1038/sj.bjc.6600860




PubMed



        
     
Free Article


 


PubMed ID 12698200
         Pubmed Central ID 2747567 


 



2.
Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK (2003). Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol  17, 460-71.   https://doi.org/10.1210/me.2002-0214




PubMed


 


PubMed ID 12554791
    
     


 



3.
Lee AV, Zhang P, Ivanova M, Bonnette S, Oesterreich S, Rosen JM, Grimm S, Hovey RC, Vonderhaar BK, Kahn CR, Torres D, George J, Mohsin S, Allred DC, Hadsell DL (2003). Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland. Endocrinology  144, 2683-94.   https://doi.org/10.1210/en.2002-221103




PubMed


 


PubMed ID 12746333
    
     


 



4.
Naylor MJ, Ginsburg E, Iismaa TP, Vonderhaar BK, Wynick D, Ormandy CJ (2003). The neuropeptide galanin augments lobuloalveolar development. J Biol Chem  278, 29145-52.   https://doi.org/10.1074/jbc.M303746200




PubMed


 


PubMed ID 12759342
    
     


 



5.
Otte JM, Otte C, Beckedorf S, Schmitz F, Vonderhaar BK, Fölsch UR, Kloehn S, Herzig KH, Mönig H (2003). Expression of functional prolactin and its receptor in human colorectal cancer. Int J Colorectal Dis  18, 86-94.   https://doi.org/10.1007/s00384-002-0414-7




PubMed


 


PubMed ID 12458387
    
     


 



6.
Satoh K, Ginsburg E, Vonderhaar BK (2004). Msx-1 and Msx-2 in mammary gland development. J Mammary Gland Biol Neoplasia  9, 195-205.   https://doi.org/10.1023/B:JOMG.0000037162.84758.b5




PubMed


 


PubMed ID 15300013
    
     


 



7.
Trott JF, Hovey RC, Koduri S, Vonderhaar BK (2003). Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein. J Mol Endocrinol  30, 31-47.   https://doi.org/10.1677/jme.0.0300031




PubMed


 


PubMed ID 12580759",https://intramural.nih.gov/search/searchview.taf?ipid=36210
87,BC008281-22,"October 01, 2003 -  September 30, 2004",Mechanism of cAMP-growth regulatory function,"Yoon S Cho-Chung; MD, PhD",Douglas  Lowy; MD,"CELLULAR BIOCHEMSTRY SECT, NCI",NULL,"Rakesh  Srivastava
(University of Maryland)





Eugen  Uhlmann
(Aventis Pharma)





Robert  Klem
(Berkeley Heights, N.J., Genta Inc.)
















Sudhir  Agrawal
(Hybridon, Inc)","Sudhir  Agrawal (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)","Kevin Graham Becker; BS, MAS, PhD (NIA)","Ordered by publication type and then author name.



1.
Cheadle C, Cho-Chung YS, Becker KG, Vawter MP (2003). Application of z-score transformation to Affymetrix data. Appl Bioinformatics  2, 209-17.




PubMed


 


PubMed ID 15130792
    
     


 



2.
Cho YS, Cho-Chung YS   (2003) Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.  Clin Cancer Res 9:1171-8.




PubMed


 


PubMed ID 12631623
    
     


 



3.
Cho-Chung YS   (2003) Antisense DNAs as targeted genetic medicine to treat cancer.  Arch Pharm Res 26:183-91.




PubMed


 


PubMed ID 12723929
    
     


 



4.
Cho-Chung YS   (2003) cAMP signaling in cancer genesis and treatment.  Cancer Treat Res 115:123-43.




PubMed


 


PubMed ID 12613195
    
     


 



5.
Cho-Chung YS   (2003) CRE-enhancer DNA decoy: a tumor target-based genetic tool.  Ann N Y Acad Sci 1002:124-33.




PubMed


 


PubMed ID 14751830
    
     


 



6.
Cho-Chung YS (2004). Antisense protein kinase A RI alpha-induced tumor reversion: portrait of a microarray. Biochim Biophys Acta  1697, 71-9.   https://doi.org/10.1016/j.bbapap.2003.11.014




PubMed


 


PubMed ID 15023351
    
     


 



7.
Cho-Chung YS, Becker KG (2003). A genome-wide view of antisense. Nat Biotechnol  21, 492.   https://doi.org/10.1038/nbt0503-492a




PubMed


 


PubMed ID 12721568
    
     


 



8.
Kim YH, Lim DS, Lee JH, Lim DS, Shim WJ, Ro YM, Park GH, Becker KG, Cho-Chung YS, Kim MK (2003). Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med  35, 336-49.   https://doi.org/10.1038/emm.2003.45




PubMed


 


PubMed ID 14646586
    
     


 



9.
Mani S, Goel S, Nesterova M, Martin RM, Grindel JM, Rothenberg ML, Zhang R, Tortora G, Cho-Chung YS   (2003) Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.  Ann N Y Acad Sci 1002:252-62.




PubMed


 


PubMed ID 14751840
    
     


 



10.
Nesterova MV, Cho-Chung YS (2004). Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Clin Cancer Res  10, 4568-77.   https://doi.org/10.1158/1078-0432.CCR-03-0436




PubMed


 


PubMed ID 15240549",https://intramural.nih.gov/search/searchview.taf?ipid=36211
88,BC008303-32,"October 01, 2003 -  September 30, 2004",Regulation of Membrane Fusion by Viral and Cellular Proteins and Lipids,"Robert  Blumenthal; PhD



IRP Faculty Profile",Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"James  Hoxie
(CFAR, UPenn)





Yechiel  Shai
(Biological Chemistry, Weizmann  Institute, Israel)





Robert W Doms; MD, PhD
(Microbiology, University of Pennsylvania)





Alfredo  Garzino-Demo
(IHV)
















Eric  Hunter
(Center for AIDS Research, Univ. of Alabama)




Jeffrey D Lifson; MD
(NCI)","Vineet Narain KewalRamani; PhD (Model Development Section)



Anu  Puri; PhD (National Cancer Institute)



Julian  Bess Jr (National Cancer Institute)



Satinder  Rawat (National Cancer Institute)



Mathias  Viard (National Cancer Institute)



Ji Ming  Wang; MD, PhD (National Cancer Institute)","Marius  Clore; MD, PhD (NIDDK)","Ordered by publication type and then author name.



1.
Blumenthal R, Clague MJ, Durell SR, Epand RM (2003). Membrane fusion. Chem Rev  103, 53-69.   https://doi.org/10.1021/cr000036+




PubMed


 


PubMed ID 12517181
    
     


 



2.
Dimitrov AS, Rawat SS, Jiang S, Blumenthal R (2003). Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry  42, 14150-8.   https://doi.org/10.1021/bi035154g




PubMed


 


PubMed ID 14640682
    
     


 



3.
Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, Rawat SS, Puri A, Durell S, Blumenthal R (2003). The HIV Env-mediated fusion reaction. Biochim Biophys Acta  1614, 36-50.   https://doi.org/10.1016/s0005-2736(03)00161-5




PubMed


 


PubMed ID 12873764
    
     


 



4.
Lin X, Derdeyn CA, Blumenthal R, West J, Hunter E (2003). Progressive truncations C terminal to the membrane-spanning domain of simian immunodeficiency virus Env reduce fusogenicity and increase concentration dependence of Env for fusion. J Virol  77, 7067-77.   https://doi.org/10.1128/jvi.77.12.7067-7077.2003




PubMed



        
     
Free Article


 


PubMed ID 12768026
         Pubmed Central ID 156184 


 



5.
Peisajovich SG, Gallo SA, Blumenthal R, Shai Y (2003). C-terminal octylation rescues an inactive T20 mutant: implications for the mechanism of HIV/SIMIAN immunodeficiency virus-induced membrane fusion. J Biol Chem  278, 21012-7.   https://doi.org/10.1074/jbc.M212773200




PubMed


 


PubMed ID 12646555
    
     


 



6.
Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A (2003). Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol  20, 243-54.   https://doi.org/10.1080/0968768031000104944




PubMed


 


PubMed ID 12893532",https://intramural.nih.gov/search/searchview.taf?ipid=36212
89,BC008363-22,"October 01, 2003 -  September 30, 2004",Membrane Protein Modeling,Homer Robert Guy; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,"Yinon  Shafrir (National Cancer Institute)



Kailas  Sonawane (National Cancer Institute)



Malgorzata  Klosek (National Cancer Institute)



Stewart  Durell (National Cancer Institute)



Kai Li H Ting (National Cancer Institute)












Daniel  Flatow  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Durell SR, Shrivastava IH, Guy HR (2004). Models of the structure and voltage-gating mechanism of the shaker K+ channel. Biophys J  87, 2116-30.   https://doi.org/10.1529/biophysj.104.040618




PubMed



        
     
Free Article


 


PubMed ID 15454416
         Pubmed Central ID 1304639 


 



2.
Shafrir Y, Guy HR (2004). STAM: simple transmembrane alignment method. Bioinformatics  20, 758-69.   https://doi.org/10.1093/bioinformatics/btg482




PubMed


 


PubMed ID 14751993
    
     


 



3.
Shrivastava IH, Durell SR, Guy HR (2004). A model of voltage gating developed using the KvAP channel crystal structure. Biophys J  87, 2255-70.   https://doi.org/10.1529/biophysj.104.040592




PubMed



        
     
Free Article


 


PubMed ID 15454428
         Pubmed Central ID 1304651",https://intramural.nih.gov/search/searchview.taf?ipid=36213
90,BC008371-21,"October 01, 2003 -  September 30, 2004",DNA Deformations and Interactions with Proteins,"Robert L Jernigan; PhD

 


 

Victor  Zhurkin; PhD



IRP Faculty Profile",Jacob V. Maizel; PhD,"Molecular Structure Section, NCI

Center for Cancer Research Nanobiology Program, NCI",NULL,"Yuxin  Yin
(Department of Radiation Oncology, Columbia University)





Colin C Anderson; PhD






Wilma  Olson
(Wright-Rieman Laboratories, Rutgers University)",Michael Ye Tolstorukov (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Karamychev VN, Tatusov A, Komissarova N, Kashlev M, Neumann RD, Zhurkin VB, Panyutin IG (2003). Iodine-125 radioprobing of E. coli RNA polymerase transcription elongation complexes. Methods Enzymol  371, 106-20.   https://doi.org/10.1016/s0076-6879(03)71007-6




PubMed


 


PubMed ID 14712694
    
     


 



2.
Liu M, Tolstorukov M, Zhurkin V, Garges S, Adhya S (2004). A mutant spacer sequence between -35 and -10 elements makes the Plac promoter hyperactive and cAMP receptor protein-independent. Proc Natl Acad Sci U S A  101, 6911-6.   https://doi.org/10.1073/pnas.0401929101




PubMed



        
     
Free Article


 


PubMed ID 15118087
         Pubmed Central ID 406441 


 



3.
Semsey S, Tolstorukov MY, Virnik K, Zhurkin VB, Adhya S (2004). DNA trajectory in the Gal repressosome. Genes Dev  18, 1898-907.   https://doi.org/10.1101/gad.1209404




PubMed



        
     
Free Article


 


PubMed ID 15289461
         Pubmed Central ID 517409 


 



4.
Shchyolkina AK, Kaluzhny DN, Borisova OF, Hawkins ME, Jernigan RL, Jovin TM, Arndt-Jovin DJ, Zhurkin VB (2004). Formation of an intramolecular triple-stranded DNA structure monitored by fluorescence of 2-aminopurine or 6-methylisoxanthopterin. Nucleic Acids Res  32, 432-40.   https://doi.org/10.1093/nar/gkh158




PubMed



        
     
Free Article


 


PubMed ID 14739235
         Pubmed Central ID 373315 


 



5.
Tolstorukov MY, Jernigan RL, Zhurkin VB (2004). Protein-DNA hydrophobic recognition in the minor groove is facilitated by sugar switching. J Mol Biol  337, 65-76.   https://doi.org/10.1016/j.jmb.2004.01.011




PubMed


 


PubMed ID 15001352
    
     


 



6.
Virnik K, Lyubchenko YL, Karymov MA, Dahlgren P, Tolstorukov MY, Semsey S, Zhurkin VB, Adhya S (2003). ""Antiparallel"" DNA loop in gal repressosome visualized by atomic force microscopy. J Mol Biol  334, 53-63.   https://doi.org/10.1016/j.jmb.2003.09.030




PubMed


 


PubMed ID 14596799
    
     


 



7.
Wu Z, Delaglio F, Tjandra N, Zhurkin VB, Bax A (2003). Overall structure and sugar dynamics of a DNA dodecamer from homo- and heteronuclear dipolar couplings and 31P chemical shift anisotropy. J Biomol NMR  26, 297-315.   https://doi.org/10.1023/a:1024047103398




PubMed


 


PubMed ID 12815257",https://intramural.nih.gov/search/searchview.taf?ipid=36214
91,BC008380-20,"October 01, 2003 -  September 30, 2004",Molecular Structure of Animal Viruses and Cells by Computational Analysis,"James Carl Barrett; PhD

 




Jacob V. Maizel; PhD",NULL,"Center for Cancer Research Nanobiology Program, NCI

Office of the Director, NCI",NULL,NULL,"Jih-H.  Chen (National Cancer Institute)












Shu Yun  Le  (National Cancer Institute)","Kuan-Teh  Jeang; PhD, MD (NIAID) 












Kai  Zhang (NLM)","Ordered by publication type and then author name.



1.
Le SY, Chen JH, Konings D, Maizel JV (2003). Discovering well-ordered folding patterns in nucleotide sequences. Bioinformatics  19, 354-61.   https://doi.org/10.1093/bioinformatics/btf826




PubMed


 


PubMed ID 12584120",https://intramural.nih.gov/search/searchview.taf?ipid=36215
92,BC008382-21,"October 01, 2003 -  September 30, 2004",Computer Analysis of Nucleic Acid Structure,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"John  Grefenstette
(Bioinformatics and Compuational BIology, George Mason University)





Naga Rajan Pattabiraman; PhD
(Lombardi Cancer Center, Georgetown University Medical School)





Donald  Atha
(Biotechnology Division, National Institutes of Standards and Technology)





Gregory  Chirikjian
(Mechanical Engineering, Johns Hopkins University)





Hugo  Martinez
(Consultant, SAIC)
















Anne  Simon
(Cell Biology and Molecular Genetics, University of Maryland)","Carmen  Allegra; PhD (Medcn Br)



Kazimierz Wojcieck Kasprzak (National Cancer Institute)



John  Casey (National Cancer Institute)","Jack A Ragheb (NEI) 



John T Patton; BS, PhD (NIAID)","Ordered by publication type and then author name.



1.
Kim MK, Li W, Shapiro BA, Chirikjian GS (2003). A comparison between elastic network interpolation and MD simulation of 16S ribosomal RNA. J Biomol Struct Dyn  21, 395-405.   https://doi.org/10.1080/07391102.2003.10506935




PubMed


 


PubMed ID 14616035
    
     


 



2.
Li W, Ma B, Shapiro BA (2003). Binding interactions between the core central domain of 16S rRNA and the ribosomal protein S15 determined by molecular dynamics simulations. Nucleic Acids Res  31, 629-38.   https://doi.org/10.1093/nar/gkg149




PubMed



        
     
Free Article


 


PubMed ID 12527771
         Pubmed Central ID 140513",https://intramural.nih.gov/search/searchview.taf?ipid=36216
93,BC008396-16,"October 01, 2003 -  September 30, 2004",Molecular Information Theory,Thomas Dana Schneider; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Peter  Rogan
(Section of Medical Genetics and Molecular Medicine, Childrens Mercy Hospital and Clinics)





Ryan  Shultzaberger
(Department of Molecular and Cell Biology, Berkeley)
















K  Lewis
(Chemistry, Texas State University)","Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)



Ilya  Lyakhov (National Cancer Institute)



Robert J Fisher (National Cancer Institute)












Kenneth H Kraemer; MD  (LAB MOLECULAR CARCINOGENESIS)","Richard  Fisher (NIMH) 



James R Ellis; PhD (OD)","Ordered by publication type and then author name.



1.
Hengen PN, Lyakhov IG, Stewart LE, Schneider TD (2003). Molecular flip-flops formed by overlapping Fis sites. Nucleic Acids Res  31, 6663-73.   https://doi.org/10.1093/nar/gkg877




PubMed



        
     
Free Article


 


PubMed ID 14602927
         Pubmed Central ID 275571 


 



2.
Khan SG, Metin A, Gozukara E, Inui H, Shahlavi T, Muniz-Medina V, Baker CC, Ueda T, Aiken JR, Schneider TD, Kraemer KH (2004). Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: mutations result in reduced XPC mRNA levels that correlate with cancer risk. Hum Mol Genet  13, 343-52.   https://doi.org/10.1093/hmg/ddh026




PubMed


 


PubMed ID 14662655",https://intramural.nih.gov/search/searchview.taf?ipid=36217
94,BC008577-19,"October 01, 2003 -  September 30, 2004",Genetic Basis of Human Kidney Cancer,Berton K Zbar; PhD,NULL,"Laboratory of Immunobiology, NCI",NULL,"Eamon  Maher
(University of Birmingham, England)





Okio  Hino
(Cancer Institute, Department of Experimental Pathology)





Cheryl  Greenberg
(University of Manitoba)





Jeffrey  Gulcher
(Decode Genetics, Iceland)





Laufrey  Amundatdottir
(Decode Genetics, Iceland)





Elaine A Ostrander; PhD



Show all 7","Tibor  Borsos (National Cancer Institute)



Peter L Choyke; MD (Center for Cancer Research)



William Marston Linehan; MD (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



Jorge R Toro (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)",Joan E Bailey-Wilson; PhD (NHGRI),"Ordered by publication type and then author name.



1.
Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003). Hereditary renal cancers. Radiology  226, 33-46.   https://doi.org/10.1148/radiol.2261011296




PubMed


 


PubMed ID 12511666
    
     


 



2.
Linehan WM, Vasselli J, Srinivasan R, Walther MM, Merino M, Choyke P, Vocke C, Schmidt L, Isaacs JS, Glenn G, Toro J, Zbar B, Bottaro D, Neckers L (2004). Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res  10, 6282S-9S.   https://doi.org/10.1158/1078-0432.CCR-050013




PubMed


 


PubMed ID 15448018
    
     


 



3.
Linehan WM, Walther MM, Zbar B (2003). The genetic basis of cancer of the kidney. J Urol  170, 2163-72.   https://doi.org/10.1097/01.ju.0000096060.92397.ed




PubMed


 


PubMed ID 14634372
    
     


 



4.
Linehan WM, Zbar B (2004). Focus on kidney cancer. Cancer Cell  6, 223-8.   https://doi.org/10.1016/j.ccr.2004.09.006




PubMed


 


PubMed ID 15380513
    
     


 



5.
Lingaas F, Comstock KE, Kirkness EF, Sørensen A, Aarskaug T, Hitte C, Nickerson ML, Moe L, Schmidt LS, Thomas R, Breen M, Galibert F, Zbar B, Ostrander EA (2003). A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum Mol Genet  12, 3043-53.   https://doi.org/10.1093/hmg/ddg336




PubMed


 


PubMed ID 14532326
    
     


 



6.
Maranchie JK, Afonso A, Albert PS, Kalyandrug S, Phillips JL, Zhou S, Peterson J, Ghadimi BM, Hurley K, Riss J, Vasselli JR, Ried T, Zbar B, Choyke P, Walther MM, Klausner RD, Linehan WM (2004). Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat  23, 40-6.   https://doi.org/10.1002/humu.10302




PubMed


 


PubMed ID 14695531
    
     


 



7.
Okimoto K, Sakurai J, Kobayashi T, Mitani H, Hirayama Y, Nickerson ML, Warren MB, Zbar B, Schmidt LS, Hino O (2004). A germ-line insertion in the Birt-Hogg-Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer. Proc Natl Acad Sci U S A  101, 2023-7.   https://doi.org/10.1073/pnas.0308071100




PubMed



        
     
Free Article


 


PubMed ID 14769940
         Pubmed Central ID 357045 


 



8.
Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM (2004). Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol  172, 1256-61.   https://doi.org/10.1097/01.ju.0000139583.63354.e0




PubMed


 


PubMed ID 15371818
    
     


 



9.
Toro JR, Glenn G, Hou L, Duray P, Clark B, Merino M, Zbar B, Linehan M, Turner ML (2003). Facial papules, spontaneous pneumothorax, and renal tumors. J Am Acad Dermatol  48, 111-4.   https://doi.org/10.1067/mjd.2003.67




PubMed


 


PubMed ID 12522379
    
     


 



10.
Zbar B, Klausner R, Linehan WM (2003). Studying cancer families to identify kidney cancer genes. Annu Rev Med  54, 217-33.   https://doi.org/10.1146/annurev.med.54.101601.152514




PubMed


 


PubMed ID 12525673",https://intramural.nih.gov/search/searchview.taf?ipid=36218
95,BC008579-11,"October 01, 2003 -  September 30, 2004",Cloning and functional analysis of tumor suppressor genes  from human chromosome,"Michael I Lerman; MD, PhD","Robert  Wiltrout; PhD 
 


Berton K Zbar; PhD","Laboratory of Immunobiology, NCI",NULL,"Charles  Buys
(Genetics, University of Groningen)





George  Klein
(MTC, Karolinska Institute)





George  Klein
(MTC, Karolinska Institute)





George  Klein
(MTC, Karolinska Institute)





Terrance  Johns
(Ludwig Institute for Cancer Research)





Bruce  Johnson
(Thoracic Oncology, Harvard Medical School)


Show all 18","Robert P Nalewaik (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Stephen K Anderson; PhD (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)



Lameh  Fananapazir; MD, FRCP (National Cancer Institute)","Michael Andrew Rogawski; MD, PhD (NINDS) 












Jerrold M Ward; DVM, PhD (NIAID)","Ordered by publication type and then author name.



1.
Angeloni D, Danilkovitch-Miagkova A, Miagkov A, Leonard EJ, Lerman MI (2004). The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation. J Biol Chem  279, 3726-32.   https://doi.org/10.1074/jbc.M309342200




PubMed


 


PubMed ID 14597639
    
     


 



2.
Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, Miller AD, Lerman MI (2003). Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus. Proc Natl Acad Sci U S A  100, 4580-5.   https://doi.org/10.1073/pnas.0837136100




PubMed



        
     
Free Article


 


PubMed ID 12676986
         Pubmed Central ID 153598 


 



3.
Duh FM, Fivash M, Moody M, Li Lung M, Guo X, Stanbridge E, Dean M, Voevoda M, Hu LF, Kashuba V, Zabarovsky ER, Qian CN, Godbole S, Tean Teh B, Lerman MI (2004). Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer. Mol Cell Probes  18, 39-44.   https://doi.org/10.1016/j.mcp.2003.09.002




PubMed


 


PubMed ID 15036368
    
     


 



4.
Ivanov SV, Ward JM, Tessarollo L, McAreavey D, Sachdev V, Fananapazir L, Banks MK, Morris N, Djurickovic D, Devor-Henneman DE, Wei MH, Alvord GW, Gao B, Richardson JA, Minna JD, Rogawski MA, Lerman MI (2004). Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol  165, 1007-18.   https://doi.org/10.1016/S0002-9440(10)63362-7




PubMed



        
     
Free Article


 


PubMed ID 15331424
         Pubmed Central ID 1618598 


 



5.
Ivanova AV, Ivanov SV, Zhang X, Ivanov VN, Timofeeva OA, Lerman MI (2004). STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets. J Mol Biol  340, 641-53.   https://doi.org/10.1016/j.jmb.2004.05.025




PubMed


 


PubMed ID 15223310
    
     


 



6.
Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP (2003). Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Cancer Res  63, 1888-93.




PubMed


 


PubMed ID 12702579
    
     


 



7.
Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER (2004). Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res  64, 6438-43.   https://doi.org/10.1158/0008-5472.CAN-03-3869




PubMed


 


PubMed ID 15374952
    
     


 



8.
Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, Zabarovsky ER (2003). An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies. Cancer Res  63, 404-12.




PubMed


 


PubMed ID 12543795
    
     


 



9.
Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER (2004). Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene  23, 5719-28.   https://doi.org/10.1038/sj.onc.1207760




PubMed


 


PubMed ID 15208675",https://intramural.nih.gov/search/searchview.taf?ipid=36219
96,BC008710-26,"October 01, 2003 -  September 30, 2004",Molecular Chaperones and DNA Replication,"Sue H Wickner; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Molecular Biology, NCI",NULL,"Hideo  Iwai
(University of Zurich)





Andreas  Pluckthun
(University of Zurich)","Michael  Maurizi; PhD (Biochemistry of Proteins Section)



Byungkook  Lee; PhD (National Cancer Institute)












Susan  Gottesman; PhD  (Biochemical Genetics Section)",Kiyoshi  Mizuuchi; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36112
97,BC008714-27,"October 01, 2003 -  September 30, 2004",Bacterial Functions Involved in Cell Growth Control,"Susan  Gottesman; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Molecular Biology, NCI",NULL,"Michael  Vasil
(Department of Microbiology, University of Colorado Health Sciences Center)
















Gisela  Storz; PhD
(NICHHD)","Michael  Maurizi; PhD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)



Sue H Wickner; PhD (Experimental Immunology Branch)



Peter C Fitzgerald (National Cancer Institute)",Pamela M Fitzgerald (NIMH),"Ordered by publication type and then author name.



1.
Gottesman S (2003). Proteolysis in bacterial regulatory circuits. Annu Rev Cell Dev Biol  19, 565-87.   https://doi.org/10.1146/annurev.cellbio.19.110701.153228




PubMed


 


PubMed ID 14570582
    
     


 



2.
Massé E, Escorcia FE, Gottesman S (2003). Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli. Genes Dev  17, 2374-83.   https://doi.org/10.1101/gad.1127103




PubMed



        
     
Free Article


 


PubMed ID 12975324
         Pubmed Central ID 218075 


 



3.
Repoila F, Gottesman S (2003). Temperature sensing by the dsrA promoter. J Bacteriol  185, 6609-14.   https://doi.org/10.1128/jb.185.22.6609-6614.2003




PubMed



        
     
Free Article


 


PubMed ID 14594834
         Pubmed Central ID 262114 


 



4.
Repoila F, Majdalani N, Gottesman S (2003). Small non-coding RNAs, co-ordinators of adaptation processes in Escherichia coli: the RpoS paradigm. Mol Microbiol  48, 855-61.   https://doi.org/10.1046/j.1365-2958.2003.03454.x




PubMed


 


PubMed ID 12753181
    
     


 



5.
Zhang A, Wassarman KM, Rosenow C, Tjaden BC, Storz G, Gottesman S (2003). Global analysis of small RNA and mRNA targets of Hfq. Mol Microbiol  50, 1111-24.   https://doi.org/10.1046/j.1365-2958.2003.03734.x




PubMed


 


PubMed ID 14622403",https://intramural.nih.gov/search/searchview.taf?ipid=36220
98,BC008727-26,"October 01, 2003 -  September 30, 2004",Gene Expression and Signal Transduction in Transformation and Differentiation,J. Frederic Mushinski; MD,Beverly  Mock; PhD,"Laboratory of Genetics, NCI",NULL,"Quan-Hong  Wang
(DEPT OF PATHOLOGY, SCHI)





Larisa Y  Romanova
(MGH Dept. of Radiation Oncology, Harvard Medical School)





Michael  Kracht
(Biochemistry Department, Medizinische Hochschule Hannover)





Harald  Mischak
(Abteilung Nephrologie, Medizinische Hochschule Hannover)","Jane Beth Trepel (Cell Signaling And Oncogenesis Sect)



Siegfried  Janz; MD, DSc (National Cancer Institute)



Sabine  Mai (National Cancer Institute)












Peter  Blumberg; PhD  (Molecular Mechanisms of Tumor Promotion Section)",NULL,"Ordered by publication type and then author name.



1.
Mai S, Mushinski JF (2003). c-Myc-induced genomic instability. J Environ Pathol Toxicol Oncol  22, 179-99.   https://doi.org/10.1615/jenvpathtoxoncol.v22.i3.30




PubMed


 


PubMed ID 14529093",https://intramural.nih.gov/search/searchview.taf?ipid=36221
99,BC008751-24,"October 01, 2003 -  September 30, 2004",Regulation of Gene Transcription,"Sankar  Adhya; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Molecular Biology, NCI",NULL,NULL,Victor  Zhurkin; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Adhya S (2003). Suboperonic regulatory signals. Sci STKE  2003, pe22.   https://doi.org/10.1126/stke.2003.185.pe22




PubMed


 


PubMed ID 12783981
    
     


 



2.
Lee HJ, Lim HM, Adhya S (2004). An unsubstituted C2 hydrogen of adenine is critical and sufficient at the -11 position of a promoter to signal base pair deformation. J Biol Chem  279, 16899-902.   https://doi.org/10.1074/jbc.C400054200




PubMed


 


PubMed ID 14990576
    
     


 



3.
Lewis DE, Adhya S (2004). Axiom of determining transcription start points by RNA polymerase in Escherichia coli. Mol Microbiol  54, 692-701.   https://doi.org/10.1111/j.1365-2958.2004.04318.x




PubMed


 


PubMed ID 15491360
    
     


 



4.
Lia G, Bensimon D, Croquette V, Allemand JF, Dunlap D, Lewis DE, Adhya S, Finzi L (2003). Supercoiling and denaturation in Gal repressor/heat unstable nucleoid protein (HU)-mediated DNA looping. Proc Natl Acad Sci U S A  100, 11373-7.   https://doi.org/10.1073/pnas.2034851100




PubMed



        
     
Free Article


 


PubMed ID 14500788
         Pubmed Central ID 208764 


 



5.
Lim HM, Lewis DE, Lee HJ, Liu M, Adhya S (2003). Effect of varying the supercoiling of DNA on transcription and its regulation. Biochemistry  42, 10718-25.   https://doi.org/10.1021/bi030110t




PubMed


 


PubMed ID 12962496
    
     


 



6.
Liu M, Garges S, Adhya S (2004). lacP1 promoter with an extended -10 motif. Pleiotropic effects of cyclic AMP protein at different steps of transcription initiation. J Biol Chem  279, 54552-7.   https://doi.org/10.1074/jbc.M408609200




PubMed


 


PubMed ID 15385551
    
     


 



7.
Liu M, Tolstorukov M, Zhurkin V, Garges S, Adhya S (2004). A mutant spacer sequence between -35 and -10 elements makes the Plac promoter hyperactive and cAMP receptor protein-independent. Proc Natl Acad Sci U S A  101, 6911-6.   https://doi.org/10.1073/pnas.0401929101




PubMed



        
     
Free Article


 


PubMed ID 15118087
         Pubmed Central ID 406441 


 



8.
Roy S, Lim HM, Liu M, Adhya S (2004). Asynchronous basepair openings in transcription initiation: CRP enhances the rate-limiting step. EMBO J  23, 869-75.   https://doi.org/10.1038/sj.emboj.7600098




PubMed



        
     
Free Article


 


PubMed ID 14963488
         Pubmed Central ID 381006 


 



9.
Roy S, Semsey S, Liu M, Gussin GN, Adhya S (2004). GalR represses galP1 by inhibiting the rate-determining open complex formation through RNA polymerase contact: a GalR negative control mutant. J Mol Biol  344, 609-18.   https://doi.org/10.1016/j.jmb.2004.09.070




PubMed


 


PubMed ID 15533432
    
     


 



10.
Semsey S, Tolstorukov MY, Virnik K, Zhurkin VB, Adhya S (2004). DNA trajectory in the Gal repressosome. Genes Dev  18, 1898-907.   https://doi.org/10.1101/gad.1209404




PubMed



        
     
Free Article


 


PubMed ID 15289461
         Pubmed Central ID 517409 


 



11.
Virnik K, Lyubchenko YL, Karymov MA, Dahlgren P, Tolstorukov MY, Semsey S, Zhurkin VB, Adhya S (2003). ""Antiparallel"" DNA loop in gal repressosome visualized by atomic force microscopy. J Mol Biol  334, 53-63.   https://doi.org/10.1016/j.jmb.2003.09.030




PubMed


 


PubMed ID 14596799",https://intramural.nih.gov/search/searchview.taf?ipid=36222
100,BC008752-24,"October 01, 2003 -  September 30, 2004",Thyroid Hormone Receptors in Disease,"Sheueyann  Cheng; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Molecular Biology, NCI",NULL,"Edison  Liu
(Genome Institute of Singapore)





Graham  Williams
(Imperial College London, UK)





Fu-Chin  Liu
(National Yang-Ming University)





Carrie  Ris-Stalpers
(Academic Medical Center, University of Amsterdam)





Sam  Refetoff
(University of Chicago)





Douglas  Forrest; PhD



Show all 16",Nicolae C Popescu; PhD  (Molecular Cytogenetics Section),"Peter  McPhie; PhD (NIDDK) 



Paul S Meltzer; MD, PhD (NHGRI) 



Jerrold M Ward; DVM, PhD (NIAID) 



Louis  Sokoloff; MD (NIMH)","Ordered by publication type and then author name.



1.
Cheng SY (2003). Thyroid hormone receptor mutations in cancer. Mol Cell Endocrinol  213, 23-30.   https://doi.org/10.1016/j.mce.2003.10.051




PubMed


 


PubMed ID 15062571
    
     


 



2.
Esaki T, Suzuki H, Cook M, Shimoji K, Cheng SY, Sokoloff L, Nunez J (2003). Functional activation of cerebral metabolism in mice with mutated thyroid hormone nuclear receptors. Endocrinology  144, 4117-22.   https://doi.org/10.1210/en.2003-0414




PubMed


 


PubMed ID 12933686
    
     


 



3.
Kamiya Y, Zhang XY, Ying H, Kato Y, Willingham MC, Xu J, O'Malley BW, Cheng SY (2003). Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Endocrinology  144, 4144-53.   https://doi.org/10.1210/en.2003-0239




PubMed


 


PubMed ID 12933689
    
     


 



4.
Kato Y, Ying H, Willingham MC, Cheng SY (2004). A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis. Endocrinology  145, 4430-8.   https://doi.org/10.1210/en.2004-0612




PubMed


 


PubMed ID 15231697
    
     


 



5.
Miller LD, McPhie P, Suzuki H, Kato Y, Liu ET, Cheng SY (2004). Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance. Genome Biol  5, R31.   https://doi.org/10.1186/gb-2004-5-5-r31




PubMed



        
     
Free Article


 


PubMed ID 15128445
         Pubmed Central ID 416467 


 



6.
O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR (2003). A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol  17, 1410-24.   https://doi.org/10.1210/me.2002-0296




PubMed


 


PubMed ID 12677005
    
     


 



7.
Suzuki H, Cheng SY (2003). Compensatory role of thyroid hormone receptor (TR) alpha 1 in resistance to thyroid hormone: study in mice with a targeted mutation in the TR beta gene and deficient in TR alpha 1. Mol Endocrinol  17, 1647-55.   https://doi.org/10.1210/me.2003-0114




PubMed


 


PubMed ID 12750454
    
     


 



8.
Suzuki H, Zhang XY, Forrest D, Willingham MC, Cheng SY (2003). Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele. Mol Endocrinol  17, 895-907.   https://doi.org/10.1210/me.2002-0326




PubMed


 


PubMed ID 12576488
    
     


 



9.
Swanson EA, Gloss B, Belke DD, Kaneshige M, Cheng SY, Dillmann WH (2003). Cardiac expression and function of thyroid hormone receptor beta and its PV mutant. Endocrinology  144, 4820-5.   https://doi.org/10.1210/en.2003-0522




PubMed


 


PubMed ID 12959993
    
     


 



10.
Yen PM, Cheng SY (2003). Germline and somatic thyroid hormone receptor mutations in man. J Endocrinol Invest  26, 780-7.   https://doi.org/10.1007/BF03347365




PubMed


 


PubMed ID 14669837
    
     


 



11.
Ying H, Suzuki H, Furumoto H, Walker R, Meltzer P, Willingham MC, Cheng SY (2003). Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis  24, 1467-79.   https://doi.org/10.1093/carcin/bgg111




PubMed


 


PubMed ID 12869418
    
     


 



12.
Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY (2003). Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis. Cancer Res  63, 5274-80.




PubMed


 


PubMed ID 14500358",https://intramural.nih.gov/search/searchview.taf?ipid=36223
101,BC008753-22,"October 01, 2003 -  September 30, 2004",Immunotoxin Therapy of Solid and Hematopoietic Tumors:  Preclinical Studies,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,"Nai-Kong  Cheung
(Memorial Sloan Kettering Cancer Center)





Thomas  Licht
(University of Munich)





Giuliana  Salvatore
(Universita degli Studi di Napoli)





Isaiah  Fidler
(MD Anderson Cancer Center, University of Texas)





Darell  Bigner
(Department of Pathology, Duke University Medical Center)","Raffit  Hassan (Clinical Immunotherapy Section)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Masanori  Onda (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Gupta A, Onda M, Pastan I, Adhya S, Chaudhary VK (2003). High-density functional display of proteins on bacteriophage lambda. J Mol Biol  334, 241-54.   https://doi.org/10.1016/j.jmb.2003.09.033




PubMed


 


PubMed ID 14607116
    
     


 



2.
Hassan R, Kreitman RJ, Pastan I, Willingham MC (2005). Localization of mesothelin in epithelial ovarian cancer. Appl Immunohistochem Mol Morphol  13, 243-7.   https://doi.org/10.1097/01.pai.00000141545.36485.d6




PubMed


 


PubMed ID 16082249
    
     


 



3.
Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003). Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A  100, 6169-73.   https://doi.org/10.1073/pnas.0631749100




PubMed



        
     
Free Article


 


PubMed ID 12721372
         Pubmed Central ID 156344 


 



4.
Kitabatake Y, Hikida T, Watanabe D, Pastan I, Nakanishi S (2003). Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci U S A  100, 7965-70.   https://doi.org/10.1073/pnas.1032899100




PubMed



        
     
Free Article


 


PubMed ID 12802017
         Pubmed Central ID 164696 


 



5.
Nagata S, Numata Y, Onda M, Ise T, Hahn Y, Lee B, Pastan I (2004). Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay. J Immunol Methods  292, 141-55.   https://doi.org/10.1016/j.jim.2004.06.009




PubMed


 


PubMed ID 15350519
    
     


 



6.
Nagata S, Salvatore G, Pastan I (2003). DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins. J Immunol Methods  280, 59-72.   https://doi.org/10.1016/s0022-1759(03)00192-3




PubMed


 


PubMed ID 12972188
    
     


 



7.
Onda M, Vincent JJ, Lee B, Pastan I (2003). Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant molecules. Bioconjug Chem  14, 480-7.   https://doi.org/10.1021/bc020069r




PubMed


 


PubMed ID 12643760
    
     


 



8.
Pastan I (2003). Immunotoxins containing Pseudomonas exotoxin A: a short history. Cancer Immunol Immunother  52, 338-41.   https://doi.org/10.1007/s00262-002-0353-8




PubMed


 


PubMed ID 12700949
    
     


 



9.
Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, Pastan I, Kobayashi K (2003). Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci  23, 9078-88.




PubMed



        
     
Free Article


 


PubMed ID 14534241
         Pubmed Central ID 6740839 


 



10.
Soda T, Nakashima R, Watanabe D, Nakajima K, Pastan I, Nakanishi S (2003). Segregation and coactivation of developing neocortical layer 1 neurons. J Neurosci  23, 6272-9.




PubMed



        
     
Free Article


 


PubMed ID 12867512
         Pubmed Central ID 6740535 


 



11.
Pastan IH, Bang SH, Ho MH (submitted in 2004) Mutated Anti-cd-22 Antibodies And Immunoconjugates. Patents issued: 602004027291 (DE in 2010); 1689783 (EP in 2010); 1689783 (ES in 2010); 1689783 (FR in 2010); 1689783 (GB in 2010); 1689783 (IT in 2010); 4813364 (JP in 2011); 7,982,011 (US in 2011); 2004293471 (AU in 2011); 2547165 (CA in 2014). Patents pending: 10156976.2 (EP application); PCT/US2004/39617 (PC application). Tracking number: E-046-2004-0-AU-14 (AU application).




 



12.
Pastan IH, Ise TH, Nagata SH, Xiang LH (submitted in 2004) Irta2 Antibodies And Methods Of Use. Patent issued: 7,999,077 (US in 2011). Patent pending: PCT/US2005/034444 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=36224
102,BC008756-17,"October 01, 2003 -  September 30, 2004",Genetically Engineered Mice as Models to Study Receptor Tyrosine Kinase Function,"Glenn  Merlino; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Cell Regulation and Carcinogenesis, NCI",NULL,"Boris  Bastian
(UCSF)





Ron  DePinho
(Dana Farber, Harvard)





Frances P.  Noonan
(George Washington University Medical Center, Washington, DC)





Shelley  Berger
(Wistar Institute)





Donna  Albertson
(UCSF)
















Lynda  Chin
(Harvard Medical School)","Paul  Duray (Surgl Pathlgy Sect)



Chand  Khanna; MD (Pediatric Oncology Br)



Lee Jay Helman; MD (National Cancer Institute)



Javed  Khan; MD (Center for Cancer Research)","Paul S Meltzer; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36225
103,BC008757-17,"October 01, 2003 -  September 30, 2004",Bio-Therapies for the Treatment of Cancer and Infectious Disease,"David J Fitzgerald; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,"Randall  Mrsny
(Trinity Biosystems)





Ralf  Hertle
(University of Tuebingen,)





Gujon  Bu
(Washington Universitiy)
















Michael  Vasil
(Department of Microbiology, University of Colorado Health Sciences Center)","Susan  Gottesman; PhD (Biochemical Genetics Section)



Pierre A. Henkart; PhD (Lymphocyte Cytotoxicity Section)



Ira H Pastan; MD (National Cancer Institute)



Peter C Fitzgerald (National Cancer Institute)",Pamela M Fitzgerald (NIMH),"Ordered by publication type and then author name.



1.
Wilderman PJ, Sowa NA, FitzGerald DJ, FitzGerald PC, Gottesman S, Ochsner UA, Vasil ML (2004). Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis. Proc Natl Acad Sci U S A  101, 9792-7.   https://doi.org/10.1073/pnas.0403423101




PubMed



        
     
Free Article


 


PubMed ID 15210934
         Pubmed Central ID 470753",https://intramural.nih.gov/search/searchview.taf?ipid=36226
104,BC008758-13,"October 01, 2003 -  September 30, 2004",Transcription Machinery and Its Mechanism in Escherichia coli,Ding Jun Jin,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36227
105,BC008759-13,"October 01, 2003 -  September 30, 2004",Molecular Modeling and Bioinformatics,"Byungkook  Lee; PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,"Yoonsoo  Hahn (National Cancer Institute)



Changhoon  Kim (National Cancer Institute)



Bangalore  Sathyanarayana (National Cancer Institute)



Chin-Hsien  Tai (National Cancer Institute)



James J Vincent (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)","Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
Bera TK, Das S, Maeda H, Beers R, Wolfgang CD, Kumar V, Hahn Y, Lee B, Pastan I (2004). NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate. Proc Natl Acad Sci U S A  101, 3059-64.   https://doi.org/10.1073/pnas.0308746101




PubMed



        
     
Free Article


 


PubMed ID 14981236
         Pubmed Central ID 365744 


 



2.
Bera TK, Hahn Y, Lee B, Pastan IH (2003). TEPP, a new gene specifically expressed in testis, prostate, and placenta and well conserved in chordates. Biochem Biophys Res Commun  312, 1209-15.   https://doi.org/10.1016/j.bbrc.2003.11.031




PubMed


 


PubMed ID 14652002
    
     


 



3.
Bera TK, Huynh N, Maeda H, Sathyanarayana BK, Lee B, Pastan I (2004). Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths. Gene  337, 45-53.   https://doi.org/10.1016/j.gene.2004.05.009




PubMed


 


PubMed ID 15276201
    
     


 



4.
Goonesekere NC, Lee B (2004). Frequency of gaps observed in a structurally aligned protein pair database suggests a simple gap penalty function. Nucleic Acids Res  32, 2838-43.   https://doi.org/10.1093/nar/gkh610




PubMed



        
     
Free Article


 


PubMed ID 15155852
         Pubmed Central ID 419611 


 



5.
Hahn Y, Bera TK, Gehlhaus K, Kirsch IR, Pastan IH, Lee B (2004). Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases. Proc Natl Acad Sci U S A  101, 13257-61.   https://doi.org/10.1073/pnas.0405490101




PubMed



        
     
Free Article


 


PubMed ID 15326299
         Pubmed Central ID 516526 


 



6.
Nagata S, Numata Y, Onda M, Ise T, Hahn Y, Lee B, Pastan I (2004). Rapid grouping of monoclonal antibodies based on their topographical epitopes by a label-free competitive immunoassay. J Immunol Methods  292, 141-55.   https://doi.org/10.1016/j.jim.2004.06.009




PubMed


 


PubMed ID 15350519
    
     


 



7.
Sharma S, Sathyanarayana BK, Bird JG, Hoskins JR, Lee B, Wickner S (2004). Plasmid P1 RepA is homologous to the F plasmid RepE class of initiators. J Biol Chem  279, 6027-34.   https://doi.org/10.1074/jbc.M310917200




PubMed


 


PubMed ID 14634015",https://intramural.nih.gov/search/searchview.taf?ipid=36228
106,BC008905-23,"October 01, 2003 -  September 30, 2004",Tumor gene expression in vitro and in vivo,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Richard B Braverman (National Cancer Institute)



Raejean L Hermansen (Laboratory of Cellular Oncology)



Alex  Papageorge (National Cancer Institute)



Xiaolan  Qian; MD, PhD (National Cancer Institute)



William C Vass (National Cancer Institute)



James G McNally; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bliskovsky V, Ramsay ES, Scott J, DuBois W, Shi W, Zhang S, Qian X, Lowy DR, Mock BA (2003). Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proc Natl Acad Sci U S A  100, 14982-7.   https://doi.org/10.1073/pnas.2431627100




PubMed



        
     
Free Article


 


PubMed ID 14634209
         Pubmed Central ID 299869 


 



2.
Li S, Braverman R, Li H, Vass WC, Lowy DR, DeClue JE (2003). Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity. Mol Carcinog  37, 98-109.   https://doi.org/10.1002/mc.10125




PubMed


 


PubMed ID 12766909
    
     


 



3.
Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, Lowy DR, Mock BA (2003). p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene  22, 2285-95.   https://doi.org/10.1038/sj.onc.1206257




PubMed


 


PubMed ID 12700664",https://intramural.nih.gov/search/searchview.taf?ipid=36229
107,BC008952-18,"October 01, 2003 -  September 30, 2004",Oncogenes and tumor suppressors in murine acute myeloid leukemia,"Linda  Wolff; PhD



IRP Faculty Profile",Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,"Heidi  Scrable
(Department of Neurscience, University of Virginia)





Thirman  Michael
(Department of Medicine, University of Chicago)





Michele  Le Beau
(Department of Medicine, University of Chicago)





Janet  Rowley
(Department of Medicine, University of Chicago)





Marcos  Malumbres
(Centro Nacional De Inverstigaciones Oncologicas)





Christopher  Klug
(Department of Microbiology, University of Alabama)


Show all 12","Richard P Koller (National Cancer Institute)



Francis W Ruscetti; PhD (Laboratory of Leukocyte Biology)



Miriam R Anver (Office Of The Director)



Lionel  Feigenbaum (Office Of The Director)



John J Letterio; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36230
108,BC009003-22,"October 01, 2003 -  September 30, 2004",The Role of Cripto in the Pathogenesis of Breast and Colon Cancer,David  Salomon; PhD,Barbara V Vonderhaar; PhD,"National Cancer Institute, NCI","Brenda W Jones



Nadia Iqbal Khan







Caterina  Bianco; MD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Bianco C, Strizzi L, Rehman A, Normanno N, Wechselberger C, Sun Y, Khan N, Hirota M, Adkins H, Williams K, Margolis RU, Sanicola M, Salomon DS (2003). A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res  63, 1192-7.




PubMed


 


PubMed ID 12649175
    
     


 



2.
Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS (2003). Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat  79, 161-73.   https://doi.org/10.1023/a:1023938510508




PubMed


 


PubMed ID 12825851
    
     


 



3.
Normanno N, Bianco C, De Luca A, Maiello MR, Salomon DS (2003). Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer  10, 1-21.   https://doi.org/10.1677/erc.0.0100001




PubMed


 


PubMed ID 12653668
    
     


 



4.
Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS (2004). Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. J Cell Physiol  198, 31-9.   https://doi.org/10.1002/jcp.10375




PubMed


 


PubMed ID 14584041
    
     


 



5.
Salomon DS, Lewis MT (2004). Embryogenesis and oncogenesis: Dr Jekyll and Mr Hyde. J Mammary Gland Biol Neoplasia  9, 105-7.   https://doi.org/10.1023/B:JOMG.0000037155.93520.4a




PubMed


 


PubMed ID 15300006
    
     


 



6.
Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS (2004). Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol  201, 266-76.   https://doi.org/10.1002/jcp.20062




PubMed


 


PubMed ID 15334661",https://intramural.nih.gov/search/searchview.taf?ipid=36231
109,BC009029-12,"October 01, 2003 -  September 30, 2004",Mechanisms of CTL-Mediated Antitumor Activity In Vivo in Mouse Models of Active,Scott  Abrams; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Elwood W Mcduffie (National Cancer Institute)



Sheila  Caldwell (National Cancer Institute)



James W Hodge; PhD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)












Kristy  Greeneltch  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Caldwell SA, Ryan MH, McDuffie E, Abrams SI (2003). The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases. J Immunol  171, 2402-12.   https://doi.org/10.4049/jimmunol.171.5.2402




PubMed


 


PubMed ID 12928387
    
     


 



2.
Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW (2003). Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol  170, 6338-47.   https://doi.org/10.4049/jimmunol.170.12.6338




PubMed


 


PubMed ID 12794167",https://intramural.nih.gov/search/searchview.taf?ipid=36232
110,BC009052-15,"October 01, 2003 -  September 30, 2004",Papillomavirus Virion Proteins and Vaccines,"John  Schiller; PhD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,"Joakim  Diller
(University of Malmo)





W. Martin  Kast
(University of Southern California School of Medicine)





Diller  Joakim
(University of Malmo)





David  Morgan
(University of South Florida)





Richard  Roden; PhD, MD
(Johns Hopkins University)





Denise  Nardelli-Haefliger
(Centre Hospitalier Universitaire Vaudois)


Show all 7","Patricia  Day; PhD (National Cancer Institute)



Cynthia D Thompson (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Da Silva DM, Schiller JT, Kast WM (2003). Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines. Vaccine  21, 3219-27.   https://doi.org/10.1016/s0264-410x(03)00237-8




PubMed


 


PubMed ID 12804851
    
     


 



2.
Dahlstrom KR, Adler-Storthz K, Etzel CJ, Liu Z, Dillon L, El-Naggar AK, Spitz MR, Schiller JT, Wei Q, Sturgis EM (2003). Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res  9, 2620-6.




PubMed


 


PubMed ID 12855639
    
     


 



3.
Day PM, Lowy DR, Schiller JT (2003). Papillomaviruses infect cells via a clathrin-dependent pathway. Virology  307, 1-11.   https://doi.org/10.1016/s0042-6822(02)00143-5




PubMed


 


PubMed ID 12667809
    
     


 



4.
Lenz P, Thompson CD, Day PM, Bacot SM, Lowy DR, Schiller JT (2003). Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells. Clin Immunol  106, 231-7.   https://doi.org/10.1016/s1521-6616(02)00039-6




PubMed


 


PubMed ID 12706410
    
     


 



5.
Li Q, Cao C, Chackerian B, Schiller J, Gordon M, Ugen KE, Morgan D (2004). Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice. BMC Neurosci  5, 21.   https://doi.org/10.1186/1471-2202-5-21




PubMed



        
     
Free Article


 


PubMed ID 15186505
         Pubmed Central ID 442125 


 



6.
Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P (2003). Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst  95, 1128-37.   https://doi.org/10.1093/jnci/djg018




PubMed


 


PubMed ID 12902442
    
     


 



7.
Nonnenmacher B, Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E (2003). Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. Int J STD AIDS  14, 258-65.   https://doi.org/10.1258/095646203321264872




PubMed


 


PubMed ID 12716496
    
     


 



8.
Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A (2003). Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J Infect Dis  188, 327-38.   https://doi.org/10.1086/376505




PubMed


 


PubMed ID 12854090
    
     


 



9.
Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J (2004). A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol  93, 484-92.   https://doi.org/10.1016/j.ygyno.2004.01.044




PubMed


 


PubMed ID 15099967",https://intramural.nih.gov/search/searchview.taf?ipid=36233
111,BC009100-19,"October 01, 2003 -  September 30, 2004",Melanoma and Melanogenesis,Vincent J. Hearing; PhD,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"Donald  Hunt
(Department of Chemistry, University of Minnesota)





Shosuke  Ito
(Department of Chemistry, Fujita Health University)





M. Lynn  Lamoreux
(Department of Animal Sciences, Texas A & M University)





Ettore  Appella; MD
(NCI)
















Janusz  Beer
(Center for Devices & Radiological Health, Food & Drug Administration)",NULL,Ron  King (NHGRI),"Ordered by publication type and then author name.



1.
Basrur V, Yang F, Kushimoto T, Higashimoto Y, Yasumoto K, Valencia J, Muller J, Vieira WD, Watabe H, Shabanowitz J, Hearing VJ, Hunt DF, Appella E (2003). Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. J Proteome Res  2, 69-79.   https://doi.org/10.1021/pr025562r




PubMed


 


PubMed ID 12643545
    
     


 



2.
Costin GE, Valencia JC, Vieira WD, Lamoreux ML, Hearing VJ (2003). Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4. J Cell Sci  116, 3203-12.   https://doi.org/10.1242/jcs.00598




PubMed


 


PubMed ID 12829739
    
     


 



3.
Rouzaud F, Annereau JP, Valencia JC, Costin GE, Hearing VJ (2003). Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist. FASEB J  17, 2154-6.   https://doi.org/10.1096/fj.03-0206fje




PubMed


 


PubMed ID 14500544
    
     


 



4.
Tadokoro T, Kobayashi N, Zmudzka BZ, Ito S, Wakamatsu K, Yamaguchi Y, Korossy KS, Miller SA, Beer JZ, Hearing VJ (2003). UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J  17, 1177-9.   https://doi.org/10.1096/fj.02-0865fje




PubMed


 


PubMed ID 12692083
    
     


 



5.
Yoon TJ, Lei TC, Yamaguchi Y, Batzer J, Wolber R, Hearing VJ (2003). Reconstituted 3-dimensional human skin of various ethnic origins as an in vitro model for studies of pigmentation. Anal Biochem  318, 260-9.   https://doi.org/10.1016/s0003-2697(03)00172-6




PubMed


 


PubMed ID 12814630",https://intramural.nih.gov/search/searchview.taf?ipid=36234
112,BC009101-12,"October 01, 2003 -  September 30, 2004",Design of Antiviral Drugs Effective Against the HIV-1 Virus,"Ettore  Appella; MD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"S  Barratt-Boyes; PhD
(Infectious Diseases and Microbiology, Univ. of Pittsburgh, Grad. School of Public Health)





James  Turpin
(Prevention Sciences Branch, National Institute of Allergy and Infectious Diseases)
















Robert  Buckheit Jr.
(President and Chief Scientific Officer, ImQuest BioSciences, Inc.)",NULL,"John K. Inman; PhD (NIAID) 












Alan  Sher; PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36235
113,BC009247-24,"October 01, 2003 -  September 30, 2004",Natural Cell-Mediated Immunity Mechanism of Lysis,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,"Isaac  Blanca
(Dept. of Immunology, University of Venezuela)





Michael  Bennett
(Dept. of Pathology, University of Texas Southwestern Medical Center)





Eric  Vivier
(Campus de Luminy, Center d'Immunologie la Marseille-Luminy)





James  DiSanto
(Department of Immunology, Institute of Pasteur)





Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)
















Stephen K Anderson; PhD

(Frederick, MD 21702-1201)


Show all 7","Susan M Charbonneau (National Cancer Institute)



Daniel  McVicar; PhD (Div Clncl Scncs)



Anna T Mason (National Cancer Institute)



John W Wine (National Cancer Institute)



Robin T Winkler Pickett (National Cancer Institute)



Deborah L Hodge; PhD (Cellular and Molecular Immunology Section)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Mason LH, Willette-Brown J, Anderson SK, Alvord WG, Klabansky RL, Young HA, Ortaldo JR (2003). Receptor glycosylation regulates Ly-49 binding to MHC class I. J Immunol  171, 4235-42.   https://doi.org/10.4049/jimmunol.171.8.4235




PubMed


 


PubMed ID 14530347
    
     


 



2.
Ortaldo JR, Young HA (2003). Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J Immunol  170, 1763-9.   https://doi.org/10.4049/jimmunol.170.4.1763




PubMed


 


PubMed ID 12574340",https://intramural.nih.gov/search/searchview.taf?ipid=36236
114,BC009251-34,"October 01, 2003 -  September 30, 2004",Mechanism of Lymphocyte-Mediated Cytotoxicity,Pierre A. Henkart; PhD,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,"Charles R Mainhart (National Cancer Institute)



Wei  Xiao (National Cancer Institute)












Marta Liliana Catalfamo; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Henkart PA, Catalfamo M (2004). CD8+ effector cells. Adv Immunol  83, 233-52.   https://doi.org/10.1016/S0065-2776(04)83007-4




PubMed


 


PubMed ID 15135633",https://intramural.nih.gov/search/searchview.taf?ipid=36237
115,BC009254-30,"October 01, 2003 -  September 30, 2004",Innate Immunity,David M Segal; PhD,Alfred  Singer; MD,"Immune Targeting Section, NCI",NULL,NULL,"Chang-Woo  Lee (National Cancer Institute)



Margaret  Kennedy (National Cancer Institute)



Cynthia  Leifer (National Cancer Institute)



Alessandra  Mazzoni (National Cancer Institute)","Jessica  Bell; PhD (NIDDK) 



Joseph  Shiloach; PhD (NIDDK) 



David R Davies; PhD (NIDDK) 



David Harvey Margulies; MD, PhD (NIAID)","Ordered by publication type and then author name.



1.
Bell JK, Mullen GE, Leifer CA, Mazzoni A, Davies DR, Segal DM (2003). Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol  24, 528-33.   https://doi.org/10.1016/s1471-4906(03)00242-4




PubMed


 


PubMed ID 14552836
    
     


 



2.
Bronte V, Serafini P, De Santo C, Marigo I, Tosello V, Mazzoni A, Segal DM, Staib C, Lowel M, Sutter G, Colombo MP, Zanovello P (2003). IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol  170, 270-8.   https://doi.org/10.4049/jimmunol.170.1.270




PubMed


 


PubMed ID 12496409
    
     


 



3.
Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P (2003). L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol  24, 302-6.   https://doi.org/10.1016/s1471-4906(03)00132-7




PubMed


 


PubMed ID 12810105
    
     


 



4.
Huang LY, Aliberti J, Leifer CA, Segal DM, Sher A, Golenbock DT, Golding B (2003). Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J Immunol  171, 1441-6.   https://doi.org/10.4049/jimmunol.171.3.1441




PubMed


 


PubMed ID 12874236
    
     


 



5.
Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003). Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol  170, 2269-73.   https://doi.org/10.4049/jimmunol.170.5.2269




PubMed


 


PubMed ID 12594246
    
     


 



6.
Mullen GE, Kennedy MN, Visintin A, Mazzoni A, Leifer CA, Davies DR, Segal DM (2003). The role of disulfide bonds in the assembly and function of MD-2. Proc Natl Acad Sci U S A  100, 3919-24.   https://doi.org/10.1073/pnas.0630495100




PubMed



        
     
Free Article


 


PubMed ID 12642668
         Pubmed Central ID 153023",https://intramural.nih.gov/search/searchview.taf?ipid=36238
116,BC009255-29,"October 01, 2003 -  September 30, 2004",Application of Flow Cytometry to Cell Biology,Susan  Sharrow,Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Larry  Granger (National Cancer Institute)



Don  Plugge (National Cancer Institute)












Anthony J Adams  (Experimental Immunology Branch)",NULL,"Ordered by publication type and then author name.



1.
Bosselut R, Guinter TI, Sharrow SO, Singer A (2003). Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes ""paradoxically"" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells. J Exp Med  197, 1709-19.   https://doi.org/10.1084/jem.20030170




PubMed



        
     
Free Article


 


PubMed ID 12810689
         Pubmed Central ID 2193957 


 



2.
Catalfamo M, Karpova T, McNally J, Costes SV, Lockett SJ, Bos E, Peters PJ, Henkart PA (2004). Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity  20, 219-30.   https://doi.org/10.1016/s1074-7613(04)00027-5




PubMed


 


PubMed ID 14975243
    
     


 



3.
Chiang YJ, Sommers CL, Jordan MS, Gu H, Samelson LE, Koretzky GA, Hodes RJ (2004). Inactivation of c-Cbl reverses neonatal lethality and T cell developmental arrest of SLP-76-deficient mice. J Exp Med  200, 25-34.   https://doi.org/10.1084/jem.20040262




PubMed



        
     
Free Article


 


PubMed ID 15238603
         Pubmed Central ID 2213313 


 



4.
Chu YW, Memon SA, Sharrow SO, Hakim FT, Eckhaus M, Lucas PJ, Gress RE (2004). Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood  104, 1110-9.   https://doi.org/10.1182/blood-2003-10-3635




PubMed


 


PubMed ID 15130942
    
     


 



5.
El Kassar N, Lucas PJ, Klug DB, Zamisch M, Merchant M, Bare CV, Choudhury B, Sharrow SO, Richie E, Mackall CL, Gress RE (2004). A dose effect of IL-7 on thymocyte development. Blood  104, 1419-27.   https://doi.org/10.1182/blood-2004-01-0201




PubMed


 


PubMed ID 15155461
    
     


 



6.
Erman B, Guinter TI, Singer A (2004). Defined alphabeta T cell receptors with distinct ligand specificities do not require those ligands to signal double negative thymocyte differentiation. J Exp Med  199, 1719-24.   https://doi.org/10.1084/jem.20032204




PubMed



        
     
Free Article


 


PubMed ID 15210747
         Pubmed Central ID 2212817 


 



7.
Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, Dileepan KN, Segal DM (2004). A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J Biol Chem  279, 34698-704.   https://doi.org/10.1074/jbc.M405444200




PubMed


 


PubMed ID 15175334
    
     


 



8.
Leifer CA, Kennedy MN, Mazzoni A, Lee C, Kruhlak MJ, Segal DM (2004). TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol  173, 1179-83.   https://doi.org/10.4049/jimmunol.173.2.1179




PubMed



        
     
Free Article


 


PubMed ID 15240708
         Pubmed Central ID 2757936 


 



9.
Liu X, Bosselut R (2004). Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol  5, 280-8.   https://doi.org/10.1038/ni1040




PubMed


 


PubMed ID 14770180
    
     


 



10.
Lucas PJ, McNeil N, Hilgenfeld E, Choudhury B, Kim SJ, Eckhaus MA, Ried T, Gress RE (2004). Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. Cancer Res  64, 6524-9.   https://doi.org/10.1158/0008-5472.CAN-04-0896




PubMed


 


PubMed ID 15374963
    
     


 



11.
Lumsden JM, Williams JA, Hodes RJ (2003). Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol  170, 781-7.   https://doi.org/10.4049/jimmunol.170.2.781




PubMed


 


PubMed ID 12517941
    
     


 



12.
Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003). Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol  170, 2269-73.   https://doi.org/10.4049/jimmunol.170.5.2269




PubMed


 


PubMed ID 12594246
    
     


 



13.
Nijhara R, van Hennik PB, Gignac ML, Kruhlak MJ, Hordijk PL, Delon J, Shaw S   (2004) Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes.  J Immunol 173:4985-93.




PubMed


 


PubMed ID 15470041
    
     


 



14.
Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL, Singer A (2004). Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity  21, 289-302.   https://doi.org/10.1016/j.immuni.2004.07.016




PubMed


 


PubMed ID 15308108
    
     


 



15.
Singer A, Bosselut R (2004). CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv Immunol  83, 91-131.   https://doi.org/10.1016/S0065-2776(04)83003-7




PubMed


 


PubMed ID 15135629
    
     


 



16.
Vacchio MS, Hodes RJ (2003). CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells. J Exp Med  197, 19-26.   https://doi.org/10.1084/jem.20021429




PubMed



        
     
Free Article


 


PubMed ID 12515810
         Pubmed Central ID 2193800 


 



17.
Yu Q, Erman B, Bhandoola A, Sharrow SO, Singer A (2003). In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J Exp Med  197, 475-87.   https://doi.org/10.1084/jem.20021765




PubMed



        
     
Free Article


 


PubMed ID 12591905
         Pubmed Central ID 2193862 


 



18.
Yu Q, Erman B, Park JH, Feigenbaum L, Singer A (2004). IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med  200, 797-803.   https://doi.org/10.1084/jem.20032183




PubMed



        
     
Free Article


 


PubMed ID 15365098
         Pubmed Central ID 2211960 


 



19.
Zhang J, Chiang YJ, Hodes RJ, Siraganian RP (2004). Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J Immunol  173, 1811-8.   https://doi.org/10.4049/jimmunol.173.3.1811




PubMed


 


PubMed ID 15265912",https://intramural.nih.gov/search/searchview.taf?ipid=36113
117,BC009256-22,"October 01, 2003 -  September 30, 2004",Natural Cell-Mediated Immunity: Biology and Regulation of CD3- LGL,John R Ortaldo; PhD,NULL,"Laboratory of Experimental Immunology, NCI",NULL,"Michael  Bennett
(Dept. of Pathology, University of Texas Southwestern Medical Center)





Eric  Vivier
(Campus de Luminy, Center d'Immunologie la Marseille-Luminy)





Isaac  Blanca
(Dept. of Immunology, University of Venezuela)





Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)





Francesco  Colucci
(INSERM, Hospital Necker)





Stephen K Anderson; PhD

(Frederick, MD 21702-1201)


Show all 7","Susan M Charbonneau (National Cancer Institute)



Howard A Young; PhD (Cellular and Molecular Immunology Section)



Daniel  McVicar; PhD (Div Clncl Scncs)



Anna T Mason (National Cancer Institute)



John W Wine (National Cancer Institute)



Robin T Winkler Pickett (National Cancer Institute)","William T Murphy (OD) 












Dan L Longo; MD (NIA)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36239
118,BC009257-29,"October 01, 2003 -  September 30, 2004",Mechanisms of Cellular Immune Responses,"James Stephen Shaw; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",Michael John Kruhlak; PhD,"Dominic  Esposito
(Protein Expression Laboratory, SAIC-Frederick)





Paula  van Hennik
(Department of Experimental Immunohematology, Sanquin Research at CLB)





Herrero  Juan
(AxCell Biosciences)





Stanley  Erlandsen
(Department of Genetics, Cell Biology, & Development, University of Minnesota Medical School)





Jerome  Delon
(INSTITUT COCHIN DE GENETIQUE MOLECULAIRE)





Michelle  Gignac
(Image Analysis Laboratory, SAIC-Frederick)


Show all 8",Yin  Liu (National Cancer Institute),"Kenneth Manao Yamada; MD, PhD (NIDCR)","Ordered by publication type and then author name.



1.
Brown MJ, Nijhara R, Hallam JA, Gignac M, Yamada KM, Erlandsen SL, Delon J, Kruhlak M, Shaw S (2003). Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood  102, 3890-9.   https://doi.org/10.1182/blood-2002-12-3807




PubMed


 


PubMed ID 12907449
    
     


 



2.
Zhu G, Liu Y, Shaw J    (2004) Protein Kinase Specificity: A strategic collaboration between kinase peptide specificity and substrate recruitment. Cell Cycle., in press.",https://intramural.nih.gov/search/searchview.taf?ipid=36240
119,BC009264-21,"October 01, 2003 -  September 30, 2004",Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth,Francis W Ruscetti; PhD,John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,"Lisbeth  Welniak
(Microbilogy-Immunology, Univ. Nevada-Reno)





Stephen  Bartelmez
(Stem Cell Biology, VIA-Cell-Singapore)","Maria  Birchenall-Roberts (National Cancer Institute)



Tao  Fu (National Cancer Institute)



Yi  Huang (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)












Daniel C Bertolette  (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW (2003). Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation. Stem Cells  21, 557-67.   https://doi.org/10.1634/stemcells.21-5-557




PubMed


 


PubMed ID 12968110
    
     


 



2.
Cao Z, Flanders KC, Bertolette D, Lyakh LA, Wurthner JU, Parks WT, Letterio JJ, Ruscetti FW, Roberts AB (2003). Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. Blood  101, 498-507.   https://doi.org/10.1182/blood-2002-05-1549




PubMed


 


PubMed ID 12393416
    
     


 



3.
Muegge K, Young H, Ruscetti F, Mikovits J (2003). Epigenetic control during lymphoid development and immune responses: aberrant regulation, viruses, and cancer. Ann N Y Acad Sci  983, 55-70.   https://doi.org/10.1111/j.1749-6632.2003.tb05962.x




PubMed


 


PubMed ID 12724212",https://intramural.nih.gov/search/searchview.taf?ipid=36242
120,BC009265-22,"October 01, 2003 -  September 30, 2004",Analysis of the T Cell Repertoire,"Richard J Hodes; MD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Joy A Williams (National Cancer Institute)



Joanne  Lumsden (National Cancer Institute)












Melanie S Vacchio; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lumsden JM, Williams JA, Hodes RJ (2003). Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol  170, 781-7.   https://doi.org/10.4049/jimmunol.170.2.781




PubMed


 


PubMed ID 12517941
    
     


 



2.
Vacchio MS, Hodes RJ (2003). CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells. J Exp Med  197, 19-26.   https://doi.org/10.1084/jem.20021429




PubMed



        
     
Free Article


 


PubMed ID 12515810
         Pubmed Central ID 2193800",https://intramural.nih.gov/search/searchview.taf?ipid=36243
121,BC009266-22,"October 01, 2003 -  September 30, 2004",T Cell Regulation of B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,Joanne  Lumsden  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lumsden JM, Williams JA, Hodes RJ (2003). Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo. J Immunol  170, 781-7.   https://doi.org/10.4049/jimmunol.170.2.781




PubMed


 


PubMed ID 12517941",https://intramural.nih.gov/search/searchview.taf?ipid=36244
122,BC009267-22,"October 01, 2003 -  September 30, 2004",Immune Protection/Dysregulation in HIV/AIDS,"Gene  Shearer; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,"Matthew  Dolan
(AIDS, Wilford Hall Med Inst)





Maria  Rugeles
(Immunovirology, Unversidad de Antioquia)





Johnny  He
(Microbiol and Immunol, Indiana University School of Medicine)





Jan  Andersson
(Medicine, Karolinska Institutet)
















Claire  Chougnet
(CHRF, Children's Hospital)




Hideo  Yagita
(Immunology, Juntendo University)",Jeffrey D Lifson; MD (Office Of The Director),Jean Charles  Grivel; PhD (NICHD),"Ordered by publication type and then author name.



1.
Pinto LA, Grene E, Baker R, Trubey CM, Torres N, Trivett M, Shearer GM (2003). HIV inhibitory activity generated by antigen-stimulated cord blood leukocytes. AIDS  17, 1389-92.   https://doi.org/10.1097/00002030-200306130-00014




PubMed


 


PubMed ID 12799561
    
     


 



2.
Rugeles MT, Trubey CM, Bedoya VI, Pinto LA, Oppenheim JJ, Rybak SM, Shearer GM (2003). Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS  17, 481-6.   https://doi.org/10.1097/00002030-200303070-00002




PubMed


 


PubMed ID 12598767",https://intramural.nih.gov/search/searchview.taf?ipid=36245
123,BC009273-17,"October 01, 2003 -  September 30, 2004",T Cell Differentiation and Repertoire Selection,"Alfred  Singer; MD



IRP Faculty Profile",NULL,"Experimental Immunology Branch, NCI",NULL,NULL,"Batu M Erman (National Cancer Institute)



Terry I Guinter (National Cancer Institute)



Sophia D Sarafova (National Cancer Institute)



Xuguang C Tai (National Cancer Institute)



Qing  Yu; MD, PhD (National Cancer Institute)



Bosselut  Remy (National Cancer Institute)","Paul E Love; MD, PhD (NICHD)","Ordered by publication type and then author name.



1.
Bhandoola A, Rosenberg AS, Singer A (2003). CD4+ T-cell responses to self-peptide--MHC. Trends Immunol  24, 171.   https://doi.org/10.1016/s1471-4906(03)00061-9




PubMed


 


PubMed ID 12697444
    
     


 



2.
Bosselut R, Guinter TI, Sharrow SO, Singer A (2003). Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes ""paradoxically"" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells. J Exp Med  197, 1709-19.   https://doi.org/10.1084/jem.20030170




PubMed



        
     
Free Article


 


PubMed ID 12810689
         Pubmed Central ID 2193957 


 



3.
Doan LL, Kitay MK, Yu Q, Singer A, Herblot S, Hoang T, Bear SE, Morse HC, Tsichlis PN, Grimes HL (2003). Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment. J Immunol  170, 2356-66.   https://doi.org/10.4049/jimmunol.170.5.2356




PubMed


 


PubMed ID 12594258
    
     


 



4.
Yu Q, Erman B, Bhandoola A, Sharrow SO, Singer A (2003). In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J Exp Med  197, 475-87.   https://doi.org/10.1084/jem.20021765




PubMed



        
     
Free Article


 


PubMed ID 12591905
         Pubmed Central ID 2193862",https://intramural.nih.gov/search/searchview.taf?ipid=36246
124,BC009279-19,"October 01, 2003 -  September 30, 2004",Regulation of Expression of MHC Class I Genes,"Dinah  Singer; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Jocelyn D Weissman (National Cancer Institute)



Kevin  Howcroft (National Cancer Institute)



Aparna  Kotekar (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Maxwell P Lee; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Howcroft T, Singer D (2003). Expression of nonclassical MHC class Ib genes: comparison of regulatory elements. Immunol Res  27, 1-30.   https://doi.org/10.1385/IR:27:1:1




PubMed


 


PubMed ID 12637766
    
     


 



2.
Howcroft TK, Raval A, Weissman JD, Gegonne A, Singer DS (2003). Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression. Mol Cell Biol  23, 3377-91.   https://doi.org/10.1128/mcb.23.10.3377-3391.2003




PubMed



        
     
Free Article


 


PubMed ID 12724398
         Pubmed Central ID 154244",https://intramural.nih.gov/search/searchview.taf?ipid=36247
125,BC009281-18,"October 01, 2003 -  September 30, 2004",Receptor Mediated T and B Cell Activation,"Richard J Hodes; MD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,Karen  Hathcock (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36248
126,BC009283-20,"October 01, 2003 -  September 30, 2004",Control of Cytokine Gene Expression in Lymphoid/Myeloid Cells,"Howard A Young; PhD



IRP Faculty Profile",John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,"Rivkah  Gonsky
(UCLA)





Michael  Tovey
(Andre Lwoff Institute)





Lisa  Hensley; PhD
(FDA)





Kelly  Warfield
(USAMRIID)





Ricky  Ullrich
(USAMRIID)





Thomas  Aune
(Vanderbilt Univ.)","Della A Reynolds (National Cancer Institute)



Michael E Sanford (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bream JH, Hodge DL, Gonsky R, Spolski R, Leonard WJ, Krebs S, Targan S, Morinobu A, O'Shea JJ, Young HA (2004). A distal region in the interferon-gamma gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2. J Biol Chem  279, 41249-57.   https://doi.org/10.1074/jbc.M401168200




PubMed


 


PubMed ID 15271977
    
     


 



2.
Gamero AM, Young HA, Wiltrout RH (2004). Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer? Cancer Cell  5, 111-2.   https://doi.org/10.1016/s1535-6108(04)00028-5




PubMed


 


PubMed ID 14998485
    
     


 



3.
Ortaldo JR, Young HA (2003). Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J Immunol  170, 1763-9.   https://doi.org/10.4049/jimmunol.170.4.1763




PubMed


 


PubMed ID 12574340",https://intramural.nih.gov/search/searchview.taf?ipid=36249
127,BC009285-18,"October 01, 2003 -  September 30, 2004",Responses of MHC Class I Genes to Exogeneous Stimuli,"Dinah  Singer; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Jocelyn D Weissman (National Cancer Institute)



Helit  Cohen (National Cancer Institute)



Aparna  Kotekar (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Howcroft TK, Raval A, Weissman JD, Gegonne A, Singer DS (2003). Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression. Mol Cell Biol  23, 3377-91.   https://doi.org/10.1128/mcb.23.10.3377-3391.2003




PubMed



        
     
Free Article


 


PubMed ID 12724398
         Pubmed Central ID 154244 


 



2.
Raval A, Weissman JD, Howcroft TK, Singer DS (2003). The GTP-binding domain of class II transactivator regulates its nuclear export. J Immunol  170, 922-30.   https://doi.org/10.4049/jimmunol.170.2.922




PubMed


 


PubMed ID 12517958
    
     


 



3.
Weissman JD, Raval A, Singer DS (2003). Assay of an intrinsic acetyltransferase activity of the transcriptional coactivator CIITA. Methods Enzymol  370, 378-86.   https://doi.org/10.1016/S0076-6879(03)70033-0




PubMed


 


PubMed ID 14712661",https://intramural.nih.gov/search/searchview.taf?ipid=36250
128,BC009287-20,"October 01, 2003 -  September 30, 2004",Cytokines and T Cell Development,"Scott K Durum; PhD



IRP Faculty Profile",Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Tom  Sayers
(SAIC)





Joseph  Kovacs
(NIAID)





Annette  Khaled
(University of Central Florida)
















Timothy  Veenstra
(SAIC)","Qiong  Jiang (National Cancer Institute)



Wenqing  Li (National Cancer Institute)



Renata  Mazzucchelli (National Cancer Institute)



Annette R Khaled (National Cancer Institute)



Tad  Guszczynski (National Cancer Institute)



Terry D Copeland (National Cancer Institute)",Igal  Gery; PhD (NEI),"Ordered by publication type and then author name.



1.
Ashktorab H, Frank S, Khaled AR, Durum SK, Kifle B, Smoot DT (2004). Bax translocation and mitochondrial fragmentation induced by Helicobacter pylori. Gut  53, 805-13.   https://doi.org/10.1136/gut.2003.024372




PubMed



        
     
Free Article


 


PubMed ID 15138206
         Pubmed Central ID 1774072 


 



2.
Durum SK (2003). Bcl11: sibling rivalry in lymphoid development. Nat Immunol  4, 512-4.   https://doi.org/10.1038/ni0603-512




PubMed


 


PubMed ID 12774073
    
     


 



3.
Durum SK, Aiello FB (2003). Interleukin-7 induces MUC1. Cancer Biol Ther  2, 194-5.   https://doi.org/10.4161/cbt.2.2.351




PubMed


 


PubMed ID 12750562
    
     


 



4.
Jiang Q, Benbernou N, Chertov O, Khaled AR, Wooters J, Durum SK (2004). IL-7 induces tyrosine phosphorylation of clathrin heavy chain. Cell Signal  16, 281-6.   https://doi.org/10.1016/s0898-6568(03)00138-4




PubMed


 


PubMed ID 14636898
    
     


 



5.
Jiang Q, Li WQ, Hofmeister RR, Young HA, Hodge DR, Keller JR, Khaled AR, Durum SK (2004). Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol  24, 6501-13.   https://doi.org/10.1128/MCB.24.14.6501-6513.2004




PubMed



        
     
Free Article


 


PubMed ID 15226449
         Pubmed Central ID 434255 


 



6.
Khaled AR, Durum SK (2003). Death and Baxes: mechanisms of lymphotrophic cytokines. Immunol Rev  193, 48-57.   https://doi.org/10.1034/j.1600-065x.2003.00050.x




PubMed


 


PubMed ID 12752670
    
     


 



7.
Kim K, Khaled AR, Reynolds D, Young HA, Lee CK, Durum SK (2003). Characterization of an interleukin-7-dependent thymic cell line derived from a p53(-/-) mouse. J Immunol Methods  274, 177-84.   https://doi.org/10.1016/s0022-1759(02)00513-6




PubMed


 


PubMed ID 12609543
    
     


 



8.
Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK (2004). Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem  279, 29160-6.   https://doi.org/10.1074/jbc.M401656200




PubMed


 


PubMed ID 15123689",https://intramural.nih.gov/search/searchview.taf?ipid=36251
129,BC009290-19,"October 01, 2003 -  September 30, 2004",T Cell Activation and Apoptosis,"Jonathan D Ashwell; MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Paul  Mittelstadt; PhD



Ivana  Munitic



Albert J Fornace; MD",NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Mittelstadt PR, Ashwell JD (2003). Disruption of glucocorticoid receptor exon 2 yields a ligand-responsive C-terminal fragment that regulates gene expression. Mol Endocrinol  17, 1534-42.   https://doi.org/10.1210/me.2002-0429




PubMed


 


PubMed ID 12750452",https://intramural.nih.gov/search/searchview.taf?ipid=36252
130,BC009297-13,"October 01, 2003 -  September 30, 2004",Screening for genes essential for development of the mouse embryo,Michael Robert Kuehn; PhD,Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,"Hua-feng  Zhang (National Cancer Institute)



Meropi  Athanasiou (National Cancer Institute)



Yasuhiro  Ozawa (National Cancer Institute)












Prashant  Sharma  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36253
131,BC009304-10,"October 01, 2003 -  September 30, 2004","Structural studies on beta-1,4-Galactosyltransferase family",Pradman  Qasba; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,"Himanshu  Dubey (National Cancer Institute)



Sarah  Klein (National Cancer Institute)



Sharick  Naqi (National Cancer Institute)



Boopathy  Ramakrishna (National Cancer Institute)



Velavan  Ramasamy (National Cancer Institute)












Elizabeth  Boeggeman  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36254
132,BC009349-16,"October 01, 2003 -  September 30, 2004",Cloning and Characterization of Protein Tyrosine Kinases Involved in Leukocyte A,"Daniel  McVicar; PhD



IRP Faculty Profile",John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36256
133,BC009369-14,"October 01, 2003 -  September 30, 2004",Consequences of Chemokine-Receptor Interactions with Chemokines and Chemokine Mi,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"Xin  Chen (National Cancer Institute)



De  Yang (National Cancer Institute)












Qian  Chen  (Office Of The Director)","Paul Hunter Plotz; MD (NIAMS) 



Rachel R Caspi; PhD (NEI) 



Susan  Pierce; PhD (NIAID)","Ordered by publication type and then author name.



1.
Chen Q, Wade D, Kurosaka K, Wang ZY, Oppenheim JJ, Yang D (2004). Temporin A and related frog antimicrobial peptides use formyl peptide receptor-like 1 as a receptor to chemoattract phagocytes. J Immunol  173, 2652-9.   https://doi.org/10.4049/jimmunol.173.4.2652




PubMed


 


PubMed ID 15294982
    
     


 



2.
Chen X, Beutler JA, McCloud TG, Loehfelm A, Yang L, Dong HF, Chertov OY, Salcedo R, Oppenheim JJ, Howard OM (2003). Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity. Clin Cancer Res  9, 3115-23.




PubMed


 


PubMed ID 12912963
    
     


 



3.
Chen X, Krakauer T, Oppenheim JJ, Howard OM (2004). Yin zi huang, an injectable multicomponent chinese herbal medicine, is a potent inhibitor of T-cell activation. J Altern Complement Med  10, 519-26.   https://doi.org/10.1089/1075553041323687




PubMed


 


PubMed ID 15253857
    
     


 



4.
Chen X, Murakami T, Oppenheim JJ, Howard OMZ (2004). Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol  34, 859-869.   https://doi.org/10.1002/eji.200324506




PubMed


 


PubMed ID 14991616
    
     


 



5.
Chen X, Yang L, Zhang N, Turpin JA, Buckheit RW, Osterling C, Oppenheim JJ, Howard OM (2003). Shikonin, a component of chinese herbal medicine, inhibits chemokine receptor function and suppresses human immunodeficiency virus type 1. Antimicrob Agents Chemother  47, 2810-6.   https://doi.org/10.1128/aac.47.9.2810-2816.2003




PubMed



        
     
Free Article


 


PubMed ID 12936978
         Pubmed Central ID 182643 


 



6.
Grimm MC, Newman R, Hassim Z, Cuan N, Connor SJ, Le Y, Wang JM, Oppenheim JJ, Lloyd AR (2003). Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol  171, 4990-4.   https://doi.org/10.4049/jimmunol.171.10.4990




PubMed


 


PubMed ID 14607894
    
     


 



7.
Lin J, Dong HF, Oppenheim JJ, Howard OM (2003). Effects of astragali radix on the growth of different cancer cell lines. World J Gastroenterol  9, 670-3.   https://doi.org/10.3748/wjg.v9.i4.670




PubMed



        
     
Free Article


 


PubMed ID 12679907
         Pubmed Central ID 4611425 


 



8.
Oppenheim JJ, Biragyn A, Kwak LW, Yang D (2003). Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis  62 Suppl 2, ii17-21.   https://doi.org/10.1136/ard.62.suppl_2.ii17




PubMed



        
     
Free Article


 


PubMed ID 14532141
         Pubmed Central ID 1766745 


 



9.
Rugeles MT, Trubey CM, Bedoya VI, Pinto LA, Oppenheim JJ, Rybak SM, Shearer GM (2003). Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS  17, 481-6.   https://doi.org/10.1097/00002030-200303070-00002




PubMed


 


PubMed ID 12598767
    
     


 



10.
Salcedo R, Oppenheim JJ (2003). Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation  10, 359-70.   https://doi.org/10.1038/sj.mn.7800200




PubMed


 


PubMed ID 12851652
    
     


 



11.
Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ (2003). Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood  102, 1966-77.   https://doi.org/10.1182/blood-2002-11-3400




PubMed


 


PubMed ID 12791666
    
     


 



12.
Sun R, Iribarren P, Zhang N, Zhou Y, Gong W, Cho EH, Lockett S, Chertov O, Bednar F, Rogers TJ, Oppenheim JJ, Wang JM (2004). Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol  173, 428-36.   https://doi.org/10.4049/jimmunol.173.1.428




PubMed


 


PubMed ID 15210802
    
     


 



13.
Szabo I, Wetzel MA, Zhang N, Steele AD, Kaminsky DE, Chen C, Liu-Chen LY, Bednar F, Henderson EE, Howard OM, Oppenheim JJ, Rogers TJ (2003). Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J Leukoc Biol  74, 1074-82.   https://doi.org/10.1189/jlb.0203067




PubMed


 


PubMed ID 12972507
    
     


 



14.
Wu Z, Hoover DM, Yang D, Boulègue C, Santamaria F, Oppenheim JJ, Lubkowski J, Lu W (2003). Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A  100, 8880-5.   https://doi.org/10.1073/pnas.1533186100




PubMed



        
     
Free Article


 


PubMed ID 12840147
         Pubmed Central ID 166407 


 



15.
Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ (2004). Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol  22, 181-215.   https://doi.org/10.1146/annurev.immunol.22.012703.104603




PubMed


 


PubMed ID 15032578
    
     


 



16.
Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lubkowski J, Oppenheim JJ (2003). Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol  74, 448-55.   https://doi.org/10.1189/jlb.0103024




PubMed


 


PubMed ID 12949249
    
     


 



17.
Yang D, Rosenberg HF, Chen Q, Dyer KD, Kurosaka K, Oppenheim JJ (2003). Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood  102, 3396-403.   https://doi.org/10.1182/blood-2003-01-0151




PubMed


 


PubMed ID 12855582
    
     


 



18.
Zhang N, Hodge D, Rogers TJ, Oppenheim JJ (2003). Ca2+-independent protein kinase Cs mediate heterologous desensitization of leukocyte chemokine receptors by opioid receptors. J Biol Chem  278, 12729-36.   https://doi.org/10.1074/jbc.M300430200




PubMed


 


PubMed ID 12551901
    
     


 



19.
Zhang N, Rogers TJ, Caterina M, Oppenheim JJ (2004). Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol  173, 594-9.   https://doi.org/10.4049/jimmunol.173.1.594




PubMed


 


PubMed ID 15210821",https://intramural.nih.gov/search/searchview.taf?ipid=36257
134,BC009371-13,"October 01, 2003 -  September 30, 2004",Role of Lymphotoxin and TNF in the development and maintenance of lymphoid tissu,"Sergei A. Nedospasov; PhD, DSc","Joost J Oppenheim; MD 
 


Robert  Wiltrout; PhD","Laboratory of Molecular Immunoregulation, NCI",NULL,"Rolf  Zinkernagel
(Dept. Pathol., Inst. Exptl. Immunol., University Hospital Zurich)





Adriano  Aguzzi
(Institute of Neuropathology, University Hospital Zutich)





Dmitry  Kuprash
(Laboratory of Molecular Immunology, Engelhardt Institute of Molecular Biology)





Daniela  Mannel
(Department of Pathology, Unviersity of Regensburg)





Bernard  Ryffel
(Institute Trangenose, CNRS Orleans)","Jonathan  Keller; PhD (National Cancer Institute)



Zhenggang  Liu; PhD (Laboratory Of Genitourinary Cancer Pathogenesis)



Colin L Stewart; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Abe K, Yarovinsky FO, Murakami T, Shakhov AN, Tumanov AV, Ito D, Drutskaya LN, Pfeffer K, Kuprash DV, Komschlies KL, Nedospasov SA (2003). Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo. Blood  101, 1477-83.   https://doi.org/10.1182/blood.V101.4.1477




PubMed


 


PubMed ID 12560241
    
     


 



2.
Tumanov AV, Grivennikov SI, Shakhov AN, Rybtsov SA, Koroleva EP, Takeda J, Nedospasov SA, Kuprash DV (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol Rev  195, 106-16.   https://doi.org/10.1034/j.1600-065x.2003.00071.x




PubMed


 


PubMed ID 12969314
    
     


 



3.
Tumanov AV, Kuprash DV, Nedospasov SA (2003). The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine Growth Factor Rev  14, 275-88.   https://doi.org/10.1016/s1359-6101(03)00026-1




PubMed


 


PubMed ID 12787565",https://intramural.nih.gov/search/searchview.taf?ipid=36258
135,BC009392-11,"October 01, 2003 -  September 30, 2004",Determining the Fate of Transmembrane Proteins,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,"Mickael  Cohen (National Cancer Institute)



Yien-Che  Tsai (National Cancer Institute)



Bo  Chen (National Cancer Institute)



Jennifer  Mariano (National Cancer Institute)



Anna  Chan (National Cancer Institute)



Zlatka  Kostova-Lenard (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liang JS, Kim T, Fang S, Yamaguchi J, Weissman AM, Fisher EA, Ginsberg HN (2003). Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J Biol Chem  278, 23984-8.   https://doi.org/10.1074/jbc.M302683200




PubMed


 


PubMed ID 12670940
    
     


 



2.
Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S, Lipkowitz S, Weissman AM (2003). WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem  278, 43169-77.   https://doi.org/10.1074/jbc.M308009200




PubMed


 


PubMed ID 12907674
    
     


 



3.
Webster JM, Tiwari S, Weissman AM, Wojcikiewicz RJ (2003). Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+. J Biol Chem  278, 38238-46.   https://doi.org/10.1074/jbc.M305600200




PubMed


 


PubMed ID 12869571
    
     


 



4.
Weissman AM, Chen BM, Mariano JM, Tsai YM (submitted in 2004) The Ube2ge Binding Domain In The Ubiquitin Ligase Gp78 And Methods Of Use Thereof. Patent issued: 8,420,776 (US in 2013). Patent pending: PCT/US2005/14635 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=27445
136,BC009404-10,"October 01, 2003 -  September 30, 2004",Protein Trafficking in Lymphocytes,"Paul A Roche; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Anita C Hohenstein (National Cancer Institute)



Niti  Puri (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hiltbold EM, Poloso NJ, Roche PA (2003). MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J Immunol  170, 1329-38.   https://doi.org/10.4049/jimmunol.170.3.1329




PubMed


 


PubMed ID 12538693
    
     


 



2.
Poloso NJ, Muntasell A, Roche PA (2004). MHC class II molecules traffic into lipid rafts during intracellular transport. J Immunol  173, 4539-46.   https://doi.org/10.4049/jimmunol.173.7.4539




PubMed


 


PubMed ID 15383586
    
     


 



3.
Poloso NJ, Roche PA (2004). Association of MHC class II-peptide complexes with plasma membrane lipid microdomains. Curr Opin Immunol  16, 103-7.   https://doi.org/10.1016/j.coi.2003.11.009




PubMed


 


PubMed ID 14734117
    
     


 



4.
Puri N, Kruhlak MJ, Whiteheart SW, Roche PA (2003). Mast cell degranulation requires N-ethylmaleimide-sensitive factor-mediated SNARE disassembly. J Immunol  171, 5345-52.   https://doi.org/10.4049/jimmunol.171.10.5345




PubMed


 


PubMed ID 14607937",https://intramural.nih.gov/search/searchview.taf?ipid=36259
137,BC009405-10,"October 01, 2003 -  September 30, 2004",Regulation of Lymphocyte Proliferation and Replicative Capacity,"Richard J Hodes; MD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Karen  Hathcock (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Rafi  Ahmed; PhD (National Cancer Institute)",Peter E Lipsky; MD (NIAMS),"Ordered by publication type and then author name.



1.
Hathcock KS, Kaech SM, Ahmed R, Hodes RJ (2003). Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+ T cells. J Immunol  170, 147-52.   https://doi.org/10.4049/jimmunol.170.1.147




PubMed


 


PubMed ID 12496394",https://intramural.nih.gov/search/searchview.taf?ipid=36260
138,BC010001-09,"October 01, 2003 -  September 30, 2004",Molecular/Cellular Regulation of Hematopoiesis,Jonathan  Keller; PhD,Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"John  Gooya (National Cancer Institute)



Kimberly D Klarmann (National Cancer Institute)



Katie E Renn (National Cancer Institute)



Peter F Johnson; PhD (National Cancer Institute)



Neal G Copeland; PhD (National Cancer Institute)



Nancy L Jenkins (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Klarmann K, Ortiz M, Davies M, Keller JR (2003). Identification of in vitro growth conditions for c-Kit-negative hematopoietic stem cells. Blood  102, 3120-8.   https://doi.org/10.1182/blood-2003-04-1249




PubMed


 


PubMed ID 12855562
    
     


 



2.
Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG (2003). Bcl11a is essential for normal lymphoid development. Nat Immunol  4, 525-32.   https://doi.org/10.1038/ni925




PubMed


 


PubMed ID 12717432
    
     


 



3.
McCauslin CS, Wine J, Cheng L, Klarmann KD, Candotti F, Clausen PA, Spence SE, Keller JR (2003). In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals. Blood  102, 843-8.   https://doi.org/10.1182/blood-2002-12-3859




PubMed


 


PubMed ID 12689938",https://intramural.nih.gov/search/searchview.taf?ipid=36261
139,BC010003-09,"October 01, 2003 -  September 30, 2004",Retrovirus Gene Regulation: HTLV-1 Transmission of Replication,David  Derse; PhD,NULL,"HIV Drug Resistance Program, NCI",NULL,"Suzy  Shuker
(Department of Chemistry, Georgia Institute of Technology)





Nathaniel  Landau
(Infectious Disease Laboratory, Salk Institute for Biological Studies)
















Charles  Bangham
(Immunology, Imperial College of Medicine,)","Carl C Baker; MD, PhD (Laboratory of Cellular Oncology)



Shawn A Hill (National Cancer Institute)



Genoveffa  Franchini; MD (ANIMAL MODELS and RETROVIRAL VACCINES SECT)



Vinay K Pathak; PhD (Resistance Mechanisms Laboratory)



Gerald L Princler (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chung HK, Young HA, Goon PK, Heidecker G, Princler GL, Shimozato O, Taylor GP, Bangham CR, Derse D (2003). Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines. Blood  102, 4130-6.   https://doi.org/10.1182/blood-2003-04-1043




PubMed


 


PubMed ID 12920029
    
     


 



2.
Derse D, Heidecker G (2003). Virology. Forced entry--or does HTLV-I have the key? Science  299, 1670-1.   https://doi.org/10.1126/science.1083218




PubMed


 


PubMed ID 12637723
    
     


 



3.
Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D (2004). Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J Virol  78, 6636-48.   https://doi.org/10.1128/JVI.78.12.6636-6648.2004




PubMed



        
     
Free Article


 


PubMed ID 15163754
         Pubmed Central ID 416494 


 



4.
Hill SA, Lloyd PA, McDonald S, Wykoff J, Derse D (2003). Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. J Infect Dis  188, 424-7.   https://doi.org/10.1086/376531




PubMed


 


PubMed ID 12870124
    
     


 



5.
Liao HJ, Baker CC, Princler GL, Derse D (2004). cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing. Virology  323, 131-40.   https://doi.org/10.1016/j.virol.2003.12.028




PubMed


 


PubMed ID 15165825
    
     


 



6.
Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G (2004). HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med  10, 197-201.   https://doi.org/10.1038/nm984




PubMed


 


PubMed ID 14730358
    
     


 



7.
Princler GL, Julias JG, Hughes SH, Derse D (2003). Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology  317, 136-45.   https://doi.org/10.1016/j.virol.2003.09.010




PubMed


 


PubMed ID 14675632",https://intramural.nih.gov/search/searchview.taf?ipid=36262
140,BC010004-09,"October 01, 2003 -  September 30, 2004",Signal Transduction Pathways of Normal and Oncogenic Forms of Kit in Hematopoiet,Diana M Linnekin; PhD,Robert  Wiltrout; PhD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Johan  Lennartsson (National Cancer Institute)



Tanya  Obreiter (National Cancer Institute)



Dolores  Winterstein (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)












Shiva  Krupa  (National Cancer Institute)",Dean Darrel Metcalfe; MD (NIAID),"Ordered by publication type and then author name.



1.
Lennartsson J, Shivakrupa R, Linnekin D (2004). Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit. J Biol Chem  279, 44544-53.   https://doi.org/10.1074/jbc.M404085200




PubMed


 


PubMed ID 15308671
    
     


 



2.
Shivakrupa R, Bernstein A, Watring N, Linnekin D (2003). Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant. Cancer Res  63, 4412-9.




PubMed


 


PubMed ID 12907613
    
     


 



3.
Shivakrupa R, Linnekin D (2005). Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells. Cell Signal  17, 103-9.   https://doi.org/10.1016/j.cellsig.2004.06.004




PubMed


 


PubMed ID 15451030",https://intramural.nih.gov/search/searchview.taf?ipid=36263
141,BC010005-09,"October 01, 2003 -  September 30, 2004",The Role of Apc and beta-Catenin in Cell Regulation and Carcinogenesis,"James Ming Phang; MD



IRP Faculty Profile",Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,"Yongmin  Liu (National Cancer Institute)



Ashley  Nick (National Cancer Institute)



Gregory  Buzard; PhD (National Cancer Institute)












Gregory  Borchert  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liu Y, Borchert GL, Phang JM (2004). Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. J Biol Chem  279, 18694-700.   https://doi.org/10.1074/jbc.M308136200




PubMed


 


PubMed ID 14976201",https://intramural.nih.gov/search/searchview.taf?ipid=36264
142,BC010006-09,"October 01, 2003 -  September 30, 2004",Developmental Signal Transduction in Xenopus Oocytes and Embryos,"Ira  Daar; PhD



IRP Faculty Profile",NULL,"Regulation of Cell Growth Laboratory, NCI",NULL,"Tony  Pawson; PhD
(Samuel Lunenfeld Research Institute, Mount Sinai Hospital)





Sally  Moody
(Anatomy and Cell Biology, George washington University)","Kathleen  Soria (National Cancer Institute)



Alan O Perantoni; PhD (National Cancer Institute)



Colin L Stewart; PhD (National Cancer Institute)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)



Deborah K Morrison (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bong YS, Park YH, Lee HS, Mood K, Ishimura A, Daar IO (2004). Tyr-298 in ephrinB1 is critical for an interaction with the Grb4 adaptor protein. Biochem J  377, 499-507.   https://doi.org/10.1042/BJ20031449




PubMed



        
     
Free Article


 


PubMed ID 14535844
         Pubmed Central ID 1223872 


 



2.
Mood K, Bong YS, Lee HS, Ishimura A, Daar IO (2004). Contribution of JNK, Mek, Mos and PI-3K signaling to GVBD in Xenopus oocytes. Cell Signal  16, 631-42.   https://doi.org/10.1016/j.cellsig.2003.10.005




PubMed


 


PubMed ID 14751548
    
     


 



3.
Moore KB, Mood K, Daar IO, Moody SA (2004). Morphogenetic movements underlying eye field formation require interactions between the FGF and ephrinB1 signaling pathways. Dev Cell  6, 55-67.   https://doi.org/10.1016/s1534-5807(03)00395-2




PubMed


 


PubMed ID 14723847
    
     


 



4.
Murakami MS, Moody SA, Daar IO, Morrison DK (2004). Morphogenesis during Xenopus gastrulation requires Wee1-mediated inhibition of cell proliferation. Development  131, 571-80.   https://doi.org/10.1242/dev.00971




PubMed


 


PubMed ID 14711880
    
     


 



5.
Park EK, Warner N, Bong YS, Stapleton D, Maeda R, Pawson T, Daar IO (2004). Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos. Mol Biol Cell  15, 1647-55.   https://doi.org/10.1091/mbc.e03-09-0674




PubMed



        
     
Free Article


 


PubMed ID 14742708
         Pubmed Central ID 379263",https://intramural.nih.gov/search/searchview.taf?ipid=36265
143,BC010007-09,"October 01, 2003 -  September 30, 2004",Roles of polo kinases and interacting proteins in the cell cycle,Douglas K Ferris; PhD,Nancy H Colburn; PhD,"Laboratory of Leukocyte Biology, NCI",NULL,NULL,"Thomas  Conrads (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Andrea L Ferris (National Cancer Institute)



Timothy D. Veenstra; PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36266
144,BC010008-09,"October 01, 2003 -  September 30, 2004",The Genetics of Susceptibility to Mouse Plasma Cell Tumors,"Beverly  Mock; PhD



IRP Faculty Profile",NULL,"Laboratory of Genetics, NCI",NULL,NULL,"Edward S Ramsay (National Cancer Institute)



Shuling  Zhang (National Cancer Institute)



Ron  DePinho (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)












Valery  Bliskovsky; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bliskovsky V, Ramsay ES, Scott J, DuBois W, Shi W, Zhang S, Qian X, Lowy DR, Mock BA (2003). Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. Proc Natl Acad Sci U S A  100, 14982-7.   https://doi.org/10.1073/pnas.2431627100




PubMed



        
     
Free Article


 


PubMed ID 14634209
         Pubmed Central ID 299869 


 



2.
Zhang S, Qian X, Redman C, Bliskovski V, Ramsay ES, Lowy DR, Mock BA (2003). p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. Oncogene  22, 2285-95.   https://doi.org/10.1038/sj.onc.1206257




PubMed


 


PubMed ID 12700664",https://intramural.nih.gov/search/searchview.taf?ipid=36267
145,BC010012-09,"October 01, 2003 -  September 30, 2004",Mechanisms of Immune-mediated Tumor Cell Destruction,Thomas Joseph Sayers; PhD,John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,NULL,"Mark  Smyth (National Cancer Institute)












Alan  Brooks  (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB (2003). Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood  101, 3991-9.   https://doi.org/10.1182/blood-2002-09-2859




PubMed


 


PubMed ID 12521999
    
     


 



2.
Sayers TJ, Brooks AD, Koh CY, Ma W, Seki N, Raziuddin A, Blazar BR, Zhang X, Elliott PJ, Murphy WJ (2003). The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP. Blood  102, 303-10.   https://doi.org/10.1182/blood-2002-09-2975




PubMed


 


PubMed ID 12637321",https://intramural.nih.gov/search/searchview.taf?ipid=36268
146,BC010013-09,"October 01, 2003 -  September 30, 2004",Molecular Studies of Cellular Cytotoxicity,Stephen K Anderson; PhD,John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,"Andrew  Makrigiannis
(Molecular Immunology, Clinical Research Institute of Montreal)





Jeffrey H. Miller; PhD
(Department of Microbiology and Molecular Genetics, UCLA)",Paul  Wright (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Makrigiannis AP, Anderson SK (2003). Regulation of natural killer cell function. Cancer Biol Ther  2, 610-6.




PubMed


 


PubMed ID 14688463
    
     


 



2.
Mason LH, Willette-Brown J, Anderson SK, Alvord WG, Klabansky RL, Young HA, Ortaldo JR (2003). Receptor glycosylation regulates Ly-49 binding to MHC class I. J Immunol  171, 4235-42.   https://doi.org/10.4049/jimmunol.171.8.4235




PubMed


 


PubMed ID 14530347",https://intramural.nih.gov/search/searchview.taf?ipid=36269
147,BC010014-09,"October 01, 2003 -  September 30, 2004",Epigenetic control during embryogenesis,Kathrin  Muegge; MD,Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Rabindranath  de la Fuente






David  Munroe
(SAIC)





Weidong  Wang; PhD
(NIA)
















Ina  Dobrinski","Jiaqiang  Huang (National Cancer Institute)



Anja  Schmidtmann (National Cancer Institute)



Heming  Zhu (National Cancer Institute)



Stuart H Yuspa; MD (Laboratory of Cellular Carcinogenesis and Tumor Promotion)



Douglas K Ferris; PhD (National Cancer Institute)



Henry  Hennings; PhD (National Cancer Institute)",Patrick  Levitt (NIMH),"Ordered by publication type and then author name.



1.
Fan T, Yan Q, Huang J, Austin S, Cho E, Ferris D, Muegge K (2003). Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer Res  63, 4677-83.




PubMed


 


PubMed ID 12907649
    
     


 



2.
Huang J, Fan T, Yan Q, Zhu H, Fox S, Issaq HJ, Best L, Gangi L, Munroe D, Muegge K (2004). Lsh, an epigenetic guardian of repetitive elements. Nucleic Acids Res  32, 5019-28.   https://doi.org/10.1093/nar/gkh821




PubMed



        
     
Free Article


 


PubMed ID 15448183
         Pubmed Central ID 521642 


 



3.
Muegge K (2003). Modifications of histone cores and tails in V(D)J recombination. Genome Biol  4, 211.   https://doi.org/10.1186/gb-2003-4-4-211




PubMed



        
     
Free Article


 


PubMed ID 12702201
         Pubmed Central ID 154571 


 



4.
Muegge K, Young H, Ruscetti F, Mikovits J (2003). Epigenetic control during lymphoid development and immune responses: aberrant regulation, viruses, and cancer. Ann N Y Acad Sci  983, 55-70.   https://doi.org/10.1111/j.1749-6632.2003.tb05962.x




PubMed


 


PubMed ID 12724212
    
     


 



5.
Yan Q, Huang J, Fan T, Zhu H, Muegge K (2003). Lsh, a modulator of CpG methylation, is crucial for normal histone methylation. EMBO J  22, 5154-62.   https://doi.org/10.1093/emboj/cdg493




PubMed



        
     
Free Article


 


PubMed ID 14517253
         Pubmed Central ID 204476",https://intramural.nih.gov/search/searchview.taf?ipid=36270
148,BC010015-09,"October 01, 2003 -  September 30, 2004","Identification of Cellular Receptors Involved in HIV Infection, Tumor Metastasis","Ji Ming  Wang; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"Keqiang  Chen (Laboratory of Molecular Immunoregulation)



Nancy M Dunlop (National Cancer Institute)



Wang-Hua  Gong (National Cancer Institute)



Jinyue  Hu (National Cancer Institute)



Jian Hong  Chen (National Cancer Institute)



Pablo  Iribarren (National Cancer Institute)",Thomas F Rogers (NIAID),"Ordered by publication type and then author name.



1.
Grimm MC, Newman R, Hassim Z, Cuan N, Connor SJ, Le Y, Wang JM, Oppenheim JJ, Lloyd AR (2003). Cutting edge: vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J Immunol  171, 4990-4.   https://doi.org/10.4049/jimmunol.171.10.4990




PubMed


 


PubMed ID 14607894
    
     


 



2.
Iribarren P, Cui YH, Le Y, Ying G, Zhang X, Gong W, Wang JM (2003). IL-4 down-regulates lipopolysaccharide-induced formyl peptide receptor 2 in murine microglial cells by inhibiting the activation of mitogen-activated protein kinases. J Immunol  171, 5482-8.   https://doi.org/10.4049/jimmunol.171.10.5482




PubMed


 


PubMed ID 14607954
    
     


 



3.
Le Y, Cui Y, Ying G, Iribarren P, Wang JM (2003). The role of chemokine receptors in the promotion of viral infections. Contrib Microbiol  10, 210-31.   https://doi.org/10.1159/000068137




PubMed


 


PubMed ID 12530328",https://intramural.nih.gov/search/searchview.taf?ipid=36271
149,BC010017-09,"October 01, 2003 -  September 30, 2004","The Use of Bacteriophage in the Prevention, Diagnosis, and Treatment of Human Di","Sankar  Adhya; PhD



IRP Faculty Profile",Ira H Pastan; MD,"Laboratory of Molecular Biology, NCI",NULL,NULL,"Andrei  Trostel (National Cancer Institute)



Christal  Vitiello (National Cancer Institute)



Rotem  Edgar (National Cancer Institute)



Michael  McKinstry (National Cancer Institute)












Se Chang  Park  (National Cancer Institute)",Carl R Merril; MD (NIMH),"Ordered by publication type and then author name.



1.
Gupta A, Onda M, Pastan I, Adhya S, Chaudhary VK (2003). High-density functional display of proteins on bacteriophage lambda. J Mol Biol  334, 241-54.   https://doi.org/10.1016/j.jmb.2003.09.033




PubMed


 


PubMed ID 14607116
    
     


 



2.
Merril CR, Scholl D, Adhya SL (2003). The prospect for bacteriophage therapy in Western medicine. Nat Rev Drug Discov  2, 489-97.   https://doi.org/10.1038/nrd1111




PubMed


 


PubMed ID 12776223",https://intramural.nih.gov/search/searchview.taf?ipid=36272
150,BC010020-09,"October 01, 2003 -  September 30, 2004",Clinical Trials with Immunotoxins,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,"Raffit  Hassan (Clinical Immunotherapy Section)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



David J Fitzgerald; PhD (National Cancer Institute)



Wyndham H Wilson; MD, PhD (Medcn Br)



Alan S Wayne; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Sampson JH, Akabani G, Archer GE, Bigner DD, Berger MS, Friedman AH, Friedman HS, Herndon JE, Kunwar S, Marcus S, McLendon RE, Paolino A, Penne K, Provenzale J, Quinn J, Reardon DA, Rich J, Stenzel T, Tourt-Uhlig S, Wikstrand C, Wong T, Williams R, Yuan F, Zalutsky MR, Pastan I (2003). Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J Neurooncol  65, 27-35.   https://doi.org/10.1023/a:1026290315809




PubMed


 


PubMed ID 14649883",https://intramural.nih.gov/search/searchview.taf?ipid=36273
151,BC010021-09,"October 01, 2003 -  September 30, 2004",Biology of Mammary Gland Development and Tumorigenesis,"Gilbert  Smith; PhD



IRP Faculty Profile",Barbara V Vonderhaar; PhD,"ONCOGENETICS SECT, NCI",Robert  Callahan; PhD,NULL,"Corinne A Boulanger-Espeut (National Cancer Institute)



David  Salomon; PhD (TUMOR GROWTH FACTOR SECT)



Karen  Hathcock (National Cancer Institute)",Lothar  Hennighausen; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Henry MD, Triplett AA, Oh KB, Smith GH, Wagner KU (2004). Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene  23, 6980-5.   https://doi.org/10.1038/sj.onc.1207827




PubMed


 


PubMed ID 15286714
    
     


 



2.
Nemade RV, Bierie B, Nozawa M, Bry C, Smith GH, Vasioukhin V, Fuchs E, Hennighausen L (2004). Biogenesis and function of mouse mammary epithelium depends on the presence of functional alpha-catenin. Mech Dev  121, 91-9.   https://doi.org/10.1016/j.mod.2003.09.007




PubMed



        
     
Free Article


 


PubMed ID 14706703
         Pubmed Central ID 2405923 


 



3.
Smith GH, Boulanger CA (2003). Mammary epithelial stem cells: transplantation and self-renewal analysis. Cell Prolif  36 Suppl 1, 3-15.   https://doi.org/10.1046/j.1365-2184.36.s.1.2.x




PubMed


 


PubMed ID 14521512",https://intramural.nih.gov/search/searchview.taf?ipid=36274
152,BC010024-09,"October 01, 2003 -  September 30, 2004",Myc-activating chromosomal translocations,"Siegfried  Janz; MD, DSc",Beverly  Mock; PhD,"Laboratory of Genetics, NCI",NULL,"Freda  Stevenson
(Southampton University)





Brian  Van Ness
(University of Minnesota, Department of Genetics and Cell Biology)
















John  Shaughnessy
(Lambert Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences)","Walter M Kuehl; MD, PhD (Cancer Genetics Branch)



John J Letterio; MD (Laboratory of Cell Regulation and Carcinogenesis)



Tasuku  Honjo; MD (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Charles  Rabkin (National Cancer Institute)",Herbert Carpenter Morse; MD (NIAID),"Ordered by publication type and then author name.



1.
Kovalchuk AL, Kim JS, Janz S (2003). E mu/S mu transposition into Myc is sometimes a precursor for T(12;15) translocation in mouse B cells. Oncogene  22, 2842-50.   https://doi.org/10.1038/sj.onc.1206345




PubMed


 


PubMed ID 12743607
    
     


 



2.
Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S (2003). BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations. Cancer Res  63, 8656-63.




PubMed


 


PubMed ID 14695177",https://intramural.nih.gov/search/searchview.taf?ipid=36276
153,BC010025-09,"October 01, 2003 -  September 30, 2004",The Role of AP-1 and Other Transcription Factors in Cancer Cause and Prevention,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Gene Regulation Section, NCI",NULL,"Powel  Brown
(Baylor Breast Center, Baylor College of Medicine)





Linda  Resar
(Johns Hopkins)





Thomas  Weber
(Pacific Northwest National Laboratory)
















G. Timothy  Bowden
(Arizona Cancer Center)




Raymond  Reeves
(Washington State University)","George R.  Beck, Jr. (National Cancer Institute)



Glenn  Hegamyer (National Cancer Institute)



Timothy D. Veenstra; PhD (National Cancer Institute)



Thomas  Conrads (National Cancer Institute)



Jay  Tichelaar (National Cancer Institute)



Larry K Keefer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cooper SJ, MacGowan J, Ranger-Moore J, Young MR, Colburn NH, Bowden GT (2003). Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res  1, 848-54.




PubMed


 


PubMed ID 14517347
    
     


 



2.
Dhar A, Brindley JM, Stark C, Citro ML, Keefer LK, Colburn NH (2003). Nitric oxide does not mediate but inhibits transformation and tumor phenotype. Mol Cancer Ther  2, 1285-93.




PubMed


 


PubMed ID 14707269
    
     


 



3.
Hou DX, Kai K, Li JJ, Lin S, Terahara N, Wakamatsu M, Fujii M, Young MR, Colburn N (2004). Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis  25, 29-36.   https://doi.org/10.1093/carcin/bgg184




PubMed


 


PubMed ID 14514663
    
     


 



4.
Hu J, Nakano H, Sakurai H, Colburn NH (2004). Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis  25, 1991-2003.   https://doi.org/10.1093/carcin/bgh198




PubMed


 


PubMed ID 15192014
    
     


 



5.
Young MR, Yang HS, Colburn NH (2003). Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4. Trends Mol Med  9, 36-41.   https://doi.org/10.1016/s1471-4914(02)00009-6




PubMed


 


PubMed ID 12524209",https://intramural.nih.gov/search/searchview.taf?ipid=36277
154,BC010026-09,"October 01, 2003 -  September 30, 2004",Genes Differentially Expressed During Tumor Promotion and Progression,"Nancy H Colburn; PhD



IRP Faculty Profile",NULL,"Gene Regulation Section, NCI",NULL,"William  Merrick
(Case Western Reserve University)





Heike  Allgayer
(University of Munich)





Nahum  Sonenberg
(McGill University)





Stephen J.  Lockett
(SAIC-Frederick)
















Raymond  Reeves
(Washington State University)","Glenn  Hegamyer (National Cancer Institute)



George R.  Beck, Jr. (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Timothy  Clair; MS (National Cancer Institute)



Timothy D. Veenstra; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Jansen AP, Camalier CE, Stark C, Colburn NH (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther  3, 103-10.




PubMed


 


PubMed ID 14985450
    
     


 



2.
Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N, Colburn NH (2003). The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol  23, 26-37.   https://doi.org/10.1128/mcb.23.1.26-37.2003




PubMed



        
     
Free Article


 


PubMed ID 12482958
         Pubmed Central ID 140682 


 



3.
Yang HS, Knies JL, Stark C, Colburn NH (2003). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene  22, 3712-20.   https://doi.org/10.1038/sj.onc.1206433




PubMed


 


PubMed ID 12802278",https://intramural.nih.gov/search/searchview.taf?ipid=36278
155,BC010027-10,"October 01, 2003 -  September 30, 2004",Function of Steroid Receptors in Subcellular Compartments,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Carol T Comlish (National Cancer Institute)



Anindya P Hendarwanto (National Cancer Institute)



Elizabeth  Martinez (National Cancer Institute)



Brittney  O'Dale (National Cancer Institute)



Dawn A Walker (National Cancer Institute)












Pamela J Badger  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36279
156,BC010029-09,"October 01, 2003 -  September 30, 2004",Involvement of Valosin-Containing Protein in Ubiquitin-Proteasome Mediated Degra,Chou-Chi  Li; PhD,Nancy H Colburn; PhD,"Laboratory of Leukocyte Biology, NCI",NULL,"Virginia  Kimonis
(Div. Genetics & Metabolism, Harvard University)





Cecile  Pickart
(Molecular Microbiology, Johns Hopkins University)","Qing  Wang (National Cancer Institute)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)",NULL,"Ordered by publication type and then author name.



1.
Song C, Wang Q, Li CC (2003). ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J Biol Chem  278, 3648-55.   https://doi.org/10.1074/jbc.M208422200




PubMed


 


PubMed ID 12446676
    
     


 



2.
Wang Q, Song C, Li CC (2003). Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem Biophys Res Commun  300, 253-60.   https://doi.org/10.1016/s0006-291x(02)02840-1




PubMed


 


PubMed ID 12504076
    
     


 



3.
Wang Q, Song C, Yang X, Li CC (2003). D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J Biol Chem  278, 32784-93.   https://doi.org/10.1074/jbc.M303869200




PubMed


 


PubMed ID 12807884",https://intramural.nih.gov/search/searchview.taf?ipid=36280
157,BC010030-09,"October 01, 2003 -  September 30, 2004",Biochemical Analysis of Multidrug Resistance-linked Transport Proteins,"Suresh V Ambudkar; PhD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"Rajendra  Prasad
(Membrane Biology Laboratory, Jawaharlal Nehru University)





Pornngarm  Limtrakul
(Department of Biochemistry, Chiang Mai University)





Merritt  Andrus","Zuben  Sauna; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, Gottesman MM (2003). P-glycoprotein: from genomics to mechanism. Oncogene  22, 7468-85.   https://doi.org/10.1038/sj.onc.1206948




PubMed


 


PubMed ID 14576852
    
     


 



2.
Golin J, Ambudkar SV, Gottesman MM, Habib AD, Sczepanski J, Ziccardi W, May L (2003). Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J Biol Chem  278, 5963-9.   https://doi.org/10.1074/jbc.M210908200




PubMed


 


PubMed ID 12496287
    
     


 



3.
Polgar O, Robey RW, Morisaki K, Dean M, Michejda C, Sauna ZE, Ambudkar SV, Tarasova N, Bates SE (2004). Mutational analysis of ABCG2: role of the GXXXG motif. Biochemistry  43, 9448-56.   https://doi.org/10.1021/bi0497953




PubMed


 


PubMed ID 15260487
    
     


 



4.
Sauna ZE, Andrus MB, Turner TM, Ambudkar SV (2004). Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy. Biochemistry  43, 2262-71.   https://doi.org/10.1021/bi035965k




PubMed


 


PubMed ID 14979722
    
     


 



5.
Sauna ZE, Peng XH, Nandigama K, Tekle S, Ambudkar SV (2004). The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1). Mol Pharmacol  65, 675-84.   https://doi.org/10.1124/mol.65.3.675




PubMed


 


PubMed ID 14978246
    
     


 



6.
Shukla S, Ambudkar SV, Prasad R (2004). Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. J Antimicrob Chemother  54, 38-45.   https://doi.org/10.1093/jac/dkh308




PubMed


 


PubMed ID 15190023
    
     


 



7.
Shukla S, Saini P, Smriti S, Jha SV, Ambudkar R, Prasad   (2003) Functional characterization of Candida albicans ABC transporter Cdr1p.  Eukaryot Cell 2:1361-75.




PubMed



        
     
Free Article


 


PubMed ID 14665469
         Pubmed Central ID 326652 


 



8.
Shukla S, Sauna ZE, Prasad R, Ambudkar SV (2004). Disulfiram is a potent modulator of multidrug transporter Cdr1p of Candida albicans. Biochem Biophys Res Commun  322, 520-5.   https://doi.org/10.1016/j.bbrc.2004.07.151




PubMed


 


PubMed ID 15325261",https://intramural.nih.gov/search/searchview.taf?ipid=36281
158,BC010033-09,"October 01, 2003 -  September 30, 2004",Inflammation and  Cancer,"Curtis  Harris; MD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,"L.  Marnett
(Vanderbilt University, School of Medicine)





J.  Swenberg
(University of North Carolina)





V.  Rotter
(Weizman Institute of Science)





T. R Billiar
(University of Pittsburg)





R. N.  DuBois
(Vanderbilt University)","Weidong  Jiang (National Cancer Institute)



Elisa A Spillare (National Cancer Institute)



David Anderson Wink (National Cancer Institute)












Elise Dawn Bowman  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC   (2003) Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.  Cancer Res 63:728-34.




PubMed


 


PubMed ID 12566320
    
     


 



2.
Goodman JE, Hofseth LJ, Hussain SP, Harris CC (2004). Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen  44, 3-9.   https://doi.org/10.1002/em.20024




PubMed


 


PubMed ID 15199542
    
     


 



3.
Hofseth LJ, Hussain SP, Wogan GN, Harris CC   (2003) Nitric oxide in cancer and chemoprevention.  Free Radic Biol Med 34:955-68.




PubMed


 


PubMed ID 12684081
    
     


 



4.
Hofseth LJ, Khan MA, Ambrose M, Nikolayeva O, Xu-Welliver M, Kartalou M, Hussain SP, Roth RB, Zhou X, Mechanic LE, Zurer I, Rotter V, Samson LD, Harris CC   (2003) The adaptive imbalance in base excision-repair enzymes generates microsatellite instability in chronic inflammation.  J Clin Invest 112:1887-94.




PubMed



        
     
Free Article


 


PubMed ID 14679184
         Pubmed Central ID 296999 


 



5.
Hofseth LJ, Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC (2003). Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A  100, 143-8.   https://doi.org/10.1073/pnas.0237083100




PubMed



        
     
Free Article


 


PubMed ID 12518062
         Pubmed Central ID 140909 


 



6.
Hussain SP, Hofseth LJ, Harris CC   (2003) Radical causes of cancer.  Nat Rev Cancer 3:276-85.




PubMed


 


PubMed ID 12671666
    
     


 



7.
Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC, Wogan GN   (2004) Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53.  Cancer Res 64:3022-9.




PubMed


 


PubMed ID 15126337
    
     


 



8.
Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, Wink DA (2004). Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A  101, 8894-9.   https://doi.org/10.1073/pnas.0400453101




PubMed



        
     
Free Article


 


PubMed ID 15178764
         Pubmed Central ID 428443 


 



9.
Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC, Rotter V   (2004) The role of p53 in base excision repair following genotoxic stress.  Carcinogenesis 25:11-9.




PubMed


 


PubMed ID 14555612",https://intramural.nih.gov/search/searchview.taf?ipid=36282
159,BC010036-09,"October 01, 2003 -  September 30, 2004",Comparative functional genomics approach to identify best-fit models to study hu,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",NULL,"Jan  Reddy
(Dpt. Pathology, Northwestern University)





Marcello  Arsura
(Department of Pharmacology &Therapeutic, University of Tennessee)","Diego F Calvisi (National Cancer Institute)



Valentina  Factor (Cellular and Molecular Biology Section)



Ju-Seog  Lee; PhD (National Cancer Institute)



Tanya N Hoang (Cellular and Molecular Biology Section)












Timothy V Benjamin  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, Oliver AA, Factor V, Heuchel R, Mercurio F, Thorgeirsson SS, Sonenshein GE (2003). Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene  22, 412-25.   https://doi.org/10.1038/sj.onc.1206132




PubMed


 


PubMed ID 12545162
    
     


 



2.
Meyer K, Lee JS, Dyck PA, Cao WQ, Rao MS, Thorgeirsson SS, Reddy JK (2003). Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Carcinogenesis  24, 975-84.   https://doi.org/10.1093/carcin/bgg040




PubMed


 


PubMed ID 12771043",https://intramural.nih.gov/search/searchview.taf?ipid=36283
160,BC010037-09,"October 01, 2003 -  September 30, 2004",Mechanisms of Mammary Gland Carcinogenesis of Heterocyclic amines,Elizabeth  Snyderwine; PhD,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,NULL,"Cunping  Qiu (National Cancer Institute)



Liang  Shan (National Cancer Institute)



Andriana  Papaconstantinou (National Cancer Institute)



Ilanchezhian  Shanmugam (National Cancer Institute)



Minshu R Yu (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Qiu C, Shan L, Yu M, Snyderwine EG (2003). Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res  63, 5674-8.




PubMed


 


PubMed ID 14522882
    
     


 



2.
Qiu C, Yu M, Shan L, Snyderwine EG (2003). Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Oncogene  22, 1253-60.   https://doi.org/10.1038/sj.onc.1206233




PubMed


 


PubMed ID 12606953",https://intramural.nih.gov/search/searchview.taf?ipid=36284
161,BC010038-09,"October 01, 2003 -  September 30, 2004",Molecular Cytogenetics of Solid Tumors,Nicolae C Popescu; PhD,"Snorri S. Thorgeirsson; MD, PhD","Laboratory of Experimental Carcinogenesis, NCI",NULL,"Timothy  Ley
(Department of medicine and Genetics, Washington University St. Lous School of Medicine)





Ley  Timothy
(Division of Oncology, Washington Univ. Sch. Medicine)





Kay  Huebner
(Kimmel Cancer Center, Thomas Jefferson University Philadelphia)





Anil B.  Mukherjee
(Sect. Developmental Genetics, NICHD)
















Marcello  Aldaz
(Science Park Research Division, Univ. Texas, MD Anderson Cancer Center)","Drazen  Zimonjic; PhD (National Cancer Institute)



Robert  Weinberg (National Cancer Institute)












Marian E Durkin  (Molecular Cytogenetics Section)



Ira H Pastan; MD  (Molecular Biology Section)",NULL,"Ordered by publication type and then author name.



1.
Choi MS, Anderson MA, Zhang Z, Zimonjic DB, Popescu N, Mukherjee AB (2003). Neutral ceramidase gene: role in regulating ceramide-induced apoptosis. Gene  315, 113-22.   https://doi.org/10.1016/s0378-1119(03)00721-2




PubMed


 


PubMed ID 14557071
    
     


 



2.
Park SW, Durkin ME, Thorgeirsson SS, Popescu NC (2003). DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma. Int J Oncol  23, 133-7.




PubMed


 


PubMed ID 12792785
    
     


 



3.
Park SW, Ludes-Meyers J, Zimonjic DB, Durkin ME, Popescu NC, Aldaz CM (2004). Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Br J Cancer  91, 753-9.   https://doi.org/10.1038/sj.bjc.6602023




PubMed



        
     
Free Article


 


PubMed ID 15266310
         Pubmed Central ID 2364795 


 



4.
Popescu NC (2003). Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett  192, 1-17.   https://doi.org/10.1016/s0304-3835(02)00596-7




PubMed


 


PubMed ID 12637148
    
     


 



5.
Popescu NC (2004). Fragile sites and cancer genes on the short arm of chromosome 8. Lancet Oncol  5, 77; discussion 77.   https://doi.org/10.1016/S1470-2045(04)01377-4




PubMed


 


PubMed ID 14761808
    
     


 



6.
Popescu NC, Durkin ME (2004). Rho GTPase activating protein cDNA on chromosome 13q12 is the deleted in liver cancer (DLC2) gene. Biochem Biophys Res Commun  315, 781.   https://doi.org/10.1016/j.bbrc.2004.02.010




PubMed


 


PubMed ID 14985079
    
     


 



7.
Rikiyama T, Curtis J, Oikawa M, Zimonjic DB, Popescu N, Murphy BA, Wilson MA, Johnson AC (2003). GCF2: expression and molecular analysis of repression. Biochim Biophys Acta  1629, 15-25.   https://doi.org/10.1016/s0167-4781(03)00156-8




PubMed


 


PubMed ID 14522076
    
     


 



8.
Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC (2004). Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol  6, 168-70.   https://doi.org/10.1038/ncb1095




PubMed


 


PubMed ID 14755273
    
     


 



9.
Shan Z, Haaf T, Popescu NC (2003). Identification and characterization of a gene encoding a putative mouse Rho GTPase activating protein gene 8, Arhgap8. Gene  303, 55-61.   https://doi.org/10.1016/s0378-1119(02)01143-5




PubMed


 


PubMed ID 12559566
    
     


 



10.
Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, Zimonjic DB, Popescu NC, DiPersio JF, Ley TJ (2003). High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood  102, 1857-65.   https://doi.org/10.1182/blood-2002-12-3779




PubMed


 


PubMed ID 12750176
    
     


 



11.
Yuan BZ, Durkin ME, Popescu NC (2003). Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet  140, 113-7.   https://doi.org/10.1016/s0165-4608(02)00674-x




PubMed


 


PubMed ID 12645648
    
     


 



12.
Yuan BZ, Jefferson AM, Baldwin KT, Thorgeirsson SS, Popescu NC, Reynolds SH (2004). DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas. Oncogene  23, 1405-11.   https://doi.org/10.1038/sj.onc.1207291




PubMed


 


PubMed ID 14661059
    
     


 



13.
Yuan BZ, Jefferson AM, Popescu NC, Reynolds SH (2004). Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine. Neoplasia  6, 412-9.   https://doi.org/10.1593/neo.03490




PubMed



        
     
Free Article


 


PubMed ID 15256063
         Pubmed Central ID 1502114 


 



14.
Yuan BZ, Zhou X, Durkin ME, Zimonjic DB, Gumundsdottir K, Eyfjord JE, Thorgeirsson SS, Popescu NC (2003). DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene  22, 445-50.   https://doi.org/10.1038/sj.onc.1206064




PubMed


 


PubMed ID 12545165
    
     


 



15.
Yuan BZ, Zhou X, Zimonjic DB, Durkin ME, Popescu NC (2003). Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma. J Mol Diagn  5, 48-53.   https://doi.org/10.1016/S1525-1578(10)60451-5




PubMed



        
     
Free Article


 


PubMed ID 12552080
         Pubmed Central ID 1907373 


 



16.
Zhang H, Meng LH, Zimonjic DB, Popescu NC, Pommier Y (2004). Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases. Nucleic Acids Res  32, 2087-92.   https://doi.org/10.1093/nar/gkh525




PubMed



        
     
Free Article


 


PubMed ID 15096574
         Pubmed Central ID 407812 


 



17.
Zhou X, Thorgeirsson SS, Popescu NC (2004). Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene  23, 1308-13.   https://doi.org/10.1038/sj.onc.1207246




PubMed


 


PubMed ID 14647417
    
     


 



18.
Zimonjic DB, Durkin ME, Keck-Waggoner CL, Park SW, Thorgeirsson SS, Popescu NC (2003). SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma. Neoplasia  5, 390-6.   https://doi.org/10.1016/s1476-5586(03)80041-6




PubMed



        
     
Free Article


 


PubMed ID 14670176
         Pubmed Central ID 1502609",https://intramural.nih.gov/search/searchview.taf?ipid=36285
162,BC010041-09,"October 01, 2003 -  September 30, 2004","Oligosaccharide Inhibitor Interactions with beta-1,4-Galactosyltransferase-1",Pradman  Qasba; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,"Boopathy  Ramakrishna (National Cancer Institute)



Velavan  Ramasamy (National Cancer Institute)












Elizabeth  Boeggeman  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36286
163,BC010045-09,"October 01, 2003 -  September 30, 2004",Pattern Discovery for Combinatorial Databases,"Bruce Allen Shapiro; PhD



IRP Faculty Profile",Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Jason  Wang
(College of Computing Sciences, New Jersey Institute of Technology)





Kaizhong  Wang
(Computer Science, University of Western Ontario)





Dennis  Shasha
(Computer Science, New York University)",Kazimierz Wojcieck Kasprzak (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36288
164,BC010049-09,"October 01, 2003 -  September 30, 2004",TGF-beta1 in Hematopoietic and Immune Cell Differentiation and Function,John J Letterio; MD,NULL,"Laboratory of Cell Regulation and Carcinogenesis, NCI",NULL,"John  Shaughnessy
(Myeloma Research Institute, University of Arkansas)





Curt  Civin
(Pediatric Hematology Oncology, The Johns Hopkins University)





Michael  Sporn
(Pharmacology, Dartmouth College)","Michael  Potter; MD (Laboratory of Genetics)



Frank M Balis; MD, PhD (Pharmclgy And Experimental Therapeutics Sect)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Francis W Ruscetti; PhD (Laboratory of Leukocyte Biology)



Anita B Roberts; PhD (National Cancer Institute)



Seong-Jin  Kim; PhD (National Cancer Institute)","Chuxia  Deng; PhD (NIDDK) 



Ethan M Shevach; MD (NIAID) 



Marika  Kullberg; PhD (NIAID) 



Ashok Balkrishna Kulkarni; PhD (NIDCR)","Ordered by publication type and then author name.



1.
Cao Z, Flanders KC, Bertolette D, Lyakh LA, Wurthner JU, Parks WT, Letterio JJ, Ruscetti FW, Roberts AB (2003). Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells. Blood  101, 498-507.   https://doi.org/10.1182/blood-2002-05-1549




PubMed


 


PubMed ID 12393416
    
     


 



2.
Kim SJ, Letterio J (2003). Transforming growth factor-beta signaling in normal and malignant hematopoiesis. Leukemia  17, 1731-7.   https://doi.org/10.1038/sj.leu.2403069




PubMed


 


PubMed ID 12970772
    
     


 



3.
Mamura M, Lee W, Sullivan TJ, Felici A, Sowers AL, Allison JP, Letterio JJ (2004). CD28 disruption exacerbates inflammation in Tgf-beta1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood  103, 4594-601.   https://doi.org/10.1182/blood-2003-08-2897




PubMed


 


PubMed ID 15016653
    
     


 



4.
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ (2004). Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med  351, 552-9.   https://doi.org/10.1056/NEJMoa031197




PubMed


 


PubMed ID 15295048",https://intramural.nih.gov/search/searchview.taf?ipid=36289
165,BC010251-09,"October 01, 2003 -  September 30, 2004",Biological Activity and Structural Analysis of Secreted Frizzled-Related Protein,"Jeffrey S Rubin; MD, PhD",Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,"Yoshimi  Endo (National Cancer Institute)



Farhana  Feroze-Merzoug (National Cancer Institute)



Samilia  Obeng-Gyasi (National Cancer Institute)



Hakki  Sercan (National Cancer Institute)



William G Taylor (National Cancer Institute)



Vladimir  Wolf (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dabdoub A, Donohue MJ, Brennan A, Wolf V, Montcouquiol M, Sassoon DA, Hseih JC, Rubin JS, Salinas PC, Kelley MW (2003). Wnt signaling mediates reorientation of outer hair cell stereociliary bundles in the mammalian cochlea. Development  130, 2375-84.   https://doi.org/10.1242/dev.00448




PubMed


 


PubMed ID 12702652
    
     


 



2.
Qiang YW, Endo Y, Rubin JS, Rudikoff S (2003). Wnt signaling in B-cell neoplasia. Oncogene  22, 1536-45.   https://doi.org/10.1038/sj.onc.1206239




PubMed


 


PubMed ID 12629517",https://intramural.nih.gov/search/searchview.taf?ipid=36290
166,BC010252-09,"October 01, 2003 -  September 30, 2004",Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.,Francis W Ruscetti; PhD,John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,NULL,"Yi  Huang (National Cancer Institute)



Kathryn  Jones; PhD (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Gene  Shearer; PhD (National Cancer Institute)



Cari  Sadowski (National Cancer Institute)












Daniel C Bertolette  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R (2004). Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci U S A  101, 15452-7.   https://doi.org/10.1073/pnas.0402874101




PubMed



        
     
Free Article


 


PubMed ID 15489273
         Pubmed Central ID 524434 


 



2.
Nath MD, Ruscetti FW, Petrow-Sadowski C, Jones KS (2003). Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation. Blood  101, 3085-92.   https://doi.org/10.1182/blood-2002-07-2277




PubMed


 


PubMed ID 12506039
    
     


 



3.
Polianova MT, Ruscetti FW, Pert CB, Tractenberg RE, Leoung G, Strang S, Ruff MR (2003). Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). Peptides  24, 1093-8.   https://doi.org/10.1016/s0196-9781(03)00176-1




PubMed


 


PubMed ID 14499289
    
     


 



4.
Ruff MR, Polianova M, Yang QE, Leoung GS, Ruscetti FW, Pert CB (2003). Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors. Curr HIV Res  1, 51-67.   https://doi.org/10.2174/1570162033352066




PubMed


 


PubMed ID 15043212
    
     


 



5.
Taub DD, Mikovits JA, Nilsson G, Schaffer EM, Key ML, Petrow-Sadowski C, Ruscetti FW (2004). Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4. Cell Immunol  230, 65-80.   https://doi.org/10.1016/j.cellimm.2004.09.005




PubMed


 


PubMed ID 15598422
    
     


 



6.
Wielgosz MM, Rauch DA, Jones KS, Ruscetti FW, Ratner L (2005). Cholesterol dependence of HTLV-I infection. AIDS Res Hum Retroviruses  21, 43-50.   https://doi.org/10.1089/aid.2005.21.43




PubMed



        
     
Free Article


 


PubMed ID 15665643
         Pubmed Central ID 2671014",https://intramural.nih.gov/search/searchview.taf?ipid=36291
167,BC010253-09,"October 01, 2003 -  September 30, 2004",Molecular Mechanisms of Growth Factor Modulated Proliferation,William  Farrar,Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,"Han-jong  Kim (National Cancer Institute)



Nima  Sharifi (National Cancer Institute)



David R Hodge (National Cancer Institute)



Suneethe  Thomas (National Cancer Institute)



Lihua  Wang (National Cancer Institute)



Xiaohu  Zhang (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chatti K, Farrar WL, Duhé RJ (2004). Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state. Biochemistry  43, 4272-83.   https://doi.org/10.1021/bi036109b




PubMed


 


PubMed ID 15065871
    
     


 



2.
Hodge DR, Xiao W, Wang LH, Li D, Farrar WL (2004). Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells. Cancer Biol Ther  3, 188-94.   https://doi.org/10.4161/cbt.3.2.621




PubMed


 


PubMed ID 14726660
    
     


 



3.
Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T (2004). Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol  172, 2332-40.   https://doi.org/10.4049/jimmunol.172.4.2332




PubMed


 


PubMed ID 14764702
    
     


 



4.
Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA, Farrar WL (2004). Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res  64, 3465-73.   https://doi.org/10.1158/0008-5472.CAN-03-3970




PubMed


 


PubMed ID 15150099
    
     


 



5.
Wang LH, Yang XY, Zhang X, Huang J, Hou J, Li J, Xiong H, Mihalic K, Zhu H, Xiao W, Farrar WL (2004). Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells. Immunity  20, 205-18.   https://doi.org/10.1016/s1074-7613(04)00030-5




PubMed


 


PubMed ID 14975242
    
     


 



6.
Wang LH, Yang XY, Zhang X, Mihalic K, Fan YX, Xiao W, Howard OM, Appella E, Maynard AT, Farrar WL (2004). Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. Nat Med  10, 40-7.   https://doi.org/10.1038/nm969




PubMed


 


PubMed ID 14702633
    
     


 



7.
Wang LH, Yang XY, Zhang X, Mihalic K, Xiao W, Farrar WL (2003). The cis decoy against the estrogen response element suppresses breast cancer cells via target disrupting c-fos not mitogen-activated protein kinase activity. Cancer Res  63, 2046-51.




PubMed


 


PubMed ID 12727818",https://intramural.nih.gov/search/searchview.taf?ipid=36292
168,BC010256-09,"October 01, 2003 -  September 30, 2004",Analysis of the function of the nodal gene during embryonic development,Michael Robert Kuehn; PhD,Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,"Yasuhiro  Ozawa (National Cancer Institute)












Allison  Galica  (National Cancer Institute)",Amit  Kumar; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36295
169,BC010257-09,"October 01, 2003 -  September 30, 2004",Ligand-receptor-antibody interactions in virus entry and signal transduction: mo,Dimiter Stanchev Dimitrov; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Dennis  Burton; PhD
(Scripps Research Institute)





Gerald  Quinnan
(Medicine, USUHS)





Hana  Golding
(Retrovirus Research, FDA)





Christopher  Broder
(Immunology and Microbiology, USUHS)","Igor A Sidorov (National Cancer Institute)



Xiaodong  Xiao (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Dean H. Hamer; PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)",Peter D Kwong; PhD (NIAID),"Ordered by publication type and then author name.



1.
Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X (2004). Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Biochemistry  43, 1410-7.   https://doi.org/10.1021/bi035323x




PubMed


 


PubMed ID 14769016
    
     


 



2.
Dimitrov DS (2004). Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol  2, 109-22.   https://doi.org/10.1038/nrmicro817




PubMed


 


PubMed ID 15043007
    
     


 



3.
Huang CC, Venturi M, Majeed S, Moore MJ, Phogat S, Zhang MY, Dimitrov DS, Hendrickson WA, Robinson J, Sodroski J, Wyatt R, Choe H, Farzan M, Kwong PD (2004). Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc Natl Acad Sci U S A  101, 2706-11.   https://doi.org/10.1073/pnas.0308527100




PubMed



        
     
Free Article


 


PubMed ID 14981267
         Pubmed Central ID 365685 


 



4.
Prabakaran P, Xiao X, Dimitrov DS (2004). A model of the ACE2 structure and function as a SARS-CoV receptor. Biochem Biophys Res Commun  314, 235-41.   https://doi.org/10.1016/j.bbrc.2003.12.081




PubMed


 


PubMed ID 14715271
    
     


 



5.
Sidorov IA, Gee D, Dimitrov DS (2004). A kinetic model of telomere shortening in infants and adults. J Theor Biol  226, 169-75.   https://doi.org/10.1016/j.jtbi.2003.08.009




PubMed


 


PubMed ID 14643186
    
     


 



6.
Xiao X, Dimitrov DS (2004). The SARS-CoV S glycoprotein. Cell Mol Life Sci  61, 2428-30.   https://doi.org/10.1007/s00018-004-4257-y




PubMed


 


PubMed ID 15526150
    
     


 



7.
Xiao X, Feng Y, Chakraborti S, Dimitrov DS (2004). Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain. Biochem Biophys Res Commun  322, 93-9.   https://doi.org/10.1016/j.bbrc.2004.07.084




PubMed


 


PubMed ID 15313178
    
     


 



8.
Zhang MY, Shu Y, Rudolph D, Prabakaran P, Labrijn AF, Zwick MB, Lal RB, Dimitrov DS (2004). Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning. J Mol Biol  335, 209-19.   https://doi.org/10.1016/j.jmb.2003.09.055




PubMed


 


PubMed ID 14659751
    
     


 



9.
Zhang MY, Shu Y, Sidorov I, Dimitrov DS (2004). Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades. Antiviral Res  61, 161-4.   https://doi.org/10.1016/j.antiviral.2003.09.009




PubMed


 


PubMed ID 15168796
    
     


 



10.
Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS (2004). Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J Virol  78, 9233-42.   https://doi.org/10.1128/JVI.78.17.9233-9242.2004




PubMed



        
     
Free Article


 


PubMed ID 15308718
         Pubmed Central ID 506938 


 



11.
Lobanenkov V, Abdullaev Z, Loukinov D, Pack S (submitted in 2004) Method Of Detecting Cancer Based On Immune Reaction To Boris. Patent issued: 7,785,814 (US in 2010). Patents pending: 05799643.1 (ES application); 05799643.1 (FR application); 05799643.1 (GB application); 05799643.1 (IT application); PCT/US2005/33796 (PC application); 60/611,798 (US application); 05799643.1 (DE application); 05799643.1 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=36296
170,BC010258-08,"October 01, 2003 -  September 30, 2004",Molecular mechanisms regulating the transition from innate to adaptive immunity,Teizo  Yoshimura; PhD,Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Michel  Faure
(Research, SUGEN, Inc.)
















Akihiro  Matsukawa
(Department of Pathology, Experimental Medicine, School of Medicine, Kumamoto University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Galligan C, Yoshimura T (2003). Phenotypic and functional changes of cytokine-activated neutrophils. Chem Immunol Allergy  83, 24-44.   https://doi.org/10.1159/000071555




PubMed


 


PubMed ID 12947977
    
     


 



2.
Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, Howard OM, Yoshimura T (2004). Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis. Arthritis Rheum  50, 1806-14.   https://doi.org/10.1002/art.20275




PubMed


 


PubMed ID 15188357
    
     


 



3.
Jeevan A, Yoshimura T, Lee KE, McMurray DN (2003). Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination. Infect Immun  71, 354-64.   https://doi.org/10.1128/iai.71.1.354-364.2003




PubMed



        
     
Free Article


 


PubMed ID 12496185
         Pubmed Central ID 143318 


 



4.
Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T (2004). Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology  111, 186-94.   https://doi.org/10.1111/j.0019-2805.2003.01794.x




PubMed



        
     
Free Article


 


PubMed ID 15027904
         Pubmed Central ID 1782413 


 



5.
Lasco TM, Yamamoto T, Yoshimura T, Allen SS, Cassone L, McMurray DN (2003). Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect Immun  71, 7035-42.   https://doi.org/10.1128/iai.71.12.7035-7042.2003




PubMed



        
     
Free Article


 


PubMed ID 14638793
         Pubmed Central ID 308898 


 



6.
Matsuyama W, Faure M, Yoshimura T (2003). Activation of discoidin domain receptor 1 facilitates the maturation of human monocyte-derived dendritic cells through the TNF receptor associated factor 6/TGF-beta-activated protein kinase 1 binding protein 1 beta/p38 alpha mitogen-activated protein kinase signaling cascade. J Immunol  171, 3520-32.   https://doi.org/10.4049/jimmunol.171.7.3520




PubMed


 


PubMed ID 14500648
    
     


 



7.
Matsuyama W, Kamohara H, Galligan C, Faure M, Yoshimura T (2003). Interaction of discoidin domain receptor 1 isoform b (DDR1b) with collagen activates p38 mitogen-activated protein kinase and promotes differentiation of macrophages. FASEB J  17, 1286-8.   https://doi.org/10.1096/fj.02-0320fje




PubMed


 


PubMed ID 12738814
    
     


 



8.
Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T (2004). Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol  172, 2332-40.   https://doi.org/10.4049/jimmunol.172.4.2332




PubMed


 


PubMed ID 14764702",https://intramural.nih.gov/search/searchview.taf?ipid=36297
171,BC010262-08,"October 01, 2003 -  September 30, 2004",Molecular Genetics of the MHC,"Mary  Carrington; MS, PhD",Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Richard  Single
(Medical Biostatistics, University of Vermont)
















Stephan  Beck
(Sanger Centre)","Jie  Cheng (National Cancer Institute)



Amy  Poisson (National Cancer Institute)



Xiaojiang  Gao (National Cancer Institute)



Maureen P Martin (National Cancer Institute)












Arman A Bashirova  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36298
172,BC010263-08,"October 01, 2003 -  September 30, 2004",Comparative Feline Genomics:  High-Throughput BAC/PAC Contig Mapping of the Majo,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Pieter  deJong
(CHORI)
















William  Nash
(H & W Sytogenetics Service)","Naoya  Yuhki; MD (National Cancer Institute)



Joan C Menninger (National Cancer Institute)



Janice S Martenson (National Cancer Institute)












Thomas  Beck  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Beck TW, Menninger J, Murphy WJ, Nash WG, O'brien SJ, Yuhki N (2005). The feline major histocompatibility complex is rearranged by an inversion with a breakpoint in the distal class I region. Immunogenetics  56, 702-9.   https://doi.org/10.1007/s00251-004-0742-6




PubMed


 


PubMed ID 15592824",https://intramural.nih.gov/search/searchview.taf?ipid=36299
173,BC010265-08,"October 01, 2003 -  September 30, 2004",Developing the Feline Radiation Hybrid Map,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"Nicole  Crumpler (National Cancer Institute)



Joan C Menninger (National Cancer Institute)



Emma  Teeling (National Cancer Institute)



William J. Murphy (Laboratory of Molecular Immunoregulation)



Alfred L Roca (National Cancer Institute)












Nuria  Vasquez-Salat  (National Cancer Institute)","Alejandro Alberto Schaffer; PhD (NLM) 












Richa  Agarwala; BTech, MS, PhD (NLM)","Ordered by publication type and then author name.



1.
Kuznetsov SB, Matveeva NM, Murphy WJ, O'Brien SJ, Serov OL (2003). Mapping of 53 loci in American mink (Mustela vison). J Hered  94, 386-91.   https://doi.org/10.1093/jhered/esg084




PubMed


 


PubMed ID 14557391
    
     


 



2.
Murphy WJ, Bourque G, Tesler G, Pevzner P, O'Brien SJ (2003). Reconstructing the genomic architecture of mammalian ancestors using multispecies comparative maps. Hum Genomics  1, 30-40.   https://doi.org/10.1186/1479-7364-1-1-30




PubMed



        
     
Free Article


 


PubMed ID 15601531
         Pubmed Central ID 3525001 


 



3.
Murphy WJ, Frönicke L, O'Brien SJ, Stanyon R (2003). The origin of human chromosome 1 and its homologs in placental mammals. Genome Res  13, 1880-8.   https://doi.org/10.1101/gr.1022303




PubMed



        
     
Free Article


 


PubMed ID 12869576
         Pubmed Central ID 403779 


 



4.
Murphy WJ, Pevzner PA, O'Brien SJ (2004). Mammalian phylogenomics comes of age. Trends Genet  20, 631-9.   https://doi.org/10.1016/j.tig.2004.09.005




PubMed


 


PubMed ID 15522459
    
     


 



5.
O'Brien SJ, Murphy WJ (2003). Genomics. A dog's breakfast? Science  301, 1854-5.   https://doi.org/10.1126/science.1090531




PubMed


 


PubMed ID 14512608
    
     


 



6.
Springer MS, Murphy WJ, Eizirik E, O'Brien SJ (2003). Placental mammal diversification and the Cretaceous-Tertiary boundary. Proc Natl Acad Sci U S A  100, 1056-61.   https://doi.org/10.1073/pnas.0334222100




PubMed



        
     
Free Article


 


PubMed ID 12552136
         Pubmed Central ID 298725 


 



7.
Teeling EC, Madsen O, Murphy WJ, Springer MS, O'Brien SJ (2003). Nuclear gene sequences confirm an ancient link between New Zealand's short-tailed bat and South American noctilionoid bats. Mol Phylogenet Evol  28, 308-19.   https://doi.org/10.1016/s1055-7903(03)00117-9




PubMed


 


PubMed ID 12878467",https://intramural.nih.gov/search/searchview.taf?ipid=36300
174,BC010269-08,"October 01, 2003 -  September 30, 2004",Effects of genetic variation on infectious disease,"Mary  Carrington; MS, PhD",Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Howard  Strickler
(Albert Einstein College of Medicine)





Amalio  Telenti
(University Hospital of Lausanne)





David  Thomas
(Dept of Medicine, Johns Hopkins University School of Medicine)





Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)
















Salim  Khakoo
(University Medicine, University of Southhampton)","Xiaojiang  Gao (National Cancer Institute)



Maureen P Martin (National Cancer Institute)



George  Nelson (National Cancer Institute)












Arman A Bashirova  (National Cancer Institute)



Allan  Hildesheim; PhD  (Interdisciplinary Studies Sect)",NULL,"Ordered by publication type and then author name.



1.
Bashirova AA, Wu L, Cheng J, Martin TD, Martin MP, Benveniste RE, Lifson JD, KewalRamani VN, Hughes A, Carrington M (2003). Novel member of the CD209 (DC-SIGN) gene family in primates. J Virol  77, 217-27.   https://doi.org/10.1128/jvi.77.1.217-227.2003




PubMed



        
     
Free Article


 


PubMed ID 12477827
         Pubmed Central ID 140574 


 



2.
Carrington M, O'Brien SJ (2003). The influence of HLA genotype on AIDS. Annu Rev Med  54, 535-51.   https://doi.org/10.1146/annurev.med.54.101601.152346




PubMed


 


PubMed ID 12525683
    
     


 



3.
Karacki PS, Gao X, Thio CL, Thomas DL, Goedert JJ, Vlahov D, Kaslow RA, Strathdee S, Hilgartner MW, O'Brien SJ, Carrington M (2004). MICA and recovery from hepatitis C virus and hepatitis B virus infections. Genes Immun  5, 261-6.   https://doi.org/10.1038/sj.gene.6364065




PubMed


 


PubMed ID 15029237
    
     


 



4.
Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M (2004). HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science  305, 872-4.   https://doi.org/10.1126/science.1097670




PubMed


 


PubMed ID 15297676
    
     


 



5.
Liu C, Carrington M, Kaslow RA, Gao X, Rinaldo CR, Jacobson LP, Margolick JB, Phair J, O'Brien SJ, Detels R (2003). Association of polymorphisms in human leukocyte antigen class I and transporter associated with antigen processing genes with resistance to human immunodeficiency virus type 1 infection. J Infect Dis  187, 1404-10.   https://doi.org/10.1086/374394




PubMed


 


PubMed ID 12717621
    
     


 



6.
Liu C, Carrington M, Kaslow RA, Gao X, Rinaldo CR, Jacobson LP, Margolick JB, Phair J, O'Brien SJ, Detels R (2004). Lack of associations between HLA class II alleles and resistance to HIV-1 infection among white, non-Hispanic homosexual men. J Acquir Immune Defic Syndr  37, 1313-7.   https://doi.org/10.1097/01.qai.0000127026.47429.5c




PubMed


 


PubMed ID 15385740
    
     


 



7.
Maloney EM, Nagai M, Hisada M, Soldan SS, Goebel PB, Carrington M, Sawada T, Brennan MB, Cranston B, Hanchard B, Jacobson S (2004). Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. J Infect Dis  189, 41-5.   https://doi.org/10.1086/380567




PubMed


 


PubMed ID 14702151
    
     


 



8.
Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol  77, 12083-7.   https://doi.org/10.1128/jvi.77.22.12083-12087.2003




PubMed



        
     
Free Article


 


PubMed ID 14581545
         Pubmed Central ID 254245 


 



9.
Wu L, Martin TD, Carrington M, KewalRamani VN (2004). Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology  318, 17-23.   https://doi.org/10.1016/j.virol.2003.09.028




PubMed


 


PubMed ID 14972530",https://intramural.nih.gov/search/searchview.taf?ipid=36301
175,BC010270-08,"October 01, 2003 -  September 30, 2004",High-Throughput Genotyping for Genetic Epidemiology,Michael W Smith,Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"David  Altshuler
(Massachusetts Institute of Technology)





Yvette  Berthier-Schaad
(Johns Hopkins University)





Jean-Paul  Chretien
(Johns Hopkins University)





Francisco  De La Vega
(Applied Biosystems)





Dennis  Gilbert
(Applied Biosystems)





Michael  Klag
(Johns Hopkins University)


Show all 11","Mary  Mcnally (National Cancer Institute)



David  Alschuler (National Cancer Institute)","Lev G Goldfarb; MD, PhD (NINDS)","Ordered by publication type and then author name.



1.
Oleksyk TK, Goldfarb LG, Sivtseva T, Danilova AP, Osakovsky VL, Shrestha S, O'Brien SJ, Smith MW (2004). Evaluating association and transmission of eight inflammatory genes with Viliuisk encephalomyelitis susceptibility. Eur J Immunogenet  31, 121-8.   https://doi.org/10.1111/j.1365-2370.2004.00459.x




PubMed


 


PubMed ID 15182325
    
     


 



2.
Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, et al. [7 more authors] (2004). A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet  74, 1001-13.   https://doi.org/10.1086/420856




PubMed



        
     
Free Article


 


PubMed ID 15088270
         Pubmed Central ID 1181963",https://intramural.nih.gov/search/searchview.taf?ipid=36302
176,BC010271-08,"October 01, 2003 -  September 30, 2004","Identification of Genes Involved in HIV-1/AIDS, HBV and HCV",Michael W Smith,Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Gregory D.  Kirk
(Department of Epidemiology, Johns Hopkins University)





David  Thomas
(Johns Hopkins University)





Sharyne M.  Donfield
(Rho Incorporated)





Trevor  Woodage
(Applied Biosystems)
















Chloe L.  Thio
(Department of Medicine, Johns Hopkins University)","Sadeep  Shrestha (National Cancer Institute)



Steffanie  Strathdee (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36303
177,BC010272-08,"October 01, 2003 -  September 30, 2004",Facilitating Access to Information on Humans Proteins and their Phosphorylation,"James Stephen Shaw; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36304
178,BC010275-07,"October 01, 2003 -  September 30, 2004",Neuronal Cell Death Regulation in Drosophila,"Florence M Davidson; MS, PhD, BA",Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,"Steve  Britt
(University of Colorado Health Sciences Center)





Laura  Torroja
(Universidad Autonome de Madrid)
















Bertrand  Mollereau
(Rockefeller University)",Elise C Kohn; MD  (Tumor Invasion And Metastases Sect),"Chi-Hon  Lee; MD, MS, PhD (NICHD)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36305
179,BC010276-07,"October 01, 2003 -  September 30, 2004",Protein Folding Mechanism,"Yawen  Bai; PhD



IRP Faculty Profile",Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,NULL,"Ngoc-Diep  Vu (National Cancer Institute)



Zheng  Zhou (National Cancer Institute)












Hangiao  Feng  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bai Y (2003). Hidden intermediates and levinthal paradox in the folding of small proteins. Biochem Biophys Res Commun  305, 785-8.   https://doi.org/10.1016/s0006-291x(03)00800-3




PubMed


 


PubMed ID 12767898
    
     


 



2.
Bai Y, Feng H (2004). Selection of stably folded proteins by phage-display with proteolysis. Eur J Biochem  271, 1609-14.   https://doi.org/10.1111/j.1432-1033.2004.04074.x




PubMed


 


PubMed ID 15096199
    
     


 



3.
Bai Y, Zhou H, Zhou Y (2004). Critical nucleation size in the folding of small apparently two-state proteins. Protein Sci  13, 1173-81.   https://doi.org/10.1110/ps.03587604




PubMed



        
     
Free Article


 


PubMed ID 15075405
         Pubmed Central ID 2286761 


 



4.
Feng H, Bai Y (2004). Repacking of hydrophobic residues in a stable mutant of apocytochrome b562 selected by phage-display and proteolysis. Proteins  56, 426-9.   https://doi.org/10.1002/prot.20161




PubMed


 


PubMed ID 15229877
    
     


 



5.
Feng H, Takei J, Lipsitz R, Tjandra N, Bai Y (2003). Specific non-native hydrophobic interactions in a hidden folding intermediate: implications for protein folding. Biochemistry  42, 12461-5.   https://doi.org/10.1021/bi035561s




PubMed


 


PubMed ID 14580191
    
     


 



6.
Feng H, Vu ND, Bai Y (2004). Detection and structure determination of an equilibrium unfolding intermediate of Rd-apocytochrome b562: native fold with non-native hydrophobic interactions. J Mol Biol  343, 1477-85.   https://doi.org/10.1016/j.jmb.2004.08.099




PubMed


 


PubMed ID 15491625
    
     


 



7.
Vu ND, Feng H, Bai Y (2004). The folding pathway of barnase: the rate-limiting transition state and a hidden intermediate under native conditions. Biochemistry  43, 3346-56.   https://doi.org/10.1021/bi0362267




PubMed


 


PubMed ID 15035606",https://intramural.nih.gov/search/searchview.taf?ipid=36306
180,BC010277-07,"October 01, 2003 -  September 30, 2004",Mechanisms of Chromosome Maintenance in Bacteria,"Dhruba K Chattoraj; PhD



IRP Faculty Profile",Michael Joseph Lichten; PhD,"National Cancer Institute, NCI",NULL,NULL,NULL,Paul F Morrison; PhD (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36307
181,BC010278-07,"October 01, 2003 -  September 30, 2004",Imaging cellular assemblies with three-dimensional electron microscopy,"Sriram  Subramaniam; PhD



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,"Peter  Peters
(Netherlands Cancer Institute)





Ben  Lich
(FEI Inc.)
















Guillermo  Sapiro
(Electrical Engineering, Uinversity of Minnesota)","Jurgen A Heymann (National Cancer Institute)



Teruhisa  Hirai (National Cancer Institute)



Martin  Kessel; BSc, PhD (National Cancer Institute)



Stanton  Lee (National Cancer Institute)



Jonathan  Lefman (National Cancer Institute)



Jeffrey  Lengyel (National Cancer Institute)",Richard D Leapman; PhD (OD),"Ordered by publication type and then author name.



1.
Heymann JA, Hirai T, Shi D, Subramaniam S (2003). Projection structure of the bacterial oxalate transporter OxlT at 3.4A resolution. J Struct Biol  144, 320-6.   https://doi.org/10.1016/j.jsb.2003.09.002




PubMed


 


PubMed ID 14643200
    
     


 



2.
Hirai T, Heymann JA, Maloney PC, Subramaniam S (2003). Structural model for 12-helix transporters belonging to the major facilitator superfamily. J Bacteriol  185, 1712-8.   https://doi.org/10.1128/jb.185.5.1712-1718.2003




PubMed



        
     
Free Article


 


PubMed ID 12591890
         Pubmed Central ID 148079 


 



3.
Hirai T, Subramaniam S (2003). Structural insights into the mechanism of proton pumping by bacteriorhodopsin. FEBS Lett  545, 2-8.   https://doi.org/10.1016/s0014-5793(03)00386-7




PubMed


 


PubMed ID 12788485
    
     


 



4.
Weis RM, Hirai T, Chalah A, Kessel M, Peters PJ, Subramaniam S (2003). Electron microscopic analysis of membrane assemblies formed by the bacterial chemotaxis receptor Tsr. J Bacteriol  185, 3636-43.   https://doi.org/10.1128/jb.185.12.3636-3643.2003




PubMed



        
     
Free Article


 


PubMed ID 12775701
         Pubmed Central ID 156230 


 



5.
Wu X, Milne JL, Borgnia MJ, Rostapshov AV, Subramaniam S, Brooks BR (2003). A core-weighted fitting method for docking atomic structures into low-resolution maps: application to cryo-electron microscopy. J Struct Biol  141, 63-76.   https://doi.org/10.1016/s1047-8477(02)00570-1




PubMed



        
     
Free Article


 


PubMed ID 12576021
         Pubmed Central ID 6413516 


 



6.
Zhang P, Borgnia MJ, Mooney P, Shi D, Pan M, O'Herron P, Mao A, Brogan D, Milne JL, Subramaniam S (2003). Automated image acquisition and processing using a new generation of 4K x 4K CCD cameras for cryo electron microscopic studies of macromolecular assemblies. J Struct Biol  143, 135-44.   https://doi.org/10.1016/s1047-8477(03)00124-2




PubMed


 


PubMed ID 12972350",https://intramural.nih.gov/search/searchview.taf?ipid=36308
182,BC010279-07,"October 01, 2003 -  September 30, 2004",Interaction of Progesterone Receptor with Chromatin,Catharine L Smith; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Anna  Riegel
(Pharmacology, Georgetown University School of Medicine)





D  Smith
(Pathology Operations, Amgen)",NULL,NULL,"Ordered by publication type and then author name.



1.
Botos J, Xian W, Smith DF, Smith CL (2004). Progesterone receptor deficient in chromatin binding has an altered cellular state. J Biol Chem  279, 15231-9.   https://doi.org/10.1074/jbc.M309718200




PubMed


 


PubMed ID 14744870",https://intramural.nih.gov/search/searchview.taf?ipid=36309
183,BC010283-07,"October 01, 2003 -  September 30, 2004",DNA Repair,"Andre A Nussenzweig; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Hua Tang (Henry)  Chen (National Cancer Institute)



Simone  Difilippantonio (National Cancer Institute)



Oscar  Fernandez-Capetillo (National Cancer Institute)



Alicia  Lee (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)












Arkady  Celeste  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36311
184,BC010284-07,"October 01, 2003 -  September 30, 2004",Mechanisms of Tumor Suppression by Transforming Growth Factor-beta,Adam  Glick; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Anjali  Shukla (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)












Dong-Soon  Bae  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liu X, Lee J, Cooley M, Bhogte E, Hartley S, Glick A (2003). Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. Cancer Res  63, 7760-8.




PubMed


 


PubMed ID 14633701
    
     


 



2.
Vijayachandra K, Lee J, Glick AB (2003). Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res  63, 3447-52.




PubMed


 


PubMed ID 12839923",https://intramural.nih.gov/search/searchview.taf?ipid=36312
185,BC010285-07,"October 01, 2003 -  September 30, 2004",Development and Utilization of Models for Inducible Gene Expression in the Epide,Adam  Glick; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Nicholas  Blazanin (National Cancer Institute)



Andrew  Ryscavage (National Cancer Institute)



Anjali  Shukla (National Cancer Institute)












Dong-Soon  Bae  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36313
186,BC010286-07,"October 01, 2003 -  September 30, 2004",Cell regulation by oncogenes in Development,"Steven X Hou



IRP Faculty Profile",Berton K Zbar; PhD,"Laboratory of Immunobiology, NCI",NULL,"Ting  Xie
(Stowers Institute)





Francis  Castets
(Unite de Neurocybernetique Cellulaire)
















Xinhua  Lin
(Children's Hospital Medical Center)","Michael  Dean; PhD (National Cancer Institute)



Maria  Eriksson; PhD (National Cancer Institute)












Neal G Copeland; PhD  (National Cancer Institute)","J Silvio  Gutkind; PhD (NIDCR) 



Brian Clay Oliver; PhD (NIDDK)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36314
187,BC010288-07,"October 01, 2003 -  September 30, 2004",Genetics of Susceptibility to Development of Skin Tumors:  Mechanisms of Action,Henry  Hennings; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,Alesia J Holly  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Horn EJ, Albor A, Liu Y, El-Hizawi S, Vanderbeek GE, Babcock M, Bowden GT, Hennings H, Lozano G, Weinberg WC, Kulesz-Martin M (2004). RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis  25, 157-67.   https://doi.org/10.1093/carcin/bgh003




PubMed


 


PubMed ID 14578165
    
     


 



2.
Kozikowski AP, Nowak I, Petukhov PA, Etcheberrigaray R, Mohamed A, Tan M, Lewin N, Hennings H, Pearce LL, Blumberg PM (2003). New amide-bearing benzolactam-based protein kinase C modulators induce enhanced secretion of the amyloid precursor protein metabolite sAPPalpha. J Med Chem  46, 364-73.   https://doi.org/10.1021/jm020350r




PubMed


 


PubMed ID 12540236",https://intramural.nih.gov/search/searchview.taf?ipid=36315
188,BC010289-07,"October 01, 2003 -  September 30, 2004",Chromatin Targets of Cyclic Nucleotide Signaling Pathways,Catharine L Smith; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Jackie  Dudley; PhD
(University of Texas)
















Hans-Gottfried  Genieser
(BIOLOG Life Science Institute)",NULL,NULL,"Ordered by publication type and then author name.



1.
Mulholland NM, Snyder SK, Kolla SS, Smith CL (2003). Chromatin-dependent regulation of the MMTV promoter by cAMP signaling is mediated through distinct pathways. Exp Cell Res  287, 361-73.   https://doi.org/10.1016/s0014-4827(03)00153-8




PubMed


 


PubMed ID 12837291",https://intramural.nih.gov/search/searchview.taf?ipid=36316
189,BC010292-06,"October 01, 2003 -  September 30, 2004",Enzymes and substrates of the ubiquitin conjugating system,"Allan M Weissman; MD



IRP Faculty Profile",NULL,"Regulation of Cell Growth Laboratory, NCI",Karen H Vousden,NULL,"Jane P Jensen (National Cancer Institute)



Kevin L Lorick; PhD (National Cancer Institute)



Shervon  Pierre (National Cancer Institute)



Yien-Che  Tsai (National Cancer Institute)



Michael Robert Kuehn; PhD (National Cancer Institute)



Robert Andrew Byrd (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Itoh M, Kim CH, Palardy G, Oda T, Jiang YJ, Maust D, Yeo SY, Lorick K, Wright GJ, Ariza-McNaughton L, Weissman AM, Lewis J, Chandrasekharappa SC, Chitnis AB (2003). Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. Dev Cell  4, 67-82.   https://doi.org/10.1016/s1534-5807(02)00409-4




PubMed


 


PubMed ID 12530964
    
     


 



2.
Wu PY, Hanlon M, Eddins M, Tsui C, Rogers RS, Jensen JP, Matunis MJ, Weissman AM, Weisman AM, Weissman AM, Wolberger C, Wolberger CP, Pickart CM (2003). A conserved catalytic residue in the ubiquitin-conjugating enzyme family. EMBO J  22, 5241-50.   https://doi.org/10.1093/emboj/cdg501




PubMed



        
     
Free Article


 


PubMed ID 14517261
         Pubmed Central ID 204484",https://intramural.nih.gov/search/searchview.taf?ipid=27541
190,BC010298-07,"October 01, 2003 -  September 30, 2004",Gene Discovery,"Ira H Pastan; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,"Sudipto  Das (National Cancer Institute)



Robert  Strausberg (Office Of Science Planning and Assessment)



Maria  Gallo (National Cancer Institute)



Robert J Kreitman; MD, PhD (Clinical Immunotherapy Section)



Vasantha  Kumar (National Cancer Institute)



Nicolae C Popescu; PhD (Molecular Cytogenetics Section)",NULL,"Ordered by publication type and then author name.



1.
Bera TK, Hahn Y, Lee B, Pastan IH (2003). TEPP, a new gene specifically expressed in testis, prostate, and placenta and well conserved in chordates. Biochem Biophys Res Commun  312, 1209-15.   https://doi.org/10.1016/j.bbrc.2003.11.031




PubMed


 


PubMed ID 14652002
    
     


 



2.
Cheng WS, Giandomenico V, Pastan I, Essand M (2003). Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter. Endocrinology  144, 3433-40.   https://doi.org/10.1210/en.2003-0121




PubMed


 


PubMed ID 12865322
    
     


 



3.
Egland KA, Vincent JJ, Strausberg R, Lee B, Pastan I (2003). Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins. Proc Natl Acad Sci U S A  100, 1099-104.   https://doi.org/10.1073/pnas.0337425100




PubMed



        
     
Free Article


 


PubMed ID 12538848
         Pubmed Central ID 298733 


 



4.
Lelong-Rebel IH, Rebel G, Cardarelli CO, Pastan I, Gottesman MM (2003). Modulation by the ATP/GTP ratio of the phosphorylation level of P-glycoprotein and of various plasma membrane proteins of KB-V1 multidrug resistant cells. Anticancer Res  23, 2363-75.




PubMed


 


PubMed ID 12894516
    
     


 



5.
Maitra R, Grigoryev DN, Bera TK, Pastan IH, Lee B (2003). Cloning, molecular characterization, and expression analysis of Copine 8. Biochem Biophys Res Commun  303, 842-7.   https://doi.org/10.1016/s0006-291x(03)00445-5




PubMed


 


PubMed ID 12670487
    
     


 



6.
Olsson P, Motegi A, Bera TK, Lee B, Pastan I (2003). PRAC2: a new gene expressed in human prostate and prostate cancer. Prostate  56, 123-30.   https://doi.org/10.1002/pros.10185




PubMed


 


PubMed ID 12746837",https://intramural.nih.gov/search/searchview.taf?ipid=36318
191,BC010300-07,"October 01, 2003 -  September 30, 2004",Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages,"Daniel  McVicar; PhD



IRP Faculty Profile",John R Ortaldo; PhD,"Laboratory of Experimental Immunology, NCI",NULL,"Edward  Cho
(Image Analysis Laboratory, National Cancer Institite)




Weihua  Zhang; PhD
(Human Genetics Research Div., Univ. of Southampton)","Stephen K Anderson; PhD (National Cancer Institute)



Jennifer L Amato (National Cancer Institute)","Ivo  Francischetti; MD, PhD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36320
192,BC010301-07,"October 01, 2003 -  September 30, 2004",Development of Recombinant Toxins for Treatment of Patients with Hematologic Mal,"Robert J Kreitman; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,"Kakushi  Matsushita
(1st Department of Internal Medicine, Kagoshima University, Japan)





Arthur  Frankel; MD
(Scott & White Memorial Hospital, Cancer Research Institute)





Mark  Willingham
(Wake Forest University School of Medicine)





Harry  Findleyl
(Emory University School of Medicine)





Shoji  Hirashima
(Daiichi)
















Giuliana  Salvatore
(Universita degli Studi di Napoli)","Ira H Pastan; MD (National Cancer Institute)



David J Fitzgerald; PhD (National Cancer Institute)



Byungkook  Lee; PhD (National Cancer Institute)



Alan S Wayne; MD (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



John Charles Morris; MD (National Cancer Institute)","Pierre  Noel (CC) 



Margaret E Rick; MD (CC) 



Jorge A Carrasquillo; MD (CC) 



George J Grimes (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36321
193,BC010303-06,"October 01, 2003 -  September 30, 2004",MicroArray Explorer for the data mining of expression profiles of DNA microarray,Peter F Lemkin; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Shyam  Sundaram
(HHS, SRA/BIAMAS/CIT)





Gregory  Alvord
(Data Management Services)





Mariusz  Lubomirski
(HHS, CSS/DMS-Frederick)
















Jonathan  Evans; MD
(University of Bristol)




Lothar  Hennighausen; PhD
(NIDDK)",Gregory  Thornwall  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36322
194,BC010304-06,"October 01, 2003 -  September 30, 2004",Biochemical Basis of T Cell Activation,"Lawrence Elliot Samelson; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular and Molecular Biology, NCI",NULL,"Roy A Mariuzza; PhD
(University of Maryland)





Vivian  Braciali
(University of Texas Medical Branch)





Julian  Watts
(Institute for Systems Biology)
















Ruedi  Aebersold
(Institute for Systems Biology)","David  Nelson; MD, PhD (Center for Cancer Research)","Paul E Love; MD, PhD (NICHD) 



Peter W Schuck; PhD (OD)","Ordered by publication type and then author name.



1.
Bunnell SC, Barr VA, Fuller CL, Samelson LE (2003). High-resolution multicolor imaging of dynamic signaling complexes in T cells stimulated by planar substrates. Sci STKE  2003, PL8.   https://doi.org/10.1126/stke.2003.177.pl8




PubMed


 


PubMed ID 12684528
    
     


 



2.
Fuller CL, Braciale VL, Samelson LE (2003). All roads lead to actin: the intimate relationship between TCR signaling and the cytoskeleton. Immunol Rev  191, 220-36.   https://doi.org/10.1034/j.1600-065x.2003.00004.x




PubMed


 


PubMed ID 12614363
    
     


 



3.
Saitoh S, Odom S, Gomez G, Sommers CL, Young HA, Rivera J, Samelson LE (2003). The four distal tyrosines are required for LAT-dependent signaling in FcepsilonRI-mediated mast cell activation. J Exp Med  198, 831-43.   https://doi.org/10.1084/jem.20030574




PubMed



        
     
Free Article


 


PubMed ID 12953098
         Pubmed Central ID 2194190 


 



4.
Salazar-Fontana LI, Barr V, Samelson LE, Bierer BE (2003). CD28 engagement promotes actin polymerization through the activation of the small Rho GTPase Cdc42 in human T cells. J Immunol  171, 2225-32.   https://doi.org/10.4049/jimmunol.171.5.2225




PubMed


 


PubMed ID 12928366",https://intramural.nih.gov/search/searchview.taf?ipid=36323
195,BC010305-06,"October 01, 2003 -  September 30, 2004",Genetic effects of the MHC and KIR locus on autoimmune disease and cancer,"Mary  Carrington; MS, PhD",Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Dafna  Gladman
(University of Toronto)





John  Trowsdale
(University of Cambridge)





John  Rioux
(MIT)





Metka  Ravnik-Glavac
(University of Lubljana)
















Ruth  Allen
(Environmental Protection Agency, Washington, DC)




Katherine  Siminovitch
(Department of Medicine, University of Toronto)","Xiaojiang  Gao (National Cancer Institute)



Maureen P Martin (National Cancer Institute)



Mary  Mcnally (National Cancer Institute)



George  Nelson (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36327
196,BC010306-06,"October 01, 2003 -  September 30, 2004",Identification of Needle Sharing: A Risk Factor for Viral Infection,Michael W Smith,Stephen J O'Brien; PhD,"Laboratory of Genomic Diversity, NCI",NULL,"Carl  Broman
(Johns Hopkins University)





Steffanie  Strathdee
(Johns Hopkins University)





Trevor  Woodage
(Applied Biosystems)





Terri  Beaty
(Johns Hopkins University)
















David  Vlahov
(New York Academy of Medicine, University of California, San Diego)",Sadeep  Shrestha  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36328
197,BC010307-05,"October 01, 2003 -  September 30, 2004",Cell Growth Control In Vivo by C/EBPbeta and C/EBPdelta,"Gisela Esta Sterneck; PhD



IRP Faculty Profile",Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,"Jan  McAllister
(Department of Cellular and Molecular Physiology, Pennsylviana State University College of Medicine)





Robert  Smart
(Department of Environmental and Molecular Toxicology, North Carolina State University)





Simon  Williams
(Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center)





Lane  Christenson
(Center for Research on Reproduction and Women's Health, University of Pennsylvania)





Lothar  Hennighausen; PhD
(NIDDK)
















Kelly  Mayo
(Biochemistry, Molecular Biology & Cell Biology, Northwestern University)","Karl Thomas Ried; MD (Acquired Gene Rearrangements Sect)



Shikha  Sharan (National Cancer Institute)



Michael I Lerman; MD, PhD (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)



Lisa M Gangi (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36115
198,BC010308-06,"October 01, 2003 -  September 30, 2004",In vivo Imaging Analysis of Steroid/Nuclear Receptor Function,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Carol T Comlish (National Cancer Institute)



Cem C Elbi (National Cancer Institute)



Anindya P Hendarwanto (National Cancer Institute)



Geetha V Rayasam (National Cancer Institute)



Dawn A Walker (National Cancer Institute)



Ronald G Wolford (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dohoney KM, Guillerm C, Whiteford C, Elbi C, Lambert PF, Hager GL, Brady JN (2004). Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage. Oncogene  23, 49-57.   https://doi.org/10.1038/sj.onc.1207005




PubMed


 


PubMed ID 14712210
    
     


 



2.
Elbi C, Walker DA, Lewis M, Romero G, Sullivan WP, Toft DO, Hager GL, DeFranco DB (2004). A novel in situ assay for the identification and characterization of soluble nuclear mobility factors. Sci STKE  2004, pl10.   https://doi.org/10.1126/stke.2382004pl10




PubMed


 


PubMed ID 15213337
    
     


 



3.
Karpova TS, Baumann CT, He L, Wu X, Grammer A, Lipsky P, Hager GL, McNally JG (2003). Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J Microsc  209, 56-70.   https://doi.org/10.1046/j.1365-2818.2003.01100.x




PubMed


 


PubMed ID 12535185
    
     


 



4.
Maruvada P, Baumann CT, Hager GL, Yen PM (2003). Dynamic shuttling and intranuclear mobility of nuclear hormone receptors. J Biol Chem  278, 12425-32.   https://doi.org/10.1074/jbc.M202752200




PubMed


 


PubMed ID 12506123",https://intramural.nih.gov/search/searchview.taf?ipid=36329
199,BC010309-06,"October 01, 2003 -  September 30, 2004",Genome Organization and Nuclear Architecture,"Thomas A Misteli; PhD



IRP Faculty Profile",Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Deirdre  Brown; PhD
(Department of Psychology, Lancaster University)





Susan  Gasser
(FMI)
















Tina  Izard
(St. Jude's Research Hospital)","Stephen A Mabon (National Cancer Institute)



Manjari  Mazumdar (National Cancer Institute)



Eran  Meshorer (National Cancer Institute)



Luis F Parada (National Cancer Institute)



Paola  Scaffidi (National Cancer Institute)



Evi  Soutoglou (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cheutin T, McNairn AJ, Jenuwein T, Gilbert DM, Singh PB, Misteli T (2003). Maintenance of stable heterochromatin domains by dynamic HP1 binding. Science  299, 721-5.   https://doi.org/10.1126/science.1078572




PubMed


 


PubMed ID 12560555
    
     


 



2.
Mazumdar M, Sundareshan S, Misteli T (2004). Human chromokinesin KIF4A functions in chromosome condensation and segregation. J Cell Biol  166, 613-20.   https://doi.org/10.1083/jcb.200401142




PubMed



        
     
Free Article


 


PubMed ID 15326200
         Pubmed Central ID 2172419 


 



3.
Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G (2004). HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat Med  10, 197-201.   https://doi.org/10.1038/nm984




PubMed


 


PubMed ID 14730358
    
     


 



4.
Parada LF, Mcqueen PG, Misteli T   (2004) Tissue-specific spatial organization of genomes.  Genome Biol 5:R44.




 



5.
Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T (2003). Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet  34, 287-91.   https://doi.org/10.1038/ng1177




PubMed


 


PubMed ID 12808455",https://intramural.nih.gov/search/searchview.taf?ipid=36330
200,BC010312-06,"October 01, 2003 -  September 30, 2004",Analysis of cellular gene expression in HPV infection and cervical cancer,"Carl C Baker; MD, PhD",Douglas  Lowy; MD,"Laboratory of Cellular Oncology, NCI",NULL,NULL,"Janet M Dipasquale (National Cancer Institute)



Jesse F Quintero (National Cancer Institute)



Sophia S Wang; PhD (National Cancer Institute)



Mark  Schiffman; MD (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Zhi Ming  Zheng; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fu B, Quintero J, Baker CC (2003). Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Cancer Res  63, 7815-24.




PubMed


 


PubMed ID 14633708",https://intramural.nih.gov/search/searchview.taf?ipid=36332
201,BC010313-06,"October 01, 2003 -  September 30, 2004",Molecular profiling of human hepatocellular cancer,"Xin Wei Wang; PhD



IRP Faculty Profile",NULL,"Laboratory of Human Carcinogenesis, NCI",NULL,"Zhao-You  Tang
(Liver Cancer Institute)
















Lun-Xiu  Qin
(Liver Cancer Institute)","Marshonna J Forgues (National Cancer Institute)



Richard  Simon (National Cancer Institute)",Larry W Fisher; PhD (NIDCR),"Ordered by publication type and then author name.



1.
Kim JW, Wang XW (2003). Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis  24, 363-9.   https://doi.org/10.1093/carcin/24.3.363




PubMed


 


PubMed ID 12663493
    
     


 



2.
Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW (2003). Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med  9, 416-23.   https://doi.org/10.1038/nm843




PubMed


 


PubMed ID 12640447",https://intramural.nih.gov/search/searchview.taf?ipid=36333
202,BC010317-06,"October 01, 2003 -  September 30, 2004",Rapid Analysis of Single Nucleotide Polymorphism Genotypes in AIDS Cohorts,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,NULL,"George  Nelson (National Cancer Institute)



James  Lautenberger; PhD (National Cancer Institute)



Sher  Hendrickson (National Cancer Institute)



Bailey  Kessing (National Cancer Institute)



Michael J Malasky (National Cancer Institute)



Janice S Martenson (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
An P, Vlahov D, Margolick JB, Phair J, O'Brien TR, Lautenberger J, O'Brien SJ, Winkler CA (2003). A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. J Infect Dis  188, 228-31.   https://doi.org/10.1086/376455




PubMed


 


PubMed ID 12854077",https://intramural.nih.gov/search/searchview.taf?ipid=36335
203,BC010319-06,"October 01, 2003 -  September 30, 2004",Structural Analysis of Biological Membrane Proteins,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Xiu-Gong  Gao (National Cancer Institute)



Michael  Maurizi; PhD (Biochemistry of Proteins Section)



Matti  Virkkunen; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gao X, Wen X, Esser L, Quinn B, Yu L, Yu CA, Xia D (2003). Structural basis for the quinone reduction in the bc1 complex: a comparative analysis of crystal structures of mitochondrial cytochrome bc1 with bound substrate and inhibitors at the Qi site. Biochemistry  42, 9067-80.   https://doi.org/10.1021/bi0341814




PubMed


 


PubMed ID 12885240",https://intramural.nih.gov/search/searchview.taf?ipid=36338
204,BC010326-05,"October 01, 2003 -  September 30, 2004",Structural Chemistry of Biomolecular Systems by X-ray Diffraction,"Xinhua  Ji; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,"Jianhua  Gan (National Cancer Institute)



Gary  Shaw (National Cancer Institute)












Ramalakshmi  Darbha  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blaszczyk J, Gan J, Tropea JE, Court DL, Waugh DS, Ji X (2004). Noncatalytic assembly of ribonuclease III with double-stranded RNA. Structure  12, 457-66.   https://doi.org/10.1016/j.str.2004.02.004




PubMed


 


PubMed ID 15016361
    
     


 



2.
Darbha R, Phogat S, Labrijn AF, Shu Y, Gu Y, Andrykovitch M, Zhang MY, Pantophlet R, Martin L, Vita C, Burton DR, Dimitrov DS, Ji X (2004). Crystal structure of the broadly cross-reactive HIV-1-neutralizing Fab X5 and fine mapping of its epitope. Biochemistry  43, 1410-7.   https://doi.org/10.1021/bi035323x




PubMed


 


PubMed ID 14769016
    
     


 



3.
Knowlton JR, Bubunenko M, Andrykovitch M, Guo W, Routzahn KM, Waugh DS, Court DL, Ji X (2003). A spring-loaded state of NusG in its functional cycle is suggested by X-ray crystallography and supported by site-directed mutants. Biochemistry  42, 2275-81.   https://doi.org/10.1021/bi0272508




PubMed


 


PubMed ID 12600194",https://intramural.nih.gov/search/searchview.taf?ipid=36340
205,BC010328-05,"October 01, 2003 -  September 30, 2004",Role of C/EBP transcription factors in regulating cell growth and tumorigenesis,"Peter F Johnson; PhD



IRP Faculty Profile",Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,"Julien  Sage
(Departments of Pediatrics and Genetics, Stanford University School of Medicine)
















Richard  Schwartz
(Department of Microbiology and Molecular Genetics, Michigan State University)




Robert  Smart
(Department of Environmental and Molecular Toxicology, North Carolina State University)","Thomas  Sebastian (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Jonathan  Keller; PhD (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)



Maria  Miller (National Cancer Institute)



Stephen D Hursting; PhD, MPH (Office of Preventive Oncology)",NULL,"Ordered by publication type and then author name.



1.
Gigliotti AP, Johnson PF, Sterneck E, DeWille JW (2003). Nulliparous CCAAT/enhancer binding proteindelta (C/EBPdelta) knockout mice exhibit mammary gland ductal hyperlasia. Exp Biol Med (Maywood)  228, 278-85.   https://doi.org/10.1177/153537020322800306




PubMed


 


PubMed ID 12626772
    
     


 



2.
Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF (2003). Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem  278, 15178-84.   https://doi.org/10.1074/jbc.M300417200




PubMed


 


PubMed ID 12578822",https://intramural.nih.gov/search/searchview.taf?ipid=36341
206,BC010329-05,"October 01, 2003 -  September 30, 2004",Regulation of Ras-Dependent Signal Transduction Pathways,"Deborah K Morrison



IRP Faculty Profile",Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,"Timothy  Veenstra
(SAIC)
















Karen  Lu
(MD Anderson Cancer Center)","Ira  Daar; PhD (National Cancer Institute)



Terry D Copeland (National Cancer Institute)












Carolyn B McGill  (National Cancer Institute)",Brian W Howell; PhD (NINDS),"Ordered by publication type and then author name.



1.
Coon M, Ball A, Pound J, Ap S, Hollenback D, White T, Tulinsky J, Bonham L, Morrison DK, Finney R, Singer JW (2003). Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. Mol Cancer Ther  2, 1067-78.




PubMed


 


PubMed ID 14578472
    
     


 



2.
Haughn L, Hawley RG, Morrison DK, von Boehmer H, Hockenbery DM (2003). BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation. J Biol Chem  278, 25158-65.   https://doi.org/10.1074/jbc.M212849200




PubMed


 


PubMed ID 12721288
    
     


 



3.
Janssen RA, Kim PN, Mier JW, Morrison DK (2003). Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol Cell Biol  23, 1786-97.   https://doi.org/10.1128/mcb.23.5.1786-1797.2003




PubMed



        
     
Free Article


 


PubMed ID 12588996
         Pubmed Central ID 151698 


 



4.
Lochhead PA, Sibbet G, Kinstrie R, Cleghon T, Rylatt M, Morrison DK, Cleghon V (2003). dDYRK2: a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem J  374, 381-91.   https://doi.org/10.1042/BJ20030500




PubMed



        
     
Free Article


 


PubMed ID 12786602
         Pubmed Central ID 1223608 


 



5.
Müller J, Ritt DA, Copeland TD, Morrison DK (2003). Functional analysis of C-TAK1 substrate binding and identification of PKP2 as a new C-TAK1 substrate. EMBO J  22, 4431-42.   https://doi.org/10.1093/emboj/cdg426




PubMed



        
     
Free Article


 


PubMed ID 12941695
         Pubmed Central ID 202368 


 



6.
Morrison DK, Davis RJ (2003). Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol  19, 91-118.   https://doi.org/10.1146/annurev.cellbio.19.111401.091942




PubMed


 


PubMed ID 14570565
    
     


 



7.
Ory S, Zhou M, Conrads TP, Veenstra TD, Morrison DK (2003). Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol  13, 1356-64.   https://doi.org/10.1016/s0960-9822(03)00535-9




PubMed


 


PubMed ID 12932319",https://intramural.nih.gov/search/searchview.taf?ipid=36342
207,BC010331-05,"October 01, 2003 -  September 30, 2004",Phospholipid and Sphingolipid Signaling in Drosophila,"Jairaj K Acharya; MBBS, PhD



IRP Faculty Profile",Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,"Nicholas  Hargus (National Cancer Institute)



Michael Beth  Mowen (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)












Sanchitha  Balagatte  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Acharya U, Patel S, Koundakjian E, Nagashima K, Han X, Acharya JK (2003). Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science  299, 1740-3.   https://doi.org/10.1126/science.1080549




PubMed


 


PubMed ID 12637747
    
     


 



2.
Rohrbough J, Rushton E, Palanker L, Woodruff E, Matthies HJ, Acharya U, Acharya JK, Broadie K (2004). Ceramidase regulates synaptic vesicle exocytosis and trafficking. J Neurosci  24, 7789-803.   https://doi.org/10.1523/JNEUROSCI.1146-04.2004




PubMed



        
     
Free Article


 


PubMed ID 15356190
         Pubmed Central ID 2675194",https://intramural.nih.gov/search/searchview.taf?ipid=36343
208,BC010332-05,"October 01, 2003 -  September 30, 2004",Oncogene-dependent caspase activation,Howard O Fearnhead,Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,"Nancy  Martin (National Cancer Institute)



Leobaldo  Solorzano (National Cancer Institute)












Angel  Martin  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fearnhead HO (2004). Getting back on track, or what to do when apoptosis is de-railed: recoupling oncogenes to the apoptotic machinery. Cancer Biol Ther  3, 21-8.   https://doi.org/10.4161/cbt.3.1.538




PubMed


 


PubMed ID 14726669
    
     


 



2.
Martin AG, Nguyen J, Wells JA, Fearnhead HO (2004). Apo cytochrome c inhibits caspases by preventing apoptosome formation. Biochem Biophys Res Commun  319, 944-50.   https://doi.org/10.1016/j.bbrc.2004.05.084




PubMed


 


PubMed ID 15184073",https://intramural.nih.gov/search/searchview.taf?ipid=36344
209,BC010333-05,"October 01, 2003 -  September 30, 2004",The Segregation of Bacterial Chromosomes to Daughter Cells,"Stuart J Austin



IRP Faculty Profile",Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Yongfang  Li (National Cancer Institute)



Lucretia D Reaves (National Cancer Institute)



Kirill V Sergueev (National Cancer Institute)



Brenda L Youngren (National Cancer Institute)



Alena  Dabrazhynetskaya (National Cancer Institute)












Therese G Brendler; BS, PhD  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36345
210,BC010334-05,"October 01, 2003 -  September 30, 2004",Posttranscriptional control of gene expression,"Barbara K Felber



IRP Faculty Profile",NULL,"Human Retrovirus Pathogenesis Section, NCI",NULL,NULL,"Rashmi  Jalah (National Cancer Institute)



Daniel  Michalowski (National Cancer Institute)



Samantha  Sadtler (National Cancer Institute)



Irina  Tretyakova (National Cancer Institute)



Andrei S Zolotukhin (National Cancer Institute)












Jenifer L Bear  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Zolotukhin AS, Michalowski D, Bear J, Smulevitch SV, Traish AM, Peng R, Patton J, Shatsky IN, Felber BK (2003). PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol  23, 6618-30.   https://doi.org/10.1128/mcb.23.18.6618-6630.2003




PubMed



        
     
Free Article


 


PubMed ID 12944487
         Pubmed Central ID 193712",https://intramural.nih.gov/search/searchview.taf?ipid=36346
211,BC010335-05,"October 01, 2003 -  September 30, 2004",Regulation of Gene Expression and the Cell Cycle,"Donald L Court; PhD



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Michael Marc Gottesman; MD
(Office Of Intramural Research)





David  Friedman
(Microbiology & Immunology, Michigan University)
















Ariella  Oppenheim; PhD
(Hebrew University-Hadassah Medical School)","Mikhail G Bubunenko (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)



Stuart J Austin (National Cancer Institute)



Mikhail V Kashlev (National Cancer Institute)



David S Waugh; PhD (Protein Engineering Section)



Jeffrey N Strathern (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blaszczyk J, Gan J, Tropea JE, Court DL, Waugh DS, Ji X (2004). Noncatalytic assembly of ribonuclease III with double-stranded RNA. Structure  12, 457-66.   https://doi.org/10.1016/j.str.2004.02.004




PubMed


 


PubMed ID 15016361
    
     


 



2.
Kim HC, Zhou JG, Wilson HR, Mogilnitskiy G, Court DL, Gottesman ME (2003). Phage HK022 Nun protein represses translation of phage lambda N (transcription termination/translation repression). Proc Natl Acad Sci U S A  100, 5308-12.   https://doi.org/10.1073/pnas.0430995100




PubMed



        
     
Free Article


 


PubMed ID 12684530
         Pubmed Central ID 154341 


 



3.
Knowlton JR, Bubunenko M, Andrykovitch M, Guo W, Routzahn KM, Waugh DS, Court DL, Ji X (2003). A spring-loaded state of NusG in its functional cycle is suggested by X-ray crystallography and supported by site-directed mutants. Biochemistry  42, 2275-81.   https://doi.org/10.1021/bi0272508




PubMed


 


PubMed ID 12600194
    
     


 



4.
Wilson HR, Zhou JG, Yu D, Court DL (2004). Translation repression by an RNA polymerase elongation complex. Mol Microbiol  53, 821-8.   https://doi.org/10.1111/j.1365-2958.2004.04170.x




PubMed


 


PubMed ID 15255895",https://intramural.nih.gov/search/searchview.taf?ipid=36347
212,BC010336-05,"October 01, 2003 -  September 30, 2004",Recombineering: Chromosome Engineering by Homologous Recombination in E. coli,"Donald L Court; PhD



IRP Faculty Profile",Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Mikhail G Bubunenko (National Cancer Institute)



Nina  Costantino (National Cancer Institute)



James A Sawitzke (National Cancer Institute)



Nancy L Jenkins (National Cancer Institute)



Shyam K Sharan (National Cancer Institute)



Neal G Copeland; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Costantino N, Court DL (2003). Enhanced levels of lambda Red-mediated recombinants in mismatch repair mutants. Proc Natl Acad Sci U S A  100, 15748-53.   https://doi.org/10.1073/pnas.2434959100




PubMed



        
     
Free Article


 


PubMed ID 14673109
         Pubmed Central ID 307639 


 



2.
Court DL, Swaminathan S, Yu D, Wilson H, Baker T, Bubunenko M, Sawitzke J, Sharan SK (2003). Mini-lambda: a tractable system for chromosome and BAC engineering. Gene  315, 63-9.   https://doi.org/10.1016/s0378-1119(03)00728-5




PubMed


 


PubMed ID 14557065
    
     


 



3.
Li XT, Costantino N, Lu LY, Liu DP, Watt RM, Cheah KS, Court DL, Huang JD (2003). Identification of factors influencing strand bias in oligonucleotide-mediated recombination in Escherichia coli. Nucleic Acids Res  31, 6674-87.   https://doi.org/10.1093/nar/gkg844




PubMed



        
     
Free Article


 


PubMed ID 14602928
         Pubmed Central ID 275540 


 



4.
Oppenheim AB, Rattray AJ, Bubunenko M, Thomason LC, Court DL (2004). In vivo recombineering of bacteriophage lambda by PCR fragments and single-strand oligonucleotides. Virology  319, 185-9.   https://doi.org/10.1016/j.virol.2003.11.007




PubMed


 


PubMed ID 14980479
    
     


 



5.
Yu D, Sawitzke JA, Ellis H, Court DL (2003). Recombineering with overlapping single-stranded DNA oligonucleotides: testing a recombination intermediate. Proc Natl Acad Sci U S A  100, 7207-12.   https://doi.org/10.1073/pnas.1232375100




PubMed



        
     
Free Article


 


PubMed ID 12771385
         Pubmed Central ID 165854 


 



6.
Court DL, Costantino NL, Datta SL (submitted in 2004) Plasmids And Phages For Homologus Recombination And Methods Of Use. Patents issued: 7,674,621 (US in 2010); 8,541,229 (US in 2013); 8,859,277 (US in 2015); 9,371,532 (US in 2016).",https://intramural.nih.gov/search/searchview.taf?ipid=36348
213,BC010337-05,"October 01, 2003 -  September 30, 2004",Identification of protein factors and pathways leading to establishment and main,"Mikhail V Kashlev



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Brad  Cairns
(Oncological Sciences, University of Utah School of Medicine)





Herman  Heumann
(Max Plank Institute)





Carlos  Bustamante
(University of California, Berkeley)
















Michelle  Wang
(Cornell University)","Xinhua  Ji; PhD (Biomolecular Structure Section)



Jeffrey N Strathern (National Cancer Institute)












Donald L Court; PhD  (Molecular Control and Genetics Section)



Maria L Kireeva  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kireeva ML, Lubkowska L, Komissarova N, Kashlev M (2003). Assays and affinity purification of biotinylated and nonbiotinylated forms of double-tagged core RNA polymerase II from Saccharomyces cerevisiae. Methods Enzymol  370, 138-55.   https://doi.org/10.1016/S0076-6879(03)70012-3




PubMed


 


PubMed ID 14712640",https://intramural.nih.gov/search/searchview.taf?ipid=36349
214,BC010338-05,"October 01, 2003 -  September 30, 2004",The Role of Fgf Signaling in Vertebrate Development,"Mark B Lewandoski



IRP Faculty Profile",Colin L Stewart; PhD,"Genetics of Vertebrate Development Section, NCI",NULL,NULL,"Catherine P Wilson (National Cancer Institute)



Nakisha  Moore (National Cancer Institute)



Alan O Perantoni; PhD (National Cancer Institute)












Samuel  Waters  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Waters ST, Wilson CP, Lewandoski M (2003). Cloning and embryonic expression analysis of the mouse Gbx1 gene. Gene Expr Patterns  3, 313-7.   https://doi.org/10.1016/s1567-133x(03)00041-3




PubMed


 


PubMed ID 12799077",https://intramural.nih.gov/search/searchview.taf?ipid=36350
215,BC010339-05,"October 01, 2003 -  September 30, 2004",The Role of Rx in the Adult Retina,"Mark B Lewandoski



IRP Faculty Profile",Colin L Stewart; PhD,"Genetics of Vertebrate Development Section, NCI",NULL,NULL,Catherine P Wilson  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kim YS, Nakanishi G, Lewandoski M, Jetten AM (2003). GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions. Nucleic Acids Res  31, 5513-25.   https://doi.org/10.1093/nar/gkg776




PubMed



        
     
Free Article


 


PubMed ID 14500813
         Pubmed Central ID 206473 


 



2.
Waters ST, Wilson CP, Lewandoski M (2003). Cloning and embryonic expression analysis of the mouse Gbx1 gene. Gene Expr Patterns  3, 313-7.   https://doi.org/10.1016/s1567-133x(03)00041-3




PubMed


 


PubMed ID 12799077",https://intramural.nih.gov/search/searchview.taf?ipid=36351
216,BC010340-05,"October 01, 2003 -  September 30, 2004",Ty Element Retrotransposition in Saccharomyces cerevisiae,David J. Garfinkel; PhD,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Katherine  Nyswaner (National Cancer Institute)



Karen  Stefanisko (National Cancer Institute)



Anuradha  Sundararajan (National Cancer Institute)



Kathleen  Turner (National Cancer Institute)












Sharon  Moore  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Martin SL, Garfinkel DJ (2003). Survival strategies for transposons and genomes. Genome Biol  4, 313.   https://doi.org/10.1186/gb-2003-4-4-313




PubMed



        
     
Free Article


 


PubMed ID 12702203
         Pubmed Central ID 154573 


 



2.
Sundararajan A, Lee BS, Garfinkel DJ (2003). The Rad27 (Fen-1) nuclease inhibits Ty1 mobility in Saccharomyces cerevisiae. Genetics  163, 55-67.




PubMed



        
     
Free Article


 


PubMed ID 12586696
         Pubmed Central ID 1462422",https://intramural.nih.gov/search/searchview.taf?ipid=36352
217,BC010341-05,"October 01, 2003 -  September 30, 2004",Protein Expression and Purification in the Fast Lane,"David S Waugh; PhD



IRP Faculty Profile",Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,"Sreedevi  Nallamsetty (National Cancer Institute)



Kerri  Penrose (National Cancer Institute)



Jason  Phan (National Cancer Institute)



Brian  Austin (National Cancer Institute)



Florian  Schubot (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Fox JD, Routzahn KM, Bucher MH, Waugh DS (2003). Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers. FEBS Lett  537, 53-7.   https://doi.org/10.1016/s0014-5793(03)00070-x




PubMed


 


PubMed ID 12606030
    
     


 



2.
Fox JD, Waugh DS (2003). Maltose-binding protein as a solubility enhancer. Methods Mol Biol  205, 99-117.   https://doi.org/10.1385/1-59259-301-1:99




PubMed


 


PubMed ID 12491882
    
     


 



3.
Zhdanov AS, Phan J, Evdokimov AG, Tropea JE, Kapust RB, Li M, Wlodawer A, Waugh DS (2003). [Tobacco etch virus proteinase: crystal structure of the active enzyme and its inactive mutant]. Bioorg Khim  29, 457-60.




PubMed


 


PubMed ID 14601399",https://intramural.nih.gov/search/searchview.taf?ipid=36353
218,BC010342-05,"October 01, 2003 -  September 30, 2004",Structural Proteomics of the Yersinia Yop Virulon,"David S Waugh; PhD



IRP Faculty Profile",Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",NULL,"Gregory  Plano; PhD
(Microbiology and Immunology, University of Miami School of Medicine)





Zygmunt  Derewenda
(Physiological Biophysics, University of Virginia School of Medicine)





Robert  Ulrich
(Molecular Immunology, USAMRIID)





Kurt  Schesser
(Microbiology and Immunology, University of Miami School of Medicine)",Terrence R Burke; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Lee K, Gao Y, Yao ZJ, Phan J, Wu L, Liang J, Waugh DS, Zhang ZY, Burke TR (2003). Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase. Bioorg Med Chem Lett  13, 2577-81.   https://doi.org/10.1016/s0960-894x(03)00481-5




PubMed


 


PubMed ID 12852970
    
     


 



2.
Phan J, Lee K, Cherry S, Tropea JE, Burke TR, Waugh DS (2003). High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. Biochemistry  42, 13113-21.   https://doi.org/10.1021/bi030156m




PubMed


 


PubMed ID 14609321",https://intramural.nih.gov/search/searchview.taf?ipid=36354
219,BC010343-05,"October 01, 2003 -  September 30, 2004","Transcription Through Nucleosomes in Vitro by E. coli RNA polymerase, RNA Polyme","Mikhail V Kashlev



IRP Faculty Profile",Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Peter  Geiduschek
(University of California, San Diego)





George  Kassavetis
(University of California, San Diego)





Michelle  Wang
(Cornell University)





Blaine  Bartholomew
(Southern Illinois University)
















Zach  Burton
(Michigan State University)",Maria L Kireeva  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Kireeva ML, Lubkowska L, Komissarova N, Kashlev M (2003). Assays and affinity purification of biotinylated and nonbiotinylated forms of double-tagged core RNA polymerase II from Saccharomyces cerevisiae. Methods Enzymol  370, 138-55.   https://doi.org/10.1016/S0076-6879(03)70012-3




PubMed


 


PubMed ID 14712640
    
     


 



2.
Walter W, Kireeva ML, Studitsky VM, Kashlev M (2003). Bacterial polymerase and yeast polymerase II use similar mechanisms for transcription through nucleosomes. J Biol Chem  278, 36148-56.   https://doi.org/10.1074/jbc.M305647200




PubMed


 


PubMed ID 12851391
    
     


 



3.
Walter W, Kireeva ML, Tchernajenko V, Kashlev M, Studitsky VM (2003). Assay of the fate of the nucleosome during transcription by RNA polymerase II. Methods Enzymol  371, 564-77.   https://doi.org/10.1016/S0076-6879(03)71042-8




PubMed


 


PubMed ID 14712729",https://intramural.nih.gov/search/searchview.taf?ipid=36355
220,BC010345-05,"October 01, 2003 -  September 30, 2004",The Role of Wnt Genes in Vertebrate Development and Cancer,"Terence P Yamaguchi; PhD



IRP Faculty Profile",Colin L Stewart; PhD,"Cell Signaling in Vertebrate Development Section, NCI",NULL,NULL,"Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)",NULL,"Ordered by publication type and then author name.



1.
Warming S, Suzuki T, Yamaguchi TP, Jenkins NA, Copeland NG (2004). Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas. Oncogene  23, 2727-31.   https://doi.org/10.1038/sj.onc.1207452




PubMed


 


PubMed ID 15048087",https://intramural.nih.gov/search/searchview.taf?ipid=36356
221,BC010346-05,"October 01, 2003 -  September 30, 2004",Structural Biology of Proteins Involved in Signal Transduction and Regulation of,"Robert Andrew Byrd



IRP Faculty Profile",NULL,"Structural Biophysics Laboratory, NCI",NULL,"Raj  Puri; MD, PhD
(CBER, FDA)





Ermanno  Gherardi
(Growth Factors Group, MRC)





Warren J Leonard; MD
(NHLBI)





Kurt  Zilm
(Chemistry, Yale University)","Donald L Court; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)



Allan M Weissman; MD (Laboratory of Protein Dynamics and Signaling)












Amanda S Altieri; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Altieri AS, Byrd RA (2004). Automation of NMR structure determination of proteins. Curr Opin Struct Biol  14, 547-53.   https://doi.org/10.1016/j.sbi.2004.09.003




PubMed


 


PubMed ID 15465314
    
     


 



2.
Gaponenko V, Sarma SP, Altieri AS, Horita DA, Li J, Byrd RA (2004). Improving the accuracy of NMR structures of large proteins using pseudocontact shifts as long-range restraints. J Biomol NMR  28, 205-12.   https://doi.org/10.1023/B:JNMR.0000013706.09264.36




PubMed


 


PubMed ID 14752254
    
     


 



3.
Kuszewski J, Schwieters CD, Garrett DS, Byrd RA, Tjandra N, Clore GM (2004). Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments. J Am Chem Soc  126, 6258-73.   https://doi.org/10.1021/ja049786h




PubMed


 


PubMed ID 15149223
    
     


 



4.
Morcombe CR, Gaponenko V, Byrd RA, Zilm KW (2004). Diluting abundant spins by isotope edited radio frequency field assisted diffusion. J Am Chem Soc  126, 7196-7.   https://doi.org/10.1021/ja047919t




PubMed


 


PubMed ID 15186155
    
     


 



5.
Paulson EK, Morcombe CR, Gaponenko V, Dancheck B, Byrd RA, Zilm KW (2003). High-sensitivity observation of dipolar exchange and NOEs between exchangeable protons in proteins by 3D solid-state NMR spectroscopy. J Am Chem Soc  125, 14222-3.   https://doi.org/10.1021/ja037559u




PubMed


 


PubMed ID 14624539
    
     


 



6.
Paulson EK, Morcombe CR, Gaponenko V, Dancheck B, Byrd RA, Zilm KW (2003). Sensitive high resolution inverse detection NMR spectroscopy of proteins in the solid state. J Am Chem Soc  125, 15831-6.   https://doi.org/10.1021/ja037315+




PubMed


 


PubMed ID 14677974",https://intramural.nih.gov/search/searchview.taf?ipid=36357
222,BC010347-05,"October 01, 2003 -  September 30, 2004",Design of Drugs Against Cancer and Viral Diseases,Christopher J Michejda; PhD,Robert Andrew Byrd,"Structural Biophysics Laboratory, NCI",NULL,"Sid  Kar
(SURGERY, University of Pittsburgh)





Brian  Carr
(SURGERY, University of Pittsburgh)





Edward  Arnold
(BIOCHEMISTRY, Rutgers University)
















William  Jorgensen
(CHEMISTRY, Yale University)","David W Farnsworth (National Cancer Institute)



Teresa  Kosakowska Cholo (National Cancer Institute)



Zoltan  Szekely (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Paul L Boyer (National Cancer Institute)



John G Julias (National Cancer Institute)",Barbara  Jaruga; PhD (NIAAA),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36358
223,BC010348-05,"October 01, 2003 -  September 30, 2004",Protein Structure,"Alexander  Wlodawer; PhD



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,"Ben  Dunn
(Biochem. & Mol. Biol., University of Florida)





J.  Elder






Eileen  Jaffe
(Inst. for Cancer Research, Fox Chase Cancer Center)





Jonathan  Leis
(Northwestern University School of Medicine)





Witold  Filipowicz
(Friedrich Miescher-Institut)





Toru  Nakayama
(Biomolecular Engineering, Tohoku University)


Show all 9","Alla E Gustchina (National Cancer Institute)



Maria E Miller (National Cancer Institute)



Alexander S Zdanov (National Cancer Institute)












Istvan  Botos; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Botos I, Wlodawer A (2003). Cyanovirin-N: a sugar-binding antiviral protein with a new twist. Cell Mol Life Sci  60, 277-87.   https://doi.org/10.1007/s000180300023




PubMed


 


PubMed ID 12678493
    
     


 



2.
Chang C, Magracheva E, Kozlov S, Fong S, Tobin G, Kotenko S, Wlodawer A, Zdanov A (2003). Crystal structure of interleukin-19 defines a new subfamily of helical cytokines. J Biol Chem  278, 3308-13.   https://doi.org/10.1074/jbc.M208602200




PubMed


 


PubMed ID 12403790
    
     


 



3.
Lubkowski J, Dauter M, Aghaiypour K, Wlodawer A, Dauter Z (2003). Atomic resolution structure of Erwinia chrysanthemi L-asparaginase. Acta Crystallogr D Biol Crystallogr  59, 84-92.   https://doi.org/10.1107/s0907444902019443




PubMed


 


PubMed ID 12499544
    
     


 



4.
Wlodawer A, Durell SR, Li M, Oyama H, Oda K, Dunn BM (2003). A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct Biol  3, 8.   https://doi.org/10.1186/1472-6807-3-8




PubMed



        
     
Free Article


 


PubMed ID 14609438
         Pubmed Central ID 280685 


 



5.
Wlodawer A, Li M, Gustchina A, Oyama H, Dunn BM, Oda K (2003). Structural and enzymatic properties of the sedolisin family of serine-carboxyl peptidases. Acta Biochim Pol  50, 81-102.   https://doi.org/035001081




PubMed


 


PubMed ID 12673349",https://intramural.nih.gov/search/searchview.taf?ipid=36359
224,BC010349-05,"October 01, 2003 -  September 30, 2004",Genomic Imprinting in Development and Disease,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,"Lidia F Hernandez (National Cancer Institute)



Serguei V Kozlov (National Cancer Institute)



Shoichi  Sunahara (National Cancer Institute)












John P Hagan  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hernandez L, Kozlov S, Piras G, Stewart CL (2003). Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci U S A  100, 13344-9.   https://doi.org/10.1073/pnas.2234026100




PubMed



        
     
Free Article


 


PubMed ID 14581617
         Pubmed Central ID 263813 


 



2.
Ren J, Lee S, Pagliardini S, Gérard M, Stewart CL, Greer JJ, Wevrick R (2003). Absence of Ndn, encoding the Prader-Willi syndrome-deleted gene necdin, results in congenital deficiency of central respiratory drive in neonatal mice. J Neurosci  23, 1569-73.




PubMed



        
     
Free Article


 


PubMed ID 12629158
         Pubmed Central ID 6741983 


 



3.
Seong E, Saunders TL, Stewart CL, Burmeister M (2004). To knockout in 129 or in C57BL/6: that is the question. Trends Genet  20, 59-62.   https://doi.org/10.1016/j.tig.2003.12.006




PubMed


 


PubMed ID 14746984",https://intramural.nih.gov/search/searchview.taf?ipid=36360
225,BC010350-05,"October 01, 2003 -  September 30, 2004",Pathogenicity and immunogenicity of live attenuated SIV strains,"Barbara K Felber



IRP Faculty Profile","Jay Arthur Berzofsky; MD, PhD","Human Retrovirus Pathogenesis Section, NCI",NULL,"Marta  Marthas
(University of California, Davis, California Regional Primate Center)





Ruth  Ruprecht
(Dana-Farber Cancer Institute)





Elisa  Izaurralde
(European Molecular Biology Laboratory)",NULL,Nancy R Miller (NIAID),"Ordered by publication type and then author name.



1.
Calarota SA, Otero M, Hermanstyne K, Hermanstayne K, Lewis M, Rosati M, Felber BK, Pavlakis GN, Boyer JD, Weiner DB (2003). Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques. J Immunol Methods  279, 55-67.   https://doi.org/10.1016/s0022-1759(03)00246-1




PubMed


 


PubMed ID 12969547",https://intramural.nih.gov/search/searchview.taf?ipid=36361
226,BC010376-05,"October 01, 2003 -  September 30, 2004",Leukemia Inhibitory Factor and Embryo Development,Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,"Clara  Rodriguez (National Cancer Institute)



Tatiana  Cohen (National Cancer Institute)



Lori  Sewell (National Cancer Institute)



Eiichi  Hondo (National Cancer Institute)



Ruth  Wolfe (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cheng JG, Stewart CL (2003). Loss of cyclooxygenase-2 retards decidual growth but does not inhibit embryo implantation or development to term. Biol Reprod  68, 401-4.   https://doi.org/10.1095/biolreprod.102.009589




PubMed


 


PubMed ID 12533402
    
     


 



2.
Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee HS, Jr-Gang-Cheng VA, Sciorra I, Daar S, Spiegel AJ, Morris CL, Stewart   (2003) The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning.  Development 130:4623-37.




PubMed


 


PubMed ID 12925589",https://intramural.nih.gov/search/searchview.taf?ipid=36362
227,BC010377-05,"October 01, 2003 -  September 30, 2004","The Nuclear Envelope in Development, Disease and Ageing",Colin L Stewart; PhD,NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,"Roland  Foisner
(Cell Biology, Vienna Biocenter)





Richard  Lee
(Cardiovascular Division, Brigham and Womens Hospital Harvard)





Brian  Burke
(Cell Biology, University of Florida)
















Larry  Gerace
(Scripps Institute)","Lidia F Hernandez (National Cancer Institute)



Serguei V Kozlov (National Cancer Institute)



Thomas A Misteli; PhD (National Cancer Institute)",Kenneth R. Boheler; PhD (NIA),"Ordered by publication type and then author name.



1.
Alsheimer M, Liebe B, Sewell L, Stewart CL, Scherthan H, Benavente R (2004). Disruption of spermatogenesis in mice lacking A-type lamins. J Cell Sci  117, 1173-8.   https://doi.org/10.1242/jcs.00975




PubMed


 


PubMed ID 14996939
    
     


 



2.
De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Lévy N (2003). Lamin a truncation in Hutchinson-Gilford progeria. Science  300, 2055.   https://doi.org/10.1126/science.1084125




PubMed


 


PubMed ID 12702809
    
     


 



3.
Mounkes L, Kozlov S, Burke B, Stewart CL (2003). The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev  13, 223-30.   https://doi.org/10.1016/s0959-437x(03)00058-3




PubMed


 


PubMed ID 12787783
    
     


 



4.
Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Stewart CL (2003). A progeroid syndrome in mice is caused by defects in A-type lamins. Nature  423, 298-301.   https://doi.org/10.1038/nature01631




PubMed


 


PubMed ID 12748643
    
     


 



5.
Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven SH, Michalicek J, Otway R, Verheyen F, Rainer S, Stewart CL, Martin D, Feneley MP, Fatkin D (2004). Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest  113, 357-69.   https://doi.org/10.1172/JCI19448




PubMed



        
     
Free Article


 


PubMed ID 14755333
         Pubmed Central ID 324538",https://intramural.nih.gov/search/searchview.taf?ipid=36363
228,BC010378-05,"October 01, 2003 -  September 30, 2004",Macromolecular Crystallography Activity at Beamline X9B of the National Synchrot,"Zbigniew  Dauter



IRP Faculty Profile",NULL,"Macromolecular Crystallography Laboratory, NCI",NULL,NULL,"Sankaran  Banumathi (National Cancer Institute)



John  Cobuzzi (National Cancer Institute)



Miroslawa  Dauter (National Cancer Institute)



Robert  Jedrzejczak (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)












Peter  Zwart  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Baker T, Dauter Z (2003). Changing of the guard. Acta Crystallogr D Biol Crystallogr  59, 1.   https://doi.org/10.1107/s090744490202245x




PubMed


 


PubMed ID 12499532
    
     


 



2.
Banumathi S, Dauter M, Dauter Z (2003). Phasing at high resolution using Ta6Br12 cluster. Acta Crystallogr D Biol Crystallogr  59, 492-8.   https://doi.org/10.1107/s0907444903000064




PubMed


 


PubMed ID 12595706
    
     


 



3.
Dauter Z (2003). Protein structures at atomic resolution. Methods Enzymol  368, 288-337.   https://doi.org/10.1016/S0076-6879(03)68016-X




PubMed


 


PubMed ID 14674280
    
     


 



4.
Dauter Z (2003). Twinned crystals and anomalous phasing. Acta Crystallogr D Biol Crystallogr  59, 2004-16.   https://doi.org/10.1107/s0907444903021085




PubMed


 


PubMed ID 14573956
    
     


 



5.
Kang BS, Cooper DR, Jelen F, Devedjiev Y, Derewenda U, Dauter Z, Otlewski J, Derewenda ZS (2003). PDZ tandem of human syntenin: crystal structure and functional properties. Structure  11, 459-68.   https://doi.org/10.1016/s0969-2126(03)00052-2




PubMed


 


PubMed ID 12679023
    
     


 



6.
Kim JK, Yang IS, Rhee S, Dauter Z, Lee YS, Park SS, Kim KH (2003). Crystal structures of glutaryl 7-aminocephalosporanic acid acylase: insight into autoproteolytic activation. Biochemistry  42, 4084-93.   https://doi.org/10.1021/bi027181x




PubMed


 


PubMed ID 12680762
    
     


 



7.
Kim MH, Cierpicki T, Derewenda U, Krowarsch D, Feng Y, Devedjiev Y, Dauter Z, Walsh CA, Otlewski J, Bushweller JH, Derewenda ZS (2003). The DCX-domain tandems of doublecortin and doublecortin-like kinase. Nat Struct Biol  10, 324-33.   https://doi.org/10.1038/nsb918




PubMed


 


PubMed ID 12692530
    
     


 



8.
Kim MH, Derewenda U, Devedjiev Y, Dauter Z, Derewenda ZS (2003). Purification and crystallization of the N-terminal domain from the human doublecortin-like kinase. Acta Crystallogr D Biol Crystallogr  59, 502-5.   https://doi.org/10.1107/s0907444903000027




PubMed


 


PubMed ID 12595708
    
     


 



9.
Lubkowski J, Dauter M, Aghaiypour K, Wlodawer A, Dauter Z (2003). Atomic resolution structure of Erwinia chrysanthemi L-asparaginase. Acta Crystallogr D Biol Crystallogr  59, 84-92.   https://doi.org/10.1107/s0907444902019443




PubMed


 


PubMed ID 12499544
    
     


 



10.
Miller M, Shuman JD, Sebastian T, Dauter Z, Johnson PF (2003). Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem  278, 15178-84.   https://doi.org/10.1074/jbc.M300417200




PubMed


 


PubMed ID 12578822
    
     


 



11.
Nagem RA, Polikarpov I, Dauter Z (2003). Phasing on rapidly soaked ions. Methods Enzymol  374, 120-37.   https://doi.org/10.1016/S0076-6879(03)74005-1




PubMed


 


PubMed ID 14696370
    
     


 



12.
Ramagopal UA, Dauter M, Dauter Z (2003). Phasing on anomalous signal of sulfurs: what is the limit? Acta Crystallogr D Biol Crystallogr  59, 1020-7.   https://doi.org/10.1107/s0907444903007467




PubMed


 


PubMed ID 12777765
    
     


 



13.
Ramagopal UA, Dauter M, Dauter Z (2003). SAD manganese in two crystal forms of glucose isomerase. Acta Crystallogr D Biol Crystallogr  59, 868-75.   https://doi.org/10.1107/s0907444903005663




PubMed


 


PubMed ID 12777803
    
     


 



14.
Usón I, Schmidt B, von Bülow R, Grimme S, von Figura K, Dauter M, Rajashankar KR, Dauter Z, Sheldrick GM (2003). Locating the anomalous scatterer substructures in halide and sulfur phasing. Acta Crystallogr D Biol Crystallogr  59, 57-66.   https://doi.org/10.1107/s090744490201884x




PubMed


 


PubMed ID 12499540",https://intramural.nih.gov/search/searchview.taf?ipid=36364
229,BC010379-05,"October 01, 2003 -  September 30, 2004",Search for the Structural Basis of Biomacromolecular Function and Activity,Yun  Wang,NULL,"Laboratory of Molecular Pathophysiology and Experimental Therapeutics, NCI",NULL,NULL,"Joseph  Walsh (National Cancer Institute)



Ping  Yu (National Cancer Institute)



Javier  Cabello-Villegas (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Neamati N, Murthy M, Wang YX (2003). Preparation of DNA-protein complexes suitable for spectroscopic analysis. Methods Mol Med  85, 185-202.   https://doi.org/10.1385/1-59259-380-1:185




PubMed


 


PubMed ID 12710209
    
     


 



2.
Walsh JD, Cabello-Villegas J, Wang YX (2004). Periodicity in residual dipolar couplings and nucleic acid structures. J Am Chem Soc  126, 1938-9.   https://doi.org/10.1021/ja039446g




PubMed


 


PubMed ID 14971918
    
     


 



3.
Wu Y, Migliorini M, Yu P, Strickland DK, Wang YX (2003). 1H, 13C and 15N resonance assignments of domain 1 of receptor associated protein. J Biomol NMR  26, 187-8.   https://doi.org/10.1023/a:1023534107920




PubMed


 


PubMed ID 12766414",https://intramural.nih.gov/search/searchview.taf?ipid=36365
230,BC010380-05,"October 01, 2003 -  September 30, 2004",Recombination and Regulation,Jeffrey N Strathern,NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Alison J Rattray (National Cancer Institute)



Brenda K Shafer (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)












Deanna R Gotte  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36366
231,BC010381-05,"October 01, 2003 -  September 30, 2004",Studies on Silencing,Amar J S Klar; PhD,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Michael J Bonaduce (National Cancer Institute)



Bum-Soo  Lee (National Cancer Institute)



Gurjeet  Singh (National Cancer Institute)












Athanasios  Armakolas  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Singh G, Klar AJ (2003). DNA sequence of the mat2,3 region of Schizosaccharomyces kambucha shares high homology with the corresponding sequence from Sz. pombe. Yeast  20, 1273-8.   https://doi.org/10.1002/yea.1042




PubMed


 


PubMed ID 14618565",https://intramural.nih.gov/search/searchview.taf?ipid=36367
232,BC010382-05,"October 01, 2003 -  September 30, 2004",Chemotherapy Adjuvants,Robert C Moschel; PhD,Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,"Henry  Friedman
(Oncology, Duke University Medical Center)





Leonard  Erickson
(Oncology, Indiana University Cancer Center)





Anthony  Pegg
(Department of Physiology, Penn State College of Medicine)",Gary T Pauly  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Moschel RC, Loktionova NC, Pauly GC, Pegg AC, Wei GC (submitted in 2004) O6-alkylguanine-dna Alkyltransferase Inactivators And Beta-glucuronidase Cleavable Prodrugs. Patent issued: 7,825,096 (US in 2011). Patents pending: 08731524.8 (EP application); PCT/US2008/56025 (PC application); 2008222753 (AU application); 2,679,103 (CA application). Tracking number: E-307-2004-1-EP-07 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=36368
233,BC010383-05,"October 01, 2003 -  September 30, 2004",Chemistry and Mutagenicity of Site-Specific Carcinogen-DNA Damage,Robert C Moschel; PhD,Larry K Keefer; PhD,"Laboratory of Comparative Carcinogenesis, NCI",NULL,NULL,Gary T Pauly (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36369
234,BC010385-05,"October 01, 2003 -  September 30, 2004",Studies on mat1 Imprinting,Amar J S Klar; PhD,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,"Bum-Soo  Lee (National Cancer Institute)












Michael J Bonaduce  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36370
235,BC010386-05,"October 01, 2003 -  September 30, 2004",Human Handedness Studies,Amar J S Klar; PhD,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,Athanasios  Armakolas  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Klar AJ (2003). Human handedness and scalp hair-whorl direction develop from a common genetic mechanism. Genetics  165, 269-76.




PubMed



        
     
Free Article


 


PubMed ID 14504234
         Pubmed Central ID 1462764",https://intramural.nih.gov/search/searchview.taf?ipid=36371
236,BC010387-05,"October 01, 2003 -  September 30, 2004",Functional Analysis of Breast Cancer Susceptibility Genes in Mice,"Shyam K Sharan



IRP Faculty Profile",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"Jodi  Flaws; PhD
(Department of Epidemiology and Preventive Medicine, Department of Veterinary Biosciences, University of Illinois)





Mary Ann  Handel
(Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville)





Jonathan  Evans; MD
(University of Bristol)",NULL,NULL,"Ordered by publication type and then author name.



1.
Court DL, Swaminathan S, Yu D, Wilson H, Baker T, Bubunenko M, Sawitzke J, Sharan SK (2003). Mini-lambda: a tractable system for chromosome and BAC engineering. Gene  315, 63-9.   https://doi.org/10.1016/s0378-1119(03)00728-5




PubMed


 


PubMed ID 14557065
    
     


 



2.
Sharan SK, Pyle A, Coppola V, Babus J, Swaminathan S, Benedict J, Swing D, Martin BK, Tessarollo L, Evans JP, Flaws JA, Handel MA (2004). BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development  131, 131-42.   https://doi.org/10.1242/dev.00888




PubMed


 


PubMed ID 14660434
    
     


 



3.
Swaminathan S, Sharan SK (2004). Bacterial artificial chromosome engineering. Methods Mol Biol  256, 89-106.   https://doi.org/10.1385/1-59259-753-X:089




PubMed


 


PubMed ID 15024162
    
     


 



4.
Swing DA, Sharan SK (2004). BAC rescue: a tool for functional analysis of the mouse genome. Methods Mol Biol  256, 183-98.   https://doi.org/10.1385/1-59259-753-X:183




PubMed


 


PubMed ID 15024167
    
     


 



5.
Yang Y, Sharan SK (2003). A simple two-step, 'hit and fix' method to generate subtle mutations in BACs using short denatured PCR fragments. Nucleic Acids Res  31, e80.   https://doi.org/10.1093/nar/gng080




PubMed



        
     
Free Article


 


PubMed ID 12888532
         Pubmed Central ID 169966 


 



6.
Yang Y, Swaminathan S, Martin BK, Sharan SK (2003). Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model. Hum Mol Genet  12, 2121-31.   https://doi.org/10.1093/hmg/ddg222




PubMed


 


PubMed ID 12915465",https://intramural.nih.gov/search/searchview.taf?ipid=36372
237,BC010390-05,"October 01, 2003 -  September 30, 2004",Role of Neurotrophins and Their Receptors in the Development of the Mammalian Ne,"Lino  Tessarollo



IRP Faculty Profile",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"Bernd  Fritzsch
(Biomedical Sciences, Creighton University)





Colin  Fletcher
(Novartis Research Institute)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36373
238,BC010391-05,"October 01, 2003 -  September 30, 2004",Role of Neurotrophins and Their Receptors in Nonneuronal Organ Development,"Lino  Tessarollo



IRP Faculty Profile",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Coppola V, Barrick CA, Southon EA, Celeste A, Wang K, Chen B, Haddad el-B, Yin J, Nussenzweig A, Subramaniam A, Tessarollo L (2004). Ablation of TrkA function in the immune system causes B cell abnormalities. Development  131, 5185-95.   https://doi.org/10.1242/dev.01383




PubMed


 


PubMed ID 15459109
    
     


 



2.
Youn YH, Feng J, Tessarollo L, Ito K, Sieber-Blum M (2003). Neural crest stem cell and cardiac endothelium defects in the TrkC null mouse. Mol Cell Neurosci  24, 160-70.   https://doi.org/10.1016/s1044-7431(03)00125-8




PubMed


 


PubMed ID 14550777",https://intramural.nih.gov/search/searchview.taf?ipid=36374
239,BC010392-05,"October 01, 2003 -  September 30, 2004",Myeloid Leukemia: Disease Gene Identification and Mouse Model Development,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,"Renee B Bradford (National Cancer Institute)



Linda S Cleveland (National Cancer Institute)



Utpal P Dave (National Cancer Institute)



Yang  Du (National Cancer Institute)



Iben S Hanson (National Cancer Institute)



Deborah B Householder (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG (2003). Bcl11a is essential for normal lymphoid development. Nat Immunol  4, 525-32.   https://doi.org/10.1038/ni925




PubMed


 


PubMed ID 12717432",https://intramural.nih.gov/search/searchview.taf?ipid=36375
240,BC010393-05,"October 01, 2003 -  September 30, 2004",Development of New Genetic Tools,Neal G Copeland; PhD,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,"Renee B Bradford (National Cancer Institute)



Linda S Cleveland (National Cancer Institute)



Utpal P Dave (National Cancer Institute)



Yang  Du (National Cancer Institute)



Iben S Hanson (National Cancer Institute)



Deborah B Householder (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Davé UP, Jenkins NA, Copeland NG (2004). Gene therapy insertional mutagenesis insights. Science  303, 333.   https://doi.org/10.1126/science.1091667




PubMed


 


PubMed ID 14726584",https://intramural.nih.gov/search/searchview.taf?ipid=36376
241,BC010394-05,"October 01, 2003 -  September 30, 2004",A Genetic Approach to the Study of Vesicle Transport in the Mouse,Nancy  Jenkins-Copeland; PhD,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,John A Hammer; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Montcouquiol M, Rachel RA, Lanford PJ, Copeland NG, Jenkins NA, Kelley MW (2003). Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature  423, 173-7.   https://doi.org/10.1038/nature01618




PubMed


 


PubMed ID 12724779",https://intramural.nih.gov/search/searchview.taf?ipid=36377
242,BC010397-05,"October 01, 2003 -  September 30, 2004","Pathogenic mechanisms of HIV, viral reservoirs and sanctuaries","George N Pavlakis; MD, PhD



IRP Faculty Profile","Jay Arthur Berzofsky; MD, PhD","Human Retrovirus Section, NCI",NULL,"Ralf  Schneider
(GSF-National Research Center for Environment and Health)





Xiao-Fang  Yu
(Johns Hopkins University)





Markus  Neumann
(GSF-National Research Center for Environment and Health)","Antonio L Valentin (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",Dong  Liu; PhD (NIA),"Ordered by publication type and then author name.



1.
Calarota SA, Otero M, Hermanstyne K, Hermanstayne K, Lewis M, Rosati M, Felber BK, Pavlakis GN, Boyer JD, Weiner DB (2003). Use of interleukin 15 to enhance interferon-gamma production by antigen-specific stimulated lymphocytes from rhesus macaques. J Immunol Methods  279, 55-67.   https://doi.org/10.1016/s0022-1759(03)00246-1




PubMed


 


PubMed ID 12969547
    
     


 



2.
Fitzgerald JC, Gao GP, Reyes-Sandoval A, Pavlakis GN, Xiang ZQ, Wlazlo AP, Giles-Davis W, Wilson JM, Ertl HC (2003). A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J Immunol  170, 1416-22.   https://doi.org/10.4049/jimmunol.170.3.1416




PubMed


 


PubMed ID 12538702
    
     


 



3.
Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, Kalyanaraman VS, Pavlakis GN, Robert-Guroff M (2003). Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. J Virol  77, 8607-20.   https://doi.org/10.1128/jvi.77.16.8607-8620.2003




PubMed



        
     
Free Article


 


PubMed ID 12885879
         Pubmed Central ID 167211 


 



4.
Warming S, Liu P, Suzuki T, Akagi K, Lindtner S, Pavlakis GN, Jenkins NA, Copeland NG (2003). Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein. Blood  101, 1934-40.   https://doi.org/10.1182/blood-2002-08-2652




PubMed


 


PubMed ID 12393497
    
     


 



5.
Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M (2003). Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine  21, 4022-35.   https://doi.org/10.1016/s0264-410x(03)00266-4




PubMed


 


PubMed ID 12922139
    
     


 



6.
Zhao J, Pinczewski J, Gómez-Román VR, Venzon D, Kalyanaraman VS, Markham PD, Aldrich K, Moake M, Montefiori DC, Lou Y, Pavlakis GN, Robert-Guroff M (2003). Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen. J Virol  77, 8354-65.   https://doi.org/10.1128/jvi.77.15.8354-8365.2003




PubMed



        
     
Free Article


 


PubMed ID 12857905
         Pubmed Central ID 165263",https://intramural.nih.gov/search/searchview.taf?ipid=36378
243,BC010399-05,"October 01, 2003 -  September 30, 2004",NMR Group Project: Biophysical Studies of Oligonucleotides Containing Conformati,"Joseph John Barchi



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,Melissa  Maderia  (National Cancer Institute),Adriaan  Bax; PhD (NIDDK),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36379
244,BC010411-05,"October 01, 2003 -  September 30, 2004",Initiation of DNA replication in Mammalian Cells,"Mirit I Aladjem; PhD



IRP Faculty Profile",Yves  Pommier; PhD,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Tsutomu  Shimura (National Cancer Institute)



Chiimei (Cindy) L Tseng (National Cancer Institute)



Lixin  Wang (National Cancer Institute)












Haiqing  Fu  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aladjem MI, Fanning E (2004). The replicon revisited: an old model learns new tricks in metazoan chromosomes. EMBO Rep  5, 686-91.   https://doi.org/10.1038/sj.embor.7400185




PubMed



        
     
Free Article


 


PubMed ID 15229645
         Pubmed Central ID 1299096 


 



2.
Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, Pilch DR, Rogakou EP, Celeste A, Chen HT, Nussenzweig A, Aladjem MI, Bonner WM, Pommier Y (2003). Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem  278, 20303-12.   https://doi.org/10.1074/jbc.M300198200




PubMed


 


PubMed ID 12660252
    
     


 



3.
Lin CM, Fu H, Martinovsky M, Bouhassira E, Aladjem MI (2003). Dynamic alterations of replication timing in mammalian cells. Curr Biol  13, 1019-28.   https://doi.org/10.1016/s0960-9822(03)00382-8




PubMed


 


PubMed ID 12814547
    
     


 



4.
Nenguke T, Aladjem MI, Gusella JF, Wexler NS, Arnheim N, Venezuela HD Project (2003). Candidate DNA replication initiation regions at human trinucleotide repeat disease loci. Hum Mol Genet  12, 1021-8.   https://doi.org/10.1093/hmg/ddg111




PubMed


 


PubMed ID 12700170
    
     


 



5.
Wang L, Lin CM, Brooks S, Cimbora D, Groudine M, Aladjem MI (2004). The human beta-globin replication initiation region consists of two modular independent replicators. Mol Cell Biol  24, 3373-86.   https://doi.org/10.1128/mcb.24.8.3373-3386.2004




PubMed



        
     
Free Article


 


PubMed ID 15060158
         Pubmed Central ID 381644",https://intramural.nih.gov/search/searchview.taf?ipid=36380
245,BC010412-05,"October 01, 2003 -  September 30, 2004",Structural Analysis of Macromolecular Complexes by High Resolution Electron Micr,Jacqueline L Milne,Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Mario  Borgnia (National Cancer Institute)












Dan  Shi  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36381
246,BC010413-04,"October 01, 2003 -  September 30, 2004",Organization and Function of Chromosomal Regions that are Required for Stability,"Vladimir L Larionov; PhD, DSc",James Carl Barrett; PhD,"Genome Structure and Function Section, NCI",NULL,"William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)





Christopher  Walsh
(Howard Hughes Medical Institute)
















Mitsuo  Oshimura
(Genetics, Tottori University)




Jeffrey  Trent; PhD
(Translational Genomic)","Natalay  Kouprina (National Cancer Institute)



Vladimir  Noskov; PhD (National Cancer Institute)","Victor  Lobanenkov (NIAID) 



Minoru S. H. Ko; MD, PhD (NIA)","Ordered by publication type and then author name.



1.
Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, Lamerdin J, Hellsten U, Goodstein D, Couronne O, Tran-Gyamfi M, Aerts A, Altherr M, Ashworth L, Bajorek E, Black S, Branscomb E, Caenepeel S, Carrano A, Caoile C, Chan YM, Christensen M, Cleland CA, Copeland A, Dalin E, Dehal P, et al. [73 more authors] (2004). The DNA sequence and biology of human chromosome 19. Nature  428, 529-35.   https://doi.org/10.1038/nature02399




PubMed


 


PubMed ID 15057824
    
     


 



2.
Kouprina N, Mullokandov M, Rogozin IB, Collins NK, Solomon G, Otstot J, Risinger JI, Koonin EV, Barrett JC, Larionov V (2004). The SPANX gene family of cancer/testis-specific antigens: rapid evolution and amplification in African great apes and hominids. Proc Natl Acad Sci U S A  101, 3077-82.   https://doi.org/10.1073/pnas.0308532100




PubMed



        
     
Free Article


 


PubMed ID 14973187
         Pubmed Central ID 365747 


 



3.
Kouprina N, Noskov VN, Koriabine M, Leem SH, Larionov V (2004). Exploring transformation-associated recombination cloning for selective isolation of genomic regions. Methods Mol Biol  255, 69-89.   https://doi.org/10.1385/1-59259-752-1:069




PubMed


 


PubMed ID 15020816
    
     


 



4.
Kouprina N, Pavlicek A, Mochida GH, Solomon G, Gersch W, Yoon YH, Collura R, Ruvolo M, Barrett JC, Woods CG, Walsh CA, Jurka J, Larionov V (2004). Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion. PLoS Biol  2, E126.   https://doi.org/10.1371/journal.pbio.0020126




PubMed



        
     
Free Article


 


PubMed ID 15045028
         Pubmed Central ID 374243 


 



5.
Leem SH, Kouprina N, Grimwood J, Kim JH, Mullokandov M, Yoon YH, Chae JY, Morgan J, Lucas S, Richardson P, Detter C, Glavina T, Rubin E, Barrett JC, Larionov V (2004). Closing the gaps on human chromosome 19 revealed genes with a high density of repetitive tandemly arrayed elements. Genome Res  14, 239-46.   https://doi.org/10.1101/gr.1929904




PubMed



        
     
Free Article


 


PubMed ID 14718380
         Pubmed Central ID 327099",https://intramural.nih.gov/search/searchview.taf?ipid=36117
247,BC010414-05,"October 01, 2003 -  September 30, 2004",Signal transduction during T-lymphocyte differentiation,"Remy J Bosselut; MD, PhD



IRP Faculty Profile",NULL,"Laboratory of Immune Cell Biology, NCI",Jonathan D Ashwell; MD,NULL,"Alfred  Singer; MD (National Cancer Institute)












Xiaolong  Liu  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bosselut R (2004). CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals. Nat Rev Immunol  4, 529-40.   https://doi.org/10.1038/nri1392




PubMed


 


PubMed ID 15229472
    
     


 



2.
Bosselut R, Guinter TI, Sharrow SO, Singer A (2003). Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes ""paradoxically"" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells. J Exp Med  197, 1709-19.   https://doi.org/10.1084/jem.20030170




PubMed



        
     
Free Article


 


PubMed ID 12810689
         Pubmed Central ID 2193957 


 



3.
Liu X, Adams A, Wildt KF, Aronow B, Feigenbaum L, Bosselut R (2003). Restricting Zap70 expression to CD4+CD8+ thymocytes reveals a T cell receptor-dependent proofreading mechanism controlling the completion of positive selection. J Exp Med  197, 363-73.   https://doi.org/10.1084/jem.20021698




PubMed



        
     
Free Article


 


PubMed ID 12566420
         Pubmed Central ID 2193832 


 



4.
Liu X, Bosselut R (2004). Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo. Nat Immunol  5, 280-8.   https://doi.org/10.1038/ni1040




PubMed


 


PubMed ID 14770180
    
     


 



5.
Singer A, Bosselut R (2004). CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision. Adv Immunol  83, 91-131.   https://doi.org/10.1016/S0065-2776(04)83003-7




PubMed


 


PubMed ID 15135629",https://intramural.nih.gov/search/searchview.taf?ipid=36382
248,BC010415-05,"October 01, 2003 -  September 30, 2004",GDNF/c-RET signaling during mammalian development and diseases,Liya  Shen; PhD,Stuart H Yuspa; MD,"Office of the Director, NCI",NULL,NULL,"Sungho  Maeng (National Cancer Institute)



Brian  Enright (National Cancer Institute)



Sheelu  Varghese (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36383
249,BC010417-05,"October 01, 2003 -  September 30, 2004","Cell Senescence, Carcinogenesis, and Aging",James Carl Barrett; PhD,NULL,"Genome Structure and Function Section, NCI

National Cancer Institute, NCI",NULL,"William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)





Takeki  Tsutsui
(Nippon Dental University of Tokyo)





Angelo  De Marzo
(John Hopkins)





Mitsuo  Oshimura
(Genetics, Tottori University)





Bertram  Opalka
(University of Essen)
















Jeffrey  Kent
(Translational Genomics Research Institute)","Kristin  Bauer (National Cancer Institute)



Emily  Clarke (National Cancer Institute)



Steven Frank Goldberg (National Cancer Institute)



Izumi  Horikawa (National Cancer Institute)



Jackie Ann Lavigne (National Cancer Institute)



Shuanfang  Li (National Cancer Institute)","Victor  Lobanenkov (NIAID) 



Mark Paul Mattson; PhD (NIA)","Ordered by publication type and then author name.



1.
Burroughs KD, Oh J, Barrett JC, DiAugustine RP (2003). Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1? Mol Cancer Res  1, 312-22.




PubMed


 


PubMed ID 12612059
    
     


 



2.
Horikawa I, Barrett JC (2003). Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis  24, 1167-76.   https://doi.org/10.1093/carcin/bgg085




PubMed


 


PubMed ID 12807729
    
     


 



3.
Kenney NJ, Bowman A, Korach KS, Barrett JC, Salomon DS (2003). Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse. Breast Cancer Res Treat  79, 161-73.   https://doi.org/10.1023/a:1023938510508




PubMed


 


PubMed ID 12825851
    
     


 



4.
Li S, Hansman R, Newbold R, Davis B, McLachlan JA, Barrett JC (2003). Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog  38, 78-84.   https://doi.org/10.1002/mc.10147




PubMed


 


PubMed ID 14502647
    
     


 



5.
Li S, Hursting SD, Davis BJ, McLachlan JA, Barrett JC (2003). Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann N Y Acad Sci  983, 161-9.   https://doi.org/10.1111/j.1749-6632.2003.tb05971.x




PubMed


 


PubMed ID 12724221
    
     


 



6.
Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC (2004). Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol  6, 168-70.   https://doi.org/10.1038/ncb1095




PubMed


 


PubMed ID 14755273
    
     


 



7.
Shigeeda N, Uchida M, Barrett JC, Tsutsui T (2003). Candidate chromosomal regions for genes involved in activation of alternative lengthening of telomeres in human immortal cell lines. Exp Gerontol  38, 641-51.   https://doi.org/10.1016/s0531-5565(03)00072-x




PubMed


 


PubMed ID 12814799
    
     


 



8.
Tsutsui T, Kumakura S, Tamura Y, Tsutsui TW, Sekiguchi M, Higuchi T, Barrett JC (2003). Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities. Carcinogenesis  24, 953-65.   https://doi.org/10.1093/carcin/bgg024




PubMed


 


PubMed ID 12771041
    
     


 



9.
Tsutsui T, Tamura Y, Yagi E, Someya H, Hori I, Metzler M, Barrett JC (2003). Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int J Cancer  105, 312-20.   https://doi.org/10.1002/ijc.11046




PubMed


 


PubMed ID 12704663
    
     


 



10.
Xiao X, Athanasiou M, Sidorov IA, Horikawa I, Cremona G, Blair D, Barret JC, Dimitrov DS (2003). Role of Ets/Id proteins for telomerase regulation in human cancer cells. Exp Mol Pathol  75, 238-47.   https://doi.org/10.1016/s0014-4800(03)00092-3




PubMed


 


PubMed ID 14611815
    
     


 



11.
Yamamoto A, Kumakura S, Uchida M, Barrett JC, Tsutsui T (2003). Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone. Int J Cancer  106, 301-9.   https://doi.org/10.1002/ijc.11219




PubMed


 


PubMed ID 12845665
    
     


 



12.
Yawata T, Kamino H, Kugoh H, Katoh M, Nomura N, Oishi M, Horikawa I, Barrett JC, Oshimura M (2003). Identification of a 
PubMed


 


PubMed ID 12527897",https://intramural.nih.gov/search/searchview.taf?ipid=36384
250,BC010418-05,"October 01, 2003 -  September 30, 2004",Signal Transduction and Cell Migration,Carole A Parent; PhD,Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,"Pavla  Roselova (National Cancer Institute)



Anna  Bagorda (National Cancer Institute)



Gene  Garcia (National Cancer Institute)












Vassil  Mihaylov  (National Cancer Institute)",Alan Robert Kimmel; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Huang YE, Iijima M, Parent CA, Funamoto S, Firtel RA, Devreotes P (2003). Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells. Mol Biol Cell  14, 1913-22.   https://doi.org/10.1091/mbc.e02-10-0703




PubMed



        
     
Free Article


 


PubMed ID 12802064
         Pubmed Central ID 165086 


 



2.
Kimmel AR, Parent CA (2003). The signal to move: D. discoideum go orienteering. Science  300, 1525-7.   https://doi.org/10.1126/science.1085439




PubMed


 


PubMed ID 12791977
    
     


 



3.
Kriebel PW, Barr VA, Parent CA (2003). Adenylyl cyclase localization regulates streaming during chemotaxis. Cell  112, 549-60.   https://doi.org/10.1016/s0092-8674(03)00081-3




PubMed


 


PubMed ID 12600317",https://intramural.nih.gov/search/searchview.taf?ipid=36385
251,BC010419-05,"October 01, 2003 -  September 30, 2004",Molecular mechanisms of TGF-beta signaling pathway,"Ying  Zhang



IRP Faculty Profile",Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,NULL,"Yu-an  Yang (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Derynck R, Zhang YE (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature  425, 577-84.   https://doi.org/10.1038/nature02006




PubMed


 


PubMed ID 14534577
    
     


 



2.
Ying SX, Hussain ZJ, Zhang YE (2003). Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem  278, 39029-36.   https://doi.org/10.1074/jbc.M301193200




PubMed



        
     
Free Article


 


PubMed ID 12871975
         Pubmed Central ID 3230132",https://intramural.nih.gov/search/searchview.taf?ipid=36386
252,BC010420-04,"October 01, 2003 -  September 30, 2004",De Novo Methylation and Cancer,Keith D Robertson; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Theresa  Geiman (National Cancer Institute)



Umesh  Sankpal (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36118
253,BC010424-05,"October 01, 2003 -  September 30, 2004",Hypoxia and Tumorigenesis,Eric  Huang; MD,Curtis  Harris; MD,"Laboratory of Human Carcinogenesis, NCI",NULL,"Adrian L.  Harris
(Weatherall Institute of Molecular Medicine, Oxford University)





John  Park
(NOB, NINDS)





Olivier  Bernard
(Hopital Necker, INSERM)





Hani S El-Gabalawy; MD

















Paul  Modrich
(Biochemistry, Duke University Medical Center)




Peter  Ratcliffe
(Herny Wellcome Building of Genomic Medicine, Oxford University)",NULL,Melissa  Kitner-Triolo; PhD (NIA),"Ordered by publication type and then author name.



1.
Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, Huang LE, Kim MS, Park JW (2003). Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion. Cancer Res  63, 8700-7.




PubMed


 


PubMed ID 14695184
    
     


 



2.
Huang LE, Bunn HF (2003). Hypoxia-inducible factor and its biomedical relevance. J Biol Chem  278, 19575-8.   https://doi.org/10.1074/jbc.R200030200




PubMed


 


PubMed ID 12639949
    
     


 



3.
Kageyama Y, Koshiji M, To KK, Tian YM, Ratcliffe PJ, Huang LE (2004). Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation. FASEB J  18, 1028-30.   https://doi.org/10.1096/fj.03-1233fje




PubMed


 


PubMed ID 15084514
    
     


 



4.
Kaufman B, Scharf O, Arbeit J, Ashcroft M, Brown JM, Bruick RK, Chapman JD, Evans SM, Giaccia AJ, Harris AL, Huang E, Johnson R, Kaelin W, Koch CJ, Maxwell P, Mitchell J, Neckers L, Powis G, Rajendran J, Semenza GL, Simons J, Storkebaum E, Welch MJ, Whitelaw M, Melillo G, et al. [1 more author] (2004). Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. Cancer Res  64, 3350-6.   https://doi.org/10.1158/0008-5472.can-03-2611




PubMed


 


PubMed ID 15126380
    
     


 



5.
Koshiji M, Huang LE (2004). Dynamic balancing of the dual nature of HIF-1alpha for cell survival. Cell Cycle  3, 853-4.   https://doi.org/10.4161/cc.3.7.990




PubMed


 


PubMed ID 15190211
    
     


 



6.
Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE (2004). HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J  23, 1949-56.   https://doi.org/10.1038/sj.emboj.7600196




PubMed



        
     
Free Article


 


PubMed ID 15071503
         Pubmed Central ID 404317",https://intramural.nih.gov/search/searchview.taf?ipid=36387
254,BC010425-05,"October 01, 2003 -  September 30, 2004",Human T-Cell Responses to Tumor Antigens,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,"Mario  Roselli
(Oncology, Tor Vergata)
















Fiorella  Guadagni
(Pathology, Regina Elena Cancer Institute)",Kwong Yok Tsang (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Palena C, Arlen P, Zeytin H, Greiner JW, Schlom J, Tsang KY (2003). Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens. Cytokine  24, 128-42.   https://doi.org/10.1016/j.cyto.2003.07.004




PubMed


 


PubMed ID 14572791
    
     


 



2.
Palena C, Schlom J, Tsang KY (2003). Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptide. Clin Cancer Res  9, 1616-27.




PubMed


 


PubMed ID 12738714
    
     


 



3.
Palena C, Zhu M, Schlom J, Tsang KY (2004). Human B cells that hyperexpress a triad of costimulatory molecules via avipox-vector infection: an alternative source of efficient antigen-presenting cells. Blood  104, 192-9.   https://doi.org/10.1182/blood-2003-09-3211




PubMed


 


PubMed ID 15010371
    
     


 



4.
Tsang KY, Palena C, Gulley J, Arlen P, Schlom J (2004). A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1. Clin Cancer Res  10, 2139-49.   https://doi.org/10.1158/1078-0432.ccr-1011-03




PubMed


 


PubMed ID 15041735
    
     


 



5.
Kashmiri SV, Padlan EV, Schlom JV (submitted in 2004) Framework Residue Substituted Humanized Col-1 Antibodies And Their Use. Patents issued: 1833850 (EP in 2011); 7,855,276 (US in 2011); 2005322869 (AU in 2011); 8,828,717 (US in 2014). Patents pending: PCT/US2005/047431 (PC application); 2593693 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=36388
255,BC010426-05,"October 01, 2003 -  September 30, 2004",The Use of Cancer Vaccines and Combination Therapies,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Charlese  Garnett (National Cancer Institute)



Mala  Chakraborty (National Cancer Institute)



Chie  Saito-Kudo (National Cancer Institute)



James W Hodge; PhD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW (2004). External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res  64, 4328-37.   https://doi.org/10.1158/0008-5472.CAN-04-0073




PubMed


 


PubMed ID 15205348
    
     


 



2.
Grosenbach DW, Schlom J, Gritz L, Gómez Yafal A, Hodge JW (2003). A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. Cell Immunol  222, 45-57.   https://doi.org/10.1016/s0008-8749(03)00080-7




PubMed


 


PubMed ID 12798307
    
     


 



3.
Hodge JW, Chakraborty M, Kudo-Saito C, Garnett CT, Schlom J (2005). Multiple costimulatory modalities enhance CTL avidity. J Immunol  174, 5994-6004.   https://doi.org/10.4049/jimmunol.174.10.5994




PubMed



        
     
Free Article


 


PubMed ID 15879092
         Pubmed Central ID 1924685 


 



4.
Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J (2003). Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res  9, 1837-49.




PubMed


 


PubMed ID 12738742
    
     


 



5.
Hodge JW, Poole DJ, Aarts WM, Gómez Yafal A, Gritz L, Schlom J (2003). Modified vaccinia virus ankara recombinants are as potent as vaccinia recombinants in diversified prime and boost vaccine regimens to elicit therapeutic antitumor responses. Cancer Res  63, 7942-9.




PubMed


 


PubMed ID 14633725
    
     


 



6.
Hodge JW, Tsang KY, Poole DJ, Schlom J (2003). General keynote: vaccine strategies for the therapy of ovarian cancer. Gynecol Oncol  88, S97-104; discussion S110-3.   https://doi.org/10.1006/gyno.2002.6694




PubMed


 


PubMed ID 12586096
    
     


 



7.
Kudo-Saito C, Schlom J, Hodge JW (2004). Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules. Clin Cancer Res  10, 1090-9.   https://doi.org/10.1158/1078-0432.ccr-03-0145




PubMed


 


PubMed ID 14871989
    
     


 



8.
Oh S, Hodge JW, Ahlers JD, Burke DS, Schlom J, Berzofsky JA (2003). Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol  170, 2523-30.   https://doi.org/10.4049/jimmunol.170.5.2523




PubMed


 


PubMed ID 12594278
    
     


 



9.
Yang S, Hodge JW, Grosenbach DW, Schlom J (2005). Vaccines with enhanced costimulation maintain high avidity memory CTL. J Immunol  175, 3715-23.   https://doi.org/10.4049/jimmunol.175.6.3715




PubMed



        
     
Free Article


 


PubMed ID 16148117
         Pubmed Central ID 1350817 


 



10.
Yang S, Tsang KY, Schlom J (2005). Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells. Clin Cancer Res  11, 5603-15.   https://doi.org/10.1158/1078-0432.CCR-05-0670




PubMed



        
     
Free Article


 


PubMed ID 16061879
         Pubmed Central ID 1351007",https://intramural.nih.gov/search/searchview.taf?ipid=36389
256,BC010427-05,"October 01, 2003 -  September 30, 2004",Mechanism of Human T-Cell Activation,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Sven  Mostbock (National Cancer Institute)



Helen B Sabzevari (National Cancer Institute)



Christine  Lutsiak (National Cancer Institute)



Jun  Zhou (National Cancer Institute)",Peter W Schuck; PhD (OD),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36390
257,BC010428-05,"October 01, 2003 -  September 30, 2004",Cytokines as Biologic Adjuvants,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Experimental Oncology Section, NCI

Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Stephen D Hursting; PhD, MPH (National Cancer Institute)



Arti C Patel (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Palena C, Arlen P, Zeytin H, Greiner JW, Schlom J, Tsang KY (2003). Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens. Cytokine  24, 128-42.   https://doi.org/10.1016/j.cyto.2003.07.004




PubMed


 


PubMed ID 14572791
    
     


 



2.
Zeytin HE, Patel AC, Rogers CJ, Canter D, Hursting SD, Schlom J, Greiner JW (2004). Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice. Cancer Res  64, 3668-78.   https://doi.org/10.1158/0008-5472.CAN-03-3878




PubMed


 


PubMed ID 15150127",https://intramural.nih.gov/search/searchview.taf?ipid=36391
258,BC010429-05,"October 01, 2003 -  September 30, 2004",Novel Recombinant Immunoglobulin Forms for Cancer Therapy and Diagnosis,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Syed V. S. Kashmiri; PhD (National Cancer Institute)












Roberto  De Pascalis  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
De Pascalis R, Gonzales NR, Padlan EA, Schuck P, Batra SK, Schlom J, Kashmiri SV (2003). In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants. Clin Cancer Res  9, 5521-31.




PubMed


 


PubMed ID 14654532
    
     


 



2.
Gonzales NR, Padlan EA, De Pascalis R, Schuck P, Schlom J, Kashmiri SV (2003). Minimizing immunogenicity of the SDR-grafted humanized antibody CC49 by genetic manipulation of the framework residues. Mol Immunol  40, 337-49.   https://doi.org/10.1016/s0161-5890(03)00166-4




PubMed


 


PubMed ID 14522015",https://intramural.nih.gov/search/searchview.taf?ipid=36392
259,BC010431-05,"October 01, 2003 -  September 30, 2004",Metastasis Suppressor Genes For Prostate Cancer,James Carl Barrett; PhD,NULL,"Genome Structure and Function Section, NCI

National Cancer Institute, NCI",NULL,"Yuxin  Yin
(Department of Radiation Oncology, Columbia University)





Michael  Sporn; MD
(Dartmouth)





Zheng  Cui
(Wake Forest University School of Medicine, Winston-Salem, NC)
















Colin C Anderson; PhD","Kristin  Bauer (National Cancer Institute)



Vladimir  Noskov; PhD (National Cancer Institute)



Jun-ichirou  Ohzeki (National Cancer Institute)



Susan N Perkins; PhD (National Cancer Institute)



John I Risinger; PhD (National Cancer Institute)



Joseph  Riss; PhD (National Cancer Institute)",Victor  Lobanenkov (NIAID),"Ordered by publication type and then author name.



1.
Gao AC, Lou W, Dong JT, Barrett JC, Danielpour D, Isaacs JT (2003). Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. Prostate  57, 256-60.   https://doi.org/10.1002/pros.10309




PubMed


 


PubMed ID 14601021",https://intramural.nih.gov/search/searchview.taf?ipid=36393
260,BC010434-03,"October 01, 2003 -  September 30, 2004","Regulation of cell growth and differentiation: Roles of osteopontin, Nrf2 and th",George R Beck,Nancy H Colburn; PhD,"Basic Research Laboratory, NCI",George R Beck,"Myung-Haing  Cho
(Toxicology, Seoul National University)





Timothy  Veenstra
(SAIC)





Elizabeth  Moran
(Biochemistry, Temple University)
















T  Conrads
(SAIC-Frederick)",NULL,NULL,"Ordered by publication type and then author name.



1.
Beck GR (2003). Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem  90, 234-43.   https://doi.org/10.1002/jcb.10622




PubMed


 


PubMed ID 14505340
    
     


 



2.
Beck GR, Knecht N (2003). Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem  278, 41921-9.   https://doi.org/10.1074/jbc.M304470200




PubMed


 


PubMed ID 12920127
    
     


 



3.
Beck GR, Moran E, Knecht N (2003). Inorganic phosphate regulates multiple genes during osteoblast differentiation, including Nrf2. Exp Cell Res  288, 288-300.   https://doi.org/10.1016/s0014-4827(03)00213-1




PubMed


 


PubMed ID 12915120
    
     


 



4.
Conrads KA, Yu LR, Lucas DA, Zhou M, Chan KC, Simpson KA, Schaefer CF, Issaq HJ, Veenstra TD, Beck GR, Conrads TP   (2004) Quantitative proteomic analysis of inorganic phosphate-induced murine MC3T3-E1 osteoblast cells.  Electrophoresis 25:1342-52.




PubMed


 


PubMed ID 15174057",https://intramural.nih.gov/search/searchview.taf?ipid=36119
261,BC010435-04,"October 01, 2003 -  September 30, 2004",Developmental Therapeutics,Sandra M Swain; MD,NULL,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Jennifer A Low (National Cancer Institute)



Suparna B Wedam (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)












Allyson  Parr  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36394
262,BC010436-02,"October 01, 2003 -  September 30, 2004",Mechanisms of Chromosome Rearrangements in the Evolution of the Genome,Roscoe  Stanyon,Ilan  Kirsch; MD,"Mouse Cancer Genetics Program, NCI",NULL,"Norbert  Arnold
(Klinik fr Gynaekologie und Geburtshilfe, Universitaetsklinikum Kiel)





Stefan  Muller
(Institute of Human Genetics and Anthropology, University of Munich)
















Mariano  Rocchi
(Department of Human Genetics, University of Bari)","Francesca  Dumas (National Cancer Institute)



Marta  Svartman (National Cancer Institute)



Gary  Stone (National Cancer Institute)



Hector  Seuanez (National Cancer Institute)



Michael John Difilippantonio; PhD (Acquired Gene Rearrangements Sect)



Francesca  Bigoni (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bigoni F, Stanyon R, Wimmer R, Schempp W (2003). Chromosome painting shows that the proboscis monkey (Nasalis larvatus) has a derived karyotype and is phylogenetically nested within Asian Colobines. Am J Primatol  60, 85-93.   https://doi.org/10.1002/ajp.10095




PubMed


 


PubMed ID 12874840
    
     


 



2.
Bonvicino CR, Penna-Firme V, do Nascimento FF, Lemos B, Stanyon R, Seuánez HN (2003). The lowest diploid number (2n = 16) yet found in any primate: Callicebus lugens (Humboldt, 1811). Folia Primatol (Basel)  74, 141-9.   https://doi.org/10.1159/000070647




PubMed


 


PubMed ID 12826733
    
     


 



3.
Frönicke L, Wienberg J, Stone G, Adams L, Stanyon R (2003). Towards the delineation of the ancestral eutherian genome organization: comparative genome maps of human and the African elephant (Loxodonta africana) generated by chromosome painting. Proc Biol Sci  270, 1331-40.   https://doi.org/10.1098/rspb.2003.2383




PubMed



        
     
Free Article


 


PubMed ID 12965023
         Pubmed Central ID 1691379 


 



4.
Murphy WJ, Frönicke L, O'Brien SJ, Stanyon R (2003). The origin of human chromosome 1 and its homologs in placental mammals. Genome Res  13, 1880-8.   https://doi.org/10.1101/gr.1022303




PubMed



        
     
Free Article


 


PubMed ID 12869576
         Pubmed Central ID 403779 


 



5.
Rambau RV, Stanyon R, Robinson TJ (2003). Molecular genetics of Rhabdomys pumilio subspecies boundaries: mtDNA phylogeography and karyotypic analysis by fluorescence in situ hybridization. Mol Phylogenet Evol  28, 564-75.   https://doi.org/10.1016/s1055-7903(03)00058-7




PubMed


 


PubMed ID 12927139
    
     


 



6.
Stanyon R, Bonvicino CR, Svartman M, Seuánez HN (2003). Chromosome painting in Callicebus lugens, the species with the lowest diploid number (2n=16) known in primates. Chromosoma  112, 201-6.   https://doi.org/10.1007/s00412-003-0261-5




PubMed


 


PubMed ID 14608465
    
     


 



7.
Stanyon R, Stone G, Garcia M, Froenicke L (2003). Reciprocal chromosome painting shows that squirrels, unlike murid rodents, have a highly conserved genome organization. Genomics  82, 245-9.   https://doi.org/10.1016/s0888-7543(03)00109-5




PubMed


 


PubMed ID 12837274
    
     


 



8.
Stanyon R, Yang F, Morescalchi AM, Galleni L (2004). Chromosome painting in the long-tailed field mouse provides insights into the ancestral murid karyotype. Cytogenet Genome Res  105, 406-11.   https://doi.org/10.1159/000078213




PubMed


 


PubMed ID 15237228
    
     


 



9.
Svartman M, Stone G, Page JE, Stanyon R (2004). A chromosome painting test of the basal eutherian karyotype. Chromosome Res  12, 45-53.   https://doi.org/10.1023/b:chro.0000009294.18760.e4




PubMed


 


PubMed ID 14984101",https://intramural.nih.gov/search/searchview.taf?ipid=36120
263,BC010439-03,"October 01, 2003 -  September 30, 2004",Maryland Breast Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Stephen J Chanock; MD, PhD



Neil Edward Caporaso; MS, MD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36324
264,BC010440-03,"October 01, 2003 -  September 30, 2004","Protein Structure, Stability, and Amyloid Formation",Ruth  Nussinov; PhD,"James Carl Barrett; PhD 
 


Jacob V. Maizel; PhD","Center for Cancer Research Nanobiology Program, NCI",NULL,"Gnana  Gnanakaran
(T10, Los Alamos National Laboratory)





Arthur  Lesk
(Biochemistry and Molecular Biology, Pennsylvania State University)
















Angel  Garcia
(T10, Los Alamos National Laboratory)","Gunasakaran  Kannan (National Cancer Institute)



Buyong  Ma (National Cancer Institute)



Hui-Hsu (Gavin)  Tsai (National Cancer Institute)



Chung  Tsai (National Cancer Institute)



David  Zanuy (National Cancer Institute)












Yongping  Pan  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Barzilai A, Kumar S, Wolfson H, Nussinov R   (2004) Potential folding-function interrelationship in proteins.  Proteins 56:635-49.




PubMed


 


PubMed ID 15281117
    
     


 



2.
Benyamini H, Gunasekaran K, Wolfson H, Nussinov R   (2003) Beta2-microglobulin amyloidosis: insights from conservation analysis and fibril modelling by protein docking techniques.  J Mol Biol 330:159-74.




PubMed


 


PubMed ID 12818210
    
     


 



3.
Benyamini H, Gunasekaran K, Wolfson H, Nussinov R   (2003) Conservation and amyloid formation: a study of the gelsolin-like family.  Proteins 51:266-82.




PubMed


 


PubMed ID 12660995
    
     


 



4.
Haspel N, Tsai CJ, Wolfson H, Nussinov R   (2003) Hierarchical protein folding pathways: a computational study of protein fragments.  Proteins 51:203-15.




PubMed


 


PubMed ID 12660989
    
     


 



5.
Haspel N, Tsai CJ, Wolfson H, Nussinov R   (2003) Reducing the computational complexity of protein folding via fragment folding and assembly.  Protein Sci 12:1177-87.




PubMed



        
     
Free Article


 


PubMed ID 12761388
         Pubmed Central ID 2323902 


 



6.
Kumar S, Nussinov R   (2004) Different roles of electrostatics in heat and in cold: adaptation by citrate synthase.  Chembiochem 5:280-90.




PubMed


 


PubMed ID 14997520
    
     


 



7.
Kumar S, Tsai CJ, Nussinov R   (2003) Temperature range of thermodynamic stability for the native state of reversible two-state proteins.  Biochemistry 42:4864-73.




PubMed


 


PubMed ID 12718527
    
     


 



8.
Ma B, Nussinov R   (2003) Energy landscape and dynamics of the beta-hairpin G peptide and its isomers: Topology and sequences.  Protein Sci 12:1882-93.




PubMed



        
     
Free Article


 


PubMed ID 12930988
         Pubmed Central ID 2323986 


 



9.
Ma B, Nussinov R   (2003) Molecular dynamics simulations of the unfolding of beta(2)-microglobulin and its variants.  Protein Eng 16:561-75.




PubMed


 


PubMed ID 12968074
    
     


 



10.
Tsai HH, Zanuy D, Haspel N, Gunasekaran K, Ma B, Tsai CJ, Nussinov R (2004). The stability and dynamics of the human calcitonin amyloid peptide DFNKF. Biophys J  87, 146-58.   https://doi.org/10.1529/biophysj.104.040352




PubMed



        
     
Free Article


 


PubMed ID 15240453
         Pubmed Central ID 1304338 


 



11.
Zanuy D, Ma B, Nussinov R   (2003) Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL.  Biophys J 84:1884-94.




PubMed



        
     
Free Article


 


PubMed ID 12609890
         Pubmed Central ID 1302757 


 



12.
Zanuy D, Nussinov R   (2003) The sequence dependence of fiber organization A comparative molecular dynamics study of the islet amyloid polypeptide segments 22-27 and 22-29.  J Mol Biol 329:565-84.




PubMed


 


PubMed ID 12767835
    
     


 



13.
Zanuy D, Porat Y, Gazit E, Nussinov R   (2004) Peptide sequence and amyloid formation; molecular simulations and experimental study of a human islet amyloid polypeptide fragment and its analogs.  Structure (Camb) 12:439-55.




PubMed


 


PubMed ID 15016360",https://intramural.nih.gov/search/searchview.taf?ipid=36325
265,BC010441-03,"October 01, 2003 -  September 30, 2004",Biomolecular Recognition and Binding Mechanisms,Ruth  Nussinov; PhD,"James Carl Barrett; PhD 
 


Jacob V. Maizel; PhD","Center for Cancer Research Nanobiology Program, NCI",NULL,"R. Babu  Venkataraghavan
(Center for Systems Biology, Institute for Advanced Study)





Shira  Mintz
(Department of Human Genetics, Tel Aviv University)
















Arnold  Levine
(Center for Systems Biology, Institute for Advanced Study)","Buyong  Ma (National Cancer Institute)



Yongping  Pan (National Cancer Institute)



Chung  Tsai (National Cancer Institute)












Gunasakaran  Kannan  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Gunasekaran K, Ma B, Nussinov R (2004). Is allostery an intrinsic property of all dynamic proteins? Proteins  57, 433-43.   https://doi.org/10.1002/prot.20232




PubMed


 


PubMed ID 15382234
    
     


 



2.
Gunasekaran K, Tsai CJ, Kumar S, Zanuy D, Nussinov R   (2003) Extended disordered proteins: targeting function with less scaffold.  Trends Biochem Sci 28:81-5.




PubMed


 


PubMed ID 12575995
    
     


 



3.
Gunasekaran K, Tsai CJ, Nussinov R   (2004) Analysis of ordered and disordered protein complexes reveals structural features discriminating between stable and unstable monomers.  J Mol Biol 341:1327-41.




PubMed


 


PubMed ID 15321724
    
     


 



4.
Halperin I, Wolfson H, Nussinov R   (2003) SiteLight: binding-site prediction using phage display libraries.  Protein Sci 12:1344-59.




PubMed



        
     
Free Article


 


PubMed ID 12824481
         Pubmed Central ID 2323941 


 



5.
Halperin I, Wolfson H, Nussinov R   (2004) Protein-protein interactions; coupling of structurally conserved residues and of hot spots across interfaces Implications for docking.  Structure (Camb) 12:1027-38.




PubMed


 


PubMed ID 15274922
    
     


 



6.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ   (2003) Protein structure prediction via combinatorial assembly of sub-structural units.  Bioinformatics 19 Suppl 1:i158-68.




PubMed


 


PubMed ID 12855452
    
     


 



7.
Keskin O, Tsai CJ, Wolfson H, Nussinov R   (2004) A new, structurally nonredundant, diverse data set of protein-protein interfaces and its implications.  Protein Sci 13:1043-55.




PubMed



        
     
Free Article


 


PubMed ID 15044734
         Pubmed Central ID 2280042 


 



8.
Ma B, Elkayam T, Wolfson H, Nussinov R   (2003) Protein-protein interactions: structurally conserved residues distinguish between binding sites and exposed protein surfaces.  Proc Natl Acad Sci U S A 100:5772-7.




PubMed



        
     
Free Article


 


PubMed ID 12730379
         Pubmed Central ID 156276 


 



9.
Pan Y, Ma B, Keskin O, Nussinov R (2004). Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain. J Biol Chem  279, 30523-30.   https://doi.org/10.1074/jbc.M404364200




PubMed


 


PubMed ID 15131118
    
     


 



10.
Schneidman-Duhovny D, Inbar Y, Polak V, Shatsky M, Halperin I, Benyamini H, Barzilai A, Dror O, Haspel N, Nussinov R, Wolfson HJ   (2003) Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking.  Proteins 52:107-12.




PubMed


 


PubMed ID 12784375
    
     


 



11.
Schneidman-Duhovny D, Nussinov R, Wolfson HJ   (2004) Predicting molecular interactions in silico: II Protein-protein and protein-drug docking.  Curr Med Chem 11:91-107.




PubMed


 


PubMed ID 14754428
    
     


 



12.
Shulman-Peleg A, Nussinov R, Wolfson HJ   (2004) Recognition of functional sites in protein structures.  J Mol Biol 339:607-33.




PubMed


 


PubMed ID 15147845",https://intramural.nih.gov/search/searchview.taf?ipid=36326
266,BC010442-03,"October 01, 2003 -  September 30, 2004",Method Development: Efficient Computer Vision Based Algorithms,Ruth  Nussinov; PhD,"James Carl Barrett; PhD 
 


Jacob V. Maizel; PhD","Center for Cancer Research Nanobiology Program, NCI",NULL,NULL,"Chung  Tsai (National Cancer Institute)












Buyong  Ma  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dror O, Benyamini H, Nussinov R, Wolfson H   (2003) MASS: multiple structural alignment by secondary structures.  Bioinformatics 19 Suppl 1:i95-104.




PubMed


 


PubMed ID 12855444
    
     


 



2.
Dror O, Benyamini H, Nussinov R, Wolfson HJ   (2003) Multiple structural alignment by secondary structures: algorithm and applications.  Protein Sci 12:2492-507.




PubMed



        
     
Free Article


 


PubMed ID 14573862
         Pubmed Central ID 2366961 


 



3.
Dror O, Shulman-Peleg A, Nussinov R, Wolfson HJ   (2004) Predicting molecular interactions in silico: I A guide to pharmacophore identification and its applications to drug design.  Curr Med Chem 11:71-90.




PubMed


 


PubMed ID 14754427
    
     


 



4.
Haspel N, Tsai CJ, Wolfson H, Nussinov R   (2003) Hierarchical protein folding pathways: a computational study of protein fragments.  Proteins 51:203-15.




PubMed


 


PubMed ID 12660989
    
     


 



5.
Haspel N, Tsai CJ, Wolfson H, Nussinov R   (2003) Reducing the computational complexity of protein folding via fragment folding and assembly.  Protein Sci 12:1177-87.




PubMed



        
     
Free Article


 


PubMed ID 12761388
         Pubmed Central ID 2323902 


 



6.
Inbar Y, Benyamini H, Nussinov R, Wolfson HJ   (2003) Protein structure prediction via combinatorial assembly of sub-structural units.  Bioinformatics 19 Suppl 1:i158-68.




PubMed


 


PubMed ID 12855452
    
     


 



7.
Schneidman-Duhovny D, Inbar Y, Polak V, Shatsky M, Halperin I, Benyamini H, Barzilai A, Dror O, Haspel N, Nussinov R, Wolfson HJ   (2003) Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking.  Proteins 52:107-12.




PubMed


 


PubMed ID 12784375
    
     


 



8.
Schneidman-Duhovny D, Nussinov R, Wolfson HJ   (2004) Predicting molecular interactions in silico: II Protein-protein and protein-drug docking.  Curr Med Chem 11:91-107.




PubMed


 


PubMed ID 14754428
    
     


 



9.
Shatsky M, Dror O, Schneidman-Duhovny D, Nussinov R, Wolfson HJ   (2004) BioInfo3D: a suite of tools for structural bioinformatics.  Nucleic Acids Res 32:W503-7.




PubMed



        
     
Free Article


 


PubMed ID 15215437
         Pubmed Central ID 441551 


 



10.
Shatsky M, Nussinov R, Wolfson HJ   (2004) A method for simultaneous alignment of multiple protein structures.  Proteins 56:143-56.




PubMed


 


PubMed ID 15162494
    
     


 



11.
Shatsky M, Nussinov R, Wolfson HJ   (2004) FlexProt: alignment of flexible protein structures without a predefinition of hinge regions.  J Comput Biol 11:83-106.




PubMed


 


PubMed ID 15072690
    
     


 



12.
Shulman-Peleg A, Nussinov R, Wolfson HJ   (2004) Recognition of functional sites in protein structures.  J Mol Biol 339:607-33.




PubMed


 


PubMed ID 15147845",https://intramural.nih.gov/search/searchview.taf?ipid=36331
267,BC010446-03,"October 01, 2003 -  September 30, 2004",DNA Double Strand Break Repair in Drosophila Melanogaster,Yikang  Rong,Carl  Wu; PhD,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,NULL,"Deepa  Srikanta (National Cancer Institute)



Germana  Colazzo (National Cancer Institute)



Min  Gong (National Cancer Institute)












Xiaolin  Bi  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bi X, Wei SC, Rong YS (2004). Telomere protection without a telomerase; the role of ATM and Mre11 in Drosophila telomere maintenance. Curr Biol  14, 1348-53.   https://doi.org/10.1016/j.cub.2004.06.063




PubMed


 


PubMed ID 15296751
    
     


 



2.
Gong M, Rong YS (2003). Targeting multi-cellular organisms. Curr Opin Genet Dev  13, 215-20.   https://doi.org/10.1016/s0959-437x(03)00018-2




PubMed


 


PubMed ID 12672500
    
     


 



3.
Rong YS, Golic KG (2003). The homologous chromosome is an effective template for the repair of mitotic DNA double-strand breaks in Drosophila. Genetics  165, 1831-42.




PubMed



        
     
Free Article


 


PubMed ID 14704169
         Pubmed Central ID 1462885",https://intramural.nih.gov/search/searchview.taf?ipid=36337
268,BC010447-02,"October 01, 2003 -  September 30, 2004",Cell Cycle and Cancer,Anita B Roberts; PhD,NULL,"National Cancer Institute, NCI","Huei-Min  Lin







Wan  Jiao",NULL,Ji Hyeon  Lee (Laboratory of Cell Regulation and Carcinogenesis),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36121
269,BC010448-03,"October 01, 2003 -  September 30, 2004",Genetic Alterations in Lung Cancer,Jonathan S Wiest; PhD,NULL,"Office of the Director, NCI",NULL,NULL,"Nicolae C Popescu; PhD (National Cancer Institute)



Jamie  Dempsey (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)












Zhihong  Shan  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36395
270,BC010449-03,"October 01, 2003 -  September 30, 2004",Role of Uteroglobin-Related Protein (UGRP) 1 in Lung Inflammation,"Shioko  Kimura; PhD



IRP Faculty Profile",NULL,"Laboratory of Metabolism, NCI",NULL,NULL,"Atsushi  Yamada (National Cancer Institute)



Takeshi  Tomita (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)












Reiko  Kuratoni  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36396
271,BC010450-03,"October 01, 2003 -  September 30, 2004",Development of Akt Inhibitors,"Phillip A Dennis; MD, PhD",NULL,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Junji  Tsurutani (National Cancer Institute)



Chunyu  Zhang (National Cancer Institute)



Edward A Sausville (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)












Joell  Gills  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Castillo SS, Brognard J, Petukhov PA, Zhang C, Tsurutani J, Granville CA, Li M, Jung M, West KA, Gills JG, Kozikowski AP, Dennis PA (2004). Preferential inhibition of Akt and killing of Akt-dependent cancer cells by rationally designed phosphatidylinositol ether lipid analogues. Cancer Res  64, 2782-92.   https://doi.org/10.1158/0008-5472.can-03-1530




PubMed


 


PubMed ID 15087394
    
     


 



2.
Gills JJ, Dennis PA (2004). The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt. Expert Opin Investig Drugs  13, 787-97.   https://doi.org/10.1517/13543784.13.7.787




PubMed


 


PubMed ID 15212619
    
     


 



3.
Gills JJ, Granville CA, Dennis PA (2004). Targeting aberrant signal transduction pathways in lung cancer. Cancer Biol Ther  3, 147-55.   https://doi.org/10.4161/cbt.3.2.612




PubMed


 


PubMed ID 14764993
    
     


 



4.
Kozikowski AP, Sun H, Brognard J, Dennis PA (2003). Novel PI analogues selectively block activation of the pro-survival serine/threonine kinase Akt. J Am Chem Soc  125, 1144-5.   https://doi.org/10.1021/ja0285159




PubMed


 


PubMed ID 12553797",https://intramural.nih.gov/search/searchview.taf?ipid=36397
272,BC010451-03,"October 01, 2004 -  September 30, 2005",NMR Group Project: Preparation and Properties of Novel Multivalent Nanoparticles,"Joseph John Barchi



IRP Faculty Profile",Victor  Marquez; PhD,"Laboratory of Medicinal Chemistry, NCI","Celeste A Constantine



Serge A Svarovsky","Vadislav  Glinskii
(Biochemistry, University of Missouri)




Kate  Rittenhouse-Olson
(Biotechnical and Clinical Laboratory Science, University of Buffalo)","Kent W Hunter; PhD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Barchi J, Szekely Z   (2005) Synthesis of gold nanoparticles bearing the Thomsen-Friedenreich disaccharide: a new multivalent presentation of an important tumor antigen.  Tetrahedron: Asymmetry  pp.




 



2.
Barchi J, Taraban M   (2004) Facile photochemical synthesis of mixed siloxyacetal glycosides as potential pH-sensitized prodrugs for selective treatment of solid tumors.  Org Biomol Chem  pp.",https://intramural.nih.gov/search/searchview.taf?ipid=41913
273,BC010453-03,"October 01, 2003 -  September 30, 2004",Identify SNPs and Polymorphisms that are Important in the Development of Prostat,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Douglas K Price (National Cancer Institute)



Nicola F Smith (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)












Matthew G Permenter  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Macpherson GR, Ng SS, Forbes SL, Melillo G, Karpova T, McNally J, Conrads TP, Veenstra TD, Martinez A, Cuttitta F, Price DK, Figg WD (2003). Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol Cancer Ther  2, 845-54.




PubMed


 


PubMed ID 14555703
    
     


 



2.
Price DK, Franks ME, Figg WD (2004). Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism. J Urol  171, S45-9; discussion S49.   https://doi.org/10.1097/01.ju.0000108402.60404.48




PubMed


 


PubMed ID 14713753
    
     


 



3.
Rudek MA, Venitz J, Ando Y, Reed E, Pluda JM, Figg WD (2003). Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies. J Clin Pharmacol  43, 1124-35.   https://doi.org/10.1177/0091270003256675




PubMed


 


PubMed ID 14517195
    
     


 



4.
Sparreboom A, Danesi R, Ando Y, Chan J, Figg WD (2003). Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat  6, 71-84.   https://doi.org/10.1016/s1368-7646(03)00005-0




PubMed


 


PubMed ID 12729805",https://intramural.nih.gov/search/searchview.taf?ipid=36398
274,BC010455-03,"October 01, 2003 -  September 30, 2004",The Role of Wnts in the Formation of the Vertebrate Body Plan,"Terence P Yamaguchi; PhD



IRP Faculty Profile",NULL,"Cancer and Developmental Biology Laboratory, NCI",NULL,NULL,"William  Dunty (National Cancer Institute)



Jaime  Greear (National Cancer Institute)



Masaaki  Nakaya (National Cancer Institute)



Chizuru  Nakaya (National Cancer Institute)



Kristin  Biris (National Cancer Institute)



Tadasuke  Tsukiyama (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36399
275,BC010458-03,"October 01, 2003 -  September 30, 2004",Molecular Genetic Basis for Gynecologic Neoplasias,James Carl Barrett; PhD,NULL,"Genome Structure and Function Section, NCI

National Cancer Institute, NCI",NULL,"William  Isaacs; PhD
(Department of Urology, Johns Hopkins School of Medicine)





Takeki  Tsutsui
(Nippon Dental University of Tokyo)





L J Roberts; PhD
(Pharmacology, Vanderbilt University School of Medicine)
















Jeffrey  Trent; PhD
(Translational Genomic)","Kristin  Bauer (National Cancer Institute)



Vladimir  Noskov; PhD (National Cancer Institute)



Jun-ichirou  Ohzeki (National Cancer Institute)



Susan N Perkins; PhD (National Cancer Institute)



John I Risinger; PhD (National Cancer Institute)



Joseph  Riss; PhD (National Cancer Institute)","Victor  Lobanenkov (NIAID) 



Mark Paul Mattson; PhD (NIA)","Ordered by publication type and then author name.



1.
Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF, Veenstra TD (2004). High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer  11, 163-78.   https://doi.org/10.1677/erc.0.0110163




PubMed


 


PubMed ID 15163296
    
     


 



2.
Li S, Chiang TC, Richard-Davis G, Barrett JC, Mclachlan JA (2003). DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. Gynecol Oncol  90, 123-30.   https://doi.org/10.1016/s0090-8258(03)00194-x




PubMed


 


PubMed ID 12821352
    
     


 



3.
Risinger JI, Maxwell GL, Berchuck A, Barrett JC (2003). Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers. Ann N Y Acad Sci  983, 208-12.   https://doi.org/10.1111/j.1749-6632.2003.tb05975.x




PubMed


 


PubMed ID 12724225
    
     


 



4.
Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC (2003). Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res  63, 6-11.




PubMed


 


PubMed ID 12517768
    
     


 



5.
Rustin GJ, Bast RC, Kelloff GJ, Barrett JC, Carter SK, Nisen PD, Sigman CC, Parkinson DR, Ruddon RW (2004). Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res  10, 3919-26.   https://doi.org/10.1158/1078-0432.CCR-03-0787




PubMed


 


PubMed ID 15173101",https://intramural.nih.gov/search/searchview.taf?ipid=36401
276,BC010459-03,"October 01, 2003 -  September 30, 2004",Gene Methylation in Prostate Cancer,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Roycelynn  Mentor-Marcel (National Cancer Institute)



Elyse  Walk (National Cancer Institute)



Joseph A Tangrea (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Jeffrey C Hanson (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA (2004). Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate  60, 25-31.   https://doi.org/10.1002/pros.20013




PubMed


 


PubMed ID 15129426
    
     


 



2.
Woodson K, Hanson J, Tangrea J (2004). A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett  205, 181-8.   https://doi.org/10.1016/j.canlet.2003.11.027




PubMed


 


PubMed ID 15036650
    
     


 



3.
Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J (2003). Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate  55, 199-205.   https://doi.org/10.1002/pros.10236




PubMed


 


PubMed ID 12692786",https://intramural.nih.gov/search/searchview.taf?ipid=36402
277,BC010465-01,"October 01, 2003 -  September 30, 2004",Protemics bioinformatics tools,Peter F Lemkin; PhD,Jacob V. Maizel; PhD,"Center for Cancer Research Nanobiology Program, NCI",NULL,"Carl R Merril; MD
(NIMH)





C  Taylor
(Georgetown University)
















Mark  Kimpel
(Indiana U. Sch. Medicine)","Lance A Liotta; MD, PhD (Lab Pathlgy)



Djamel None Medjahed (National Cancer Institute)



Emmanual  Petricoin (National Cancer Institute)












Gregory  Thornwall  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=30699
278,BC010469-02,"October 01, 2003 -  September 30, 2004",Molecular Targets Development Program,Michael  Lee,NULL,"Mechanisms Of Gene Regulation Section, NCI",NULL,NULL,NULL,"Angie  Dull (NCI) 



Tawnya Carlene McKee; BA, PhD (NCI) 



Naoya  Oku (NCI) 



Megan  Procario (NCI) 



Kentaro  Takada (NCI) 



Kathryn  Tworkoski (NCI)","Ordered by publication type and then author name.



1.
Beutler JA, Neighbors JA, Wiemer DA (submitted in 2004) Schweinfurthin Analogues. Patents issued: 7,902,228 (US in 2011); 1732915 (EP in 2016). Patents pending: PCT/US2005/010482 (PC application); 11/093,270 (US application); 13/014,479 (US application); 2005227328 (AU application); 2,560,557 (CA application).",https://intramural.nih.gov/search/searchview.taf?ipid=36457
279,BC010470-02,"October 01, 2003 -  September 30, 2004",Bioinformatic Tools in Cancer Research,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,"Imtiaz  Yakub
(Baylor)





Brian  Osborne
(Cognia Corporation)





David  Wheeler
(Baylor)





Richard A. Gibbs; PhD
(Molecular and Human Genetics, Baylor College of Medicine)
















Huitao  Sheng
(Columbia University)","William  Rowe (National Cancer Institute)



Peisen  Zhang (National Cancer Institute)



Jinghui  Zhang (National Cancer Institute)



Michael  Edmonson (National Cancer Institute)



Carl F Schaefer (National Cancer Institute)












Richard  Finney  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Zhang J, Rowe WL, Clark AG, Buetow KH (2003). Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet  73, 1073-81.   https://doi.org/10.1086/379154




PubMed



        
     
Free Article


 


PubMed ID 14560401
         Pubmed Central ID 1180487",https://intramural.nih.gov/search/searchview.taf?ipid=36406
280,BC010472-02,"October 01, 2003 -  September 30, 2004",High-density marker studies near founder BRCA1/2 mutations,"Jeffery P Struewing; MS, MD",Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,"Andrew  Collins
(Human Genetics Division, University of Southampton)





N.  Ellis
(Memorial Sloan Kettering Cancer Center)





Ken  Offit
(Memorial Sloan-Kettering Cancer Center)",NULL,NULL,"Ordered by publication type and then author name.



1.
Struewing JP (2004). Genomic approaches to identifying breast cancer susceptibility factors. Breast Dis  19, 3-9.   https://doi.org/10.3233/bd-2004-19102




PubMed


 


PubMed ID 15687692",https://intramural.nih.gov/search/searchview.taf?ipid=36456
281,BC010473-02,"October 01, 2003 -  September 30, 2004",Normal Tissue Response to Ionizing Radiation,"Angelo  Russo; MD, PhD",James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,NULL,"Jonathan D Ashwell; MD (National Cancer Institute)



Rajani  Choudhuri (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)","Catherine A Wolkow; PhD (NIA) 



Terence Martyn Phillips; PhD, DSc (OD) 



Martin J Lizak; PhD (NINDS) 



Paul D Smith; PhD (NIBIB) 



Amir Hossein Gandjbakhche; PhD (NICHD)","Ordered by publication type and then author name.



1.
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB (2004). Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol  14, 259-66.   https://doi.org/10.1016/j.semradonc.2004.04.001




PubMed


 


PubMed ID 15254869
    
     


 



2.
Samuni Y, Gamson J, Samuni A, Yamada K, Russo A, Krishna MC, Mitchell JB (2004). Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid Redox Signal  6, 587-95.   https://doi.org/10.1089/152308604773934341




PubMed


 


PubMed ID 15130285
    
     


 



3.
Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, Mitchell JB, Wynshaw-Boris A (2004). Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet  13, 1793-802.   https://doi.org/10.1093/hmg/ddh189




PubMed


 


PubMed ID 15213104
    
     


 



4.
Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ (2004). The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res  10, 1807-12.   https://doi.org/10.1158/1078-0432.ccr-03-0194




PubMed


 


PubMed ID 15014035
    
     


 



5.
Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, Sowers A, Mitchell JB, Roberts AB, Russo A (2004). Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem  279, 15167-76.   https://doi.org/10.1074/jbc.M309798200




PubMed


 


PubMed ID 14732719",https://intramural.nih.gov/search/searchview.taf?ipid=36450
282,BC010474-02,"October 01, 2003 -  September 30, 2004",Signal Transduction Mechanisms of Type I IFNs,John R Ortaldo; PhD,Robert  Wiltrout; PhD,"Laboratory of Experimental Immunology, NCI",NULL,"Andrew  Larner
(Immunology, Cleveland Clinic Foundation)
















Richard A Lempicki; PhD
(SAIC)","Howard A Young; PhD (National Cancer Institute)



Thomas  Welte (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36414
283,BC010475-02,"October 01, 2003 -  September 30, 2004",Natural Products Chemistry and Molecular Target Lead Discovery,Michael  Lee,NULL,"Mechanisms Of Gene Regulation Section, NCI",NULL,NULL,NULL,"Laura  Cartner (NCI) 



Joseph  Collins (NCI) 



Richard W Fuller (NCI) 



Tawnya Carlene McKee; BA, PhD (NCI) 



Naoya  Oku (NCI) 



Girma M Woldemichael (NCI)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36417
284,BC010476-02,"October 01, 2003 -  September 30, 2004",Time Domian Electron Paramagnetic Resonance Imaging,Michael  Lee,James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,NULL,Sankaran  Subramanian; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36435
285,BC010477-02,"October 01, 2003 -  September 30, 2004",Overhauser Enhanced Magnetic Resonance Imaging (OMRI),Michael  Lee,James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,NULL,"Kelly  Grimes (National Cancer Institute)



Atsuka  Matsumoto (National Cancer Institute)



Shingo  Matsumoto (National Cancer Institute)



Ken-Ichiro  Matsumoto (National Cancer Institute)



Sankaran  Subramanian; MD (National Cancer Institute)



Aravalluvan  Thirumaran (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36433
286,BC010478-02,"October 01, 2003 -  September 30, 2004",Continuous Wave Electron Paramagnetic Resonance Imaging,Michael  Lee,James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,NULL,Sankaran  Subramanian; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36434
287,BC010479-02,"October 01, 2003 -  September 30, 2004",Regulation of Melanocyte Development and Differentiation,Mark  Udey; MD,NULL,"Office of the Director, NCI",NULL,"Yehoash  Raphael; PhD
(Department of Otolaryngology, University of Michigan)





David F Dolan; PhD
(Department of Otolaryngology, University of Michigan)",NULL,William James Pavan; PhD (NHGRI),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36420
288,BC010481-02,"October 01, 2003 -  September 30, 2004",Structure and Function of HIV-1 Reverse Transcriptase,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"Maxine  Linial
(University of Washington)





Michael  Parniak; PhD
(Department of Medicine, McGill University)





Eddy  Arnold; PhD
(Chemistry and Chemical Biology, CABM and Rutgers University)","Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)



Linda L Dunn (National Cancer Institute)



Andrea L Ferris (National Cancer Institute)



John G Julias (National Cancer Institute)



Mary J McWilliams (National Cancer Institute)



Edward  Wu (National Cancer Institute)",Donald M Jerina; PhD (NIDDK),"Ordered by publication type and then author name.



1.
Choi Y, George C, Comin MJ, Barchi JJ, Kim HS, Jacobson KA, Balzarini J, Mitsuya H, Boyer PL, Hughes SH, Marquez VE (2003). A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. J Med Chem  46, 3292-9.   https://doi.org/10.1021/jm030116g




PubMed


 


PubMed ID 12852759
    
     


 



2.
Golinelli MP, Hughes SH (2003). Secondary structure in the nucleic acid affects the rate of HIV-1 nucleocapsid-mediated strand annealing. Biochemistry  42, 8153-62.   https://doi.org/10.1021/bi027039w




PubMed


 


PubMed ID 12846564
    
     


 



3.
Kroeger Smith MB, Hose BM, Hawkins A, Lipchock J, Farnsworth DW, Rizzo RC, Tirado-Rives J, Arnold E, Zhang W, Hughes SH, Jorgensen WL, Michejda CJ, Smith RH (2003). Molecular modeling calculations of HIV-1 reverse transcriptase nonnucleoside inhibitors: correlation of binding energy with biological activity for novel 2-aryl-substituted benzimidazole analogues. J Med Chem  46, 1940-7.   https://doi.org/10.1021/jm020271f




PubMed


 


PubMed ID 12723956
    
     


 



4.
Lewi PJ, de Jonge M, Daeyaert F, Koymans L, Vinkers M, Heeres J, Janssen PA, Arnold E, Das K, Clark AD, Hughes SH, Boyer PL, de Béthune MP, Pauwels R, Andries K, Kukla M, Ludovici D, De Corte B, Kavash R, Ho C, Lewis PJ (2003). On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data. J Comput Aided Mol Des  17, 129-34.   https://doi.org/10.1023/a:1025313705564




PubMed


 


PubMed ID 13677481
    
     


 



5.
Sarafianos SG, Clark AD, Tuske S, Squire CJ, Das K, Sheng D, Ilankumaran P, Ramesha AR, Kroth H, Sayer JM, Jerina DM, Boyer PL, Hughes SH, Arnold E (2003). Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J Biol Chem  278, 16280-8.   https://doi.org/10.1074/jbc.M212911200




PubMed


 


PubMed ID 12554739",https://intramural.nih.gov/search/searchview.taf?ipid=36425
289,BC010482-02,"October 01, 2003 -  September 30, 2004",Retroviral Replication and Vector Design,"Stephen H Hughes; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"John  Coffin
(Tufts University School of Medicine)





Mark  Federspiel
(Mayo Clinic)





John  Young






Jerry  Dodgson
(Michigan State University)","Sally E Spence (Molecular Genetics of Development Section)



Linda L Dunn (National Cancer Institute)



Andrea L Ferris (National Cancer Institute)



John G Julias (National Cancer Institute)



Mary J McWilliams (National Cancer Institute)



Edward  Wu (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Julias JG, McWilliams MJ, Sarafianos SG, Alvord WG, Arnold E, Hughes SH (2003). Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity. J Virol  77, 8548-54.   https://doi.org/10.1128/jvi.77.15.8548-8554.2003




PubMed



        
     
Free Article


 


PubMed ID 12857924
         Pubmed Central ID 165255 


 



2.
McWilliams MJ, Julias JG, Sarafianos SG, Alvord WG, Arnold E, Hughes SH (2003). Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer. J Virol  77, 11150-7.   https://doi.org/10.1128/jvi.77.20.11150-11157.2003




PubMed



        
     
Free Article


 


PubMed ID 14512562
         Pubmed Central ID 224987 


 



3.
Princler GL, Julias JG, Hughes SH, Derse D (2003). Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology  317, 136-45.   https://doi.org/10.1016/j.virol.2003.09.010




PubMed


 


PubMed ID 14675632",https://intramural.nih.gov/search/searchview.taf?ipid=36424
290,BC010483-02,"October 01, 2003 -  September 30, 2004",TEM5 Ligand Hunt,Bradley D St Croix,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,"Steven  Seaman (National Cancer Institute)



Janine  Stevens (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36451
291,BC010484-02,"October 01, 2003 -  September 30, 2004",Functional Analysis of TEM5 and TEM8,Bradley D St Croix,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,"Michael  Cullen (National Cancer Institute)



Steven  Seaman (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B   (2004) TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).  Cancer Res 64:817-20.




PubMed


 


PubMed ID 14871805",https://intramural.nih.gov/search/searchview.taf?ipid=36452
292,BC010485-02,"October 01, 2003 -  September 30, 2004",Mechanism of DC-SIGN-Mediated Transmission of HIV,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",Stephen H Hughes; PhD,"HIV Drug Resistance Program, NCI",NULL,"Laura  Kiessling
(University of Wisconsin-Madison)





Dan  Littman
(New York University Medical Center)





Derya  Unutmaz
(Vanderbilt University)
















Thomas  Hope
(University of Illinois-Chicago)","Mary  Carrington; MS, PhD (Laboratory of Genomic Diversity)



Li  Wu (National Cancer Institute)



Robert  Blumenthal; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)



Alan  Rein; PhD (National Cancer Institute)



Melissa  Pope (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ (2003). Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science  300, 1295-7.   https://doi.org/10.1126/science.1084238




PubMed


 


PubMed ID 12730499",https://intramural.nih.gov/search/searchview.taf?ipid=36430
293,BC010486-02,"October 01, 2003 -  September 30, 2004",Search for New Tumor Endothelial Markers,Bradley D St Croix,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Steven  Seaman  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36453
294,BC010488-02,"October 01, 2003 -  September 30, 2004",Development of a Macaque Model to Evaluate HIV-1 Nonnucleoside Reverse Transcrip,"Vineet Narain KewalRamani; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"Christopher  Miller
(University of California-Davis)
















Jason  Kimata
(Southwest Foundation)","Li  Wu (National Cancer Institute)



Stephen H Hughes; PhD (National Cancer Institute)



Jeffrey D Lifson; MD (Office Of The Director)",NULL,"Ordered by publication type and then author name.



1.
Ambrose Z, Boltz V, Palmer S, Coffin JM, Hughes SH, Kewalramani VN (2004). In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J Virol  78, 13553-61.   https://doi.org/10.1128/JVI.78.24.13553-13561.2004




PubMed



        
     
Free Article


 


PubMed ID 15564466
         Pubmed Central ID 533891",https://intramural.nih.gov/search/searchview.taf?ipid=36432
295,BC010492-02,"October 01, 2003 -  September 30, 2004",Modified Nucleosides as Probes of Replication Complexes,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,NULL,"Marion Karla Bona; PhD (National Cancer Institute)



Scott R Budihas; PhD (National Cancer Institute)



George J Klarmann (National Cancer Institute)



Jennifer T Miller (National Cancer Institute)



Jason William Rausch (National Cancer Institute)



John  Marino (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lener D, Kvaratskhelia M, Le Grice SF (2003). Nonpolar thymine isosteres in the Ty3 polypurine tract DNA template modulate processing and provide a model for its recognition by Ty3 reverse transcriptase. J Biol Chem  278, 26526-32.   https://doi.org/10.1074/jbc.M302374200




PubMed


 


PubMed ID 12730227
    
     


 



2.
Rausch JW, Qu J, Yi-Brunozzi HY, Kool ET, Le Grice SF (2003). Hydrolysis of RNA/DNA hybrids containing nonpolar pyrimidine isosteres defines regions essential for HIV type 1 polypurine tract selection. Proc Natl Acad Sci U S A  100, 11279-84.   https://doi.org/10.1073/pnas.1932546100




PubMed



        
     
Free Article


 


PubMed ID 12972638
         Pubmed Central ID 208748",https://intramural.nih.gov/search/searchview.taf?ipid=36438
296,BC010493-02,"October 01, 2003 -  September 30, 2004",High-Resolution Protein and Nucleic Acid Footprinting,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Parniak; PhD
(Department of Medicine, McGill University)
















Daniele  Fabris
(University of Maryland Baltimore County)




John  Marino
(National Institute of Standards and Technology, CARB)","Marion Karla Bona; PhD (National Cancer Institute)



Scott R Budihas; PhD (National Cancer Institute)



Christopher J Michejda; PhD (Molecular Aspects of Drug Design Section)



George J Klarmann (National Cancer Institute)



Jennifer T Miller (National Cancer Institute)



Jason William Rausch (National Cancer Institute)","Robert  Craigie; PhD (NIDDK) 



Robert Joseph Crouch; PhD (NICHD)","Ordered by publication type and then author name.



1.
Kvaratskhelia M, Le Grice SFJ   (2007) Structural analysis of protein-RNA interactions with mass spectrometry.  Methods Mol Biol, in press.




 



2.
Le Grice SF (2003). ""In the beginning"": initiation of minus strand DNA synthesis in retroviruses and LTR-containing retrotransposons. Biochemistry  42, 14349-55.   https://doi.org/10.1021/bi030201q




PubMed


 


PubMed ID 14661945
    
     


 



3.
Post K, Guo J, Howard KJ, Powell MD, Miller JT, Hizi A, Le Grice SF, Levin JG (2003). Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription. J Virol  77, 7623-34.   https://doi.org/10.1128/jvi.77.13.7623-7634.2003




PubMed



        
     
Free Article


 


PubMed ID 12805462
         Pubmed Central ID 164806 


 



4.
Rigourd M, Bec G, Bénas P, Le Grice SF, Ehresmann B, Ehresmann C, Marquet R (2003). Effects of tRNA 3 Lys aminoacylation on the initiation of HIV-1 reverse transcription. Biochimie  85, 521-5.   https://doi.org/10.1016/s0300-9084(03)00045-2




PubMed


 


PubMed ID 12763311
    
     


 



5.
Roda RH, Balakrishnan M, Hanson MN, Wohrl BM, Le Grice SF, Roques BP, Gorelick RJ, Bambara RA (2003). Role of the Reverse Transcriptase, Nucleocapsid Protein, and Template Structure in the Two-step Transfer Mechanism in Retroviral Recombination. J Biol Chem  278, 31536-46.   https://doi.org/10.1074/jbc.M304608200




PubMed


 


PubMed ID 12801926",https://intramural.nih.gov/search/searchview.taf?ipid=36439
297,BC010494-02,"October 01, 2003 -  September 30, 2004",HIV-1 RNase H as a Therapeutic Target,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"Michael  Parniak; PhD
(Department of Medicine, McGill University)





Monica  Roth
(Robert Wood Johnson Medical School, University of Medicine and Dentistry)
















Ernesto  Freire
(Johns Hopkins University)




Matthias  Gtte
(Lady Davis Institute-Jewish General Hospital, McGill University AIDS Centre)","Marion Karla Bona; PhD (National Cancer Institute)



Scott R Budihas; PhD (National Cancer Institute)



Vinay K Pathak; PhD (Viral Mutation Section)



George J Klarmann (National Cancer Institute)



Jennifer T Miller (National Cancer Institute)



Jason William Rausch (National Cancer Institute)","Robert Joseph Crouch; PhD (NICHD) 



Peter W Schuck; PhD (OD)","Ordered by publication type and then author name.



1.
Parniak MA, Min KL, Budihas SR, Le Grice SF, Beutler JA (2003). A fluorescence-based high-throughput screening assay for inhibitors of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H activity. Anal Biochem  322, 33-9.   https://doi.org/10.1016/j.ab.2003.06.001




PubMed


 


PubMed ID 14705777",https://intramural.nih.gov/search/searchview.taf?ipid=36436
298,BC010495-02,"October 01, 2003 -  September 30, 2004",Unnatural Amino Acids as Probes of RT Structure and Function,"Stuart F J Le Grice; PhD



IRP Faculty Profile",NULL,"HIV Drug Resistance Program, NCI",NULL,"Matthias  Gtte
(Lady Davis Institute-Jewish General Hospital, McGill University AIDS Centre)




Stephen S Hecht; PhD
(University of  Minnesota Cancer Center)","Marion Karla Bona; PhD (National Cancer Institute)



Scott R Budihas; PhD (National Cancer Institute)



George J Klarmann (National Cancer Institute)



Jennifer T Miller (National Cancer Institute)



Jason William Rausch (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36437
299,BC010499-02,"October 01, 2003 -  September 30, 2004",Maryland Prostate Cancer Case-Control Study,"Stefan  Ambs



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Neil Edward Caporaso; MS, MD",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36404
300,BC010500-02,"October 01, 2003 -  September 30, 2004",The Molecular Profile of Inflammatory Breast Cancer,"Stefan  Ambs



IRP Faculty Profile",NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36405
301,BC010504-02,"October 01, 2003 -  September 30, 2004",Genetic Recombination in Retroviruses,"Wei-Shau  Hu; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Kazushi  Motomura (National Cancer Institute)



Jianbo  Chen (National Cancer Institute)



Olga  Nikolaitchik (National Cancer Institute)



Vitaly  Boyko (National Cancer Institute)



William W Fu (National Cancer Institute)



Maria  Leavitt (National Cancer Institute)","Frank  Maldarelli (NIAID) 



Douglas  Powell (OD)","Ordered by publication type and then author name.



1.
Hu WS, Rhodes T, Dang Q, Pathak V (2003). Retroviral recombination: review of genetic analyses. Front Biosci  8, d143-55.   https://doi.org/10.2741/940




PubMed


 


PubMed ID 12456341
    
     


 



2.
Rhodes T, Wargo H, Hu WS (2003). High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol  77, 11193-200.   https://doi.org/10.1128/jvi.77.20.11193-11200.2003




PubMed



        
     
Free Article


 


PubMed ID 14512567
         Pubmed Central ID 224990 


 



3.
Svarovskaia ES, Cheslock SR, Zhang WH, Hu WS, Pathak VK (2003). Retroviral mutation rates and reverse transcriptase fidelity. Front Biosci  8, d117-34.   https://doi.org/10.2741/957




PubMed


 


PubMed ID 12456349",https://intramural.nih.gov/search/searchview.taf?ipid=36422
302,BC010505-02,"October 01, 2003 -  September 30, 2004",Retroviral Double Infection and Its Relationship to Recombination,"Wei-Shau  Hu; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",John Miller Coffin; PhD,NULL,"Vinay K Pathak; PhD (Viral Mutation Section)



Alan  Rein; PhD (Retrovirus Assembly Section)



William W Fu (National Cancer Institute)","Frank  Maldarelli (NIAID) 



Douglas  Powell (OD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36423
303,BC010506-02,"October 01, 2003 -  September 30, 2004","Mechanisms of Virus Assembly, RNA Packaging, and Replication","Wei-Shau  Hu; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"William W Fu (National Cancer Institute)



Connor F.  McGrath (National Cancer Institute)



Vinay K Pathak; PhD (Viral Mutation Section)



Alan  Rein; PhD (Retrovirus Assembly Section)","Lauren A Henderson (NIMH) 












Richard  Fisher (NIMH)","Ordered by publication type and then author name.



1.
Cheslock SR, Poon DT, Fu W, Rhodes TD, Henderson LE, Nagashima K, McGrath CF, Hu WS (2003). Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination. J Virol  77, 7058-66.   https://doi.org/10.1128/jvi.77.12.7058-7066.2003




PubMed



        
     
Free Article


 


PubMed ID 12768025
         Pubmed Central ID 156152 


 



2.
Fu W, Hu WS (2003). Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle. J Virol  77, 754-61.   https://doi.org/10.1128/jvi.77.1.754-761.2003




PubMed



        
     
Free Article


 


PubMed ID 12477882
         Pubmed Central ID 140598",https://intramural.nih.gov/search/searchview.taf?ipid=36421
304,BC010509-02,"October 01, 2003 -  September 30, 2004",Retroviral Assembly,Michael  Lee,NULL,"Mechanisms Of Gene Regulation Section, NCI",NULL,"Markus  Thali
(Dept. Microbiology, University of Vermont)
















Ganjam  Kalpana
(Albert Einstein)",NULL,Eric O Freed; PhD (NCI),There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36463
305,BC010510-02,"October 01, 2003 -  September 30, 2004",Trageted therapy of mesothelin expressing cancers using the anti-mesothelin immu,"Raffit  Hassan



IRP Faculty Profile",NULL,"Laboratory of Molecular Biology, NCI",NULL,NULL,"Kelly  Cahill (National Cancer Institute)



Sonya  Duke (National Cancer Institute)



Linda  Ellison-Dejewski (National Cancer Institute)



Rita  Mincemoyer (National Cancer Institute)



Jingli  Zhang (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36419
306,BC010511-02,"October 01, 2003 -  September 30, 2004",Retrovirus Assembly and Maturation,"Alan  Rein; PhD



IRP Faculty Profile",Stephen H Hughes; PhD,"HIV Drug Resistance Program, NCI",NULL,"Susan  Krueger; PhD
(Center for Neutron Research, NIST)
















Mamuka  Kvaratskhelia; PhD
(College of Pharmacy, Ohio State University)","Ya-Xiong  Feng (National Cancer Institute)



Demetria P Harvin (National Cancer Institute)



Catherine S Hibbert (National Cancer Institute)



Shilpa  Kulkarni (National Cancer Institute)



Jane  Mirro (National Cancer Institute)



Samuel J Rulli (National Cancer Institute)","Robert  Fisher (NIMH) 



Judith Goldstein Levin; PhD (NICHD)","Ordered by publication type and then author name.



1.
Bouamr F, Melillo JA, Wang MQ, Nagashima K, de Los Santos M, Rein A, Goff SP (2003). PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol  77, 11882-95.   https://doi.org/10.1128/jvi.77.22.11882-11895.2003




PubMed



        
     
Free Article


 


PubMed ID 14581525
         Pubmed Central ID 253756 


 



2.
Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S (2003). Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene  22, 2021-33.   https://doi.org/10.1038/sj.onc.1206199




PubMed


 


PubMed ID 12673207
    
     


 



3.
Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A (2003). Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol  20, 243-54.   https://doi.org/10.1080/0968768031000104944




PubMed


 


PubMed ID 12893532
    
     


 



4.
Rein A (2003). Genetic footprinting of a retroviral Gag gene suggests an important role in virus replication. Proc Natl Acad Sci U S A  100, 11929-30.   https://doi.org/10.1073/pnas.2135539100




PubMed



        
     
Free Article


 


PubMed ID 14530396
         Pubmed Central ID 218688",https://intramural.nih.gov/search/searchview.taf?ipid=36448
307,BC010512-02,"October 01, 2003 -  September 30, 2004",Interactions of Retroviral Proteins with Nucleic Acids,"Alan  Rein; PhD



IRP Faculty Profile",Stephen H Hughes; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Ya-Xiong  Feng (National Cancer Institute)



Demetria P Harvin (National Cancer Institute)



Catherine S Hibbert (National Cancer Institute)



Shilpa  Kulkarni (National Cancer Institute)



Jane  Mirro (National Cancer Institute)



Samuel J Rulli (National Cancer Institute)",Robert  Fisher (NIMH),"Ordered by publication type and then author name.



1.
Muriaux D, Rein A (2003). Encapsidation and transduction of cellular genes by retroviruses. Front Biosci  8, d135-42.   https://doi.org/10.2741/950




PubMed


 


PubMed ID 12456352",https://intramural.nih.gov/search/searchview.taf?ipid=36449
308,BC010516-02,"October 01, 2003 -  September 30, 2004",Gated Optical Detectors/Dose Guided Radiotherapy,Robert R Miller,NULL,"Radiation Onclgy Br, NCI",NULL,"Brian  Justus
(Optical Sciences Division, Naval Research Lab (NRL))





Paul  Falkenstien
(Optical Sciences Division, Naval Research Lab (NRL))





Alan  Huston
(Optical Sciences Division, Naval Research Lab (NRL))","Frank S Harrington (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36458
309,BC010517-02,"October 01, 2003 -  September 30, 2004",Large Databases of Small Molecules - Drug Development Tool and Public Resource,"Marc C Nicklaus



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,"Vladimir  Poroikov
(Lab. of Structure-Function Based Drug Design, Russian Academy of Medical Sciences)
















Wolf-Dietrich  Ihlenfeldt
(Xemistry)",NULL,NULL,"Ordered by publication type and then author name.



1.
Poroikov VV, Filimonov DA, Ihlenfeldt WD, Gloriozova TA, Lagunin AA, Borodina YV, Stepanchikova AV, Nicklaus MC (2003). PASS biological activity spectrum predictions in the enhanced open NCI database browser. J Chem Inf Comput Sci  43, 228-36.   https://doi.org/10.1021/ci020048r




PubMed


 


PubMed ID 12546557",https://intramural.nih.gov/search/searchview.taf?ipid=36461
310,BC010518-02,"October 01, 2003 -  September 30, 2004",Role of BMP and FGF signaling during limb development,"Mark B Lewandoski



IRP Faculty Profile",Colin L Stewart; PhD,"Genetics of Vertebrate Development Section, NCI",NULL,NULL,Catherine P Wilson (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Waters ST, Wilson CP, Lewandoski M (2003). Cloning and embryonic expression analysis of the mouse Gbx1 gene. Gene Expr Patterns  3, 313-7.   https://doi.org/10.1016/s1567-133x(03)00041-3




PubMed


 


PubMed ID 12799077",https://intramural.nih.gov/search/searchview.taf?ipid=36467
311,BC010519-02,"October 01, 2003 -  September 30, 2004",Development of Novel Therapeutic Strategies for Thoracic Malignancies by Targeti,"Dao M Nguyen; MD, MS","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,"Bing Liang  Fang
(Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center)





Jean-Pierre  Rosat
(Apoxis, SA)
















Avi  Ashkenazi
(Genentech, Inc.)","Len  Neckers; PhD (National Cancer Institute)



Stanley  Lipkowitz; MD, PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Finkelstein SE, Schrump DS, Nguyen DM, Hewitt SM, Kunst TF, Summers RM (2003). Comparative evaluation of super high-resolution CT scan and virtual bronchoscopy for the detection of tracheobronchial malignancies. Chest  124, 1834-40.   https://doi.org/10.1378/chest.124.5.1834




PubMed


 


PubMed ID 14605057
    
     


 



2.
Finkelstein SE, Schrump DS, Nguyen DM, Mullick R, Summers RM (2003). Novel thoracic imaging augments diagnosis of bronchial obstruction. Ann Thorac Surg  76, 296.   https://doi.org/10.1016/s0003-4975(02)04386-2




PubMed


 


PubMed ID 12842569
    
     


 



3.
Finkelstein SE, Summers RM, Nguyen DM, Schrump DS (2004). Virtual bronchoscopy for evaluation of airway disease. Thorac Surg Clin  14, 79-86.   https://doi.org/10.1016/S1547-4127(04)00037-4




PubMed


 


PubMed ID 15382311
    
     


 



4.
Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS (2004). Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg  127, 365-75.   https://doi.org/10.1016/j.jtcvs.2003.09.033




PubMed


 


PubMed ID 14762343
    
     


 



5.
Nguyen DM, Schrump DS (2004). Growth factor receptors as targets for lung cancer therapy. Semin Thorac Cardiovasc Surg  16, 3-12.   https://doi.org/10.1053/j.semtcvs.2003.12.002




PubMed


 


PubMed ID 15366682
    
     


 



6.
Nguyen DM, Schrump WD, Chen GA, Tsai W, Nguyen P, Trepel JB, Schrump DS (2004). Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells. Clin Cancer Res  10, 1813-25.   https://doi.org/10.1158/1078-0432.ccr-0901-3




PubMed


 


PubMed ID 15014036
    
     


 



7.
Nguyen DM, Schrump WD, Tsai WS, Chen A, Stewart JH, Steiner F, Schrump DS (2003). Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway. J Thorac Cardiovasc Surg  125, 1132-42.   https://doi.org/10.1067/mtc.2003.180




PubMed


 


PubMed ID 12771887",https://intramural.nih.gov/search/searchview.taf?ipid=36459
312,BC010520-02,"October 01, 2003 -  September 30, 2004",Characterization of the polo-box binding proteins in budding yeast and mammalian,"Kyung  Lee; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,"Han-Sung  Kang  (National Cancer Institute)



Toru  Miki; PhD  (MOLECULAR BIOLOGY SECT)",NULL,"Ordered by publication type and then author name.



1.
Park CJ, Song S, Giddings TH, Ro HS, Sakchaisri K, Park JE, Seong YS, Winey M, Lee KS (2004). Requirement for Bbp1p in the proper mitotic functions of Cdc5p in Saccharomyces cerevisiae. Mol Biol Cell  15, 1711-23.   https://doi.org/10.1091/mbc.e03-07-0461




PubMed



        
     
Free Article


 


PubMed ID 14767068
         Pubmed Central ID 379269",https://intramural.nih.gov/search/searchview.taf?ipid=36441
313,BC010521-02,"October 01, 2003 -  September 30, 2004",Regulation of G2/M transition,"Kyung  Lee; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,"Jeremy  Thorner
(Molecular and Cell Biology, Univ. California-Berkeley)





Daniel  Lew
(Pharmacology and Cancer Biology, Duke University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Park CJ, Song S, Lee PR, Shou W, Deshaies RJ, Lee KS (2003). Loss of CDC5 function in Saccharomyces cerevisiae leads to defects in Swe1p regulation and Bfa1p/Bub2p-independent cytokinesis. Genetics  163, 21-33.




PubMed



        
     
Free Article


 


PubMed ID 12586693
         Pubmed Central ID 1462412",https://intramural.nih.gov/search/searchview.taf?ipid=36442
314,BC010522-02,"October 01, 2003 -  September 30, 2004",Isolation and characterization of novel anti-mitotic agents using yeast system,"Kyung  Lee; PhD



IRP Faculty Profile",Frank Jess Gonzalez; PhD,"Laboratory of Metabolism, NCI",NULL,NULL,Stuart  Yaspa (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Seong YS, Min C, Li L, Yang JY, Kim SY, Cao X, Kim K, Yuspa SH, Chung HH, Lee KS (2003). Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026. Cancer Res  63, 7384-91.




PubMed


 


PubMed ID 14612537",https://intramural.nih.gov/search/searchview.taf?ipid=36440
315,BC010523-01,"October 01, 2003 -  September 30, 2004",RNAi and Epigenetic Control of Higher-Order Chromatin Assembly,"Carl  Wu; PhD



IRP Faculty Profile",NULL,"Laboratory Of Biochemistry & Molecular Biology, NCI",NULL,"Rui-Ming  Xu
(Cold Spring Harbor Laboratory)





Robert  Martienssen
(Cold Spring Harbor Laboratory)





David  Allis
(University of Virginia)





Danesh  Moazed
(Harvard Medical School)





Amikam  Cohen
(Hebrew University)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=30670
316,BC010524-02,"October 01, 2003 -  September 30, 2004",HIV Integrase Modeling and Computer-Aided Inhibitor Development,"Marc C Nicklaus



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,"Yves  Pommier; PhD (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Vinay K Pathak; PhD (National Cancer Institute)












Rajeshri  Karki  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Karki RG, Tang Y, Burke TR, Nicklaus MC (2004). Model of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design. J Comput Aided Mol Des  18, 739-60.   https://doi.org/10.1007/s10822-005-0365-5




PubMed


 


PubMed ID 16075307
    
     


 



2.
Marchand C, Johnson AA, Karki RG, Pais GC, Zhang X, Cowansage K, Patel TA, Nicklaus MC, Burke TR, Pommier Y (2003). Metal-dependent inhibition of HIV-1 integrase by beta-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharmacol  64, 600-9.   https://doi.org/10.1124/mol.64.3.600




PubMed


 


PubMed ID 12920196
    
     


 



3.
Zhang X, Pais GC, Svarovskaia ES, Marchand C, Johnson AA, Karki RG, Nicklaus MC, Pathak VK, Pommier Y, Burke TR (2003). Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors. Bioorg Med Chem Lett  13, 1215-9.   https://doi.org/10.1016/s0960-894x(03)00059-3




PubMed


 


PubMed ID 12643946",https://intramural.nih.gov/search/searchview.taf?ipid=36460
317,BC010525-02,"October 01, 2003 -  September 30, 2004",Immune Reconstitution,"Ronald E Gress; MD



IRP Faculty Profile",NULL,"Transplantation Immunology Section, NCI",NULL,"Mark  Hellerstein
(Nutrition, UCSF)
















Greg  Hadley
(University of Maryland)","Frances  Hakim; PhD (National Cancer Institute)



Howard A Young; PhD (National Cancer Institute)","Paul E Love; MD, PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36416
318,BC010527-02,"October 01, 2003 -  September 30, 2004",Characterization of the Genetic Diversity of HIV-1 in Infected Individuals [Prot,John Miller Coffin; PhD,NULL,"HIV Drug Resistance Program, NCI",NULL,"John W Mellors






Joseph  Margolick
(School of Public Health, Johns Hopkins University)





Scott  Wegner
(Henry M. Jackson Foundation)","Wei-Shau  Hu; PhD (National Cancer Institute)



Robert  Yarchoan; MD (HIV and AIDS Malignancy Br)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)












Frank  Maldarelli  (National Cancer Institute)","Shyamasundaran  Kottilil; MD, PhD (NIAID) 



H. Clifford  Lane; MD (NIAID) 



Henry  Masur; MD (NHLBI) 



Michael  Polis; MD (NIAID) 












Judith  Falloon; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36410
319,BC010528-02,"October 01, 2003 -  September 30, 2004",In Vivo Assessment of Residual Drug Activity in Patients with Genotypic and Phen,John Miller Coffin; PhD,NULL,"HIV Drug Resistance Program, NCI",NULL,NULL,"Robert  Yarchoan; MD (HIV and AIDS Malignancy Br)



Steven Leonard Zeichner; MD, PhD (National Cancer Institute)












Frank  Maldarelli  (National Cancer Institute)","Shyamasundaran  Kottilil; MD, PhD (NIAID) 



H. Clifford  Lane; MD (NIAID) 



Henry  Masur; MD (NHLBI) 



Michael  Polis; MD (NIAID) 












Judith  Falloon; MD (NIAID)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36408
320,BC010529-02,"October 01, 2003 -  September 30, 2004",Regulated proteolysis in developmental signaling,Michael  Lee,Allan M Weissman; MD,"Regulation of Cell Growth Laboratory, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36413
321,BC010530-02,"October 01, 2003 -  September 30, 2004",Molecular Therapeutics for HIV/AIDS,"Dean H. Hamer; PhD



IRP Faculty Profile",Michael Joseph Lichten; PhD,"Laboratory of Biochemistry, NCI",NULL,"Michael  Root
(Center for Human Virology, Thomas Jefferson Medical School)
















Jerome  Zack
(Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, UCLA)","Stella t  Hu (National Cancer Institute)



Kira K Lueders; PhD (National Cancer Institute)



Victor  Marquez; PhD (ORGANIC CHEMSTRY SECT)



Louise L Mchugh (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)","Mario  Roederer; PhD (NIAID) 



Edward Alan Berger; PhD (NIAID) 



Daniel C Douek; MD (NIAID)","Ordered by publication type and then author name.



1.
Hamer DH (submitted in 2004) A Commensal Strain Of E. Coli Encoding An Hiv Gp41 Protein (issued) Live Microbial Microbiocides (as Filed). Patents issued: 1786445 (EP in 2011); 1786445 (FR in 2011); 1786445 (GB in 2011); 1786445 (IE in 2011); 1786445 (NL in 2011); 1786445 (CH in 2011); 602005028427 (DE in 2011); 8,349,586 (US in 2013). Patent pending: 13/735,638 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36418
322,BC010532-02,"October 01, 2003 -  September 30, 2004",Elucidation of Mechanisms of Reverse Transcriptase Template Switching and in Viv,"Vinay K Pathak; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Rebekah A Thorick (National Cancer Institute)



David  Derse; PhD (National Cancer Institute)



Wei-Shau  Hu; PhD (National Cancer Institute)



Robert  Gorelick (National Cancer Institute)",Frank  Maldarelli (NIAID),"Ordered by publication type and then author name.



1.
Hu WS, Rhodes T, Dang Q, Pathak V (2003). Retroviral recombination: review of genetic analyses. Front Biosci  8, d143-55.   https://doi.org/10.2741/940




PubMed


 


PubMed ID 12456341
    
     


 



2.
Voronin YA, Pathak VK (2003). Frequent dual initiation of reverse transcription in murine leukemia virus-based vectors containing two primer-binding sites. Virology  312, 281-94.   https://doi.org/10.1016/s0042-6822(03)00300-3




PubMed


 


PubMed ID 12919734",https://intramural.nih.gov/search/searchview.taf?ipid=36464
323,BC010533-02,"October 01, 2003 -  September 30, 2004",Identification of Structural Determinants of Reverse Transcriptase that Influenc,"Vinay K Pathak; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Galina  Nikolenko (National Cancer Institute)



Evguenia  Svarovskaia (National Cancer Institute)












Jean L Mbisa  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Svarovskaia ES, Cheslock SR, Zhang WH, Hu WS, Pathak VK (2003). Retroviral mutation rates and reverse transcriptase fidelity. Front Biosci  8, d117-34.   https://doi.org/10.2741/957




PubMed


 


PubMed ID 12456349",https://intramural.nih.gov/search/searchview.taf?ipid=36465
324,BC010534-02,"October 01, 2003 -  September 30, 2004",Development of Antiviral Drugs that Target HIV-1 Integrase and Characterization,"Vinay K Pathak; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Yijun  Zhang (National Cancer Institute)



Terrence R Burke; PhD (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)












Evguenia  Svarovskaia  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Zhang X, Pais GC, Svarovskaia ES, Marchand C, Johnson AA, Karki RG, Nicklaus MC, Pathak VK, Pommier Y, Burke TR (2003). Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors. Bioorg Med Chem Lett  13, 1215-9.   https://doi.org/10.1016/s0960-894x(03)00059-3




PubMed


 


PubMed ID 12643946",https://intramural.nih.gov/search/searchview.taf?ipid=36466
325,BC010537-02,"October 01, 2003 -  September 30, 2004",Molecular and Genetic Characterization of Mammalian MHC,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Claire  Waa
(Michigan, Broad Institute)
















Kersten  Lindblad-Toh
(Michigan, Broad Institute)","Yasuko  Ishida (National Cancer Institute)



Thomas  Beck (National Cancer Institute)



Naoya  Yuhki; MD (National Cancer Institute)












Joan C Menninger  (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Beck TW, Menninger J, Murphy WJ, Nash WG, O'brien SJ, Yuhki N (2005). The feline major histocompatibility complex is rearranged by an inversion with a breakpoint in the distal class I region. Immunogenetics  56, 702-9.   https://doi.org/10.1007/s00251-004-0742-6




PubMed


 


PubMed ID 15592824",https://intramural.nih.gov/search/searchview.taf?ipid=36462
326,BC010538-02,"October 01, 2003 -  September 30, 2004",Molecular Analysis of Breast Cancer Metastasis to the Brain,"Patricia  Steeg; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,NULL,"Robert  Weil; MD (NINDS) 



Paul S Meltzer; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Steeg PS (2003). Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer  3, 55-63.   https://doi.org/10.1038/nrc967




PubMed


 


PubMed ID 12509767",https://intramural.nih.gov/search/searchview.taf?ipid=36454
327,BC010539-02,"October 01, 2003 -  September 30, 2004",Identification of Modifier Gene of Tumors Associated with NF1 and Astrocytoma,"Karlyne M Reilly; BS, PhD",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"Karl  Broman
(University of Michigan)





Shirley  Tsang
(LMT, SAIC-Frederick)





Tyler  Jacks
(CCR, MIT)





Charles D Smith
(Pharmacology, Pennsylvania State University)",NULL,NULL,"Ordered by publication type and then author name.



1.
Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, Messerli SM, McClatchey AI, Niwa-Kawakita M, Ratner N, Reilly KM, Zhu Y, Giovannini M (2004). Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res  64, 3718-24.   https://doi.org/10.1158/0008-5472.CAN-03-4079




PubMed


 


PubMed ID 15150133",https://intramural.nih.gov/search/searchview.taf?ipid=36446
328,BC010540-02,"October 01, 2003 -  September 30, 2004",Molecular Mechanisms of Proliferation and Infiltration of Astrocytoma,"Karlyne M Reilly; BS, PhD",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"Ruth  Chalmers-Redman
(IAL, SAIC-Frederick)





Kelly  Nicholas
(CCR, UCSF)
















Nancy  Ratner
(Division of Experimental Hematology, Children's Hospital Medical Center)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36447
329,BC010541-02,"October 01, 2003 -  September 30, 2004",Development of Mouse Astrocytoma Model for Preclinical Testing of Experimental T,"Karlyne M Reilly; BS, PhD",Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"Eric  Holland
(CCR, Memorial Sloan Kettering)
















Carlos  Garcia
(Cytorex Biosciences, Inc.)",Melinda  Hollingshead (National Cancer Institute),"Herman D Morris (NINDS) 



Jeeva P Munasinghe (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36445
330,BC010542-02,"October 01, 2003 -  September 30, 2004",Biology of Keratinocyte and Cancer Stem Cells,Jonathan  Vogel; MD,Mark  Udey; MD,"Office of the Director, NCI",NULL,NULL,"William G Telford (Experimental Transplantation and Immunology Branch)



Josip  Blonder (National Cancer Institute)



Atsushi  Terunuma (National Cancer Institute)



Carole L Yee (National Cancer Institute)



Timothy D. Veenstra; PhD (National Cancer Institute)












Thomas  Conrads  (Laboratory of Pathology)",Richard  Fisher (NIMH),"Ordered by publication type and then author name.



1.
Hoang VM, Conrads TP, Veenstra TD, Blonder J, Terunuma A, Vogel JC, Fisher RJ (2003). Quantitative proteomics employing primary amine affinity tags. J Biomol Tech  14, 216-23.




PubMed



        
     
Free Article


 


PubMed ID 13678152
         Pubmed Central ID 2279946 


 



2.
Ohyama M, Vogel JC (2003). Gene delivery to the hair follicle. J Investig Dermatol Symp Proc  8, 204-6.   https://doi.org/10.1046/j.1087-0024.2003.00810.x




PubMed


 


PubMed ID 14582674
    
     


 



3.
Terunuma A, Jackson KL, Kapoor V, Telford WG, Vogel JC (2003). Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells. J Invest Dermatol  121, 1095-103.   https://doi.org/10.1046/j.1523-1747.2003.12531.x




PubMed


 


PubMed ID 14708612
    
     


 



4.
Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC (2004). Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes. Gene Ther  11, 1729-34.   https://doi.org/10.1038/sj.gt.3302344




PubMed


 


PubMed ID 15334113",https://intramural.nih.gov/search/searchview.taf?ipid=36443
331,BC010543-01,"October 01, 2003 -  September 30, 2004",HSP90 as a Moleculear Target for Ionizing Radiation,"David R Gius; MD, PhD",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,"Matthew  Bradbury (National Cancer Institute)



David  Mattson (National Cancer Institute)



Karen L Ortiz-Cruz (National Cancer Institute)



Deedee Kay Smart (National Cancer Institute)



Lunching  Sun (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D (2003). Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res  63, 8984-95.




PubMed


 


PubMed ID 14695217",https://intramural.nih.gov/search/searchview.taf?ipid=30665
332,BC010544-01,"October 01, 2003 -  September 30, 2004",Epigenetic regulation of of Gene Expression and multi-modality resistance in tum,"David R Gius; MD, PhD",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Ohiro Y, Usheva A, Kobayashi S, Duffy SL, Nantz R, Gius D, Horikoshi N (2003). Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53. Mol Cell Biol  23, 322-34.   https://doi.org/10.1128/mcb.23.1.322-334.2003




PubMed



        
     
Free Article


 


PubMed ID 12482984
         Pubmed Central ID 140653",https://intramural.nih.gov/search/searchview.taf?ipid=30666
333,BC010545-01,"October 01, 2003 -  September 30, 2004",Sulfhydryl switches and free-radical scavenger involvement in tumor cell oxidati,"David R Gius; MD, PhD",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,"Matthew  Bradbury (National Cancer Institute)



David  Mattson (National Cancer Institute)



Karen L Ortiz-Cruz (National Cancer Institute)



Deedee Kay Smart (National Cancer Institute)



Lunching  Sun (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lagunas L, Bradbury CM, Laszlo A, Hunt CR, Gius D (2004). Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun  313, 863-70.   https://doi.org/10.1016/j.bbrc.2003.12.018




PubMed


 


PubMed ID 14706622",https://intramural.nih.gov/search/searchview.taf?ipid=30667
334,BC010547-02,"October 01, 2003 -  September 30, 2004",Development of Drugs That Target Prostate Cancer,"William D Figg; PharmD



IRP Faculty Profile",Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Douglas K Price (National Cancer Institute)



Patricia  Steeg; PhD (Women's Cancer Sect)



Bill  Dahut (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



2.
Ng SS, Figg WD (2003). Antitumor activity of herbal supplements in human prostate cancer xenografts implanted in immunodeficient mice. Anticancer Res  23, 3585-90.




PubMed


 


PubMed ID 14666653",https://intramural.nih.gov/search/searchview.taf?ipid=36411
335,BC010549-01,"October 01, 2003 -  September 30, 2004",Zebrafish models of human leukemia and sarcoma,"Dennis D Hickstein



IRP Faculty Profile",Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,"Hatem  Sabaawy (National Cancer Institute)



Sunita  Sharma (National Cancer Institute)



Mizuki  Azuma (National Cancer Institute)












Lisa  Embree  (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI) 



Brant M Weinstein; PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=30674
336,BC010550-01,"October 01, 2003 -  September 30, 2004",Isolation and Characterisation of Transcription Factories from E. coli and the y,"Mikhail V Kashlev



IRP Faculty Profile",Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Komissarova N, Kireeva ML, Becker J, Sidorenkov I, Kashlev M (2003). Engineering of elongation complexes of bacterial and yeast RNA polymerases. Methods Enzymol  371, 233-51.   https://doi.org/10.1016/S0076-6879(03)71017-9




PubMed


 


PubMed ID 14712704",https://intramural.nih.gov/search/searchview.taf?ipid=30685
337,BC010555-02,"October 01, 2003 -  September 30, 2004",Generation of T-cell responses by dendritic cell presentation of tumor cells,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Donna M Perry lalley (National Cancer Institute)



Qiong J Wang (National Cancer Institute)



Cynthia  Liu (National Cancer Institute)



Kenichi  Hanada (National Cancer Institute)



Craig A Mckinney (National Cancer Institute)



Nicholas Phillip Restifo; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Freedman NM, Sundaram SK, Kurdziel K, Carrasquillo JA, Whatley M, Carson JM, Sellers D, Libutti SK, Yang JC, Bacharach SL (2003). Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med Mol Imaging  30, 46-53.   https://doi.org/10.1007/s00259-002-0981-4




PubMed


 


PubMed ID 12483409
    
     


 



2.
Hanada K, Yewdell JW, Yang JC (2004). Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature  427, 252-6.   https://doi.org/10.1038/nature02240




PubMed


 


PubMed ID 14724640",https://intramural.nih.gov/search/searchview.taf?ipid=36444
338,BC010556-02,"October 01, 2003 -  September 30, 2004",Of Mice and Men: Using Mutations to Characterize Disease Processes,Nancy  Jenkins-Copeland; PhD,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,NULL,Allan M Weissman; MD (Regulation of Cell Growth Laboratory),"Mary A Kelly (NIDCR) 












Heinz  Arnheiter; MD (NINDS)","Ordered by publication type and then author name.



1.
Montcouquiol M, Rachel RA, Lanford PJ, Copeland NG, Jenkins NA, Kelley MW (2003). Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature  423, 173-7.   https://doi.org/10.1038/nature01618




PubMed


 


PubMed ID 12724779",https://intramural.nih.gov/search/searchview.taf?ipid=36429
339,BC010558-01,"October 01, 2004 -  September 30, 2005",The Maintenance of Plasmids in Pathogenic Organisms,"Stuart J Austin



IRP Faculty Profile",NULL,"Gene Regulation and Chromosome Biology Laboratory, NCI","Alena V Dabrazhynetskaya



Brenda L Youngren",NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36685
340,BC010560-01,"October 01, 2003 -  September 30, 2004",Adjuvant Therapy of Breast Cancer,Sandra M Swain; MD,NULL,"Cancer Therapeutics Branch, NCI",NULL,"Charles  Geyer
(NSABP)
















Norman  Wolmark
(National Surgical Adjuvant Breast and Bowel Project)","Fatou  Hughes (National Cancer Institute)



Herbert  Kotz (National Cancer Institute)



Brenda A Lee (National Cancer Institute)



Marianne  Poruchynsky (National Cancer Institute)



Gail L Taylor (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36616
341,BC010561-01,"October 01, 2003 -  September 30, 2004",Transcription factor mobility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Keiko  Ozato; PhD
(NICHHD)
















Robert  Pego
(Mathematics, Carnegie Mellon)","Tatiana  Karpova (National Cancer Institute)



Hillary  Mueller (National Cancer Institute)



Brian  Sprague (National Cancer Institute)



Diana  Stavreva (National Cancer Institute)



Elise C Kohn; MD (National Cancer Institute)












Teresa  Chen  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36736
342,BC010562-01,"October 01, 2003 -  September 30, 2004",Molecular Interaction Maps and Analysis of Bioregulatory Networks,"Mirit I Aladjem; PhD



IRP Faculty Profile",NULL,"Developmental Therapeutics Branch, NCI",NULL,NULL,"Tsutomu  Shimura (National Cancer Institute)



Chiimei (Cindy) L Tseng (National Cancer Institute)



Lixin  Wang (National Cancer Institute)



Yves  Pommier; PhD (National Cancer Institute)



Kurt  Kohn; PhD (National Cancer Institute)



John N.  Weinstein (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Aladjem MI, Pasa S, Parodi S, Weinstein JN, Pommier Y, Kohn KW (2004). Molecular interaction maps--a diagrammatic graphical language for bioregulatory networks. Sci STKE  2004, pe8.   https://doi.org/10.1126/stke.2222004pe8




PubMed


 


PubMed ID 14997004",https://intramural.nih.gov/search/searchview.taf?ipid=36681
343,BC010563-01,"October 01, 2003 -  September 30, 2004",Modulating T cell tolerance to elicit tumor immunity and autoimmunity,"Joost J Oppenheim; MD



IRP Faculty Profile",NULL,"Laboratory of Molecular Immunoregulation, NCI",NULL,"Stephen  Schoenberger
(Division of Cellular Immunology, La Jolla Institute for Allergy and Immunology)





Andrew  Weinberg
(Robert W. Franz Cancer Research Center, Earle Chiles Cancer Institute)





Protul  Shrikant
(Department of Immunology, Roswell Park Cancer Institute)
















Eugene  Kwon
(Androgen Ablation to Elicit Prostate Cancer Immunity, Mayo Clinic)","Fran  Dorsey (National Cancer Institute)



Qingyong  Ji (National Cancer Institute)



Vinod  Singh (National Cancer Institute)



Jami D Willette brown (National Cancer Institute)



Thomas  Wuest (National Cancer Institute)












Michael  Anderson  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36714
344,BC010564-01,"October 01, 2003 -  September 30, 2004",Large Scale Chromatin Structure,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,"Gerd  Schneider
(BESSY)
















Zlatko  Trajanoski
(Bioinformatics, Graz University of Technology)","Hillary  Mueller (National Cancer Institute)












Tatiana  Karpova  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36737
345,BC010565-01,"October 01, 2003 -  September 30, 2004",Ras Signalling in Human Melanoma,Mark  Udey; MD,NULL,"Office of the Director, NCI",NULL,NULL,"Steven  Kahn (National Cancer Institute)












Shunlin  Jiang  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36711
346,BC010567-01,"October 01, 2003 -  September 30, 2004",Malignant Progression in Human Melanoma,Mark  Udey; MD,NULL,"Office of the Director, NCI",NULL,NULL,Shunlin  Jiang  (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36712
347,BC010568-01,"October 01, 2003 -  September 30, 2004",Studies of the anti-tumor mechanisms of the inflammatory cytokines tumor necrosi,"H Richard Alexander; MD, PhD","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Derrick D Cox; MD (National Cancer Institute)



Jeffrey M Farma (National Cancer Institute)



Cynthia B Helsabeck (National Cancer Institute)



Susan E Ohl (National Cancer Institute)



James F Pingpank (National Cancer Institute)



Romi K Sawhney (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alexander HR (2003). Hyperthermia and its modern use in cancer treatment. Cancer  98, 219-21.   https://doi.org/10.1002/cncr.11471




PubMed


 


PubMed ID 12872338
    
     


 



2.
Alexander HR, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C, Beresneva T (2003). Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res  9, 6343-9.




PubMed


 


PubMed ID 14695133
    
     


 



3.
Weinreich DM, Elaraj DM, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Spiess PJ, Alexander HR (2003). Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice. Cancer Res  63, 5957-61.




PubMed


 


PubMed ID 14522922",https://intramural.nih.gov/search/searchview.taf?ipid=36682
348,BC010570-01,"October 01, 2003 -  September 30, 2004",Characterization of Proteins in the Tumor Microenvironment That Influence Tumor,"H Richard Alexander; MD, PhD","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Derrick D Cox; MD (National Cancer Institute)



Jeffrey M Farma (National Cancer Institute)



Cynthia B Helsabeck (National Cancer Institute)



Susan E Ohl (National Cancer Institute)



James F Pingpank (National Cancer Institute)



Romi K Sawhney (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Weinreich DM, Elaraj DM, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Spiess PJ, Alexander HR (2003). Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice. Cancer Res  63, 5957-61.




PubMed


 


PubMed ID 14522922",https://intramural.nih.gov/search/searchview.taf?ipid=36683
349,BC010571-01,"October 01, 2003 -  September 30, 2004",Fluorescence Imaging Facility,James G McNally; PhD,Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Anita B Roberts; PhD (National Cancer Institute)



Seong-Jin  Kim; PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Genoveffa  Franchini; MD (National Cancer Institute)



Pierre A. Henkart; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, Lewis MG, Berzofsky JA, Belyakov IM, Moss B, Tartaglia J, Bray M, Hirsch V, Golding H, Franchini G (2003). Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques. J Infect Dis  188, 1181-91.   https://doi.org/10.1086/378518




PubMed


 


PubMed ID 14551889
    
     


 



2.
Felici A, Wurthner JU, Parks WT, Giam LR, Reiss M, Karpova TS, McNally JG, Roberts AB (2003). TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. EMBO J  22, 4465-77.   https://doi.org/10.1093/emboj/cdg428




PubMed



        
     
Free Article


 


PubMed ID 12941698
         Pubmed Central ID 202370 


 



3.
Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G (2003). Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription. J Biol Chem  278, 12310-8.   https://doi.org/10.1074/jbc.M211167200




PubMed


 


PubMed ID 12501250
    
     


 



4.
He L, Bradrick TD, Karpova TS, Wu X, Fox MH, Fischer R, McNally JG, Knutson JR, Grammer AC, Lipsky PE (2003). Flow cytometric measurement of fluorescence (Förster) resonance energy transfer from cyan fluorescent protein to yellow fluorescent protein using single-laser excitation at 458 nm. Cytometry A  53, 39-54.   https://doi.org/10.1002/cyto.a.10037




PubMed


 


PubMed ID 12701131
    
     


 



5.
He L, Olson DP, Wu X, Karpova TS, McNally JG, Lipsky PE (2003). A flow cytometric method to detect protein-protein interaction in living cells by directly visualizing donor fluorophore quenching during CFP-->YFP fluorescence resonance energy transfer (FRET). Cytometry A  55, 71-85.   https://doi.org/10.1002/cyto.a.10073




PubMed


 


PubMed ID 14505312
    
     


 



6.
Karpova TS, Baumann CT, He L, Wu X, Grammer A, Lipsky P, Hager GL, McNally JG (2003). Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. J Microsc  209, 56-70.   https://doi.org/10.1046/j.1365-2818.2003.01100.x




PubMed


 


PubMed ID 12535185
    
     


 



7.
Macpherson GR, Ng SS, Forbes SL, Melillo G, Karpova T, McNally J, Conrads TP, Veenstra TD, Martinez A, Cuttitta F, Price DK, Figg WD (2003). Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol Cancer Ther  2, 845-54.




PubMed


 


PubMed ID 14555703",https://intramural.nih.gov/search/searchview.taf?ipid=36735
350,BC010572-01,"October 01, 2003 -  September 30, 2004",Thyroid NodulesCancer and Radiation,"Jeffery P Struewing; MS, MD",Kenneth  Buetow; PhD,"Family Studies Sect, NCI",NULL,NULL,"Marbin A Pineda (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)












Elisha E Peterson  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer  4, 9.   https://doi.org/10.1186/1471-2407-4-9




PubMed



        
     
Free Article


 


PubMed ID 15113441
         Pubmed Central ID 408462",https://intramural.nih.gov/search/searchview.taf?ipid=36615
351,BC010575-01,"October 01, 2003 -  September 30, 2004",IN SEARCH OF NEW MOLECULAR MARKERS IN THE DIAGNOSIS OF OVARIAN AND  ENDOMETRIAL,"Maria  Merino; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Sedric V Cade (National Cancer Institute)



Martha Maria Nicacio Quezado; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)












David M Berman  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, Young RH   (2004) Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior.  Hum Pathol 35:949-60.




PubMed


 


PubMed ID 15297962",https://intramural.nih.gov/search/searchview.taf?ipid=36738
352,BC010576-01,"October 01, 2003 -  September 30, 2004","Nutrition Intervention Trials in Linxian, China","Sanford Martin Dawsey; MD



IRP Faculty Profile","Philip  Taylor; MD, ScD","Cancer Prevention Studies Br, NCI",NULL,"Zhi-Wei  Dong
(CICAMS)





Guo-Qing  Wang
(CICAMS)





Wen-Qiang  Wei
(EPIDEMIOLOGY, CICAMS)
















You-Lin  Qiao
(EPIDEMIOLOGY, CICAMS)","Farin  Kamangar (National Cancer Institute)



Mark J Roth (National Cancer Institute)



Philip  Taylor (National Cancer Institute)



Laura  Johnson (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Steven  Mark (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, Taylor PR, Dong ZW, Mark SD, Dawsey SM (2005). Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst  97, 301-6.   https://doi.org/10.1093/jnci/dji042




PubMed


 


PubMed ID 15713965
    
     


 



2.
Abnet CC, Qiao YL, Dawsey SM, Buckman DW, Yang CS, Blot WJ, Dong ZW, Taylor PR, Mark SD (2003). Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China. Cancer Causes Control  14, 645-55.   https://doi.org/10.1023/a:1025619608851




PubMed


 


PubMed ID 14575362
    
     


 



3.
Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2005). Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol  34, 467-74.   https://doi.org/10.1093/ije/dyh375




PubMed


 


PubMed ID 15659476
    
     


 



4.
Savage SA, Abnet CC, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ (2004). Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev  13, 2251-7.




PubMed


 


PubMed ID 15598788
    
     


 



5.
Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev  12, 1222-6.




PubMed


 


PubMed ID 14652285
    
     


 



6.
Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, Wang W, Blot WJ, Dong ZW, Mark SD (2003). Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst  95, 1414-6.   https://doi.org/10.1093/jnci/djg044




PubMed


 


PubMed ID 13130117
    
     


 



7.
Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR, Mark SD (2004). Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr  79, 80-5.   https://doi.org/10.1093/ajcn/79.1.80




PubMed


 


PubMed ID 14684401",https://intramural.nih.gov/search/searchview.taf?ipid=36693
353,BC010577-01,"October 01, 2003 -  September 30, 2004",Analysis of Tn-binding Antibody and Lectin Specificity,Victor  Marquez; PhD,NULL,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,"Timothy  Roach (National Cancer Institute)












Zhitao  Li  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36709
354,BC010578-01,"October 01, 2003 -  September 30, 2004",Targeting TEMs in Preclinical Tumor Models,Bradley D St Croix,NULL,"Mouse Cancer Genetics Program, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B   (2004) TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).  Cancer Res 64:817-20.




PubMed


 


PubMed ID 14871805
    
     


 



2.
Nanda A, St Croix B   (2004) Tumor endothelial markers: new targets for cancer therapy.  Curr Opin Oncol 16:44-9.




PubMed


 


PubMed ID 14685092",https://intramural.nih.gov/search/searchview.taf?ipid=36093
355,BC010579-01,"October 01, 2003 -  September 30, 2004",Papillomavirus Virion Proteins and Vaccines,"Douglas  Lowy; MD



IRP Faculty Profile",NULL,"Laboratory of Cellular Oncology, NCI",NULL,NULL,John  Schiller; PhD  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Day PM, Lowy DR, Schiller JT (2003). Papillomaviruses infect cells via a clathrin-dependent pathway. Virology  307, 1-11.   https://doi.org/10.1016/s0042-6822(02)00143-5




PubMed


 


PubMed ID 12667809
    
     


 



2.
Lenz P, Thompson CD, Day PM, Bacot SM, Lowy DR, Schiller JT (2003). Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells. Clin Immunol  106, 231-7.   https://doi.org/10.1016/s1521-6616(02)00039-6




PubMed


 


PubMed ID 12706410
    
     


 



3.
Lowy DR, Frazer IH (2003). Chapter 16: Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr   111-6  https://doi.org/10.1093/oxfordjournals.jncimonographs.a003472




PubMed


 


PubMed ID 12807954
    
     


 



4.
Lowy DR, Gillison ML (2003). A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst  95, 1648-50.   https://doi.org/10.1093/jnci/djg125




PubMed


 


PubMed ID 14625250
    
     


 



5.
Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P (2003). Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst  95, 1128-37.   https://doi.org/10.1093/jnci/djg018




PubMed


 


PubMed ID 12902442
    
     


 



6.
Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A (2003). Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J Infect Dis  188, 327-38.   https://doi.org/10.1086/376505




PubMed


 


PubMed ID 12854090",https://intramural.nih.gov/search/searchview.taf?ipid=36734
356,BC010580-01,"October 01, 2003 -  September 30, 2004",Ph II Trial of PEG-Intron in Children with Diffuse Pontine Gliomas,"Howard A Fine; MD, PhD",NULL,"National Cancer Institute, NCI",Paul Stuart Albert,NULL,NULL,"John Anthony Butman; MD, PhD (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36666
357,BC010584-01,"October 01, 2004 -  September 30, 2005",A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatri,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson",NULL,"Frank M Balis; MD, PhD (National Cancer Institute)","Joseph A Frank; MD, MS (CC) 



Bobbi K Lewis (CC)",There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36664
358,BC010585-01,"October 01, 2004 -  September 30, 2005",A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent o,"Katherine Elizabeth Warren; MD



IRP Faculty Profile",NULL,"Neuro-Oncology Branch, NCI","David D Draper



Karna L Robinson","Susan  Blaney
(Pediatric Oncology, Texas Children's Cancer Center)




Henry  Friedman
(Oncology, Duke University Medical Center)




J. Russell  Geyer
(Pediatric Oncology, Children's Hospital & Regional Medical Center)




Stewart  Goldman
(Pediatric Oncology, Children's Memorial Hospital)




Mark  Kieran
(Pediatric Oncology, Dana Farber Cancer Institute)




Larry  Kun
(Radiation Oncology, St. Jude Children's Research Hospital)


Show all 10","Howard A Fine; MD, PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36665
359,BC010586-01,"October 01, 2003 -  September 30, 2004",Evaluation of the Natural History of Patients with Tumors of the Central Nervous,"Howard A Fine; MD, PhD",NULL,"National Cancer Institute, NCI",NULL,NULL,NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36661
360,BC010591-01,"October 01, 2003 -  September 30, 2004",Characterization of Xenograft Models of Childhood Cancers,"Javed  Khan; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Qingrong  Chen (National Cancer Institute)



Braden T Greer (National Cancer Institute)



Jun S Wei (National Cancer Institute)



Craig C Whiteford (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Williams RD, Hing SN, Greer BT, Whiteford CC, Wei JS, Natrajan R, Kelsey A, Rogers S, Campbell C, Pritchard-Jones K, Khan J (2004). Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer  41, 65-79.   https://doi.org/10.1002/gcc.20060




PubMed


 


PubMed ID 15236318",https://intramural.nih.gov/search/searchview.taf?ipid=36730
361,BC010592-01,"October 01, 2003 -  September 30, 2004",Comparative Genomic Hybridization of Neuroblastoma,"Javed  Khan; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,"Frank  Berthold
(Department of Pediatrics, Klinik fr Kinderheilkunde der Universitt zu Kln)





Daniel  Catchpoole
(Tumor Bank, The Children's Hospital at Westmead)





Frank  Westermann
(Department of Tumour Genetics, German Cancer Research Center)
















Manfred  Schwab
(Department of Tumour Genetics, German Cancer Research Center)","Qingrong  Chen (National Cancer Institute)



Braden T Greer (National Cancer Institute)



Jun S Wei (National Cancer Institute)



Craig C Whiteford (National Cancer Institute)












Sven  Bilke  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36731
362,BC010593-01,"October 01, 2003 -  September 30, 2004",Gene Expression Profiling of Normal Tissues,"Javed  Khan; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Qingrong  Chen (National Cancer Institute)



Braden T Greer (National Cancer Institute)



Jun S Wei (National Cancer Institute)



Craig C Whiteford (National Cancer Institute)



Carol J Thiele (National Cancer Institute)












Sven  Bilke  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bomprezzi R, Ringnér M, Kim S, Bittner ML, Khan J, Chen Y, Elkahloun A, Yu A, Bielekova B, Meltzer PS, Martin R, McFarland HF, Trent JM (2003). Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. Hum Mol Genet  12, 2191-9.   https://doi.org/10.1093/hmg/ddg221




PubMed


 


PubMed ID 12915464",https://intramural.nih.gov/search/searchview.taf?ipid=36728
363,BC010594-01,"October 01, 2003 -  September 30, 2004",Molecular Mechanisms of Drugs Using cDNA Microarrays,"Javed  Khan; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Qingrong  Chen (National Cancer Institute)



Braden T Greer (National Cancer Institute)



Jun S Wei (National Cancer Institute)



Craig C Whiteford (National Cancer Institute)



Carol J Thiele (National Cancer Institute)












Sven  Bilke  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Greer BT, Khan J (2004). Diagnostic classification of cancer using DNA microarrays and artificial intelligence. Ann N Y Acad Sci  1020, 49-66.   https://doi.org/10.1196/annals.1310.007




PubMed


 


PubMed ID 15208183
    
     


 



2.
Williams RD, Hing SN, Greer BT, Whiteford CC, Wei JS, Natrajan R, Kelsey A, Rogers S, Campbell C, Pritchard-Jones K, Khan J (2004). Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer  41, 65-79.   https://doi.org/10.1002/gcc.20060




PubMed


 


PubMed ID 15236318",https://intramural.nih.gov/search/searchview.taf?ipid=36729
364,BC010595-01,"October 01, 2003 -  September 30, 2004",Mechanism of APOBEC3G-Mediated Hypermutation and Inhibition of HIV-1 Replication,"Vinay K Pathak; PhD



IRP Faculty Profile",Stuart F J Le Grice; PhD,"HIV Drug Resistance Program, NCI",NULL,NULL,"Patricia  Henry (National Cancer Institute)



Evguenia  Svarovskaia (National Cancer Institute)



Hongzhan  Xu (National Cancer Institute)



Yijun  Zhang (National Cancer Institute)



Jean L Mbisa (National Cancer Institute)



Rebekah A Thorick (National Cancer Institute)",Klaus  Strebel; PhD (NIAID),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36742
365,BC010596-01,"October 01, 2003 -  September 30, 2004",Pediatric Graft-vs-Host Disease,Alan S Wayne; MD,Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Steven  Pavletic; MD, MS (National Cancer Institute)












Cynthia  Love  (National Cancer Institute)",Michael R Robinson; MD (NEI),"Ordered by publication type and then author name.



1.
Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR, Childs R, Barrett AJ, Csaky KG (2004). Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant  33, 1031-5.   https://doi.org/10.1038/sj.bmt.1704453




PubMed


 


PubMed ID 15048138",https://intramural.nih.gov/search/searchview.taf?ipid=36669
366,BC010597-01,"October 01, 2003 -  September 30, 2004",Vaccine Clinical Trials,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI","Philip M Arlen; MD



Mary P Pazdur



Lisa M Skarupa",NULL,"James L Gulley; MD, PhD (Experimental Oncology Section)



Jennifer L Marte (Biostatistics and Data Management Section)



Steve L Morin (National Cancer Institute)



Sharon P Thomas (National Cancer Institute)



Donna  Drake (Biostatistics and Data Management Section)



William Laurence Dahut; MD (Medical Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Morse MA, Nair SK, Mosca PJ, Hobeika AC, Clay TM, Deng Y, Boczkowski D, Proia A, Neidzwiecki D, Clavien PA, Hurwitz HI, Schlom J, Gilboa E, Lyerly HK (2003). Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA. Cancer Invest  21, 341-9.   https://doi.org/10.1081/cnv-120018224




PubMed


 


PubMed ID 12901279
    
     


 



2.
Palena C, Arlen P, Zeytin H, Greiner JW, Schlom J, Tsang KY (2003). Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens. Cytokine  24, 128-42.   https://doi.org/10.1016/j.cyto.2003.07.004




PubMed


 


PubMed ID 14572791
    
     


 



3.
Palena C, Schlom J, Tsang KY (2003). Differential gene expression profiles in a human T-cell line stimulated with a tumor-associated self-peptide versus an enhancer agonist peptide. Clin Cancer Res  9, 1616-27.




PubMed


 


PubMed ID 12738714
    
     


 



4.
Tsang KY, Palena C, Gulley J, Arlen P, Schlom J (2004). A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1. Clin Cancer Res  10, 2139-49.   https://doi.org/10.1158/1078-0432.ccr-1011-03




PubMed


 


PubMed ID 15041735",https://intramural.nih.gov/search/searchview.taf?ipid=36088
367,BC010598-01,"October 01, 2003 -  September 30, 2004",Development of Novel Vaccine Strategies,"Jeffrey  Schlom; PhD



IRP Faculty Profile",NULL,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Grosenbach DW, Schlom J, Gritz L, Gómez Yafal A, Hodge JW (2003). A recombinant vector expressing transgenes for four T-cell costimulatory molecules (OX40L, B7-1, ICAM-1, LFA-3) induces sustained CD4+ and CD8+ T-cell activation, protection from apoptosis, and enhanced cytokine production. Cell Immunol  222, 45-57.   https://doi.org/10.1016/s0008-8749(03)00080-7




PubMed


 


PubMed ID 12798307
    
     


 



2.
Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J (2003). Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res  9, 1837-49.




PubMed


 


PubMed ID 12738742",https://intramural.nih.gov/search/searchview.taf?ipid=36089
368,BC010599-01,"October 01, 2003 -  September 30, 2004",Mechanisms of Transcriptional Repression by Histone Deacetylase Inhibitors,Catharine L Smith; PhD,NULL,"Hormone Action and Oncogenesis Section, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Mulholland NM, Soeth E, Smith CL (2003). Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Oncogene  22, 4807-18.   https://doi.org/10.1038/sj.onc.1206722




PubMed


 


PubMed ID 12894222",https://intramural.nih.gov/search/searchview.taf?ipid=36090
369,BC010600-01,"October 01, 2003 -  September 30, 2004",Study of AAA proteins by X-ray protein crystallography,"Di S Xia; PhD, MS, BS



IRP Faculty Profile",Michael Marc Gottesman; MD,"Laboratory of Cell Biology, NCI",NULL,NULL,"Dongyang  Li (National Cancer Institute)












Lothar  Esser  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36671
370,BC010601-01,"October 01, 2003 -  September 30, 2004","Physiological role of TNF and Lymphotoxin in host defense, autoimmunity and canc","Sergei A. Nedospasov; PhD, DSc","Joost J Oppenheim; MD 
 


Robert  Wiltrout; PhD","Laboratory of Molecular Immunoregulation, NCI",NULL,"Dmitry  Kuprash
(Laboratory of Molecular Immunology, Engelhardt Institute of Molecular Biology)





Daniela  Mannel
(Pathology, University of Regensburg)
















Bernhard  Ryffel
(CNRS, Institute Transgenose)","Sergei  Grivennikov (National Cancer Institute)



Dmitry  Liepinsh (National Cancer Institute)



Yuriy  Shebzukhov (National Cancer Institute)












Ludmila  Drutskaya  (National Cancer Institute)",Stuart H Yuspa; MD (NCI),"Ordered by publication type and then author name.



1.
Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem  279, 10822-8.   https://doi.org/10.1074/jbc.M313141200




PubMed


 


PubMed ID 14701813",https://intramural.nih.gov/search/searchview.taf?ipid=36739
371,BC010602-01,"October 01, 2003 -  September 30, 2004",Characterization of human cancer antigens defined by serology,"Sergei A. Nedospasov; PhD, DSc",Joost J Oppenheim; MD,"Laboratory of Molecular Immunoregulation, NCI",NULL,NULL,Yuriy  Shebzukhov  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36740
372,BC010603-01,"October 01, 2003 -  September 30, 2004",Receptor -directed therapy,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Metabolism Br, NCI",NULL,NULL,"Shaila  Farooque (National Cancer Institute)



Wendy W Gao (National Cancer Institute)



Leslie S Moses (National Cancer Institute)



Diana  O'Hagan (National Cancer Institute)



Arlethia J Spencer (National Cancer Institute)



John N Brady; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bleesing JJ, Janik JE, Fleisher TA (2003). Common expression of an unusual CD45 isoform on T cells from patients with large granular lymphocyte leukaemia and autoimmune lymphoproliferative syndrome. Br J Haematol  120, 93-6.   https://doi.org/10.1046/j.1365-2141.2003.04034.x




PubMed


 


PubMed ID 12492582",https://intramural.nih.gov/search/searchview.taf?ipid=36715
373,BC010604-01,"October 01, 2003 -  September 30, 2004",Epigenetic Studies of Gastro-Intestinal Cancers,Karen  Woodson,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Jeffrey C Hanson (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)



Sanford Martin Dawsey; MD (National Cancer Institute)



Mark J Roth (National Cancer Institute)



Christian Cormac Abnet; PhD, MPH (National Cancer Institute)












Lisa  Adams  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36670
374,BC010607-01,"October 01, 2003 -  September 30, 2004",Ras-mediated signals in human epithelial cell transformation and metastasis,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Medcn Br, NCI",NULL,NULL,"Monika  Chock (National Cancer Institute)



Michael  Oberst (National Cancer Institute)



Claire  Pollock (National Cancer Institute)



Ivy (Juan Juan)  Yin (National Cancer Institute)












Stacey  Beberman  (National Cancer Institute)",Alan Paul Koretsky; PhD (NINDS),"Ordered by publication type and then author name.



1.
Ward Y, Spinelli B, Quon MJ, Chen H, Ikeda SR, Kelly K (2004). Phosphorylation of critical serine residues in Gem separates cytoskeletal reorganization from down-regulation of calcium channel activity. Mol Cell Biol  24, 651-61.   https://doi.org/10.1128/mcb.24.2.651-661.2004




PubMed



        
     
Free Article


 


PubMed ID 14701738
         Pubmed Central ID 343818",https://intramural.nih.gov/search/searchview.taf?ipid=36727
375,BC010620-01,"October 01, 2003 -  September 30, 2004",Clinical Studies of Multidrug Resistance Reversal,Susan  Bates; MD,Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC (2003). Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res  9, 650-6.




PubMed


 


PubMed ID 12576431
    
     


 



2.
Fojo T, Bates S (2003). Strategies for reversing drug resistance. Oncogene  22, 7512-23.   https://doi.org/10.1038/sj.onc.1206951




PubMed


 


PubMed ID 14576855
    
     


 



3.
Stein WD, Litman T, Fojo T, Bates SE (2004). A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins. Cancer Res  64, 2805-16.   https://doi.org/10.1158/0008-5472.can-03-3383




PubMed


 


PubMed ID 15087397
    
     


 



4.
Stein WD, Robey R, Dardarelli C, Gottesman MM, Bates SE   (2003) Low and high concentrations of the topo II inhibitor daunorubicin in NIH3T3 cells reversible G2/M versus irreversible G1 and S arrest.  Cell Cycle 2:134-42.",https://intramural.nih.gov/search/searchview.taf?ipid=36691
376,BC010621-01,"October 01, 2003 -  September 30, 2004",II. Clinical and Laboratory Studies of the Histone Deacetylase Inhibitor Depsipe,Susan  Bates; MD,Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Robert W Robey (National Cancer Institute)



Kenneth A Steadman (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



John  Wright (National Cancer Institute)



William D Figg; PharmD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)","Douglas R Rosing; MD (NHLBI) 



George J Grimes (CC)","Ordered by publication type and then author name.



1.
Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S, Fojo T (2003). The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res  9, 5394-401.




PubMed


 


PubMed ID 14614025",https://intramural.nih.gov/search/searchview.taf?ipid=36689
377,BC010622-01,"October 01, 2003 -  September 30, 2004",III. Investigation of the ABC Half-Transporter ABCG2,Susan  Bates; MD,Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,"Thomas  Litman
(Bioinformatics Centre, University of Copenhagen)





Balazs  Sarkadi
(Dept Cell Metabolism, National Insitute of Hematology and Immunology)





Douglas  Ross
(Medicine Department, University of Maryland Greenebaum Cancer Center)
















Gary  Kruh; MD, PhD
(Medical Science Division, Fox Chase Cancer Center)","Robert W Robey (National Cancer Institute)



Kenneth A Steadman (National Cancer Institute)



Zhirong  Zhan (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)



Suresh V Ambudkar; PhD (National Cancer Institute)



Michael Marc Gottesman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD (2003). Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res  63, 4048-54.




PubMed


 


PubMed ID 12874005
    
     


 



2.
Robey RW, Honjo Y, Morisaki K, Nadjem TA, Runge S, Risbood M, Poruchynsky MS, Bates SE (2003). Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity. Br J Cancer  89, 1971-8.   https://doi.org/10.1038/sj.bjc.6601370




PubMed



        
     
Free Article


 


PubMed ID 14612912
         Pubmed Central ID 2394461",https://intramural.nih.gov/search/searchview.taf?ipid=36690
378,BC010623-01,"October 01, 2003 -  September 30, 2004",The molecular recotnition of proteins by antibodies: A model for protein-protein,"Sandra  Smith-Gill; MS, PhD, BS",NULL,"Basic Research Laboratory, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA (2003). X-ray snapshots of the maturation of an antibody response to a protein antigen. Nat Struct Biol  10, 482-8.   https://doi.org/10.1038/nsb930




PubMed


 


PubMed ID 12740607",https://intramural.nih.gov/search/searchview.taf?ipid=36091
379,BC010625-01,"October 01, 2003 -  September 30, 2004",Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance,"Antonio  Fojo; MD, PhD",Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,"Robert  Kramer
(Bristol Myers Squibb Pharmaceutical Research Institute)





Eva  Nogales
(Lawrence Berkeley National Laboratory, and Molecular and Cell Biology Department, UC Berkeley)
















Francis  Lee
(Bristol Myers Squibb Pharmaceutical Research Institute)","Shana Y Trostel (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)












Marianne  Poruchynsky  (National Cancer Institute)",Danny L Sackett; PhD (NICHD),"Ordered by publication type and then author name.



1.
Abraham J, Agrawal M, Bakke S, Rutt A, Edgerly M, Balis FM, Widemann B, Davis L, Damle B, Sonnichsen D, Lebwohl D, Bates S, Kotz H, Fojo T (2003). Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days. J Clin Oncol  21, 1866-73.   https://doi.org/10.1200/JCO.2003.03.063




PubMed


 


PubMed ID 12721265
    
     


 



2.
Agrawal M, Edgerly M, Fojo T, Kotz H (2003). Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog. Gynecol Oncol  90, 96-9.   https://doi.org/10.1016/s0090-8258(03)00146-x




PubMed


 


PubMed ID 12821348",https://intramural.nih.gov/search/searchview.taf?ipid=36702
380,BC010627-01,"October 01, 2003 -  September 30, 2004",Clinical Pharmacology,"William D Figg; PharmD



IRP Faculty Profile",NULL,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Douglas K Price (National Cancer Institute)



Nicola F Smith (National Cancer Institute)



William Laurence Dahut; MD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Philip M Arlen; MD (National Cancer Institute)



James L Gulley; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T (2004). A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res  10, 4724-33.   https://doi.org/10.1158/1078-0432.CCR-0829-03




PubMed


 


PubMed ID 15269145
    
     


 



2.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



3.
Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB (2003). Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. J Clin Oncol  21, 2299-304.   https://doi.org/10.1200/JCO.2003.08.045




PubMed


 


PubMed ID 12805330
    
     


 



4.
Hussain MM, Kotz H, Minasian L, Premkumar A, Sarosy G, Reed E, Zhai S, Steinberg SM, Raggio M, Oliver VK, Figg WD, Kohn EC (2003). Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. J Clin Oncol  21, 4356-63.   https://doi.org/10.1200/JCO.2003.04.136




PubMed


 


PubMed ID 14645425
    
     


 



5.
Hwang K, Acharya MR, Sausville EA, Zhai S, Woo EW, Venitz J, Figg WD, Sparreboom A (2004). Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  804, 289-94.   https://doi.org/10.1016/j.jchromb.2004.01.023




PubMed


 


PubMed ID 15081922
    
     


 



6.
Hwang K, Piekarz RL, Bates SE, Figg WD, Sparreboom A (2004). Determination of the cyclic depsipeptide FK228, a histone deacetylase inhibitor, by liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  809, 81-6.   https://doi.org/10.1016/j.jchromb.2004.06.007




PubMed


 


PubMed ID 15282096
    
     


 



7.
Lepper ER, Swain SM, Tan AR, Figg WD, Sparreboom A (2003). Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor. J Chromatogr B Analyt Technol Biomed Life Sci  796, 181-8.   https://doi.org/10.1016/j.jchromb.2003.08.015




PubMed


 


PubMed ID 14552829
    
     


 



8.
Rudek MA, Bauer KS, Lush RM, Stinson SF, Senderowicz AM, Headlee DJ, Arbuck SG, Cox MC, Murgo AJ, Sausville EA, Figg WD (2003). Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. Ann Pharmacother  37, 1369-74.   https://doi.org/10.1345/aph.1C404




PubMed


 


PubMed ID 14519054
    
     


 



9.
Tan AR, Yang X, Hewitt SM, Berman A, Lepper ER, Sparreboom A, Parr AL, Figg WD, Chow C, Steinberg SM, Bacharach SL, Whatley M, Carrasquillo JA, Brahim JS, Ettenberg SA, Lipkowitz S, Swain SM (2004). Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Clin Oncol  22, 3080-90.   https://doi.org/10.1200/JCO.2004.08.189




PubMed


 


PubMed ID 15284258
    
     


 



10.
Tohnya TM, Ng SS, Dahut WL, Wright JJ, Arlen PM, Gulley JL, Parker C, Zeldis J, Figg WD (2004). A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer. Clin Prostate Cancer  2, 241-3.   https://doi.org/10.3816/cgc.2004.n.006




PubMed


 


PubMed ID 15072608
    
     


 



11.
Uchio EM, Linehan WM, Figg WD, Walther MM (2003). A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder. J Urol  169, 357-60.   https://doi.org/10.1097/01.ju.0000032745.90528.dc




PubMed


 


PubMed ID 12478189",https://intramural.nih.gov/search/searchview.taf?ipid=36701
381,BC010628-01,"October 01, 2003 -  September 30, 2004",Epigenetic control of mammalian retrotransposons,Michael  Lee,Berton K Zbar; PhD,"Laboratory of Immunobiology, NCI",NULL,"Jef D. Boeke
(Department of Molecular Biology and Genetics, Johns Hopkins University)
















Gary  Ketner
(Molecular Microbiology and Immunology, Johns Hopkins)","Jingfeng  Li (National Cancer Institute)



Pawan  Tiwary (National Cancer Institute)



Karl Thomas Ried; MD (National Cancer Institute)












Manoj  Kannan  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36617
382,BC010630-01,"October 01, 2003 -  September 30, 2004",Cancer Vaccines and Modulation of Checkpoint Controls in Immunization,John  Janik; MD,"Thomas Alexander Waldmann; MD, PhD","Metabolism Br, NCI",NULL,NULL,"Wendy W Gao (National Cancer Institute)



Leslie S Moses (National Cancer Institute)



Diana  O'Hagan (National Cancer Institute)



Arlethia J Spencer (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berzofsky JA, Ahlers JD, Janik J, Morris J, Oh S, Terabe M, Belyakov IM (2004). Progress on new vaccine strategies against chronic viral infections. J Clin Invest  114, 450-62.   https://doi.org/10.1172/JCI22674




PubMed



        
     
Free Article


 


PubMed ID 15314679
         Pubmed Central ID 503779 


 



2.
Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC (2004). Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest  113, 1515-25.   https://doi.org/10.1172/JCI21926




PubMed



        
     
Free Article


 


PubMed ID 15173875
         Pubmed Central ID 419494",https://intramural.nih.gov/search/searchview.taf?ipid=36716
383,BC010631-01,"October 01, 2003 -  September 30, 2004",Characterization of candidate histone methyltransferases,Michael  Lee,Berton K Zbar; PhD,"Laboratory of Immunobiology, NCI",NULL,NULL,"Zofia  Koscielniak (National Cancer Institute)












Elizabeth  Flynn  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36618
384,BC010632-01,"October 01, 2003 -  September 30, 2004",Tancription Machinery and  Regulation in E. coli,Ding Jun Jin,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,"Fred  Blattner
(UW-Madison, Wisconsin)
















Reid  Johnson
(UC-Los Angeles)","Anne-Marie  Hansen (National Cancer Institute)



Chang Hong  Liu (National Cancer Institute)



Huijun  Zhi (National Cancer Institute)



Xinhua  Ji; PhD (National Cancer Institute)












Julio  Cabrera  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cabrera JE, Jin DJ (2003). The distribution of RNA polymerase in Escherichia coli is dynamic and sensitive to environmental cues. Mol Microbiol  50, 1493-505.   https://doi.org/10.1046/j.1365-2958.2003.03805.x




PubMed


 


PubMed ID 14651633
    
     


 



2.
Hansen AM, Lehnherr H, Wang X, Mobley V, Jin DJ (2003). Escherichia coli SspA is a transcription activator for bacteriophage P1 late genes. Mol Microbiol  48, 1621-31.   https://doi.org/10.1046/j.1365-2958.2003.03533.x




PubMed


 


PubMed ID 12791143
    
     


 



3.
Zhi H, Wang X, Cabrera JE, Johnson RC, Jin DJ (2003). Fis stabilizes the interaction between RNA polymerase and the ribosomal promoter rrnB P1, leading to transcriptional activation. J Biol Chem  278, 47340-9.   https://doi.org/10.1074/jbc.M305430200




PubMed


 


PubMed ID 13679374",https://intramural.nih.gov/search/searchview.taf?ipid=36725
385,BC010633-01,"October 01, 2003 -  September 30, 2004",Transcription Regulation and Pathogenesis in H. pylori,Ding Jun Jin,Jeffrey N Strathern,"Gene Regulation and Chromosome Biology Laboratory, NCI",NULL,NULL,Yi  Yang  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36726
386,BC010634-01,"October 01, 2003 -  September 30, 2004",Pubertal study of offspring of preeclamptics and normotensives,Michele  Forman; PhD,Douglas  Lowy; MD,"Genome Structure and Function Section, NCI",NULL,"Lisa  Colbert
(University of Wisconsin)
















Lars  Vatten
(Epidemiology, University of Trondheim)","James Carl Barrett; PhD (National Cancer Institute)



Paul Stuart Albert (National Cancer Institute)



Katherine Ann McGlynn; PhD (National Cancer Institute)












Barry Ira Graubard; PhD  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36707
387,BC010635-01,"October 01, 2003 -  September 30, 2004",Childhood Cancer Pooling Project,Michele  Forman; PhD,Douglas  Lowy; MD,"Genome Structure and Function Section, NCI",NULL,"Eve  Roman
(University of York)





Xiao-Ou  Shu
(Vanderbilt University)
















Joachim  Schuez
(University of Mainz)","Barry Ira Graubard; PhD (National Cancer Institute)












Martha S Linet; PhD  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36704
388,BC010636-01,"October 01, 2003 -  September 30, 2004","Cervical Cancer in Shanxi Province, China",Michele  Forman; PhD,Douglas  Lowy; MD,"Genome Structure and Function Section, NCI",NULL,"You-Lin  Qiao
(Cancer Institute of the Chinese Academy of Science)





Jerome  Belinson
(Cleveland Clinic)
















Fanghui  Zhao","Arti C Patel (National Cancer Institute)












Barry Ira Graubard; PhD  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36705
389,BC010637-01,"October 01, 2003 -  September 30, 2004","Early puberty, higher obesity, and lower energy expenditure in African American",Michele  Forman; PhD,Douglas  Lowy; MD,"Genome Structure and Function Section, NCI",NULL,"Fred  Kadlubar
(Molecular Epidemiology, FDA)
















Paul  Kaplowitz
(Pediatric Endocrinology, Children's National Medical Center)","James Carl Barrett; PhD (National Cancer Institute)



Marie  Cantwell (National Cancer Institute)












Paul Stuart Albert  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36706
390,BC010638-01,"October 01, 2003 -  September 30, 2004",The role of c-met in liver biology,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Elizabeth A Conner,NULL,"Timothy V Benjamin (National Cancer Institute)



Valentina  Factor (Cellular and Molecular Biology Section)



Luis Enrique Gomez-Quiroz (National Cancer Institute)



Tanya N Hoang (Cellular and Molecular Biology Section)



Shoshiro  Oe (National Cancer Institute)



Aranzazu  Sanchez Munoz (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36619
391,BC010639-01,"October 01, 2003 -  September 30, 2004",In Silico Screening for Cancer Targets,"Marc C Nicklaus



IRP Faculty Profile",Victor  Marquez; PhD,"ORGANIC CHEMSTRY SECT, NCI",NULL,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)



Donald P Bottaro; PhD (National Cancer Institute)












Megan  Peach  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36741
392,BC010642-01,"October 01, 2004 -  September 30, 2005",Chemistry,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Richard  Cysyk; PhD,NULL,Leonard  Neckers; PhD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36096
393,BC010644-01,"October 01, 2004 -  September 30, 2005",Preclinical Models Strategy Team,"Patricia  Steeg; PhD



IRP Faculty Profile",NULL,"Molecular Therapeutics Program, NCI",Lyuba  Varticovski,NULL,Glenn  Merlino; PhD (National Cancer Institute),NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36094
394,BC010645-01,"October 01, 2003 -  September 30, 2004",Study of Uncontrolled Tissue Growth and Cell Invasion in Drosophila,"Steven X Hou



IRP Faculty Profile",Berton K Zbar; PhD,"Laboratory of Immunobiology, NCI",NULL,NULL,"Helen  Hyunhe shin (National Cancer Institute)



Changwan  Lu (National Cancer Institute)



Su-Wan  Oh (National Cancer Institute)



Shree Ram  Singh (National Cancer Institute)



Hong  Wang (National Cancer Institute)



Grace Zhiyu  Zheng (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36713
395,BC010646-01,"October 01, 2003 -  September 30, 2004",Chromatin Remodeling Proteins,"Gordon Lee Hager; PhD



IRP Faculty Profile",NULL,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Ronit  Salomon (National Cancer Institute)












Sam  John  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36710
396,CP004410-28,"October 01, 2003 -  September 30, 2003",Family Studies,"Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Xiaohong Rose Yang; PhD,"Donato  Calista
(Bufalini Hospital)





Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)





David  Hogg
(University of Toronto)





Mark R Kelley; PhD
(Department of Pediatrics, Indiana School of Medicine)





Jeannette  Korczak
(Karmanos Cancer Institute)





Y.  Reid
(American Type Culture Collection)


Show all 7","Mary C Fraser (National Cancer Institute)



Nancy E Weissman (National Cancer Institute)



Mary Louise McMaster; MD (National Cancer Institute)



Naoko  Ishibe; ScD (National Cancer Institute)



Neil Edward Caporaso; MS, MD (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA (2004). Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet  41, 421-4.   https://doi.org/10.1136/jmg.2004.019349




PubMed



        
     
Free Article


 


PubMed ID 15173226
         Pubmed Central ID 1735800 


 



2.
Ishibe N, Goldin LR, Caporaso NE, Sgambati MT, Dean M, Albitar M, Manshouri T, Gerrard B, Marti GE (2003). ATM mutations and protein expression are not associated with familial B-CLL cases. Leuk Res  27, 973-5.   https://doi.org/10.1016/s0145-2126(03)00067-5




PubMed


 


PubMed ID 12860021",https://intramural.nih.gov/search/searchview.taf?ipid=33710
397,CP005779-10,"October 01, 2003 -  September 30, 2003",Epidemiology and Natural History of Human Immunodeficiency Viruses,Robert  Biggar; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",James Jerome Goedert; MD,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Modi WS, Goedert JJ, Strathdee S, Buchbinder S, Detels R, Donfield S, O'Brien SJ, Winkler C (2003). MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS  17, 2357-65.   https://doi.org/10.1097/00002030-200311070-00011




PubMed


 


PubMed ID 14571188",https://intramural.nih.gov/search/searchview.taf?ipid=33708
398,CP005780-10,"October 01, 2003 -  September 30, 2003",Epidemiology and Natural History of HTLV-II,Robert  Biggar; MD,NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Stephen  Wiktor
(Centers of Disease Control and Prevention)
















Francis  Black
(Yale University School of Public Health)","James Jerome Goedert; MD (National Cancer Institute)



Michie  Hisada; MD, MPH, ScD (National Cancer Institute)












Elizabeth M Maloney  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=33709
399,CP005781-10,"October 01, 2003 -  September 30, 2003",HIV and AIDS-Associated Cancers,"Charles  Rabkin



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Shou-Jiang  Gao
(University of Texas)





Lisa  Jacobson
(Johns Hopkins University School of Public Health)





Evelyene  Lennette
(Virolab, Inc.)





Richard  Miller
(Medical Followup Agency)





Debbie  van Baarle
(University of Amsterdam)





Bea  van den Berg
(Child Health and Development Study)


Show all 7",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33706
400,CP005782-10,"October 01, 2003 -  September 30, 2003",Epidemiology of Oncogenic Viruses,"Thomas R O'Brien; BA, MPH, MD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Elizabeth M Maloney



Michie  Hisada; MD, MPH, ScD



Eric Andrew Engels; PhD







Charles  Rabkin","M. Elaine  Eyster
(Pennsylvania State University)





Arye  Rubinstein
(Albert Einstein College of Medicine)
















Richard  Ambinder
(Johns Hopkins)","Robert  Biggar; MD (Infection & Immunoepidemiology Branch)












Ruth  Pfeiffer; PhD  (Biostatistics Branch)",NULL,"Ordered by publication type and then author name.



1.
Blattner WA, Oursler KA, Cleghorn F, Charurat M, Sill A, Bartholomew C, Jack N, O'Brien T, Edwards J, Tomaras G, Weinhold K, Greenberg M (2004). Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS. J Infect Dis  189, 1793-801.   https://doi.org/10.1086/386306




PubMed


 


PubMed ID 15122515
    
     


 



2.
Tanaka Y, Pfeiffer R, Yeo AE, Mizokami M, Edlin BR, Castle P, O'Brien TR, Alter HJ, Shih JW (2004). PCR-probe capture hybridization assay and statistical model for SEN virus prevalence estimation. J Med Virol  73, 123-30.   https://doi.org/10.1002/jmv.20067




PubMed


 


PubMed ID 15042659",https://intramural.nih.gov/search/searchview.taf?ipid=33707
401,CP005803-10,"October 01, 2003 -  September 30, 2003",Genetic Epidemiology,"Alisa  Goldstein; PhD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",Xiaohong Rose Yang; PhD,"Florence  Demenais
(Institut National de la Sante et de la Recherche Medicale)





David  Hogg
(University of Toronto)





Theodora  Stavrou
(Children's National Medical Center)





Julianne  Byrne
(Washington Children's hospital)





Jorgen  Olsen
(Danish Cancer Society)





Lene  Mellemkjaer
(Danish Cancer Society)


Show all 9","Mary C Fraser (National Cancer Institute)



Yan  Bai (National Cancer Institute)



Gladys M. Glenn; MD, PhD (National Cancer Institute)



Lynn Rachel Goldin; PhD (National Cancer Institute)



Naoko  Ishibe; ScD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
(2003) Genomic regions linked to alcohol consumption in the Framingham Heart Study.  BMC Genet 4:S101.




 



2.
Baccarelli A, Calista D, Minghetti P, Marinelli B, Albetti B, Tseng T, Hedayati M, Grossman L, Landi G, Struewing JP, Landi MT (2004). XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br J Cancer  90, 497-502.   https://doi.org/10.1038/sj.bjc.6601385




PubMed



        
     
Free Article


 


PubMed ID 14735199
         Pubmed Central ID 2409542 


 



3.
Choo D, Shotland L, Mastroianni M, Glenn G, van Waes C, Linehan WM, Oldfield EH (2004). Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg  100, 480-7.   https://doi.org/10.3171/jns.2004.100.3.0480




PubMed


 


PubMed ID 15035284
    
     


 



4.
Hu N, Goldstein AM, Albert PS, Giffen C, Tang ZZ, Ding T, Taylor PR, Emmert-Buck MR (2003). Evidence for a familial esophageal cancer susceptibility gene on chromosome 13. Cancer Epidemiol Biomarkers Prev  12, 1112-5.




PubMed


 


PubMed ID 14578153
    
     


 



5.
Hu N, Wang C, Su H, Li WJ, Emmert-Buck MR, Li G, Roth MJ, Tang ZZ, Lu N, Giffen C, Albert PS, Taylor PR, Goldstein AM (2004). High frequency of CDKN2A alterations in esophageal squamous cell carcinoma from a high-risk Chinese population. Genes Chromosomes Cancer  39, 205-16.   https://doi.org/10.1002/gcc.10315




PubMed


 


PubMed ID 14732922
    
     


 



6.
Millen AE, Tucker MA, Hartge P, Halpern A, Elder DE, Guerry D, Holly EA, Sagebiel RW, Potischman N (2004). Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev  13, 1042-51.




PubMed


 


PubMed ID 15184262
    
     


 



7.
Pithukpakorn M, Glenn G (2004) von Hippel-Lindau Syndrome. Community Oncology 1:232-243




 



8.
Struewing J, Hartge P, Wacholder S, Tucker M, Greene M (2004) BRCA1 and Sex Ratio. European J of Human Genetics 12:663-667




 



9.
Struewing JP, Hartge P, Wacholder S, Tucker MA, Greene MH (2004). BRCA1 and sex ratio. Eur J Hum Genet  12, 663-7.   https://doi.org/10.1038/sj.ejhg.5201210




PubMed


 


PubMed ID 15114373",https://intramural.nih.gov/search/searchview.taf?ipid=33705
402,CP005804-10,"October 01, 2003 -  September 30, 2003",Pharmacogenetic Studies,"Neil Edward Caporaso; MS, MD



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",NULL,"Y.  Reid
(American Type Culture Collection)
















Janis  Beach
(Information Management Systems)","Andrew Wells Bergen (Office of the Director)



Alisa  Goldstein; PhD (National Cancer Institute)



Lynn Rachel Goldin; PhD (National Cancer Institute)



Naoko  Ishibe; ScD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Baccarelli A, Pesatori AC, Masten SA, Patterson DG, Needham LL, Mocarelli P, Caporaso NE, Consonni D, Grassman JA, Bertazzi PA, Landi MT (2004). Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy. Toxicol Lett  149, 287-93.   https://doi.org/10.1016/j.toxlet.2003.12.062




PubMed


 


PubMed ID 15093275
    
     


 



2.
Landi MT, Baccarelli A, Seveso Study Group (2003). Correspondence re: K. Toide et al, Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. 12: 219-222, 2003. Cancer Epidemiol Biomarkers Prev  12, 1116-7; author reply 1118.




PubMed


 


PubMed ID 14578154",https://intramural.nih.gov/search/searchview.taf?ipid=33704
403,CP005805-10,"October 01, 2003 -  September 30, 2003",Late Effects of Cancer Treatment,"Margaret Anne Tucker



IRP Faculty Profile",NULL,"Genetic Epidemiology Branch, NCI",NULL,NULL,"Dilys  Parry; PhD (National Cancer Institute)












Mary C Fraser  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=33703
404,CP010119-09,"October 01, 2003 -  September 30, 2003",Studies of Occupational Cancer (Pesticides),Michael  Alavanja; PhD,NULL,"National Cancer Institute, NCI","Joanne S Colt



Mary Helen Ward; MS, PhD



Shelia K Zahm; ScM, ScD



Jerome  Delon; PhD



Debra  Silverman; ScD, ScM



Mustafa  Dosemeci; PhD



Show all 12","Andrew  Olshan
(University of North Carolina)





Andrew  Olshan; PhD
(Department of Epidemiology, University of North Carolina)





Sandra  Petralia
(Roche Laboratories)





Dennis  Weisenburger
(University of Nebraska Medical Center)
















Lisbeth  Lopez-Carrillo
(Mexican National Institute of Public Health)",Patricia S Stewart; PhD (Occupational and Environmental Epidemiology Branch),NULL,"Ordered by publication type and then author name.



1.
Alavanja MC, Hoppin JA, Kamel F (2004). Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health  25, 155-97.   https://doi.org/10.1146/annurev.publhealth.25.101802.123020




PubMed


 


PubMed ID 15015917
    
     


 



2.
Flower KB, Hoppin JA, Lynch CF, Blair A, Knott C, Shore DL, Sandler DP (2004). Cancer risk and parental pesticide application in children of Agricultural Health Study participants. Environ Health Perspect  112, 631-5.   https://doi.org/10.1289/ehp.6586




PubMed



        
     
Free Article


 


PubMed ID 15064173
         Pubmed Central ID 1241933 


 



3.
Hoppin JA, Umbach DM, London SJ, Alavanja MC, Sandler DP (2004). Diesel exhaust, solvents, and other occupational exposures as risk factors for wheeze among farmers. Am J Respir Crit Care Med  169, 1308-13.   https://doi.org/10.1164/rccm.200309-1228OC




PubMed


 


PubMed ID 15070818
    
     


 



4.
Zhang Y, Wise JP, Holford TR, Xie H, Boyle P, Zahm SH, Rusiecki J, Zou K, Zhang B, Zhu Y, Owens PH, Zheng T (2004). Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol  160, 1177-83.   https://doi.org/10.1093/aje/kwh346




PubMed


 


PubMed ID 15583370",https://intramural.nih.gov/search/searchview.taf?ipid=33698
405,CP010120-09,"October 01, 2003 -  September 30, 2004",Studies of Occupational Cancer,"Aaron E Blair; PhD, MPH",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Dalsu  Baris



Joanne S Colt



Bu Tian  Ji



Mary Helen Ward; MS, PhD



Joseph B Coble



Roel  Vermeulen



Show all 19","Leon  Burmeister
(University of Iowa)





Larwence  Figgs
(St. Louis University)





Daniel  Lackland
(Medical University of South Carolina)





J.  Nichols
(Medical University of South Carolina)





Dennis  Zaebst
(National Institute for Occupational Safety and Health)





Dennis  Weisenburger
(University of Nebraska Medical Center)


Show all 9","David C Montefiori; PhD (National Cancer Institute)



Jay  Lubin; PhD (Biostatistics Branch)



Jennifer A Rusiecki (National Cancer Institute)












Michael  Hauptmann; PhD  (Biostatistics Branch)



Manolis  Kogevinas  (National Cancer Institute)



Shelia K Zahm; ScM, ScD  (Office of the Director)",Wei  Huang; PhD (NIA),"Ordered by publication type and then author name.



1.
(2004) A Population-Based case-control study of Occupation and Renal Cell carcinoma risk in Iowa.  J Occup Environ Med 46:235-240.




 



2.
Adegoke OJ, Blair A, Ou Shu X, Sanderson M, Addy CL, Dosemeci M, Zheng W (2004). Agreement of job-exposure matrix (JEM) assessed exposure and self-reported exposure among adult leukemia patients and controls in Shanghai. Am J Ind Med  45, 281-8.   https://doi.org/10.1002/ajim.10351




PubMed


 


PubMed ID 14991855
    
     


 



3.
Bakke B, Ulvestad B, Stewart P, Eduard W   (2004) Cumulative exposure to dust and gases as determinants of lung function decline in tunnel construction workers.  Occup Environ Med 61:262-9.




PubMed



        
     
Free Article


 


PubMed ID 14985522
         Pubmed Central ID 1740732 


 



4.
Casanova M, Cole P, Collins JJ, Conolly R, Delzell E, Heck Hd HA, Leonard R, Lewis R, Marsh GM, Ott MG, Sorahan T, Axten CW   (2004) Re: Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries.  J Natl Cancer Inst 96:966-7; author reply 967-8.




PubMed


 


PubMed ID 15199116
    
     


 



5.
Chiu BC, Weisenburger DD, Zahm SH, Cantor KP, Gapstur SM, Holmes F, Burmeister LF, Blair A (2004). Agricultural pesticide use, familial cancer, and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev  13, 525-31.




PubMed


 


PubMed ID 15066915
    
     


 



6.
Elci OC, Akpinar-Elci M, Alavanja M, Dosemeci M (2003). Occupation and the risk of lung cancer by histologic types and morphologic distribution: a case control study in Turkey. Monaldi Arch Chest Dis  59, 183-8.




PubMed


 


PubMed ID 15065312
    
     


 



7.
Elci OC, Akpinar-Elci M, Blair A, Dosemeci M (2003). Risk of laryngeal cancer by occupational chemical exposure in Turkey. J Occup Environ Med  45, 1100-6.   https://doi.org/10.1097/01.jom.0000085890.50021.6f




PubMed


 


PubMed ID 14534452
    
     


 



8.
Fransman W, Vermeulen R, Kromhout H (2004). Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Ann Occup Hyg  48, 237-44.   https://doi.org/10.1093/annhyg/meh017




PubMed


 


PubMed ID 15059800
    
     


 



9.
Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A (2003). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst  95, 1615-23.   https://doi.org/10.1093/jnci/djg083




PubMed


 


PubMed ID 14600094
    
     


 



10.
Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A (2004). Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol  159, 1117-30.   https://doi.org/10.1093/aje/kwh174




PubMed


 


PubMed ID 15191929
    
     


 



11.
Jackson LW, Correa-Villaseor A, Lees PS, Dominici F, Stewart PA, Breysse PN, Matanoski G   (2004) Parental lead exposure and total anomalous pulmonary venous return.  Birth Defects Res A Clin Mol Teratol 70:185-93.




PubMed


 


PubMed ID 15108245
    
     


 



12.
Keohavong P, Gao WM, Zheng KC, Mady H, Lan Q, Melhem M, Mumford J (2004). Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis. Anal Biochem  324, 92-9.   https://doi.org/10.1016/j.ab.2003.09.030




PubMed


 


PubMed ID 14654050
    
     


 



13.
Kogevinas M, Zahm SH (2003). Introduction: epidemiologic research on occupational health in women. Am J Ind Med  44, 563-4.   https://doi.org/10.1002/ajim.10317




PubMed


 


PubMed ID 14635232
    
     


 



14.
Kromhout H, Fransman W, Vermeulen R, Roff M, van Hemmen JJ (2004). Variability of task-based dermal exposure measurements from a variety of workplaces. Ann Occup Hyg  48, 187-96.   https://doi.org/10.1093/annhyg/meh030




PubMed


 


PubMed ID 15059794
    
     


 



15.
Lan Q, He X (2004). Molecular epidemiological studies on the relationship between indoor coal burning and lung cancer in Xuan Wei, China. Toxicology  198, 301-5.   https://doi.org/10.1016/j.tox.2004.02.006




PubMed


 


PubMed ID 15138056
    
     


 



16.
Lee WJ, Baris D, Järvholm B, Silverman DT, Bergdahl IA, Blair A (2003). Multiple myeloma and diesel and other occupational exposures in swedish construction workers. Int J Cancer  107, 134-8.   https://doi.org/10.1002/ijc.11351




PubMed


 


PubMed ID 12925968
    
     


 



17.
Vermeulen R, Li G, Lan Q, Dosemeci M, Rappaport SM, Bohong X, Smith MT, Zhang L, Hayes RB, Linet M, Mu R, Wang L, Xu J, Yin S, Rothman N (2004). Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann Occup Hyg  48, 105-16.   https://doi.org/10.1093/annhyg/meh005




PubMed


 


PubMed ID 14990432
    
     


 



18.
Wilson RT, Moore LE, Dosemeci M (2004). Occupational exposures and salivary gland cancer mortality among African American and white workers in the United States. J Occup Environ Med  46, 287-97.   https://doi.org/10.1097/01.jom.0000116802.01928.83




PubMed


 


PubMed ID 15091292
    
     


 



19.
Zhang L, Hayes RB, Guo W, McHale CM, Yin S, Wiencke JK, Patrick O'Neill J, Rothman N, Li GL, Smith MT (2004). Lack of increased genetic damage in 1,3-butadiene-exposed Chinese workers studied in relation to EPHX1 and GST genotypes. Mutat Res  558, 63-74.   https://doi.org/10.1016/j.mrgentox.2003.11.001




PubMed



        
     
Free Article


 


PubMed ID 15036120
         Pubmed Central ID 1249498",https://intramural.nih.gov/search/searchview.taf?ipid=33700
406,CP010121-09,"October 01, 2003 -  September 30, 2003",Molecular Epidemiology Studies of Occupational and Environmental Exposures,"Nathaniel C Rothman; MD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI",Juan  Alguacil-ojeda,"Stephen  Rappaport
(University of North Carolina)





Martyn  Smith
(University of California at Berkeley)





Wei  Zheng
(University of South Carolina)





John D  Tessari
(Colorado State University)
















Larwence  Figgs
(St. Louis University)","Mary Helen Ward; MS, PhD (National Cancer Institute)



Shelia K Zahm; ScM, ScD (National Cancer Institute)



Mustafa  Dosemeci; PhD (National Cancer Institute)



Michael  Alavanja; PhD (National Cancer Institute)



Kenneth  Cantor; PhD (National Cancer Institute)



Aaron E Blair; PhD, MPH (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alguacil J, Porta M, Kauppinen T, Malats N, Kogevinas M, Carrato A   (2003) Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.  Int J Cancer 107:635-41.




PubMed


 


PubMed ID 14520703
    
     


 



2.
Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC (2004). SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev  13, 681-7.




PubMed


 


PubMed ID 15159297
    
     


 



3.
Waidyanatha S, Rothman N, Li G, Smith MT, Yin S, Rappaport SM (2004). Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal Biochem  327, 184-99.   https://doi.org/10.1016/j.ab.2004.01.008




PubMed


 


PubMed ID 15051535",https://intramural.nih.gov/search/searchview.taf?ipid=33701
407,CP010122-09,"October 01, 2003 -  September 30, 2003",Occupational Exposure Assessment,Patricia S Stewart; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joseph B Coble



Mark Christopher Donahue



Qing  Lan","Berit  Bakke
(National Institute of Occupational Health)





Robert  Branch
(University of Pittsburgh)





Harvey  Checkoway
(University of Washington)





Pierluigi  Cocco
(University of Cagliari)





Hans  Kromhout
(University of Utrecht)





Peter  Lees
(Johns Hopkins University)


Show all 53","Roel  Vermeulen (National Cancer Institute)



Carol  Rice (National Cancer Institute)



Michael  Alavanja; PhD (National Cancer Institute)



Dalsu  Baris (National Cancer Institute)



Aaron E Blair; PhD, MPH (National Cancer Institute)



Kenneth  Cantor; PhD (National Cancer Institute)",Ralph E. Wilson (NIEHS),There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33699
408,CP010123-09,"October 01, 2003 -  September 30, 2003",Studies of Occupational Cancer among Women and Minorities,Wong H Chow,NULL,"Occupational and Environmental Epidemiology Branch, NCI",Patricia S Stewart; PhD,"Eleuterio  Bravo-Otero
(University of Puerto Rico)





S.  Cooper
(The University of Texas)





Yu-Tang  Gao
(Shanghai Cancer Institute)





N.  Heyer
(University of Washington)





L.  Hoffman-Goetz
(University of Waterloo)





Fan  Jin
(Shanghai Cancer Institute)


Show all 20","Dalsu  Baris (National Cancer Institute)



Aaron E Blair; PhD, MPH (National Cancer Institute)



Linda M Brown; MPH, DPhil (Biostatistics Branch)



Kenneth  Cantor; PhD (National Cancer Institute)



Mustafa  Dosemeci; PhD (National Cancer Institute)



Lawrence  Engel (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Morton LM, Engels EA, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Zhang B, Flynn S, Tallini G, Owens PH, Zheng T (2004). Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev  13, 425-30.




PubMed


 


PubMed ID 15006919
    
     


 



2.
Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, Flynn S, Tallini G, Zhang B, Owens PH, Zheng T (2003). Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer  89, 2087-92.   https://doi.org/10.1038/sj.bjc.6601388




PubMed



        
     
Free Article


 


PubMed ID 14647142
         Pubmed Central ID 2376853 


 



3.
Rosenthal AD, Jin F, Shu XO, Yang G, Elasy TA, Chow WH, Ji BT, Xu HX, Li Q, Gao YT, Zheng W (2004). Body fat distribution and risk of diabetes among Chinese women. Int J Obes Relat Metab Disord  28, 594-9.   https://doi.org/10.1038/sj.ijo.0802597




PubMed


 


PubMed ID 14770196
    
     


 



4.
Zahm SH, Blair A (2003). Occupational cancer among women: where have we been and where are we going? Am J Ind Med  44, 565-75.   https://doi.org/10.1002/ajim.10270




PubMed


 


PubMed ID 14635233
    
     


 



5.
Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Flynn S, Tallini G, Owens PH, Zheng T (2004). Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol  159, 148-54.   https://doi.org/10.1093/aje/kwh033




PubMed


 


PubMed ID 14718216
    
     


 



6.
Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, Zhang B, Zou K, Flynn S, Tallini G, Owens PH, Zheng T (2004). Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control  15, 419-28.   https://doi.org/10.1023/B:CACO.0000027506.55846.5d




PubMed


 


PubMed ID 15141141
    
     


 



7.
Zheng T, Holford TR, Leaderer B, Zhang Y, Zahm SH, Flynn S, Tallini G, Zhang B, Zhou K, Owens PH, Lan Q, Rothman N, Boyle P (2004). Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol  159, 454-66.   https://doi.org/10.1093/aje/kwh067




PubMed


 


PubMed ID 14977641",https://intramural.nih.gov/search/searchview.taf?ipid=33702
409,CP010124-09,"October 01, 2003 -  September 30, 2004",Cervical cancer and human papillomavirus (HPV) infection,"Mark  Schiffman; MD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","Sophia S Wang; PhD







Louise  Brinton; PhD




Philip E Castle; PhD, MPH","Robert  Burk
(Albert Einstein College of Medicine)





Peggy  Crowley-Nowick
(Brigham and Women's Hospital, Harvard Medical School)





Sharon  Hillier
(University of Pittsburgh)





Martha  Hutchinson
(Brown University)





Ana Cecilia  Rodriguez
(Costa Rican Social Security)





David  Schneider; PhD
(Department of Biology, Whitehead Institute)


Show all 15","Allan  Hildesheim; PhD (National Cancer Institute)



Sean Fitzgerald Altekruse (Cancer Statistics Branch)



James V Lacey; MPH, PhD (National Cancer Institute)



Nilanjan  Chatterjee (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Tammy S Shields (National Cancer Institute)",Mohammed A. Khan; PhD (NHLBI),"Ordered by publication type and then author name.



1.
(2003) A Population based study of Herpes Simplex Virus 2 seroprevalence in rural Costa Rica.  Sex Transm Dis 79:460-465.




 



2.
(2004) Performance of Direct Visual Inspection of the Cervix with Acetic Acid and Magnification in a Previously Screened Population.  J Low Gen Tract Dis 2-Aug:132-138.




 



3.
Barr E, Koutsky LA   (2004) Re: Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.  J Natl Cancer Inst 96:412-3; author reply 413-4.




PubMed


 


PubMed ID 14996866
    
     


 



4.
Bratti MC, Rodríguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, Guillén D, Hutchinson M, Sherman ME, Eklund C, Schussler J, Buckland J, Morera LA, Cárdenas F, Barrantes M, Pérez E, Cox TJ, Burk RD, Herrero R (2004). Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,. Rev Panam Salud Publica  15, 75-89.   https://doi.org/10.1590/s1020-49892004000200002




PubMed


 


PubMed ID 15030652
    
     


 



5.
Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003). Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res  63, 7215-20.




PubMed


 


PubMed ID 14612516
    
     


 



6.
Castle PE, Hildesheim A, Schiffman M, Gaydos CA, Cullen A, Herrero R, Bratti MC, Freer E (2003). Stability of archived liquid-based cytologic specimens. Cancer  99, 320-2.   https://doi.org/10.1002/cncr.11723




PubMed


 


PubMed ID 14579301
    
     


 



7.
Castle PE, Phillips TM, Hildesheim A, Herrero R, Bratti MC, Rodríguez AC, Morera LA, Pfeiffer R, Hutchinson ML, Pinto LA, Schiffman M (2003). Immune profiling of plasma and cervical secretions using recycling immunoaffinity chromatography. Cancer Epidemiol Biomarkers Prev  12, 1449-56.




PubMed


 


PubMed ID 14693736
    
     


 



8.
Castle PE, Rodriguez AC, Bowman FP, Herrero R, Schiffman M, Bratti MC, Morera LA, Schust D, Crowley-Nowick P, Hildesheim A (2004). Comparison of ophthalmic sponges for measurements of immune markers from cervical secretions. Clin Diagn Lab Immunol  11, 399-405.   https://doi.org/10.1128/cdli.11.2.399-405.2004




PubMed



        
     
Free Article


 


PubMed ID 15013994
         Pubmed Central ID 371211 


 



9.
Castle PE, Schiffman M, Bratti MC, Hildesheim A, Herrero R, Hutchinson ML, Rodriguez AC, Wacholder S, Sherman ME, Kendall H, Viscidi RP, Jeronimo J, Schussler JE, Burk RD (2004). A population-based study of vaginal human papillomavirus infection in hysterectomized women. J Infect Dis  190, 458-67.   https://doi.org/10.1086/421916




PubMed


 


PubMed ID 15243917
    
     


 



10.
Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T (2003). Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol  163, 1405-16.   https://doi.org/10.1016/S0002-9440(10)63498-0




PubMed



        
     
Free Article


 


PubMed ID 14507648
         Pubmed Central ID 1868295 


 



11.
Jeronimo J, Castle PE, Herrero R, Burk RD, Schiffman M (2003). HPV testing and visual inspection for cervical cancer screening in resource-poor regions. Int J Gynaecol Obstet  83, 311-3.   https://doi.org/10.1016/s0020-7292(03)00299-6




PubMed


 


PubMed ID 14643047
    
     


 



12.
Pastrana DV, Buck CB, Pang YY, Thompson CD, Castle PE, FitzGerald PC, Krüger Kjaer S, Lowy DR, Schiller JT (2004). Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology  321, 205-16.   https://doi.org/10.1016/j.virol.2003.12.027




PubMed


 


PubMed ID 15051381
    
     


 



13.
Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M   (2003) Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions.  Cancer Epidemiol Biomarkers Prev 12:1038-44.




PubMed


 


PubMed ID 14578140
    
     


 



14.
Shields TS, Falk RT, Herrero R, Schiffman M, Weiss NS, Bratti C, Rodriguez AC, Sherman ME, Burk RD, Hildesheim A (2004). A case-control study of endogenous hormones and cervical cancer. Br J Cancer  90, 146-52.   https://doi.org/10.1038/sj.bjc.6601514




PubMed



        
     
Free Article


 


PubMed ID 14710222
         Pubmed Central ID 2395325 


 



15.
Solomon D, Schiffman M (2004). Have we resolved how to triage equivocal cervical cytology? J Natl Cancer Inst  96, 250-1.   https://doi.org/10.1093/jnci/djh063




PubMed


 


PubMed ID 14970266
    
     


 



16.
Viscidi RP, Schiffman M, Hildesheim A, Herrero R, Castle PE, Bratti MC, Rodriguez AC, Sherman ME, Wang S, Clayman B, Burk RD (2004). Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev  13, 324-7.   https://doi.org/10.1158/1055-9965.epi-03-0166




PubMed


 


PubMed ID 14973086
    
     


 



17.
Wang S, Sherman M, Rader MD J, Carreon J, Schiffman M, Baker C (2005) Towards improved biomarker studies of cervical neoplasia: Effects of precolposcopic procedures on gene expression patterns. Diagnostic Molecular Pathology 2005:59-64




 



18.
Wang SS, Schiffman M, Shields TS, Herrero R, Hildesheim A, Bratti MC, Sherman ME, Rodriguez AC, Castle PE, Morales J, Alfaro M, Wright T, Chen S, Clayman B, Burk RD, Viscidi RP (2003). Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica. Br J Cancer  89, 1248-54.   https://doi.org/10.1038/sj.bjc.6601272




PubMed



        
     
Free Article


 


PubMed ID 14520455
         Pubmed Central ID 2394308 


 



19.
Wang SS, Sherman ME, Hildesheim A, Lacey JV, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer  100, 1035-44.   https://doi.org/10.1002/cncr.20064




PubMed


 


PubMed ID 14983500",https://intramural.nih.gov/search/searchview.taf?ipid=33691
410,CP010125-09,"October 01, 2003 -  September 30, 2003",Cancer Risk and Environmental Exposures,Kenneth  Cantor; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI","Patricia S Stewart; PhD



Qing  Lan","Charles  Lynch
(University of Iowa)





Charles C. Lynch; PhD, MD
(University of Iowa)





R. William  Field
(University of Iowa, Iowa City, IO)





Manolis  Kogevinas






John  Reif
(Colorado State University)





J. W. Brock; PhD
(Centers for Disease Control)


Show all 19","Joanne S Colt (National Cancer Institute)



Daryl  Freedman (National Cancer Institute)



Shelia K Zahm; ScM, ScD (National Cancer Institute)



Mary Helen Ward; MS, PhD (National Cancer Institute)



Lawrence  Engel (National Cancer Institute)



Claudine M Samanic (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH (2004). Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol  159, 381-9.   https://doi.org/10.1093/aje/kwh054




PubMed


 


PubMed ID 14769642
    
     


 



2.
Coss A, Cantor KP, Reif JS, Lynch CF, Ward MH (2004). Pancreatic cancer and drinking water and dietary sources of nitrate and nitrite. Am J Epidemiol  159, 693-701.   https://doi.org/10.1093/aje/kwh081




PubMed


 


PubMed ID 15033647
    
     


 



3.
De Roos AJ, Ward MH (2004). Drinking water and cancer. Epidemiology  15, 378-80.   https://doi.org/10.1097/01.ede.0000122631.63762.b2




PubMed


 


PubMed ID 15097029
    
     


 



4.
De Roos AJ, Ward MH, Lynch CF, Cantor KP (2003). Nitrate in public water supplies and the risk of colon and rectum cancers. Epidemiology  14, 640-9.   https://doi.org/10.1097/01.ede.0000091605.01334.d3




PubMed


 


PubMed ID 14569178
    
     


 



5.
Moore LE, Smith AH, Eng C, DeVries S, Kalman D, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn C, Biggs ML, Bates MN, Waldman FM (2003). P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis  24, 1785-91.   https://doi.org/10.1093/carcin/bgg136




PubMed


 


PubMed ID 12919957
    
     


 



6.
Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP (2004). History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol  159, 42-8.   https://doi.org/10.1093/aje/kwh014




PubMed


 


PubMed ID 14693658
    
     


 



7.
Villanueva CM, Cantor KP, Cordier S, Jaakkola JJ, King WD, Lynch CF, Porru S, Kogevinas M (2004). Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology  15, 357-67.   https://doi.org/10.1097/01.ede.0000121380.02594.fc




PubMed


 


PubMed ID 15097021",https://intramural.nih.gov/search/searchview.taf?ipid=33711
411,CP010126-09,"October 01, 2003 -  September 30, 2003",Hormone-Related Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI","James V Lacey; MPH, PhD","Douglas  Bauer
(University of California at San Francisco)





Ralph  Coates
(Centers for Disease Control and Prevention)





Joanne  Dorgan; PhD
(NCI)





R. Loren  Erickson
(Department of Defense)





Larwence  Figgs
(St. Louis University)





Jolanta  Lissowsaka
(Maria Sklodowsak-Curie Memorial Cancer Center)


Show all 10","Tammy S Shields (National Cancer Institute)



Xia  Xu (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Roni T Falk (National Cancer Institute)



Allan  Hildesheim; PhD (National Cancer Institute)



Lori C Sakoda (National Cancer Institute)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Brinton LA, Krüger Kjaer S, Thomsen BL, Sharif HF, Graubard BI, Olsen JH, Bock JE (2004). Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertil Steril  81, 1083-91.   https://doi.org/10.1016/j.fertnstert.2003.08.042




PubMed


 


PubMed ID 15066468
    
     


 



2.
Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL (2004). Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol  103, 1194-203.   https://doi.org/10.1097/01.AOG.0000128139.92313.74




PubMed


 


PubMed ID 15172852
    
     


 



3.
Fergenbaum JH, Garcia-Closas M, Hewitt SM, Lissowska J, Sakoda LC, Sherman ME (2004). Loss of antigenicity in stored sections of breast cancer tissue microarrays. Cancer Epidemiol Biomarkers Prev  13, 667-72.




PubMed


 


PubMed ID 15066936
    
     


 



4.
Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ (2004). Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer  100, 1595-604.   https://doi.org/10.1002/cncr.20169




PubMed


 


PubMed ID 15073845
    
     


 



5.
Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA (2004). Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. Cancer Epidemiol Biomarkers Prev  13, 607-12.




PubMed


 


PubMed ID 15066926",https://intramural.nih.gov/search/searchview.taf?ipid=33712
412,CP010127-09,"October 01, 2003 -  September 30, 2004",Etiologic Studies of Diet and Cancer,Arthur  Schatzkin; PhD,NULL,"Nutritional Epidemiology Branch, NCI","Marcia A Wright



Susie  Chang







Tanuja  Rastogi","Colin  Begg
(Memorial Sloan-Kettering Cancer Center)





Sheila  Bingham
(University of Cambridge)





M. Robert  Cooper
(Wake Forest University School of Medicine)





Stanley  Hamilton
(M.D. Anderson Cancer Center)





Frank  Iber
(Edward Hines Jr. Veterans Administration Hospital)





Rudolf  Kaaks
(International Agency for Research on Cancer)


Show all 15","Mary Helen Ward; MS, PhD (National Cancer Institute)



Stephanie Joan Weinstein (National Cancer Institute)



Raymond  Carroll (National Cancer Institute)



James V Lacey; MPH, PhD (National Cancer Institute)



Ulrike  Peters (National Cancer Institute)



Catherine G Schairer (National Cancer Institute)",Rhonda Woods Carroll (NIAMS),"Ordered by publication type and then author name.



1.
(2004) Dietary protein and the risk of cholecystectomy in a cohort of US women: the Nurses Health Study.  Am J Epidemiol 160:18-Nov.




 



2.
Caan B, Ballard-Barbash R, Slattery ML, Pinsky JL, Iber FL, Mateski DJ, Marshall JR, Paskett ED, Shike M, Weissfeld JL, Schatzkin A, Lanza E (2004). Low energy reporting may increase in intervention participants enrolled in dietary intervention trials. J Am Diet Assoc  104, 357-66; quiz 491.   https://doi.org/10.1016/j.jada.2003.12.023




PubMed


 


PubMed ID 14993857
    
     


 



3.
Cantwell M, Mittl B, Curtin J, Carroll R, Potischman N, Caporaso N, Sinha R (2004). Relative validity of a food frequency questionnaire with a meat-cooking and heterocyclic amine module. Cancer Epidemiol Biomarkers Prev  13, 293-8.   https://doi.org/10.1158/1055-9965.epi-270-2




PubMed


 


PubMed ID 14973110
    
     


 



4.
Eastham JA, Riedel E, Latkany L, Fleisher M, Schatzkin A, Lanza E, Shike M, Polyp Prevention Trial Study Group (2003). Dietary manipulation, ethnicity, and serum PSA levels. Urology  62, 677-82.   https://doi.org/10.1016/s0090-4295(03)00576-4




PubMed


 


PubMed ID 14550442
    
     


 



5.
Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA (2004). Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab  89, 2248-53.   https://doi.org/10.1210/jc.2003-031874




PubMed


 


PubMed ID 15126549
    
     


 



6.
Giles GG, Severi G, English DR, Hopper JL   (2004) Frequency of ejaculation and risk of prostate cancer.  JAMA 292:329; author reply 329.




PubMed


 


PubMed ID 15265846
    
     


 



7.
Hemilä H, Virtamo J, Albanes D, Kaprio J (2003). Physical activity and the common cold in men administered vitamin E and beta-carotene. Med Sci Sports Exerc  35, 1815-20.   https://doi.org/10.1249/01.MSS.0000093616.60899.92




PubMed


 


PubMed ID 14600543
    
     


 



8.
Hemilä H, Virtamo J, Albanes D, Kaprio J (2004). Vitamin E and beta-carotene supplementation and hospital-treated pneumonia incidence in male smokers. Chest  125, 557-65.   https://doi.org/10.1378/chest.125.2.557




PubMed


 


PubMed ID 14769738
    
     


 



9.
Holick CN, Michaud DS, Leitzmann MF, Willett WC, Giovannucci E (2003). Aspirin use and lung cancer in men. Br J Cancer  89, 1705-8.   https://doi.org/10.1038/sj.bjc.6601343




PubMed



        
     
Free Article


 


PubMed ID 14583773
         Pubmed Central ID 2394407 


 



10.
Kant AK, Graubard BI (2003). Predictors of reported consumption of low-nutrient-density foods in a 24-h recall by 8-16 year old US children and adolescents. Appetite  41, 175-80.   https://doi.org/10.1016/s0195-6663(03)00060-6




PubMed


 


PubMed ID 14550315
    
     


 



11.
Kant AK, Graubard BI (2004). Eating out in America, 1987-2000: trends and nutritional correlates. Prev Med  38, 243-9.   https://doi.org/10.1016/j.ypmed.2003.10.004




PubMed


 


PubMed ID 14715218
    
     


 



12.
Kant AK, Graubard BI, Schatzkin A (2004). Dietary patterns predict mortality in a national cohort: the National Health Interview Surveys, 1987 and 1992. J Nutr  134, 1793-9.   https://doi.org/10.1093/jn/134.7.1793




PubMed


 


PubMed ID 15226471
    
     


 



13.
Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC (2004). Diet, nutrition and the prevention of cancer. Public Health Nutr  7, 187-200.   https://doi.org/10.1079/phn2003588




PubMed


 


PubMed ID 14972060
    
     


 



14.
Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, Pietinen P (2003). Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev  12, 1209-12.




PubMed


 


PubMed ID 14652283
    
     


 



15.
Krone CA, Harms LC   (2003) Re: Zinc supplement use and risk of prostate cancer.  J Natl Cancer Inst 95:1556; author reply 1556-7.




PubMed


 


PubMed ID 14559884
    
     


 



16.
Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E (2004). Ejaculation frequency and subsequent risk of prostate cancer. JAMA  291, 1578-86.   https://doi.org/10.1001/jama.291.13.1578




PubMed


 


PubMed ID 15069045
    
     


 



17.
Männistö S, Smith-Warner SA, Spiegelman D, Albanes D, Anderson K, van den Brandt PA, Cerhan JR, Colditz G, Feskanich D, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Miller AB, Rohan TE, Virtamo J, Willett WC, Hunter DJ (2004). Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev  13, 40-8.   https://doi.org/10.1158/1055-9965.epi-038-3




PubMed


 


PubMed ID 14744731
    
     


 



18.
Mahabir S, Leitzmann MF, Pietinen P, Albanes D, Virtamo J, Taylor PR (2004). Physical activity and renal cell cancer risk in a cohort of male smokers. Int J Cancer  108, 600-5.   https://doi.org/10.1002/ijc.11580




PubMed


 


PubMed ID 14696127
    
     


 



19.
Mai V, Katki HA, Harmsen H, Gallaher D, Schatzkin A, Baer DJ, Clevidence B (2004). Effects of a controlled diet and black tea drinking on the fecal microflora composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study. J Nutr  134, 473-8.   https://doi.org/10.1093/jn/134.2.473




PubMed


 


PubMed ID 14747691
    
     


 



20.
Mathew A, Peters U, Chatterjee N, Kulldorff M, Sinha R (2004). Fat, fiber, fruits, vegetables, and risk of colorectal adenomas. Int J Cancer  108, 287-92.   https://doi.org/10.1002/ijc.10984




PubMed


 


PubMed ID 14639617
    
     


 



21.
Peters U, DeMarini DM, Sinha R, Brooks LR, Warren SH, Chatterjee N, Rothman N (2003). Urinary mutagenicity and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev  12, 1253-6.




PubMed


 


PubMed ID 14652290
    
     


 



22.
Platz EA, Leitzmann MF, Michaud DS, Willett WC, Giovannucci E (2003). Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res  63, 8542-8.




PubMed


 


PubMed ID 14679023
    
     


 



23.
Platz EA, Leitzmann MF, Rimm EB, Willett WC, Giovannucci E (2004). Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. Am J Epidemiol  159, 444-53.   https://doi.org/10.1093/aje/kwh062




PubMed


 


PubMed ID 14977640
    
     


 



24.
Raman A, Schoeller DA, Subar AF, Troiano RP, Schatzkin A, Harris T, Bauer D, Bingham SA, Everhart JE, Newman AB, Tylavsky FA (2004). Water turnover in 458 American adults 40-79 yr of age. Am J Physiol Renal Physiol  286, F394-401.   https://doi.org/10.1152/ajprenal.00295.2003




PubMed


 


PubMed ID 14600032
    
     


 



25.
Rastogi T, Reddy KS, Vaz M, Spiegelman D, Prabhakaran D, Willett WC, Stampfer MJ, Ascherio A (2004). Diet and risk of ischemic heart disease in India. Am J Clin Nutr  79, 582-92.   https://doi.org/10.1093/ajcn/79.4.582




PubMed


 


PubMed ID 15051601
    
     


 



26.
Sass DA, Schoen RE, Weissfeld JL, Weissfeld L, Thaete FL, Kuller LH, McAdams M, Lanza E, Schatzkin A (2004). Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol  99, 687-93.   https://doi.org/10.1111/j.1572-0241.2004.04136.x




PubMed


 


PubMed ID 15089903
    
     


 



27.
Schatzkin A, Kipnis V, Carroll RJ, Midthune D, Subar AF, Bingham S, Schoeller DA, Troiano RP, Freedman LS (2003). A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) study. Int J Epidemiol  32, 1054-62.   https://doi.org/10.1093/ije/dyg264




PubMed


 


PubMed ID 14681273
    
     


 



28.
Stolzenberg-Solomon R, El-ghormli L, Schatzkin A, Rosen C, Clevidence B, Campbell W, Snyder K, Judd J, Taylor P (2004). Effects of a low fat, high fiber-carbohydrate diet on components of the IGF axis measured in plasma: a controlled feeding study in men. Cancer Epidemiol Biomarkers Prev  13, 1086-7.




PubMed


 


PubMed ID 15184271
    
     


 



29.
Stolzenberg-Solomon RZ, Limburg P, Pollak M, Taylor PR, Virtamo J, Albanes D (2004). Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev  13, 438-44.




PubMed


 


PubMed ID 15006921
    
     


 



30.
Tooze JA, Subar AF, Thompson FE, Troiano R, Schatzkin A, Kipnis V (2004). Psychosocial predictors of energy underreporting in a large doubly labeled water study. Am J Clin Nutr  79, 795-804.   https://doi.org/10.1093/ajcn/79.5.795




PubMed


 


PubMed ID 15113717
    
     


 



31.
Trabulsi J, Troiano RP, Subar AF, Sharbaugh C, Kipnis V, Schatzkin A, Schoeller DA (2003). Precision of the doubly labeled water method in a large-scale application: evaluation of a streamlined-dosing protocol in the Observing Protein and Energy Nutrition (OPEN) study. Eur J Clin Nutr  57, 1370-7.   https://doi.org/10.1038/sj.ejcn.1601698




PubMed


 


PubMed ID 14576749
    
     


 



32.
Weinstein SJ, Hartman TJ, Stolzenberg-Solomon R, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D (2003). Null association between prostate cancer and serum folate, vitamin B(6), vitamin B(12), and homocysteine. Cancer Epidemiol Biomarkers Prev  12, 1271-2.




PubMed


 


PubMed ID 14652294
    
     


 



33.
Woodson K, Flood A, Green L, Tangrea JA, Hanson J, Cash B, Schatzkin A, Schoenfeld P (2004). Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women. J Natl Cancer Inst  96, 407-10.   https://doi.org/10.1093/jnci/djh042




PubMed


 


PubMed ID 14996863
    
     


 



34.
Wright ME, Mayne ST, Stolzenberg-Solomon RZ, Li Z, Pietinen P, Taylor PR, Virtamo J, Albanes D (2004). Development of a comprehensive dietary antioxidant index and application to lung cancer risk in a cohort of male smokers. Am J Epidemiol  160, 68-76.   https://doi.org/10.1093/aje/kwh173




PubMed


 


PubMed ID 15229119
    
     


 



35.
Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E (2004). Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev  13, 260-9.   https://doi.org/10.1158/1055-9965.epi-03-0012




PubMed


 


PubMed ID 14973107",https://intramural.nih.gov/search/searchview.taf?ipid=33746
413,CP010128-09,"October 01, 2003 -  September 30, 2003",Therapeutic and Diagnostic Factors as Related to Cancer Risk,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Willard  Barnes
(Georgetown University Medical Center)





Lenore  Buckley
(Virginia Commonwealth University)





Theodore  Colton
(Boston University School of Public Health)





Olga  Dvorkina
(SUNY Health Sciences Center)





Olympia  Hadjimichael
(Yale University)





Susanne  Kruger-Kjaer
(Danish Cancer Registry)


Show all 13","Allan  Hildesheim; PhD (National Cancer Institute)



Robert  Hoover; MD, ScD (National Cancer Institute)



Catherine G Schairer (National Cancer Institute)



Arthur  Schatzkin; PhD (National Cancer Institute)



Patricia  Hartge; ScD (National Cancer Institute)



Rebecca  Troisi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA (2005) Melanoma, thyroid, cervical and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193:668-674




 



2.
Brinton L (2005) Response to ""Do drugs that stimulate ovulation increase the risk for endometrial stromal sarcoma?"". Hum Reproduction 20:1112-1116",https://intramural.nih.gov/search/searchview.taf?ipid=33713
414,CP010131-09,"October 01, 2003 -  September 30, 2004",Studies of Medical Radiation and Other Therapeutic Agents,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Steven L Simon



Elaine  Ron; PhD







Rochelle E Curtis




Cecile M Ronckers","Michael  Andersson
(Danish Cancer Society)





Anders  Ekbom
(Karolinska Institute)





Bengt  Glimelius
(Uppsala University)





Mary  Gospodarowicz
(Princess Margaret Hospital)





Eric  Holowaty
(Cancer Care Ontario)





Hans-Jochem  Kolb
(University of Munich)


Show all 20","Michele M Doody; MS (National Cancer Institute)



Peter D Inskip; ScD (National Cancer Institute)



Lois B Travis; PhD (National Cancer Institute)



Alice  Sigurdson; PhD (National Cancer Institute)



Kiyohiko  Mabuchi; MD, DPhil (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
(2003) Second Primary Cancers: An Overview.  J Nutr 113:3849S.




 



2.
(2004) The Geographic distribution of radionuclide depositioin across the continental US from atmospheric nuclear testing.  J Environ Radiat 74:91-105.




 



3.
Curtis RE, Freedman DM, Sherman ME, Fraumeni JF (2004). Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer. J Natl Cancer Inst  96, 70-4.   https://doi.org/10.1093/jnci/djh007




PubMed


 


PubMed ID 14709741
    
     


 



4.
Lubin JH, Schafer DW, Ron E, Stovall M, Carroll RJ (2004). A reanalysis of thyroid neoplasms in the Israeli tinea capitis study accounting for dose uncertainties. Radiat Res  161, 359-68.   https://doi.org/10.1667/rr3135




PubMed


 


PubMed ID 14982478
    
     


 



5.
Mack WJ, Preston-Martin S, Dal Maso L, Galanti R, Xiang M, Franceschi S, Hallquist A, Jin F, Kolonel L, La Vecchia C, Levi F, Linos A, Lund E, McTiernan A, Mabuchi K, Negri E, Wingren G, Ron E (2003). A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control  14, 773-85.   https://doi.org/10.1023/a:1026349702909




PubMed


 


PubMed ID 14674742
    
     


 



6.
Momani MS, Shore-Freedman E, Collins BJ, Lubin J, Ron E, Schneider AB (2004). Familial concordance of thyroid and other head and neck tumors in an irradiated cohort: analysis of contributing factors. J Clin Endocrinol Metab  89, 2185-91.   https://doi.org/10.1210/jc.2003-031906




PubMed


 


PubMed ID 15126540
    
     


 



7.
Preston-Martin S, Franceschi S, Ron E, Negri E (2003). Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control  14, 787-9.   https://doi.org/10.1023/a:1026312203045




PubMed


 


PubMed ID 14674743
    
     


 



8.
Ronckers C, Land C, Hayes R, Verduijn P, van Leeuwen F (2004). Factors impacting questionnaire response in a Dutch retrospective cohort study. Ann Epidemiol  14, 66-72.   https://doi.org/10.1016/s1047-2797(03)00123-6




PubMed


 


PubMed ID 14664782
    
     


 



9.
Sigurdson AJ, Jones IM (2003). Second cancers after radiotherapy: any evidence for radiation-induced genomic instability? Oncogene  22, 7018-27.   https://doi.org/10.1038/sj.onc.1206989




PubMed


 


PubMed ID 14557806
    
     


 



10.
Travis LB, Boice JD, Travis WD (2003). Second primary cancers after thymoma. Int J Cancer  107, 868-70.   https://doi.org/10.1002/ijc.11480




PubMed


 


PubMed ID 14566841
    
     


 



11.
Travis LB, Hauptmann M, Gaul LK, Storm HH, Goldman MB, Nyberg U, Berger E, Janower ML, Hall P, Monson RR, Holm LE, Land CE, Schottenfeld D, Boice JD, Andersson M (2003). Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res  160, 691-706.   https://doi.org/10.1667/rr3095




PubMed


 


PubMed ID 14640794",https://intramural.nih.gov/search/searchview.taf?ipid=33714
415,CP010132-09,"October 01, 2003 -  September 30, 2003",Studies of Populations Exposed to Enviromental Sources of Radiation,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI","Elaine  Ron; PhD



Steven L Simon","Daniel  Fink
(Columbia University)





Ellen  Greenebaum
(Columbia University)





Boris  Gusev
(Kazakh Institute for Radiation Medicine and Ecology)





Terry  Hartman
(Pennsylvania State University)





Geoffrey  Howe
(Columbia University)





Robert  McConnell
(Columbia University)


Show all 13","Ruth Anne Kleinerman; MPH (National Cancer Institute)



Andre  Bouville (National Cancer Institute)



Nickolas  Luckyanov (National Cancer Institute)



Ihor  Masnyk (National Cancer Institute)



Jay  Lubin; PhD (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL, Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB, Zaider M (2003). Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A  100, 13761-6.   https://doi.org/10.1073/pnas.2235592100




PubMed



        
     
Free Article


 


PubMed ID 14610281
         Pubmed Central ID 283495 


 



2.
Gavrilin Y, Khrouch V, Shinkarev S, Drozdovitch V, Minenko V, Shemiakina E, Ulanovsky A, Bouville A, Anspaugh L, Voillequé P, Luckyanov N (2004). Individual thyroid dose estimation for a case-control study of Chernobyl-related thyroid cancer among children of Belarus-part I: 131I, short-lived radioiodines (132I, 133I, 135I), and short-lived radiotelluriums (131MTe and 132Te). Health Phys  86, 565-85.   https://doi.org/10.1097/00004032-200406000-00002




PubMed


 


PubMed ID 15167120
    
     


 



3.
Lubin JH, Wang ZY, Boice JD, Xu ZY, Blot WJ, De Wang L, Kleinerman RA (2004). Risk of lung cancer and residential radon in China: pooled results of two studies. Int J Cancer  109, 132-7.   https://doi.org/10.1002/ijc.11683




PubMed


 


PubMed ID 14735479",https://intramural.nih.gov/search/searchview.taf?ipid=33692
416,CP010133-09,"October 01, 2003 -  September 30, 2003",Studies of Populations Exposed to Occupational Sources of Radiation,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Michele M Doody; MS



Daryl  Freedman



Maureen Cusack Hatch; MD



Peter D Inskip; ScD



Alice  Sigurdson; PhD







Andre  Bouville","William  Bigbee
(University of Pittsburgh)





Terry  Hartman
(Pennsylvania State University)





Geoffrey  Howe
(Columbia University)





Juozas  Kurtinaitis
(Lithuanian Cancer Registry)





Dale  Preston
(Radiation Effects Research Foundation)





S.  Salomaa
(Finnish Center for Radiation and Nuclear Safety)


Show all 13","Rochelle E Curtis (Radiation Epidemiology Branch)



Elaine  Ron; PhD (Radiation Epidemiology Branch)



Steven L Simon (Radiation Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
Freedman DM, Sigurdson A, Doody MM, Mabuchi K, Linet MS (2003). Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prev  12, 1540-3.




PubMed


 


PubMed ID 14693751
    
     


 



2.
Freedman DM, Sigurdson A, Doody MM, Rao RS, Linet MS (2003). Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control  14, 847-57.   https://doi.org/10.1023/b:caco.0000003839.56954.73




PubMed


 


PubMed ID 14682442
    
     


 



3.
Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer  4, 9.   https://doi.org/10.1186/1471-2407-4-9




PubMed



        
     
Free Article


 


PubMed ID 15113441
         Pubmed Central ID 408462",https://intramural.nih.gov/search/searchview.taf?ipid=33715
417,CP010134-09,"October 01, 2003 -  September 30, 2004",Studies of Atomic Bomb Survivors,Charles E. Land; PhD,NULL,"Radiation Epidemiology Branch, NCI",NULL,"Suminori  Akiba
(Kagoshima University)




Michinori  Kabuto
(National Institute for Environmental Studies)




Tim  Key
(Oxford University)




Kazunori  Kodama
(Radiation Effects Research Foundation, Japan)




Dale  Preston
(Radiation Effects Research Foundation)




Richard  Stevens
(University of Connecticut Health Center)


Show all 8",NULL,NULL,"Ordered by publication type and then author name.



1.
Fujita Y, Ito C, Mabuchi K (2004). Surveillance of mortality among atomic bomb survivors living in the United States using the National Death Index. J Epidemiol  14, 17-22.   https://doi.org/10.2188/jea.14.17




PubMed


 


PubMed ID 15065688
    
     


 



2.
Land CE, Tokunaga M, Koyama K, Soda M, Preston DL, Nishimori I, Tokuoka S (2003). Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res  160, 707-17.   https://doi.org/10.1667/rr3082




PubMed


 


PubMed ID 14640793
    
     


 



3.
Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K (2003). Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res  160, 381-407.   https://doi.org/10.1667/rr3049




PubMed


 


PubMed ID 12968934",https://intramural.nih.gov/search/searchview.taf?ipid=33716
418,CP010135-09,"October 01, 2003 -  September 30, 2003",Studies of Non-Ionizing Radiation-Related Cancer,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"Radiation Epidemiology Branch, NCI",Deirdre A Hill,"W.  Bleyer
(Children's Cancer Group)





Jonathan  Buckley
(University of Southern California)





Howard  Fine
(Brigham and Women's Hospital)





Frank  Groves
(University of South Carolina)





Elizabeth  Hatch
(Boston University)





Jay  Loeffler
(Massachusetts General Hospital)


Show all 9","Ruth Anne Kleinerman; MPH (National Cancer Institute)



Joseph B Coble (Occupational and Environmental Epidemiology Branch)



Ravindra  Kodali; PhD (National Cancer Institute)



Sholom  Wacholder; PhD (National Cancer Institute)



Mustafa  Dosemeci; PhD (National Cancer Institute)



Nathaniel C Rothman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hill DA, Inskip PD, Shapiro WR, Selker RG, Fine HA, Black PM, Linet MS (2003). Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev  12, 1443-8.




PubMed


 


PubMed ID 14693735
    
     


 



2.
Rajaraman P, De Roos AJ, Stewart PA, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD (2004). Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med  45, 395-407.   https://doi.org/10.1002/ajim.10363




PubMed


 


PubMed ID 15095422",https://intramural.nih.gov/search/searchview.taf?ipid=33717
419,CP010136-09,"October 01, 2003 -  September 30, 2003",Cancer Risk in Human Populations,"Debra  Silverman; ScD, ScM



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Joseph B Coble







Juan  Alguacil-ojeda",NULL,"Dalsu  Baris (National Cancer Institute)



Joanne S Colt (National Cancer Institute)



Linda M Brown; MPH, DPhil (Biostatistics Branch)



Mary Helen Ward; MS, PhD (National Cancer Institute)



Lawrence  Engel (National Cancer Institute)



Claudine M Samanic (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alguacil J, Silverman DT (2004). Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol Biomarkers Prev  13, 55-8.   https://doi.org/10.1158/1055-9965.epi-03-0033




PubMed


 


PubMed ID 14744733
    
     


 



2.
Gammon MD, Terry MB, Arber N, Chow WH, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni JF, Weinstein IB, Hibshoosh H (2004). Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev  13, 34-9.   https://doi.org/10.1158/1055-9965.epi-03-0198




PubMed


 


PubMed ID 14744730
    
     


 



3.
Lissowska J, Gail MH, Pee D, Groves FD, Sobin LH, Nasierowska-Guttmejer A, Sygnowska E, Zatonski W, Blot WJ, Chow WH (2004). Diet and stomach cancer risk in Warsaw, Poland. Nutr Cancer  48, 149-59.   https://doi.org/10.1207/s15327914nc4802_4




PubMed


 


PubMed ID 15231449",https://intramural.nih.gov/search/searchview.taf?ipid=33718
420,CP010138-07,"October 01, 2003 -  September 30, 2004",Genetic Epidemiology of BRCA1/2,"Jeffery P Struewing; MS, MD",Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Denise L Stredrick (National Cancer Institute)



Mark H Greene; MD (National Cancer Institute)



Margaret Anne Tucker (National Cancer Institute)



Elisha E Peterson (National Cancer Institute)","Barbara B Biesecker; PhD, MS, CGC (NHGRI)","Ordered by publication type and then author name.



1.
Mateus Pereira LH, Sigurdson AJ, Doody MM, Pineda MA, Alexander BH, Greene MH, Struewing JP (2004). CHEK2:1100delC and female breast cancer in the United States. Int J Cancer  112, 541-3.   https://doi.org/10.1002/ijc.20439




PubMed


 


PubMed ID 15382084
    
     


 



2.
Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP (2004). Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer  4, 9.   https://doi.org/10.1186/1471-2407-4-9




PubMed



        
     
Free Article


 


PubMed ID 15113441
         Pubmed Central ID 408462",https://intramural.nih.gov/search/searchview.taf?ipid=33719
421,CP010139-07,"October 01, 2003 -  September 30, 2004",Molecular Genetic Epidemiology of Primary Hepatocellular Carcinoma,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,NULL,NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=33720
422,CP010140-07,"October 01, 2003 -  September 30, 2004",Molecular Genetic Epidemiology of leading  U.S. Cancers,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,"N. NEELY  Kazerouni
(NATIONAL CENTER FOR ENVIRONMENTAL HEALTH, Center for Disease Control)





David  Flockhart
(DEPARTMENT OF MEDICINE, Indiana University-Purdue University Indianapolis)","Mark H Greene; MD (National Cancer Institute)



Philip Samuel Rosenberg; PhD (National Cancer Institute)












Dong-Ho  Nahm; MD, PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP (2004). Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics  83, 395-401.   https://doi.org/10.1016/j.ygeno.2003.09.007




PubMed


 


PubMed ID 14962665",https://intramural.nih.gov/search/searchview.taf?ipid=33721
423,CP010141-07,"October 01, 2003 -  September 30, 2004",The Cancer Genome Anatomy Project's Genetic Annotation Initiative,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Carl F Schaefer (National Cancer Institute)



Denise M Hise (National Cancer Institute)



Dongeun  Park; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Clifford RJ, Edmonson MN, Nguyen C, Buetow KH (2004). Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics  20, 1006-14.   https://doi.org/10.1093/bioinformatics/bth029




PubMed


 


PubMed ID 14751981
    
     


 



2.
Clifford RJ, Edmonson MN, Nguyen C, Scherpbier T, Hu Y, Buetow KH (2004). Bioinformatics tools for single nucleotide polymorphism discovery and analysis. Ann N Y Acad Sci  1020, 101-9.   https://doi.org/10.1196/annals.1310.011




PubMed


 


PubMed ID 15208187",https://intramural.nih.gov/search/searchview.taf?ipid=33745
424,CP010142-06,"October 01, 2003 -  September 30, 2003",Pharmacogenetic Determinants of Outcomes Following Treatment for Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",NULL,"Joseph  Constantino
(National Surgical Adjuvant Breast & Bowel Project Statistical Center)





Howard  McLeod
(Washington University)





Gareth  Morgan
(University of Leeds)





Michael  Pollak
(McGill University)





Larry  Wickerham
(NSABP Group Headquarters)





Norman  Wolmark
(National Surgical Adjuvant Breast and Bowel Project)


Show all 7","Michael  Martin (National Cancer Institute)



Hormuzdiar Aspandiar Katki; MS (National Cancer Institute)



Barry Ira Graubard; PhD (National Cancer Institute)



Richard  Hayes; PhD (National Cancer Institute)



Michael  Martin (Medical Oncology Branch)



Meredith  Yeager (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Savage SA, Stewart BJ, Liao JS, Helman LJ, Chanock SJ (2005) Telomere stability genes are not mutated in osteosarcoma cell lines. Cancer Genet Cytogenet 160:79-81",https://intramural.nih.gov/search/searchview.taf?ipid=33722
425,CP010144-06,"October 01, 2003 -  September 30, 2003",Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI",Blanche P Alter,"Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)





Tim  Bishop
(Institute for Cancer Research)





Robert  Brodsky
(Johns Hopkins University School of Medicine)





Joseph  Califano
(Johns Hopkins University School of Medicine)





Peter  Durie
(Toronto Hospital for Sick Children)





Lawrence  Einhorn
(Indiana University Medical Center)


Show all 63","June  Peters (National Cancer Institute)



Nancy E Weissman (National Cancer Institute)



Philip Samuel Rosenberg; PhD (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)



Sadie  Hutson (National Cancer Institute)



Patricia  Hartge; ScD (National Cancer Institute)","Roy A Mariuzza,; PhD (NICHD)","Ordered by publication type and then author name.



1.
(2003) Diamond-Blackfan Anemia (DBA): Identification of nonpenetrant individuals in the molecular era.  Blood 102:1847.




 



2.
(2003) How can we quantify the risk of squamous cell cancer (SCC) and death in transplanted versus non-transplanted patients with Fanconi anemia (FA)?  Blood 102:3642.




 



3.
Alter B (2005) Diamond-Blackfan Anemia: A ""Cultural"" Diagnosis. Blood 105:435-436




 



4.
Alter B, Joenje H, Oostra A, Pals G (2005) Fanconi Anemia: Adult Head and Neck Cancer and Hematopoietic Mosaicism. Arch Otolaryngol 131:635-639




 



5.
Alter B, Lipton J (2005) Anemia, Fanconi. eMedicine Journal [serial online], 2005 update of 2002 publication, http:www emedicine compedtopic3022 htm n/a:n/a




 



6.
Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, Greene MH, Maslansky B, Fischbein A, Gruber SB, Rennert G, Ronchetti RD, Hewitt SM, Struewing JP, Iscovich J (2003). A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet  40, 787-92.   https://doi.org/10.1136/jmg.40.10.787




PubMed



        
     
Free Article


 


PubMed ID 14569130
         Pubmed Central ID 1735297 


 



7.
Kate N, Kanetsky P, Hawes R, Letrero R, Dudakia D, Vaughn D, Johnson L, Robertson K, Tucker K, Friedlander M, Phillips K, Hogg D, Jewett M, Lohynska R, Daugaard G, Richard S, BonaitiPellie C, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston W, Daly P, Looijenga L, Guilford P, et al. [26 more authors] (2005) The Y Deletion grgr and the Risk of Testicular Germ Cell Tumor. American Journal of Human Genetics 77:1034-1043




 



8.
Modugno F   (2003) Ovarian cancer and high-risk women-implications for prevention, screening, and early detection.  Gynecol Oncol 91:15-31.




PubMed


 


PubMed ID 14529658
    
     


 



9.
Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston WJ, Daly PA, Looijenga LH, Guilford P, et al. [14 more authors] (2004). Somatic mutations of KIT in familial testicular germ cell tumours. Br J Cancer  90, 2397-401.   https://doi.org/10.1038/sj.bjc.6601880




PubMed



        
     
Free Article


 


PubMed ID 15150569
         Pubmed Central ID 2410291 


 



10.
Rosenberg PS, Alter BP, Socié G, Gluckman E (2005). Secular trends in outcomes for Fanconi anemia patients who receive transplants: implications for future studies. Biol Blood Marrow Transplant  11, 672-9.   https://doi.org/10.1016/j.bbmt.2005.05.007




PubMed


 


PubMed ID 16125637
    
     


 



11.
Rosenberg PS, Huang Y, Alter BP (2004). Individualized risks of first adverse events in patients with Fanconi anemia. Blood  104, 350-5.   https://doi.org/10.1182/blood-2004-01-0083




PubMed


 


PubMed ID 15059844
    
     


 



12.
Tong BC, Dhir K, Ha PK, Westra WH, Alter BP, Sidransky D, Koch WM, Califano JA (2004). Use of single nucleotide polymorphism arrays to identify a novel region of loss on chromosome 6q in squamous cell carcinomas of the oral cavity. Head Neck  26, 345-52.   https://doi.org/10.1002/hed.10391




PubMed


 


PubMed ID 15054738
    
     


 



13.
Wideroff L, Vadaparampil S, Greene M, Taplin S, Olson L, Freedman A (2005) Hereditary BreastOvarian and Colorectal Cancer Genetics Knowledge in a National Sample of US Physicians. Journal of Medical Genetics 42:749-755",https://intramural.nih.gov/search/searchview.taf?ipid=33723
426,CP010145-05,"October 01, 2003 -  September 30, 2003",Intervention Trials in Persons at Increased Genetic Risk of Cancer,"Mark H Greene; MD



IRP Faculty Profile",NULL,"Clinical Genetics Branch, NCI","Blanche P Alter







Jennifer T Loud




June  Peters","Deborah A. Bell; MD
(Department of Laboratory Medicine and Pathology, Mayo Clinic)





Molly  Brewer
(Arizona Cancer Center)





Robert  Brodsky
(Johns Hopkins University School of Medicine)





Joseph  Califano
(Johns Hopkins University School of Medicine)





M.  Constenino
(BioTech Laboratories)





Dianne  Finkelstein
(Massachusetts General Hospital)


Show all 20","Margaret Anne Tucker (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)












Michele M Doody; MS  (Radiation Epidemiology Branch)



Ruthann  Giusti  (National Cancer Institute)



Alice  Sigurdson; PhD  (Risk Analysis Section)



Nancy E Weissman  (Genetic Epidemiology Branch)",NULL,"Ordered by publication type and then author name.



1.
(2003) Feasibility and Utility of the Colored Eco-Genetic Relational Map (CEGRM) in Women at risk for Hereditary Breast Cancer.  Am J Hum Genet 73:1110.




 



2.
Friedrichsen DM, Malone KE, Doody DR, Daling JR, Ostrander EA (2004). Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women. Breast Cancer Res  6, R629-35.   https://doi.org/10.1186/bcr933




PubMed



        
     
Free Article


 


PubMed ID 15535844
         Pubmed Central ID 1064080",https://intramural.nih.gov/search/searchview.taf?ipid=33724
427,CP010146-05,"October 01, 2003 -  September 30, 2004",Genetic Modifiers of Intitiation and Progression of Mammary Cancer,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Population Genetics, NCI",NULL,"Bruce  Ponder
(Department of Oncology, University of Cambridge)





Danny  Welch
(Department of Pathology, University of Alabama, Birmingham)





Robert C Williams; PhD
(Dept. of Anthropology, Arizona State University)","Kenneth  Buetow; PhD (National Cancer Institute)



Douglas  Lowy; MD (National Cancer Institute)



Edison  Liu (National Cancer Institute)","John W Daly; PhD (NIDDK) 



Kenneth A Jacobson; BA, MS, PhD (NIDDK)","Ordered by publication type and then author name.



1.
Hunter K, Welch DR, Liu ET (2003). Genetic background is an important determinant of metastatic potential. Nat Genet  34, 23-4; author reply 25.   https://doi.org/10.1038/ng0503-23b




PubMed


 


PubMed ID 12721549
    
     


 



2.
Hunter KW (2003). Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination. Cancer Lett  200, 97-105.   https://doi.org/10.1016/s0304-3835(03)00420-8




PubMed


 


PubMed ID 14568162
    
     


 



3.
Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, Hissong B, Weaver Z, Ried T (2003). The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res  63, 2179-87.




PubMed


 


PubMed ID 12727837
    
     


 



4.
Park YG, Clifford R, Buetow KH, Hunter KW (2003). Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res  13, 118-21.   https://doi.org/10.1101/gr.786403




PubMed



        
     
Free Article


 


PubMed ID 12529314
         Pubmed Central ID 430946 


 



5.
Welch DR, Hunter KW (2003). A new member of the growing family of metastasis suppressors identified in prostate cancer. J Natl Cancer Inst  95, 839-41.   https://doi.org/10.1093/jnci/95.12.839




PubMed


 


PubMed ID 12813161",https://intramural.nih.gov/search/searchview.taf?ipid=33696
428,CP010147-05,"October 01, 2003 -  September 30, 2004",Genetic Predisposition to Aflatoxin-Induced Hepatocellular Carcinoma,"Kent W Hunter; PhD



IRP Faculty Profile",NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Kenneth  Buetow; PhD (National Cancer Institute)



Katherine Ann McGlynn; PhD (National Cancer Institute)












Luanne  Lukes  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH (2003). Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res  63, 4594-601.




PubMed


 


PubMed ID 12907637",https://intramural.nih.gov/search/searchview.taf?ipid=33725
429,CP010149-05,"October 01, 2003 -  September 30, 2003",Epidemiology and Natural History of HTLV-I,"Michie  Hisada; MD, MPH, ScD",NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD



Hongzhen  Li; MD, PhD","Rainford  Wilks
(University of the West Indies)





Barrie  Hanchard
(University of the West Indies)
















Owen  Morgan
(University of the West Indies)","Elizabeth M Maloney (National Cancer Institute)



Ven  Natarajan; PhD (National Cancer Institute)












James Jerome Goedert; MD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Maloney EM, Nagai M, Hisada M, Soldan SS, Goebel PB, Carrington M, Sawada T, Brennan MB, Cranston B, Hanchard B, Jacobson S (2004). Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. J Infect Dis  189, 41-5.   https://doi.org/10.1086/380567




PubMed


 


PubMed ID 14702151",https://intramural.nih.gov/search/searchview.taf?ipid=36718
430,CP010150-05,"October 01, 2003 -  September 30, 2003","HIV, human herpesvirus 8, and cancer","Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI","Robert  Biggar; MD



Elizabeth M Brawner







Hong-Chuan  Li","Amy  Chadburn
( Weill Medical College of Cornell University, New York, New York)
















Ethel  Cesarman
( Weill Medical College of Cornell University, New York, New York)","Denise  Whitby (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)



Charles  Rabkin (National Cancer Institute)



Sam  Mbulaiteye (National Cancer Institute)



Elizabeth  Brown (National Cancer Institute)



Jonnae  Atkinson (National Cancer Institute)",Jane Chestnut Atkinson; DDS (NIDCR),"Ordered by publication type and then author name.



1.
(2004) A Model to Estimate Risk of Infection with Human Herpesvirus 8 Associated with Transfusion from Cross-Sectional Data.  Biometrics 60:249-256.




 



2.
Li H, Loehrer PJ, Hisada M, Henley J, Whitby D, Engels EA (2004). Absence of human T-cell lymphotropic virus type I and human foamy virus in thymoma. Br J Cancer  90, 2181-5.   https://doi.org/10.1038/sj.bjc.6601841




PubMed



        
     
Free Article


 


PubMed ID 15150553
         Pubmed Central ID 2409482",https://intramural.nih.gov/search/searchview.taf?ipid=33726
431,CP010151-05,"October 01, 2003 -  September 30, 2003",KSHV and other oncogenic viruses,Denise  Whitby,NULL,"Office of the Director, NCI",NULL,"Morten  Frisch
(Danish Serum Institute)





Philip  Pellet
(Centers of Disease Control and Prevention)





Paolo  Boffetta
(International Agency for Research on Cancer)





Paul  Brennan
(International Agency for Research on Cancer, Lyon, France)





Pierluigi  Cocco
(University of Cagliari)





Jose  Iscovich
(International Fertility Institute)


Show all 30","Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)



Charles  Rabkin (National Cancer Institute)



Eric Andrew Engels; PhD (National Cancer Institute)



Michie  Hisada; MD, MPH, ScD (National Cancer Institute)



Patricia  Hartge; ScD (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
de Sanjosé S, Goedert JJ, Marshall V, Bellas C, Benavente Y, Bosch R, Domingo A, Fernandez de Sevilla A, Servitje O, Whitby D (2004). Risk of malignant lymphoma associated with human herpesvirus-8: a case-control study in Spain. Br J Cancer  90, 2145-8.   https://doi.org/10.1038/sj.bjc.6601858




PubMed



        
     
Free Article


 


PubMed ID 15150582
         Pubmed Central ID 2409501 


 



2.
Whitby D, Marshall VA, Bagni RK, Wang CD, Gamache CJ, Guzman JR, Kron M, Ebbesen P, Biggar RJ (2004). Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol  85, 155-63.   https://doi.org/10.1099/vir.0.19465-0




PubMed


 


PubMed ID 14718630",https://intramural.nih.gov/search/searchview.taf?ipid=33727
432,CP010152-05,"October 01, 2003 -  September 30, 2003",Etiologic Studies in PLCO Trial,Richard  Hayes; PhD,NULL,"Occupational and Environmental Epidemiology Branch, NCI",Wen-Yi  Huang,NULL,"Jimmie B Vaught (National Cancer Institute)



Bu Tian  Ji (National Cancer Institute)",Wei  Huang; PhD (NIA),"Ordered by publication type and then author name.



1.
Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee (2004). The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. Urol Oncol  22, 358-61.   https://doi.org/10.1016/j.urolonc.2004.04.013




PubMed


 


PubMed ID 15283897
    
     


 



2.
Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB (2004). Risk behaviours and benign prostatic hyperplasia. BJU Int  93, 1241-5.   https://doi.org/10.1111/j.1464-410X.2004.04839.x




PubMed


 


PubMed ID 15180615
    
     


 



3.
Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA, Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team (2004). Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev  13, 546-52.




PubMed


 


PubMed ID 15066918",https://intramural.nih.gov/search/searchview.taf?ipid=33728
433,CP010153-05,"October 01, 2003 -  September 30, 2003","Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C","Mary Helen Ward; MS, PhD



IRP Faculty Profile",NULL,"Occupational and Environmental Epidemiology Branch, NCI","Patricia S Stewart; PhD



Won Jin Lee; PhD","David  Camann
(Southwest Research Institute)





James  Giglierano
(Iowa Department of Natural Resources)





Charles  Lynch
(University of Iowa)





Charles C. Lynch; PhD, MD
(University of Iowa)





D.  Riley
(University of Iowa)





Dennis  Weisenburger
(University of Nebraska Medical Center)


Show all 7","Joanne S Colt (National Cancer Institute)



Barry Ira Graubard; PhD (National Cancer Institute)



Debra  Silverman; ScD, ScM (National Cancer Institute)



Kenneth  Cantor; PhD (National Cancer Institute)



Shelia K Zahm; ScM, ScD (National Cancer Institute)



Patricia  Hartge; ScD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Maxwell SK, Nuckols JR, Ward MH, Hoffer RM   (2004) An automated approach to mapping corn from Landsat imagery.  Computers Electronics in Agriculture 43:43-54.




 



2.
Nuckols JR, Ward MH, Jarup L (2004). Using geographic information systems for exposure assessment in environmental epidemiology studies. Environ Health Perspect  112, 1007-15.   https://doi.org/10.1289/ehp.6738




PubMed



        
     
Free Article


 


PubMed ID 15198921
         Pubmed Central ID 1247194",https://intramural.nih.gov/search/searchview.taf?ipid=36719
434,CP010154-05,"October 01, 2003 -  September 30, 2004",Genetics and Epigenetics of Cancer,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Mitsutaka  Kadota (National Cancer Institute)



Liu  Xiaofeng (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)












Sheryl  Gere  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee MP (2003). Genome-wide analysis of epigenetics in cancer. Ann N Y Acad Sci  983, 101-9.   https://doi.org/10.1111/j.1749-6632.2003.tb05965.x




PubMed


 


PubMed ID 12724215
    
     


 



2.
Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP (2003). Allelic variation in gene expression is common in the human genome. Genome Res  13, 1855-62.   https://doi.org/10.1101/gr.1006603




PubMed



        
     
Free Article


 


PubMed ID 12902379
         Pubmed Central ID 403776 


 



3.
Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP (2003). Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res  63, 655-7.




PubMed


 


PubMed ID 12566310",https://intramural.nih.gov/search/searchview.taf?ipid=33729
435,CP010155-05,"October 01, 2003 -  September 30, 2004",Informatics Solutions to Biomedical Research,Maxwell P Lee; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,"Howard  Yang (National Cancer Institute)



Dinah  Singer; PhD (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)



Kenneth  Buetow; PhD (National Cancer Institute)



Thomas  Howcroft; PhD (National Cancer Institute)



Kent W Hunter; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP (2003). Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res  63, 655-7.




PubMed


 


PubMed ID 12566310
    
     


 



2.
Yang HH, Hu Y, Edmonson M, Buetow K, Lee MP (2003). Computation method to identify differential allelic gene expression and novel imprinted genes. Bioinformatics  19, 952-5.   https://doi.org/10.1093/bioinformatics/btg127




PubMed


 


PubMed ID 12761057",https://intramural.nih.gov/search/searchview.taf?ipid=33730
436,CP010156-04,"October 01, 2003 -  September 30, 2004",Genetic studies in melanoma,"Jeffery P Struewing; MS, MD",Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Margaret Anne Tucker (National Cancer Institute)



Alisa  Goldstein; PhD (National Cancer Institute)



Maria Teresa Pia Landi; MD, PhD (National Cancer Institute)












Marbin A Pineda  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA (2004). Prospective risk of cancer in CDKN2A germline mutation carriers. J Med Genet  41, 421-4.   https://doi.org/10.1136/jmg.2004.019349




PubMed



        
     
Free Article


 


PubMed ID 15173226
         Pubmed Central ID 1735800",https://intramural.nih.gov/search/searchview.taf?ipid=33697
437,CP010157-04,"October 01, 2003 -  September 30, 2004","Genetic, epidemiologic, and biochemical studies of DNA damage repair","Jeffery P Struewing; MS, MD",Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,"Linda  Titua-Ernstoff
(Department of Epidemiology, Dartmouth University)





Irene  Jones
(Lawrence Livermore)





Polly  Newcomb
(Comprehensive Cancer Center, University of Wisconsin)","Alice  Sigurdson; PhD (National Cancer Institute)



Montserrat  Garcia-Closas; MD, PhD (National Cancer Institute)



Michael  Hauptmann; PhD (National Cancer Institute)



Charles E. Land; PhD (National Cancer Institute)",Katharine D Egan (NIMH),"Ordered by publication type and then author name.



1.
Mateus Pereira LH, Sigurdson AJ, Doody MM, Pineda MA, Alexander BH, Greene MH, Struewing JP (2004). CHEK2:1100delC and female breast cancer in the United States. Int J Cancer  112, 541-3.   https://doi.org/10.1002/ijc.20439




PubMed


 


PubMed ID 15382084",https://intramural.nih.gov/search/searchview.taf?ipid=33695
438,CP010158-04,"October 01, 2003 -  September 30, 2003",Studies of Rare Cancers,Louise  Brinton; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Evelyene  Lennette
(Virolab, Inc.)





Lene  Mellemkjaer
(Danish Cancer Society)





Jorgen  Olsen
(Danish Cancer Society)





Asif  Rashid
(MD Anderson Cancer Center)





Juergen  Reichardt
(University of Southern California)





Frank  Stanczyk
(University of Southern California)


Show all 11","Michelle D Althuis (National Cancer Institute)



Yan  Bai (National Cancer Institute)












Alisa  Goldstein; PhD  (Population And Statistical Genetics Sect)



Allan  Hildesheim; PhD  (Interdisciplinary Studies Sect)



Ann  Hsing; PhD  (Hormonal Studies Sect)



Katherine Ann McGlynn; PhD  (Hormonal Studies Sect)

Show all 7.",NULL,"Ordered by publication type and then author name.



1.
Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, Liu MY, Chen JY, Brinton LA, Cheng YJ, Yang CS (2003). Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev  12, 1100-4.




PubMed


 


PubMed ID 14578150
    
     


 



2.
El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003). The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med  139, 817-23.   https://doi.org/10.7326/0003-4819-139-10-200311180-00009




PubMed


 


PubMed ID 14623619
    
     


 



3.
Pickard A, Chen CJ, Diehl SR, Liu MY, Cheng YJ, Hsu WL, Sun B, Hsu MM, Chen IH, Chen JY, Yang CS, Mittl BL, Chou SP, Ruggles DD, Goldstein AM, Hildesheim A (2004). Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan. Int J Cancer  111, 117-23.   https://doi.org/10.1002/ijc.20222




PubMed


 


PubMed ID 15185352
    
     


 



4.
Smits KM, Benhamou S, Garte S, Weijenberg MP, Alamanos Y, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Boffetta P, Bouchardy C, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Coutelle C, Daly AK, Muzi G, Dolzan V, Duzhak TG, Farker K, Golka K, Haugen A, Hein DW, et al. [45 more authors] (2004). Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer  110, 266-70.   https://doi.org/10.1002/ijc.20114




PubMed


 


PubMed ID 15069692
    
     


 



5.
Ueki T, Hsing AW, Gao YT, Wang BS, Shen MC, Cheng J, Deng J, Fraumeni JF, Rashid A (2004). Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res  10, 1717-25.   https://doi.org/10.1158/1078-0432.ccr-1137-3




PubMed


 


PubMed ID 15014024",https://intramural.nih.gov/search/searchview.taf?ipid=33731
439,CP010162-04,"October 01, 2003 -  September 30, 2004",Gene expression profiles in lung cancer using cDNA rrays,Jin  Jen,Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Junya  Fukuoka (National Cancer Institute)



Rajbir  Gill (National Cancer Institute)



Kyeong-Man  Hong (National Cancer Institute)



Sei Hoon  Yang (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dracheva T, Jen J (2003). Profiling lung adenocarcinoma: insights from genes and more genes. Cancer Biol Ther  2, 299-300.   https://doi.org/10.4161/cbt.2.3.447




PubMed


 


PubMed ID 12878870
    
     


 



2.
Krop I, Player A, Tablante A, Taylor-Parker M, Lahti-Domenici J, Fukuoka J, Batra SK, Papadopoulos N, Richards WG, Sugarbaker DJ, Wright RL, Shim J, Stamey TA, Sellers WR, Loda M, Meyerson M, Hruban R, Jen J, Polyak K (2004). Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res  2, 489-94.




PubMed


 


PubMed ID 15383627",https://intramural.nih.gov/search/searchview.taf?ipid=33732
440,CP010163-04,"October 01, 2003 -  September 30, 2004",Genetic analysis in early age of onset lung cancer patients,Jin  Jen,Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Joanna H Shih (National Cancer Institute)



James Carl Barrett; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dracheva T, Jen J (2003). Profiling lung adenocarcinoma: insights from genes and more genes. Cancer Biol Ther  2, 299-300.   https://doi.org/10.4161/cbt.2.3.447




PubMed


 


PubMed ID 12878870",https://intramural.nih.gov/search/searchview.taf?ipid=33733
441,CP010164-04,"October 01, 2003 -  September 30, 2004",Development of non-small cell lung cancer tissue microarray for systematic analy,Jin  Jen,Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Joanna H Shih (National Cancer Institute)



Michael R Emmert-Buck; MD, PhD (National Cancer Institute)



Curtis  Harris; MD (National Cancer Institute)



William  Travis (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Player A, Gillespie J, Fujii T, Fukuoka J, Dracheva T, Meerzaman D, Hong KM, Curran J, Attoh G, Travis W, Jen J (2003). Identification of TDE2 gene and its expression in non-small cell lung cancer. Int J Cancer  107, 238-43.   https://doi.org/10.1002/ijc.11391




PubMed


 


PubMed ID 12949800",https://intramural.nih.gov/search/searchview.taf?ipid=33734
442,CP010165-04,"October 01, 2003 -  September 30, 2004",Mechanisms of gene expression changes in lung cancer,Jin  Jen,Kenneth  Buetow; PhD,"Laboratory of Population Genetics, NCI",NULL,NULL,"Kent W Hunter; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)



Ilona  Linnoila; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Player A, Gillespie J, Fujii T, Fukuoka J, Dracheva T, Meerzaman D, Hong KM, Curran J, Attoh G, Travis W, Jen J (2003). Identification of TDE2 gene and its expression in non-small cell lung cancer. Int J Cancer  107, 238-43.   https://doi.org/10.1002/ijc.11391




PubMed


 


PubMed ID 12949800",https://intramural.nih.gov/search/searchview.taf?ipid=33735
443,CP010167-04,"October 01, 2003 -  September 30, 2003",General Studies of Epidemiology,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Chester  Douglass
(Harvard School of Dentistry)





Sheila  McGuire
(Harvard School of Dentistry)
















Colin C Anderson; PhD",Rebecca  Troisi  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33736
444,CP010168-04,"October 01, 2003 -  September 30, 2003",Early Life Exposures and Subsequent Cancer Risk,"Robert  Hoover; MD, ScD



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Elizabeth  Hatch
(Boston University)





Arthur  Herbst
(University of Chicago)





Kenneth  Noller
(New England Medical Center)





Julie  Palmer
(Boston University)





Stanley  Robboy; MD
(Pathology and Obstetrics & Gynecology, Duke University Medical Center)





Pentti  Siiteri
(University of California)


Show all 12","Nancy K Carter (National Cancer Institute)












Rebecca  Troisi  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Troisi R, Potischman N, Johnson CN, Roberts JM, Lykins D, Harger G, Markovic N, Siiteri P, Hoover RN (2003). Estrogen and androgen concentrations are not lower in the umbilical cord serum of pre-eclamptic pregnancies. Cancer Epidemiol Biomarkers Prev  12, 1268-70.




PubMed


 


PubMed ID 14652293",https://intramural.nih.gov/search/searchview.taf?ipid=33737
445,CP010169-03,"October 01, 2003 -  September 30, 2003","Nutrition, Metabolism, and Cancer","Regina Gale Ziegler; PhD, MPH



IRP Faculty Profile",NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Abraham  Nomura
(School of Public Health, University of Hawaii)





Emanuel  Petricoin, III
(Food and Drug Administration)





Malcolm  Pike
(University of Southern California)





Michael  Pollak
(McGill University)





Frank  Stanczyk
(University of Southern California)





Ray  Greenberg
(University of South Carolina)


Show all 11","Louise  Brinton; PhD (National Cancer Institute)



Roni T Falk (National Cancer Institute)



Mitchell Henry Gail; PhD, MD (National Cancer Institute)



Gloria L Gridley (National Cancer Institute)



Patricia  Hartge; ScD (National Cancer Institute)



Richard  Hayes; PhD (National Cancer Institute)",Thomas  Casale; MD (NIA),"Ordered by publication type and then author name.



1.
Tseng M, Breslow RA, DeVellis RF, Ziegler RG (2004). Dietary patterns and prostate cancer risk in the National Health and Nutrition Examination Survey Epidemiological Follow-up Study cohort. Cancer Epidemiol Biomarkers Prev  13, 71-7.   https://doi.org/10.1158/1055-9965.epi-03-0076




PubMed


 


PubMed ID 14744736
    
     


 



2.
Ziegler RG (2004). Phytoestrogens and breast cancer. Am J Clin Nutr  79, 183-4.   https://doi.org/10.1093/ajcn/79.2.183




PubMed


 


PubMed ID 14749221",https://intramural.nih.gov/search/searchview.taf?ipid=33743
446,CP010170-04,"October 01, 2003 -  September 30, 2003",Multidisciplinary Studies of Lymphoma,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",NULL,"Scott  Davis
(Fred Hutchinson Cancer Research Center)





Richard  Severson
(Barbara Karmanos Cancer Institute)





Anneclaire  De Roos
(University of Washington, Seattle, WA)





Tongzong  Zheng
(Yale University, New Haven, CT)
















Wendy  Cozen
(Norris Comprehensive Cancer Center)","Joanne S Colt (National Cancer Institute)



Shelia K Zahm; ScM, ScD (National Cancer Institute)



Martha S Linet; PhD (National Cancer Institute)



Aaron E Blair; PhD, MPH (National Cancer Institute)



Mary Helen Ward; MS, PhD (National Cancer Institute)



Nathaniel C Rothman; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, Colt J, Goldin L, Severson RK (2004). Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev  13, 1415-21.




PubMed


 


PubMed ID 15342441
    
     


 



2.
Colt JS, Lubin J, Camann D, Davis S, Cerhan J, Severson RK, Cozen W, Hartge P (2004). Comparison of pesticide levels in carpet dust and self-reported pest treatment practices in four US sites. J Expo Anal Environ Epidemiol  14, 74-83.   https://doi.org/10.1038/sj.jea.7500307




PubMed


 


PubMed ID 14726946
    
     


 



3.
Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, Whitby D, Colt JS, Hartge P (2004). Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer  111, 76-80.   https://doi.org/10.1002/ijc.20021




PubMed


 


PubMed ID 15185346",https://intramural.nih.gov/search/searchview.taf?ipid=33738
447,CP010171-04,"October 01, 2003 -  September 30, 2003",Assessing the Risk of Breast and Ovarian Cancer,Patricia  Hartge; ScD,NULL,"Epidemiology and Biostatistics Program, NCI",NULL,NULL,Barry Ira Graubard; PhD  (Biostatistics Branch),NULL,"Ordered by publication type and then author name.



1.
Sturgeon SR, Graubard BI, Schairer C, McAdams M, Hoover RN, Gail MH (2003). Population-density and county-level variation in breast cancer mortality rates among white women residing in the Northeastern and Southern United States. Cancer Causes Control  14, 923-31.   https://doi.org/10.1023/b:caco.0000007963.56703.9d




PubMed


 


PubMed ID 14750531",https://intramural.nih.gov/search/searchview.taf?ipid=33739
448,CP010172-04,"October 01, 2003 -  September 30, 2004",Simian Virus 40 (SV40),"Eric Andrew Engels; PhD



IRP Faculty Profile",NULL,"Infection & Immunoepidemiology Branch, NCI",NULL,"Morten  Frisch
(Danish Serum Institute)




Denise  Galloway
(Fred Hutchinson Cancer Center)




Robert  Garcea
(University of Colorado Health Sciences Center)




Mark A. Klebanoff; MD, MPH
(NICHHD)




David  Malkin
(University of Toronto Hospital for Sick Children)




Keerti  Shah
(Johns Hopkins University)


Show all 7",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36720
449,CP010175-04,"October 01, 2003 -  September 30, 2004",Molecular Targets - Colon Cancer,Kenneth  Buetow; PhD,NULL,"Laboratory of Population Genetics, NCI",NULL,NULL,Leslie  Derr (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Fukuoka J, Fujii T, Shih JH, Dracheva T, Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, Hewitt S, Travis WD, Jen J (2004). Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer. Clin Cancer Res  10, 4314-24.   https://doi.org/10.1158/1078-0432.CCR-03-0489




PubMed


 


PubMed ID 15240517",https://intramural.nih.gov/search/searchview.taf?ipid=33740
450,CP010176-04,"October 01, 2003 -  September 30, 2003",Epidemiology and Natural History of Cancer-Associated Viruses,James Jerome Goedert; MD,NULL,"Infection & Immunoepidemiology Branch, NCI","Elizabeth M Maloney







Robert  Biggar; MD","Morten  Frisch
(Danish Serum Institute)





Angelos  Hatzakis
(University of Athens Medical School)





Michael  Lederman; MD
(Case Western Reserve University)





Nino  Romano
(University of Palermo)





Cloe  Thio
(Dept of Medicine, Johns Hopkins University School of Medicine)





David  Thomas
(Dept of Medicine, Johns Hopkins University School of Medicine)


Show all 8","Thomas R O'Brien; BA, MPH, MD (National Cancer Institute)



Thomas  Fears; PhD (Biostatistics Branch)



Philip Samuel Rosenberg; PhD (National Cancer Institute)



Michie  Hisada; MD, MPH, ScD (National Cancer Institute)



Charles  Rabkin (National Cancer Institute)



Denise  Whitby (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
(2004) Viral clearance occurs very early during the natural resolution of Hepatitis C virus infection in persons with Haemphilia.  Haemophilia 10:75-80.




 



2.
Augenbraun M, Goedert JJ, Thomas D, Feldman J, Seaberg EC, French AL, Robison E, Nowicki M, Terrault N (2003). Incident hepatitis C virus in women with human immunodeficiency virus infection. Clin Infect Dis  37, 1357-64.   https://doi.org/10.1086/379075




PubMed


 


PubMed ID 14583870
    
     


 



3.
Kirk GD, Lesi OA, Mendy M, Akano AO, Sam O, Goedert JJ, Hainaut P, Hall AJ, Whittle H, Montesano R (2004). The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology  39, 211-9.   https://doi.org/10.1002/hep.20027




PubMed


 


PubMed ID 14752840
    
     


 



4.
Montella M, Serraino D, Crispo A, Romano N, Fusco M, Goedert JJ (2004). Infection with human herpes virus type 8 in an area at high prevalence for hepatitis C virus infection in southern Italy. J Viral Hepat  11, 268-70.   https://doi.org/10.1111/j.1365-2893.2004.00499.x




PubMed


 


PubMed ID 15117330
    
     


 



5.
O'Brien TR, Kirk G, Zhang M (2004). Hepatocellular carcinoma: paradigm of preventive oncology. Cancer J  10, 67-73.   https://doi.org/10.1097/00130404-200403000-00002




PubMed


 


PubMed ID 15130266
    
     


 



6.
Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A, Kessing BD, Malasky MJ, Scafe C, Le E, De Jager PL, Mignault AA, Yi Z, De The G, Essex M, Sankale JL, Moore JH, Poku K, Phair JP, Goedert JJ, Vlahov D, Williams SM, Tishkoff SA, Winkler CA, De La Vega FM, et al. [7 more authors] (2004). A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet  74, 1001-13.   https://doi.org/10.1086/420856




PubMed



        
     
Free Article


 


PubMed ID 15088270
         Pubmed Central ID 1181963 


 



7.
Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol  77, 12083-7.   https://doi.org/10.1128/jvi.77.22.12083-12087.2003




PubMed



        
     
Free Article


 


PubMed ID 14581545
         Pubmed Central ID 254245",https://intramural.nih.gov/search/searchview.taf?ipid=33741
451,CP010177-04,"October 01, 2003 -  September 30, 2003",HPV Vaccine Trials,"Allan  Hildesheim; PhD



IRP Faculty Profile",NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Clayton  Harro
(Johns Hopkins School of Medicine)





Rolando  Herrero
(Ministry of Health)





Ana Cecilia  Rodriguez
(Costa Rican Social Security)
















Concepcion  Bratti
(Costa Rican Social Security)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33742
452,CP010178-03,"October 01, 2003 -  September 30, 2003",Core Genotyping Facility,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Office of the Director, NCI","Andrew Wells Bergen







Kashif  Haque




Robert  Welch




Meredith  Yeager",NULL,"Tabassum  Bandey (National Cancer Institute)



Merideth  Brown (National Cancer Institute)



Michael  Beerman (National Cancer Institute)



Ian K Barrow (National Cancer Institute)



Alison  Smoot-Pierce (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Erichsen HC, Chanock SJ (2004). SNPs in cancer research and treatment. Br J Cancer  90, 747-51.   https://doi.org/10.1038/sj.bjc.6601574




PubMed



        
     
Free Article


 


PubMed ID 14970847
         Pubmed Central ID 2410167 


 



2.
Haque KA, Pfeiffer RM, Beerman MB, Struewing JP, Chanock SJ, Bergen AW (2003). Performance of high-throughput DNA quantification methods. BMC Biotechnol  3, 20.   https://doi.org/10.1186/1472-6750-3-20




PubMed



        
     
Free Article


 


PubMed ID 14583097
         Pubmed Central ID 280658 


 



3.
Hughes AL, Packer B, Welch R, Bergen AW, Chanock SJ, Yeager M (2003). Widespread purifying selection at polymorphic sites in human protein-coding loci. Proc Natl Acad Sci U S A  100, 15754-7.   https://doi.org/10.1073/pnas.2536718100




PubMed



        
     
Free Article


 


PubMed ID 14660790
         Pubmed Central ID 307640 


 



4.
Hughes AL, Packer B, Welch R, Bergen AW, Chanock SJ, Yeager M (2005) Effects of natural selection on interpopulation divergence at polymorphic sites in human protein-coding loci. Genetics 170:1181-1187




 



5.
Packer BR, Yeager M, Staats B, Welch R, Crenshaw A, Kiley M, Eckert A, Beerman M, Miller E, Bergen A, Rothman N, Strausberg R, Chanock SJ (2004). SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res  32, D528-32.   https://doi.org/10.1093/nar/gkh005




PubMed



        
     
Free Article


 


PubMed ID 14681474
         Pubmed Central ID 308740",https://intramural.nih.gov/search/searchview.taf?ipid=33744
453,CP010180-03,"October 01, 2003 -  September 30, 2004",Prostate Cancer Studies,Ann  Hsing; PhD,NULL,"Hormonal and Reproductive Epidemiology Branch, NCI",NULL,"Peter  Carroll
(UCSF)




Chawnshang  Chang
(University of Rochester)




Chu  Chen
(University of Washington)




Streamson  Chua
(Columbia University)




Angelo  DeMarzo
(Johns Hopkins U)




Yu-Tang  Gao
(Shanghai Cancer Institute)


Show all 13",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36717
454,CP010181-02,"October 01, 2003 -  September 30, 2003",Methods for Epidemiology Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Steven  Mark; MD, ScD







Zhaohai  Li","Joanna H Shih
(NCI)





Efstathia  Bura
(The George Washington University, Washington, DC)





Kari  Hemminki; PhD
(Department of Biosciences, Karolinska Institute)





Jacques  Benichou
(University of Rouen Medical School)





Celia  Byrne
(George Washington University)





Raymond  Carroll
(Texas A&M University)


Show all 10","Sowmya  Rao (National Cancer Institute)



Nilanjan  Chatterjee (National Cancer Institute)



Joseph L Gastwirth (National Cancer Institute)



Michael  Hauptmann; PhD (National Cancer Institute)



Hormuzdiar Aspandiar Katki; MS (National Cancer Institute)



Philip Samuel Rosenberg; PhD (National Cancer Institute)","Sridhar  Rao (NLM) 












Edward David Korn; PhD (NHLBI)","Ordered by publication type and then author name.



1.
Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Meadows AT, Reaman GH, Robison LL (2004). Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood. Pediatr Blood Cancer  42, 364-72.   https://doi.org/10.1002/pbc.10449




PubMed


 


PubMed ID 14966835
    
     


 



2.
Byrne J, Fears TR, Mills JL, Zeltzer LK, Sklar C, Nicholson HS, Haupt R, Reaman GH, Meadows AT, Robison LL (2004). Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer  42, 589-97.   https://doi.org/10.1002/pbc.20033




PubMed


 


PubMed ID 15127413
    
     


 



3.
Davis WW, Graubard BI, Hartman AM, Stillman FA (2003). Descriptive methods for evaluation of state-based intervention programs. Eval Rev  27, 506-34.   https://doi.org/10.1177/0193841X03254405




PubMed


 


PubMed ID 14531317
    
     


 



4.
Li Z, Gastwirth JL (2004). On the power of affected relative pair designs for linkage studies. Ann Hum Genet  68, 65-8.   https://doi.org/10.1046/j.1529-8817.2003.00066.x




PubMed


 


PubMed ID 14748831
    
     


 



5.
Rosenberg PS, Katki H, Swanson CA, Brown LM, Wacholder S, Hoover RN (2003). Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challenge. Stat Med  22, 3369-81.   https://doi.org/10.1002/sim.1638




PubMed


 


PubMed ID 14566921
    
     


 



6.
Rutter JL, Chatterjee N, Wacholder S, Struewing J (2003). The HER2 I655V polymorphism and breast cancer risk in Ashkenazim. Epidemiology  14, 694-700.   https://doi.org/10.1097/01.ede.0000083227.74669.7b




PubMed


 


PubMed ID 14569185
    
     


 



7.
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst  96, 434-42.   https://doi.org/10.1093/jnci/djh075




PubMed


 


PubMed ID 15026468
    
     


 



8.
Yu B, Gastwirth JL (2003). The use of the 'reverse Cornfield inequality' to assess the sensitivity of a non-significant association to an omitted variable. Stat Med  22, 3383-401.   https://doi.org/10.1002/sim.1639




PubMed


 


PubMed ID 14566922",https://intramural.nih.gov/search/searchview.taf?ipid=33694
455,CP010182-02,"October 01, 2003 -  September 30, 2003",Epidemiologic Field Studies,"Mitchell Henry Gail; PhD, MD



IRP Faculty Profile",NULL,"Biostatistics Branch, NCI","Linda M Brown; MPH, DPhil","G. Marie  Swanson
(Michigan State University)





John  Boice, Jr.
(International Epidemiology Institute)





Z.  Wang
(Laboratory of Industrial Hygiene)





Liangjun  Wang; PhD
(Dept. Biological Sciences, Southern Methodist University)





Susan  Conrath
(US Environmental Protection Agency, Washington, DC)





Daniel  Schafer
(Oregon State University)


Show all 32","Patricia  Hartge; ScD (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)



Catherine G Schairer (National Cancer Institute)



Mark H Greene; MD (National Cancer Institute)



Dupont  Guerry (National Cancer Institute)



Thomas  Fears; PhD (National Cancer Institute)",Linda M Pottern (NHLBI),"Ordered by publication type and then author name.



1.
Baris D, Silverman DT, Brown LM, Swanson GM, Hayes RB, Schwartz AG, Liff JM, Schoenberg JB, Pottern LM, Greenberg RS, Stewart PA (2004). Occupation, pesticide exposure and risk of multiple myeloma. Scand J Work Environ Health  30, 215-22.   https://doi.org/10.5271/sjweh.782




PubMed


 


PubMed ID 15250650
    
     


 



2.
Chatterjee N, Hartge P, Wacholder S (2003). Adjustment for competing risk in kin-cohort estimation. Genet Epidemiol  25, 303-13.   https://doi.org/10.1002/gepi.10269




PubMed


 


PubMed ID 14639700
    
     


 



3.
Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, Brinton LA, Eley JW, Coates RJ (2004). Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer  100, 1595-604.   https://doi.org/10.1002/cncr.20169




PubMed


 


PubMed ID 15073845
    
     


 



4.
Lacey JV, Sherman ME, Hartge P, Schatzkin A, Schairer C (2004). Medication use and risk of ovarian carcinoma: a prospective study. Int J Cancer  108, 281-6.   https://doi.org/10.1002/ijc.11538




PubMed


 


PubMed ID 14639616
    
     


 



5.
Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME (2004). Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer  108, 773-9.   https://doi.org/10.1002/ijc.11624




PubMed


 


PubMed ID 14696106
    
     


 



6.
Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD (2003). Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev  12, 1222-6.




PubMed


 


PubMed ID 14652285
    
     


 



7.
Sturgeon SR, Potischman N, Malone KE, Dorgan JF, Daling J, Schairer C, Brinton LA (2004). Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer Causes Control  15, 45-53.   https://doi.org/10.1023/B:CACO.0000016574.79728.11




PubMed


 


PubMed ID 14970734
    
     


 



8.
Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, Fan JH, Gunter EW, Taylor PR, Mark SD (2004). Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr  79, 80-5.   https://doi.org/10.1093/ajcn/79.1.80




PubMed


 


PubMed ID 14684401",https://intramural.nih.gov/search/searchview.taf?ipid=33747
456,CP010183-02,"October 01, 2003 -  September 30, 2004",Descriptive Studies and Record Linkage,Susan Shaw Devesa,NULL,"Biostatistics Branch, NCI","Gloria L Gridley



Linda M Brown; MPH, DPhil



Mitchell Henry Gail; PhD, MD



Philip Samuel Rosenberg; PhD



Catherine G Schairer



Ruth  Pfeiffer; PhD



Show all 7","Susan  Sturgeon
(University of Massachusetts)





Wei-Cheng  You
(Beijing Institute for Cancer Research)





Maria  Hewitt
(National Academy of Sciences)





Ahmedin  Jemal
(American Cancer Society)





Jorgen  Olsen
(Danish Cancer Society)





Johan  Askling
(Karolinska Institute)


Show all 35","Dan J Grauman (Office of the Director)



Lynn A Ries (Cancer Statistics Branch)



Mustafa  Dosemeci; PhD (Occupational and Environmental Epidemiology Branch)



Joseph  Fraumeni; MD (Office of the Director)



James Jerome Goedert; MD (Infection & Immunoepidemiology Branch)



Ann  Hsing; PhD (Hormonal and Reproductive Epidemiology Branch)","Maria T Canto (NIDCR) 



William  Anderson (NHLBI)","Ordered by publication type and then author name.



1.
Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004). Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat  83, 77-86.   https://doi.org/10.1023/B:BREA.0000010701.08825.2d




PubMed


 


PubMed ID 14997057
    
     


 



2.
Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, Olsen JH, Hemminki K, Linet MS (2004). Familial aggregation of Hodgkin lymphoma and related tumors. Cancer  100, 1902-8.   https://doi.org/10.1002/cncr.20189




PubMed


 


PubMed ID 15112271
    
     


 



3.
Kjaer SK, Mellemkjaer L, Brinton LA, Johansen C, Gridley G, Olsen JH (2004). Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol  33, 596-602.   https://doi.org/10.1093/ije/dyh046




PubMed


 


PubMed ID 15163640
    
     


 



4.
Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF (2004). Obesity and cancer risk among white and black United States veterans. Cancer Causes Control  15, 35-43.   https://doi.org/10.1023/B:CACO.0000016573.79453.ba




PubMed


 


PubMed ID 14970733
    
     


 



5.
Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S (2004). Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis. Cancer  100, 1045-52.   https://doi.org/10.1002/cncr.20080




PubMed


 


PubMed ID 14983501",https://intramural.nih.gov/search/searchview.taf?ipid=33693
457,CP010184-02,"October 01, 2003 -  September 30, 2003",Consultation and Collaboration,Jay  Lubin; PhD,NULL,"National Cancer Institute, NCI","Aaron E Blair; PhD, MPH



Scott R Diehl; PhD



Nilanjan  Chatterjee



Wong H Chow



Joanne S Colt



Michele M Doody; MS



Show all 46","David  Brenner
(Columbia University)





Robert  Burk
(Albert Einstein College of Medicine)





Julianne  Byrne
(Washington Children's hospital)





David  Camann
(Southwest Research Institute)





Scott  Davis
(Fred Hutchinson Cancer Research Center)





Joanne  Dorgan; PhD
(NCI)


Show all 81","Joseph A Tangrea (Cancer Prevention Studies Branch)



Jeffery P Struewing; MS, MD (Laboratory of Population Genetics)



Robert  Biggar; MD (Infection & Immunoepidemiology Branch)



Linda M Brown; MPH, DPhil (Biostatistics Branch)



Philip E Castle; PhD, MPH (Hormonal and Reproductive Epidemiology Branch)



Joseph B Coble (Occupational and Environmental Epidemiology Branch)","Jane  Hoppin; ScD (NIEHS) 



Joni L Rutter (NIDA) 



Dale  Sandler; PhD (NIEHS) 



Yoshimasa  Tanaka (NIAID) 



Clarice  Weinberg; PhD (NIEHS) 



Wei  Huang; PhD (NIA)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33749
458,CP010185-02,"October 01, 2003 -  September 30, 2003",Bioterrorism Studies,"Martha S Linet; PhD



IRP Faculty Profile",NULL,"National Cancer Institute, NCI","Nickolas  Luckyanov



Charles E. Land; PhD



Kiyohiko  Mabuchi; MD, DPhil



Ethel  Gilbert



Andre  Bouville







Maureen Cusack Hatch; MD",NULL,"Elaine  Ron; PhD (Radiation Epidemiology Branch)



Steven L Simon (Radiation Epidemiology Branch)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=33748
459,SC000164-13,"October 01, 2003 -  September 30, 2004",The Molecular Mechanisms of Oncogene Action,Michael  Birrer,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Howard  Donninger (National Cancer Institute)



Fumihiro  Hommura (National Cancer Institute)



Virna D Leaner (National Cancer Institute)



Haihao  Sun (National Cancer Institute)



Liewei  Xu (National Cancer Institute)



Tomas A Bonome (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36477
460,SC000165-13,"October 01, 2003 -  September 30, 2004",The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,Michael  Birrer,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Tomas A Bonome (National Cancer Institute)



Howard  Donninger (National Cancer Institute)



Fumihiro  Hommura (National Cancer Institute)



Virna D Leaner (National Cancer Institute)



Haihao  Sun (National Cancer Institute)



Liewei  Xu (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36478
461,SC000166-13,"October 01, 2003 -  September 30, 2004",Transforming Growth Factor-beta in Lung Cancer and Carcinogenesis,Sonia B Jakowlew; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Mi Jung  Lim (National Cancer Institute)



Laurent L Ozbun (National Cancer Institute)



Lalage  Wakefield; PhD (Laboratory of Cell Regulation and Carcinogenesis)



Jyotsna  Pandey (National Cancer Institute)



Luigi M De Luca; PhD (National Cancer Institute)












Lana  Kandalaft  (National Cancer Institute)",Gary  Wright; PhD (NIA),"Ordered by publication type and then author name.



1.
Andreola F, Calvisi DF, Elizondo G, Jakowlew SB, Mariano J, Gonzalez FJ, De Luca LM (2004). Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletion. Hepatology  39, 157-66.   https://doi.org/10.1002/hep.20004




PubMed


 


PubMed ID 14752834
    
     


 



2.
Bodegas E, Martínez A, Ozbun LL, Garayoa M, Letterio JJ, Montuenga LM, Jakowlew SB (2004). Depressed adrenomedullin in the embryonic transforming growth factor-beta1 null mouse becomes elevated postnatally. Int J Dev Biol  48, 67-70.   https://doi.org/10.1387/ijdb.15005577




PubMed


 


PubMed ID 15005577
    
     


 



3.
Jakowlew SB, Mariano J (2003). Detection of the transcripts and proteins for the transforming growth factor-beta isoforms and receptors in mouse lung tumorigenesis using in situ hybridization and immunohistochemistry in paraffin-embedded tissue sections. Methods Mol Med  74, 145-66.   https://doi.org/10.1385/1-59259-323-2:145




PubMed


 


PubMed ID 12415692
    
     


 



4.
Kang Y, Hebron H, Ozbun L, Mariano J, Minoo P, Jakowlew SB (2004). Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis. Mol Carcinog  40, 212-31.   https://doi.org/10.1002/mc.20034




PubMed


 


PubMed ID 15264213
    
     


 



5.
Ozbun LL, Martínez A, Angdisen J, Umphress S, Kang Y, Wang M, You M, Jakowlew SB (2003). Differentially expressed nucleolar TGF-beta1 target (DENTT) in mouse development. Dev Dyn  226, 491-511.   https://doi.org/10.1002/dvdy.10257




PubMed


 


PubMed ID 12619135
    
     


 



6.
Zhang F, Pao W, Umphress S, Jakowlew S, Meyer AM, Dwyer-Nield LD, Takeda K, Gelfand EW, Fisher J, Malkinson AM, Mason RJ (2004). Serum levels of surfactant protein D are increased in mice with lung tumors. Chest  125, 109S.




PubMed


 


PubMed ID 15136449
    
     


 



7.
Zhang F, Pao W, Umphress SM, Jakowlew SB, Meyer AM, Dwyer-Nield LD, Nielsen LD, Takeda K, Gelfand EW, Fisher JH, Zhang L, Malkinson AM, Mason RJ (2003). Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Res  63, 5889-94.




PubMed


 


PubMed ID 14522914",https://intramural.nih.gov/search/searchview.taf?ipid=36479
462,SC000167-13,"October 01, 2003 -  September 30, 2004",Molecular Pathology of Pulmonary Carcinogenesis,Ilona  Linnoila; MD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Franco  DeMayo
(Cell Biology, Baylor Medical College)





Steven H.  Reynolds
(NIOSH, CDC)





Ralph  Meuwissen
(Molecular Genetics, Netherlands Cancer Institute)
















Doug  Ball
(Oncology, Johns Hopkins University)




H. Leighton  Grimes
(Surgery, U. Louisville)",Wayne  Glasgow; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Means-Markwell M, Linnoila RI, Williams J, Jänne PA, Kaye F, O'Neil K, Johnson BE (2003). Prospective study of the airways and pulmonary parenchyma of patients at risk for a second lung cancer. Clin Cancer Res  9, 5915-21.




PubMed


 


PubMed ID 14676115
    
     


 



2.
Meuwissen R, Linn SC, Linnoila RI, Zevenhoven J, Mooi WJ, Berns A (2003). Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell  4, 181-9.   https://doi.org/10.1016/s1535-6108(03)00220-4




PubMed


 


PubMed ID 14522252",https://intramural.nih.gov/search/searchview.taf?ipid=36480
463,SC000170-13,"October 01, 2003 -  September 30, 2004",Clinical Evaluation of New Intervention Agents,Christian Arthur Combs; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Michael  Placke
(Wyeth Pharmaceuticals)





Elaine  Liversidge
(ELAN Pharmaceuticals)





Robert  Greer
(Oral Pathology, University of Colorado Lung Cancer Spore)





Richard  Lee
(Cardiovascular Division, Brigham and Womens Hospital Harvard)





John  Patton
(Nektar)
















Paul  Cavanaugh
(Merck Research Laboratory)",NULL,NULL,"Ordered by publication type and then author name.



1.
Ballaz S, Mulshine JL   (2003) The potential contributions of chronic inflammation to lung carcinogenesis.  Clin Lung Cancer 5:46-62.




PubMed


 


PubMed ID 14596704
    
     


 



2.
Garayoa M, Man YG, Mart-nez A, Cuttitta F, Mulshine JL   (2003) Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia.  Am J Respir Cell Mol Biol 28:80-5.




PubMed


 


PubMed ID 12495935
    
     


 



3.
Mart-nez A, Lehman TA, Modali R, Mulshine JL   (2003) Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.  Methods Mol Med 74:187-200.




PubMed


 


PubMed ID 12415694
    
     


 



4.
Mulshine JL   (2003) Screening for lung cancer: in pursuit of pre-metastatic disease.  Nat Rev Cancer 3:65-73.




PubMed


 


PubMed ID 12509768
    
     


 



5.
Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF (2004). Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res  10, 1565-73.   https://doi.org/10.1158/1078-0432.ccr-1020-3




PubMed


 


PubMed ID 15014005
    
     


 



6.
Mulshine JL, Hirsch FR   (2003) Lung cancer chemoprevention: moving from concept to a reality.  Lung Cancer 41 Suppl 1:S163-74.




PubMed


 


PubMed ID 12867075
    
     


 



7.
Warner EE, Mulshine JL   (2003) Surgical considerations with lung cancer screening.  J Surg Oncol 84:1-6.




PubMed


 


PubMed ID 12949983",https://intramural.nih.gov/search/searchview.taf?ipid=36481
464,SC000171-13,"October 01, 2003 -  September 30, 2004",Biological Regulation of Lung Cancer Growth,Christian Arthur Combs; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"David  Yankelevitz
(Cornell Medical Center, Cornell University)





Claudia  Henschke
(Cornell Medical Center, Cornell University)





Kenneth  Cowan
(University of Nebraska)
















Frank  Ondrey, MD., PhD
(University of Minnesota)","Anatoly  Mayburd (National Cancer Institute)



Jordi  Tauler-Vaillet (National Cancer Institute)



Luigi M De Luca; PhD (National Cancer Institute)












Ingalill  Avis  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ballaz S, Mulshine JL   (2003) The potential contributions of chronic inflammation to lung carcinogenesis.  Clin Lung Cancer 5:46-62.




PubMed


 


PubMed ID 14596704
    
     


 



2.
Hattery D, Hattery B, Chernomordik V, Smith P, Loew M, Mulshine J, Gandjbakhche A (2004). Differential oblique angle spectroscopy of the oral epithelium. J Biomed Opt  9, 951-60.   https://doi.org/10.1117/1.1781161




PubMed


 


PubMed ID 15447016",https://intramural.nih.gov/search/searchview.taf?ipid=36482
465,SC000173-13,"October 01, 2003 -  September 30, 2004",Identification of Peptide Growth Factors That Regulate Human Tumor Proliferation,Frank  Cuttitta; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Enrique  Zudaire Ubani; PhD,"Vundavalli  Murty
(Pathology, College of Physicians & Surgeons of Columbia University)
















John  Chirgwin
(Internal Medicine, University of Virginia Health System)","Sergio  Portal (National Cancer Institute)



William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Laurent L Ozbun (National Cancer Institute)



Sonia B Jakowlew; PhD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)



Michael  Birrer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Abasolo I, Yang L, Haleem R, Xiao W, Pio R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A, Wang Z (2003). Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo. Mol Cell Endocrinol  199, 179-87.   https://doi.org/10.1016/s0303-7207(02)00229-0




PubMed


 


PubMed ID 12581889
    
     


 



2.
Macpherson GR, Ng SS, Forbes SL, Melillo G, Karpova T, McNally J, Conrads TP, Veenstra TD, Martinez A, Cuttitta F, Price DK, Figg WD (2003). Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol Cancer Ther  2, 845-54.




PubMed


 


PubMed ID 14555703
    
     


 



3.
Martínez A, Pío R, Zipfel PF, Cuttitta F (2003). Mapping of the adrenomedullin-binding domains in human complement factor H. Hypertens Res  26 Suppl, S55-9.   https://doi.org/10.1291/hypres.26.s55




PubMed


 


PubMed ID 12630812
    
     


 



4.
Zudaire E, Martínez A, Cuttitta F (2003). Adrenomedullin and cancer. Regul Pept  112, 175-83.   https://doi.org/10.1016/s0167-0115(03)00037-5




PubMed


 


PubMed ID 12667640",https://intramural.nih.gov/search/searchview.taf?ipid=36483
466,SC000181-12,"October 01, 2003 -  September 30, 2004",The Molecular Genetics of Gynecologic Cancers,Michael  Birrer,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Tomas A Bonome (National Cancer Institute)



Howard  Donninger (National Cancer Institute)



Fumihiro  Hommura (National Cancer Institute)



Virna D Leaner (National Cancer Institute)



Haihao  Sun (National Cancer Institute)



Fred  Wamunyokoli (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36484
467,SC000192-11,"October 01, 2003 -  September 30, 2004",Growth of Human Tumor Cell Lines in Protein-free/Hormone-Free Media,Frank  Cuttitta; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",Enrique  Zudaire Ubani; PhD,"Vundavalli  Murty
(Pathology, College of Physicians & Surgeons of Columbia University)
















John  Chirgwin
(Internal Medicine, University of Virginia Health System)","Sergio  Portal (National Cancer Institute)



William G Stetler-Stevenson; MD, PhD (National Cancer Institute)



Michael  Birrer (National Cancer Institute)



Sonia B Jakowlew; PhD (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)



Lino  Tessarollo (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Abasolo I, Yang L, Haleem R, Xiao W, Pio R, Cuttitta F, Montuenga LM, Kozlowski JM, Calvo A, Wang Z (2003). Overexpression of adrenomedullin gene markedly inhibits proliferation of PC3 prostate cancer cells in vitro and in vivo. Mol Cell Endocrinol  199, 179-87.   https://doi.org/10.1016/s0303-7207(02)00229-0




PubMed


 


PubMed ID 12581889
    
     


 



2.
Martínez A, Pío R, Zipfel PF, Cuttitta F (2003). Mapping of the adrenomedullin-binding domains in human complement factor H. Hypertens Res  26 Suppl, S55-9.   https://doi.org/10.1291/hypres.26.s55




PubMed


 


PubMed ID 12630812
    
     


 



3.
Zudaire E, Martínez A, Cuttitta F (2003). Adrenomedullin and cancer. Regul Pept  112, 175-83.   https://doi.org/10.1016/s0167-0115(03)00037-5




PubMed


 


PubMed ID 12667640
    
     


 



4.
Zudaire E, Martínez A, Ozbun LL, Cuttitta F (2004). Characterization of adrenomedullin in non-human primates. Biochem Biophys Res Commun  321, 859-69.   https://doi.org/10.1016/j.bbrc.2004.07.032




PubMed


 


PubMed ID 15358106",https://intramural.nih.gov/search/searchview.taf?ipid=36485
468,SC000550-24,"October 01, 2003 -  September 30, 2004",Lymphoma Disease Discovery and Defintion,"Elaine S Jaffe; MD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Mark  Raffeld; MD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Jorge R Toro (National Cancer Institute)



Guihua  Yue; PhD (National Cancer Institute)",Stephen E Straus; MD (NCCIH),"Ordered by publication type and then author name.



1.
Calvo KR, Traverse-Glehen A, Pittaluga S, Jaffe ES (2004). Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol  11, 227-38.   https://doi.org/10.1097/01.pap.0000138144.11635.f8




PubMed


 


PubMed ID 15322489
    
     


 



2.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004). Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood  103, 275-82.   https://doi.org/10.1182/blood-2003-05-1545




PubMed


 


PubMed ID 14504078
    
     


 



3.
Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH (2005). High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood  105, 496-502.   https://doi.org/10.1182/blood-2004-05-1982




PubMed


 


PubMed ID 15358629
    
     


 



4.
Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Ott G, Müller-Hermelink HK, Delabie J, Braziel RM, Jaffe ES, Campo E, Lynch JC, Connors JM, Vose JM, Armitage JO, et al. [3 more authors] (2004). BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol  165, 159-66.   https://doi.org/10.1016/s0002-9440(10)63284-1




PubMed



        
     
Free Article


 


PubMed ID 15215171
         Pubmed Central ID 1618550 


 



5.
Jaffe ES (2004). Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst  96, 571-3.   https://doi.org/10.1093/jnci/djh138




PubMed


 


PubMed ID 15100327
    
     


 



6.
Jaffe ES, Banks PM, Nathwani B, Said J, Swerdlow SH, Ad Hoc Committee on reporting of lymphoid neoplasms, Association of Directors of Anatomic and Surgical Pathology (2004). Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod Pathol  17, 131-5.   https://doi.org/10.1038/sj.modpathol.3800028




PubMed


 


PubMed ID 14657953
    
     


 



7.
Jaffe ES, Krenacs L, Raffeld M (2003). Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol  40, 175-84.   https://doi.org/10.1016/s0037-1963(03)00132-x




PubMed


 


PubMed ID 12876666
    
     


 



8.
Janik JE, Morris JC, Pittaluga S, McDonald K, Raffeld M, Jaffe ES, Grant N, Gutierrez M, Waldmann TA, Wilson WH (2004). Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. Blood  104, 3355-7.   https://doi.org/10.1182/blood-2003-11-3922




PubMed


 


PubMed ID 15205267
    
     


 



9.
Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, Dale JK, Straus SE, Cohen JI (2004). Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood  103, 1244-52.   https://doi.org/10.1182/blood-2003-06-2171




PubMed


 


PubMed ID 14576041
    
     


 



10.
Leonard GD, Hegde U, Butman J, Jaffe ES, Wilson WH (2003). Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol  21, 2993-5.   https://doi.org/10.1200/JCO.2003.07.104




PubMed


 


PubMed ID 12885820
    
     


 



11.
Martinez A, Pittaluga S, Villamor N, Colomer D, Rozman M, Raffeld M, Montserrat E, Campo E, Jaffe ES (2004). Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol  28, 849-58.   https://doi.org/10.1097/00000478-200407000-00002




PubMed


 


PubMed ID 15223953
    
     


 



12.
Murdock J, Jaffe ES, Wilson WH, McManus DT, Alexander HD, Morris TC (2004). Aggressive natural killer cell leukemia/lymphoma: case report, use of telesynergy and review of the literature. Leuk Lymphoma  45, 1269-73.   https://doi.org/10.1080/10428190310001646879




PubMed


 


PubMed ID 15360011
    
     


 



13.
Papadopoulos EJ, Jaffe ES, Elgart GW, Raffeld M, Turner ML (2004). Periodic fever with atypical dyshidrosis--quiz case. Arch Dermatol  140, 479-84.   https://doi.org/10.1001/archderm.140.4.479-a




PubMed


 


PubMed ID 15096381
    
     


 



14.
Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E, Liotta LA, Jaffe ES (2004). Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest  84, 235-44.   https://doi.org/10.1038/labinvest.3700051




PubMed


 


PubMed ID 14767488",https://intramural.nih.gov/search/searchview.taf?ipid=36486
469,SC000852-51,"October 01, 2003 -  September 30, 2004",Cytology Applied to Human Diagnostic Problems and Research Problems,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,"Amy Victoria Rapkiewicz (National Cancer Institute)












Virginia A Espina  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC (2003). The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res  9, 44-51.




PubMed


 


PubMed ID 12538450",https://intramural.nih.gov/search/searchview.taf?ipid=36487
470,SC000853-51,"October 01, 2003 -  September 30, 2004",Surgical Pathology,"Maria  Merino; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Sedric V Cade (National Cancer Institute)



Martha Maria Nicacio Quezado; MD (National Cancer Institute)



William Marston Linehan; MD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R, Heo S, Merino M, Nieman LK (2003). Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril  79, 1078-85.   https://doi.org/10.1016/s0015-0282(03)00155-9




PubMed


 


PubMed ID 12738499",https://intramural.nih.gov/search/searchview.taf?ipid=36488
471,SC000891-21,"October 01, 2003 -  September 30, 2004",Stimulated Motility in Tumor Cells,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,"Eun Jin Koh (National Cancer Institute)



Elliott  Schiffman (National Cancer Institute)



Mary  Stracke (National Cancer Institute)












Timothy  Clair; MS  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML (2003). Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res  63, 5446-53.




PubMed


 


PubMed ID 14500380
    
     


 



2.
Woodhouse EC, Fisher A, Bandle RW, Bryant-Greenwood B, Charboneau L, Petricoin EF, Liotta LA (2003). Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci U S A  100, 11463-8.   https://doi.org/10.1073/pnas.2031202100




PubMed



        
     
Free Article


 


PubMed ID 14500904
         Pubmed Central ID 208780",https://intramural.nih.gov/search/searchview.taf?ipid=36489
472,SC000892-21,"October 01, 2003 -  September 30, 2004",Molecular Biology of the Metastatic Phenotype,"Patricia  Steeg; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Christine  Horak (National Cancer Institute)



Douglas  Halverson (National Cancer Institute)



Massimiliano  Salerno (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ouatas T, Halverson D, Steeg PS (2003). Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin Cancer Res  9, 3763-72.




PubMed


 


PubMed ID 14506169
    
     


 



2.
Ouatas T, Salerno M, Palmieri D, Steeg PS (2003). Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr  35, 73-9.   https://doi.org/10.1023/a:1023497924277




PubMed


 


PubMed ID 12848344
    
     


 



3.
Salerno M, Ouatas T, Palmieri D, Steeg PS (2003). Inhibition of signal transduction by the nm23 metastasis suppressor: possible mechanisms. Clin Exp Metastasis  20, 3-10.   https://doi.org/10.1023/a:1022578000022




PubMed


 


PubMed ID 12650601
    
     


 



4.
Steeg PS (2003). Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer  3, 55-63.   https://doi.org/10.1038/nrc967




PubMed


 


PubMed ID 12509767
    
     


 



5.
Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M (2003). Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer  4, 51-62.   https://doi.org/10.3816/cbc.2003.n.012




PubMed


 


PubMed ID 12744759
    
     


 



6.
Steeg PS, Palmieri D, Ouatas T, Salerno M (2003). Histidine kinases and histidine phosphorylated proteins in mammalian cell biology, signal transduction and cancer. Cancer Lett  190, 1-12.   https://doi.org/10.1016/s0304-3835(02)00499-8




PubMed


 


PubMed ID 12536071",https://intramural.nih.gov/search/searchview.taf?ipid=36490
473,SC003638-35,"October 01, 2003 -  September 30, 2004",Studies of DNA Repair in Human Degenerative Diseases,Jay H Robbins; MD,Mark  Udey; MD,"Office of the Director, NCI",NULL,NULL,"Mary  Ganges (National Cancer Institute)



Nihkil  Mull (National Cancer Institute)



Raghu  Nath (National Cancer Institute)



Kathleen M O'Brien (National Cancer Institute)



Kenneth H Kraemer; MD (National Cancer Institute)












Edward  Brant  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36491
474,SC003657-30,"October 01, 2003 -  September 30, 2004",Immunopathologic Mechanisms Involved in Inflammatory Skin Diseases,"Stephen I Katz; PhD, MD",NULL,"Office of the Director, NCI",NULL,NULL,"Brian  Kim (National Cancer Institute)



Jina  Lewis (National Cancer Institute)



Jay T Linton (National Cancer Institute)



Fumi  Miyagawa (National Cancer Institute)



Satoshi  Takeuchi (National Cancer Institute)



Fumiko  Takeuchi (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36492
475,SC003669-15,"October 01, 2003 -  September 30, 2004",Regulation of Cutaneous Accessory Cell Activity in Health and Disease,Mark  Udey; MD,NULL,"Office of the Director, NCI",NULL,"Robert  Modlin
(Medicine/Dermatology, UCLA School of Medicine)





Peter  Sieling
(Medicine/Dermatology, UCLA School of Medicine)





Esther  von Stebut
(Dermatology, University of Mainz)
















Erika  Crouch
(Pathology, Washington University School of Medicine)","Cheryl  Eberting (National Cancer Institute)



Xu  Feng (National Cancer Institute)



Flora  Kim (National Cancer Institute)



Carl  Koch (National Cancer Institute)



Wolfgang  Leitner (National Cancer Institute)



Melanie  Neutzner (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blauvelt A, Hwang ST, Udey MC (2003). 11. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol  111, S560-70.   https://doi.org/10.1067/mai.2003.78




PubMed


 


PubMed ID 12592302
    
     


 



2.
Shibagaki N, Udey MC (2003). Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma. Eur J Immunol  33, 850-60.   https://doi.org/10.1002/eji.200323709




PubMed


 


PubMed ID 12672050
    
     


 



3.
Udey MC (2003). In this issue: progress towards a more complete understanding of two important immune diseases involving skin. J Invest Dermatol  120, viii.   https://doi.org/10.1046/j.1523-1747.2003.12115.x




PubMed


 


PubMed ID 12648241
    
     


 



4.
Von Stebut E, Ehrchen JM, Belkaid Y, Kostka SL, Molle K, Knop J, Sunderkotter C, Udey MC (2003). Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB/c mice. J Exp Med  198, 191-9.   https://doi.org/10.1084/jem.20030159




PubMed



        
     
Free Article


 


PubMed ID 12860932
         Pubmed Central ID 2194079",https://intramural.nih.gov/search/searchview.taf?ipid=36493
476,SC003670-12,"October 01, 2003 -  September 30, 2004",Keratinocyte Gene Therapy,Jonathan  Vogel; MD,Mark  Udey; MD,"Office of the Director, NCI",NULL,"Lorne  Taichman
(SUNY - Stony Brook)





Wolfgang  Pfutzner
(Dermatology, University of Munich)
















Cynthia E Dunbar; MD
(NHLBI)","Carole L Yee (National Cancer Institute)



Guihua  Yue; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ohyama M, Vogel JC (2003). Gene delivery to the hair follicle. J Investig Dermatol Symp Proc  8, 204-6.   https://doi.org/10.1046/j.1087-0024.2003.00810.x




PubMed


 


PubMed ID 14582674
    
     


 



2.
Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC (2004). Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes. Gene Ther  11, 1729-34.   https://doi.org/10.1038/sj.gt.3302344




PubMed


 


PubMed ID 15334113",https://intramural.nih.gov/search/searchview.taf?ipid=36494
477,SC003800-34,"October 01, 2003 -  September 30, 2004",Surgical Consultants & Collaborative Research Involving Surgical Services at NIH,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgy Br, NCI",NULL,NULL,"Richard Eldon Royal (National Cancer Institute)



Richard  Sherry; MD (National Cancer Institute)



H Richard Alexander; MD, PhD (National Cancer Institute)



David  Danforth (National Cancer Institute)



Udai S Kammula (National Cancer Institute)



Steven  Libutti; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36495
478,SC003811-30,"October 01, 2003 -  September 30, 2004",The Immunotherapy of Animal and Human Cancer,"Steven Aaron Rosenberg; MD, PhD



IRP Faculty Profile",NULL,"Surgy Br, NCI",David  Danforth,NULL,"Peter  Attia (National Cancer Institute)



David  Schrump; MD (Thoracic Onclgy Sect)



H Richard Alexander; MD, PhD (Surgl Metabolism Sect)



Ajay V Maker (National Cancer Institute)



Daniel  Powell (National Cancer Institute)



Mojgan  Ahmadzadeh (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Dudley ME, Rosenberg SA (2003). Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer  3, 666-75.   https://doi.org/10.1038/nrc1167




PubMed



        
     
Free Article


 


PubMed ID 12951585
         Pubmed Central ID 2305722 


 



2.
Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA (2003). Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother  26, 332-42.   https://doi.org/10.1097/00002371-200307000-00005




PubMed



        
     
Free Article


 


PubMed ID 12843795
         Pubmed Central ID 2305721 


 



3.
Elaraj DM, White DE, Steinberg SM, Haworth L, Rosenberg SA, Yang JC (2004). A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinoma. J Immunother  27, 259-64.   https://doi.org/10.1097/00002371-200407000-00001




PubMed



        
     
Free Article


 


PubMed ID 15235386
         Pubmed Central ID 2275325 


 



4.
Finkelstein SE, Carrasquillo JA, Hoffman JM, Galen B, Choyke P, White DE, Rosenberg SA, Sherry RM (2004). A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy. Ann Surg Oncol  11, 731-8.   https://doi.org/10.1245/ASO.2004.01.023




PubMed



        
     
Free Article


 


PubMed ID 15249335
         Pubmed Central ID 2227906 


 



5.
Finkelstein SE, Heimann DM, Klebanoff CA, Antony PA, Gattinoni L, Hinrichs CS, Hwang LN, Palmer DC, Spiess PJ, Surman DR, Wrzesiniski C, Yu Z, Rosenberg SA, Restifo NP (2004). Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol  76, 333-7.   https://doi.org/10.1189/jlb.0304120




PubMed



        
     
Free Article


 


PubMed ID 15155774
         Pubmed Central ID 1484508 


 



6.
Huang J, El-Gamil M, Dudley ME, Li YF, Rosenberg SA, Robbins PF (2004). T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene product. J Immunol  172, 6057-64.   https://doi.org/10.4049/jimmunol.172.10.6057




PubMed



        
     
Free Article


 


PubMed ID 15128789
         Pubmed Central ID 2305724 


 



7.
Javia LR, Rosenberg SA (2003). CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother  26, 85-93.   https://doi.org/10.1097/00002371-200301000-00009




PubMed



        
     
Free Article


 


PubMed ID 12514432
         Pubmed Central ID 2410039 


 



8.
Khong HT, Yang JC, Topalian SL, Sherry RM, Mavroukakis SA, White DE, Rosenberg SA (2004). Immunization of HLA-A*0201 and/or HLA-DPbeta1*04 patients with metastatic melanoma using epitopes from the NY-ESO-1 antigen. J Immunother  27, 472-7.   https://doi.org/10.1097/00002371-200411000-00007




PubMed



        
     
Free Article


 


PubMed ID 15534491
         Pubmed Central ID 2227905 


 



9.
Liu K, Rosenberg SA (2003). Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent. J Immunother  26, 190-201.   https://doi.org/10.1097/00002371-200305000-00003




PubMed



        
     
Free Article


 


PubMed ID 12806273
         Pubmed Central ID 2553215 


 



10.
Maccalli C, Li YF, El-Gamil M, Rosenberg SA, Robbins PF (2003). Identification of a colorectal tumor-associated antigen (COA-1) recognized by CD4(+) T lymphocytes. Cancer Res  63, 6735-43.




PubMed



        
     
Free Article


 


PubMed ID 14583468
         Pubmed Central ID 2275323 


 



11.
Morgan RA, Dudley ME, Yu YY, Zheng Z, Robbins PF, Theoret MR, Wunderlich JR, Hughes MS, Restifo NP, Rosenberg SA (2003). High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens. J Immunol  171, 3287-95.   https://doi.org/10.4049/jimmunol.171.6.3287




PubMed



        
     
Free Article


 


PubMed ID 12960359
         Pubmed Central ID 2248799 


 



12.
Nagorsen D, Panelli M, Dudley ME, Finkelstein SE, Rosenberg SA, Marincola FM (2003). Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells. Gene Ther  10, 1754-65.   https://doi.org/10.1038/sj.gt.3302066




PubMed



        
     
Free Article


 


PubMed ID 12939642
         Pubmed Central ID 2275329 


 



13.
Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC, Heimann DM, Klebanoff CA, Yu Z, Hwang LN, Feigenbaum L, Kruisbeek AM, Rosenberg SA, Restifo NP (2003). Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med  198, 569-80.   https://doi.org/10.1084/jem.20030590




PubMed



        
     
Free Article


 


PubMed ID 12925674
         Pubmed Central ID 2194177 


 



14.
Parkhurst MR, DePan C, Riley JP, Rosenberg SA, Shu S (2003). Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules. J Immunol  170, 5317-25.   https://doi.org/10.4049/jimmunol.170.10.5317




PubMed



        
     
Free Article


 


PubMed ID 12734382
         Pubmed Central ID 2553207 


 



15.
Parkhurst MR, Riley JP, Igarashi T, Li Y, Robbins PF, Rosenberg SA (2004). Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase. Clin Cancer Res  10, 4688-98.   https://doi.org/10.1158/1078-0432.CCR-04-0325




PubMed



        
     
Free Article


 


PubMed ID 15269141
         Pubmed Central ID 2374668 


 



16.
Phan GQ, Touloukian CE, Yang JC, Restifo NP, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (2003). Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J Immunother  26, 349-56.   https://doi.org/10.1097/00002371-200307000-00007




PubMed



        
     
Free Article


 


PubMed ID 12843797
         Pubmed Central ID 1679660 


 



17.
Robbins PF, Dudley ME, Wunderlich J, El-Gamil M, Li YF, Zhou J, Huang J, Powell DJ, Rosenberg SA (2004). Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy. J Immunol  173, 7125-30.   https://doi.org/10.4049/jimmunol.173.12.7125




PubMed



        
     
Free Article


 


PubMed ID 15585832
         Pubmed Central ID 2175171 


 



18.
Rosenberg SA, Yang JC, Robbins PF, Wunderlich JR, Hwu P, Sherry RM, Schwartzentruber DJ, Topalian SL, Restifo NP, Filie A, Chang R, Dudley ME (2003). Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma. J Immunother  26, 385-93.   https://doi.org/10.1097/00002371-200309000-00001




PubMed



        
     
Free Article


 


PubMed ID 12973027
         Pubmed Central ID 1764125 


 



19.
Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Topalian SL, Sherry RM, Restifo NP, Wunderlich JR, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, Gritz L, Panicali DL, White DE (2003). Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma. Clin Cancer Res  9, 2973-80.




PubMed



        
     
Free Article


 


PubMed ID 12912944
         Pubmed Central ID 2259234 


 



20.
Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA (2003). A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med  349, 427-34.   https://doi.org/10.1056/NEJMoa021491




PubMed



        
     
Free Article


 


PubMed ID 12890841
         Pubmed Central ID 2275324 


 



21.
Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA (2003). Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol  21, 3127-32.   https://doi.org/10.1200/JCO.2003.02.122




PubMed



        
     
Free Article


 


PubMed ID 12915604
         Pubmed Central ID 2275327 


 



22.
Zhou J, Dudley ME, Rosenberg SA, Robbins PF (2004). Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma. J Immunol  173, 7622-9.   https://doi.org/10.4049/jimmunol.173.12.7622




PubMed



        
     
Free Article


 


PubMed ID 15585890
         Pubmed Central ID 2174603 


 



23.
Morgan RA, Hsu CA, Rosenberg SA (submitted in 2004) Adoptive Immunotherapy With Enhanced T Lymphocyte Survival. Patents issued: 7,998,736 (US in 2011); 2005336093 (AU in 2011); 1809321 (BE in 2012); 1809321 (CH in 2012); 1809321 (DE in 2012); 1809321 (DK in 2012); 1809321 (EP in 2012); 1809321 (ES in 2012); 1809321 (FI in 2012); 1809321 (FR in 2012); 1809321 (GB in 2012); 1809321 (IE in 2012); 1809321 (IT in 2012); 1809321 (NL in 2012); 1809321 (PT in 2012); 1809321 (SE in 2012); 1809321 (AT in 2012); 2590401 (CA in 2015). Patent pending: PCT/US2005/036407 (PC application).




 



24.
Morgan RA, Rosenberg SA (submitted in 2004) A Method To Enable Normal Lymphocytes To Recognize And Destroy Melanoma Tumor Cells Expressing The Mart-1 Tumor Antigen. Patent issued: 7,915,036 (US in 2011). Patents pending: 2,580,412 (CA application); PCT/US2004/29608 (PC application).",https://intramural.nih.gov/search/searchview.taf?ipid=36496
479,SC004002-35,"October 01, 2003 -  September 30, 2004",Defects in Immunoregulatory Cell Receptors in Patients with Leukemia/Lymphoma,"Thomas Alexander Waldmann; MD, PhD



IRP Faculty Profile",NULL,"Metabolism Br, NCI",NULL,"Gillian  Warfe
(University of the West Indies)
















Steven J Jacobson; PhD
(NINDS)","Jurgen  Muller (National Cancer Institute)



C  Kisker; PhD (National Cancer Institute)","Jorge A Carrasquillo; MD (CC) 



William  Eckelman; MD (CC) 



Roland M Martin; MD (NINDS) 



Robert B. Nussenblatt; MD (NEI) 



Henry F McFarland; MD (NINDS)","Ordered by publication type and then author name.



1.
Dubois S, Shou W, Haneline LS, Fleischer S, Waldmann TA, Müller JR (2003). Distinct pathways involving the FK506-binding proteins 12 and 12.6 underlie IL-2-versus IL-15-mediated proliferation of T cells. Proc Natl Acad Sci U S A  100, 14169-74.   https://doi.org/10.1073/pnas.2335979100




PubMed



        
     
Free Article


 


PubMed ID 14605212
         Pubmed Central ID 283564 


 



2.
Foss FM, Waldmann TA (2003). Interleukin-2 receptor-directed therapies for cutaneous lymphomas. Hematol Oncol Clin North Am  17, 1449-58.   https://doi.org/10.1016/s0889-8588(03)00110-2




PubMed


 


PubMed ID 14710895
    
     


 



3.
Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, Tagaya Y (2005). Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood  105, 721-7.   https://doi.org/10.1182/blood-2003-12-4187




PubMed


 


PubMed ID 15367431
    
     


 



4.
Kobayashi H, Kawamoto S, Brechbiel MW, Jo SK, Hu X, Yang T, Diwan BA, Waldmann TA, Schnermann J, Choyke PL, Star RA (2004). Micro-MRI methods to detect renal cysts in mice. Kidney Int  65, 1511-6.   https://doi.org/10.1111/j.1523-1755.2004.00532.x




PubMed


 


PubMed ID 15086495
    
     


 



5.
Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW (2003). Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med  50, 758-66.   https://doi.org/10.1002/mrm.10583




PubMed


 


PubMed ID 14523962
    
     


 



6.
Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst  96, 703-8.   https://doi.org/10.1093/jnci/djh124




PubMed


 


PubMed ID 15126607
    
     


 



7.
Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Brechbiel MW, Choyke PL (2003). Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase. Bioconjug Chem  14, 1044-7.   https://doi.org/10.1021/bc034064l




PubMed


 


PubMed ID 13129410
    
     


 



8.
Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW (2003). Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res  63, 271-6.




PubMed


 


PubMed ID 12543772
    
     


 



9.
Mandler R, Kobayashi H, Hinson ER, Brechbiel MW, Waldmann TA (2004). Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity. Cancer Res  64, 1460-7.   https://doi.org/10.1158/0008-5472.can-03-2485




PubMed


 


PubMed ID 14973048
    
     


 



10.
Nussenblatt RB, Thompson DJ, Li Z, Chan CC, Peterson JS, Robinson RR, Shames RS, Nagarajan S, Tang MT, Mailman M, Velez G, Roy C, Levy-Clarke GA, Suhler EB, Djalilian A, Sen HN, Al-Khatib S, Ursea R, Srivastava S, Bamji A, Mellow S, Sran P, Waldmann TA, Buggage RR (2003). Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun  21, 283-93.   https://doi.org/10.1016/s0896-8411(03)00113-6




PubMed


 


PubMed ID 14599854
    
     


 



11.
Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP (2003). Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci U S A  100, 3392-7.   https://doi.org/10.1073/pnas.0630592100




PubMed



        
     
Free Article


 


PubMed ID 12626740
         Pubmed Central ID 152303 


 



12.
Panyi G, Bagdány M, Bodnár A, Vámosi G, Szentesi G, Jenei A, Mátyus L, Varga S, Waldmann TA, Gáspar R, Damjanovich S (2003). Colocalization and nonrandom distribution of Kv1.3 potassium channels and CD3 molecules in the plasma membrane of human T lymphocytes. Proc Natl Acad Sci U S A  100, 2592-7.   https://doi.org/10.1073/pnas.0438057100




PubMed



        
     
Free Article


 


PubMed ID 12604782
         Pubmed Central ID 151385 


 



13.
Vámosi G, Bodnár A, Vereb G, Jenei A, Goldman CK, Langowski J, Tóth K, Mátyus L, Szöllösi J, Waldmann TA, Damjanovich S (2004). IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci U S A  101, 11082-7.   https://doi.org/10.1073/pnas.0403916101




PubMed



        
     
Free Article


 


PubMed ID 15263076
         Pubmed Central ID 503744 


 



14.
Vereb G, Szöllosi J, Matkó J, Nagy P, Farkas T, Vigh L, Mátyus L, Waldmann TA, Damjanovich S (2003). Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci U S A  100, 8053-8.   https://doi.org/10.1073/pnas.1332550100




PubMed



        
     
Free Article


 


PubMed ID 12832616
         Pubmed Central ID 166180 


 



15.
Waldmann T (2003). ABCs of radioisotopes used for radioimmunotherapy: alpha- and beta-emitters. Leuk Lymphoma  44 Suppl 3, S107-13.   https://doi.org/10.1080/10428190310001623685




PubMed


 


PubMed ID 15202533
    
     


 



16.
Waldmann TA (2003). A novel means of favorably tipping the balance between cytopathic and regulatory T cells. Immunity  19, 465-6.   https://doi.org/10.1016/s1074-7613(03)00273-5




PubMed


 


PubMed ID 14563310
    
     


 



17.
Waldmann TA (2003). IL-15 in the life and death of lymphocytes: immunotherapeutic implications. Trends Mol Med  9, 517-21.   https://doi.org/10.1016/j.molmed.2003.10.005




PubMed


 


PubMed ID 14659465
    
     


 



18.
Waldmann TA (2003). Immunotherapy: past, present and future. Nat Med  9, 269-77.   https://doi.org/10.1038/nm0303-269




PubMed


 


PubMed ID 12612576
    
     


 



19.
Waldmann TA (2003). The meandering 45-year odyssey of a clinical immunologist. Annu Rev Immunol  21, 1-27.   https://doi.org/10.1146/annurev.immunol.21.120601.140933




PubMed


 


PubMed ID 12359737
    
     


 



20.
Waldmann TA (2004). Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases. Arthritis Res Ther  6, 174-7.   https://doi.org/10.1186/ar1202




PubMed



        
     
Free Article


 


PubMed ID 15225362
         Pubmed Central ID 464917 


 



21.
Wesley JN, McGee EC, Garmestani K, Brechbiel MW, Yordanov AT, Wu C, Gansow OA, Eckelman WC, Bacher JD, Flynn M, Goldman CK, MacLin M, Schwartz UP, Jackson-White T, Phillip CM, Decker J, Waldmann TA (2004). Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At. Nucl Med Biol  31, 357-64.   https://doi.org/10.1016/j.nucmedbio.2003.08.011




PubMed


 


PubMed ID 15028248
    
     


 



22.
Yao Z, Zhang M, Garmestani K, Axworthy DB, Mallett RW, Fritzberg AR, Theodore LJ, Plascjak PS, Eckelman WC, Waldmann TA, Pastan I, Paik CH, Brechbiel MW, Carrasquillo JA (2004). Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N"",N""'-tetraacetic acid-biotin. Clin Cancer Res  10, 3137-46.   https://doi.org/10.1158/1078-0432.ccr-03-0171




PubMed


 


PubMed ID 15131055
    
     


 



23.
Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA (2004). Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia. Cancer Res  64, 5825-9.   https://doi.org/10.1158/0008-5472.CAN-04-1088




PubMed


 


PubMed ID 15313926
    
     


 



24.
Zhang M, Zhang Z, Garmestani K, Schultz J, Axworthy DB, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA (2003). Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. Proc Natl Acad Sci U S A  100, 1891-5.   https://doi.org/10.1073/pnas.0437788100




PubMed



        
     
Free Article


 


PubMed ID 12569172
         Pubmed Central ID 149929 


 



25.
Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA (2003). Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H. Cancer Res  63, 6453-7.




PubMed


 


PubMed ID 14559836
    
     


 



26.
Zhang Z, Zhang M, Ravetch JV, Goldman C, Waldmann TA (2003). Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507. Blood  102, 284-8.   https://doi.org/10.1182/blood-2002-11-3601




PubMed


 


PubMed ID 12649132
    
     


 



27.
Dingivan C, Waldmann T, Zhang M, Zhang Z (submitted in 2004) Methods Of Preventing Or Treating T Cell Malignancies By Adminstering Cd2 Antagonists. Patent issued: 2003273299 (AU in 2011). Patents pending: 2497628 (CA application); 03824932.4 (CN application); 03755798.0 (EP application); 2004-534750 (JP application); PCT/US03/28088 (PC application); 10/657,006 (US application); 2010200956 (AU application). Tracking number: E-082-2004-2-EP-09 (EP application).",https://intramural.nih.gov/search/searchview.taf?ipid=36497
480,SC004016-31,"October 01, 2003 -  September 30, 2004",Insulin-like Growth Factor I Receptor Signaling,Peter  Nissley; PhD,"Thomas Alexander Waldmann; MD, PhD","Metabolism Br, NCI",NULL,NULL,Cheryl  Thomas  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Jackson-Booth PG, Terry C, Lackey B, Lopaczynska M, Nissley P (2003). Inhibition of the biologic response to insulin-like growth factor I in MCF-7 breast cancer cells by a new monoclonal antibody to the insulin-like growth factor-I receptor. The importance of receptor down-regulation. Horm Metab Res  35, 850-6.   https://doi.org/10.1055/s-2004-814144




PubMed


 


PubMed ID 14710368
    
     


 



2.
Spence SL, Dey BR, Terry C, Albert P, Nissley P, Furlanetto RW (2003). Interaction of 14-3-3 proteins with the insulin-like growth factor I receptor (IGFIR): evidence for a role of 14-3-3 proteins in IGFIR signaling. Biochem Biophys Res Commun  312, 1060-6.   https://doi.org/10.1016/j.bbrc.2003.11.043




PubMed


 


PubMed ID 14651979",https://intramural.nih.gov/search/searchview.taf?ipid=36498
481,SC004017-26,"October 01, 2003 -  September 30, 2004",Biology of the Immune Response,"David  Nelson; MD, PhD","Thomas Alexander Waldmann; MD, PhD","Metabolism Br, NCI",NULL,"David  Hilbert
(HGSI, Inc.)





Tadashi  Ariga
(Pediatrics, Hokkaido University)





Tim  Behrens
(Rheumatology, U. Minnesota)





Gary S. Gilkeson; MD
(Medical University of South Carolina)





Lennart  Hammarstrom
(Immunology, Karolinska Institute)





Adrian  Thrasher
(Inst. Child Health)


Show all 9","Donn M Stewart; MD (National Cancer Institute)



Lan  Tian (National Cancer Institute)



Musafumi  Yamada (National Cancer Institute)



Stephen J Chanock; MD, PhD (National Cancer Institute)












Haiying  Qin  (National Cancer Institute)","Warren  Strober; MD (NIAID) 



Pamela Lee Schwartzberg; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, Nelson DL, Candotti F (2003). Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest  111, 1389-97.   https://doi.org/10.1172/JCI15485




PubMed



        
     
Free Article


 


PubMed ID 12727931
         Pubmed Central ID 154438",https://intramural.nih.gov/search/searchview.taf?ipid=36499
482,SC004020-27,"October 01, 2003 -  September 30, 2004","Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS","Jay Arthur Berzofsky; MD, PhD



IRP Faculty Profile",NULL,"Lymphoid Malignancies Branch, NCI",NULL,"Donald  Burke
(Ctr Immunization Research, Johns Hopkins Sch Publ Health)





Debra  Donaldson; PhD
(Immunology, Wyeth-Genetics Institute)





Steven  Ledbetter
(Genzyme Corp.)





N  Noben-Trauth; PhD
(Department of Immunology, George  Washsington University)





David I. Watkins; PhD
(Wisconsin Regional Primate Research Center, University of Wisconsin)





Dennis M Klinman; MD, PhD



Show all 14","Sangkon  Oh (National Cancer Institute)



James T Snyder; PhD (National Cancer Institute)



Masaki  Terabe (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Ira H Pastan; MD (National Cancer Institute)



Lalage  Wakefield; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahlers JD, Belyakov IM, Berzofsky JA (2003). Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines. Curr Mol Med  3, 285-301.   https://doi.org/10.2174/1566524033479843




PubMed


 


PubMed ID 12699364
    
     


 



2.
Belyakov IM, Ahlers JD, Berzofsky JA (2004). Mucosal AIDS vaccines: current status and future directions. Expert Rev Vaccines  3, S65-73.   https://doi.org/10.1586/14760584.3.4.s65




PubMed


 


PubMed ID 15285706
    
     


 



3.
Belyakov IM, Berzofsky JA (2004). Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity  20, 247-53.   https://doi.org/10.1016/s1074-7613(04)00053-6




PubMed


 


PubMed ID 15030769
    
     


 



4.
Belyakov IM, Earl P, Dzutsev A, Kuznetsov VA, Lemon M, Wyatt LS, Snyder JT, Ahlers JD, Franchini G, Moss B, Berzofsky JA (2003). Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A  100, 9458-63.   https://doi.org/10.1073/pnas.1233578100




PubMed



        
     
Free Article


 


PubMed ID 12869693
         Pubmed Central ID 170940 


 



5.
Belyakov IM, Hammond SA, Ahlers JD, Glenn GM, Berzofsky JA (2004). Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest  113, 998-1007.   https://doi.org/10.1172/JCI20261




PubMed



        
     
Free Article


 


PubMed ID 15057306
         Pubmed Central ID 379323 


 



6.
Berzofsky JA, Ahlers JD, Janik J, Morris J, Oh S, Terabe M, Belyakov IM (2004). Progress on new vaccine strategies against chronic viral infections. J Clin Invest  114, 450-62.   https://doi.org/10.1172/JCI22674




PubMed



        
     
Free Article


 


PubMed ID 15314679
         Pubmed Central ID 503779 


 



7.
Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC (2004). Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest  113, 1515-25.   https://doi.org/10.1172/JCI21926




PubMed



        
     
Free Article


 


PubMed ID 15173875
         Pubmed Central ID 419494 


 



8.
Lee WJ, Cantor KP, Berzofsky JA, Zahm SH, Blair A (2004). Non-Hodgkin's lymphoma among asthmatics exposed to pesticides. Int J Cancer  111, 298-302.   https://doi.org/10.1002/ijc.20273




PubMed


 


PubMed ID 15197786
    
     


 



9.
Oh S, Berzofsky JA, Burke DS, Waldmann TA, Perera LP (2003). Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci U S A  100, 3392-7.   https://doi.org/10.1073/pnas.0630592100




PubMed



        
     
Free Article


 


PubMed ID 12626740
         Pubmed Central ID 152303 


 



10.
Oh S, Hodge JW, Ahlers JD, Burke DS, Schlom J, Berzofsky JA (2003). Selective induction of high avidity CTL by altering the balance of signals from APC. J Immunol  170, 2523-30.   https://doi.org/10.4049/jimmunol.170.5.2523




PubMed


 


PubMed ID 12594278
    
     


 



11.
Oh S, Terabe M, Pendleton CD, Bhattacharyya A, Bera TK, Epel M, Reiter Y, Phillips J, Linehan WM, Kasten-Sportes C, Pastan I, Berzofsky JA (2004). Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Res  64, 2610-8.   https://doi.org/10.1158/0008-5472.can-03-2183




PubMed


 


PubMed ID 15059918
    
     


 



12.
Okazaki T, Pendleton CD, Lemonnier F, Berzofsky JA (2003). Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen. J Immunol  171, 2548-55.   https://doi.org/10.4049/jimmunol.171.5.2548




PubMed


 


PubMed ID 12928405
    
     


 



13.
Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A (2003). Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. J Infect Dis  188, 327-38.   https://doi.org/10.1086/376505




PubMed


 


PubMed ID 12854090
    
     


 



14.
Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA (2004). Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol  78, 7052-60.   https://doi.org/10.1128/JVI.78.13.7052-7060.2004




PubMed



        
     
Free Article


 


PubMed ID 15194781
         Pubmed Central ID 421672 


 



15.
Terabe M, Berzofsky JA (2004). Immunoregulatory T cells in tumor immunity. Curr Opin Immunol  16, 157-62.   https://doi.org/10.1016/j.coi.2004.01.010




PubMed


 


PubMed ID 15023407
    
     


 



16.
Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen W, Wahl SM, Ledbetter S, Pratt B, Letterio JJ, Paul WE, Berzofsky JA (2003). Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. J Exp Med  198, 1741-52.   https://doi.org/10.1084/jem.20022227




PubMed



        
     
Free Article


 


PubMed ID 14657224
         Pubmed Central ID 2194133 


 



17.
Terabe M, Park JM, Berzofsky JA (2004). Role of IL-13 in regulation of anti-tumor immunity and tumor growth. Cancer Immunol Immunother  53, 79-85.   https://doi.org/10.1007/s00262-003-0445-0




PubMed


 


PubMed ID 14610620",https://intramural.nih.gov/search/searchview.taf?ipid=36500
483,SC004024-17,"October 01, 2003 -  September 30, 2004",Molecular Biology of Human Lymphoid Malignancies,"Louis  Staudt; MD



IRP Faculty Profile","Thomas Alexander Waldmann; MD, PhD","Metabolism Br, NCI",NULL,"John  Chan
(Univ. of Nebraska Medical Center)





Richard  Fisher
(Southwest Oncology Group)





Elias  Campo
(Hematopathology, University of Barcelona, Spain)





Erlend  Smeland
(Norwegian Radium Hospital)





Konrad  Muller-Hermelink
(Univ. of Wuerzburg)





Anne  Rosenwald; PhD
(Biochemistry, Georgetown)


Show all 8","Neta  Goldschmidt (National Cancer Institute)



Elaine M Hurt (National Cancer Institute)



Laurence  Lamy (National Cancer Institute)



Lam  Lloyd (National Cancer Institute)



Vu  Ngo (National Cancer Institute)



Arthur L Shaffer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM (2004). Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell  5, 191-9.   https://doi.org/10.1016/s1535-6108(04)00019-4




PubMed


 


PubMed ID 14998494
    
     


 



2.
Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM (2004). Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood  104, 1428-34.   https://doi.org/10.1182/blood-2003-09-3236




PubMed


 


PubMed ID 15138159
    
     


 



3.
Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, et al. [13 more authors] (2003). Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med  198, 851-62.   https://doi.org/10.1084/jem.20031074




PubMed



        
     
Free Article


 


PubMed ID 12975453
         Pubmed Central ID 2194208 


 



4.
Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, et al. [14 more authors] (2003). The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell  3, 185-97.   https://doi.org/10.1016/s1535-6108(03)00028-x




PubMed


 


PubMed ID 12620412
    
     


 



5.
Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, Glimcher LH, Staudt LM (2004). XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity  21, 81-93.   https://doi.org/10.1016/j.immuni.2004.06.010




PubMed


 


PubMed ID 15345222
    
     


 



6.
Staudt LM (2003). Molecular diagnosis of the hematologic cancers. N Engl J Med  348, 1777-85.   https://doi.org/10.1056/NEJMra020067




PubMed


 


PubMed ID 12724484
    
     


 



7.
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003). ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood  101, 4944-51.   https://doi.org/10.1182/blood-2002-10-3306




PubMed


 


PubMed ID 12595313
    
     


 



8.
Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM (2003). A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A  100, 9991-6.   https://doi.org/10.1073/pnas.1732008100




PubMed



        
     
Free Article


 


PubMed ID 12900505
         Pubmed Central ID 187912 


 



9.
Staudt L, Armitage J, Bea S, Campo Guerri E, Chan W, Connors J, Dave S, Delabie J, Fisher R, Fu K, Gascoyne R, Greiner T, Holte H, Jaffe E, Kvaloy S, Lister T, Lopez-guillermo A, Miller T, Montserrat E, Moreno V, Muller-hermelink H, Ott G, Powell J, Rimsza L, Rosenwald A, Salaverria I, Smeland E, Tan B, Thomas G, Vose J, Weisenburger D, Wilson W, Wright G, Zetti A (submitted in 2004) Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas. Patents issued: 8,131,475 (US in 2012); 2007277142 (AU in 2014). Patents pending: 2897828 (CA application); 07810823.0 (EP application); 10014565.5 (EP application); PCT/US2007/016843 (PC application); 13/409,416 (US application); 15/630,751 (US application); 2,659,194 (CA application). Tracking number: E-108-2004-1-US-04 (US application).




 



10.
Staudt L, Dave S, Tan B, Wright G (submitted in 2004) Methods For Diagnosing Lymphoma Types. Patent issued: 7,711,492 (US in 2010). Patent pending: 12/592,778 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36501
484,SC006321-25,"October 01, 2003 -  September 30, 2004",Modulation of Therapeutic Response,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radlgy Biology Br, NCI",NULL,NULL,"John Andrew Cook; PhD (National Cancer Institute)



William  Degraff (National Cancer Institute)



Lawrence S Myers (National Cancer Institute)



Ayelet  Samuni (National Cancer Institute)



Kathleen C Flanders; PhD (National Cancer Institute)



Anita B Roberts; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM (2004). Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood  104, 1428-34.   https://doi.org/10.1182/blood-2003-09-3236




PubMed


 


PubMed ID 15138159
    
     


 



2.
Samuni Y, Gamson J, Samuni A, Yamada K, Russo A, Krishna MC, Mitchell JB (2004). Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid Redox Signal  6, 587-95.   https://doi.org/10.1089/152308604773934341




PubMed


 


PubMed ID 15130285
    
     


 



3.
Schubert R, Erker L, Barlow C, Yakushiji H, Larson D, Russo A, Mitchell JB, Wynshaw-Boris A (2004). Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum Mol Genet  13, 1793-802.   https://doi.org/10.1093/hmg/ddh189




PubMed


 


PubMed ID 15213104
    
     


 



4.
Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ (2004). The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res  10, 1807-12.   https://doi.org/10.1158/1078-0432.ccr-03-0194




PubMed


 


PubMed ID 15014035
    
     


 



5.
Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, Samuni AM, Felici A, Reiss M, Yarkoni S, Sowers A, Mitchell JB, Roberts AB, Russo A (2004). Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem  279, 15167-76.   https://doi.org/10.1074/jbc.M309798200




PubMed


 


PubMed ID 14732719",https://intramural.nih.gov/search/searchview.taf?ipid=36502
485,SC006329-23,"October 01, 2003 -  September 30, 2004",Clinical Radiation Physics Service,Robert R Miller,NULL,"Radiation Onclgy Br, NCI",NULL,NULL,"Frank S Harrington (National Cancer Institute)



George  Li (National Cancer Institute)



Holly  Ning (National Cancer Institute)



Hu-Chen  Xie (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36468
486,SC006330-23,"October 01, 2003 -  September 30, 2004",Radiation Field Modeling and Computerized Treatment Planning,Robert R Miller,NULL,"Radiation Onclgy Br, NCI",NULL,NULL,"George  Li (National Cancer Institute)



Holly  Ning (National Cancer Institute)



Hu-Chen  Xie (National Cancer Institute)



Norman Norman Coleman; MD (National Cancer Institute)



Kevin A Camphausen; MD (National Cancer Institute)



David R Gius; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36469
487,SC006353-22,"October 01, 2003 -  September 30, 2004",Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,"David  Scheinberg
(Memorial Sloan-Kettering)





Greg  Adams
(Fox Chase Cancer Center)





Andrew  Scott
(Ludwig Institute)
















George  Sgouros
(Johs Hopkins)","Diane E Milenic (National Cancer Institute)



Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)","William  Eckelman; MD (CC) 



Jorge A Carrasquillo; MD (CC)","Ordered by publication type and then author name.



1.
Blend MJ, Stastny JJ, Swanson SM, Brechbiel MW (2003). Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent. Cancer Biother Radiopharm  18, 355-63.   https://doi.org/10.1089/108497803322285107




PubMed


 


PubMed ID 12954122
    
     


 



2.
Chappell LL, Ma D, Milenic DE, Garmestani K, Venditto V, Beitzel MP, Brechbiel MW (2003). Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N"",N""'-tetraacetic acid for radiolabeling proteins. Nucl Med Biol  30, 581-95.   https://doi.org/10.1016/s0969-8051(03)00033-7




PubMed


 


PubMed ID 12900284
    
     


 



3.
Dadachova E, Burns T, Bryan RA, Apostolidis C, Brechbiel MW, Nosanchuk JD, Casadevall A, Pirofski L (2004). Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrob Agents Chemother  48, 1624-9.   https://doi.org/10.1128/aac.48.5.1624-1629.2004




PubMed



        
     
Free Article


 


PubMed ID 15105113
         Pubmed Central ID 400592 


 



4.
Michel RB, Brechbiel MW, Mattes MJ (2003). A comparison of 4 radionuclides conjugated to antibodies for single-cell kill. J Nucl Med  44, 632-40.




PubMed


 


PubMed ID 12679410
    
     


 



5.
Michel RB, Rosario AV, Brechbiel MW, Jackson TJ, Goldenberg DM, Mattes MJ (2003). Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74. Nucl Med Biol  30, 715-23.   https://doi.org/10.1016/s0969-8051(03)00082-9




PubMed


 


PubMed ID 14499329
    
     


 



6.
Milenic D, Garmestani K, Dadachova E, Chappell L, Albert P, Hill D, Schlom J, Brechbiel M (2004). Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother Radiopharm  19, 135-47.   https://doi.org/10.1089/108497804323071904




PubMed


 


PubMed ID 15186593
    
     


 



7.
Milenic DE, Brady ED, Brechbiel MW (2004). Antibody-targeted radiation cancer therapy. Nat Rev Drug Discov  3, 488-99.   https://doi.org/10.1038/nrd1413




PubMed


 


PubMed ID 15173838
    
     


 



8.
Milenic DE, Brechbiel MW (2004). Targeting of radio-isotopes for cancer therapy. Cancer Biol Ther  3, 361-70.   https://doi.org/10.4161/cbt.3.4.790




PubMed


 


PubMed ID 14976424
    
     


 



9.
Milenic DE, Garmestani K, Brady ED, Albert PS, Ma D, Abdulla A, Brechbiel MW (2004). Targeting of HER2 antigen for the treatment of disseminated peritoneal disease. Clin Cancer Res  10, 7834-41.   https://doi.org/10.1158/1078-0432.CCR-04-1226




PubMed


 


PubMed ID 15585615
    
     


 



10.
Mitchell P, Lee FT, Hall C, Rigopoulos A, Smyth FE, Hekman AM, van Schijndel GM, Powles R, Brechbiel MW, Scott AM (2003). Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies. J Nucl Med  44, 1105-12.




PubMed


 


PubMed ID 12843229
    
     


 



11.
Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortar A, Kuroki DW, Wagner JE, Vitetta ES, Kersey JH (2004). Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody. Cancer Biother Radiopharm  19, 11-23.   https://doi.org/10.1089/108497804773391630




PubMed


 


PubMed ID 15068607
    
     


 



12.
Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Skubitz KM, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortari A, Kuroki DW, Wagner JE, Kersey JH (2003). Preclinical studies targeting normal and leukemic hematopoietic cells with Yttrium-90-labeled anti-CD45 antibody in vitro and in vivo in nude mice. Cancer Biother Radiopharm  18, 133-45.   https://doi.org/10.1089/108497803765036300




PubMed


 


PubMed ID 12804039
    
     


 



13.
Wesley JN, McGee EC, Garmestani K, Brechbiel MW, Yordanov AT, Wu C, Gansow OA, Eckelman WC, Bacher JD, Flynn M, Goldman CK, MacLin M, Schwartz UP, Jackson-White T, Phillip CM, Decker J, Waldmann TA (2004). Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At. Nucl Med Biol  31, 357-64.   https://doi.org/10.1016/j.nucmedbio.2003.08.011




PubMed


 


PubMed ID 15028248
    
     


 



14.
Zhang M, Zhang Z, Garmestani K, Schultz J, Axworthy DB, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA (2003). Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. Proc Natl Acad Sci U S A  100, 1891-5.   https://doi.org/10.1073/pnas.0437788100




PubMed



        
     
Free Article


 


PubMed ID 12569172
         Pubmed Central ID 149929",https://intramural.nih.gov/search/searchview.taf?ipid=36503
488,SC006358-21,"October 01, 2003 -  September 30, 2004","Radiolysis, Photolysis and Sonolysis of Cells and their Constituents",Peter  Riesz; PhD,James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,"Takashi  Kondo
(Department of Radiological Sciences, Toyama Medical and Pharmaceutical University)





Norio  Miyoshi
(Department of Pathology, Fukui Medical University)
















Ionel  Rosenthal
(Dept of Food Science, The Volcani Center/Agricultural Organization)",Joe  Sostaric  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36504
489,SC006387-17,"October 01, 2003 -  September 30, 2004",Nitroxides as Protectors Against Oxidative Stress,"James B Mitchell; PhD



IRP Faculty Profile",NULL,"Radlgy Biology Br, NCI",NULL,NULL,"John Andrew Cook; PhD (National Cancer Institute)



William  Degraff (National Cancer Institute)



Lawrence S Myers (National Cancer Institute)



Ayelet  Samuni (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Cook JA, Gius D, Wink DA, Krishna MC, Russo A, Mitchell JB (2004). Oxidative stress, redox, and the tumor microenvironment. Semin Radiat Oncol  14, 259-66.   https://doi.org/10.1016/j.semradonc.2004.04.001




PubMed


 


PubMed ID 15254869
    
     


 



2.
Hu G, Lyeth BG, Zhao X, Mitchell JB, Watson JC (2003). Neuroprotection by the stable nitroxide 3-carbamoyl-proxyl during reperfusion in a rat model of transient focal ischemia. J Neurosurg  98, 393-6.   https://doi.org/10.3171/jns.2003.98.2.0393




PubMed


 


PubMed ID 12593628
    
     


 



3.
Kaufman B, Scharf O, Arbeit J, Ashcroft M, Brown JM, Bruick RK, Chapman JD, Evans SM, Giaccia AJ, Harris AL, Huang E, Johnson R, Kaelin W, Koch CJ, Maxwell P, Mitchell J, Neckers L, Powis G, Rajendran J, Semenza GL, Simons J, Storkebaum E, Welch MJ, Whitelaw M, Melillo G, et al. [1 more author] (2004). Proceedings of the Oxygen Homeostasis/Hypoxia Meeting. Cancer Res  64, 3350-6.   https://doi.org/10.1158/0008-5472.can-03-2611




PubMed


 


PubMed ID 15126380
    
     


 



4.
Samuni AM, DeGraff W, Cook JA, Krishna MC, Russo A, Mitchell JB (2004). The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells. Free Radic Biol Med  37, 1648-55.   https://doi.org/10.1016/j.freeradbiomed.2004.08.006




PubMed


 


PubMed ID 15477016
    
     


 



5.
Samuni Y, Gamson J, Samuni A, Yamada K, Russo A, Krishna MC, Mitchell JB (2004). Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid Redox Signal  6, 587-95.   https://doi.org/10.1089/152308604773934341




PubMed


 


PubMed ID 15130285
    
     


 



6.
Vitolo JM, Cotrim AP, Sowers AL, Russo A, Wellner RB, Pillemer SR, Mitchell JB, Baum BJ (2004). The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res  10, 1807-12.   https://doi.org/10.1158/1078-0432.ccr-03-0194




PubMed


 


PubMed ID 15014035",https://intramural.nih.gov/search/searchview.taf?ipid=36505
490,SC006538-11,"October 01, 2003 -  September 30, 2004",Development of Angiogenesis Inhibitors,"William D Figg; PharmD



IRP Faculty Profile",Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,"Kurt  Eger
(Pharmacuetical Institute, University of Leipzig)
















Frederick  Luzzio
(Department of Chemistry, University of Louisville)","Douglas K Price (National Cancer Institute)



Fumio  Hanaoka; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T (2004). A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res  10, 4724-33.   https://doi.org/10.1158/1078-0432.CCR-0829-03




PubMed


 


PubMed ID 15269145
    
     


 



2.
Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K (2004). Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol  22, 499-506.   https://doi.org/10.1200/JCO.2004.07.022




PubMed


 


PubMed ID 14752073
    
     


 



3.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



4.
Fine HA, Wen PY, Maher EA, Viscosi E, Batchelor T, Lakhani N, Figg WD, Purow BW, Borkowf CB (2003). Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. J Clin Oncol  21, 2299-304.   https://doi.org/10.1200/JCO.2003.08.045




PubMed


 


PubMed ID 12805330
    
     


 



5.
Franks ME, Macpherson GR, Figg WD (2004). Thalidomide. Lancet  363, 1802-11.   https://doi.org/10.1016/S0140-6736(04)16308-3




PubMed


 


PubMed ID 15172781
    
     


 



6.
Hussain MM, Kotz H, Minasian L, Premkumar A, Sarosy G, Reed E, Zhai S, Steinberg SM, Raggio M, Oliver VK, Figg WD, Kohn EC (2003). Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. J Clin Oncol  21, 4356-63.   https://doi.org/10.1200/JCO.2003.04.136




PubMed


 


PubMed ID 14645425
    
     


 



7.
Hwang K, Acharya MR, Sausville EA, Zhai S, Woo EW, Venitz J, Figg WD, Sparreboom A (2004). Determination of MS-275, a novel histone deacetylase inhibitor, in human plasma by liquid chromatography-electrospray mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci  804, 289-94.   https://doi.org/10.1016/j.jchromb.2004.01.023




PubMed


 


PubMed ID 15081922
    
     


 



8.
Kurdziel KA, Figg WD, Carrasquillo JA, Huebsch S, Whatley M, Sellers D, Libutti SK, Pluda JM, Dahut W, Reed E, Bacharach SL (2003). Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol  5, 86-93.   https://doi.org/10.1016/s1536-1632(03)00039-8




PubMed


 


PubMed ID 14499149
    
     


 



9.
Lakhani NJ, Sarkar MA, Venitz J, Figg WD (2003). 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy  23, 165-72.   https://doi.org/10.1592/phco.23.2.165.32088




PubMed


 


PubMed ID 12587805
    
     


 



10.
Rudek MA, Bauer KS, Lush RM, Stinson SF, Senderowicz AM, Headlee DJ, Arbuck SG, Cox MC, Murgo AJ, Sausville EA, Figg WD (2003). Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. Ann Pharmacother  37, 1369-74.   https://doi.org/10.1345/aph.1C404




PubMed


 


PubMed ID 14519054
    
     


 



11.
Rudek MA, Venitz J, Ando Y, Reed E, Pluda JM, Figg WD (2003). Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: clinical and experimental studies. J Clin Pharmacol  43, 1124-35.   https://doi.org/10.1177/0091270003256675




PubMed


 


PubMed ID 14517195
    
     


 



12.
Tohnya TM, Ng SS, Dahut WL, Wright JJ, Arlen PM, Gulley JL, Parker C, Zeldis J, Figg WD (2004). A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer. Clin Prostate Cancer  2, 241-3.   https://doi.org/10.3816/cgc.2004.n.006




PubMed


 


PubMed ID 15072608
    
     


 



13.
Uchio EM, Linehan WM, Figg WD, Walther MM (2003). A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder. J Urol  169, 357-60.   https://doi.org/10.1097/01.ju.0000032745.90528.dc




PubMed


 


PubMed ID 12478189
    
     


 



14.
Zhai S, Sausville EA, Senderowicz AM, Ando Y, Headlee D, Messmann RA, Arbuck S, Murgo AJ, Melillo G, Fuse E, Figg WD (2003). Clinical pharmacology and pharmacogenetics of flavopiridol 1-h i.v. infusion in patients with refractory neoplasms. Anticancer Drugs  14, 125-35.   https://doi.org/10.1097/00001813-200302000-00006




PubMed


 


PubMed ID 12569299",https://intramural.nih.gov/search/searchview.taf?ipid=36509
491,SC006579-21,"October 01, 2003 -  September 30, 2004",Genes Involved in Cellular Differentiation and Proliferation,Ilan  Kirsch; MD,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,K  Lewis  (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Erez A, Perelman M, Hewitt SM, Cojacaru G, Goldberg I, Shahar I, Yaron P, Muler I, Campaner S, Amariglio N, Rechavi G, Kirsch IR, Krupsky M, Kaminski N, Izraeli S (2004). Sil overexpression in lung cancer characterizes tumors with increased mitotic activity. Oncogene  23, 5371-7.   https://doi.org/10.1038/sj.onc.1207685




PubMed


 


PubMed ID 15107824",https://intramural.nih.gov/search/searchview.taf?ipid=36510
492,SC006581-21,"October 01, 2003 -  September 30, 2004",Molecular Pathogenesis of Multiple Myeloma,"Walter M Kuehl; MD, PhD",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,"John  Shaughnessy
(Lambert Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences)





Rafael  Fonseca
(Division of Hematology, Mayo Clinic)





Leif  Bergsagel
(Division of Hematology, Cornell Medical School)",Louis  Staudt; MD (Lymphoid Malignancies Branch),NULL,"Ordered by publication type and then author name.



1.
Barillé-Nion S, Barlogie B, Bataille R, Bergsagel PL, Epstein J, Fenton RG, Jacobson J, Kuehl WM, Shaughnessy J, Tricot G (2003). Advances in biology and therapy of multiple myeloma. Hematology Am Soc Hematol Educ Program   248-78




PubMed


 


PubMed ID 14633785
    
     


 



2.
Bergsagel PL, Kuehl WM (2003). Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma. Immunol Rev  194, 96-104.   https://doi.org/10.1034/j.1600-065x.2003.00052.x




PubMed


 


PubMed ID 12846810
    
     


 



3.
Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD, Stewart AK, Avet-Loiseau H (2004). Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res  64, 1546-58.   https://doi.org/10.1158/0008-5472.can-03-2876




PubMed


 


PubMed ID 14989251
    
     


 



4.
Hideshima T, Bergsagel PL, Kuehl WM, Anderson KC (2004). Advances in biology of multiple myeloma: clinical applications. Blood  104, 607-18.   https://doi.org/10.1182/blood-2004-01-0037




PubMed


 


PubMed ID 15090448
    
     


 



5.
Hurt EM, Wiestner A, Rosenwald A, Shaffer AL, Campo E, Grogan T, Bergsagel PL, Kuehl WM, Staudt LM (2004). Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. Cancer Cell  5, 191-9.   https://doi.org/10.1016/s1535-6108(04)00019-4




PubMed


 


PubMed ID 14998494",https://intramural.nih.gov/search/searchview.taf?ipid=36511
493,SC006587-20,"October 01, 2003 -  September 30, 2004",Gene Rearrangements as Tumor Specific Markers,Ilan  Kirsch; MD,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,Kenneth E Nakahara  (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36512
494,SC006659-22,"October 01, 2003 -  September 30, 2004",Molecular Genetics of Kidney Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Br, NCI",NULL,NULL,"Donald P Bottaro; PhD (National Cancer Institute)



Jonathan A Coleman (National Cancer Institute)



Gagani  Dharmawardana (National Cancer Institute)



Sarah  Fowler (National Cancer Institute)



Michael M Frank (National Cancer Institute)



Robert  Grubb (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF, Emmert-Buck MR (2003). Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics  3, 413-21.   https://doi.org/10.1002/pmic.200390056




PubMed


 


PubMed ID 12687609
    
     


 



2.
Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, Barrett JC (2004). Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem  92, 491-501.   https://doi.org/10.1002/jcb.20067




PubMed


 


PubMed ID 15156561
    
     


 



3.
Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR (2003). Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol  12, 63-70.   https://doi.org/10.1097/00019606-200306000-00001




PubMed


 


PubMed ID 12766610
    
     


 



4.
Bottaro DP, Liotta LA (2003). Cancer: Out of air is not out of action. Nature  423, 593-5.   https://doi.org/10.1038/423593a




PubMed


 


PubMed ID 12789320
    
     


 



5.
Carvallo C, Geller N, Kurlander R, Srinivasan R, Mena O, Igarashi T, Griffith LM, Linehan WM, Childs RW (2004). Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors. Blood  103, 1560-3.   https://doi.org/10.1182/blood-2003-04-1170




PubMed


 


PubMed ID 14551148
    
     


 



6.
Choo D, Shotland L, Mastroianni M, Glenn G, van Waes C, Linehan WM, Oldfield EH (2004). Endolymphatic sac tumors in von Hippel-Lindau disease. J Neurosurg  100, 480-7.   https://doi.org/10.3171/jns.2004.100.3.0480




PubMed


 


PubMed ID 15035284
    
     


 



7.
Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM (2003). Hereditary renal cancers. Radiology  226, 33-46.   https://doi.org/10.1148/radiol.2261011296




PubMed


 


PubMed ID 12511666
    
     


 



8.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



9.
Drachenberg D, Childs RW (2003). Allogeneic stem cell transplantation as immunotherapy for renal cell carcinoma: from immune enhancement to immune replacement. Urol Clin North Am  30, 611-22.   https://doi.org/10.1016/s0094-0143(03)00025-9




PubMed


 


PubMed ID 12953759
    
     


 



10.
Drachenberg DE, Mena OJ, Choyke PL, Linehan WM, Walther MM (2004). Parenchymal sparing surgery for central renal tumors in patients with hereditary renal cancers. J Urol  172, 49-53.   https://doi.org/10.1097/01.ju.0000130930.70356.28




PubMed


 


PubMed ID 15201735
    
     


 



11.
Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004). The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol  172, 63-5.   https://doi.org/10.1097/01.ju.0000132127.79974.3f




PubMed


 


PubMed ID 15201738
    
     


 



12.
Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CP, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF (2003). Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics  3, 2142-6.   https://doi.org/10.1002/pmic.200300598




PubMed


 


PubMed ID 14595813
    
     


 



13.
Hwang J, Shoaf G, Uchio EM, Watson J, Pacak K, Linehan WM, Walther MM (2004). Laparoscopic management of extra-adrenal pheochromocytoma. J Urol  171, 72-6.   https://doi.org/10.1097/01.ju.0000102081.46348.a4




PubMed


 


PubMed ID 14665847
    
     


 



14.
Hwang JJ, Uchio EM, Linehan WM, Walther MM (2003). Hereditary kidney cancer. Urol Clin North Am  30, 831-42.   https://doi.org/10.1016/s0094-0143(03)00054-5




PubMed


 


PubMed ID 14680318
    
     


 



15.
Hwang JJ, Uchio EM, Patel SV, Linehan WM, Walther MM, Pacak K (2003). Diagnostic localization of malignant bladder pheochromocytoma using 6-18F fluorodopamine positron emission tomography. J Urol  169, 274-5.   https://doi.org/10.1097/01.ju.0000040140.76287.b0




PubMed


 


PubMed ID 12478157
    
     


 



16.
Hwang JJ, Uchio EM, Pavlovich CP, Pautler SE, Libutti SK, Linehan WM, Walther MM (2003). Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach. J Urol  169, 895-8.   https://doi.org/10.1097/01.ju.0000049518.15260.1f




PubMed


 


PubMed ID 12576808
    
     


 



17.
Hwang JJ, Walther MM, Pautler SE, Coleman JA, Hvizda J, Peterson J, Linehan WM, Wood BJ (2004). Radio frequency ablation of small renal tumors:: intermediate results. J Urol  171, 1814-8.   https://doi.org/10.1097/01.ju.0000119905.72574.de




PubMed



        
     
Free Article


 


PubMed ID 15076283
         Pubmed Central ID 2408954 


 



18.
Igarashi T, Wynberg J, Srinivasan R, Becknell B, McCoy JP, Takahashi Y, Suffredini DA, Linehan WM, Caligiuri MA, Childs RW (2004). Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood  104, 170-7.   https://doi.org/10.1182/blood-2003-12-4438




PubMed


 


PubMed ID 15016654
    
     


 



19.
Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, Linehan WM, Morton RA, Kim SJ (2003). Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells. Clin Cancer Res  9, 6046-51.




PubMed


 


PubMed ID 14676131
    
     


 



20.
Linehan WM (2003). Molecular targeting of VHL gene pathway in clear cell kidney cancer. J Urol  170, 593-4.   https://doi.org/10.1097/01.ju.0000077210.05543.ae




PubMed


 


PubMed ID 12853837
    
     


 



21.
Linehan WM, Walther MM, Zbar B (2003). The genetic basis of cancer of the kidney. J Urol  170, 2163-72.   https://doi.org/10.1097/01.ju.0000096060.92397.ed




PubMed


 


PubMed ID 14634372
    
     


 



22.
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Hose C, Linehan WM, Worrell R, Rubinstein L, Sausville EA, Vistica DT (2004). Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1. J Urol  171, 1688-97.   https://doi.org/10.1097/01.ju.0000108860.03389.1b




PubMed


 


PubMed ID 15017268
    
     


 



23.
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003). von Hippel-Lindau disease. Lancet  361, 2059-67.   https://doi.org/10.1016/S0140-6736(03)13643-4




PubMed


 


PubMed ID 12814730
    
     


 



24.
Maranchie JK, Afonso A, Albert PS, Kalyandrug S, Phillips JL, Zhou S, Peterson J, Ghadimi BM, Hurley K, Riss J, Vasselli JR, Ried T, Zbar B, Choyke P, Walther MM, Klausner RD, Linehan WM (2004). Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location. Hum Mutat  23, 40-6.   https://doi.org/10.1002/humu.10302




PubMed


 


PubMed ID 14695531
    
     


 



25.
Maranchie JK, Linehan WM (2003). Genetic disorders and renal cell carcinoma. Urol Clin North Am  30, 133-41.   https://doi.org/10.1016/s0094-0143(02)00120-9




PubMed


 


PubMed ID 12580565
    
     


 



26.
Oh S, Terabe M, Pendleton CD, Bhattacharyya A, Bera TK, Epel M, Reiter Y, Phillips J, Linehan WM, Kasten-Sportes C, Pastan I, Berzofsky JA (2004). Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Res  64, 2610-8.   https://doi.org/10.1158/0008-5472.can-03-2183




PubMed


 


PubMed ID 15059918
    
     


 



27.
Pavlovich CP, Padilla-Nash H, Wangsa D, Nickerson ML, Matrosova V, Linehan WM, Ried T, Phillips JL (2003). Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer  37, 252-60.   https://doi.org/10.1002/gcc.10209




PubMed


 


PubMed ID 12759923
    
     


 



28.
Stevens J, Nichelson E, Linehan WM, Thompson N, Liewehr D, Venzon D, Walther MM (2004). Risk factors for skin breakdown after renal and adrenal surgery. Urology  64, 246-9.   https://doi.org/10.1016/j.urology.2004.03.024




PubMed


 


PubMed ID 15302471
    
     


 



29.
Toro JR, Nickerson ML, Wei MH, Warren MB, Glenn GM, Turner ML, Stewart L, Duray P, Tourre O, Sharma N, Choyke P, Stratton P, Merino M, Walther MM, Linehan WM, Schmidt LS, Zbar B (2003). Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet  73, 95-106.   https://doi.org/10.1086/376435




PubMed



        
     
Free Article


 


PubMed ID 12772087
         Pubmed Central ID 1180594 


 



30.
Uchio EM, Linehan WM, Figg WD, Walther MM (2003). A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder. J Urol  169, 357-60.   https://doi.org/10.1097/01.ju.0000032745.90528.dc




PubMed


 


PubMed ID 12478189
    
     


 



31.
Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM (2003). Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A  100, 6958-63.   https://doi.org/10.1073/pnas.1131754100




PubMed



        
     
Free Article


 


PubMed ID 12777628
         Pubmed Central ID 165812 


 



32.
Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS (2004). Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol  17, 998-1011.   https://doi.org/10.1038/modpathol.3800152




PubMed


 


PubMed ID 15143337
    
     


 



33.
Weeks DC, Walther MM, Stratakis CA, Hwang JJ, Linehan WM, Phillips JL (2004). Bilateral testicular adrenal rests after bilateral adrenalectomies in a cushingoid patient with von Hippel-Lindau disease. Urology  63, 981-2.   https://doi.org/10.1016/j.urology.2004.01.023




PubMed


 


PubMed ID 15135000
    
     


 



34.
Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA (2004). Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate  60, 25-31.   https://doi.org/10.1002/pros.20013




PubMed


 


PubMed ID 15129426
    
     


 



35.
Yacoub A, Mitchell C, Brannon J, Rosenberg E, Qiao L, McKinstry R, Linehan WM, Su ZS, Sarkar D, Lebedeva IV, Valerie K, Gopalkrishnan RV, Grant S, Fisher PB, Dent P (2003). MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity. Mol Cancer Ther  2, 623-32.




PubMed


 


PubMed ID 12883035
    
     


 



36.
Zbar B, Klausner R, Linehan WM (2003). Studying cancer families to identify kidney cancer genes. Annu Rev Med  54, 217-33.   https://doi.org/10.1146/annurev.med.54.101601.152514




PubMed


 


PubMed ID 12525673
    
     


 



37.
Zeeberg BR, Riss J, Kane DW, Bussey KJ, Uchio E, Linehan WM, Barrett JC, Weinstein JN (2004). Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics. BMC Bioinformatics  5, 80.   https://doi.org/10.1186/1471-2105-5-80




PubMed



        
     
Free Article


 


PubMed ID 15214961
         Pubmed Central ID 459209",https://intramural.nih.gov/search/searchview.taf?ipid=36513
495,SC006660-20,"October 01, 2003 -  September 30, 2004",Defining the T-cell response to human renal cancer,"James Chung-Yin Yang; MD, PhD



IRP Faculty Profile","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Donna M Perry lalley (National Cancer Institute)



Qiong J Wang (National Cancer Institute)



Cynthia  Liu (National Cancer Institute)



Kenichi  Hanada (National Cancer Institute)



Craig A Mckinney (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hanada K, Yewdell JW, Yang JC (2004). Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature  427, 252-6.   https://doi.org/10.1038/nature02240




PubMed


 


PubMed ID 14724640",https://intramural.nih.gov/search/searchview.taf?ipid=36470
496,SC006663-15,"October 01, 2003 -  September 30, 2004",Characterization and Regulation of High Risk and Malignant Breast Epithelium,David  Danforth,"Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Jo Anne N Zujewski (National Cancer Institute)



Andrea  Abati; BS, MD (National Cancer Institute)



Joanna H Shih (National Cancer Institute)



Maria  Merino; PhD (National Cancer Institute)



David Erwin Kleiner; MD, PhD (National Cancer Institute)



Richard  Simon (National Cancer Institute)",Jorge A Carrasquillo; MD (CC),"Ordered by publication type and then author name.



1.
Danforth DN, Cowan K, Altemus R, Merino M, Chow C, Berman A, Chaudhry U, Shriver C, Steinberg SM, Zujewski J (2003). Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial. Ann Surg Oncol  10, 635-44.   https://doi.org/10.1245/aso.2003.12.008




PubMed


 


PubMed ID 12839848
    
     


 



2.
Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA (2004). Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab  89, 2248-53.   https://doi.org/10.1210/jc.2003-031874




PubMed


 


PubMed ID 15126549
    
     


 



3.
Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM (2003). Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer  98, 697-702.   https://doi.org/10.1002/cncr.11580




PubMed


 


PubMed ID 12910512",https://intramural.nih.gov/search/searchview.taf?ipid=36514
497,SC006664-15,"October 01, 2003 -  September 30, 2004",Specific Immune Recognition of Tumor-Associated Antigens by Human T cells,Suzanne L. Topalian; MD,"Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,"Michael  Nishimura
(Surgery, U. Chicago)





Drew  Pardoll
(Oncology, Johns Hopkins University School of Medicine)





Roy A Mariuzza; PhD
(University of Maryland)





Dennis  Panicali
(Therion Biologics)
















Lieping  Chen
(Dermatology, Johns Hopkins University School of Medicine)",NULL,NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36515
498,SC006670-12,"October 01, 2003 -  September 30, 2004",Molecular Approaches to the Development of Novel Tumor Immunotherapies,"Nicholas Phillip Restifo; MD



IRP Faculty Profile","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,NULL,"Steven  Finkelstein; MD (National Cancer Institute)



Luca  Gattinoni (National Cancer Institute)



Leroy  Hwang (National Cancer Institute)



Keith William Kerstann (National Cancer Institute)



Christopher Austin Klebanoff (Surgery Branch)



Douglas  Palmer (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rosenberg SA, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, White DE (2003). Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen. Hum Gene Ther  14, 709-14.   https://doi.org/10.1089/104303403765255110




PubMed



        
     
Free Article


 


PubMed ID 12804135
         Pubmed Central ID 2078240",https://intramural.nih.gov/search/searchview.taf?ipid=36516
499,SC006731-16,"October 01, 2003 -  September 30, 2004",Laboratory and Clinical Studies in Drug Resistance Reversal,Susan  Bates; MD,NULL,"Cancer Therapeutics Branch, NCI",NULL,"Wilfred  Stein
(Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University of Jerusalem)





Thomas  Litman
(Bio Informatics Center, University of Copenhagen)
















Balash  Sarkadi
(Budapest, Hungary, National Institute of Hematology and Immunology)","William D Figg; PharmD (National Cancer Institute)



Antonio  Fojo; MD, PhD (National Cancer Institute)



Alexander  Sparreboom (National Cancer Institute)



Christopher J Michejda; PhD (National Cancer Institute)



Nadya I Tarasova; PhD (National Cancer Institute)



Michael  Dean; PhD (National Cancer Institute)","William  Eckelman; MD (CC) 



April R Robbins; PhD (NIDDK) 



Danny L Sackett; PhD (NICHD)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36517
500,SC006732-16,"October 01, 2003 -  September 30, 2004",Multidrug resistance Mediated by P-glycoprotein,"Antonio  Fojo; MD, PhD",Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Susan  Bates; MD (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)



Frank M Balis; MD, PhD (Office of the Director)



Francis W Ruscetti; PhD (National Cancer Institute)












Lyn  Mickley Huff  (National Cancer Institute)",Danny L Sackett; PhD (NICHD),"Ordered by publication type and then author name.



1.
Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC (2003). Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res  9, 650-6.




PubMed


 


PubMed ID 12576431
    
     


 



2.
Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T (2004). A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res  10, 4724-33.   https://doi.org/10.1158/1078-0432.CCR-0829-03




PubMed


 


PubMed ID 15269145
    
     


 



3.
Fojo T, Bates S (2003). Strategies for reversing drug resistance. Oncogene  22, 7512-23.   https://doi.org/10.1038/sj.onc.1206951




PubMed


 


PubMed ID 14576855",https://intramural.nih.gov/search/searchview.taf?ipid=36518
501,SC006737-13,"October 01, 2003 -  September 30, 2004",Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Br, NCI",NULL,"John Louis  Medabalimi
(Laboratory of Chemical Physics, NIDDK)





John J. Mieyal; PhD
(Department of Pharmacology, Case Western Reserve University)





Jean  Chmielewski
(Purdue University)





Katherine  Staskus
(Pathology, University of Minnesota)
















Rodney L.  Levine
(Laboratory of Biochemistry, NHLBI)","David A Davis; MD (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)



Victoria Y Wang (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)



Giovanna  Tosato; PhD (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)","Amir Hossein Gandjbakhche; PhD (NICHD) 



Henry M. Fales; PhD (NHLBI) 



Paul T Wingfield; PhD (NIAMS)","Ordered by publication type and then author name.



1.
Bryant-Greenwood P, Sorbara L, Filie AC, Little R, Yarchoan R, Wilson W, Raffeld M, Abati A (2003). Infection of mesothelial cells with human herpes virus 8 in human immunodeficiency virus-infected patients with Kaposi's sarcoma, Castleman's disease, and recurrent pleural effusions. Mod Pathol  16, 145-53.   https://doi.org/10.1097/01.MP.0000052374.61768.79




PubMed


 


PubMed ID 12591967
    
     


 



2.
Davis DA, Brown CA, Newcomb FM, Boja ES, Fales HM, Kaufman J, Stahl SJ, Wingfield P, Yarchoan R (2003). Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation. J Virol  77, 3319-25.   https://doi.org/10.1128/jvi.77.5.3319-3325.2003




PubMed



        
     
Free Article


 


PubMed ID 12584357
         Pubmed Central ID 149757 


 



3.
Haque M, Davis DA, Wang V, Widmer I, Yarchoan R (2003). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J Virol  77, 6761-8.   https://doi.org/10.1128/jvi.77.12.6761-6768.2003




PubMed



        
     
Free Article


 


PubMed ID 12767996
         Pubmed Central ID 156153 


 



4.
Kumar PP, Little RF, Yarchoan R (2003). Update on Kaposi's Sarcoma: A Gammaherpesvirus- induced Malignancy. Curr Infect Dis Rep  5, 85-92.   https://doi.org/10.1007/s11908-003-0069-8




PubMed


 


PubMed ID 12525295
    
     


 



5.
Little RF, Merced-Galindez F, Staskus K, Whitby D, Aoki Y, Humphrey R, Pluda JM, Marshall V, Walters M, Welles L, Rodriguez-Chavez IR, Pittaluga S, Tosato G, Yarchoan R (2003). A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis  187, 149-53.   https://doi.org/10.1086/346159




PubMed


 


PubMed ID 12508160
    
     


 



6.
Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H, Franchini G, Gutierrez M, Raffeld M, Jaffe ES, Shearer G, Yarchoan R, Wilson WH (2003). Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood  101, 4653-9.   https://doi.org/10.1182/blood-2002-11-3589




PubMed


 


PubMed ID 12609827
    
     


 



7.
Little RF, Yarchoan R (2003). The use of antiretroviral therapy in patients undergoing treatment for HIV-related neoplastic disease. Res Initiat Treat Action  9, 19-25.




PubMed


 


PubMed ID 14971362
    
     


 



8.
Little RF, Yarchoan R (2003). Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host. Semin Hematol  40, 163-71.   https://doi.org/10.1053/shem.2003.50016




PubMed


 


PubMed ID 12704593
    
     


 



9.
Smith SM, Pentlicky S, Klase Z, Singh M, Neuveut C, Lu CY, Reitz MS, Yarchoan R, Marx PA, Jeang KT (2003). An in vivo replication-important function in the second coding exon of Tat is constrained against mutation despite cytotoxic T lymphocyte selection. J Biol Chem  278, 44816-25.   https://doi.org/10.1074/jbc.M307546200




PubMed


 


PubMed ID 12947089
    
     


 



10.
Villalba S, Salvucci O, Aoki Y, De La Luz Sierra M, Gupta G, Davis D, Wyvill K, Little R, Yarchoan R, Tosato G (2003). Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo. J Leukoc Biol  74, 880-8.   https://doi.org/10.1189/jlb.0403149




PubMed


 


PubMed ID 12960279
    
     


 



11.
Yao L, Salvucci O, Cardones AR, Hwang ST, Aoki Y, De La Luz Sierra M, Sajewicz A, Pittaluga S, Yarchoan R, Tosato G (2003). Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood  102, 3900-5.   https://doi.org/10.1182/blood-2003-02-0641




PubMed


 


PubMed ID 12907452",https://intramural.nih.gov/search/searchview.taf?ipid=36519
502,SC006738-12,"October 01, 2003 -  September 30, 2004",Development of Antiviral Therapy of HIV-1 Infection,Hiroaki  Mitsuya,Robert  Yarchoan; MD,"HIV and AIDS Malignancy Br, NCI",NULL,NULL,"Mardy  Sek (National Cancer Institute)



Sadahiro  Tamiya (National Cancer Institute)












Shintaro  Matsumi  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36471
503,SC006741-11,"October 01, 2003 -  September 30, 2004",Lymphoma Studies,"Wyndham H Wilson; MD, PhD



IRP Faculty Profile",NULL,"Medcn Br, NCI",NULL,NULL,"John  Janik; MD (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Larry  Kwak (National Cancer Institute)



Stefania  Pittaluga (National Cancer Institute)



Richard  Little; MD, PhD (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36472
504,SC006743-11,"October 01, 2004 -  September 30, 2005",Signal Transduction Events and the Regulation of Cell Growth,Jane Beth Trepel,Lee Jay Helman; MD,"Medical Oncology Branch, NCI",Sunmin T Lee,"Charles  Erlichman
(Medicine, Mayo Clinic)




Julio  Herrera
(Dept. Biochem., Mol Biol., Biophys., University of Minnesota)




Patricia  LoRusso
(Medicine, Karmanos Cancer Institute)","Jeffrey S Rubin; MD, PhD (Laboratory of Cellular and Molecular Biology)



Seong-Jin  Kim; PhD (National Cancer Institute)



J. Frederic Mushinski; MD (National Cancer Institute)



Leonard  Neckers; PhD (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)



Chand  Khanna; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ, Tofilon PJ (2004). Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res  64, 316-21.   https://doi.org/10.1158/0008-5472.can-03-2630




PubMed


 


PubMed ID 14729640
    
     


 



2.
Edelman MJ, Bauer K, Khanwani S, Tait N, Trepel J, Karp J, Nemieboka N, Chung EJ, Van Echo D (2003). Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug. Cancer Chemother Pharmacol  51, 439-44.   https://doi.org/10.1007/s00280-003-0580-5




PubMed


 


PubMed ID 12736763
    
     


 



3.
Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L (2003). Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J  370, 1011-7.   https://doi.org/10.1042/BJ20021279




PubMed



        
     
Free Article


 


PubMed ID 12479793
         Pubmed Central ID 1223232 


 



4.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003). IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J  17, 2115-7.   https://doi.org/10.1096/fj.03-0329fje




PubMed


 


PubMed ID 12958148
    
     


 



5.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003). Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem  278, 7445-52.   https://doi.org/10.1074/jbc.M209804200




PubMed


 


PubMed ID 12488445
    
     


 



6.
Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA (2004). Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells. Mol Cancer Ther  3, 715-25.




PubMed


 


PubMed ID 15210858
    
     


 



7.
Nguyen DM, Schrump WD, Chen GA, Tsai W, Nguyen P, Trepel JB, Schrump DS (2004). Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells. Clin Cancer Res  10, 1813-25.   https://doi.org/10.1158/1078-0432.ccr-0901-3




PubMed


 


PubMed ID 15014036
    
     


 



8.
Ochel HJ, Gademann G, Trepel J, Neckers L (2003). Modulation of prion protein structural integrity by geldanamycin. Glycobiology  13, 655-60.   https://doi.org/10.1093/glycob/cwg081




PubMed


 


PubMed ID 12773477
    
     


 



9.
Polzin RG, Benlhabib H, Trepel J, Herrera JE (2004). E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Gene  341, 209-18.   https://doi.org/10.1016/j.gene.2004.06.052




PubMed


 


PubMed ID 15474303
    
     


 



10.
Shibata MA, Kavanaugh C, Shibata E, Abe H, Nguyen P, Otsuki Y, Trepel JB, Green JE (2003). Comparative effects of lovastatin on mammary and prostate oncogenesis in transgenic mouse models. Carcinogenesis  24, 453-9.   https://doi.org/10.1093/carcin/24.3.453




PubMed


 


PubMed ID 12663504
    
     


 



11.
Trapani V, Patel V, Leong CO, Ciolino HP, Yeh GC, Hose C, Trepel JB, Stevens MF, Sausville EA, Loaiza-Pérez AI (2003). DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br J Cancer  88, 599-605.   https://doi.org/10.1038/sj.bjc.6600722




PubMed



        
     
Free Article


 


PubMed ID 12592376
         Pubmed Central ID 2377159 


 



12.
Trepel J, Birrer MJ (2003). A link between histone deacetylase inhibitors and NF- kappaB signaling. Cell Cycle  2, 452-3.   https://doi.org/10.4161/cc.2.5.487




PubMed


 


PubMed ID 12963841
    
     


 



13.
Trepel JB (2003). Ion channels as molecular targets in prostate cancer. Clin Prostate Cancer  2, 188-9.   https://doi.org/10.1016/s1540-0352(11)70042-7




PubMed


 


PubMed ID 15040864
    
     


 



14.
Xu W, Yuan X, Jung YJ, Yang Y, Basso A, Rosen N, Chung EJ, Trepel J, Neckers L (2003). The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res  63, 7777-84.




PubMed


 


PubMed ID 14633703
    
     


 



15.
Chung ES, Trepel JS (submitted in 2004) Pharmacodynamic Assays. Patents issued: 2005218769 (AU in 2012); 2557568 (CA in 2014); 9,389,223 (US in 2016). Patents pending: 05723905.5 (DE application); 05723905.5 (EP application); 05723905.5 (FR application); 05723905.5 (GB application); 15/208,324 (US application); 15/445,975 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36520
505,SC006813-22,"October 01, 2003 -  September 30, 2004",Cell and Molecular Genetic Analysis of Pediatric Tumors,"Carol J Thiele



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Maria  Tsokos; MD (National Cancer Institute)



Deborah A O'Brien; PhD (National Cancer Institute)



Susan  Bates; MD (National Cancer Institute)



Phillip A Dennis; MD, PhD (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)












Javed  Khan; MD  (Center for Cancer Research)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36522
506,SC006830-34,"October 01, 2003 -  September 30, 2004","Treatment of Infections in Immunocompromised Children with Cancer, BMT, and HIV",Thomas J. Walsh; MD,Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,NULL,"Hee-Sup  Kim (National Cancer Institute)



Caron A Lyman (National Cancer Institute)



Elizabeth  O'Shaughnessy (National Cancer Institute)



Joanne  Peter (National Cancer Institute)



Miki  Kasai (National Cancer Institute)



Robert  Schaufele (National Cancer Institute)","Anthony F Suffredini; MD (CC) 



Richard  Childs; MD (NHLBI) 



John D. Bacher; BS, DVM, MS (OD)","Ordered by publication type and then author name.



1.
Abzug MJ, Walsh TJ (2004). Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J  23, 769-73.   https://doi.org/10.1097/01.inf.0000134314.65398.bf




PubMed


 


PubMed ID 15295229
    
     


 



2.
Anaissie EJ, Stratton SL, Dignani MC, Lee CK, Summerbell RC, Rex JH, Monson TP, Walsh TJ (2003). Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood  101, 2542-6.   https://doi.org/10.1182/blood-2002-02-0530




PubMed


 


PubMed ID 12468437
    
     


 



3.
Benjamin DK, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH (2003). Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics  112, 543-7.   https://doi.org/10.1542/peds.112.3.543




PubMed


 


PubMed ID 12949281
    
     


 



4.
Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ (2003). Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics  112, 634-40.   https://doi.org/10.1542/peds.112.3.634




PubMed


 


PubMed ID 12949295
    
     


 



5.
Choi EH, Foster CB, Taylor JG, Erichsen HC, Chen RA, Walsh TJ, Anttila VJ, Ruutu T, Palotie A, Chanock SJ (2003). Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis  187, 1153-6.   https://doi.org/10.1086/368345




PubMed


 


PubMed ID 12660931
    
     


 



6.
Cortez KJ, Walsh TJ, Bennett JE (2003). Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis  36, 1619-22.   https://doi.org/10.1086/375235




PubMed


 


PubMed ID 12802765
    
     


 



7.
Gil-Lamaignere C, Roilides E, Lyman CA, Simitsopoulou M, Stergiopoulou T, Maloukou A, Walsh TJ (2003). Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury. Infect Immun  71, 6472-8.   https://doi.org/10.1128/iai.71.11.6472-6478.2003




PubMed



        
     
Free Article


 


PubMed ID 14573669
         Pubmed Central ID 219606 


 



8.
Groll AH, Gea-Banacloche JC, Glasmacher A, Just-Nuebling G, Maschmeyer G, Walsh TJ (2003). Clinical pharmacology of antifungal compounds. Infect Dis Clin North Am  17, 159-91, ix.   https://doi.org/10.1016/s0891-5520(02)00068-5




PubMed


 


PubMed ID 12751265
    
     


 



9.
Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ (2004). Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis  190, 641-9.   https://doi.org/10.1086/422009




PubMed


 


PubMed ID 15243943
    
     


 



10.
O'Sullivan CE, Kasai M, Francesconi A, Petraitis V, Petraitiene R, Kelaher AM, Sarafandi AA, Walsh TJ (2003). Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis. J Clin Microbiol  41, 5676-82.   https://doi.org/10.1128/jcm.41.12.5676-5682.2003




PubMed



        
     
Free Article


 


PubMed ID 14662960
         Pubmed Central ID 308994 


 



11.
Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE, Infectious Diseases Society of America (2004). Guidelines for treatment of candidiasis. Clin Infect Dis  38, 161-89.   https://doi.org/10.1086/380796




PubMed


 


PubMed ID 14699449
    
     


 



12.
Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E (2003). Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis  36, 1122-31.   https://doi.org/10.1086/374557




PubMed


 


PubMed ID 12715306
    
     


 



13.
Petraitiene R, Petraitis V, Lyman CA, Groll AH, Mickiene D, Peter J, Bacher J, Roussillon K, Hemmings M, Armstrong D, Avila NA, Walsh TJ (2004). Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrob Agents Chemother  48, 1188-96.   https://doi.org/10.1128/aac.48.4.1188-1196.2004




PubMed



        
     
Free Article


 


PubMed ID 15047519
         Pubmed Central ID 375262 


 



14.
Petraitis V, Petraitiene R, Sarafandi AA, Kelaher AM, Lyman CA, Casler HE, Sein T, Groll AH, Bacher J, Avila NA, Walsh TJ (2003). Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis  187, 1834-43.   https://doi.org/10.1086/375420




PubMed


 


PubMed ID 12792859
    
     


 



15.
Roden MM, Nelson LD, Knudsen TA, Jarosinski PF, Starling JM, Shiflett SE, Calis K, DeChristoforo R, Donowitz GR, Buell D, Walsh TJ (2003). Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. Clin Infect Dis  36, 1213-20.   https://doi.org/10.1086/374553




PubMed


 


PubMed ID 12746764
    
     


 



16.
Roilides E, Farmaki E, Evdoridou J, Francesconi A, Kasai M, Filioti J, Tsivitanidou M, Sofianou D, Kremenopoulos G, Walsh TJ (2003). Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol  41, 735-41.   https://doi.org/10.1128/jcm.41.2.735-741.2003




PubMed



        
     
Free Article


 


PubMed ID 12574275
         Pubmed Central ID 149715 


 



17.
Roilides E, Lyman CA, Sein T, Petraitiene R, Walsh TJ (2003). Macrophage colony-stimulating factor enhances phagocytosis and oxidative burst of mononuclear phagocytes against Penicillium marneffei conidia. FEMS Immunol Med Microbiol  36, 19-26.   https://doi.org/10.1016/S0928-8244(03)00035-X




PubMed


 


PubMed ID 12727361
    
     


 



18.
Steinbach WJ, Perfect JR, Schell WA, Walsh TJ, Benjamin DK (2004). In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother  48, 3217-25.   https://doi.org/10.1128/AAC.48.9.3217-3225.2004




PubMed



        
     
Free Article


 


PubMed ID 15328076
         Pubmed Central ID 514747 


 



19.
Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E (2004). Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect  10 Suppl 1, 48-66.   https://doi.org/10.1111/j.1470-9465.2004.00839.x




PubMed


 


PubMed ID 14748802
    
     


 



20.
Walsh TJ, Karlsson MO, Driscoll T, Arguedas AG, Adamson P, Saez-Llorens X, Vora AJ, Arrieta AC, Blumer J, Lutsar I, Milligan P, Wood N (2004). Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother  48, 2166-72.   https://doi.org/10.1128/AAC.48.6.2166-2172.2004




PubMed



        
     
Free Article


 


PubMed ID 15155217
         Pubmed Central ID 415618 


 



21.
Walsh TJ, Petraitis V, Petraitiene R, Field-Ridley A, Sutton D, Ghannoum M, Sein T, Schaufele R, Peter J, Bacher J, Casler H, Armstrong D, Espinel-Ingroff A, Rinaldi MG, Lyman CA (2003). Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis  188, 305-19.   https://doi.org/10.1086/377210




PubMed


 


PubMed ID 12854088
    
     


 



22.
Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, Murray H, Mya-San C, Bacher J, Petraitis V (2004). Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol  42, 4744-8.   https://doi.org/10.1128/JCM.42.10.4744-4748.2004




PubMed



        
     
Free Article


 


PubMed ID 15472335
         Pubmed Central ID 522332 


 



23.
Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE (2004). Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med  351, 1391-402.   https://doi.org/10.1056/NEJMoa040446




PubMed


 


PubMed ID 15459300
    
     


 



24.
Winn RM, Gil-Lamaignere C, Roilides E, Simitsopoulou M, Lyman CA, Maloukou A, Walsh TJ (2003). Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species. J Infect Dis  188, 585-90.   https://doi.org/10.1086/377099




PubMed


 


PubMed ID 12898448",https://intramural.nih.gov/search/searchview.taf?ipid=36523
507,SC006880-27,"October 01, 2003 -  September 30, 2004",Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Can,"Frank M Balis; MD, PhD",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,"Susan  Blaney
(Pediatric Oncology, Baylor Univ.)





John  Hicks
(Pathology, Baylor University)





Stacey  Berg
(Pediatric Oncology, Baylor Univ.)





Ronald  Przygodzki; MD
(Armed Forces Institute of Pathology)





John  Maris
(Pharmacology, Children's Hospital of Philadelphia)





Roger  Packer
(Neurology, Children's Natl. Med. Ctr.)


Show all 12","Diane  Cole (National Cancer Institute)



Elizabeth  Fox; MD (National Cancer Institute)



Peter L Choyke; MD (Center for Cancer Research)



Nalini M Jayaprakash (National Cancer Institute)



Robert F Murphy (Pharmclgy And Experimental Therapeutics Sect)



Antonio  Fojo; MD, PhD (National Cancer Institute)","John D. Bacher; BS, DVM, MS (OD) 



Paul S Meltzer; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Abraham J, Agrawal M, Bakke S, Rutt A, Edgerly M, Balis FM, Widemann B, Davis L, Damle B, Sonnichsen D, Lebwohl D, Bates S, Kotz H, Fojo T (2003). Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days. J Clin Oncol  21, 1866-73.   https://doi.org/10.1200/JCO.2003.03.063




PubMed


 


PubMed ID 12721265
    
     


 



2.
Adamson PC, Blaney SM, Widemann BC, Kitchen B, Murphy RF, Hannah AL, Cropp GF, Patel M, Gillespie AF, Whitcomb PG, Balis FM (2004). Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101. Cancer Chemother Pharmacol  53, 482-8.   https://doi.org/10.1007/s00280-004-0769-2




PubMed


 


PubMed ID 14999430
    
     


 



3.
Agrawal M, Abraham J, Balis FM, Edgerly M, Stein WD, Bates S, Fojo T, Chen CC (2003). Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. Clin Cancer Res  9, 650-6.




PubMed


 


PubMed ID 12576431
    
     


 



4.
Bates SE, Bakke S, Kang M, Robey RW, Zhai S, Thambi P, Chen CC, Patil S, Smith T, Steinberg SM, Merino M, Goldspiel B, Meadows B, Stein WD, Choyke P, Balis F, Figg WD, Fojo T (2004). A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res  10, 4724-33.   https://doi.org/10.1158/1078-0432.CCR-0829-03




PubMed


 


PubMed ID 15269145
    
     


 



5.
Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, Packer R, Matthay K, Jaeckle K, Cole D, Kuttesch N, Poplack DG, Balis FM (2003). Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol  21, 143-7.   https://doi.org/10.1200/JCO.2003.04.053




PubMed


 


PubMed ID 12506183
    
     


 



6.
Hawkins ME, Balis FM (2004). Use of pteridine nucleoside analogs as hybridization probes. Nucleic Acids Res  32, e62.   https://doi.org/10.1093/nar/gnh060




PubMed



        
     
Free Article


 


PubMed ID 15090623
         Pubmed Central ID 407840 


 



7.
Hazra R, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty JF, Yale K, Poblenz M, Kearney BP, Zhong L, Coakley DF, Blanche S, Bresson JL, Zuckerman JA, Zeichner SL (2004). Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children. Antimicrob Agents Chemother  48, 124-9.   https://doi.org/10.1128/aac.48.1.124-129.2004




PubMed



        
     
Free Article


 


PubMed ID 14693529
         Pubmed Central ID 310184 


 



8.
Neville K, Parise RA, Thompson P, Aleksic A, Egorin MJ, Balis FM, McGuffey L, McCully C, Berg SL, Blaney SM (2004). Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clin Cancer Res  10, 2525-9.   https://doi.org/10.1158/1078-0432.ccr-03-0155




PubMed


 


PubMed ID 15073132
    
     


 



9.
Patel M, McCully C, Godwin K, Balis FM (2003). Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates. J Neurooncol  61, 203-7.   https://doi.org/10.1023/a:1022592913323




PubMed


 


PubMed ID 12675312
    
     


 



10.
Salzer W, Steinberg SM, Liewehr DJ, Freifeld A, Balis FM, Widemann BC (2003). Evaluation and treatment of fever in the non-neutropenic child with cancer. J Pediatr Hematol Oncol  25, 606-12.   https://doi.org/10.1097/00043426-200308000-00004




PubMed


 


PubMed ID 12902912
    
     


 



11.
Thompson P, Balis F, Serabe BM, Berg S, Adamson P, Klenke R, Aiken A, Packer R, Murry DJ, Jakacki R, Blaney SM (2003). Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer. Cancer Chemother Pharmacol  52, 417-23.   https://doi.org/10.1007/s00280-003-0674-0




PubMed


 


PubMed ID 12879279
    
     


 



12.
Warren K, Gervais A, Aikin A, Egorin M, Balis FM (2004). Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors. Cancer Chemother Pharmacol  54, 206-12.   https://doi.org/10.1007/s00280-004-0791-4




PubMed


 


PubMed ID 15156345
    
     


 



13.
Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC (2004). High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer  100, 2222-32.   https://doi.org/10.1002/cncr.20255




PubMed


 


PubMed ID 15139068
    
     


 



14.
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ (2004). Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med  351, 552-9.   https://doi.org/10.1056/NEJMoa031197




PubMed


 


PubMed ID 15295048",https://intramural.nih.gov/search/searchview.taf?ipid=36524
508,SC006891-16,"October 01, 2003 -  September 30, 2004",Solid Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Br, NCI",NULL,"Ching  Lau
(Ped Heme/Onc, Texas Children's Hospital)
















Larry  Baker
(Medical Oncology, Univ. of Michagan)","Lauren M Long (National Cancer Institute)



Crystal L. Mackall; MD (Pediatric Oncology Branch)












Donna B Bernstein  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M (2003). Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest  83, 1255-65.   https://doi.org/10.1097/01.lab.0000088856.49388.ea




PubMed


 


PubMed ID 13679433
    
     


 



2.
Goorin AM, Schwartzentruber DJ, Devidas M, Gebhardt MC, Ayala AG, Harris MB, Helman LJ, Grier HE, Link MP, Pediatric Oncology Group (2003). Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol  21, 1574-80.   https://doi.org/10.1200/JCO.2003.08.165




PubMed


 


PubMed ID 12697883",https://intramural.nih.gov/search/searchview.taf?ipid=36525
509,SC006892-16,"October 01, 2003 -  September 30, 2004",Molecular Biology of Pediatric Tumors,"Lee Jay Helman; MD



IRP Faculty Profile",NULL,"Pediatric Oncology Br, NCI",NULL,NULL,"Xiaolin  Wan (National Cancer Institute)



Choh  Yeung (National Cancer Institute)



Glenn  Merlino; PhD (National Cancer Institute)












Kartik  Krishnan  (National Cancer Institute)","Derek  LeRoith; MD, PhD (NIDDK)","Ordered by publication type and then author name.



1.
Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, Yeung C, Gorlick R, Hewitt SM, Helman LJ (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med  10, 182-6.   https://doi.org/10.1038/nm982




PubMed


 


PubMed ID 14704791
    
     


 



2.
LeRoith D, Helman L (2004). The new kid on the block(ade) of the IGF-1 receptor. Cancer Cell  5, 201-2.   https://doi.org/10.1016/s1535-6108(04)00054-6




PubMed


 


PubMed ID 15050909
    
     


 



3.
Toyoshima Y, Karas M, Yakar S, Dupont J, Lee Helman, LeRoith D (2004). TDAG51 mediates the effects of insulin-like growth factor I (IGF-I) on cell survival. J Biol Chem  279, 25898-904.   https://doi.org/10.1074/jbc.M400661200




PubMed


 


PubMed ID 15037619
    
     


 



4.
Wan X, Helman LJ (2003). Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene  22, 8205-11.   https://doi.org/10.1038/sj.onc.1206878




PubMed


 


PubMed ID 14603261
    
     


 



5.
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med  10, 175-81.   https://doi.org/10.1038/nm966




PubMed


 


PubMed ID 14704789",https://intramural.nih.gov/search/searchview.taf?ipid=36526
510,SC007202-20,"October 01, 2003 -  September 30, 2004",Biostatistics and Data Management Section,"Seth M Steinberg; PhD



IRP Faculty Profile",James Carl Barrett; PhD,"Biostat and Data Mgmt Sect, NCI",NULL,NULL,"David  Liewehr (National Cancer Institute)



Janet  Doernberg (National Cancer Institute)



David J Venzon; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Alexander HR, Libutti SK, Pingpank JF, Steinberg SM, Bartlett DL, Helsabeck C, Beresneva T (2003). Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res  9, 6343-9.




PubMed


 


PubMed ID 14695133
    
     


 



2.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



3.
Edghill-Smith Y, Venzon D, Karpova T, McNally J, Nacsa J, Tsai WP, Tryniszewska E, Moniuszko M, Manischewitz J, King LR, Snodgrass SJ, Parrish J, Markham P, Sowers M, Martin D, Lewis MG, Berzofsky JA, Belyakov IM, Moss B, Tartaglia J, Bray M, Hirsch V, Golding H, Franchini G (2003). Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques. J Infect Dis  188, 1181-91.   https://doi.org/10.1086/378518




PubMed


 


PubMed ID 14551889
    
     


 



4.
Elaraj DM, White DE, Steinberg SM, Haworth L, Rosenberg SA, Yang JC (2004). A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinoma. J Immunother  27, 259-64.   https://doi.org/10.1097/00002371-200407000-00001




PubMed



        
     
Free Article


 


PubMed ID 15235386
         Pubmed Central ID 2275325 


 



5.
Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR (2003). Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol  21, 4560-7.   https://doi.org/10.1200/JCO.2003.04.150




PubMed


 


PubMed ID 14673042
    
     


 



6.
Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF (2004). Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res  10, 1565-73.   https://doi.org/10.1158/1078-0432.ccr-1020-3




PubMed


 


PubMed ID 15014005
    
     


 



7.
Nacsa J, Radaelli A, Edghill-Smith Y, Venzon D, Tsai WP, Morghen Cde G, Panicali D, Tartaglia J, Franchini G (2004). Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques. Vaccine  22, 597-606.   https://doi.org/10.1016/j.vaccine.2003.08.028




PubMed


 


PubMed ID 14741150
    
     


 



8.
Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M (2004). Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J Virol  78, 2212-21.   https://doi.org/10.1128/jvi.78.5.2212-2221.2004




PubMed



        
     
Free Article


 


PubMed ID 14963117
         Pubmed Central ID 369221 


 



9.
Stevens J, Nichelson E, Linehan WM, Thompson N, Liewehr D, Venzon D, Walther MM (2004). Risk factors for skin breakdown after renal and adrenal surgery. Urology  64, 246-9.   https://doi.org/10.1016/j.urology.2004.03.024




PubMed


 


PubMed ID 15302471
    
     


 



10.
Tan AR, Yang X, Hewitt SM, Berman A, Lepper ER, Sparreboom A, Parr AL, Figg WD, Chow C, Steinberg SM, Bacharach SL, Whatley M, Carrasquillo JA, Brahim JS, Ettenberg SA, Lipkowitz S, Swain SM (2004). Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor. J Clin Oncol  22, 3080-90.   https://doi.org/10.1200/JCO.2004.08.189




PubMed


 


PubMed ID 15284258",https://intramural.nih.gov/search/searchview.taf?ipid=29209
511,SC007256-16,"October 01, 2003 -  September 30, 2004",Mechanisms of Oncogene Action in Tumorigenesis,Frederic  Kaye; MD,NULL,"Cancer Genetics Branch, NCI",NULL,"Priscilla  Furth
(Georgetown University)





Adel  El-Naggar
(MD Anderson Cancer Center)





James  Griffin
(Dana-Farber Cancer Institute)","Sanjay R Modi (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)












Amy B Coxon  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ (2003). t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet  33, 208-13.   https://doi.org/10.1038/ng1083




PubMed


 


PubMed ID 12539049",https://intramural.nih.gov/search/searchview.taf?ipid=36527
512,SC007263-12,"October 01, 2003 -  September 30, 2004","Molecular Control of Growth, Differentiation, and Death in Epithelial Cancer Cel","Stanley  Lipkowitz; MD, PhD



IRP Faculty Profile",Lawrence Elliot Samelson; MD,"Laboratory of Cellular and Molecular Biology, NCI",NULL,"Josef  Penninger
(Institute of Molecular Biotechnology)
















David  Louis
(Neuropathology, Massachusetts General Hosp - East)","Marion M Nau (National Cancer Institute)



Maria  Zajac-Kaye; PhD (National Cancer Institute)



Sandra M Swain; MD (National Cancer Institute)



Dao M Nguyen; MD, MS (National Cancer Institute)



Barry R O'Keefe (National Cancer Institute)



Allan M Weissman; MD (Laboratory of Immune Cell Biology)",NULL,"Ordered by publication type and then author name.



1.
Griffiths EK, Sanchez O, Mill P, Krawczyk C, Hojilla CV, Rubin E, Nau MM, Khokha R, Lipkowitz S, Hui CC, Penninger JM (2003). Cbl-3-deficient mice exhibit normal epithelial development. Mol Cell Biol  23, 7708-18.   https://doi.org/10.1128/mcb.23.21.7708-7718.2003




PubMed



        
     
Free Article


 


PubMed ID 14560016
         Pubmed Central ID 207562 


 



2.
Lipkowitz S (2003). The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer. Breast Cancer Res  5, 8-15.   https://doi.org/10.1186/bcr541




PubMed



        
     
Free Article


 


PubMed ID 12559039
         Pubmed Central ID 154127 


 



3.
Magnifico A, Ettenberg S, Yang C, Mariano J, Tiwari S, Fang S, Lipkowitz S, Weissman AM (2003). WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem  278, 43169-77.   https://doi.org/10.1074/jbc.M308009200




PubMed


 


PubMed ID 12907674
    
     


 



4.
Nau MM, Lipkowitz S (2003). Comparative genomic organization of the cbl genes. Gene  308, 103-13.   https://doi.org/10.1016/s0378-1119(03)00471-2




PubMed


 


PubMed ID 12711395",https://intramural.nih.gov/search/searchview.taf?ipid=36528
513,SC007265-10,"October 01, 2003 -  September 30, 2004",Cancer Genetics,Ilan  Kirsch; MD,NULL,"Cancer Genetics Branch, NCI",NULL,NULL,"Barbara  Brogan (National Cancer Institute)



Kathy  Calzone (National Cancer Institute)



Wendy  Davis (National Cancer Institute)



Kristie  Gehlhaus (National Cancer Institute)



Oleg  Glebov (National Cancer Institute)



Nina  Joshi (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I (2003). Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med  163, 573-82.   https://doi.org/10.1001/archinte.163.5.573




PubMed


 


PubMed ID 12622604
    
     


 



2.
Junicke H, Hart JR, Kisko J, Glebov O, Kirsch IR, Barton JK (2003). A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition. Proc Natl Acad Sci U S A  100, 3737-42.   https://doi.org/10.1073/pnas.0537194100




PubMed



        
     
Free Article


 


PubMed ID 12610209
         Pubmed Central ID 152991 


 



3.
Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, Scudiero DA, Weinstein JN, Kirsch IR (2003). Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res  63, 8634-47.




PubMed


 


PubMed ID 14695175",https://intramural.nih.gov/search/searchview.taf?ipid=36529
514,SC007281-11,"October 01, 2003 -  September 30, 2004",Nitric Oxide as a Modifier of Oxidative Stress,"David Anderson Wink



IRP Faculty Profile",James B Mitchell; PhD,"Radlgy Biology Br, NCI",NULL,"Jon  Fukuto
(UCLA)





Katrina  Miranda
(Chemistry Dept, Univ. of Arizona)





Peter  Ford
(Univ. of Calif, Santa Barbara)





Nazarreano  Paoloci
(Johns Hopkins University)





David  Kass; MD
(Johns Hopkins University)





Ken  Houk
(UCLA)","Michael G Espey; MT, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Sidorkina O, Espey MG, Miranda KM, Wink DA, Laval J (2003). Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species. Free Radic Biol Med  35, 1431-8.   https://doi.org/10.1016/j.freeradbiomed.2003.08.015




PubMed


 


PubMed ID 14642390
    
     


 



2.
Tarpey MM, Wink DA, Grisham MB (2004). Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol  286, R431-44.   https://doi.org/10.1152/ajpregu.00361.2003




PubMed


 


PubMed ID 14761864
    
     


 



3.
Thomas DD, Miranda KM, Colton CA, Citrin D, Espey MG, Wink DA (2003). Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation. Antioxid Redox Signal  5, 307-17.   https://doi.org/10.1089/152308603322110887




PubMed


 


PubMed ID 12880485",https://intramural.nih.gov/search/searchview.taf?ipid=36530
515,SC009144-20,"October 01, 2003 -  September 30, 2004",Identification of Proteins Binding to c-myc Regulatory Sequences,"David  Levens; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Deborah  Boles (National Cancer Institute)



Hye-Jung  Chung (National Cancer Institute)



Fedor  Kouzine (National Cancer Institute)



Juhong  Liu (National Cancer Institute)



Zuqin  Nie; PhD (National Cancer Institute)



Suzanne  Sanford (National Cancer Institute)","G. Marius  Clore; PhD, MD (NIDDK)","Ordered by publication type and then author name.



1.
Levens DL (2003). Reconstructing MYC. Genes Dev  17, 1071-7.   https://doi.org/10.1101/gad.1095203




PubMed


 


PubMed ID 12730130",https://intramural.nih.gov/search/searchview.taf?ipid=36531
516,SC009163-17,"October 01, 2003 -  September 30, 2004",Signal Transduction Therapy--Basic Science,Elise C Kohn; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,"Shengyun  Fang
(U-Maryland)





arturo  leone
(Univ. Salerno)





Howard  Doong
(U-Maryland)





Andrew  Bateman
(McGill University)





Monica  Brown Jones
(Mayo Clinic)





Mark  Raffeld
(LP, CCR)


Show all 8",Allan M Weissman; MD (Laboratory of Immune Cell Biology),NULL,"Ordered by publication type and then author name.



1.
Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, Kohn EC (2003). CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem  278, 28490-500.   https://doi.org/10.1074/jbc.M209682200




PubMed


 


PubMed ID 12750378
    
     


 



2.
Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC (2003). The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res  9, 44-51.




PubMed


 


PubMed ID 12538450
    
     


 



3.
Jones MB, Spooner M, Kohn EC (2003). The granulin-epithelin precursor: a putative new growth factor for ovarian cancer. Gynecol Oncol  88, S136-9.   https://doi.org/10.1006/gyno.2002.6704




PubMed


 


PubMed ID 12586105
    
     


 



4.
Liotta LA, Kohn EC (2003). Cancer's deadly signature. Nat Genet  33, 10-1.   https://doi.org/10.1038/ng0103-10




PubMed


 


PubMed ID 12509774
    
     


 



5.
Liotta LA, Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC (2003). General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecol Oncol  88, S25-8; discussion S37-42.   https://doi.org/10.1006/gyno.2002.6679




PubMed


 


PubMed ID 12586081
    
     


 



6.
Romano MF, Festa M, Petrella A, Rosati A, Pascale M, Bisogni R, Poggi V, Kohn EC, Venuta S, Turco MC, Leone A (2003). BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther  2, 508-10.   https://doi.org/10.4161/cbt.2.5.524




PubMed


 


PubMed ID 14614315",https://intramural.nih.gov/search/searchview.taf?ipid=36532
517,SC009170-17,"October 01, 2003 -  September 30, 2004",Genes regulating pattern formation during embryonic development,"Susan  Mackem; MD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,NULL,Brant M Weinstein; PhD (NICHD),"Ordered by publication type and then author name.



1.
Chen Y, Knezevic V, Ervin V, Hutson R, Ward Y, Mackem S (2004). Direct interaction with Hoxd proteins reverses Gli3-repressor function to promote digit formation downstream of Shh. Development  131, 2339-47.   https://doi.org/10.1242/dev.01115




PubMed


 


PubMed ID 15102708
    
     


 



2.
Liu C, Nakamura E, Knezevic V, Hunter S, Thompson K, Mackem S (2003). A role for the mesenchymal T-box gene Brachyury in AER formation during limb development. Development  130, 1327-37.   https://doi.org/10.1242/dev.00354




PubMed


 


PubMed ID 12588849",https://intramural.nih.gov/search/searchview.taf?ipid=36533
518,SC009172-16,"October 01, 2003 -  September 30, 2004",Cellular Interactions with Thrombospondin,"David D Roberts; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Svetlana A Kuznetsova (National Cancer Institute)



Gema  Martin-Manso (National Cancer Institute)



Jo A Cashel (National Cancer Institute)



John M Sipes (National Cancer Institute)



Yifeng  Jia (National Cancer Institute)



Elizabeth  Perruccio (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Calzada MJ, Roberts DD (2005). Novel integrin antagonists derived from thrombospondins. Curr Pharm Des  11, 849-66.   https://doi.org/10.2174/1381612053381792




PubMed


 


PubMed ID 15777239
    
     


 



2.
Calzada MJ, Sipes JM, Krutzsch HC, Yurchenco PD, Annis DS, Mosher DF, Roberts DD (2003). Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin. J Biol Chem  278, 40679-87.   https://doi.org/10.1074/jbc.M302014200




PubMed


 


PubMed ID 12909644
    
     


 



3.
Calzada MJ, Zhou L, Sipes JM, Zhang J, Krutzsch HC, Iruela-Arispe ML, Annis DS, Mosher DF, Roberts DD (2004). Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo. Circ Res  94, 462-70.   https://doi.org/10.1161/01.RES.0000115555.05668.93




PubMed


 


PubMed ID 14699013
    
     


 



4.
Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C (2004). Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int  65, 459-68.   https://doi.org/10.1111/j.1523-1755.2004.00395.x




PubMed


 


PubMed ID 14717916
    
     


 



5.
Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK, Roberts DD (2003). Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res  63, 6405-12.




PubMed


 


PubMed ID 14559830
    
     


 



6.
Mazzanti CM, Tandle A, Lorang D, Costouros N, Roberts D, Bevilacqua G, Libutti SK (2004). Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. Genome Res  14, 1585-93.   https://doi.org/10.1101/gr.2552804




PubMed



        
     
Free Article


 


PubMed ID 15289477
         Pubmed Central ID 509267",https://intramural.nih.gov/search/searchview.taf?ipid=36101
519,SC009173-16,"October 01, 2003 -  September 30, 2004",Host colonization and vascular dissemination of Candida albicans,"David D Roberts; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Alexander  Peterson (National Cancer Institute)



Jo A Cashel (National Cancer Institute)



John M Sipes (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pendrak ML, Chao MP, Yan SS, Roberts DD (2004). Heme oxygenase in Candida albicans is regulated by hemoglobin and is necessary for metabolism of exogenous heme and hemoglobin to alpha-biliverdin. J Biol Chem  279, 3426-33.   https://doi.org/10.1074/jbc.M311550200




PubMed


 


PubMed ID 14615478
    
     


 



2.
Pendrak ML, Yan SS, Roberts DD (2004). Hemoglobin regulates expression of an activator of mating-type locus alpha genes in Candida albicans. Eukaryot Cell  3, 764-75.   https://doi.org/10.1128/EC.3.3.764-775.2004




PubMed



        
     
Free Article


 


PubMed ID 15189997
         Pubmed Central ID 420132 


 



3.
Pendrak ML, Yan SS, Roberts DD (2004). Sensing the host environment: recognition of hemoglobin by the pathogenic yeast Candida albicans. Arch Biochem Biophys  426, 148-56.   https://doi.org/10.1016/j.abb.2004.02.006




PubMed


 


PubMed ID 15158665",https://intramural.nih.gov/search/searchview.taf?ipid=36102
520,SC009174-16,"October 01, 2003 -  September 30, 2004",Role of Glycoconjugates in Tumor Biology,"David D Roberts; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Svetlana A Kuznetsova (National Cancer Institute)



Jo A Cashel (National Cancer Institute)



John M Sipes (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Kuznetsova SA, Roberts DD (2004). Functional regulation of T lymphocytes by modulatory extracellular matrix proteins. Int J Biochem Cell Biol  36, 1126-34.   https://doi.org/10.1016/j.biocel.2003.12.006




PubMed


 


PubMed ID 15094127
    
     


 



2.
Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ (2004). Differential expression of S100C in thyroid lesions. Int J Surg Pathol  12, 107-15.   https://doi.org/10.1177/106689690401200203




PubMed


 


PubMed ID 15173915",https://intramural.nih.gov/search/searchview.taf?ipid=36100
521,SC009179-16,"October 01, 2003 -  September 30, 2004",Tissue Inhibitors of Metalloproteinases: Regulation of Cell Growth and Different,"William G Stetler-Stevenson; MD, PhD



IRP Faculty Profile",Kathleen  Kelly; PhD,"Laboratory of Pathology, NCI",NULL,NULL,"Liliana  Guedez; PhD (National Cancer Institute)



Hongmei  Li (National Cancer Institute)



Junseo  Oh (National Cancer Institute)



Rita  Salloum (National Cancer Institute)



Dongwan  Seo (National Cancer Institute)



Beiyang  Wei (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, Bungay PM, Stetler-Stevenson WG (2003). Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol  162, 1431-9.   https://doi.org/10.1016/S0002-9440(10)64276-9




PubMed



        
     
Free Article


 


PubMed ID 12707026
         Pubmed Central ID 1851187 


 



2.
Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG (2003). TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell  114, 171-80.   https://doi.org/10.1016/s0092-8674(03)00551-8




PubMed


 


PubMed ID 12887919",https://intramural.nih.gov/search/searchview.taf?ipid=36537
522,SC009185-15,"October 01, 2003 -  September 30, 2004",Laser Capture Microdissection and Clinical Proteomics,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,"Dennis  Sgroi
(Pathology, Harvard)
















Sam  Wells
(Duke University)","Andrew  Feldman (National Cancer Institute)



Paul  Hermann (National Cancer Institute)



Mark  Lowenthal (National Cancer Institute)



Bridget  Lynch (National Cancer Institute)



Vivian E Norman (National Cancer Institute)



Amy Victoria Rapkiewicz (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berman DM, Wang Y, Liu Z, Dong Q, Burke LA, Liotta LA, Fisher R, Wu X (2004). A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res  64, 6820-6.   https://doi.org/10.1158/0008-5472.CAN-04-1916




PubMed


 


PubMed ID 15375002
    
     


 



2.
Bottaro DP, Liotta LA (2003). Cancer: Out of air is not out of action. Nature  423, 593-5.   https://doi.org/10.1038/423593a




PubMed


 


PubMed ID 12789320
    
     


 



3.
Clair T, Aoki J, Koh E, Bandle RW, Nam SW, Ptaszynska MM, Mills GB, Schiffmann E, Liotta LA, Stracke ML (2003). Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res  63, 5446-53.




PubMed


 


PubMed ID 14500380
    
     


 



4.
Conrads TP, Zhou M, Petricoin EF, Liotta L, Veenstra TD (2003). Cancer diagnosis using proteomic patterns. Expert Rev Mol Diagn  3, 411-20.   https://doi.org/10.1586/14737159.3.4.411




PubMed


 


PubMed ID 12877381
    
     


 



5.
Espina V, Woodhouse EC, Wulfkuhle J, Asmussen HD, Petricoin EF, Liotta LA (2004). Protein microarray detection strategies: focus on direct detection technologies. J Immunol Methods  290, 121-33.   https://doi.org/10.1016/j.jim.2004.04.013




PubMed


 


PubMed ID 15261576
    
     


 



6.
Geho DH, Lahar N, Ferrari M, Petricoin EF, Liotta LA (2004). Opportunities for nanotechnology-based innovation in tissue proteomics. Biomed Microdevices  6, 231-9.   https://doi.org/10.1023/B:BMMD.0000042053.51016.b4




PubMed


 


PubMed ID 15377833
    
     


 



7.
Geho DH, Smith WI, Liotta LA, Roberts DD (2003). Fibronectin-based masking molecule blocks platelet adhesion. Bioconjug Chem  14, 703-6.   https://doi.org/10.1021/bc034037v




PubMed


 


PubMed ID 12862420
    
     


 



8.
Herrmann PC, Gillespie JW, Charboneau L, Bichsel VE, Paweletz CP, Calvert VS, Kohn EC, Emmert-Buck MR, Liotta LA, Petricoin EF (2003). Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics  3, 1801-10.   https://doi.org/10.1002/pmic.200300461




PubMed


 


PubMed ID 12973739
    
     


 



9.
Interewicz B, Olszewski WL, Leak LV, Petricoin EF, Liotta LA (2004). Profiling of normal human leg lymph proteins using the 2-D electrophoresis and SELDI-TOF mass spectrophotometry approach. Lymphology  37, 65-72.




PubMed


 


PubMed ID 15328759
    
     


 



10.
Johann DJ, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA (2004). Clinical proteomics and biomarker discovery. Ann N Y Acad Sci  1022, 295-305.   https://doi.org/10.1196/annals.1318.045




PubMed


 


PubMed ID 15251975
    
     


 



11.
Johann DJ, McGuigan MD, Tomov S, Fusaro VA, Ross S, Conrads TP, Veenstra TD, Fishman DA, Whiteley GR, Petricoin EF, Liotta LA (2003). Novel approaches to visualization and data mining reveals diagnostic information in the low amplitude region of serum mass spectra from ovarian cancer patients. Dis Markers  19, 197-207.   https://doi.org/10.1155/2004/549372




PubMed



        
     
Free Article


 


PubMed ID 15258334
         Pubmed Central ID 3851062 


 



12.
Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G, Emmert-Buck MR, Petricoin EF, Krizman DB, Liotta LA, Kohn EC (2003). The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res  9, 44-51.




PubMed


 


PubMed ID 12538450
    
     


 



13.
Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L, Stracke M (2003). Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. Cancer Res  63, 2042-5.




PubMed


 


PubMed ID 12727817
    
     


 



14.
Krieg RC, Knuechel R, Schiffmann E, Liotta LA, Petricoin EF, Herrmann PC (2004). Mitochondrial proteome: cancer-altered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics  4, 2789-95.   https://doi.org/10.1002/pmic.200300796




PubMed


 


PubMed ID 15352252
    
     


 



15.
Krieg RC, Paweletz CP, Liotta LA, Petricoin EF (2003). Dilution of protein gel stain results in retention of staining capacity. Biotechniques  35, 376-8.   https://doi.org/10.2144/03352pt01




PubMed


 


PubMed ID 12951779
    
     


 



16.
Liotta LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF (2003). Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell  3, 317-25.   https://doi.org/10.1016/s1535-6108(03)00086-2




PubMed


 


PubMed ID 12726858
    
     


 



17.
Liotta LA, Kohn E (2004). Anoikis: cancer and the homeless cell. Nature  430, 973-4.   https://doi.org/10.1038/430973a




PubMed


 


PubMed ID 15329701
    
     


 



18.
Liotta LA, Kohn EC (2003). Cancer's deadly signature. Nat Genet  33, 10-1.   https://doi.org/10.1038/ng0103-10




PubMed


 


PubMed ID 12509774
    
     


 



19.
Liotta LA, Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC (2003). General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecol Oncol  88, S25-8; discussion S37-42.   https://doi.org/10.1006/gyno.2002.6679




PubMed


 


PubMed ID 12586081
    
     


 



20.
Nishizuka S, Chen ST, Gwadry FG, Alexander J, Major SM, Scherf U, Reinhold WC, Waltham M, Charboneau L, Young L, Bussey KJ, Kim S, Lababidi S, Lee JK, Pittaluga S, Scudiero DA, Sausville EA, Munson PJ, Petricoin EF, Liotta LA, Hewitt SM, Raffeld M, Weinstein JN (2003). Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res  63, 5243-50.




PubMed


 


PubMed ID 14500354
    
     


 



21.
Ornstein DK, Rayford W, Fusaro VA, Conrads TP, Ross SJ, Hitt BA, Wiggins WW, Veenstra TD, Liotta LA, Petricoin EF (2004). Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. J Urol  172, 1302-5.   https://doi.org/10.1097/01.ju.0000139572.88463.39




PubMed


 


PubMed ID 15371828
    
     


 



22.
Petricoin E, Liotta LA (2003). Counterpoint: The vision for a new diagnostic paradigm. Clin Chem  49, 1276-8.   https://doi.org/10.1373/49.8.1276




PubMed


 


PubMed ID 12881442
    
     


 



23.
Petricoin EF, Fishman DA, Conrads TP, Veenstra TD, Liotta LA (2004). Lessons from Kitty Hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics. Proteomics  4, 2357-60.   https://doi.org/10.1002/pmic.200400865




PubMed


 


PubMed ID 15274129
    
     


 



24.
Petricoin EF, Liotta LA (2003). Clinical applications of proteomics. J Nutr  133, 2476S-2484S.   https://doi.org/10.1093/jn/133.7.2476S




PubMed


 


PubMed ID 12840227
    
     


 



25.
Petricoin EF, Liotta LA (2003). Mass spectrometry-based diagnostics: the upcoming revolution in disease detection. Clin Chem  49, 533-4.   https://doi.org/10.1373/49.4.533




PubMed


 


PubMed ID 12651801
    
     


 



26.
Petricoin EF, Ornstein DK, Liotta LA (2004). Clinical proteomics: Applications for prostate cancer biomarker discovery and detection. Urol Oncol  22, 322-8.   https://doi.org/10.1016/j.urolonc.2004.04.011




PubMed


 


PubMed ID 15283891
    
     


 



27.
Petricoin EF, Rajapaske V, Herman EH, Arekani AM, Ross S, Johann D, Knapton A, Zhang J, Hitt BA, Conrads TP, Veenstra TD, Liotta LA, Sistare FD (2004). Toxicoproteomics: serum proteomic pattern diagnostics for early detection of drug induced cardiac toxicities and cardioprotection. Toxicol Pathol  32 Suppl 1, 122-30.   https://doi.org/10.1080/01926230490426516




PubMed


 


PubMed ID 15209412
    
     


 



28.
Woodhouse EC, Fisher A, Bandle RW, Bryant-Greenwood B, Charboneau L, Petricoin EF, Liotta LA (2003). Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci U S A  100, 11463-8.   https://doi.org/10.1073/pnas.2031202100




PubMed



        
     
Free Article


 


PubMed ID 14500904
         Pubmed Central ID 208780 


 



29.
Wulfkuhle JD, Liotta LA, Petricoin EF (2003). Proteomic applications for the early detection of cancer. Nat Rev Cancer  3, 267-75.   https://doi.org/10.1038/nrc1043




PubMed


 


PubMed ID 12671665
    
     


 



30.
Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF, Liotta L (2003). Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol  532, 59-68.   https://doi.org/10.1007/978-1-4615-0081-0_7




PubMed


 


PubMed ID 12908550
    
     


 



31.
Zhou M, Lucas DA, Chan KC, Issaq HJ, Petricoin EF, Liotta LA, Veenstra TD, Conrads TP (2004). An investigation into the human serum ""interactome"". Electrophoresis  25, 1289-98.   https://doi.org/10.1002/elps.200405866




PubMed


 


PubMed ID 15174051",https://intramural.nih.gov/search/searchview.taf?ipid=36538
523,SC009364-13,"October 01, 2003 -  September 30, 2004",Postmortem Pathology,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,"Paul  Hermann (National Cancer Institute)



Vivian E Norman (National Cancer Institute)



Amy Victoria Rapkiewicz (National Cancer Institute)



Julia D Wulfkuhle (National Cancer Institute)



David  Levens; PhD (National Cancer Institute)



David Erwin Kleiner; MD, PhD (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36542
524,SC009372-12,"October 01, 2003 -  September 30, 2004",Flow Cytometric Analysis of Benign and Malignant Tumors,"Maryalice  Stetler-Stevenson; MD, PhD","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"John Charles Morris; MD (National Cancer Institute)



John  Janik; MD (National Cancer Institute)



Sanguthevar  Rajasekaran; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Marti GE, Carter P, Abbasi F, Washington GC, Jain N, Zenger VE, Ishibe N, Goldin L, Fontaine L, Weissman N, Sgambati M, Fauget G, Bertin P, Vogt RF, Slade B, Noguchi PD, Stetler-Stevenson MA, Caporaso N (2003). B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom  52, 1-12.   https://doi.org/10.1002/cyto.b.10013




PubMed


 


PubMed ID 12599176
    
     


 



2.
Marti GE, Vogt RF, Stetler-Stevenson M   (2003) Clinical quantitative flow cytometry: Identifying the optimal methods for clinical quantitative flow cytometry.  Cytometry B Clin Cytom 55:59.




PubMed


 


PubMed ID 12949961
    
     


 



3.
Sausville JE, Salloum RG, Sorbara L, Kingma DW, Raffeld M, Kreitman RJ, Imus PD, Venzon D, Stetler-Stevenson M (2003). Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am J Clin Pathol  119, 213-7.   https://doi.org/10.1309/G629-9513-NGLC-UB1K




PubMed


 


PubMed ID 12579991
    
     


 



4.
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003). ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood  101, 4944-51.   https://doi.org/10.1182/blood-2002-10-3306




PubMed


 


PubMed ID 12595313",https://intramural.nih.gov/search/searchview.taf?ipid=36473
525,SC009373-12,"October 01, 2003 -  September 30, 2004",Thr Role of TIMP1 in B Cell Differentiation and Survival,"Maryalice  Stetler-Stevenson; MD, PhD","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"William G Stetler-Stevenson; MD, PhD (National Cancer Institute)












Yueqin  Liu  (National Cancer Institute)","Randy T Fischer (NIAMS) 



Amrie C Grammer; PhD (NIAMS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36474
526,SC009374-13,"October 01, 2003 -  September 30, 2004",Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,Elise C Kohn; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,"Riccardo  Alessandro
(Univ. Palermo)





Alan  Franklin
(U-Tenn)
















emanuel  petricoin
(FDA)",Steven  Libutti; MD (Center for Cancer Research),"Peter Jonathan Munson; BA, MA, PhD (CIT)","Ordered by publication type and then author name.



1.
D'Amato M, Flugy AM, Alaimo G, Bauder B, Kohn EC, De Leo G, Alessandro R (2003). Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells. Biochem Biophys Res Commun  301, 907-14.   https://doi.org/10.1016/s0006-291x(03)00062-7




PubMed


 


PubMed ID 12589798
    
     


 



2.
Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004). Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma. Cancer  100, 2139-47.   https://doi.org/10.1002/cncr.20219




PubMed


 


PubMed ID 15139056
    
     


 



3.
Liotta LA, Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC (2003). General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecol Oncol  88, S25-8; discussion S37-42.   https://doi.org/10.1006/gyno.2002.6679




PubMed


 


PubMed ID 12586081
    
     


 



4.
Moody TW, Chiles J, Moody E, Sieczkiewicz GJ, Kohn EC (2003). CAI inhibits the growth of small cell lung cancer cells. Lung Cancer  39, 279-88.   https://doi.org/10.1016/s0169-5002(02)00525-1




PubMed


 


PubMed ID 12609566
    
     


 



5.
Oliver VK, Patton AM, Desai S, Lorang D, Libutti SK, Kohn EC (2003). Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole. J Cell Physiol  197, 139-48.   https://doi.org/10.1002/jcp.10350




PubMed


 


PubMed ID 12942550
    
     


 



6.
Patton AM, Kassis J, Doong H, Kohn EC (2003). Calcium as a molecular target in angiogenesis. Curr Pharm Des  9, 543-51.   https://doi.org/10.2174/1381612033391559




PubMed


 


PubMed ID 12570802",https://intramural.nih.gov/search/searchview.taf?ipid=36543
527,SC009375-12,"October 01, 2003 -  September 30, 2004",Signal Transduction Therapy--Clinical,Elise C Kohn; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,"gordon  mills
(md anderson)





Alan  Franklin
(U-TENN)





Lori  Minasian
(DCP)





William D Figg; PharmD
(NCI)





Peter L Choyke; MD
(CC)





emanuel  petricoin
(FDA)


Show all 7",Steven  Libutti; MD (Center for Cancer Research),NULL,"Ordered by publication type and then author name.



1.
Annunziata CM, Kohn EC (2003). Is there a genomic basis for primary chemoresistance in ovarian cancer? Gynecol Oncol  90, 1-2.   https://doi.org/10.1016/s0090-8258(03)00315-9




PubMed


 


PubMed ID 12821333
    
     


 



2.
Hussain MM, Kotz H, Minasian L, Premkumar A, Sarosy G, Reed E, Zhai S, Steinberg SM, Raggio M, Oliver VK, Figg WD, Kohn EC (2003). Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer. J Clin Oncol  21, 4356-63.   https://doi.org/10.1200/JCO.2003.04.136




PubMed


 


PubMed ID 14645425
    
     


 



3.
Mills GB, Fang X, Lu Y, Hasegawa Y, Eder A, Tanyi J, Tabassam FH, Mao M, Wang H, Cheng KW, Nakayama Y, Kuo W, Erickson J, Gershenson D, Kohn EC, Jaffe R, Bast RC, Gray J (2003). Specific keynote: molecular therapeutics in ovarian cancer. Gynecol Oncol  88, S88-92; discussion S93-6.   https://doi.org/10.1006/gyno.2002.6692




PubMed


 


PubMed ID 12586094",https://intramural.nih.gov/search/searchview.taf?ipid=36544
528,SC009377-12,"October 01, 2003 -  September 30, 2004",Molecular Alterations in Premalignant and In-Situ Breast Lesions,"Patricia  Steeg; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Diane  Palmieri (National Cancer Institute)



Amina  Bouadis (National Cancer Institute)



Geeta  Upadhyay (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF, Liotta L (2003). Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol  532, 59-68.   https://doi.org/10.1007/978-1-4615-0081-0_7




PubMed


 


PubMed ID 12908550",https://intramural.nih.gov/search/searchview.taf?ipid=36545
529,SC009389-11,"October 01, 2003 -  September 30, 2004",A Mitogen-induced G Protein-coupled Receptor,"Kathleen  Kelly; PhD



IRP Faculty Profile",NULL,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"Weihua  Luo (National Cancer Institute)



Tao  Wang (National Cancer Institute)



Yvona  Ward; PhD (National Cancer Institute)












Ross  Lake  (National Cancer Institute)",Alan  Sher; PhD (NIAID),"Ordered by publication type and then author name.



1.
Tillinghast GW, Partee J, Albert P, Kelley JM, Burtow KH, Kelly K (2003). Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. Genes Chromosomes Cancer  37, 121-31.   https://doi.org/10.1002/gcc.10195




PubMed


 


PubMed ID 12696060",https://intramural.nih.gov/search/searchview.taf?ipid=36546
530,SC009392-11,"October 01, 2003 -  September 30, 2004",PROTEOMIC ANALYSIS OF MICRODISSECTED BENIGN AND MALIGNANT THYROID TISSUES: A TOO,"Maria  Merino; PhD



IRP Faculty Profile","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Sedric V Cade (National Cancer Institute)



Martha Maria Nicacio Quezado; MD (National Cancer Institute)












David M Berman  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pak H, Gourgiotis L, Chang WI, Guthrie LC, Skarulis MC, Reynolds JC, Merino MJ, Schrump DS, Libutti SK, Alexander HR, Sarlis NJ (2003). Role of metastasectomy in the management of thyroid carcinoma: the NIH experience. J Surg Oncol  82, 10-8.   https://doi.org/10.1002/jso.10189




PubMed


 


PubMed ID 12501164",https://intramural.nih.gov/search/searchview.taf?ipid=36547
531,SC009394-11,"October 01, 2003 -  September 30, 2004",Diagnostic Electron Microscopy  (EM),Maria  Tsokos; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Mones  Abu-Asab (National Cancer Institute)



Atif A Ahmed (National Cancer Institute)","Jeffrey Burnett Kopp; MD (NIDDK) 



Forbes D Porter; MD, PhD (NICHD) 



Constantine Argyrios Stratakis; MD, DSc (NICHD)","Ordered by publication type and then author name.



1.
Vaurs-Barriere C, Wong K, Weibel TD, Abu-Asab M, Weiss MD, Kaneski CR, Mixon TH, Bonavita S, Creveaux I, Heiss JD, Tsokos M, Goldin E, Quarles RH, Boespflug-Tanguy O, Schiffmann R (2003). Insertion of mutant proteolipid protein results in missorting of myelin proteins. Ann Neurol  54, 769-80.   https://doi.org/10.1002/ana.10762




PubMed



        
     
Free Article


 


PubMed ID 14681886
         Pubmed Central ID 4294275",https://intramural.nih.gov/search/searchview.taf?ipid=36548
532,SC009431-10,"October 01, 2003 -  September 30, 2004",Histologic and Molecular Characterization of Solid Pediatric Tumors,Maria  Tsokos; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Lynn Rose Sorbara (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)












Atif A Ahmed  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M (2003). Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest  83, 1255-65.   https://doi.org/10.1097/01.lab.0000088856.49388.ea




PubMed


 


PubMed ID 13679433
    
     


 



2.
Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, et al. [14 more authors] (2003). Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res  9, 5442-53.




PubMed


 


PubMed ID 14654523
    
     


 



3.
Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA (2003). Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene  22, 2334-42.   https://doi.org/10.1038/sj.onc.1206330




PubMed


 


PubMed ID 12700668",https://intramural.nih.gov/search/searchview.taf?ipid=36549
533,SC010051-09,"October 01, 2003 -  September 30, 2004",Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy,"Martin W Brechbiel; PhD



IRP Faculty Profile",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,"Diane E Milenic (National Cancer Institute)



James B Mitchell; PhD (National Cancer Institute)



Peter L Choyke; MD (Center for Cancer Research)



Merrill C. Miller; PhD (National Cancer Institute)",Robert  Star; MD (NIDDK),"Ordered by publication type and then author name.



1.
Kobayashi H, Brechbiel MW (2003). Dendrimer-based macromolecular MRI contrast agents: characteristics and application. Mol Imaging  2, 1-10.   https://doi.org/10.1162/153535003765276237




PubMed


 


PubMed ID 12926232
    
     


 



2.
Kobayashi H, Kawamoto S, Brechbiel MW, Jo SK, Hu X, Yang T, Diwan BA, Waldmann TA, Schnermann J, Choyke PL, Star RA (2004). Micro-MRI methods to detect renal cysts in mice. Kidney Int  65, 1511-6.   https://doi.org/10.1111/j.1523-1755.2004.00532.x




PubMed


 


PubMed ID 15086495
    
     


 



3.
Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW (2003). Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn Reson Med  50, 758-66.   https://doi.org/10.1002/mrm.10583




PubMed


 


PubMed ID 14523962
    
     


 



4.
Kobayashi H, Kawamoto S, Jo SK, Bryant HL, Brechbiel MW, Star RA (2003). Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem  14, 388-94.   https://doi.org/10.1021/bc025633c




PubMed


 


PubMed ID 12643749
    
     


 



5.
Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst  96, 703-8.   https://doi.org/10.1093/jnci/djh124




PubMed


 


PubMed ID 15126607
    
     


 



6.
Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Brechbiel MW, Choyke PL (2003). Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase. Bioconjug Chem  14, 1044-7.   https://doi.org/10.1021/bc034064l




PubMed


 


PubMed ID 13129410
    
     


 



7.
Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW (2003). Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res  63, 271-6.




PubMed


 


PubMed ID 12543772
    
     


 



8.
Mamede M, Saga T, Ishimori T, Higashi T, Sato N, Kobayashi H, Brechbiel MW, Konishi J (2004). Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. J Control Release  95, 133-41.   https://doi.org/10.1016/j.jconrel.2003.11.015




PubMed


 


PubMed ID 15013240
    
     


 



9.
Mamede M, Saga T, Kobayashi H, Ishimori T, Higashi T, Sato N, Brechbiel MW, Konishi J (2003). Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors. Clin Cancer Res  9, 3756-62.




PubMed


 


PubMed ID 14506168
    
     


 



10.
Nguyen TT, Pannu YS, Sung C, Dedrick RL, Walbridge S, Brechbiel MW, Garmestani K, Beitzel M, Yordanov AT, Oldfield EH (2003). Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg  98, 584-90.   https://doi.org/10.3171/jns.2003.98.3.0584




PubMed


 


PubMed ID 12650432
    
     


 



11.
Wang SJ, Brechbiel M, Wiener EC (2003). Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. Invest Radiol  38, 662-8.   https://doi.org/10.1097/01.rli.0000084887.47427.75




PubMed


 


PubMed ID 14501494
    
     


 



12.
Yordanov A, Kobayashi H, English SJ, Reijnders K, Milenic DE, Krisha MC, Mitchell JB, Brechbiel MW    (2003) Gadolinium-Labeled Dendrimers as Biometric Nanoprobes to Detect Vascular Permeability. J Mat Chem. 13:1523-5.",https://intramural.nih.gov/search/searchview.taf?ipid=36550
534,SC010052-09,"October 01, 2003 -  September 30, 2004",Drosophila Model for the Identification of Proteins Involved in Tumor Cell Motil,"Lance A Liotta; MD, PhD",NULL,"Lab Pathlgy, NCI",NULL,NULL,"Eun Jin Koh (National Cancer Institute)



Elizabeth  Woodhouse; PhD (National Cancer Institute)












Timothy  Clair; MS  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Woodhouse EC, Fisher A, Bandle RW, Bryant-Greenwood B, Charboneau L, Petricoin EF, Liotta LA (2003). Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype. Proc Natl Acad Sci U S A  100, 11463-8.   https://doi.org/10.1073/pnas.2031202100




PubMed



        
     
Free Article


 


PubMed ID 14500904
         Pubmed Central ID 208780",https://intramural.nih.gov/search/searchview.taf?ipid=36551
535,SC010056-09,"October 01, 2003 -  September 30, 2004",Mechanisms of Transcriptional Regulation in Activated T-cells,"Kevin  Gardner; MD, PhD",Gordon Lee Hager; PhD,"Laboratory of Receptor Biology and Gene Expression, NCI",NULL,NULL,"Idalia  Montano (National Cancer Institute)



Cynthia  Haggerty (National Cancer Institute)



Ernest S Kawasaki (National Cancer Institute)












Irene  Collins; PhD  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36552
536,SC010058-09,"October 01, 2003 -  September 30, 2004",Regulation of apoptosis in Ewing's sarcoma and neuroblastoma,Maria  Tsokos; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Guang  Li (Radiation Oncology Branch)



Susana  Galli (National Cancer Institute)



Yan  Ren (National Cancer Institute)



Crystal L. Mackall; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ, Tsokos M, Kontny HU, Mackall CL (2004). Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res  64, 8349-56.   https://doi.org/10.1158/0008-5472.CAN-04-1705




PubMed


 


PubMed ID 15548704
    
     


 



2.
Tsokos GC, Tsokos M (2003). The TRAIL to arthritis. J Clin Invest  112, 1315-7.   https://doi.org/10.1172/JCI20297




PubMed



        
     
Free Article


 


PubMed ID 14597758
         Pubmed Central ID 228491 


 



3.
Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ (2003). Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res  63, 1122-9.




PubMed


 


PubMed ID 12615731",https://intramural.nih.gov/search/searchview.taf?ipid=36553
537,SC010065-09,"October 01, 2003 -  September 30, 2004",A Phase I Study of 2-Chlorodeoxyadenosine and Radiation for the Treatment of Hig,"Norman Norman Coleman; MD



IRP Faculty Profile",NULL,"Radiation Onclgy Br, NCI",NULL,NULL,"Eric Y Chuang (National Cancer Institute)



Caroline  Cressey (National Cancer Institute)



Denise  Godette (National Cancer Institute)



Zhanjun  Guo (National Cancer Institute)



Patricia  Joyner (National Cancer Institute)



Shervin  Karimpour (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Camphausen K, Sproull M, Tantama S, Sankineni S, Scott T, Ménard C, Coleman CN, Brechbiel MW (2003). Evaluation of copper chelation agents as anti-angiogenic therapy. Bioorg Med Chem  11, 4287-93.   https://doi.org/10.1016/s0968-0896(03)00401-2




PubMed


 


PubMed ID 12951159
    
     


 



2.
Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW (2003). Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol  170, 6338-47.   https://doi.org/10.4049/jimmunol.170.12.6338




PubMed


 


PubMed ID 12794167
    
     


 



3.
Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K (2004). Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol  22, 499-506.   https://doi.org/10.1200/JCO.2004.07.022




PubMed


 


PubMed ID 14752073
    
     


 



4.
Coleman CN (2003). Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!). Radiology  228, 29-35.   https://doi.org/10.1148/radiol.2281021567




PubMed


 


PubMed ID 12832573
    
     


 



5.
Coleman CN, Blakely WF, Fike JR, MacVittie TJ, Metting NF, Mitchell JB, Moulder JE, Preston RJ, Seed TM, Stone HB, Tofilon PJ, Wong RS (2003). Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res  159, 812-34.   https://doi.org/10.1667/rr3021




PubMed


 


PubMed ID 12751965
    
     


 



6.
Coleman CN, Wallner PE, Abrams JS (2003). Inflammatory breast issue. J Natl Cancer Inst  95, 1182-3.   https://doi.org/10.1093/jnci/djg027




PubMed


 


PubMed ID 12928334
    
     


 



7.
Colevas AD, Brown JM, Hahn S, Mitchell J, Camphausen K, Coleman CN, Radiation Modifier Working Group of the National Cancer Institute (2003). Development of investigational radiation modifiers. J Natl Cancer Inst  95, 646-51.   https://doi.org/10.1093/jnci/95.9.646




PubMed


 


PubMed ID 12734315
    
     


 



8.
Ménard C, Camphausen K, Muanza T, Sears-Crouse N, Smith S, Ben-Josef E, Coleman CN (2003). Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results. Semin Oncol  30, 63-7.   https://doi.org/10.1053/j.seminoncol.2003.11.016




PubMed


 


PubMed ID 14727242
    
     


 



9.
Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ (2003). A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys  55, 1182-5.   https://doi.org/10.1016/s0360-3016(02)04391-2




PubMed


 


PubMed ID 12654425
    
     


 



10.
Menard C, Susil RC, Coleman CN.    (2004) Rad Onc's Big Boost. Advance for Imaging and Oncology Administrators. 14:49-50.




 



11.
Palayoor ST, Tofilon PJ, Coleman CN (2003). Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clin Cancer Res  9, 3150-7.




PubMed


 


PubMed ID 12912967
    
     


 



12.
Stone HB, Coleman CN, Anscher MS, McBride WH (2003). Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol  4, 529-36.   https://doi.org/10.1016/s1470-2045(03)01191-4




PubMed


 


PubMed ID 12965273
    
     


 



13.
Tofilon PJ, Saxman S, Coleman CN (2003). Molecular targets for radiation therapy: bringing preclinical data into clinical trials. Clin Cancer Res  9, 3518-20.




PubMed


 


PubMed ID 14506136
    
     


 



14.
Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P   (2003) CTCAE v30: development of a comprehensive grading system for the adverse effects of cancer treatment.  Semin Radiat Oncol 13:176-81.




PubMed


 


PubMed ID 12903007",https://intramural.nih.gov/search/searchview.taf?ipid=36555
538,SC010074-09,"October 01, 2003 -  September 30, 2004",Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction,"Leonard  Neckers; PhD



IRP Faculty Profile",William Marston Linehan; MD,"Urologic Oncology Br, NCI",NULL,"Daniel  Jay
(Physiology, Tufts Universityq)





Yosef  Yarden
(Biological Regulation, Weizmann Institute of Science)





Brian  Blagg
(Chemistry, University of Kansas)





Luke  Whitesell
(Pediatrics, University of Arizona)





Neal  Rosen
(Medicine, Memorial Sloan Kettering Cancer Center)





David  Toft
(Cell Biology, Mayo Clinic)


Show all 11","Edward G Mimnaugh (National Cancer Institute)



David  Schrump; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Akin C, Fumo G, Yavuz AS, Lipsky PE, Neckers L, Metcalfe DD (2004). A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood  103, 3222-5.   https://doi.org/10.1182/blood-2003-11-3816




PubMed


 


PubMed ID 15070706
    
     


 



2.
Bisht KS, Bradbury CM, Mattson D, Kaushal A, Sowers A, Markovina S, Ortiz KL, Sieck LK, Isaacs JS, Brechbiel MW, Mitchell JB, Neckers LM, Gius D (2003). Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res  63, 8984-95.




PubMed


 


PubMed ID 14695217
    
     


 



3.
Dai Q, Zhang C, Wu Y, McDonough H, Whaley RA, Godfrey V, Li HH, Madamanchi N, Xu W, Neckers L, Cyr D, Patterson C (2003). CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J  22, 5446-58.   https://doi.org/10.1093/emboj/cdg529




PubMed



        
     
Free Article


 


PubMed ID 14532117
         Pubmed Central ID 213783 


 



4.
Fumo G, Akin C, Metcalfe DD, Neckers L (2004). 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells. Blood  103, 1078-84.   https://doi.org/10.1182/blood-2003-07-2477




PubMed


 


PubMed ID 14551138
    
     


 



5.
Isaacs JS, Jung YJ, Neckers L (2004). Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway. J Biol Chem  279, 16128-35.   https://doi.org/10.1074/jbc.M313342200




PubMed


 


PubMed ID 14764593
    
     


 



6.
Isaacs JS, Xu W, Neckers L (2003). Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell  3, 213-7.   https://doi.org/10.1016/s1535-6108(03)00029-1




PubMed


 


PubMed ID 12676580
    
     


 



7.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003). IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J  17, 2115-7.   https://doi.org/10.1096/fj.03-0329fje




PubMed


 


PubMed ID 12958148
    
     


 



8.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L (2003). Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem  278, 7445-52.   https://doi.org/10.1074/jbc.M209804200




PubMed


 


PubMed ID 12488445
    
     


 



9.
Lee YS, Marcu MG, Neckers L (2004). Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin. Chem Biol  11, 991-8.   https://doi.org/10.1016/j.chembiol.2004.05.010




PubMed


 


PubMed ID 15271357
    
     


 



10.
Marcu MG, Neckers LM (2003). The C-terminal half of heat shock protein 90 represents a second site for pharmacologic intervention in chaperone function. Curr Cancer Drug Targets  3, 343-7.   https://doi.org/10.2174/1568009033481804




PubMed


 


PubMed ID 14535286
    
     


 



11.
Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, Gius D, Neckers L (2004). Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther  3, 551-66.




PubMed


 


PubMed ID 15141013
    
     


 



12.
Neckers L (2003). Development of small molecule Hsp90 inhibitors: utilizing both forward and reverse chemical genomics for drug identification. Curr Med Chem  10, 733-9.   https://doi.org/10.2174/0929867033457818




PubMed


 


PubMed ID 12678776
    
     


 



13.
Neckers L, Lee YS (2003). Cancer: the rules of attraction. Nature  425, 357-9.   https://doi.org/10.1038/425357a




PubMed


 


PubMed ID 14508471
    
     


 



14.
Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE (2004). Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin. Cancer Res  64, 286-91.   https://doi.org/10.1158/0008-5472.can-03-1242




PubMed


 


PubMed ID 14729636
    
     


 



15.
Xu W, Yuan X, Jung YJ, Yang Y, Basso A, Rosen N, Chung EJ, Trepel J, Neckers L (2003). The heat shock protein 90 inhibitor geldanamycin and the ErbB inhibitor ZD1839 promote rapid PP1 phosphatase-dependent inactivation of AKT in ErbB2 overexpressing breast cancer cells. Cancer Res  63, 7777-84.




PubMed


 


PubMed ID 14633703",https://intramural.nih.gov/search/searchview.taf?ipid=36556
539,SC010078-09,"October 01, 2003 -  September 30, 2004",Evaluation of Cellular and Humoral Immunity Against Myeloma Idiotype,Larry  Kwak,Ronald E Gress; MD,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,"Saatva  Neelapu (National Cancer Institute)












Jo Anne  Barb  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36557
540,SC010081-09,"October 01, 2003 -  September 30, 2004",Cancer Vaccines for Lymphomas,Larry  Kwak,Ronald E Gress; MD,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,"Saatva  Neelapu (National Cancer Institute)












Jo Anne  Barb  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36558
541,SC010083-08,"October 01, 2003 -  September 30, 2004",Molecular basis for augmentation of host response and understanding genetic risk,"Stephen J Chanock; MD, PhD



IRP Faculty Profile",NULL,"Pediatric Oncology Br, NCI",NULL,"Charles  Perou
(University of North Carolina)





David  Hunter
(Harvard)





Andrew  Olshan; PhD
(Department of Epidemiology, University of North Carolina)





Anne-Lise  Borresen-Dale
(Radium Hospital, Oslo)





John  Curnutte
(DNAX)





Dirk  Roos
(CLB, Amsterdam)


Show all 10","Hans  Erichsen (National Cancer Institute)



David  Nelson; MD, PhD (Metabolism Br)



Sharon Ann Savage (National Cancer Institute)



James G Taylor; MD (National Cancer Institute)



Toralf  Bernig (National Cancer Institute)



Eduardo  Tarazona-Santos (National Cancer Institute)","Steven M Holland; MD (NIAID) 



David  Nelson; PhD (NHGRI)","Ordered by publication type and then author name.



1.
Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ (2004). Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun  5, 461-76.   https://doi.org/10.1038/sj.gene.6364116




PubMed


 


PubMed ID 15306844
    
     


 



2.
Castle PE, Garcia-Closas M, Franklin T, Chanock S, Puri V, Welch R, Rothman N, Vaught J (2003). Effects of electron-beam irradiation on buccal-cell DNA. Am J Hum Genet  73, 646-51.   https://doi.org/10.1086/378077




PubMed



        
     
Free Article


 


PubMed ID 12917795
         Pubmed Central ID 1180689 


 



3.
Chanock S (2003). Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease. Semin Hematol  40, 321-8.   https://doi.org/10.1016/s0037-1963(03)00198-7




PubMed


 


PubMed ID 14582082
    
     


 



4.
Choi EH, Foster CB, Taylor JG, Erichsen HC, Chen RA, Walsh TJ, Anttila VJ, Ruutu T, Palotie A, Chanock SJ (2003). Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis  187, 1153-6.   https://doi.org/10.1086/368345




PubMed


 


PubMed ID 12660931
    
     


 



5.
Choi EH, Nutman TB, Chanock SJ (2003). Genetic variation in immune function and susceptibility to human filariasis. Expert Rev Mol Diagn  3, 367-74.   https://doi.org/10.1586/14737159.3.3.367




PubMed


 


PubMed ID 12779010
    
     


 



6.
De Roos AJ, Smith MT, Chanock S, Rothman N (2004). Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies. IARC Sci Publ   105-25




PubMed


 


PubMed ID 15055293
    
     


 



7.
Eck P, Erichsen HC, Taylor JG, Yeager M, Hughes AL, Levine M, Chanock S (2004). Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet  115, 285-94.   https://doi.org/10.1007/s00439-004-1167-x




PubMed


 


PubMed ID 15316768
    
     


 



8.
Erichsen HC, Chanock SJ (2004). SNPs in cancer research and treatment. Br J Cancer  90, 747-51.   https://doi.org/10.1038/sj.bjc.6601574




PubMed



        
     
Free Article


 


PubMed ID 14970847
         Pubmed Central ID 2410167 


 



9.
Goodman JE, Bowman ED, Chanock SJ, Alberg AJ, Harris CC (2004). Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis  25, 2467-72.   https://doi.org/10.1093/carcin/bgh260




PubMed


 


PubMed ID 15308583
    
     


 



10.
Haque KA, Pfeiffer RM, Beerman MB, Struewing JP, Chanock SJ, Bergen AW (2003). Performance of high-throughput DNA quantification methods. BMC Biotechnol  3, 20.   https://doi.org/10.1186/1472-6750-3-20




PubMed



        
     
Free Article


 


PubMed ID 14583097
         Pubmed Central ID 280658 


 



11.
Hughes AL, Packer B, Welch R, Bergen AW, Chanock SJ, Yeager M (2003). Widespread purifying selection at polymorphic sites in human protein-coding loci. Proc Natl Acad Sci U S A  100, 15754-7.   https://doi.org/10.1073/pnas.2536718100




PubMed



        
     
Free Article


 


PubMed ID 14660790
         Pubmed Central ID 307640 


 



12.
Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, Yeager M, Welch R, Chanock S, Tian L, Chapman RS, Zheng T, Keohavong P, Caporaso N, Rothman N (2004). Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis  25, 2177-81.   https://doi.org/10.1093/carcin/bgh240




PubMed


 


PubMed ID 15284179
    
     


 



13.
Lehrnbecher T, Chanock SJ (2003). Detection of common cytokine and colony stimulating factor gene polymorphisms. Methods Mol Biol  215, 71-93.   https://doi.org/10.1385/1-59259-345-3:71




PubMed


 


PubMed ID 12512292
    
     


 



14.
Lehrnbecher T, Fleischhack G, Hanisch M, Deinlein F, Simon A, Bernig T, Chanock SJ, Klingebiel T (2004). Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia. Haematologica  89, 234-6.




PubMed


 


PubMed ID 15003900
    
     


 



15.
Packer BR, Yeager M, Staats B, Welch R, Crenshaw A, Kiley M, Eckert A, Beerman M, Miller E, Bergen A, Rothman N, Strausberg R, Chanock SJ (2004). SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res  32, D528-32.   https://doi.org/10.1093/nar/gkh005




PubMed



        
     
Free Article


 


PubMed ID 14681474
         Pubmed Central ID 308740 


 



16.
Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC (2004). SNPs, haplotypes, and cancer: applications in molecular epidemiology. Cancer Epidemiol Biomarkers Prev  13, 681-7.




PubMed


 


PubMed ID 15159297
    
     


 



17.
Savage SA, Abnet CC, Haque K, Mark SD, Qiao YL, Dong ZW, Dawsey SM, Taylor PR, Chanock SJ (2004). Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev  13, 1547-9.




PubMed


 


PubMed ID 15342460
    
     


 



18.
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N (2004). Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst  96, 434-42.   https://doi.org/10.1093/jnci/djh075




PubMed


 


PubMed ID 15026468
    
     


 



19.
Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, Sloand E, Young NS (2003). Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood  102, 916-8.   https://doi.org/10.1182/blood-2003-01-0335




PubMed


 


PubMed ID 12676774",https://intramural.nih.gov/search/searchview.taf?ipid=36559
542,SC010084-33,"October 01, 2003 -  September 30, 2004",Pediatric HIV/AIDS Clinical Research,"Robert  Yarchoan; MD



IRP Faculty Profile",NULL,"HIV and AIDS Malignancy Br, NCI",NULL,NULL,"Haven  Battles (National Cancer Institute)



LaKisha  Blocker (National Cancer Institute)



Mary Jo  Vasquez (National Cancer Institute)



Lori  Wiener; PhD, LCSW-C (National Cancer Institute)



Lauren V Wood; MD (National Cancer Institute)



Carol  Worrell (National Cancer Institute)","Rachel I Gafni (NICHD) 



Richard A Koup; MD (NIAID) 



Daniel C Douek; MD (NIAID) 



Chad  Womack; PhD (NIAID)","Ordered by publication type and then author name.



1.
Hazra R, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty JF, Yale K, Poblenz M, Kearney BP, Zhong L, Coakley DF, Blanche S, Bresson JL, Zuckerman JA, Zeichner SL (2004). Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children. Antimicrob Agents Chemother  48, 124-9.   https://doi.org/10.1128/aac.48.1.124-129.2004




PubMed



        
     
Free Article


 


PubMed ID 14693529
         Pubmed Central ID 310184 


 



2.
Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV (2004). Coping styles among families of children with HIV infection. AIDS Care  16, 283-92.   https://doi.org/10.1080/09540120410001665295




PubMed


 


PubMed ID 15203422
    
     


 



3.
Srivastava S, Taylor P, Wood LV, Lee SS, Robinson MR (2004). Post-surgical scleritis associated with the ganciclovir implant. Ophthalmic Surg Lasers Imaging  35, 254-5.




PubMed


 


PubMed ID 15185797
    
     


 



4.
Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S (2004). Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics  114, e235-42.   https://doi.org/10.1542/peds.114.2.e235




PubMed


 


PubMed ID 15286262",https://intramural.nih.gov/search/searchview.taf?ipid=36560
543,SC010087-08,"October 01, 2003 -  September 30, 2004",HIV Molecular Virology and Pathogenesis,"Steven Leonard Zeichner; MD, PhD",Robert  Yarchoan; MD,"HIV and AIDS Malignancy Br, NCI",NULL,"Christian  Brander
(AIDS Research Center, Massachusetts General Hospital)





Gary  Hayward
(Johns Hopkins University, Baltimore, MD)





Hsing-Jien  Kung
(Department of Biological Chemistry, University of California, Davis)





John  Nicholas
(Deparment of Oncology, Johns Hopkins Medical School)





Steve  Piscitelli; PharmD
(Clinical Pharmacology, Virco Lab, Inc)





Jae  Jung
(New England Regional Primate Center, Harvard University)","Genoveffa  Franchini; MD (ANIMAL MODELS and RETROVIRAL VACCINES SECT)



Eric Y Chuang (National Cancer Institute)



Ruth  Pfeiffer; PhD (National Cancer Institute)","Richard A Koup; MD (NIAID) 



Barney S Graham; MD, PhD (NIAID) 



Kuan-Teh  Jeang; PhD, MD (NIAID)","Ordered by publication type and then author name.



1.
Bentley K, Deacon N, Sonza S, Zeichner S, Churchill M (2004). Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription. Arch Virol  149, 2277-94.   https://doi.org/10.1007/s00705-004-0386-8




PubMed


 


PubMed ID 15338321
    
     


 



2.
Hazra R, Balis FM, Tullio AN, DeCarlo E, Worrell CJ, Steinberg SM, Flaherty JF, Yale K, Poblenz M, Kearney BP, Zhong L, Coakley DF, Blanche S, Bresson JL, Zuckerman JA, Zeichner SL (2004). Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children. Antimicrob Agents Chemother  48, 124-9.   https://doi.org/10.1128/aac.48.1.124-129.2004




PubMed



        
     
Free Article


 


PubMed ID 14693529
         Pubmed Central ID 310184 


 



3.
Krishnan V, Zeichner SL (2004). Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency. J Virol  78, 9458-73.   https://doi.org/10.1128/JVI.78.17.9458-9473.2004




PubMed



        
     
Free Article


 


PubMed ID 15308739
         Pubmed Central ID 506933 


 



4.
Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU (2003). Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol  77, 4205-20.   https://doi.org/10.1128/jvi.77.7.4205-4220.2003




PubMed



        
     
Free Article


 


PubMed ID 12634378
         Pubmed Central ID 150665 


 



5.
Suscovich TJ, Paulose-Murphy M, Harlow JD, Chen Y, Thomas SY, Mellott TJ, Walker BD, Scadden DT, Zeichner S, Brander C (2004). Defective immune function of primary effusion lymphoma cells is associated with distinct KSHV gene expression profiles. Leuk Lymphoma  45, 1223-38.   https://doi.org/10.1080/10428190310001643358




PubMed


 


PubMed ID 15360006
    
     


 



6.
Tamula MA, Wolters PL, Walsek C, Zeichner S, Civitello L (2003). Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease. Pediatrics  112, 679-84.   https://doi.org/10.1542/peds.112.3.679




PubMed


 


PubMed ID 12949303
    
     


 



7.
Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S (2004). Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics  114, e235-42.   https://doi.org/10.1542/peds.114.2.e235




PubMed


 


PubMed ID 15286262",https://intramural.nih.gov/search/searchview.taf?ipid=36561
544,SC010090-08,"October 01, 2003 -  September 30, 2004",Fluorescent Pteridine Nucleoside Analogs,"Frank M Balis; MD, PhD",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,"Wolfgang  Pfleiderer
(Organic Chemistry, Konstanz GE)





Jean Claude  Brochon
(Biochemistry, Centre National de la Recherche Scientifique)





Lesley  Davenport
(Biochemistry, Brooklyn College)





Basil  Hanss
(Mt. Sinai University)





Anna  Shchyolkina
(Molecular Biology, Engelhardt Institute of Molecular Biology)





Craig  Martin
(University of Massachusetts)


Show all 10","Yves  Pommier; PhD (National Cancer Institute)



Stuart F J Le Grice; PhD (National Cancer Institute)



Victor  Zhurkin; PhD (National Cancer Institute)












Mary  Hawkins  (National Cancer Institute)",Jay Robert Knutson; PhD (NHLBI),"Ordered by publication type and then author name.



1.
Hawkins ME, Balis FM (2004). Use of pteridine nucleoside analogs as hybridization probes. Nucleic Acids Res  32, e62.   https://doi.org/10.1093/nar/gnh060




PubMed



        
     
Free Article


 


PubMed ID 15090623
         Pubmed Central ID 407840",https://intramural.nih.gov/search/searchview.taf?ipid=36562
545,SC010093-07,"October 01, 2003 -  September 30, 2004",Targeting the Epigenome for the Treatment and Prevention of Thoracic Malignancie,"David  Schrump; MD



IRP Faculty Profile","Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,"Nasser  Altorki
(Thoracic Surgery, Cornell University Medical Center)





Andrew  Dannenberg
(Gastroenterology, Cornell University Medical Center)
















David  Beer
(Thoracic Surgery, University of Michigan)","Ana  Hancox (National Cancer Institute)



Julie A Hong (National Cancer Institute)



Tricia  Kunst (National Cancer Institute)



Vitaliy  Pishchik (National Cancer Institute)



Jane Beth Trepel (Cell Signaling And Oncogenesis Sect)



Shirley  Thomas (National Cancer Institute)",Victor  Lobanenkov (NIAID),"Ordered by publication type and then author name.



1.
Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M (2003). Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest  83, 1255-65.   https://doi.org/10.1097/01.lab.0000088856.49388.ea




PubMed


 


PubMed ID 13679433
    
     


 



2.
Finkelstein SE, Schrump DS, Nguyen DM, Hewitt SM, Kunst TF, Summers RM (2003). Comparative evaluation of super high-resolution CT scan and virtual bronchoscopy for the detection of tracheobronchial malignancies. Chest  124, 1834-40.   https://doi.org/10.1378/chest.124.5.1834




PubMed


 


PubMed ID 14605057
    
     


 



3.
Finkelstein SE, Schrump DS, Nguyen DM, Mullick R, Summers RM (2003). Novel thoracic imaging augments diagnosis of bronchial obstruction. Ann Thorac Surg  76, 296.   https://doi.org/10.1016/s0003-4975(02)04386-2




PubMed


 


PubMed ID 12842569
    
     


 



4.
Finkelstein SE, Summers RM, Nguyen DM, Schrump DS (2004). Virtual bronchoscopy for evaluation of airway disease. Thorac Surg Clin  14, 79-86.   https://doi.org/10.1016/S1547-4127(04)00037-4




PubMed


 


PubMed ID 15382311
    
     


 



5.
Nguyen DM, Chen GA, Reddy R, Tsai W, Schrump WD, Cole G, Schrump DS (2004). Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J Thorac Cardiovasc Surg  127, 365-75.   https://doi.org/10.1016/j.jtcvs.2003.09.033




PubMed


 


PubMed ID 14762343
    
     


 



6.
Nguyen DM, Schrump DS (2004). Growth factor receptors as targets for lung cancer therapy. Semin Thorac Cardiovasc Surg  16, 3-12.   https://doi.org/10.1053/j.semtcvs.2003.12.002




PubMed


 


PubMed ID 15366682
    
     


 



7.
Nguyen DM, Schrump WD, Chen GA, Tsai W, Nguyen P, Trepel JB, Schrump DS (2004). Abrogation of p21 expression by flavopiridol enhances depsipeptide-mediated apoptosis in malignant pleural mesothelioma cells. Clin Cancer Res  10, 1813-25.   https://doi.org/10.1158/1078-0432.ccr-0901-3




PubMed


 


PubMed ID 15014036
    
     


 



8.
Nguyen DM, Schrump WD, Tsai WS, Chen A, Stewart JH, Steiner F, Schrump DS (2003). Enhancement of depsipeptide-mediated apoptosis of lung or esophageal cancer cells by flavopiridol: activation of the mitochondria-dependent death-signaling pathway. J Thorac Cardiovasc Surg  125, 1132-42.   https://doi.org/10.1067/mtc.2003.180




PubMed


 


PubMed ID 12771887
    
     


 



9.
Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM (2004). Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand. J Thorac Cardiovasc Surg  128, 883-91.   https://doi.org/10.1016/j.jtcvs.2004.06.036




PubMed


 


PubMed ID 15573073
    
     


 



10.
Schrump DS (2004). Genomic surgery for lung cancer. J Surg Res  117, 107-13.   https://doi.org/10.1016/j.jss.2003.11.024




PubMed


 


PubMed ID 15013720",https://intramural.nih.gov/search/searchview.taf?ipid=36475
546,SC010095-08,"October 01, 2003 -  September 30, 2004",Molecular Genetics of Prostate Cancer,"William Marston Linehan; MD



IRP Faculty Profile",NULL,"Urologic Oncology Br, NCI",NULL,NULL,Cliona  Stapleton; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF, Emmert-Buck MR (2003). Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications. Proteomics  3, 413-21.   https://doi.org/10.1002/pmic.200390056




PubMed


 


PubMed ID 12687609
    
     


 



2.
Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR (2003). Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol  12, 63-70.   https://doi.org/10.1097/00019606-200306000-00001




PubMed


 


PubMed ID 12766610
    
     


 



3.
Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD (2004). Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer. J Clin Oncol  22, 2532-9.   https://doi.org/10.1200/JCO.2004.05.074




PubMed


 


PubMed ID 15226321
    
     


 



4.
Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CP, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF (2003). Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics  3, 2142-6.   https://doi.org/10.1002/pmic.200300598




PubMed


 


PubMed ID 14595813
    
     


 



5.
Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA (2004). Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate  60, 25-31.   https://doi.org/10.1002/pros.20013




PubMed


 


PubMed ID 15129426",https://intramural.nih.gov/search/searchview.taf?ipid=36564
547,SC010097-05,"October 01, 2003 -  September 30, 2004",Inflammatory Breast Cancer,Sandra M Swain; MD,NULL,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Jennifer A Low (National Cancer Institute)



Suparna B Wedam (National Cancer Institute)












Allyson  Parr  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36565
548,SC010100-05,"October 01, 2003 -  September 30, 2004",Developmental Therapeutics for Improved Treatment of Tumors of the Central Nervo,"Howard A Fine; MD, PhD",NULL,"Neuro-Oncology Branch, NCI","Ai-Min  Hui



Dan  Xi; PhD","Frank  Lieberman
(Cancer Institute, University of Pittsburgh)





W.K. Alfred  Yung
(Department of Neuro-Oncology, M.D. Anderson Cancer Center)





Mark  Gilbert
(Department of Neuro-Oncology, M.D. Anderson Cancer Center)





Minesh  Mehta
(University of Wisconsin Hospital)





John  Kuhn
(UTHSC, San Antonio)





Timothy  Cloughesy
(University of California, Los Angeles)


Show all 19","Lyndon J Kim (National Cancer Institute)



David  Kobiler (National Cancer Institute)



Jeongwu  Lee (National Cancer Institute)



Sandra  Pastorino (National Cancer Institute)



Benjamin  Purow (National Cancer Institute)



Jessica  Rosewag (National Cancer Institute)","John Keenam Park (NINDS) 



Joseph A Frank; MD, MS (CC) 



Edward H. Oldfield; MD (NINDS)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36567
549,SC010277-07,"October 01, 2003 -  September 30, 2004",Chemokines in Skin Immune Cell Trafficking & Cancer Progression,"Sam  Hwang; MD, PhD",Mark  Udey; MD,"Office of the Director, NCI",NULL,NULL,"Phillip A Dennis; MD, PhD (National Cancer Institute)



Steven Frank Goldberg (National Cancer Institute)



Meilan  Zhao; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Blauvelt A, Hwang ST, Udey MC (2003). 11. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol  111, S560-70.   https://doi.org/10.1067/mai.2003.78




PubMed


 


PubMed ID 12592302
    
     


 



2.
Cardones AR, Murakami T, Hwang ST (2003). CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res  63, 6751-7.




PubMed


 


PubMed ID 14583470
    
     


 



3.
Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, Castillo SS, Dennis PA, Hwang ST (2003). Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med  198, 1337-47.   https://doi.org/10.1084/jem.20030593




PubMed



        
     
Free Article


 


PubMed ID 14581607
         Pubmed Central ID 2194242 


 



4.
Sikder H, Huso DL, Zhang H, Wang B, Ryu B, Hwang ST, Powell JD, Alani RM (2003). Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell  4, 291-9.   https://doi.org/10.1016/s1535-6108(03)00245-9




PubMed


 


PubMed ID 14585356
    
     


 



5.
Yao L, Salvucci O, Cardones AR, Hwang ST, Aoki Y, De La Luz Sierra M, Sajewicz A, Pittaluga S, Yarchoan R, Tosato G (2003). Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood  102, 3900-5.   https://doi.org/10.1182/blood-2003-02-0641




PubMed


 


PubMed ID 12907452",https://intramural.nih.gov/search/searchview.taf?ipid=36568
550,SC010278-07,"October 01, 2003 -  September 30, 2004",Waldenstrom's Macroglobulinemia,"Walter M Kuehl; MD, PhD",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,NULL,"Fernando  Polack; MD (National Cancer Institute)












Leslie Ann Brents  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36569
551,SC010279-07,"October 01, 2003 -  September 30, 2004",Mechanisms of effector activation by the RAS oncogene,Geoffrey J Clark; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,NULL,NULL,"Ordered by publication type and then author name.



1.
Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ (2003). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem  278, 28045-51.   https://doi.org/10.1074/jbc.M300554200




PubMed


 


PubMed ID 12732644
    
     


 



2.
Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ (2003). The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem  278, 21938-43.   https://doi.org/10.1074/jbc.M211019200




PubMed


 


PubMed ID 12676952",https://intramural.nih.gov/search/searchview.taf?ipid=36570
552,SC010280-07,"October 01, 2003 -  September 30, 2004",The role of Ras-related proteins in transformation,Geoffrey J Clark; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Nicholas  Nassar
(Biochemistry, SUNY)
















lawrence  quilliam
(Biochemistry, university of Indianna)",Thomas  Kensler; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ (2003). RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem  278, 28045-51.   https://doi.org/10.1074/jbc.M300554200




PubMed


 


PubMed ID 12732644",https://intramural.nih.gov/search/searchview.taf?ipid=36571
553,SC010281-07,"October 01, 2003 -  September 30, 2004",Biology and Therapy of T Cell Depletion,Crystal L. Mackall; MD,NULL,"National Cancer Institute, NCI","Hua  Zhang



John J Letterio; MD



Ronald E Gress; MD



Jay Arthur Berzofsky; MD, PhD



Lee Jay Helman; MD","William E Paul; MD
(NIAID)





Michel  Morre
(CYTHERIS, INC)
















Warren J Leonard; MD
(NHLBI)",NULL,"Daniel C Douek; MD (NIAID) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Al-Shami A, Spolski R, Kelly J, Fry T, Schwartzberg PL, Pandey A, Mackall CL, Leonard WJ (2004). A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med  200, 159-68.   https://doi.org/10.1084/jem.20031975




PubMed



        
     
Free Article


 


PubMed ID 15263024
         Pubmed Central ID 2212020 


 



2.
Bolan CD, Yau YY, Cullis HC, Horwitz ME, Mackall CL, Barrett AJ, Malech HL, Rehak NN, Wayne AS, Leitman SF (2004). Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion  44, 229-38.   https://doi.org/10.1111/j.1537-2995.2004.00668.x




PubMed


 


PubMed ID 14962314
    
     


 



3.
El Kassar N, Lucas PJ, Klug DB, Zamisch M, Merchant M, Bare CV, Choudhury B, Sharrow SO, Richie E, Mackall CL, Gress RE (2004). A dose effect of IL-7 on thymocyte development. Blood  104, 1419-27.   https://doi.org/10.1182/blood-2004-01-0201




PubMed


 


PubMed ID 15155461
    
     


 



4.
Fry TJ, Moniuszko M, Creekmore S, Donohue SJ, Douek DC, Giardina S, Hecht TT, Hill BJ, Komschlies K, Tomaszewski J, Franchini G, Mackall CL (2003). IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood  101, 2294-9.   https://doi.org/10.1182/blood-2002-07-2297




PubMed


 


PubMed ID 12411295
    
     


 



5.
Fry TJ, Sinha M, Milliron M, Chu YW, Kapoor V, Gress RE, Thomas E, Mackall CL (2004). Flt3 ligand enhances thymic-dependent and thymic-independent immune reconstitution. Blood  104, 2794-800.   https://doi.org/10.1182/blood-2003-11-3789




PubMed


 


PubMed ID 15226184
    
     


 



6.
Min B, McHugh R, Sempowski GD, Mackall C, Foucras G, Paul WE (2003). Neonates support lymphopenia-induced proliferation. Immunity  18, 131-40.   https://doi.org/10.1016/s1074-7613(02)00508-3




PubMed


 


PubMed ID 12530982
    
     


 



7.
Moniuszko M, Fry T, Tsai WP, Morre M, Assouline B, Cortez P, Lewis MG, Cairns S, Mackall C, Franchini G (2004). Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol  78, 9740-9.   https://doi.org/10.1128/JVI.78.18.9740-9749.2004




PubMed



        
     
Free Article


 


PubMed ID 15331707
         Pubmed Central ID 515001",https://intramural.nih.gov/search/searchview.taf?ipid=36572
554,SC010282-07,"October 01, 2003 -  September 30, 2004",Cytogenetic Studies of B-cell Chronic Lymphocytic Leukemia (B-CLL),Diane Carol Arthur; MD,"Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Neil Edward Caporaso; MS, MD (National Cancer Institute)



Louis  Staudt; MD (Lymphoid Malignancies Branch)



Maryalice  Stetler-Stevenson; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Rosenwald A, Chuang EY, Davis RE, Wiestner A, Alizadeh AA, Arthur DC, Mitchell JB, Marti GE, Fowler DH, Wilson WH, Staudt LM (2004). Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression response. Blood  104, 1428-34.   https://doi.org/10.1182/blood-2003-09-3236




PubMed


 


PubMed ID 15138159
    
     


 



2.
Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003). ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood  101, 4944-51.   https://doi.org/10.1182/blood-2002-10-3306




PubMed


 


PubMed ID 12595313",https://intramural.nih.gov/search/searchview.taf?ipid=36573
555,SC010288-07,"October 01, 2003 -  September 30, 2004",Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy,Daniel H Fowler,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,"Carl  June
(Abramson Family Cancer Research Center, University of Pennsylvania)





Jeff  Medin
(Dept. of Molecular Therapy, University of Toronto Cancer Institute)





Bruce  Levine
(Abramson Family Cancer Research Center, University of Pennsylvania)","J  Foley (National Cancer Institute)



Michael R Bishop; MD (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)","Charles S Carter (CC) 



Elizabeth J Read; MD (CC)","Ordered by publication type and then author name.



1.
Bishop MR, Hou JW, Wilson WH, Steinberg SM, Odom J, Castro K, Kasten-Sportes C, Gea-Banacloche J, Marchigiani D, Gress R, Fowler DH (2003). Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biol Blood Marrow Transplant  9, 162-9.   https://doi.org/10.1053/bbmt.2003.50008




PubMed


 


PubMed ID 12652466
    
     


 



2.
Jung U, Foley JE, Erdmann AA, Eckhaus MA, Fowler DH (2003). CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects. Blood  102, 3439-46.   https://doi.org/10.1182/blood-2002-12-3936




PubMed


 


PubMed ID 12855580",https://intramural.nih.gov/search/searchview.taf?ipid=36574
556,SC010289-06,"October 01, 2003 -  September 30, 2004",Immunobiology and Immunotherapy of Pediatric Tumors,Crystal L. Mackall; MD,NULL,"Pediatric Oncology Branch, NCI",NULL,"Nai-Kong  Cheung
(Memorial Sloan Kettering Cancer Center)





H. Udo  Kontny
(University of Freiburg, Germany)





Norma Lynn  Fox
(Human Genome Sciences, Inc.)





Avi  Ashkenazi
(Genentech, Inc.)
















Carl  June
(Abramson Family Cancer Research Center, University of Pennsylvania)","Hua  Zhang (National Cancer Institute)



Lee Jay Helman; MD (National Cancer Institute)



Maria  Tsokos; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Jon Marc Wigginton; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA (2003). Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene  22, 2334-42.   https://doi.org/10.1038/sj.onc.1206330




PubMed


 


PubMed ID 12700668
    
     


 



2.
Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ (2003). Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res  63, 1122-9.




PubMed


 


PubMed ID 12615731
    
     


 



3.
Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL (2003). Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther  2, 579-86.   https://doi.org/10.4161/cbt.2.5.545




PubMed


 


PubMed ID 14614331",https://intramural.nih.gov/search/searchview.taf?ipid=36575
557,SC010292-06,"October 01, 2003 -  September 30, 2004",Identification and regulation of signal transduction pathways that promote survi,"Phillip A Dennis; MD, PhD",Sandra M Swain; MD,"Cancer Therapeutics Branch, NCI",NULL,NULL,"Curtis  Harris; MD (National Cancer Institute)



Ilona  Linnoila; MD (National Cancer Institute)



Peter  Blumberg; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bianco R, Shin I, Ritter CA, Yakes FM, Basso A, Rosen N, Tsurutani J, Dennis PA, Mills GB, Arteaga CL (2003). Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene  22, 2812-22.   https://doi.org/10.1038/sj.onc.1206388




PubMed


 


PubMed ID 12743604
    
     


 



2.
Clark AS, West KA, Blumberg PM, Dennis PA (2003). Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. Cancer Res  63, 780-6.




PubMed


 


PubMed ID 12591726
    
     


 



3.
Gills JJ, Granville CA, Dennis PA (2004). Targeting aberrant signal transduction pathways in lung cancer. Cancer Biol Ther  3, 147-55.   https://doi.org/10.4161/cbt.3.2.612




PubMed


 


PubMed ID 14764993
    
     


 



4.
Lorenzo PS, Dennis PA (2003). Modulating protein kinase C (PKC) to increase the efficacy of chemotherapy: stepping into darkness. Drug Resist Updat  6, 329-39.   https://doi.org/10.1016/j.drup.2003.10.003




PubMed


 


PubMed ID 14744497
    
     


 



5.
Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, Castillo SS, Dennis PA, Hwang ST (2003). Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med  198, 1337-47.   https://doi.org/10.1084/jem.20030593




PubMed



        
     
Free Article


 


PubMed ID 14581607
         Pubmed Central ID 2194242",https://intramural.nih.gov/search/searchview.taf?ipid=36576
558,SC010294-06,"October 01, 2003 -  September 30, 2004",APPROACHES TO ENHANCE CANCER GENE THERAPY,John Charles Morris; MD,NULL,"Metabolism Br, NCI",NULL,"Guido  Forni
(Clinical and Biological Sciences, University of Turin)
















Charles  Link
(NewLink Genetics, Inc.)","Thomas Alexander Waldmann; MD, PhD (National Cancer Institute)



Jay Arthur Berzofsky; MD, PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE, Morris JC (2004). Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest  113, 1515-25.   https://doi.org/10.1172/JCI21926




PubMed



        
     
Free Article


 


PubMed ID 15173875
         Pubmed Central ID 419494 


 



2.
Kobayashi H, Kawamoto S, Sakai Y, Choyke PL, Star RA, Brechbiel MW, Sato N, Tagaya Y, Morris JC, Waldmann TA (2004). Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J Natl Cancer Inst  96, 703-8.   https://doi.org/10.1093/jnci/djh124




PubMed


 


PubMed ID 15126607
    
     


 



3.
Morris JC (2003). Cancer gene therapy: lessons learned from experiences with chemotherapy. Mol Ther  7, 717-9.   https://doi.org/10.1016/s1525-0016(03)00156-4




PubMed


 


PubMed ID 12803174
    
     


 



4.
Wolkersdörfer GW, Morris JC, Ehninger G, Ramsey WJ (2004). Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma. J Gene Med  6, 652-62.   https://doi.org/10.1002/jgm.551




PubMed


 


PubMed ID 15170736",https://intramural.nih.gov/search/searchview.taf?ipid=36577
559,SC010298-06,"October 01, 2003 -  September 30, 2004",Identification of patterns and mechanisms of chromosomal aberrations in hematolo,"Karl Thomas Ried; MD



IRP Faculty Profile",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,NULL,"Michael John Difilippantonio; PhD (National Cancer Institute)



Jens  Habermann (National Cancer Institute)



Kerstin  Heselmeyer (Cancer Genetics Branch)



Turid  Knutsen (National Cancer Institute)



Nicole E Mcneil (National Cancer Institute)



Cristina  Montagna (National Cancer Institute)","Karl  Sirotkin (NLM) 



Vemulkonda Koneti Rao; MD, FRCPA (NIAID)","Ordered by publication type and then author name.



1.
Montagna C, Lyu MS, Hunter K, Lukes L, Lowther W, Reppert T, Hissong B, Weaver Z, Ried T (2003). The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res  63, 2179-87.




PubMed


 


PubMed ID 12727837",https://intramural.nih.gov/search/searchview.taf?ipid=36578
560,SC010299-06,"October 01, 2003 -  September 30, 2004",Consequences of chromosomal aneuploidy on the cancer transcriptome,"Karl Thomas Ried; MD



IRP Faculty Profile",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,NULL,"Anitha  Clarence (National Cancer Institute)



Michael John Difilippantonio; PhD (National Cancer Institute)



Jens  Habermann (National Cancer Institute)



Nicole E Mcneil (National Cancer Institute)



Cristina  Montagna (National Cancer Institute)



Hesed M Padilla Nash (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36579
561,SC010300-06,"October 01, 2003 -  September 30, 2004",Translational genomics,"Karl Thomas Ried; MD



IRP Faculty Profile",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,NULL,"Linda I Stapleton (National Cancer Institute)



Philip E Castle; PhD, MPH (National Cancer Institute)



David  Danforth (National Cancer Institute)



Mark E Sherman; MD (National Cancer Institute)","Alejandro Alberto Schaffer; PhD (NLM) 



Richard Mark Desper (NLM)","Ordered by publication type and then author name.



1.
Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T (2003). Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am J Pathol  163, 1405-16.   https://doi.org/10.1016/S0002-9440(10)63498-0




PubMed



        
     
Free Article


 


PubMed ID 14507648
         Pubmed Central ID 1868295",https://intramural.nih.gov/search/searchview.taf?ipid=36580
562,SC010353-05,"October 01, 2003 -  September 30, 2004",Experimental therapeutics of pediatric hematopoietic malignancies,Alan S Wayne; MD,Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,"Rupert  Handgretinger
(Hematology/Oncology, St. Jude Children's Research Hospital)
















Cynthia  Schwartz
(Pediatric Oncology, Johns Hopkins University)","Michael R Bishop; MD (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Frances  Hakim; PhD (National Cancer Institute)



Crystal L. Mackall; MD (Pediatric Oncology Branch)



John  Janik; MD (Lymphoid Malignancies Branch)","Austin John Barrett; MD (NHLBI) 



Stephen E Straus; MD (NIAID) 



Roger  Kurlander; MD (CC) 



Elizabeth J Read; MD (CC) 



Charles S Carter (CC)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36581
563,SC010354-05,"October 01, 2003 -  September 30, 2004",Clinical development of novel drugs for children with cancer and neurofibromatos,"Brigitte  Widemann; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI","Elizabeth  Fox; MD



Katherine Elizabeth Warren; MD","Susan  Blaney
(Pediatric Oncology, Baylor Univ.)





Peter Charles Adamson; MD






Robert  Arceci
(Pediatrics, Johns Hopkins)





Bruce  Korf
(Genetics, University of Alabama Birmingham)





Mark  Kieran; MD, PhD
(Pediatrics, Dana Farber Cancer Institute)





Roger  Packer
(Neurology, Children's Natl. Med. Ctr.)


Show all 9","Eva  Dombi (National Cancer Institute)



Tito  Fojo (National Cancer Institute)












Frank M Balis; MD, PhD  (Pharmclgy And Experimental Therapeutics Sect)",Jo Anne N Zujewski (CC),"Ordered by publication type and then author name.



1.
Abraham J, Agrawal M, Bakke S, Rutt A, Edgerly M, Balis FM, Widemann B, Davis L, Damle B, Sonnichsen D, Lebwohl D, Bates S, Kotz H, Fojo T (2003). Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days. J Clin Oncol  21, 1866-73.   https://doi.org/10.1200/JCO.2003.03.063




PubMed


 


PubMed ID 12721265
    
     


 



2.
Salzer W, Steinberg SM, Liewehr DJ, Freifeld A, Balis FM, Widemann BC (2003). Evaluation and treatment of fever in the non-neutropenic child with cancer. J Pediatr Hematol Oncol  25, 606-12.   https://doi.org/10.1097/00043426-200308000-00004




PubMed


 


PubMed ID 12902912",https://intramural.nih.gov/search/searchview.taf?ipid=36582
564,SC010355-05,"October 01, 2003 -  September 30, 2004",Angiogenesis and Tumor Growth,"Giovanna  Tosato; PhD



IRP Faculty Profile",Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,"Matilde  Costa (National Cancer Institute)



Hyun Kyung Kyun Kim (National Cancer Institute)



Cassin Elizabeth Kimmel; BS (National Cancer Institute)



Maria N Labo (National Cancer Institute)



Takayuki  Nakayama (National Cancer Institute)



Masashi  Narazaki (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36583
565,SC010356-05,"October 01, 2003 -  September 30, 2004",A Role for KSHV (Kaposi's Sarcoma-associated Herpesvirus) in the Pathogenesis of,"Giovanna  Tosato; PhD



IRP Faculty Profile",Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,"Matilde  Costa (National Cancer Institute)



Hyun Kyung Kyun Kim (National Cancer Institute)



Cassin Elizabeth Kimmel; BS (National Cancer Institute)



Maria N Labo (National Cancer Institute)



Takayuki  Nakayama (National Cancer Institute)



Masashi  Narazaki (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36584
566,SC010357-05,"October 01, 2003 -  September 30, 2004",Oncovirus gene expression and tumorigenesis,"Zhi Ming  Zheng; MD, PhD



IRP Faculty Profile",Robert  Yarchoan; MD,"HIV and AIDS Malignancy Br, NCI",NULL,"Akila  Mayeda
(Department of Biochemistry and Molecular Biology, University of Miami School of Medicine)





Shou-Jiang  Gao
(University of Texas)
















Elliot  Androphy
(Medicine, University of Massachusetts Medical School)","Lauren V Wood; MD (National Cancer Institute)



Barbara  Detrick; PhD (National Cancer Institute)












Michael John Kruhlak; PhD  (Experimental Immunology Branch)",John Philip McCoy (NHLBI),"Ordered by publication type and then author name.



1.
Liu X, Mayeda A, Tao M, Zheng ZM (2003). Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J Virol  77, 2105-15.   https://doi.org/10.1128/jvi.77.3.2105-2115.2003




PubMed



        
     
Free Article


 


PubMed ID 12525645
         Pubmed Central ID 140879 


 



2.
Tang S, Yamanegi K, Zheng ZM (2004). Requirement of a 12-base-pair TATT-containing sequence and viral lytic DNA replication in activation of the Kaposi's sarcoma-associated herpesvirus K8.1 late promoter. J Virol  78, 2609-14.   https://doi.org/10.1128/jvi.78.5.2609-2614.2004




PubMed



        
     
Free Article


 


PubMed ID 14963167
         Pubmed Central ID 369211 


 



3.
Tao M, Kruhlak M, Xia S, Androphy E, Zheng ZM (2003). Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J Virol  77, 13232-47.   https://doi.org/10.1128/jvi.77.24.13232-13247.2003




PubMed



        
     
Free Article


 


PubMed ID 14645580
         Pubmed Central ID 296047 


 



4.
Zheng ZM (2003). Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev Med Virol  13, 173-84.   https://doi.org/10.1002/rmv.387




PubMed



        
     
Free Article


 


PubMed ID 12740832
         Pubmed Central ID 4681429 


 



5.
Zheng ZM (2004). Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J Biomed Sci  11, 278-94.   https://doi.org/10.1007/bf02254432




PubMed



        
     
Free Article


 


PubMed ID 15067211
         Pubmed Central ID 2442652 


 



6.
Zheng ZM, Tao M, Yamanegi K, Bodaghi S, Xiao W (2004). Splicing of a cap-proximal human Papillomavirus 16 E6E7 intron promotes E7 expression, but can be restrained by distance of the intron from its RNA 5' cap. J Mol Biol  337, 1091-108.   https://doi.org/10.1016/j.jmb.2004.02.023




PubMed


 


PubMed ID 15046980",https://intramural.nih.gov/search/searchview.taf?ipid=36585
567,SC010359-06,"October 01, 2003 -  September 30, 2004",The Role of Nore1 Class Effectors in Ras Mediated Transformation,Geoffrey J Clark; PhD,Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,"Michael  White
(Biochemistry, UTSouthwestern)





Bin  Teh
(Van Andel Res. Inst.)





Farida  Latif
(University of Birmingham, U.K.)",NULL,NULL,"Ordered by publication type and then author name.



1.
Vos MD, Martinez A, Ellis CA, Vallecorsa T, Clark GJ (2003). The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung. J Biol Chem  278, 21938-43.   https://doi.org/10.1074/jbc.M211019200




PubMed


 


PubMed ID 12676952",https://intramural.nih.gov/search/searchview.taf?ipid=36586
568,SC010360-06,"October 01, 2003 -  September 30, 2004",Molecular Determinants of Faithful Chromosome Transmission and Cell Cycle Regula,"Munira A Basrai; PhD



IRP Faculty Profile",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,"Forrest  Spencer
(Molecular Biology and Genetics, Johns Hopkins School of Medicine)





Roger J. Davis; PhD
( Department of Biochemistry and Molecular Biology, University of Massachusetts Medical School)





Michael  Snyder
(Molecular, Cellular and Developmental Biology, Yale University)





Richard  Wozniak
(Dept. of Cell Biology, Univ. of Alberta)





Grant  Hartzog
(MCD Biology, Univ. of California, Santa Cruz)





Jef D. Boeke
(Department of Molecular Biology and Genetics, Johns Hopkins University)","Carole  Carter (National Cancer Institute)



Michael Joseph Lichten; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Crotti LB, Basrai MA (2004). Functional roles for evolutionarily conserved Spt4p at centromeres and heterochromatin in Saccharomyces cerevisiae. EMBO J  23, 1804-14.   https://doi.org/10.1038/sj.emboj.7600161




PubMed



        
     
Free Article


 


PubMed ID 15057281
         Pubmed Central ID 394231 


 



2.
Kerscher O, Crotti LB, Basrai MA (2003). Recognizing chromosomes in trouble: association of the spindle checkpoint protein Bub3p with altered kinetochores and a unique defective centromere. Mol Cell Biol  23, 6406-18.   https://doi.org/10.1128/mcb.23.18.6406-6418.2003




PubMed



        
     
Free Article


 


PubMed ID 12944469
         Pubmed Central ID 193694",https://intramural.nih.gov/search/searchview.taf?ipid=36587
569,SC010361-05,"October 01, 2003 -  September 30, 2004",Genetic Cancer Vaccines,Larry  Kwak,Ronald E Gress; MD,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,"Saatva  Neelapu (National Cancer Institute)












Jo Anne  Barb  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36588
570,SC010362-05,"October 01, 2003 -  September 30, 2004",Maternal cohort study of the Nurses' Health Studies,Michele  Forman; PhD,Douglas  Lowy; MD,"Genome Structure and Function Section, NCI",NULL,"Karin  Michels
(Brigham Womens Hospital, Harvard University)





Janet  Rich Edwards
(Brigham Womens Hospital, Harvard University)





Graham  Coldizt
(Brigham Womens Hospital, Harvard University)
















Lisa  Colbert
(University of Wisconsin)","Barry Ira Graubard; PhD (National Cancer Institute)












James Carl Barrett; PhD  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Forman MR, Ballard-Barbash R, Kipnis V (2003). Nutritional strategies for breast cancer prevention: what have we learned and where do we go from here? Cancer  98, 1782-5.   https://doi.org/10.1002/cncr.11732




PubMed


 


PubMed ID 14584058",https://intramural.nih.gov/search/searchview.taf?ipid=36589
571,SC010364-04,"October 01, 2003 -  September 30, 2004",Tissue Microarray Design and Development for Novel Gene and Gene Product Screeni,"David Erwin Kleiner; MD, PhD","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"Yvonne  Gathright (National Cancer Institute)



Philip  Taylor; MD, ScD (Cancer Prevention Studies Br)



Stephen M Hewitt; MD, PhD (National Cancer Institute)



Mark  Raffeld; MD (Hematopathlgy Sect)



Kimberly  Tuttle (National Cancer Institute)



Elaine S Jaffe; MD (National Cancer Institute)",J Silvio  Gutkind; PhD (NIDCR),"Ordered by publication type and then author name.



1.
Hewitt SM (submitted in 2004) Template Methods And Devices For Preparing Sample Arrays. Patent issued: 7,854,899 (US in 2011).",https://intramural.nih.gov/search/searchview.taf?ipid=36476
572,SC010365-05,"October 01, 2003 -  September 30, 2004",Investigation of Graft Versus Tumor Effects in Non-hematologic Malignancies,Michael R Bishop; MD,NULL,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,"Kathleen M Castro (National Cancer Institute)



Larry  Kwak (National Cancer Institute)



Daniel H Fowler (National Cancer Institute)



Ronald E Gress; MD (National Cancer Institute)



Richard Barry Hough; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Bishop MR (2003). Nonmyeloablative allogeneic hematopoietic stem cell transplantation for metastatic breast cancer. Clin Breast Cancer  4, 39-45.   https://doi.org/10.3816/cbc.2003.n.010




PubMed


 


PubMed ID 12744757
    
     


 



2.
Bishop MR (2003). The graft-versus-lymphoma effect: fact, fiction, or opportunity? J Clin Oncol  21, 3713-5.   https://doi.org/10.1200/JCO.2003.05.984




PubMed


 


PubMed ID 12963698
    
     


 



3.
Bishop MR, Hou JW, Wilson WH, Steinberg SM, Odom J, Castro K, Kasten-Sportes C, Gea-Banacloche J, Marchigiani D, Gress R, Fowler DH (2003). Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biol Blood Marrow Transplant  9, 162-9.   https://doi.org/10.1053/bbmt.2003.50008




PubMed


 


PubMed ID 12652466
    
     


 



4.
Dean RM, Bishop MR (2003). Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep  2, 287-94.




PubMed


 


PubMed ID 12901325
    
     


 



5.
Navolanic PM, Pui CH, Larson RA, Bishop MR, Pearce TE, Cairo MS, Goldman SC, Jeha SC, Shanholtz CB, Leonard JP, McCubrey JA (2003). Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia  17, 499-514.   https://doi.org/10.1038/sj.leu.2402847




PubMed


 


PubMed ID 12646938",https://intramural.nih.gov/search/searchview.taf?ipid=36590
573,SC010366-04,"October 01, 2003 -  September 30, 2004",Identification of Genes for Predicting Prognosis in Pediatric Cancers,"Javed  Khan; MD



IRP Faculty Profile",Lee Jay Helman; MD,"Pediatric Oncology Br, NCI",NULL,"Daniel  Catchpoole
(Tumor Bank, The Children's Hospital at Westmead)





Frank  Berthold
(Department of Pediatrics, Klinik fr Kinderheilkunde der Universitt zu Kln)





Frank  Westermann
(Department of Tumour Genetics, German Cancer Research Center)
















Manfred  Schwab
(Department of Tumour Genetics, German Cancer Research Center)","Carol J Thiele (Pediatric Oncology Branch)



Glenn  Merlino; PhD (Molecular Genetics Section)



Ilan  Kirsch; MD (Cancer Genetics Branch)



Craig C Whiteford (National Cancer Institute)



Jian-xing  Ma; MD, PhD (National Cancer Institute)



Jon Marc Wigginton; MD (Pediatric Oncology Branch)",NULL,"Ordered by publication type and then author name.



1.
Williams RD, Hing SN, Greer BT, Whiteford CC, Wei JS, Natrajan R, Kelsey A, Rogers S, Campbell C, Pritchard-Jones K, Khan J (2004). Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines. Genes Chromosomes Cancer  41, 65-79.   https://doi.org/10.1002/gcc.20060




PubMed


 


PubMed ID 15236318
    
     


 



2.
Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med  10, 175-81.   https://doi.org/10.1038/nm966




PubMed


 


PubMed ID 14704789",https://intramural.nih.gov/search/searchview.taf?ipid=36591
574,SC010367-04,"October 01, 2003 -  September 30, 2004",Regulation of the cell cycle by cyclin-dependent kinases,Philipp  Kaldis; PhD,Neal G Copeland; PhD,"Mouse Cancer Genetics Program, NCI",NULL,"V  Gallo
(Neuroscience Research Ctr., George Washington University)
















Joe  Baldassare
(Molecular Pharmacology and Physiology, Saint Louis University Medical School)




Dean  Felsher
(Division of Oncology, Stanford University School of Medicine)","Ilan  Kirsch; MD (National Cancer Institute)



Peter F Johnson; PhD (National Cancer Institute)



Jonathan  Keller; PhD (National Cancer Institute)



Gallipali N. Rao; MD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P (2003). Cdk2 knockout mice are viable. Curr Biol  13, 1775-85.   https://doi.org/10.1016/j.cub.2003.09.024




PubMed


 


PubMed ID 14561402",https://intramural.nih.gov/search/searchview.taf?ipid=36592
575,SC010368-04,"October 01, 2003 -  September 30, 2004",Targeting the Tumor Vasculature to Treat Cancer,Steven  Libutti; MD,"Steven Aaron Rosenberg; MD, PhD","Surgy Br, NCI",NULL,"Renata  Pasqualini
(Urology, MD Anderson)





Martha  Zeiger
(Surgery, Johns Hopkins)





Raghu  Kalluri
(Medicine, Beth Israel Hospital)","Mei  He (National Cancer Institute)



David M Sellers (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Choy G, Choyke P, Libutti SK (2003). Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging  2, 303-12.   https://doi.org/10.1162/153535003322750646




PubMed


 


PubMed ID 14717329
    
     


 



2.
Choy G, O'Connor S, Diehn FE, Costouros N, Alexander HR, Choyke P, Libutti SK (2003). Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques  35, 1022-6, 1028-30.   https://doi.org/10.2144/03355rr02




PubMed


 


PubMed ID 14628676
    
     


 



3.
Freedman NM, Sundaram SK, Kurdziel K, Carrasquillo JA, Whatley M, Carson JM, Sellers D, Libutti SK, Yang JC, Bacharach SL (2003). Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. Eur J Nucl Med Mol Imaging  30, 46-53.   https://doi.org/10.1007/s00259-002-0981-4




PubMed


 


PubMed ID 12483409
    
     


 



4.
Hwang JJ, Uchio EM, Pavlovich CP, Pautler SE, Libutti SK, Linehan WM, Walther MM (2003). Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach. J Urol  169, 895-8.   https://doi.org/10.1097/01.ju.0000049518.15260.1f




PubMed


 


PubMed ID 12576808
    
     


 



5.
Keezer SM, Ivie SE, Krutzsch HC, Tandle A, Libutti SK, Roberts DD (2003). Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. Cancer Res  63, 6405-12.




PubMed


 


PubMed ID 14559830
    
     


 



6.
Kurdziel KA, Figg WD, Carrasquillo JA, Huebsch S, Whatley M, Sellers D, Libutti SK, Pluda JM, Dahut W, Reed E, Bacharach SL (2003). Using positron emission tomography 2-deoxy-2-[18F]fluoro-D-glucose, 11CO, and 15O-water for monitoring androgen independent prostate cancer. Mol Imaging Biol  5, 86-93.   https://doi.org/10.1016/s1536-1632(03)00039-8




PubMed


 


PubMed ID 14499149
    
     


 



7.
Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003). von Hippel-Lindau disease. Lancet  361, 2059-67.   https://doi.org/10.1016/S0140-6736(03)13643-4




PubMed


 


PubMed ID 12814730
    
     


 



8.
Oliver VK, Patton AM, Desai S, Lorang D, Libutti SK, Kohn EC (2003). Regulation of the pro-angiogenic microenvironment by carboxyamido-triazole. J Cell Physiol  197, 139-48.   https://doi.org/10.1002/jcp.10350




PubMed


 


PubMed ID 12942550
    
     


 



9.
Libutti S, Mazzanti C, Umbricht C, Zeiger M (submitted in 2004) Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions. Patents issued: 1756303 (FR in 2011); 1756303 (GB in 2011); 7,901,881 (US in 2011); 602005025211 (DE in 2011); 1756303 (EP in 2011). Patents pending: PCT/US2005/12289 (PC application); 13/024,845 (US application).",https://intramural.nih.gov/search/searchview.taf?ipid=36593
576,SC010370-04,"October 01, 2003 -  September 30, 2004",Comparative Genomics of Genes Located on Chromosomes X and Y,Stephen J O'Brien; PhD,NULL,"Laboratory of Genomic Diversity, NCI",NULL,"Scott  Cram
(Los Alamos National Lab, Life Science Division)





Jonathon  Longmire
(Bioscience Division, Los Alamos National Lab)
















Vanessa  King
(Genomic Medicine, The Center for the Advancement of Genomics)","William J. Murphy (Laboratory of Molecular Immunoregulation)



Jill  Slattery (National Cancer Institute)



Alison  Wilkerson (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Pecon-Slattery J, Pearks Wilkerson AJ, Murphy WJ, O'Brien SJ (2004). Phylogenetic assessment of introns and SINEs within the Y chromosome using the cat family felidae as a species tree. Mol Biol Evol  21, 2299-309.   https://doi.org/10.1093/molbev/msh241




PubMed


 


PubMed ID 15329385",https://intramural.nih.gov/search/searchview.taf?ipid=36594
577,SC010371-04,"October 01, 2003 -  September 30, 2004",Mechanisms of Tumor Escape and Metastatic Development in Mouse Models of Experim,Scott  Abrams; PhD,Jeffrey  Schlom; PhD,"Laboratory of Tumor Immunology and Biology, NCI",NULL,NULL,"Elwood W Mcduffie (National Cancer Institute)



Trina  Stewart (National Cancer Institute)












Kebin  Liu  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lindinger P, Mostböck S, Hammerl P, Hartl A, Thalhamer J, Abrams SI (2003). Induction of murine ras oncogene peptide-specific T cell responses by immunization with plasmid DNA-based minigene vectors. Vaccine  21, 4285-96.   https://doi.org/10.1016/s0264-410x(03)00486-9




PubMed


 


PubMed ID 14505911
    
     


 



2.
Liu K, Abrams SI (2003). Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence. J Immunol  170, 5973-80.   https://doi.org/10.4049/jimmunol.170.12.5973




PubMed


 


PubMed ID 12794124
    
     


 



3.
Liu K, Abrams SI (2003). Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma. J Immunol  170, 6329-37.   https://doi.org/10.4049/jimmunol.170.12.6329




PubMed


 


PubMed ID 12794166
    
     


 



4.
Liu K, McDuffie E, Abrams SI (2003). Exposure of human primary colon carcinoma cells to anti-Fas interactions influences the emergence of pre-existing Fas-resistant metastatic subpopulations. J Immunol  171, 4164-74.   https://doi.org/10.4049/jimmunol.171.8.4164




PubMed


 


PubMed ID 14530339",https://intramural.nih.gov/search/searchview.taf?ipid=36595
578,SC010372-04,"October 01, 2003 -  September 30, 2004",Molecular profiling of patients undergoing radiotherapy,"Kevin A Camphausen; MD



IRP Faculty Profile",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,John  Yates; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, O'Reilly MS (2003). Radiation abscopal antitumor effect is mediated through p53. Cancer Res  63, 1990-3.




PubMed


 


PubMed ID 12702593
    
     


 



2.
Chan LW, Camphausen K (2003). Angiogenic tumor markers, antiangiogenic agents and radiation therapy. Expert Rev Anticancer Ther  3, 357-66.   https://doi.org/10.1586/14737140.3.3.357




PubMed


 


PubMed ID 12820778
    
     


 



3.
Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K, Tofilon PJ (2003). Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res  63, 7377-83.




PubMed


 


PubMed ID 14612536",https://intramural.nih.gov/search/searchview.taf?ipid=36596
579,SC010373-04,"October 01, 2003 -  September 30, 2004",The synergy between radiotherapy and molecularly targeted agents,"Kevin A Camphausen; MD



IRP Faculty Profile",Norman Norman Coleman; MD,"Radiation Onclgy Br, NCI",NULL,NULL,Kenichiro  Miura; PhD (National Cancer Institute),NULL,"Ordered by publication type and then author name.



1.
Chan LW, Moses MA, Goley E, Sproull M, Muanza T, Coleman CN, Figg WD, Albert PS, Ménard C, Camphausen K (2004). Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol  22, 499-506.   https://doi.org/10.1200/JCO.2004.07.022




PubMed


 


PubMed ID 14752073",https://intramural.nih.gov/search/searchview.taf?ipid=36597
580,SC010375-04,"October 01, 2003 -  September 30, 2004",Regulation of TAFI Activity by TAF7,"Dinah  Singer; PhD



IRP Faculty Profile",Alfred  Singer; MD,"Experimental Immunology Branch, NCI",NULL,NULL,"Jocelyn D Weissman (National Cancer Institute)



Aparna  Kotekar (National Cancer Institute)



John N Brady; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Howcroft TK, Raval A, Weissman JD, Gegonne A, Singer DS (2003). Distinct transcriptional pathways regulate basal and activated major histocompatibility complex class I expression. Mol Cell Biol  23, 3377-91.   https://doi.org/10.1128/mcb.23.10.3377-3391.2003




PubMed



        
     
Free Article


 


PubMed ID 12724398
         Pubmed Central ID 154244 


 



2.
Raval A, Weissman JD, Howcroft TK, Singer DS (2003). The GTP-binding domain of class II transactivator regulates its nuclear export. J Immunol  170, 922-30.   https://doi.org/10.4049/jimmunol.170.2.922




PubMed


 


PubMed ID 12517958",https://intramural.nih.gov/search/searchview.taf?ipid=36598
581,SC010376-04,"October 01, 2003 -  September 30, 2004",Molecular mechanism of TNF signaling and apoptosis,"Zhenggang  Liu; PhD



IRP Faculty Profile",Kathleen  Kelly; PhD,"Laboratory Of Genitourinary Cancer Pathogenesis, NCI",NULL,NULL,"You Sun  Kim (National Cancer Institute)



Kenya  Lemon (National Cancer Institute)



Michael  Morgan (National Cancer Institute)



Jong Kuk  Park (National Cancer Institute)



Sergei A. Nedospasov; PhD, DSc (National Cancer Institute)












Swati  Choksi  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Devin A, Lin Y, Liu ZG (2003). The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep  4, 623-7.   https://doi.org/10.1038/sj.embor.embor854




PubMed



        
     
Free Article


 


PubMed ID 12776182
         Pubmed Central ID 1319199 


 



2.
Huang Q, Yang J, Lin Y, Walker C, Cheng J, Liu ZG, Su B (2004). Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol  5, 98-103.   https://doi.org/10.1038/ni1014




PubMed


 


PubMed ID 14661019
    
     


 



3.
Hur GM, Lewis J, Yang Q, Lin Y, Nakano H, Nedospasov S, Liu ZG (2003). The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev  17, 873-82.   https://doi.org/10.1101/gad.1062403




PubMed



        
     
Free Article


 


PubMed ID 12654725
         Pubmed Central ID 196033 


 



4.
Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L (2003). Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J  370, 1011-7.   https://doi.org/10.1042/BJ20021279




PubMed



        
     
Free Article


 


PubMed ID 12479793
         Pubmed Central ID 1223232 


 



5.
Kurenova E, Xu LH, Yang X, Baldwin AS, Craven RJ, Hanks SK, Liu ZG, Cance WG (2004). Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol Cell Biol  24, 4361-71.   https://doi.org/10.1128/mcb.24.10.4361-4371.2004




PubMed



        
     
Free Article


 


PubMed ID 15121855
         Pubmed Central ID 400455 


 



6.
Lin Y, Ryan J, Lewis J, Wani MA, Lingrel JB, Liu ZG (2003). TRAF2 exerts its antiapoptotic effect by regulating the expression of Krüppel-like factor LKLF. Mol Cell Biol  23, 5849-56.   https://doi.org/10.1128/mcb.23.16.5849-5856.2003




PubMed



        
     
Free Article


 


PubMed ID 12897154
         Pubmed Central ID 166344 


 



7.
Liu ZG (2003). Adding facets to TNF signaling. The JNK angle. Mol Cell  12, 795-6.   https://doi.org/10.1016/s1097-2765(03)00399-x




PubMed


 


PubMed ID 14580328",https://intramural.nih.gov/search/searchview.taf?ipid=36599
582,SC010378-04,"October 01, 2003 -  September 30, 2004",Activation of Proto-Oncogenes by Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",NULL,"Cancer Genetics Branch, NCI",NULL,"Trang  Hoang
(CRIM)





Keith  Humphries
(Terry Fox Labs)





Kenneth  Gross
(RPCI)","Lino  Tessarollo (National Cancer Institute)



John J Letterio; MD (National Cancer Institute)



Ilan  Kirsch; MD (National Cancer Institute)","Paul P. Liu; MD, PhD (NHGRI)","Ordered by publication type and then author name.



1.
Colaizzo-Anas T, Aplan PD (2003). Cloning and characterization of the SIL promoter. Biochim Biophys Acta  1625, 207-13.   https://doi.org/10.1016/s0167-4781(02)00597-3




PubMed


 


PubMed ID 12531481
    
     


 



2.
Deveney R, Chervinsky DS, Jani-Sait SN, Grossi M, Aplan PD (2003). Insertion of MLL sequences into chromosome band 5q31 results in an MLL-AF5Q31 fusion and is a rare but recurrent abnormality associated with infant leukemia. Genes Chromosomes Cancer  37, 326-31.   https://doi.org/10.1002/gcc.10224




PubMed


 


PubMed ID 12759932
    
     


 



3.
Gurevich RM, Aplan PD, Humphries RK (2004). NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood  104, 1127-36.   https://doi.org/10.1182/blood-2003-10-3550




PubMed


 


PubMed ID 15100157
    
     


 



4.
Levantini E, Giorgetti A, Cerisoli F, Traggiai E, Guidi A, Martin R, Acampora D, Aplan PD, Keller G, Simeone A, Iscove NN, Hoang T, Magli MC (2003). Unsuspected role of the brain morphogenetic gene Otx1 in hematopoiesis. Proc Natl Acad Sci U S A  100, 10299-303.   https://doi.org/10.1073/pnas.1734071100




PubMed



        
     
Free Article


 


PubMed ID 12934017
         Pubmed Central ID 193555 


 



5.
Pineault N, Buske C, Feuring-Buske M, Abramovich C, Rosten P, Hogge DE, Aplan PD, Humphries RK (2003). Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood  101, 4529-38.   https://doi.org/10.1182/blood-2002-08-2484




PubMed


 


PubMed ID 12543865
    
     


 



6.
Ramage JG, Vallera DA, Black JH, Aplan PD, Kees UR, Frankel AE (2003). The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells. Leuk Res  27, 79-84.   https://doi.org/10.1016/s0145-2126(02)00077-2




PubMed


 


PubMed ID 12479856
    
     


 



7.
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE, Byfield S, Felici A, Flanders KC, Walz TM, Roberts AB, Aplan PD, Balis FM, Letterio JJ (2004). Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med  351, 552-9.   https://doi.org/10.1056/NEJMoa031197




PubMed


 


PubMed ID 15295048",https://intramural.nih.gov/search/searchview.taf?ipid=36600
583,SC010379-04,"October 01, 2003 -  September 30, 2004",Mechanisms of Chromosomal Translocation,"Peter D Aplan; MD



IRP Faculty Profile",Ilan  Kirsch; MD,"Cancer Genetics Branch, NCI",NULL,"Carolyn  Felix
(CHOP)





Pieter  deJong
(CHORI)





Linda  Resar
(Johns Hopkins)





Martin  Stanulla
(University of Hannover)",NULL,NULL,"Ordered by publication type and then author name.



1.
Lin YW, Aplan PD (2004). Leukemic transformation. Cancer Biol Ther  3, 13-20.   https://doi.org/10.4161/cbt.3.1.537




PubMed


 


PubMed ID 14726677
    
     


 



2.
Lin YW, Perkins JJ, Zhang Z, Aplan PD (2004). Distinct mechanisms lead to HPRT gene mutations in leukemic cells. Genes Chromosomes Cancer  39, 311-23.   https://doi.org/10.1002/gcc.20005




PubMed


 


PubMed ID 14978792",https://intramural.nih.gov/search/searchview.taf?ipid=36601
584,SC010381-04,"October 01, 2003 -  September 30, 2004",Non-cytotoxic functions of lymphoycte granule exocytosis,Pierre A. Henkart; PhD,NULL,"Experimental Immunology Branch, NCI",NULL,NULL,"Wei  Xiao (National Cancer Institute)



Tatiana  Karpova (National Cancer Institute)



James G McNally; PhD (National Cancer Institute)



Alfred  Singer; MD (National Cancer Institute)












Marta Liliana Catalfamo; PhD  (National Cancer Institute)",NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36602
585,SC010382-04,"October 01, 2003 -  September 30, 2004",Biological Therapy and Modulation of the Tumor Microenvironment: New Strategies,Jon Marc Wigginton; MD,Robert  Wiltrout; PhD,"Pediatric Oncology Br, NCI",NULL,"Robert  Seeger
(Division of Pediatric Hematology-Oncology, Children's Hospital of Los Angeles)





Robert  Kastelein
(Department of Immunology, DNAX Research Institute)





Zdenka  Jonak
(Department of Oncology, Glaxo-Smithkline Pharmaceuticals)





Christine  Slingsby; PhD
(Crystallography, University of London)
















Jocelyn  Holash
(Regeneron Pharmaceuticals)




Paul  Sondel
(Pediatric Hematology-Oncology, University of Wisconsin Comprehensive Cancer Center)","William Marston Linehan; MD (Urologic Oncology Branch)



John  Janik; MD (National Cancer Institute)



Carol J Thiele (National Cancer Institute)



Peter L Choyke; MD (Center for Cancer Research)



Lee Jay Helman; MD (National Cancer Institute)



Thomas Joseph Sayers; PhD (National Cancer Institute)",William T Murphy (OD),"Ordered by publication type and then author name.



1.
Barenboim-Stapleton L, Yang X, Tsokos M, Wigginton JM, Padilla-Nash H, Ried T, Thiele CJ (2005). Pediatric pancreatoblastoma: histopathologic and cytogenetic characterization of tumor and derived cell line. Cancer Genet Cytogenet  157, 109-17.   https://doi.org/10.1016/j.cancergencyto.2004.05.017




PubMed


 


PubMed ID 15721631
    
     


 



2.
Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, et al. [14 more authors] (2003). Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary. Clin Cancer Res  9, 5442-53.




PubMed


 


PubMed ID 14654523
    
     


 



3.
Lee JK, Sayers TJ, Back TC, Wigginton JM, Wiltrout RH (2003). Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer. Apoptosis  8, 151-60.   https://doi.org/10.1023/a:1022918625509




PubMed


 


PubMed ID 12766475
    
     


 



4.
Murphy WJ, Welniak L, Back T, Hixon J, Subleski J, Seki N, Wigginton JM, Wilson SE, Blazar BR, Malyguine AM, Sayers TJ, Wiltrout RH (2003). Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses. J Immunol  170, 2727-33.   https://doi.org/10.4049/jimmunol.170.5.2727




PubMed


 


PubMed ID 12594303
    
     


 



5.
Salcedo R, Stauffer JK, Lincoln E, Back TC, Hixon JA, Hahn C, Shafer-Weaver K, Malyguine A, Kastelein R, Wigginton JM (2004). IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J Immunol  173, 7170-82.   https://doi.org/10.4049/jimmunol.173.12.7170




PubMed


 


PubMed ID 15585838",https://intramural.nih.gov/search/searchview.taf?ipid=36603
586,SC010384-04,"October 01, 2003 -  September 30, 2004",Hematopoietic Stem Cell Gene Therapy for Leukocyte Adhesion Deficiency,"Dennis D Hickstein



IRP Faculty Profile",Ronald E Gress; MD,"Experimental Transplantation and Immunology Branch, NCI",NULL,NULL,NULL,"Robert E Donahue; VMD, MS (NHLBI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36604
587,SC010385-05,"October 01, 2003 -  September 30, 2004",Molecular Classification of Human and Mouse Hepatocellular Carcinoma by Gene Exp,"Snorri S. Thorgeirsson; MD, PhD",NULL,"Laboratory of Experimental Carcinogenesis, NCI",Elizabeth A Conner,"Jozsef  Horti
(Dept. Chemotherapy, National Oncology Institute)





Zongtang  Sun
(Chinese Academy of Medical Sciences)





Antony  Demetris
(Dept. Pathology, University of Pittsburg)





Jan  Raddy
(Dept. Pathology, Northwestern University)
















Tania  Roskams
(Dpt. Pathology, K.U.Leuven University)","Diego F Calvisi (National Cancer Institute)



Valentina  Factor (Cellular and Molecular Biology Section)



Tanya N Hoang (Cellular and Molecular Biology Section)



Ju-Seog  Lee; PhD (National Cancer Institute)












Timothy V Benjamin  (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS (2004). Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology  40, 667-76.   https://doi.org/10.1002/hep.20375




PubMed


 


PubMed ID 15349906",https://intramural.nih.gov/search/searchview.taf?ipid=36605
588,SC010386-03,"October 01, 2003 -  September 30, 2004","Crystallographic Studies of Chemokines, Chemokine Receptors, and Related Protein",Jacek Tadeusz Lubkowski,Alexander  Wlodawer; PhD,"Macromolecular Crystallography Laboratory, NCI",NULL,"Douglas  Cines
(Dept. Pathology and Laboratory medicine, University of Pennsylvania)





Wolfgang  Lockau
(Biochemistry, Humbolt-University)





Wuyuan  Lu
(Institute of Virology, University of Maryland)
















Andrew  Mazar
(Bio-tech company, Attenuon, L.L.C.)",Joost J Oppenheim; MD (National Cancer Institute),NULL,There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36607
589,SC010387-04,"October 01, 2003 -  September 30, 2004",HIV Molecular Biology and DNA Vaccine Approaches Against AIDS,"George N Pavlakis; MD, PhD



IRP Faculty Profile","Jay Arthur Berzofsky; MD, PhD","Human Retrovirus Section, NCI",NULL,"Ralf  Schneider
(GSF-National Research Center for Environment and Health)
















Markus  Neumann
(GSF-National Research Center for Environment and Health)","Antonio L Valentin (National Cancer Institute)



Margherita  Rosati (National Cancer Institute)



Alexander  Wlodawer; PhD (National Cancer Institute)",NULL,"Ordered by publication type and then author name.



1.
Lueders KK, De Rosa SC, Valentin A, Pavlakis GN, Roederer M, Hamer DH (2004). A potent anti-HIV immunotoxin blocks spreading infection by primary HIV type 1 isolates in multiple cell types. AIDS Res Hum Retroviruses  20, 145-50.   https://doi.org/10.1089/088922204773004851




PubMed


 


PubMed ID 15018701",https://intramural.nih.gov/search/searchview.taf?ipid=36606
590,SC010437-04,"October 01, 2003 -  September 30, 2004",Molecular Pathology of Cancer,"Michael R Emmert-Buck; MD, PhD","Lance A Liotta; MD, PhD","Lab Pathlgy, NCI",NULL,NULL,"William Marston Linehan; MD (National Cancer Institute)



Philip  Taylor; MD, ScD (National Cancer Institute)","Francis S Collins; MD, PhD (NHGRI)",There were no publications during this reporting period,https://intramural.nih.gov/search/searchview.taf?ipid=36608
591,SC010438-04,"October 01, 2003 -  September 30, 2004",Immunization of Stem Cell Transplant Donors with Myeloma Antigen Vaccines,Larry  Kwak,Ronald E Gress; MD,"Experimental Transplantation And Immunology Sect, NCI",NULL,NULL,"Saatva  Neelapu (National Cancer Institute)












Jo Anne  Barb  (National Cancer Institute)",NULL,There were no publications associated with this project,https://intramural.nih.gov/search/searchview.taf?ipid=36609
